This
value
set
has
>1000
codes
in
it.
In
order
to
keep
the
publication
size
manageable,
only
a
selection
(1000
codes)
of
the
whole
set
of
codes
is
shown
|
Code
|
Display
|
|
13361-1
|
Semen
analysis
panel
|
|
15129-0
|
Deprecated
Fibrin
D-dimer
EIA
|
|
24313-9
|
Hepatitis
1996
panel
-
Serum
|
|
24314-7
|
TORCH
1996
panel
-
Serum
|
|
24315-4
|
Cytomegalovirus
IgG
and
IgM
panel
-
Serum
|
|
24316-2
|
Epstein
Barr
virus
capsid
IgG
and
IgM
panel
-
Serum
|
|
24317-0
|
Hemogram
and
platelets
WO
differential
panel
-
Blood
|
|
24318-8
|
Manual
Differential
panel
-
Blood
|
|
24319-6
|
Cardiolipin
IgG
and
IgM
panel
-
Serum
|
|
24320-4
|
Basic
metabolic
1998
panel
-
Serum
or
Plasma
|
|
24321-2
|
Basic
metabolic
2000
panel
-
Serum
or
Plasma
|
|
24322-0
|
Comprehensive
metabolic
1998
panel
-
Serum
or
Plasma
|
|
24323-8
|
Comprehensive
metabolic
2000
panel
-
Serum
or
Plasma
|
|
24324-6
|
Hepatic
function
1996
panel
-
Serum
or
Plasma
|
|
24325-3
|
Hepatic
function
2000
panel
-
Serum
or
Plasma
|
|
24326-1
|
Electrolytes
1998
panel
-
Serum
or
Plasma
|
|
24327-9
|
Electrolytes
3
panel
-
Body
fluid
|
|
24328-7
|
Electrolytes
3
panel
-
Stool
|
|
24329-5
|
Electrolytes
3
panel
-
Urine
|
|
24331-1
|
Lipid
1996
panel
-
Serum
or
Plasma
|
|
24332-9
|
Alkaline
phosphatase
isoenz
panel
-
Serum
or
Plasma
|
|
24333-7
|
Amylase
isoenzyme
3
panel
-
Serum
or
Plasma
|
|
24334-5
|
Amylase
isoenzyme
7
panel
-
Serum
|
|
24335-2
|
Creatine
kinase
panel
-
Serum
or
Plasma
|
|
24336-0
|
Gas
panel
-
Arterial
blood
|
|
24337-8
|
Gas
panel
-
Capillary
blood
|
|
24338-6
|
Gas
panel
-
Blood
|
|
24339-4
|
Gas
panel
-
Venous
blood
|
|
24340-2
|
Gas
panel
-
Body
fluid
|
|
24341-0
|
Gas
and
Carbon
monoxide
panel
-
Arterial
blood
|
|
24342-8
|
Gas
and
Carbon
monoxide
panel
-
Capillary
blood
|
|
24343-6
|
Gas
and
Carbon
monoxide
panel
-
Blood
|
|
24344-4
|
Gas
and
Carbon
monoxide
panel
-
Venous
blood
|
|
24345-1
|
Deprecated
Gas
&
CO
panel
|
|
24346-9
|
Parathyrin.intact
and
Calcium
panel
-
Serum
or
Plasma
|
|
24347-7
|
Parathyrin.mid
molecule
and
Calcium
panel
-
Serum
or
Plasma
|
|
24348-5
|
Free
T4
and
TSH
panel
-
Serum
or
Plasma
|
|
24349-3
|
Drugs
of
abuse
5
panel
-
Urine
|
|
24350-1
|
Volatiles
panel
-
Urine
|
|
24351-9
|
Protein
electrophoresis
panel
-
Serum
or
Plasma
|
|
24352-7
|
Protein
electrophoresis
panel
-
Cerebral
spinal
fluid
|
|
24353-5
|
Glucose
tolerance
2
hours
gestational
panel
-
Urine
and
Serum
or
Plasma
|
|
24356-8
|
Urinalysis
complete
panel
-
Urine
|
|
24357-6
|
Urinalysis
macro
(dipstick)
panel
-
Urine
|
|
24358-4
|
Hemogram
without
Platelets
panel
-
Blood
|
|
24359-2
|
Hemogram
without
Platelets
and
with
Manual
Differential
panel
-
Blood
|
|
24360-0
|
Hemoglobin
and
Hematocrit
panel
-
Blood
|
|
24361-8
|
Deprecated
Hemogram,
platelets
&
Differential
panel
in
Blood
|
|
24362-6
|
Renal
function
2000
panel
-
Serum
or
Plasma
|
|
24363-4
|
Acute
hepatitis
2000
panel
-
Serum
Qualitative
|
|
24364-2
|
Obstetric
1996
panel
-
Serum
and
Blood
|
|
24365-9
|
Urinalysis
microscopic
panel
-
Urine
sediment
|
|
29576-6
|
Bacterial
susceptibility
panel
|
|
29577-4
|
Fungal
susceptibility
panel
|
|
29578-2
|
Viral
susceptibility
panel
|
|
29579-0
|
Mycobacterial
susceptibility
panel
|
|
29580-8
|
Differential
panel
-
Body
fluid
|
|
29581-6
|
Differential
panel
-
Peritoneal
fluid
|
|
29582-4
|
Differential
panel
-
Synovial
fluid
|
|
29583-2
|
Differential
panel
-
Pleural
fluid
|
|
29584-0
|
Differential
panel
-
Cerebral
spinal
fluid
|
|
29585-7
|
Immunoelectrophoresis
panel
-
Urine
|
|
29586-5
|
Immunoelectrophoresis
panel
-
Serum
|
|
29587-3
|
Toxicology
panel
-
Blood
|
|
29588-1
|
Heavy
metals
panel
-
Blood
|
|
29589-9
|
Heavy
metals
panel
-
Urine
|
|
34527-2
|
Deprecated
Hemogram,
Platelets,
Differential
&
Reticulocyte
panel
in
Blood
|
|
34528-0
|
PT
panel
-
Platelet
poor
plasma
by
Coagulation
assay
|
|
34529-8
|
PT
and
aPTT
panel
-
Platelet
poor
plasma
by
Coagulation
assay
|
|
34530-6
|
ABO
and
Rh
group
panel
-
Blood
|
|
34531-4
|
Blood
type
and
Crossmatch
panel
-
Blood
|
|
34532-2
|
Blood
type
and
Indirect
antibody
screen
panel
-
Blood
|
|
34534-8
|
EKG
12
channel
panel
|
|
34535-5
|
Microalbumin/Creatinine
panel
in
random
Urine
|
|
34536-3
|
Fluid
intake
and
output
panel
24
hour
|
|
34537-1
|
Fluid
intake
and
output
panel
8
hour
|
|
34539-7
|
Protein
electrophoresis
panel
-
Urine
|
|
34540-5
|
Phenytoin
free
and
total
panel
-
Serum
or
Plasma
|
|
34541-3
|
ACTH
stimulation
test
using
IM
corticosteroids
in
Serum
or
Plasma
|
|
34542-1
|
ACTH
stimulation
test
using
IV
corticosteroids
in
Serum
or
Plasma
|
|
34543-9
|
Bilirubin
direct
and
total
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
34544-7
|
Complement
C3
and
C4
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
34545-4
|
Carbamazepine
free
and
total
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
34546-2
|
Protein
and
Glucose
panel
[Mass/volume]
-
Cerebral
spinal
fluid
|
|
34547-0
|
Complement
profile
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
34548-8
|
Sodium
and
Potassium
panel
[Moles/volume]
-
Serum
or
Plasma
|
|
34549-6
|
Follitropin
and
Lutropin
panel
[Units/volume]
-
Serum
or
Plasma
|
|
34550-4
|
Immunoglobulin
panel
[Mass/volume]
-
Serum
|
|
34551-2
|
Catecholamines
3
panel
[Mass/volume]
-
Plasma
|
|
34552-0
|
2D
echocardiogram
panel
|
|
34553-8
|
Orthostatic
blood
pressure
panel
|
|
34554-6
|
Electrolytes
1998
and
Venous
pH
panel
-
Serum
or
Plasma
+
Blood
venous
|
|
34555-3
|
Creatinine
24H
renal
clearance
panel
|
|
34556-1
|
Cell
count
panel
-
Body
fluid
|
|
34557-9
|
Cell
count
and
Differential
panel
-
Body
fluid
|
|
34558-7
|
Cell
count
panel
-
Peritoneal
fluid
|
|
34559-5
|
Cell
count
panel
-
Synovial
fluid
|
|
34560-3
|
Cell
count
and
Differential
panel
-
Synovial
fluid
|
|
34561-1
|
Cell
count
panel
-
Pleural
fluid
|
|
34562-9
|
Cell
count
and
Differential
panel
-
Pleural
fluid
|
|
34563-7
|
Cell
count
panel
-
Cerebral
spinal
fluid
|
|
34564-5
|
Cell
count
and
Differential
panel
-
Cerebral
spinal
fluid
|
|
34565-2
|
Vital
signs,
weight
and
height
panel
|
|
34566-0
|
Vital
signs
with
method
details
panel
|
|
34567-8
|
Cell
count
and
Differential
panel
-
Peritoneal
fluid
|
|
34665-0
|
TORCH
panel
-
Cerebral
spinal
fluid
|
|
34667-6
|
Heavy
metals
panel
-
Hair
|
|
34672-6
|
Immunoelectrophoresis
panel
-
24
hour
Urine
|
|
34940-7
|
Babesia
microti
IgG
and
IgM
panel
-
Serum
|
|
34941-5
|
Bordetella
pertussis
IgG
and
IgM
panel
-
Serum
|
|
34942-3
|
Borrelia
burgdorferi
IgG
and
IgM
panel
-
Serum
|
|
34943-1
|
Borrelia
burgdorferi
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
|
|
34944-9
|
Cytomegalovirus
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
|
|
34945-6
|
Herpes
virus
6
IgG
and
IgM
panel
-
Serum
|
|
34946-4
|
Herpes
virus
6
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
|
|
34947-2
|
Herpes
virus
7
IgG
and
IgM
panel
-
Serum
|
|
34948-0
|
Measles
virus
IgG
and
IgM
panel
-
Serum
|
|
34949-8
|
Measles
virus
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
|
|
34950-6
|
Parvovirus
B19
IgG
and
IgM
panel
-
Serum
|
|
34951-4
|
Phosphatidylserine
IgG
and
IgM
panel
-
Serum
|
|
34952-2
|
Rubella
virus
IgG
and
IgM
panel
-
Serum
|
|
34953-0
|
Rubella
virus
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
|
|
34954-8
|
Treponema
pallidum
IgG
and
IgM
panel
-
Serum
|
|
34955-5
|
Western
equine
encephalitis
virus
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
|
|
34994-4
|
Smear
morphology
panel
-
Blood
|
|
35083-5
|
Amino
acids
panel
[Moles/volume]
-
Serum
or
Plasma
|
|
35084-3
|
Fetal
lung
maturity
in
Amniotic
fluid
|
|
35085-0
|
Deprecated
Newborn
screening
panel
American
College
of
Medical
Genetics
(ACMG)
|
|
35086-8
|
Second
trimester
triple
maternal
screen
panel
-
Serum
or
Plasma
|
|
35087-6
|
Amino
acids
panel
-
Urine
|
|
35088-4
|
Glasgow
coma
scale
|
|
35089-2
|
History
and
physical
panel
|
|
35090-0
|
Patient
history
|
|
35091-8
|
Patient
physical
|
|
35092-6
|
Urology
testicular
ultrasound
|
|
35093-4
|
Urology
urinary
tract
ultrasound
|
|
35094-2
|
Blood
pressure
panel
|
|
35095-9
|
Body
temperature
panel
|
|
35096-7
|
OB
ultrasound
panel
|
|
35499-3
|
Pesticide
and
Insecticide
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
35500-8
|
Pesticide
and
Insecticide
panel
[Mass/volume]
-
Urine
|
|
35501-6
|
Pesticide
and
Insecticide
panel
[Mass/volume]
-
Urine
and
Serum
or
Plasma
|
|
35502-4
|
Mitochondrial
myopathy
enzyme
panel
[Enzymatic
activity/mass]
-
Tissue
|
|
35507-3
|
Amino
acids
panel
[Moles/volume]
-
Cerebral
spinal
fluid
|
|
35508-1
|
Amino
acids
panel
[Moles/volume]
-
Amniotic
fluid
|
|
35509-9
|
Amino
acids
panel
[Moles/time]
-
24
hour
Urine
|
|
35558-6
|
Cholinesterase
panel
[Enzymatic
activity/volume]
-
Blood
|
|
35563-6
|
Rickettsia
rickettsii
IgG
and
IgM
panel
-
Serum
|
|
35575-0
|
Pigeon
antibody
panel
-
Serum
|
|
35576-8
|
Hydrocarbon
and
Oxygenated
Volatiles
panel
-
Serum
or
Plasma
|
|
35577-6
|
Hypersensitivity
pneumonitis
panel
-
Serum
|
|
35650-1
|
Lymphocytic
choriomeningitis
virus
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
|
|
35666-7
|
Lymphocytic
choriomeningitis
virus
IgG
and
IgM
panel
-
Serum
|
|
35679-0
|
Varicella
zoster
virus
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
|
|
35680-8
|
Hepatitis
E
virus
IgG
and
IgM
panel
-
Serum
|
|
35681-6
|
Tissue
transglutaminase
Ab
panel
-
Serum
|
|
35682-4
|
Trypanosoma
cruzi
IgG
and
IgM
panel
-
Serum
|
|
35683-2
|
Burkholderia
pseudomallei
IgG
and
IgM
panel
-
Serum
|
|
35684-0
|
Colorado
tick
fever
virus
IgG
and
IgM
panel
-
Serum
|
|
35739-2
|
Brucella
sp
IgG
and
IgM
panel
-
Serum
|
|
35740-0
|
Rickettsia
sp
IgG
and
IgM
panel
-
Serum
|
|
35743-4
|
Eastern
equine
encephalitis
virus
IgG
and
IgM
panel
-
Unspecified
specimen
|
|
35752-5
|
Escherichia
coli
O157:H7
IgG
and
IgM
panel
-
Serum
|
|
35866-3
|
Organic
acids
panel
-
Serum
or
Plasma
|
|
38212-7
|
Pain
assessment
panel
|
|
38213-5
|
FLACC
pain
assessment
panel
|
|
38228-3
|
Braden
scale
skin
assessment
panel
|
|
38269-7
|
Study
report
Skeletal
system
DXA
|
|
38351-3
|
Herpes
virus
6
DNA
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
39135-9
|
Wound
assessment
panel
|
|
39136-7
|
Deprecated
Skin
assessment
panel
|
|
39137-5
|
Oral
assessment
panel
|
|
41359-1
|
Active
range
of
motion
panel
Quantitative
|
|
41360-9
|
Passive
range
of
motion
panel
Quantitative
|
|
41478-9
|
Bartonella
henselae
IgG
and
IgM
panel
-
Serum
|
|
41482-1
|
Chlamydia
sp
IgG
and
IgM
panel
[Titer]
-
Serum
|
|
41484-7
|
Coxsackievirus
A
Ab
panel
[Titer]
-
Serum
by
Complement
fixation
|
|
41485-4
|
Coxsackievirus
B
Ab
panel
[Titer]
-
Serum
by
Complement
fixation
|
|
41486-2
|
Coxsackievirus
B
Ab
panel
[Titer]
-
Serum
by
Neutralization
test
|
|
41493-8
|
Febrile
agglutinin
Ab
panel
[Titer]
-
Serum
|
|
41505-9
|
Parainfluenza
virus
Ag
panel
-
Unspecified
specimen
by
Immunofluorescence
|
|
41506-7
|
Polio
virus
Ab
panel
[Titer]
-
Serum
by
Neutralization
test
|
|
41839-2
|
Burkholderia
pseudomallei
IgG
and
IgM
panel
-
Serum
by
Immunofluorescence
|
|
41840-0
|
Coxiella
burnetii
phase
1
and
2
IgG
panel
[Titer]
-
Serum
|
|
41841-8
|
Coxiella
burnetii
phase
1
and
2
IgM
panel
[Titer]
-
Serum
|
|
41842-6
|
Herpes
virus
7
IgG
and
IgM
panel
[Titer]
-
Serum
by
Immunofluorescence
|
|
41843-4
|
Lymphocytic
choriomeningitis
virus
IgG
and
IgM
panel
[Titer]
-
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
41875-6
|
Bordetella
pertussis
and
Bordetella
parapertussis
DNA
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
41876-4
|
Rickettsia
typhi
and
Rickettsia
spotted
fever
group
IgG
and
IgM
panel
-
Serum
|
|
41877-2
|
Bordetella
pertussis
IgA
and
IgG
and
IgM
panel
[Units/volume]
-
Serum
by
Immunoassay
|
|
41878-0
|
Dengue
virus
IgG
and
IgM
panel
[Units/volume]
-
Serum
by
Immunoassay
|
|
42191-7
|
Hepatitis
A
and
B
and
C
7a
panel
-
Serum
|
|
42218-8
|
Sulfatide
IgG
and
IgM
panel
-
Serum
|
|
42342-6
|
Rickettsia
(Proteus)
Ab
panel
-
Serum
|
|
42359-0
|
Streptococcus
pneumoniae
14b
IgG
panel
[Mass/volume]
-
Serum
|
|
42360-8
|
Streptococcus
pneumoniae
14a
IgG
panel
[Mass/volume]
-
Serum
|
|
42361-6
|
Streptococcus
pneumoniae
12
IgG
panel
[Mass/volume]
-
Serum
|
|
42362-4
|
Streptococcus
pneumoniae
7b
IgG
panel
[Mass/volume]
-
Serum
|
|
42363-2
|
Streptococcus
pneumoniae
7a
IgG
panel
[Mass/volume]
-
Serum
|
|
42364-0
|
Streptococcus
pneumoniae
6
IgG
panel
[Mass/volume]
-
Serum
|
|
42365-7
|
Streptococcus
pneumoniae
4
IgG
panel
[Mass/volume]
-
Serum
|
|
42366-5
|
Streptococcus
pneumoniae
23
IgG
panel
[Mass/volume]
-
Serum
|
|
42760-9
|
Inflammatory
bowel
disease
Ab
panel
-
Serum
|
|
42770-8
|
Human
papilloma
virus
high
and
Low
risk
DNA
panel
-
Cervix
|
|
42929-0
|
Lactate
dehydrogenase
panel
-
Serum
or
Plasma
|
|
43098-3
|
Yersinia
sp
Ab
panel
-
Serum
|
|
43099-1
|
Vanillylmandelate
and
Creatinine
panel
-
24
hour
Urine
|
|
43100-7
|
Sjogrens
syndrome-A
and
B
extractable
nuclear
Ab
panel
-
Serum
|
|
43101-5
|
Phosphatidylserine
IgA
and
IgG
and
IgM
panel
-
Serum
|
|
43104-9
|
Paraneoplastic
Ab
panel
-
Serum
|
|
43105-6
|
Acetaldehyde
and
Paraldehyde
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
43106-4
|
Amitriptyline
and
Nortriptyline
panel
-
Serum
or
Plasma
|
|
43107-2
|
Mycoplasma
sp
and
Ureaplasma
sp
panel
-
Unspecified
specimen
by
Organism
specific
culture
|
|
43108-0
|
Metanephrine
and
Normetanephrine
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
43109-8
|
Leishmania
sp
IgG
and
IgM
panel
-
Serum
|
|
43110-6
|
Immunoglobulin
light
chains
panel
-
24
hour
Urine
|
|
43112-2
|
Herpes
simplex
virus
Ab
panel
-
Serum
|
|
43113-0
|
Hemoglobin
electrophoresis
panel
in
Blood
|
|
43116-3
|
Porphyrin
fractions
panel
-
24
hour
Urine
|
|
43117-1
|
Fluoxetine
and
Norfluoxetine
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
43118-9
|
Fat
panel
-
Stool
|
|
43119-7
|
Extractable
nuclear
Ab
panel
-
Serum
|
|
43120-5
|
Echovirus
Ab
panel
-
Serum
|
|
43122-1
|
Doxepin
and
Nordoxepin
panel
-
Serum
or
Plasma
|
|
43123-9
|
Imipramine
and
Desipramine
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
43124-7
|
Cystine
panel
-
Urine
|
|
43125-4
|
Nicotine
and
Metabolites
panel
[Mass/volume]
-
Urine
|
|
43126-2
|
Cortisol.free
panel
-
24
hour
Urine
|
|
43127-0
|
Clomipramine
and
Norclomipramine
panel
-
Serum
or
Plasma
|
|
43128-8
|
Chloride
panel
-
24
hour
Urine
|
|
43129-6
|
Brucella
abortus
IgG
and
IgM
panel
-
Serum
|
|
43130-4
|
Bile
acid
fractions
panel
[Moles/volume]
-
Serum
|
|
43131-2
|
Bacterial
Ag
panel
-
Cerebral
spinal
fluid
|
|
43133-8
|
Allopurinol
and
Oxipurinol
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
43134-6
|
Calcidiol
and
Calciferol
and
Calcitriol
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
43135-3
|
17-Ketosteroids
and
17-Ketogenic
steroids
panel
-
24
hour
Urine
|
|
43141-1
|
Synthetic
glucocorticoid
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
43142-9
|
Height
measurement
device
panel
|
|
43143-7
|
Weighing
device
panel
|
|
43144-5
|
Pedometer
device
panel
|
|
43145-2
|
Peak
flow
meter
device
panel
|
|
43146-0
|
Oxygen
saturation
device
panel
|
|
43147-8
|
Metabolism
measurement
device
panel
|
|
43148-6
|
Insulin
delivery
device
panel
|
|
43149-4
|
Heart
rate
device
panel
|
|
43150-2
|
Hemoglobin
A1c
measurement
device
panel
|
|
43151-0
|
Glucose
meter
device
panel
|
|
43152-8
|
Blood
pressure
device
panel
|
|
43153-6
|
Blood
coagulation
device
panel
|
|
43309-4
|
Desmoglein
1
and
Desmoglein
3
Ab
panel
[Units/volume]
-
Serum
|
|
43433-2
|
Acylcarnitine
panel
-
Serum
or
Plasma
|
|
43434-0
|
Bacterial
Ag
panel
-
Serum
|
|
43435-7
|
Bartonella
henselae
and
Bartonella
quintana
IgM
panel
-
Cerebral
spinal
fluid
|
|
43436-5
|
Bartonella
henselae
and
Bartonella
quintana
IgG
panel
-
Cerebral
spinal
fluid
|
|
43437-3
|
Bartonella
henselae
and
Bartonella
quintana
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
|
|
43438-1
|
Bartonella
henselae
and
Bartonella
quintana
IgG
and
IgM
panel
-
Serum
|
|
43439-9
|
Bartonella
henselae
and
Bartonella
quintana
IgG
panel
[Titer]
-
Serum
|
|
43440-7
|
Bartonella
henselae
and
Bartonella
quintana
IgM
panel
[Titer]
-
Serum
|
|
43443-1
|
Bacterial
Ag
panel
-
Urine
|
|
43674-1
|
Fatty
acid
comprehensive
(C8-C26)
panel
-
Serum
or
Plasma
|
|
43675-8
|
Fatty
acid
mitochondrial
(C8-C18)
panel
-
Serum
or
Plasma
|
|
43676-6
|
Fatty
acid
essential
(C12-C22)
panel
-
Serum
or
Plasma
|
|
43677-4
|
Fatty
acid
very
long
chain
(C22-C26)
panel
-
Serum
or
Plasma
|
|
44249-1
|
PHQ-9
quick
depression
assessment
panel
[Reported.PHQ]
|
|
44616-1
|
Deprecated
Pulse
oximetry
panel
|
|
4463-6
|
Spermatozoa
motility
and
count
panel
|
|
44789-6
|
Amylase
and
Creatinine
clearance
panel
-
Urine
and
Serum
or
Plasma
|
|
44791-2
|
Menorrhagia
coagulation
panel
-
Platelet
poor
plasma
|
|
44792-0
|
Immunoglobulin
light
chains
panel
-
Urine
|
|
44793-8
|
Immunoglobulin
light
chains
panel
[Mass/volume]
-
Serum
|
|
44906-6
|
Homovanillate
panel
-
24
hour
Urine
|
|
44907-4
|
5-Hydroxyindoleacetate
panel
-
24
hour
Urine
|
|
45023-9
|
HLA
typing
for
celiac
disease
panel
-
Blood
|
|
45024-7
|
HLA
typing
for
narcolepsy
panel
-
Blood
|
|
45027-0
|
HLA-A2
panel
-
Blood
|
|
45033-8
|
Cardiovascular
physiologic
and
EKG
assessment
panel
|
|
45057-7
|
Cardiolipin
IgA
and
IgG
and
IgM
panel
-
Serum
|
|
45058-5
|
Cyclosporine
Monoclonal
and
Polyclonal
panel
[Mass/volume]
-
Blood
|
|
45059-3
|
Ehrlichia
chaffeensis
IgG
and
IgM
panel
[Titer]
-
unspecified
time
Serum
by
Immunofluorescence
|
|
45060-1
|
Protein
and
Glucose
panel
-
Urine
by
Test
strip
|
|
45061-9
|
Spermatozoa
IgA
and
IgG
and
IgM
panel
-
Serum
|
|
45063-5
|
Varicella
zoster
virus
IgG
and
IgM
panel
-
Serum
|
|
45064-3
|
Deprecated
Basic
metabolic
panel
&
Glomerular
filtration
rate.predicted
|
|
45065-0
|
Deprecated
Comprehensive
metabolic
panel
&
Glomerular
filtration
rate.predicted
|
|
45066-8
|
Creatinine
and
Glomerular
filtration
rate.predicted
panel
-
Serum
or
Plasma
|
|
45174-0
|
Herpes
gestationis
Ab
panel
-
Serum
|
|
45268-0
|
Immunodeficiency
panel
-
Blood
by
Flow
cytometry
(FC)
|
|
45269-8
|
Chronic
leukemia
panel
-
Unspecified
specimen
by
Flow
cytometry
(FC)
|
|
45270-6
|
Acute
leukemia
panel
-
Unspecified
specimen
by
Flow
cytometry
(FC)
|
|
45350-6
|
Tick
identification
panel
|
|
45962-8
|
Minimum
data
set
for
nursing
home
resident
assessment
and
care
screen
|
|
45963-6
|
MDS
basic
assessment
tracking
form
-
version
2.0
|
|
45964-4
|
Identification
information
section
|
|
45965-1
|
Name
Set
|
|
45966-9
|
Social
security
and
medicare
numbers
Set
|
|
45967-7
|
Facility
provider
numbers
Set
|
|
45968-5
|
Reasons
for
assessment
(basic)
Set
|
|
45969-3
|
MDS
background
information
at
admission
form
-
version
2.0
|
|
45970-1
|
Demographic
information
section
|
|
45971-9
|
Residential
history
5
years
prior
to
entry
Set
|
|
45972-7
|
Language
Set
|
|
45973-5
|
Conditions
related
to
mental
retardation
and
developmental
disabilities
status
Set
|
|
45974-3
|
Mental
retardation
and
developmental
disabilities
with
organic
condition
Set
|
|
45975-0
|
Customary
routine
section
|
|
45976-8
|
Customary
routine
in
year
prior
to
date
of
entry
Set
|
|
45977-6
|
Cycle
of
daily
events
Set
|
|
45978-4
|
Eating
patterns
Set
|
|
45979-2
|
ADL
patterns
Set
|
|
45980-0
|
Involvement
patterns
Set
|
|
45981-8
|
MDS
full
assessment
form
-
version
2.0
|
|
45982-6
|
Identification
and
background
information
section
|
|
45983-4
|
Assessment
reference
date
Set
|
|
45984-2
|
Current
payment
sources
for
nursing
home
stay
Set
|
|
45985-9
|
Responsibility/legal
guardian
Set
|
|
45986-7
|
Advance
directives
Set
|
|
45987-5
|
Cognitive
patterns
section
|
|
45988-3
|
Memory
Set
|
|
45989-1
|
Memory
recall/ability
Set
|
|
45990-9
|
Indicators
of
delirium
-
periodic
disorded
thinking
or
awareness
Set
|
|
45991-7
|
Communication
and
hearing
patterns
section
|
|
45992-5
|
Communication
devices
and
techniques
Set
|
|
45993-3
|
Modes
of
expression
Set
|
|
45994-1
|
Vision
patterns
section
|
|
45995-8
|
Visual
limitations
and
dificulties
Set
|
|
45996-6
|
Mood
and
behavior
patterns
section
|
|
45997-4
|
Indicators
of
depression,
anxiety,
sad
mood
Set
|
|
45998-2
|
Verbal
expressions
of
distress
Set
|
|
45999-0
|
Sleep-cycle
issues
Set
|
|
46000-6
|
Sad,
apethetic,
anxious
appearance
Set
|
|
46001-4
|
Behavioral
symptoms
Set
|
|
46002-2
|
Psychosocial
well-being
section
|
|
46003-0
|
Sense
of
initiative/involvement
Set
|
|
46004-8
|
Unsettled
releationships
Set
|
|
46005-5
|
Past
roles
Set
|
|
46006-3
|
Physical
functioning
and
stuctural
problems
section
Set
|
|
46007-1
|
ADL
self
performance
or
support
Set
|
|
46008-9
|
Bathing
|
|
46009-7
|
Test
for
balance
Set
|
|
46010-5
|
Functional
limitation
in
range
of
motion
Set
|
|
46011-3
|
Modes
of
locomotion
Set
|
|
46012-1
|
Modes
of
transfer
Set
|
|
46013-9
|
ADL
functional
rehabilitation
potential
Set
|
|
46014-7
|
Continence
in
last
14
days
section
Set
|
|
46015-4
|
Continence
self-control
categories
Set
|
|
46016-2
|
Bowel
elimination
pattern
Set
|
|
46017-0
|
Continence
appliances
and
programs
Set
|
|
46018-8
|
Disease
or
condition
diagnoses
section
|
|
46019-6
|
Diseases
or
conditions
Set
|
|
46020-4
|
Endocrine,
metabolic
or
nutritional
diseases
or
conditions
Set
|
|
46021-2
|
Heart
or
circulation
diseases
or
conditions
Set
|
|
46022-0
|
Musculoskeletal
diseases
or
conditions
Set
|
|
46023-8
|
Neurological
diseases
or
conditions
Set
|
|
46024-6
|
Psychiatric
or
mood
diseases
or
conditions
Set
|
|
46025-3
|
Pulmonary
diseases
or
conditions
Set
|
|
46026-1
|
Sensory
diseases
or
conditions
Set
|
|
46027-9
|
Other
diseases
or
conditions
Set
|
|
46028-7
|
Infections
Set
|
|
46029-5
|
Other
current
or
more
detailed
diagnoses
and
ICD9
codes
Set
|
|
46030-3
|
Health
conditions
section
|
|
46031-1
|
Indicators
of
fluid
status
Set
|
|
46032-9
|
Other
indicators
Set
|
|
46033-7
|
Pain
symptoms
Set
|
|
46034-5
|
Pain
site
Set
|
|
46035-2
|
Accidents
Set
|
|
46036-0
|
Stability
of
conditions
Set
|
|
46037-8
|
Oral
and
nutritional
status
section
|
|
46038-6
|
Oral
problems
Set
|
|
46039-4
|
Height
and
weight
Set
|
|
46040-2
|
Weight
change
Set
|
|
46041-0
|
Nutritional
problems
Set
|
|
46042-8
|
Nutritional
approaches
Set
|
|
46043-6
|
Parenteral
or
enteral
intake
Set
|
|
46044-4
|
Oral
or
dental
status
section
|
|
46045-1
|
Oral
status
and
disease
prevention
Set
|
|
46046-9
|
Skin
condition
section
|
|
46047-7
|
Ulcers
Set
|
|
46048-5
|
Type
of
ulcer
Set
|
|
46049-3
|
Other
skin
problems
or
lesions
present
Set
|
|
46050-1
|
Skin
treatments
Set
|
|
46051-9
|
Foot
problems
and
care
Set
|
|
46052-7
|
Activity
pursuit
patterns
section
|
|
46053-5
|
Time
awake
Set
|
|
46054-3
|
Preferred
activity
settings
Set
|
|
46055-0
|
General
activity
preferences
Set
|
|
46056-8
|
Prefers
change
in
daily
routine
Set
|
|
46057-6
|
Medications
section
|
|
46058-4
|
Days
received
the
following
medication
Set
|
|
46059-2
|
Special
treatments
and
procedures
section
|
|
46060-0
|
Special
treatments,
procedures
and
programs
Set
|
|
46061-8
|
Special
care
Set
|
|
46062-6
|
Treatments
Set
|
|
46063-4
|
Programs
Set
|
|
46064-2
|
Therapies
Set
|
|
46065-9
|
Intervention
programs
for
mood,
behavior
and
cognitive
loss
Set
|
|
46066-7
|
Nursing
rehabilitation
and
restorative
care
Set
|
|
46067-5
|
Devices
and
restraints
Set
|
|
46068-3
|
Discharge
potential
and
overall
status
section
|
|
46069-1
|
Discharge
potential
Set
|
|
46070-9
|
Assessment
information
section
|
|
46071-7
|
Participation
in
assessment
Set
|
|
46072-5
|
Therapy
supplement
for
Medicare
PPS
section
|
|
46073-3
|
Special
treatments
and
procedures
Set
|
|
46074-1
|
Recreational
therapy
Set
|
|
46075-8
|
Walking
when
most
self
sufficient
Set
|
|
46076-6
|
Minimum
Data
Set
(MDS)
supplemental
items
section
-
version
2.0
|
|
46077-4
|
Influenza
vaccine
Set
|
|
46078-2
|
Pneumococcal
vaccine
Set
|
|
46079-0
|
Resident
assessment
protocol
summary
section
|
|
46101-2
|
Ordered
therapies
Set
|
|
46102-0
|
MDS
quarterly
assessment
form
-
version
2.0
|
|
46103-8
|
MDS
quarterly
assessment
form
-
version
2.0
-
optional
version
for
RUG-III
|
|
46104-6
|
MDS
quarterly
assessment
form
-
version
2.0
-
optional
version
for
RUG-III
1997
update
|
|
46105-3
|
Problem
conditions
Set
|
|
46107-9
|
Loss
of
interest
Set
|
|
46437-0
|
Rheumatoid
Factor
and
Cyclic
Citrullinated
Peptide
IgG
panel
[Units/volume]
-
Serum
|
|
46611-0
|
Mental
residual
functional
capacity
(RFC)
assessment
form
|
|
46612-8
|
Summary
conclusions
Set
|
|
46637-5
|
Residual
physical
functional
capacity
(RFC)
assessment
form
[RFC]
|
|
46959-3
|
Synthetic
glucocorticoid
panel
[Mass/volume]
-
Urine
|
|
46993-2
|
HLA
Ab
panel
-
Serum
|
|
46999-9
|
Bacterial
vaginosis
and
vaginitis
rRNA
panel
-
Vaginal
fluid
by
DNA
probe
|
|
47245-6
|
HIV
treatment
form
Document
|
|
47246-4
|
HIV
Antiretroviral
therapy
Demographic
information
section
|
|
47248-0
|
HIV
Antiretroviral
therapy
Antiretroviral
therapy
status
section
|
|
47249-8
|
HIV
Antiretroviral
therapy
HIV
care
and
family
status
section
|
|
47286-0
|
Differential
panel
-
Bone
marrow
|
|
47287-8
|
Deprecated
Hemogram
without
Platelets
panel
in
Cord
blood
|
|
47288-6
|
CBC
WO
Differential
panel
-
Cord
blood
|
|
47289-4
|
IgG
and
IgG
subclass
panel
[Mass/volume]
-
Serum
|
|
47290-2
|
IgG
subclass
panel
[Mass/volume]
-
Serum
|
|
47531-9
|
Wet
mount
panel
-
Vaginal
fluid
|
|
48073-1
|
Thyroxine
binding
globulin
panel
[Mass/volume]
-
Serum
or
Plasma
by
Electrophoresis
|
|
48593-8
|
von
Willebrand
panel
-
Platelet
poor
plasma
|
|
48596-1
|
Activated
protein
C
resistance
panel
-
Platelet
poor
plasma
|
|
48615-9
|
Insulin.free
and
Insulin.total
panel
[Units/volume]
-
Serum
or
Plasma
|
|
48644-9
|
Vanillylmandelate,
Homovanillate
and
Creatinine
panel
-
24
hour
Urine
|
|
48760-3
|
3-Hydroxy
fatty
acid
panel
-
Serum
or
Plasma
|
|
48770-2
|
Fetal
Biophysical
profile
panel
US
|
|
48796-7
|
Hepatitis
C
virus
FibroSURE
panel
-
Serum
or
Plasma
|
|
48797-5
|
Organic
acids
panel
-
Urine
|
|
48798-3
|
First
trimester
maternal
screen
panel
-
Serum
or
Plasma
|
|
48799-1
|
Second
trimester
penta
maternal
screen
panel
-
Serum
or
Plasma
|
|
48800-7
|
Second
trimester
quad
maternal
screen
panel
-
Serum
or
Plasma
|
|
48802-3
|
Alpha-1-Fetoprotein
panel
-
Serum
or
Plasma
|
|
48805-6
|
Platelet
aggregation
panel
-
Platelet
rich
plasma
|
|
48808-0
|
Leukogram
panel
-
Blood
|
|
48809-8
|
Erythrogram
panel
-
Blood
|
|
48811-4
|
Protein
fractions
3
panel
-
Serum
or
Plasma
|
|
48812-2
|
Spermatozoa
morphology
panel
|
|
48824-7
|
Respiratory
allergen
panel,
US
-
North
Atlantic
states
a
-
Serum
|
|
48825-4
|
Respiratory
allergen
panel,
US
-
Mid
Atlantic
states
-
Serum
|
|
48826-2
|
Respiratory
allergen
panel,
US
-
South
Atlantic
states
a
-
Serum
|
|
48827-0
|
Respiratory
allergen
panel,
US
-
Subtropical
Florida
-
Serum
|
|
48828-8
|
Respiratory
allergen
panel,
US
-
Greater
Ohio
valley
a
-
Serum
|
|
48829-6
|
Respiratory
allergen
panel,
US
-
South
central
states
-
Serum
|
|
48830-4
|
Respiratory
allergen
panel,
US
-
Northern
midwest
states
a
-
Serum
|
|
48831-2
|
Respiratory
allergen
panel,
US
-
Central
midwest
a
-
Serum
|
|
48832-0
|
Respiratory
allergen
panel,
US
-
Great
plains
states
a
-
Serum
|
|
48833-8
|
Respiratory
allergen
panel,
US
-
Southwestern
grassland
states
-
Serum
|
|
48834-6
|
Respiratory
allergen
panel,
US
-
Rocky
mountain
states
a
-
Serum
|
|
48835-3
|
Respiratory
allergen
panel,
US
-
Arid
southwest
-
Serum
|
|
48836-1
|
Respiratory
allergen
panel,
US
-
Southern
coastal
California
-
Serum
|
|
48837-9
|
Respiratory
allergen
panel,
US
-
California
central
valley
-
Serum
|
|
48838-7
|
Respiratory
allergen
panel,
US
-
Intermountain
west
a
-
Serum
|
|
48839-5
|
Respiratory
allergen
panel,
US
-
Inland
northwest
a
-
Serum
|
|
48840-3
|
Respiratory
allergen
panel,
US
-
Cascade
Pacific
northwest
a
-
Serum
|
|
48841-1
|
Respiratory
allergen
panel,
US
-
Alaska
a
-
Serum
|
|
48916-1
|
Respiratory
allergen
panel,
US
-
North
Atlantic
states
b
-
Serum
|
|
48917-9
|
Respiratory
allergen
panel,
US
-
South
Atlantic
states
b
-
Serum
|
|
48918-7
|
Respiratory
allergen
panel,
US
-
NC,
PA,
SC,
VA,
WV
-
Serum
|
|
48919-5
|
Respiratory
allergen
panel,
US
-
Central
Florida
-
Serum
|
|
48920-3
|
Respiratory
allergen
panel,
US
-
Southern
Florida
-
Serum
|
|
48921-1
|
Respiratory
allergen
panel,
US
-
Southeast
coast
-
Serum
|
|
48922-9
|
Respiratory
allergen
panel,
US
-
West
south
central
states
-
Serum
|
|
48923-7
|
Respiratory
allergen
panel,
US
-
Greater
Ohio
valley
b
-
Serum
|
|
48924-5
|
Respiratory
allergen
panel,
US
-
Northern
midwest
states
b
-
Serum
|
|
48925-2
|
Respiratory
allergen
panel,
US
-
Central
midwest
b
-
Serum
|
|
48926-0
|
Respiratory
allergen
panel,
US
-
Great
plains
states
b
-
Serum
|
|
48927-8
|
Respiratory
allergen
panel,
US
-
Rocky
mountain
states
b
-
Serum
|
|
48928-6
|
Respiratory
allergen
panel,
US
-
Inland
northwest
b
-
Serum
|
|
48929-4
|
Respiratory
allergen
panel,
US
-
Cascade
Pacific
northwest
b
-
Serum
|
|
48930-2
|
Respiratory
allergen
panel,
US
-
Intermountain
west
b
-
Serum
|
|
48931-0
|
Respiratory
allergen
panel,
US
-
AZ,
Southeastern
CA,
Western
NM
-
Serum
|
|
48932-8
|
Respiratory
allergen
panel,
US
-
Alaska
b
-
Serum
|
|
48933-6
|
Respiratory
allergen
panel,
US
-
Hawaii
-
Serum
|
|
49017-7
|
Respiratory
allergen
panel,
US
-
North
Atlantic
states
c
-
Serum
|
|
49018-5
|
Respiratory
allergen
panel,
US
-
Intermountain
west
c
-
Serum
|
|
49019-3
|
Respiratory
allergen
panel,
US
-
Puerto
Rico
-
Serum
|
|
49020-1
|
Respiratory
allergen
panel,
US
-
Coastal
California
-
Serum
|
|
49021-9
|
Respiratory
allergen
panel,
US
-
Greater
Ohio
valley
c
-
Serum
|
|
49022-7
|
Respiratory
allergen
panel,
US
-
Northern
midwest
states
c
-
Serum
|
|
49037-5
|
Respiratory
syncytial
virus
IgG
and
IgM
panel
[Units/volume]
-
Serum
|
|
49044-1
|
Diazepam
and
Nordiazepam
panel
-
Serum
or
Plasma
|
|
49045-8
|
PT
and
aPTT
and
Fibrinogen
panel
-
Platelet
poor
plasma
by
Coagulation
assay
|
|
49085-4
|
First
and
Second
trimester
integrated
maternal
screen
panel
|
|
49086-2
|
First
trimester
maternal
screen
with
nuchal
translucency
panel
|
|
49087-0
|
Maternal
screen
clinical
predictors
panel
|
|
49093-8
|
Arbovirus
IgG
and
IgM
panel
-
Serum
by
Immunofluorescence
|
|
49094-6
|
Arbovirus
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
49120-9
|
Immunodeficiency
follow-up
panel
-
Unspecified
specimen
by
Flow
cytometry
(FC)
|
|
49143-1
|
North
American
Association
of
Central
Cancer
Registries,
Inc
(NAACCR,
Inc)
Pathology
Laboratory
Electronic
Reporting
panel
|
|
49222-3
|
Food
allergen
panel
-
Serum
|
|
49589-5
|
Bacterial
susceptibility
panel
by
Gradient
strip
|
|
49660-4
|
HIV
susceptibility
panel
by
Genotype
method
|
|
49665-3
|
HIV
susceptibility
panel
by
Phenotype
method
|
|
49883-2
|
Hepatitis
B
virus
resistance
panel
by
Genotype
method
|
|
49885-7
|
Lymphocyte
proliferation.beryllium
stimulation
panel
-
Blood
|
|
50009-0
|
Fetal
lung
maturity
panel
-
Amniotic
fluid
|
|
50023-1
|
Hepatitis
C
virus
RNA
panel
(viral
load)
in
Serum
or
Plasma
by
Probe
and
target
amplification
method
|
|
50025-6
|
Volatiles
panel
-
Serum
or
Plasma
|
|
50179-1
|
Calcitonin
Calcium
and
Pentagastrin
challenge
panel
-
Serum
or
Plasma
|
|
50189-0
|
Neonatal
bilirubin
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
50190-8
|
Iron
and
Iron
binding
capacity
panel
-
Serum
or
Plasma
|
|
50191-6
|
Occult
blood
panel
-
Gastric
fluid
|
|
50196-5
|
Occult
blood
panel
-
Stool
|
|
50197-3
|
aPTT
panel
-
Platelet
poor
plasma
|
|
50219-5
|
Respiratory
pathogens
DNA
and
RNA
12a
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
50261-7
|
Deprecated
Renal
function
panel
&
Glomerular
filtration
rate.predicted
|
|
50262-5
|
Reticulocytes
panel
-
Blood
|
|
50334-2
|
Acylglycines
panel
[Mass
Ratio]
-
Urine
|
|
50337-5
|
Carbamazepine
free
and
total
and
10,11-Epoxide
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
50399-5
|
Deprecated
Clinical
genetic
report
summary
panel
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
50545-3
|
Bacterial
susceptibility
panel
by
Minimum
inhibitory
concentration
(MIC)
|
|
50546-1
|
Bacterial
susceptibility
panel
by
Disk
diffusion
(KB)
|
|
50554-5
|
Urinalysis
microscopic
panel
[#/volume]
-
Urine
by
Automated
count
|
|
50556-0
|
Urinalysis
dipstick
panel
-
Urine
by
Automated
test
strip
|
|
50564-4
|
Urinalysis
panel
-
Urine
by
Auto
|
|
50579-2
|
Gastric
analysis
panel
-
Gastric
fluid
|
|
50580-0
|
Maternal
screen
for
fetal
abnormalities
such
as
Open
Neural
Tube
Defects,
Trisomy
21
or
Trisomy
18
panel
-
Serum
or
Plasma
|
|
50581-8
|
Adenosine
monophosphate.cyclic
stimulation
panel
-
Urine
|
|
50582-6
|
Glucose
tolerance
gestational
panel
-
Urine
and
Serum
or
Plasma
|
|
50583-4
|
Glucose
screen
gestational
panel
-
Urine
and
Serum
or
Plasma
|
|
50584-2
|
Lactose
challenge
(hydrogen
breath
test)
panel
-
Exhaled
gas
|
|
50585-9
|
Triple
bolus
stimulation
panel
-
Serum
or
Plasma
|
|
50586-7
|
Glucose
tolerance
3
hours
panel
-
Serum
or
Plasma
|
|
50587-5
|
Glucose
tolerance
4
hours
panel
-
Serum
or
Plasma
|
|
50588-3
|
Glucose
tolerance
5
hours
panel
-
Serum
or
Plasma
|
|
50589-1
|
Glucose
tolerance
6
hours
panel
-
Serum
or
Plasma
|
|
50604-8
|
HPA
panel
[Type]
in
Blood
|
|
50607-1
|
Neisseria
meningitidis
Ag
panel
-
Unspecified
specimen
by
Latex
agglutination
|
|
50608-9
|
Glucose
tolerance
3
hours
gestational
panel
-
Serum
or
Plasma
|
|
50624-6
|
HIV
1
RNA
panel
(viral
load)
in
Cerebral
spinal
fluid
by
Probe
and
target
amplification
method
|
|
50673-3
|
Insulin
XXX
challenge
panel
-
Serum
|
|
50676-6
|
Calcium-phosphorus
product
panel
-
Serum
or
Plasma
|
|
50677-4
|
Semen
analysis
post
vasectomy
panel
|
|
50710-3
|
Influenza
virus
susceptibility
panel
|
|
50736-8
|
Serotonin
release.heparin.unfractionated
panel
-
Serum
|
|
50737-6
|
Serotonin
release.heparin.porcine
panel
-
Serum
|
|
50738-4
|
Serotonin
release.heparin.low
molecular
weight
panel
-
Serum
|
|
50739-2
|
Serotonin
release.heparin.porcine
and
low
molecular
weight
panel
-
Serum
|
|
50943-0
|
Reasons
for
assessment
(full)
Set
|
|
51410-9
|
Environmental
stressors
panel
-
Water
|
|
51411-7
|
Environmental
stressors
panel
-
Air
|
|
51662-5
|
Core
respiratory
allergens
panel
-
Serum
|
|
51782-1
|
Drugs
of
abuse
7
and
Alcohol
and
Tricyclics
panel
-
Urine
by
Screen
method
|
|
51956-1
|
DNA
region
analysis
test
coverage
panel
|
|
51960-3
|
DNA
marker
results
panel
|
|
51962-9
|
Pharmacogenetic
DNA
analysis
panel
|
|
51966-0
|
Genetic
disease
DNA
analysis
panel
|
|
51972-8
|
Gas
panel
-
Venous
cord
blood
|
|
51973-6
|
Gas
panel
-
Mixed
venous
blood
|
|
51974-4
|
Gas
panel
-
Arterial
cord
blood
|
|
51990-0
|
Basic
metabolic
panel
-
Blood
|
|
51991-8
|
Reference
lab
test
panel
|
|
51992-6
|
Heavy
metals
panel
-
Serum
or
Plasma
|
|
51993-4
|
Metanephrine
and
Normetanephrine
panel
[Mass/volume]
-
Urine
|
|
52135-1
|
t(9;22)(q34.1;q11)(ABL1,BCR)
transcript
detection
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
52762-2
|
Intrinsic
coagulation
system
thromboelastography
panel
-
Blood
|
|
52763-0
|
Extrinsic
coagulation
system
thromboelastography
panel
-
Blood
|
|
52764-8
|
Extrinsic
coagulation
system
with
fibrinolysis
inhibition
thromboelastography
panel
-
Blood
|
|
52765-5
|
Thromboelastography
without
activation
panel
-
Blood
|
|
52777-0
|
Intrinsic
coagulation
system
with
heparin
inhibition
thromboelastography
panel
-
Blood
|
|
53041-0
|
DNA
region
of
interest
panel
|
|
53042-8
|
DNA
marker
assessed
panel
|
|
53043-6
|
DNA
marker
analysis
test
coverage
panel
|
|
53044-4
|
DNA
marker
identified
panel
|
|
53261-4
|
Amino
acid
newborn
screen
panel
|
|
53262-2
|
Carnitine
newborn
screen
panel
|
|
53263-0
|
Urinalysis
yeast
variants
panel
-
Urine
by
Computer
assisted
method
|
|
53264-8
|
Urinalysis
yeast
variants
panel
[#/volume]
-
Urine
by
Computer
assisted
method
|
|
53267-1
|
Urinalysis
yeast
variants
panel
[#/area]
-
Urine
by
Computer
assisted
method
|
|
53270-5
|
Urinalysis
type
of
non-squamous
epithelial
cells
panel
-
Urine
by
Computer
assisted
method
|
|
53273-9
|
Urinalysis
type
of
non-squamous
epithelial
cells
panel
[#/volume]
-
Urine
by
Computer
assisted
method
|
|
53276-2
|
Urinalysis
type
of
non-squamous
epithelial
cells
panel
[#/area]
-
Urine
by
Computer
assisted
method
|
|
53277-0
|
Urinalysis
type
of
cast
panel
-
Urine
by
Computer
assisted
method
|
|
53281-2
|
Urinalysis
type
of
cast
panel
[#/volume]
-
Urine
by
Computer
assisted
method
|
|
53293-7
|
Urinalysis
microscopic
panel
[#/area]
-
Urine
sediment
by
Automated
count
|
|
53295-2
|
Urinalysis
type
of
crystal
panel
[#/volume]
-
Urine
by
Computer
assisted
method
|
|
53305-9
|
Urinalysis
type
of
crystal
panel
[#/area]
-
Urine
by
Computer
assisted
method
|
|
53325-7
|
Urinalysis
type
of
crystal
panel
-
Urine
by
Computer
assisted
method
|
|
53330-7
|
Urinalysis
type
of
cast
panel
[#/area]
-
Urine
by
Computer
assisted
method
|
|
53333-1
|
Urinalysis
other
formed
elements
panel
-
Urine
by
Computer
assisted
method
|
|
53351-3
|
Urinalysis
other
formed
elements
panel
[#/volume]
-
Urine
by
Computer
assisted
method
|
|
53575-7
|
VAP
cholesterol
panel
-
Serum
or
Plasma
|
|
53598-9
|
Irritable
bowel
disease
prognostic
panel
-
Serum
or
Plasma
by
Immunoassay
|
|
53703-5
|
Mycobacterium
bovis
tuberculin
stimulated
gamma
interferon
panel
-
Blood
|
|
53705-0
|
Myasthenia
gravis
evaluation
pediatric
panel
-
Serum
|
|
53706-8
|
Myasthenia
grav
eval
adult
rflx
panel
-
Serum
|
|
53745-6
|
Benzodiazepines
panel
-
Urine
|
|
53746-4
|
Barbiturates
panel
-
Urine
|
|
53747-2
|
Cocaine
panel
-
Urine
|
|
53759-7
|
Natural
killer
cell
panel
-
Blood
by
Flow
cytometry
(FC)
|
|
53764-7
|
Prostate
specific
Ag
panel
-
Serum
or
Plasma
|
|
53766-2
|
Estrogen
fraction
panel
-
Serum
or
Plasma
|
|
53775-3
|
Hepatitis
A
virus
Ab
panel
-
Serum
|
|
53780-3
|
Chromium
panel
-
Urine
|
|
53781-1
|
Acetaminophen
and
Propoxyphene
panel
[Mass/volume]
-
Urine
|
|
53783-7
|
HTT
gene
mutation
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
53800-9
|
Platelets
panel
-
Blood
by
Automated
count
|
|
53803-3
|
Transferrin.carbohydrate
deficient
panel
-
Serum
or
Plasma
|
|
53804-1
|
Arbovirus
IgG
panel
-
Serum
by
Immunofluorescence
|
|
53932-0
|
Streptococcus
pneumoniae
14a
and
Corynebacterium
diphtheriae
toxin
and
Clostridium
tetani
toxin
Ab.IgG
panel
-
Serum
|
|
54075-7
|
Endocrine
newborn
screening
panel
(SI
units)
|
|
54076-5
|
Endocrine
newborn
screening
panel
|
|
54077-3
|
Thyroid
newborn
screening
panel
(SI
units)
|
|
54078-1
|
Cystic
fibrosis
newborn
screening
panel
|
|
54079-9
|
Galactosemia
newborn
screening
panel
|
|
54080-7
|
Galactosemia
newborn
screening
panel
(SI
units)
|
|
54081-5
|
Hemoglobinopathies
newborn
screening
panel
|
|
54082-3
|
Infectious
diseases
newborn
screening
panel
|
|
54089-8
|
Newborn
screening
panel
American
Health
Information
Community
(AHIC)
|
|
54090-6
|
Thyroid
newborn
screening
panel
|
|
54097-1
|
Organophosphonate
nerve
agent
metabolite
panel
[Mass/volume]
-
Urine
|
|
54111-0
|
Newborn
hearing
screening
panel
|
|
54145-8
|
Bacterial
vaginosis
and
vaginitis
DNA
panel
-
Vaginal
fluid
by
Probe
and
signal
amplification
method
|
|
54225-8
|
Immune
response
panel
-
Unspecified
specimen
by
Flow
cytometry
(FC)
|
|
54226-6
|
Lymphoma
panel
-
Unspecified
specimen
by
Flow
cytometry
(FC)
|
|
54227-4
|
Lymphoma
-
acute
screen
panel
-
Unspecified
specimen
by
Flow
cytometry
(FC)
|
|
54228-2
|
Lymphoma
-
CLL
screen
panel
-
Unspecified
specimen
by
Flow
cytometry
(FC)
|
|
54229-0
|
Lymphoma
-
T-cell
screen
panel
-
Unspecified
specimen
by
Flow
cytometry
(FC)
|
|
54230-8
|
Cell
count
and
Diff
panel
with
Gluc
and
Prot
-
Cerebral
spinal
fluid
|
|
54231-6
|
Semen
analysis
fertility
panel
|
|
54232-4
|
Metabolic
panel.large
animal
-
Serum
or
Plasma
|
|
54233-2
|
Metabolic
panel.small
animal
-
Serum
or
Plasma
|
|
54234-0
|
Cell
count
and
Diff
panel
with
Gluc
and
Prot
-
Body
fluid
|
|
54235-7
|
Cortisol
challenge
panel
-
Saliva
(oral
fluid)
|
|
54246-4
|
Protein
and
Glucose
panel
[Mass/volume]
-
Body
fluid
|
|
54450-2
|
CYP2C9
and
VKORC1
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
54932-9
|
Centers
for
Environmental
Health
abrine
and
ricinine
panel
[Mass/volume]
-
Urine
|
|
55101-0
|
Respiratory
pathogens
panel
-
Unspecified
specimen
by
Organism
specific
culture
|
|
55116-8
|
Centers
for
Environmental
Health
volatile
organic
compounds
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
55117-6
|
Centers
for
Environmental
Health
trace
metals
screen
panel
[Mass/volume]
-
Urine
|
|
55118-4
|
Centers
for
Environmental
Health
trace
metals
panel
[Mass/volume]
-
Urine
|
|
55119-2
|
Centers
for
Environmental
Health
nitrogen
mustard
metabolite
panel
[Mass/volume]
-
Urine
|
|
55120-0
|
Centers
for
Environmental
Health
metabolic
toxin
panel
[Mass/volume]
-
Urine
|
|
55121-8
|
Multiple
sclerosis
panel
-
Serum
and
CSF
|
|
55150-7
|
Anaplasma
phagocytophilum
IgG
and
IgM
panel
-
Serum
Qualitative
|
|
55151-5
|
Aldosterone
and
renin
activity
panel
-
Plasma
|
|
55152-3
|
Amiodarone
and
Desethylamiodarone
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
55153-1
|
Biotinidase
panel
-
Serum
or
Plasma
|
|
55155-6
|
Flunitrazepam
and
7-Aminoflunitrazepam
panel
[Mass/volume]
-
Urine
|
|
55157-2
|
Risperidone
and
9-Hydroxyrisperidone
panel
-
Serum
or
Plasma
|
|
55160-6
|
Adenovirus
IgG
and
IgM
panel
-
Serum
|
|
55161-4
|
Bordetella
pertussis
IgA
and
IgG
panel
-
Serum
by
Immunoassay
|
|
55162-2
|
HTLV
I+II
Ab
panel
-
Serum
Qualitative
|
|
55163-0
|
Streptococcus
pyogenes
enzyme
Ab
panel
-
Serum
Qualitative
|
|
55164-8
|
Paroxysmal
nocturnal
panel
-
Blood
|
|
55207-5
|
Genetic
analysis
discrete
result
panel
|
|
55208-3
|
DNA
analysis
discrete
sequence
variation
panel
|
|
55231-5
|
Electrolytes
panel
-
Blood
|
|
55232-3
|
Genetic
analysis
summary
panel
|
|
55233-1
|
Genetic
analysis
master
panel
|
|
55234-9
|
Alpha
thalassemia
gene
deletion
panel
[Presence]
-
Blood
by
Molecular
genetics
method
|
|
55235-6
|
Abnormal
hemoglobin
gene
panel
-
Blood
by
Molecular
genetics
method
|
|
55255-4
|
Pyridinoline
panel
-
Urine
|
|
55295-0
|
Protein
electrophoresis
and
Immunoglobulins
panel
-
Serum
|
|
55394-1
|
Protein
and
Glucose
panel
-
Cerebral
spinal
fluid
|
|
55395-8
|
Phospholipid
IgA
and
IgG
and
IgM
panel
-
Serum
|
|
55396-6
|
Beta
2
glycoprotein
1
IgA
and
IgG
panel
-
Serum
|
|
55397-4
|
Short
myasthenia
gravis
panel
-
Serum
|
|
55398-2
|
Short
Fibrin
D-dimer
FEU
and
DDU
panel
-
Platelet
poor
plasma
|
|
55399-0
|
Diabetes
tracking
panel
|
|
55401-4
|
Warfarin
tracking
panel
-
Platelet
poor
plasma
|
|
55402-2
|
West
Nile
virus
IgG
and
IgM
panel
-
Serum
|
|
55403-0
|
Asthma
tracking
panel
|
|
55405-5
|
Heart
failure
tracking
panel
|
|
55409-7
|
Exercise
tracking
panel
|
|
55413-9
|
Pedometer
tracking
panel
|
|
55415-4
|
Oxygen
therapy
tracking
panel
|
|
55417-0
|
Short
blood
pressure
panel
|
|
55418-8
|
Weight
and
Height
tracking
panel
|
|
55419-6
|
Home
drug
screening
panel
-
Urine
|
|
55427-9
|
Seizure
disorder
tracking
panel
|
|
55429-5
|
Short
blood
count
panel
-
Blood
|
|
55441-0
|
Antithrombin
Ag
in
Platelet
poor
plasma
|
|
55442-8
|
Antithrombin
in
Platelet
poor
plasma
|
|
55443-6
|
Cardiolipin
Ab
in
Serum
|
|
55444-4
|
Cardiolipin
IgA
Ab
in
Serum
|
|
55445-1
|
Cardiolipin
IgM
Ab
in
Serum
|
|
55446-9
|
Cardiolipin
IgG
Ab
in
Serum
|
|
55447-7
|
Coagulation
factor
VIII
Ag
in
Platelet
poor
plasma
|
|
55448-5
|
Complement
total
hemolytic
CH50
in
Serum
or
Plasma
|
|
55449-3
|
Fibrin
D-dimer
in
Platelet
poor
plasma
|
|
55450-1
|
Fibrin+Fibrinogen
fragments
in
Serum
|
|
55451-9
|
Fibrin+Fibrinogen
fragments
in
Platelet
poor
plasma
|
|
55452-7
|
Fibrinogen
in
Platelet
poor
plasma
|
|
55453-5
|
Haptoglobin
in
Serum
or
Plasma
|
|
55454-3
|
Hemoglobin
A1c
in
Blood
|
|
55455-0
|
Hemoglobin
F
in
Unspecified
specimen
|
|
55456-8
|
Hemoglobin
S
in
Blood
|
|
55457-6
|
Free
Hemoglobin
in
Plasma
|
|
55458-4
|
Interferon
alpha
in
Serum
or
Plasma
|
|
55459-2
|
Prekallikrein
(Fletcher
Factor)
in
Platelet
poor
plasma
|
|
55460-0
|
Protein
C
Ag
in
Platelet
poor
plasma
|
|
55461-8
|
Protein
C
in
Platelet
poor
plasma
|
|
55462-6
|
Thyrotropin
in
Serum
or
Plasma
|
|
55466-7
|
Influenza
virus
A
H1
2009
pandemic
RNA
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
55728-0
|
Yersinia
sp
IgG
and
IgM
panel
-
Serum
|
|
55744-7
|
howRU
|
|
56146-4
|
Fungal
Ab
panel
-
Serum
|
|
56148-0
|
Smith
extractable
nuclear
Ab
and
Ribonucleoprotein
extractable
nuclear
Ab
panel
-
Serum
|
|
56149-8
|
Beta
2
glycoprotein
and
Cardiolipin
Ab
and
Phosphatidylserine
panel
-
Serum
|
|
56152-2
|
Beta
2
glycoprotein
1
Ab
IgA
and
IgG
and
IgM
panel
-
Serum
|
|
56156-3
|
Candida
albicans
IgA
and
IgG
and
IgM
Ab
panel
-
Serum
|
|
57019-2
|
Urinalysis
dipstick
W
Reflex
Culture
panel
-
Urine
|
|
57020-0
|
Urinalysis
dipstick
W
Reflex
Microscopic
panel
-
Urine
|
|
57021-8
|
CBC
W
Auto
Differential
panel
-
Blood
|
|
57022-6
|
CBC
W
Reflex
Manual
Differential
panel
-
Blood
|
|
57023-4
|
Auto
Differential
panel
-
Blood
|
|
57031-7
|
Herpesviruses
6
DNA
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
57084-6
|
Fatty
acid
oxidation
newborn
screen
panel
|
|
57085-3
|
Organic
acid
newborn
screen
panel
|
|
57086-1
|
Congenital
adrenal
hyperplasia
newborn
screening
panel
|
|
57087-9
|
Biotinidase
newborn
screening
panel
|
|
57128-1
|
Newborn
Screening
Report
summary
panel
|
|
57698-3
|
Lipid
panel
with
direct
LDL
-
Serum
or
Plasma
|
|
57717-1
|
Newborn
screen
card
data
panel
|
|
57765-0
|
Disaccharidases
panel
-
Small
intestine
Tissue
|
|
57767-6
|
Trimipramine
and
Nortrimipramine
panel
-
Serum
or
Plasma
|
|
57770-0
|
Toxoplasma
gondii
IgG
and
IgM
panel
-
Serum
|
|
57772-6
|
Metanephrine.free
and
Normetanephrine.free
panel
[Moles/volume]
-
Serum
or
Plasma
|
|
57774-2
|
Colorado
tick
fever
virus
IgG
and
IgM
panel
[Titer]
-
Serum
|
|
57775-9
|
Valproate.free
and
Valproate
panel
-
Serum
or
Plasma
|
|
57776-7
|
Gliadin
peptide
IgA
and
IgG
panel
-
Serum
|
|
57777-5
|
Myeloperoxidase
Ab
and
Proteinase
3
panel
-
Serum
|
|
57778-3
|
Immunoglobulin
light
chains.free
panel
-
Serum
|
|
57780-9
|
Thyroglobulin
and
Thyrogobulin
Ab
panel
-
Serum
or
Plasma
|
|
57782-5
|
CBC
with
Ordered
Manual
Differential
panel
-
Blood
|
|
57794-0
|
Newborn
screening
test
results
panel
-
Dried
blood
spot
|
|
57795-7
|
Fecal
hydrolysis
panel
-
Stool
|
|
57803-9
|
Occult
blood
panel
-
Stool
by
Immunologic
method
|
|
58077-9
|
Urinalysis
complete
W
Reflex
Culture
panel
-
Urine
|
|
58091-0
|
Glucose-6-Phosphate
dehydrogenase
newborn
screen
panel
|
|
58092-8
|
Acylcarnitine
newborn
screen
panel
|
|
58406-0
|
Platelet
morphology
panel
-
Blood
|
|
58407-8
|
Leukocyte
morphology
panel
-
Blood
|
|
58408-6
|
Erythrocyte
morphology
panel
-
Blood
|
|
58410-2
|
Complete
blood
count
(hemogram)
panel
-
Blood
by
Automated
count
|
|
58431-8
|
Microalbumin
panel
-
24
hour
Urine
|
|
58446-6
|
Creatinine
24H
renal
clearance
adjusted
for
body
surface
area
panel
|
|
58447-4
|
Microalbumin/Creatinine
panel
in
24H
Urine
|
|
58713-9
|
Streptococcal
DNAse
B
and
ASO
antibodies
panel
-
Serum
|
|
58715-4
|
Adulterants
panel
-
Urine
|
|
58716-2
|
Testosterone.free+weakly
bound
and
total
panel
-
Serum
or
Plasma
|
|
58732-9
|
Porphyrin
fractions
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
58733-7
|
Mycoplasma
pneumoniae
IgG
and
IgM
panel
-
Serum
|
|
58735-2
|
Alpha-1-Fetoprotein
panel
-
Amniotic
fluid
|
|
58736-0
|
Manganese
panel
-
Urine
|
|
58953-1
|
Meperidine
and
Normeperidine
panel
-
Urine
|
|
59049-7
|
Coccidioides
sp
IgG
and
IgM
panel
-
Unspecified
specimen
|
|
59059-6
|
Inflammatory
bowel
disease
Ab
7
panel
-
Serum
|
|
59062-0
|
Lipoprofile
panel
-
Serum
or
Plasma
|
|
59063-8
|
Lymphocyte
proliferation
panel
-
Blood
|
|
59257-6
|
Cell
count
and
Differential
panel
-
Pericardial
fluid
|
|
59852-4
|
North
American
Association
of
Central
Cancer
Registries,
Inc
(NAACCR,
Inc)
version
12
panel
|
|
60342-3
|
Borrelia
burgdorferi
IgG
panel
-
Serum
by
Immunoblot
(IB)
|
|
60343-1
|
Borrelia
burgdorferi
IgM
panel
-
Serum
by
Immunoblot
(IB)
|
|
60566-7
|
Respiratory
pathogens
DNA
and
RNA
12b
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
60587-3
|
Cell
count
and
Differential
panel
-
Peritoneal
dialysis
fluid
|
|
62300-9
|
Lysosomal
storage
disorders
newborn
screening
panel
|
|
62304-1
|
Fabry
disease
newborn
screening
panel
|
|
62307-4
|
Krabbe
disease
newborn
screening
panel
|
|
62311-6
|
Gaucher
disease
newborn
screening
panel
|
|
62315-7
|
Niemann
Pick
disease
A/B
newborn
screening
panel
|
|
62333-0
|
Severe
combined
immunodeficiency
(SCID)
newborn
screening
panel
|
|
62341-3
|
Borrelia
burgdorferi
IgG+IgM
with
reflex
to
immune
blot
panel
-
Serum
|
|
62426-2
|
Bordetella
sp
DNA
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
63414-7
|
Pompe
disease
newborn
screening
panel
|
|
63430-3
|
Human
coronavirus
RNA
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
63486-5
|
Nut
allergen
panel
-
Serum
|
|
64017-7
|
Chlamydia
trachomatis
and
Neisseria
gonorrhoeae
rRNA
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
64116-7
|
Hemoglobin
observations
newborn
screening
panel
|
|
64418-7
|
KIR
genotyping
panel
-
Blood
or
Tissue
|
|
64433-6
|
Fragile
X
protein
(FMRP)
panel
-
Blood
|
|
65632-2
|
Clozapine
and
Norclozapine
panel
-
Serum
or
Plasma
|
|
65634-8
|
Creatinine
24
hour
urine
panel
-
24
hour
Urine
|
|
65750-2
|
Drugs
of
abuse
5
panel
-
Urine
by
Screen
method
|
|
65758-5
|
CD4
T-cell
absolute
panel
-
Blood
|
|
65759-3
|
T-cell
subsets
CD4
and
CD8
panel
-
Blood
|
|
65833-6
|
Address
Facility
|
|
67767-4
|
HEDIS
2012
panel
|
|
67790-6
|
Thromboelastography
panel
-
Blood
|
|
67795-5
|
Vital
signs,
weight,
height,
head
circumference
and
oximetry
panel
HITSP
|
|
67822-7
|
Fentanyl
and
Norfentanyl
panel
-
Urine
|
|
67866-4
|
Babesia
identification
panel
-
Unspecified
specimen
|
|
68314-4
|
Meperidine
and
Normeperidine
panel
-
Serum
or
Plasma
|
|
68315-1
|
Transcortin
and
Cortisol.free
panel
-
Serum
or
Plasma
|
|
68317-7
|
Metanephrine,
Normetanephrine
and
Creatinine
panel
-
Urine
|
|
68318-5
|
Hypoglycemics
panel
-
Serum
or
Plasma
|
|
68320-1
|
Polio
virus
Ab
panel
[Titer]
-
Serum
|
|
68501-6
|
Serotonin
release.heparin.unfractionated
and
low
molecular
weight
panel
-
Serum
|
|
68982-8
|
PFGE
panel
-
Isolate
|
|
68991-9
|
Epidemiologically
important
information
for
public
health
reporting
panel
|
|
68992-7
|
Specimen-related
information
panel
|
|
69008-1
|
Cocaine
panel
-
Meconium
by
Confirmatory
method
|
|
69018-0
|
Lymphocyte
proliferation
mitogen
panel
-
Blood
by
Flow
cytometry
(FC)
|
|
69021-4
|
Amphetamines
panel
-
Meconium
by
Confirmatory
method
|
|
69026-3
|
Opiates
panel
-
Meconium
by
Confirmatory
method
|
|
69034-7
|
Eastern
equine
encephalitis
virus
IgG
and
IgM
panel
-
Serum
by
Immunofluorescence
|
|
69035-4
|
Eastern
equine
encephalitis
virus
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
69036-2
|
Western
equine
encephalitis
virus
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
69039-6
|
Enterocyte
Ab
panel
-
Serum
|
|
69040-4
|
Chronic
urticaria
index
panel
-
Serum
or
Plasma
|
|
69041-2
|
Western
equine
encephalitis
virus
IgG
and
IgM
panel
-
Serum
by
Immunofluorescence
|
|
69042-0
|
Lymphocyte
proliferation
antigen
panel
-
Blood
by
Flow
cytometry
(FC)
|
|
69459-6
|
Care
record
summary
panel
|
|
69552-8
|
Thromboelastography
after
addtion
of
heparinase
panel
-
Blood
|
|
69554-4
|
Lactose
tolerance
panel
[Moles/volume]
in
Serum
or
Plasma
|
|
69555-1
|
Lactose
tolerance
panel
[Mass/volume]
in
Serum
or
Plasma
|
|
69571-8
|
Bacterial
vaginosis
DNA
and
score
panel
-
Vaginal
fluid
by
Probe
and
target
amplification
method
|
|
69581-7
|
National
(USA)
PFGE
cluster
code
or
CDC
cluster
[Identifier]
in
Isolate
|
|
69726-8
|
Tissue
transglutaminase
IgA
+
Gliadin
peptides
IgA
and
IgG
panel
-
Serum
|
|
69738-3
|
Differential
panel,
method
unspecified
-
Blood
|
|
69739-1
|
Drugs
of
abuse
panel
-
Urine
|
|
69740-9
|
Cell
count
panel
-
Pericardial
fluid
|
|
69741-7
|
Differential
panel
-
Pericardial
fluid
|
|
69742-5
|
CBC
W
Differential
panel,
method
unspecified
-
Blood
|
|
69756-5
|
Bordetella
sp
filamentous
hemagglutinin
and
pertussis
toxin
IgA
and
IgG
panel
-
Serum
by
IB.test
strip
|
|
69999-1
|
Positive
airway
pressure
panel
|
|
70130-0
|
Rickettsia
typhus
group
and
Rickettsia
spotted
fever
group
acute
and
convalescent
IgG
and
IgM
panel
-
Serum
by
Immunofluorescence
|
|
70161-5
|
Chlamydia
trachomatis
and
Neisseria
gonorrhoeae
rRNA
panel
-
Urine
by
Probe
and
target
amplification
method
|
|
70162-3
|
Chlamydia
trachomatis
and
Neisseria
gonorrhoeae
rRNA
panel
-
Urethra
by
Probe
and
target
amplification
method
|
|
70163-1
|
Chlamydia
trachomatis
and
Neisseria
gonorrhoeae
rRNA
panel
-
Cervix
by
Probe
and
target
amplification
method
|
|
70164-9
|
Chlamydia
trachomatis
and
Neisseria
gonorrhoeae
rRNA
panel
-
Vaginal
fluid
by
Probe
and
target
amplification
method
|
|
70219-1
|
Basic
metabolic
2008
panel
with
ionized
calcium
-
Serum
or
Plasma
|
|
71432-9
|
Human
papilloma
virus
16
and
18
and
31+33+35+39+45+51+52+56+58+59+66+68
DNA
-
Cervix
|
|
71775-1
|
Mycobacterium
tuberculosis
stimulated
gamma
interferon
panel
-
Blood
|
|
72103-5
|
Acute
and
chronic
leukemia
fusion
transcript
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
72104-3
|
Acute
and
chronic
leukemia
fusion
transcript
per
control
transcript
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
72105-0
|
Vital
signs
and
oximetry
-
admission,
home
health,
interim,
discharge
[CARE]
|
|
72171-2
|
Glucose
tolerance
2
hours
panel
-
Serum
or
Plasma
|
|
72199-3
|
HEDIS
2013
panel
|
|
72203-3
|
Parathyrin.intact
intraoperative
panel
-
Serum
or
Plasma
|
|
72257-9
|
Platelet
function.collagen
+
Adenosine
diphosphate
induced
and
Epinephrine
induced
panel
-
Blood
|
|
72264-5
|
Bilirubin
excess
and
oxyhemoglobin
and
methemoglobin
and
xanthochromia
and
albumin
quotient
panel
-
Serum
and
CSF
|
|
72272-8
|
Amylase
and
triacylglycerol
lipase
panel
-
Serum
or
Plasma
|
|
72283-5
|
Nail
assessment
panel
|
|
72284-3
|
Skin
assessment
panel
|
|
72286-8
|
Wound
dressing
panel
|
|
72287-6
|
Wound
size
panel
|
|
72292-6
|
Wound
exudate
panel
|
|
72299-1
|
Wound
tunneling
and
undermining
panel
|
|
72369-2
|
Body
site
identification
panel
|
|
72372-6
|
Wound
bed
and
edge
panel
|
|
72393-2
|
Cell
count
and
Differential
panel
-
Vitreous
fluid
by
Manual
count
|
|
72394-0
|
Cell
count
panel
-
Vitreous
fluid
by
Manual
count
|
|
72395-7
|
Differential
panel
-
Vitreous
fluid
|
|
72476-5
|
Methadone
panel
-
Saliva
(oral
fluid)
by
Confirmatory
method
|
|
72478-1
|
Synthetic
cannabinoids
panel
-
Urine
by
Confirmatory
method
|
|
72479-9
|
Drugs
of
abuse
panel
-
Blood
by
Screen
method
|
|
72480-7
|
Barbiturates
panel
-
Blood
by
Confirmatory
method
|
|
72481-5
|
Candida
sp
6
panel
-
Vaginal
fluid
by
Probe
and
target
amplification
method
|
|
72488-0
|
Beta
2
glycoprotein
1
IgG
and
IgM
panel
-
Serum
|
|
72661-2
|
Intrinsic
coagulation
factor
activity
4
panel
-
Platelet
poor
plasma
by
Coagulation
assay
|
|
72662-0
|
Extrinsic
coagulation
factor
activity
4
panel
-
Platelet
poor
plasma
|
|
72670-3
|
Metanephrine,
Normetanephrine,
3-Methoxytyramine
and
Creatinine
panel
-
Urine
|
|
72694-3
|
Cholinesterase
activity
panel
-
Serum
or
Plasma
|
|
72695-0
|
Erythrocyte
enzyme
panel
-
Red
Blood
Cells
|
|
72718-0
|
Borderline
symptom
list
-
behavior
supplement
|
|
72719-8
|
Borderline
symptom
list
-
23
item
[BSL-23]
|
|
72727-1
|
Del(13)(q14)
and
del(17)(p13)
in
Blood
or
Tissue
|
|
72828-7
|
Chlamydia
trachomatis
and
Neisseria
gonorrhoeae
DNA
panel
-
Unspecified
specimen
|
|
72852-7
|
Cytomegalovirus
resistance
panel
by
Genotype
method
|
|
72862-6
|
Hepatitis
C
virus
resistance
panel
by
Genotype
method
|
|
72886-5
|
CYP2D6
gene
and
CYP2C19
gene
targeted
mutation
analysis
panel
-
Blood,
Tissue
or
Saliva
by
Molecular
genetics
method
|
|
72892-3
|
Staphylococcus
aureus
and
Methicillin
(mecA)
genes
panel
-
Nose
by
Probe
and
target
amplification
method
|
|
72905-3
|
Neutrophil
Ab
and
HLA
Ab
screen
panel
-
Serum
or
Plasma
|
|
72906-1
|
HNA
Ab
panel
-
Serum
or
Plasma
|
|
72907-9
|
HNA
genotype
panel
-
Serum
or
Plasma
|
|
72908-7
|
Drug
induced
platelet
Ab
panel
-
Serum
or
Plasma
|
|
72909-5
|
Drug
induced
neutrophil
Ab
panel
-
Serum
or
Plasma
|
|
73660-3
|
Propoxyphene
panel
-
Saliva
(oral
fluid)
|
|
73661-1
|
Methadone
panel
-
Saliva
(oral
fluid)
by
Screen
method
|
|
73662-9
|
Benzodiazepines
panel
-
Saliva
(oral
fluid)
by
Screen
method
|
|
73663-7
|
Barbiturates
panel
-
Saliva
(oral
fluid)
by
Confirmatory
method
|
|
73724-7
|
Bile
acid
dihydroxy
and
trihydroxy
panel
-
Serum
or
Plasma
|
|
73725-4
|
Bile
acid
panel
-
24
hour
Stool
|
|
73738-7
|
Newborn
screening
test
results
panel
-
Point
of
Care
|
|
73741-1
|
Newborn
hearing
screen
panel
of
Ear
-
left
|
|
73744-5
|
Newborn
hearing
screen
panel
of
Ear
-
right
|
|
73790-8
|
Neonatal
skin
risk
assessment
scale
panel
[NSRAS]
|
|
73805-4
|
CCHD
newborn
screening
panel
|
|
73852-6
|
7-Dehydrocholesterol
and
8-Dehydrocholesterol
panel
-
Serum
or
Plasma
|
|
73865-8
|
Catecholamines
3
panel
[Moles/volume]
-
Plasma
|
|
73866-6
|
Catecholamines
3
and
creatinine
panel
[Molar
ratio]
-
Urine
|
|
73879-9
|
Catecholamine
metabolites
and
creatinine
panel
-
Urine
|
|
73885-6
|
Steroid
fractions
panel
-
24
hour
Urine
|
|
73886-4
|
Steroid
fractions
panel
-
Urine
|
|
73897-1
|
Chronic
lyme
disease
panel
-
Blood
by
Flow
cytometry
(FC)
|
|
73967-2
|
Noninvasive
prenatal
fetal
aneuploidy
test
panel
-
Plasma
cell-free
DNA
|
|
73979-7
|
Keyhole
limpet
hemocyanin
Ab
panel
-
Serum
or
Plasma
|
|
74028-2
|
Virtual
Medical
Record
for
Clinical
Decision
Support
panel
HL7.VMR-CDS
|
|
74029-0
|
Periodontal
attachment
-
recommended
CDA
set
|
|
74032-4
|
Arbovirus
IgM
panel
-
Serum
|
|
74080-3
|
Patient
safety
event
report
-
hospital
-
medication
or
other
substance
-
version
1.2
[AHRQ]
|
|
74219-7
|
Weight
difference
pre
dialysis
and
post
dialysis
panel
|
|
74281-7
|
Mycobacterium
tuberculosis
stimulated
gamma
interferon
and
spot
count
panel
-
Blood
|
|
74352-6
|
Cryoglobulin
and
cryofibrinogen
panel
-
Serum
and
Plasma
|
|
74353-4
|
Sodium
and
Potassium
panel
[Moles/volume]
-
Blood
|
|
74408-6
|
Middle
east
respiratory
syndrome
coronavirus
(MERS-CoV)
RNA
panel
-
Unspecified
specimen
|
|
74409-4
|
MICA
IgG
panel
-
Serum
|
|
74410-2
|
Polychlorinated
biphenyl
(PCB)
panel
-
Serum
or
Plasma
by
Confirmatory
method
|
|
74412-8
|
CBC
W
Differential
panel
-
Cord
blood
|
|
74413-6
|
Differential
panel
-
Cord
blood
|
|
74439-1
|
Gamma
aminobutyrate
free
and
total
panel
-
Cerebral
spinal
fluid
|
|
74445-8
|
Porphyrin
fractions
panel
[Moles/mass]
-
Stool
|
|
74446-6
|
Stone
analysis
panel
|
|
74447-4
|
Sugars
and
polyols
panel
[Molar
ratio]
-
Urine
|
|
74514-1
|
Amino
acids
panel
[Moles/volume]
-
Urine
|
|
74519-0
|
Complement
activity
panel
-
Serum
|
|
74526-5
|
Delta
aminolevulinate,
porphobilinogen
and
creatinine
panel
-
24
hour
Urine
|
|
74527-3
|
Delta
aminolevulinate,
porphobilinogen
and
creatinine
panel
-
Urine
|
|
74533-1
|
Fatty
acid
oxidation
panel
-
Fibroblast
|
|
74545-5
|
Tryptophan-related
indole
profiling
panel
-
Platelet
rich
plasma
|
|
74633-9
|
Dimethylacetal
(DMA)
panel
-
Fibroblast
|
|
74634-7
|
Dimethylacetal
(DMA)
panel
-
Red
Blood
Cells
|
|
74635-4
|
Bacterial
vaginosis
DNA
panel
-
Vaginal
fluid
by
Probe
and
target
amplification
method
|
|
74728-7
|
Vital
signs,
weight,
height,
head
circumference,
oximetry,
BMI,
and
BSA
panel
-
HL7.CCDAr1.1
|
|
74749-3
|
Gram
positive
blood
culture
panel
by
Nucleic
acid
capture
and
probe
detection
in
Positive
blood
culture
|
|
74760-0
|
Hydrocodone
and
hydromorphone
panel
-
Urine
by
Confirmatory
method
|
|
74764-2
|
Soluble
fms-like
tyrosine
kinase-1
and
placental
growth
factor
panel
-
Serum
or
Plasma
|
|
74773-3
|
Immunoglobulin
light
chains
and
heavy
chains
panel
-
Serum
or
Plasma
|
|
74787-3
|
Influenza
virus
B
Victoria
and
Yamagata
lineage
RNA
panel
-
Unspecified
specimen
|
|
74788-1
|
Lactulose
challenge
(hydrogen
breath
test)
panel
-
Exhaled
gas
|
|
74789-9
|
Fructose
challenge
(hydrogen
breath
test)
panel
-
Exhaled
gas
|
|
74790-7
|
Glucose
challenge
(hydrogen
breath
test)
panel
-
Exhaled
gas
|
|
74831-9
|
Metanephrine
and
Normetanephrine
panel
[Moles/volume]
-
Urine
|
|
74835-0
|
Porphyrin
fractions
panel
-
Stool
|
|
74874-9
|
Metabolic
disorder
therapy
monitoring
panel
-
Dried
blood
spot
|
|
74885-5
|
HER2
panel
-
Tissue
by
Fluorescent
in
situ
hybridization
(FISH)
|
|
74888-9
|
Sterols
panel
[Moles/volume]
-
Serum
or
Plasma
|
|
74910-1
|
Porphyrin
fractions
and
creatinine
panel
[Molar
ratio]
-
24
hour
Urine
|
|
74914-3
|
Acylglycines
panel
[Molar
ratio]
-
Urine
|
|
74978-8
|
Cerebroside
sulfatase
and
N-Acetylgalactosamine-4-Sulfatase
panel
[Enzymatic
activity/mass]
-
Leukocytes
|
|
74991-1
|
Amino
acids
panel
[Molar
ratio]
-
Urine
|
|
74993-7
|
Chloride
and
sodium
panel
[Moles/volume]
-
Sweat
|
|
75021-6
|
Olanzapine
panel
-
Serum
or
Plasma
|
|
75199-0
|
Congenital
syphilis
case
investigation
and
report
panel
[CDC.CS]
|
|
75243-6
|
Norton
scale
panel
|
|
75256-8
|
Disability
information
and
assistance
needed
panel
[HHS.ACA
Section
4302.ONC]
|
|
75258-4
|
PROMIS
short
form
-
sleep
disturbance
4a
-
version
1.0
|
|
75259-2
|
PROMIS
short
form
-
pain
intensity
3a
-
version
1.0
|
|
75282-4
|
Nutrition
assessment
panel
|
|
75283-2
|
Food
and
nutrition
history
panel
|
|
75284-0
|
Food
and
nutrient
intake
panel
|
|
75285-7
|
Comparative
nutrition
assessment
standards
panel
|
|
75286-5
|
Nutrition
related
anthropometric
measurements
panel
|
|
75287-3
|
Food
and
beverage
intake
panel
|
|
75304-6
|
Nutrition
status
observation
panel
|
|
75418-4
|
PCORI
patient-reported
outcomes
common
measures
-
core
and
recommended
[PROMIS]
|
|
75419-2
|
PCORI
patient-reported
outcomes
recommended
measures
[PROMIS]
|
|
75420-0
|
PCORI
patient-reported
outcomes
core
pediatric
measures
[PROMIS]
|
|
75421-8
|
PCORI
patient-reported
outcomes
core
adult
measures
[PROMIS]
|
|
75515-7
|
Lupus
anticoagulant
aPTT
and
dRVVT
screening
panel
W
Reflex
|
|
75547-0
|
Noninvasive
prenatal
fetal
aneuploidy
and
microdeletion
panel
based
on
Plasma
cell-free+WBC
DNA
by
Dosage
of
chromosome-specific
circulating
cell
free
(ccf)
DNA
|
|
75619-7
|
National
Health
Care
Surveys
report
|
|
75620-5
|
TNM
clinical
staging
before
treatment
panel
Cancer
|
|
75621-3
|
TNM
pathologic
staging
after
surgery
panel
Cancer
|
|
75622-1
|
HIV
1
and
2
tests
-
Meaningful
Use
set
|
|
75635-3
|
Rheumatoid
arthritis
disease
activity
panel
-
Serum
or
Plasma
by
VectraDA
|
|
75641-1
|
Electrolytes
3
panel
-
Cerebral
spinal
fluid
|
|
75667-6
|
Electrolytes
3
panel
-
24
hour
Urine
|
|
75673-4
|
Gram
negative
blood
culture
panel
by
Nucleic
acid
capture
and
probe
detection
in
Positive
blood
culture
|
|
75689-0
|
Iron
panel
-
Serum
or
Plasma
|
|
75697-3
|
Bilirubin
fractions
panel
[Moles/volume]
-
Serum
or
Plasma
|
|
75742-7
|
Dartmouth
COOP
Functional
Assessment
Charts
-
2
weeks
|
|
75743-5
|
Dartmouth
COOP
Functional
Assessment
Charts
-
4
weeks
|
|
75772-4
|
Advance
directives
panel
[ADVault]
|
|
75814-4
|
Antihistamines
panel
-
Serum
or
Plasma
or
Urine
by
Screen
method
|
|
75815-1
|
Antipsychotics
drug
panel
-
Blood
or
Urine
by
Screen
method
|
|
75842-5
|
Clinical
disease
activity
index
[CDAI]
|
|
75843-3
|
Simplified
disease
activity
index
[SDAI]
|
|
75858-1
|
Sterols
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
75860-7
|
Hepatitis
A
virus
RNA
and
Parvovirus
B19
DNA
panel
-
Plasma
from
donor
by
Probe
and
target
amplification
method
|
|
75881-3
|
Lupus
anticoagulant
aPTT,
dRVVT
and
PT
screening
panel
W
Reflex
|
|
76067-8
|
Abbreviated
Injury
Scale
panel
AAAM
|
|
76091-8
|
Respiratory
pathogens
DNA
and
RNA
4
panel
-
Nasopharynx
by
Probe
and
target
amplification
method
|
|
76133-8
|
Sugar
absorption
test
panel
[Molar
ratio]
-
5
hour
Urine
|
|
76452-2
|
APTA
Registry
patient
registration
panel
|
|
76453-0
|
Physical
therapy
initial
visit
panel
|
|
76454-8
|
Physical
therapy
subsequent
visit
panel
|
|
76455-5
|
Physical
therapy
re-evaluation
panel
|
|
76456-3
|
Physical
therapy
conclusion
of
care
panel
|
|
76478-7
|
Acetylcholinesterase
panel
-
Amniotic
fluid
|
|
76499-3
|
Humiliation,
Afraid,
Rape,
and
Kick
questionnaire
[HARK]
|
|
76506-5
|
Social
connection
and
isolation
panel
|
|
76546-1
|
Breast
cancer
10-year
risk
of
distant
recurrence
panel
by
Prosigna
|
|
76585-9
|
Wound
microorganism
gene
identification
panel
by
Probe
and
target
amplification
method
|
|
76586-7
|
ENT
microorganism
gene
identification
panel
by
Probe
and
target
amplification
method
|
|
76621-2
|
Lysosomal
acid
lipase
panel
-
Fibroblast
|
|
76623-8
|
Mitochondrial
respiratory
chain
enzyme
analysis
panel
-
Fibroblast
|
|
76659-2
|
Antipsychotics
drug
panel
-
Urine
by
Screen
method
|
|
76700-4
|
PROMIS
short
form
-
physical
function
4a
-
version
1.0
|
|
76701-2
|
PROMIS
short
form
-
satisfaction
with
participation
in
social
roles
8a
-
version
1.0
|
|
76702-0
|
PROMIS
short
form
-
physical
function
20a
-
version
1.0
|
|
76703-8
|
PROMIS
short
form
-
sleep
disturbance
6a
-
version
1.0
|
|
76704-6
|
PROMIS
short
form
-
satisfaction
with
participation
in
social
roles
4a
-
version
1.0
|
|
76731-9
|
PROMIS
short
form
-
ability
to
participate
in
social
roles
and
activities
8a
-
version
2.0
|
|
76732-7
|
PROMIS
short
form
-
companionship
4a
-
version
2.0
|
|
76733-5
|
PROMIS
short
form
-
companionship
6a
-
version
2.0
|
|
76734-3
|
PROMIS
short
form
-
emotional
support
6a
-
version
2.0
|
|
76735-0
|
PROMIS
short
form
-
emotional
support
4a
-
version
2.0
|
|
76736-8
|
PROMIS
short
form
-
emotional
support
8a
-
version
2.0
|
|
76770-7
|
Trace
elements
panel
-
Hair
|
|
76771-5
|
Respiratory
pathogens
RNA
8
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
76774-9
|
PROMIS
item
bank
-
satisfaction
with
social
roles
and
activities
-
version
2.0
|
|
76787-1
|
PROMIS
item
bank
-
ability
to
participate
in
social
roles
and
activities
-
version
2.0
|
|
76788-9
|
PROMIS
item
bank
-
companionship
-
version
2.0
|
|
76789-7
|
PROMIS
item
bank
-
emotional
support
-
version
2.0
|
|
76790-5
|
PROMIS
item
bank
-
informational
support
-
version
2.0
|
|
76791-3
|
PROMIS
item
bank
-
instrumental
support
-
version
2.0
|
|
76792-1
|
PROMIS
short
form
-
informational
support
4a
-
version
2.0
|
|
76793-9
|
PROMIS
short
form
-
informational
support
6a
-
version
2.0
|
|
76794-7
|
PROMIS
short
form
-
informational
support
8a
-
version
2.0
|
|
76795-4
|
PROMIS
short
form
-
instrumental
support
4a
-
version
2.0
|
|
76796-2
|
PROMIS
short
form
-
instrumental
support
6a
-
version
2.0
|
|
76797-0
|
PROMIS
short
form
-
instrumental
support
8a
-
version
2.0
|
|
76798-8
|
PROMIS
short
form
-
satisfaction
with
social
roles
and
activities
4a
-
version
2.0
|
|
76799-6
|
PROMIS
short
form
-
satisfaction
with
social
roles
and
activities
6a
-
version
2.0
|
|
76800-2
|
PROMIS
short
form
-
satisfaction
with
social
roles
and
activities
8a
-
version
2.0
|
|
76801-0
|
PROMIS
short
form
-
social
isolation
4a
-
version
2.0
|
|
76802-8
|
PROMIS
short
form
-
social
isolation
6a
-
version
2.0
|
|
76803-6
|
PROMIS
short
form
-
social
isolation
8a
-
version
2.0
|
|
76804-4
|
PROMIS
short
form
-
physical
function
6b
-
version
1.2
|
|
76805-1
|
PROMIS
short
form
-
physical
function
8b
-
version
1.2
|
|
76806-9
|
PROMIS
item
bank
-
social
isolation
-
version
2.0
|
|
76889-5
|
PROMIS
item
bank
-
alcohol
-
positive
expectancies
-
version
1.0
|
|
76899-4
|
PROMIS
item
bank
-
alcohol
-
alcohol
use
-
version
1.0
|
|
76938-0
|
PROMIS
item
bank
-
alcohol
-
negative
consequences
-
version
1.0
|
|
76939-8
|
PROMIS
item
bank
-
alcohol
-
positive
outcomes
-
version
1.0
|
|
76940-6
|
PROMIS
item
bank
-
alcohol
-
negative
expectancies
-
version
1.0
|
|
77003-2
|
PROMIS
short
form
-
alcohol
-
alcohol
use
7a
-
version
1.0
|
|
77004-0
|
PROMIS
short
form
-
alcohol
-
negative
consequences
7a
-
version
1.0
|
|
77005-7
|
PROMIS
short
form
-
alcohol
-
negative
expectancies
7a
-
version
1.0
|
|
77006-5
|
PROMIS
short
form
-
alcohol
-
positive
expectancies
7a
-
version
1.0
|
|
77007-3
|
PROMIS
short
form
-
alcohol
-
positive
consequences
7a
-
version
1.0
|
|
77009-9
|
Porphyrin
fractions
panel
[Moles/volume]
-
Serum
or
Plasma
|
|
77018-0
|
Noninvasive
prenatal
fetal
13
and
18
and
21
aneuploidy
panel
-
Plasma
cell-free
DNA
by
Sequencing
|
|
77019-8
|
Noninvasive
prenatal
fetal
18
and
21
aneuploidy
panel
-
Plasma
cell-free
DNA
by
Sequencing
|
|
77029-7
|
Respiratory
pathogens
DNA
and
RNA
14
panel
-
Nasopharynx
by
Probe
and
target
amplification
method
|
|
77151-9
|
Energy
content
panel
-
24
hour
Stool
|
|
77165-9
|
Anaplasma
phagocytophilum
and
Ehrlichia
chaffeensis
IgG
panel
[Titer]
-
Serum
|
|
77166-7
|
Chlamydia
sp
IgG
and
IgM
panel
[Titer]
-
Serum
by
Immunofluorescence
|
|
77175-8
|
Coxiella
burnetii
phase
1
and
2
IgG
and
IgM
panel
-
Serum
|
|
77176-6
|
Hepatitis
B
virus
little
e
Ag
and
Ab
panel
-
Serum
|
|
77190-7
|
Hepatitis
B
virus
core
and
surface
Ab
and
surface
Ag
panel
-
Serum
|
|
77197-2
|
Noninvasive
arteriosclerosis
studies
panel
|
|
77217-8
|
Salivary
gland
protein
1
and
Carbonic
anhydrase
6
and
Parotid
secretory
protein
IgA
and
IgG
and
IgM
panel
-
Serum
by
Immunoassay
|
|
77249-1
|
Weight
management
summary
-
recommended
IHE
set
|
|
77250-9
|
Mumps
virus
IgG
and
IgM
panel
-
Serum
|
|
77310-1
|
Measles
virus
Ab.IgG
associated
observations
panel
-
Serum
|
|
77347-3
|
Beta-2
transferrin
panel
-
Serum
or
Plasma
and
CSF
|
|
77364-8
|
Tryptophan,
kynurenin
and
3-hydroxykynurenin
panel
-
Serum
or
Plasma
|
|
77365-5
|
Nitrogen
panel
-
24
hour
Stool
|
|
77366-3
|
Metanephrine.free
and
Normetanephrine.free
and
3-Methoxytyramine.free
panel
[Moles/volume]
-
Serum
or
Plasma
|
|
77374-7
|
Clomipramine
trough,
Clomipramine+Norclomipramine
trough
and
Norclomipramine
panel
-
Serum
or
Plasma
|
|
77376-2
|
Human
papilloma
virus
16
and
18
and
31+33+35+39+45+51+52+56+58+59+66+68
DNA
-
Anorectal
|
|
77378-8
|
Human
papilloma
virus
16
and
18
and
31+33+35+39+45+51+52+56+58+59+66+68
DNA
-
Unspecified
specimen
|
|
77381-2
|
Protein
electrophoresis
panel
in
Urine
collected
for
unspecified
duration
|
|
77398-6
|
Mumps
virus
IgG
and
IgM
index
panel
-
Serum
|
|
77547-8
|
American
National
Adult
Reading
Test
(AmNART)
panel
|
|
77548-6
|
Client
accessibility
panel
[NMMDS]
|
|
77564-3
|
Brief
Pain
Inventory
Short
Form
-
pain
interference
panel
|
|
77574-2
|
Global
measure
of
physical
function
panel
APTA
|
|
77575-9
|
Condition-
or
population-specific
panel
APTA
|
|
77576-7
|
Self-care
and
mobility
panel
APTA
|
|
77577-5
|
Chlamydia
trachomatis
and
Neisseria
gonorrhoeae
DNA
panel
-
Urethra
by
Probe
and
target
amplification
method
|
|
77637-7
|
HLA-A
and
B
and
C
(class
I)
IgG
panel
[Identifier]
-
Serum
or
Plasma
by
Immunoassay
|
|
77638-5
|
HLA-DP
and
DQ
and
DR
(class
II)
IgG
panel
[Identifier]
-
Serum
or
Plasma
by
Immunoassay
|
|
77639-3
|
HLA
class
I
and
II
IgG
panel
-
Serum
or
Plasma
by
Immunoassay
|
|
77717-7
|
Unified
Parkinson's
Disease
Rating
Scale
(UPDRS)
panel
|
|
77737-5
|
Mycobacterium
abscessus
complex
clarithromycin
resistance
(erm(41))
gene
panel
-
Isolate
by
Probe
and
target
amplification
method
|
|
77742-5
|
HTLV
I
and
II
panel
-
Serum
or
Plasma
by
Immunoblot
(IB)
|
|
77875-3
|
PROMIS
pediatric
short
form
-
emotional
distress
-
anxiety
8b
-
version
1.1
|
|
78000-7
|
Case
notification
panel
[CDC.PHIN]
|
|
78013-0
|
HLA-A
and
B
and
DRB
and
DQB1
panel
[Type]
-
Blood
or
Tissue
by
Low
resolution
|
|
78161-7
|
PROMIS
pediatric
item
bank
-
physical
function
-
upper
extremity
-
version
2.0
|
|
78344-9
|
Fatty
acid
comprehensive
(C8-C26)
panel
-
Red
Blood
Cells
|
|
78361-3
|
Fatty
acid
and
triglyceride
panel
-
24
hour
Stool
|
|
78365-4
|
Imipramine
trough,
Imipramine+desimipramine
trough
and
Desipramine
panell
-
Serum
or
Plasma
|
|
78434-8
|
Carbamazepine
free
and
total
trough
and
10,11-Epoxide
panel
-
Serum
or
Plasma
|
|
78435-5
|
Mirtazapine
trough
and
Normirtazapine
panel
-
Serum
or
Plasma
|
|
78436-3
|
Primidone
and
phenobarbital
trough
panel
-
Serum
or
Plasma
|
|
78437-1
|
Fluoxetine
trough,
Fluoxetine+norfluoxetine
trough
and
Norfluoxetine
panel
-
Serum
or
Plasma
|
|
78438-9
|
Sertraline
trough
and
Norsertraline
panel
-
Serum
or
Plasma
|
|
78439-7
|
Phenytoin
free
and
total
trough
panel
-
Serum
or
Plasma
|
|
78440-5
|
Risperidone
trough
and
9-Hydroxyrisperidone
panel
-
Serum
or
Plasma
|
|
78698-8
|
Liver
fibrosis
score
panel
-
Serum
or
Plasma
Calculated
by
HepaScore
|
|
78699-6
|
Liver
fibrosis
score
panel
-
Serum
or
Plasma
Calculated
by
FibroMeter
|
|
78747-3
|
Peritoneal
equilibration
test
panel
-
Peritoneal
dialysis
fluid
|
|
78895-0
|
Coronary
angiography
panel
|
|
78914-9
|
Percutaneous
coronary
intervention
panel
|
|
78921-4
|
Bordetella
pertussis
and
Bordetella
parapertussis
DNA
and
culture
panel
-
Nasopharynx
|
|
78922-2
|
Respiratory
pathogens
DNA
and
RNA
panel
-
Nasopharynx
by
Probe
and
target
amplification
method
|
|
78923-0
|
Comorbid
condition
panel
|
|
78933-9
|
Assisted
circulation
procedures
performed
panel
|
|
78939-6
|
Percutaneous
coronary
intervention
device
panel
|
|
78942-0
|
Catheterization
and
angiography
device
panel
|
|
78950-3
|
Left
ventricle
Segmental
wall
motion
panel
by
Angiogram
|
|
78960-2
|
Aldosterone
and
renin
concentration
panel
-
Plasma
|
|
78993-3
|
Prolactin
isoforms
panel
-
Serum
or
Plasma
|
|
79062-6
|
PROMIS
item
bank
-
physical
function
w
mobility
aids
-
version
1.0
|
|
79063-4
|
PROMIS
short
form
-
physical
function
w
mobility
aids
-
version
1.0
|
|
79115-2
|
General
Practitioner
Assessment
of
Cognition
[GPCOG]
|
|
79160-8
|
Cold
agglutinin
panel
-
Serum
|
|
79161-6
|
Nortriptyline
and
E-10-hydroxynortriptyline
and
Z-10-hydroxynortriptyline
panel
-
Serum
or
Plasma
|
|
79162-4
|
Chlordiazepoxide
and
Norchlordiazepoxide
panel
-
Serum
or
Plasma
|
|
79165-7
|
Oxcarbazepine
trough
and
10-hydroxycarbazepine
panel
-
Serum
or
Plasma
|
|
79191-3
|
Patient
demographics
panel
|
|
79221-8
|
Steroid
fractions
panel
-
Serum
or
Plasma
|
|
79284-6
|
Carnitine
biosynthesis
intermediates
panel
-
Dried
blood
spot
|
|
79285-3
|
Carnitine
biosynthesis
intermediates
panel
-
Serum
or
Plasma
|
|
79286-1
|
Carnitine
biosynthesis
intermediates
panel
-
Cerebral
spinal
fluid
|
|
79287-9
|
Carnitine
biosynthesis
intermediates
panel
-
Urine
|
|
79288-7
|
Creatine
and
guanidinoacetate
panel
-
Cerebral
spinal
fluid
|
|
79289-5
|
Creatine
and
guanidinoacetate
panel
-
Serum
or
Plasma
|
|
79290-3
|
Creatine,
guanidinoacetate
and
creatinine
panel
-
Urine
|
|
79294-5
|
D-
and
L-2-hydroxyglutarate
panel
-
Cerebral
spinal
fluid
|
|
79295-2
|
D-
and
L-2-hydroxyglutarate
panel
-
Serum
or
Plasma
|
|
79296-0
|
D-
and
L-2-hydroxyglutarate
panel
-
Amniotic
fluid
|
|
79297-8
|
D-
and
L-2-hydroxyglutarate
panel
-
Urine
|
|
79298-6
|
D-
and
L-2-hydroxyglutarate
panel
-
Dried
blood
spot
|
|
79381-0
|
Gastrointestinal
pathogens
panel
-
Stool
by
Probe
and
target
amplification
method
|
|
79391-9
|
Catecholamine
metabolites
panel
-
Cerebral
spinal
fluid
|
|
79399-2
|
Synovial
fluid
analysis
panel
-
Synovial
fluid
|
|
79408-1
|
Clobazam
and
norclobazam
panel
-
Serum
or
Plasma
|
|
79409-9
|
Dothiepin+nordothiepin
trough
and
dothiepin
sulfoxide
panel
-
Serum
or
Plasma
|
|
79412-3
|
Mianserin
trough
and
Normianserin
panel
-
Serum
or
Plasma
|
|
79424-8
|
Serial
sputum
smears
for
diagnosing
pulmonary
tuberculosis
panel
-
by
Acid
fast
stain
-
Ziehl-Neelsen
|
|
79448-7
|
Staphylococcus
aureus
and
Methicillin-resistant
Staphylococcus
aureus
panel
-
Nose
by
Probe
and
target
amplification
method
|
|
79499-0
|
Catecholamine
metabolites
panel
-
Serum
or
Plasma
|
|
79563-3
|
Mucopolysaccharidosis
type
I
newborn
screening
panel
|
|
79572-4
|
Folate
and
tryptophan
and
metabolites
panel
-
Cerebral
spinal
fluid
|
|
79573-2
|
Riboflavin
and
flavin
mononucleotide
and
flavin
adenine
dinucleotide
panel
-
Serum
or
Plasma
|
|
79575-7
|
Metanephrine,
Normetanephrine,
3-Methoxytyramine
and
Creatinine
panel
-
24
hour
Urine
|
|
79583-1
|
R-
and
S-beta
aminoisobutyrate
and
D-
and
L-serine
panel
-
Serum
or
Plasma
|
|
79584-9
|
Beta
alanine
and
Beta
aminoisobutyrate
and
Gamma
aminobutyrate
panel
-
Urine
|
|
79586-4
|
R-
and
S-beta
aminoisobutyrate
and
D-
and
L-serine
panel
-
Cerebral
spinal
fluid
|
|
79603-7
|
Beta
alanine
and
Beta
aminoisobutyrate
and
Gamma
aminobutyrate
panel
-
Cerebral
spinal
fluid
|
|
79605-2
|
R-
and
S-beta
aminoisobutyrate
and
D-
and
L-serine
panel
-
Urine
|
|
79621-9
|
Phenylalanine
and
Tyrosine
panel
-
Dried
blood
spot
|
|
79650-8
|
Beta
alanine
and
Beta
aminoisobutyrate
and
Gamma
aminobutyrate
panel
-
Serum
or
Plasma
|
|
79665-6
|
Purine
and
Pyrimidine
panel
-
Serum
or
Plasma
|
|
79668-0
|
Purine
and
Pyrimidine
panel
-
Cerebral
spinal
fluid
|
|
79673-0
|
Purine
and
Pyrimidine
panel
-
Urine
|
|
79894-2
|
Electroretinography
(ERG)
measurements
panel
|
|
79895-9
|
Subjective
refraction
measurements
panel
|
|
79896-7
|
Tonometry
measurements
panel
|
|
79898-3
|
Objective
refraction
measurements
panel
|
|
80163-9
|
Bile
alcohols
panel
-
Urine
|
|
80168-8
|
Pterins
panel
-
Cerebral
spinal
fluid
|
|
80169-6
|
Pterins
panel
-
Serum
or
Plasma
|
|
80170-4
|
Pterins
panel
-
Urine
|
|
80178-7
|
S-adenosylmethionine
and
S-adenosylhomocystine
panel
-
Serum
or
Plasma
|
|
80179-5
|
S-adenosylmethionine
and
S-adenosylhomocystine
panel
-
Cerebral
spinal
fluid
|
|
80190-2
|
Catheterization
and
angiography
procedure
details
panel
|
|
80191-0
|
Spasm
stress
test
panel
|
|
80192-8
|
Coronary
segment
additional
details
panel
|
|
80346-0
|
Nursing
physiologic
assessment
panel
|
|
80354-4
|
Herpes
simplex
virus
1
and
2
DNA
panel
-
Anogenital
specimen
by
Probe
and
target
amplification
method
|
|
80376-7
|
Rotavirus
and
Adenovirus
Ag
panel
-
Stool
by
Rapid
immunoassay
|
|
80381-7
|
Influenza
virus
A
and
B
Ag
panel
-
Nasopharynx
by
Rapid
immunoassay
|
|
80439-3
|
Alcohol
intake
panel
|
|
80440-1
|
Bioactive
compound
intake
panel
|
|
80441-9
|
Breast
milk
andor
formula
intake
panel
|
|
80442-7
|
Breast
milk
intake
panel
|
|
80443-5
|
Calorie
intake
panel
|
|
80444-3
|
Fluid
intake
panel
|
|
80445-0
|
Food
amounts
panel
|
|
80446-8
|
Infant
formula
intake
panel
|
|
80447-6
|
Meal
andor
snack
pattern
panel
|
|
80453-4
|
Food
intake
panel
|
|
80454-2
|
Enteral
tube
nutritional
intake
panel
|
|
80525-9
|
Uroflowmetry
panel
|
|
80527-5
|
Percutaneous
coronary
intervention
individual
lesion
details
panel
|
|
80528-3
|
Catheterization
and
angiography
preoperative
information
panel
|
|
80716-4
|
Activated
T-cell
(CD38+HLA-DR+)
subsets
panel
-
Blood
|
|
80717-2
|
B-cell
CD27
and
IgD
subsets
panel
-
Blood
|
|
80718-0
|
Lymphocyte
TCR
gamma
delta
and
alpha
beta
subsets
panel
-
Blood
|
|
80720-6
|
T-cell
naive
and
memory
and
effector
(CD27
and
CD45RA)
subsets
panel
-
Blood
|
|
80722-2
|
Lymphocyte
T-cell
and
B-cell
and
Natural
killer
subsets
[Interpretation]
in
Blood
Narrative
|
|
80827-9
|
Clostridium
botulinum
and
Clostridium
baratii
toxins
gene
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
80831-1
|
Pepsin
A
Panel
-
Lower
respiratory
specimen
|
|
81154-7
|
Dengue
and
Chikungunya
and
Zika
virus
panel
by
Probe
and
target
amplification
method
|
|
81186-9
|
Gastric
cancer
pathology
panel
|
|
81205-7
|
Cryoglobulin
IgA
and
IgG
and
IgM
and
C3
panel
-
Serum
|
|
81207-3
|
Amitriptyline
and
Nortriptyline
panel
-
Gastric
fluid
|
|
81208-1
|
Amitriptyline
and
Nortriptyline
panel
-
Urine
|
|
81209-9
|
Clomipramine
and
Norclomipramine
panel
-
Urine
|
|
81210-7
|
Clomipramine
and
Norclomipramine
panel
-
Gastric
fluid
|
|
81211-5
|
Amitriptyline
and
Nortriptyline
panel
-
Unspecified
specimen
|
|
81212-3
|
Clomipramine
and
Norclomipramine
panel
-
Unspecified
specimen
|
|
81231-3
|
Protein
electrophoresis
panel
-
24
hour
Urine
|
|
81232-1
|
Supersaturation
panel
-
24
hour
Urine
|
|
81233-9
|
Influenza
virus
types
A
and
B
and
subtypes
panel
-
Respiratory
specimen
|
|
81234-7
|
Varicella
zoster
virus
IgG
and
IgM
panel
-
Serum
or
Plasma
Qualitative
|
|
81235-4
|
Varicella
zoster
virus
surveillance
panel
|
|
81240-4
|
Document
template
attachment
request
modifier
codes
|
|
81246-1
|
HIV
2
RNA
panel
-
Serum
or
Plasma
by
Probe
and
target
amplification
method
|
|
81247-9
|
Master
HL7
genetic
variant
reporting
panel
|
|
81250-3
|
Simple
variant
panel
|
|
81251-1
|
Complex
variant
panel
|
|
81272-7
|
Cell
count
and
Differential
panel
-
Dialysis
fluid
|
|
81273-5
|
Fentanyl
and
Norfentanyl
panel
-
Unspecified
specimen
|
|
81274-3
|
Doxepin
and
Nordoxepin
panel
-
Gastric
fluid
|
|
81275-0
|
Fentanyl
and
Norfentanyl
panel
-
Serum
or
Plasma
|
|
81276-8
|
Doxepin
and
Nordoxepin
panel
-
Urine
|
|
81277-6
|
Fentanyl
and
Norfentanyl
panel
-
Gastric
fluid
|
|
81278-4
|
Meperidine
and
Normeperidine
panel
-
Gastric
fluid
|
|
81279-2
|
Meperidine
and
Normeperidine
panel
-
Unspecified
specimen
|
|
81280-0
|
Differential
panel
-
Dialysis
fluid
|
|
81281-8
|
Heparin
dose
response
panel
-
Blood
|
|
81294-1
|
Genetic
form
configuration
controls
Nominal
|
|
81297-4
|
Structural
variant
panel
|
|
81323-8
|
Urine
collection
associated
observations
panel
-
24
hour
Urine
|
|
81324-6
|
Glucose
tolerance
2
hours
gestational
panel
-
Serum
or
Plasma
|
|
81492-1
|
PROMIS
item
bank
-
cognitive
function
-
abilities
subset
-
version
2.0
|
|
81524-1
|
PROMIS
item
bank
-
cognitive
function
-
version
2.0
|
|
81525-8
|
PROMIS
short
form
-
cognitive
function
-
abilities
subset
4a
-
version
2.0
|
|
81526-6
|
PROMIS
short
form
-
cognitive
function
-
abilities
subset
6a
-
version
2.0
|
|
81527-4
|
PROMIS
short
form
-
cognitive
function
-
abilities
subset
8a
-
version
2.0
|
|
81528-2
|
PROMIS
short
form
-
cognitive
function
4a
-
version
2.0
|
|
81529-0
|
PROMIS
short
form
-
cognitive
function
6a
-
version
2.0
|
|
81530-8
|
PROMIS
short
form
-
cognitive
function
8a
-
version
2.0
|
|
81620-7
|
Differential
panel
-
Bronchial
specimen
|
|
81621-5
|
Herpes
simplex
virus
1
and
2
IgG
panel
-
Serum
or
Plasma
|
|
81630-6
|
Methotrexate
polyglutamates
1-5
and
total
panel
-
Red
Blood
Cells
|
|
81632-2
|
Immunoglobulin
light
chains
panel
-
Serum
by
Nephelometry
|
|
81642-1
|
CYP3A4
and
CYP3A5
gene
targeted
mutation
analysis
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
81654-6
|
Respiratory
bacteria
and
viruses
DNA
and
RNA
[Identifier]
in
Tissue
by
Probe
and
target
amplification
method
|
|
81659-5
|
Escherichia
coli
shiga-like
toxin
1
and
2
(stx1
and
stx2)
genes
panel
-
Stool
by
Probe
and
target
amplification
method
|
|
81667-8
|
Output
count
panel
|
|
81671-0
|
Tissue
perfusion
assessment
panel
|
|
81674-4
|
Nutrition
and
fluid
intake
assessment
panel
|
|
81677-7
|
Output
assessment
panel
|
|
81711-4
|
Microsatellite
instability
marker
panel
-
Tissue
|
|
81763-5
|
Phytanate
and
pristanate
panel
-
Serum
or
Plasma
|
|
81895-5
|
Macronutrient
intake
panel
|
|
81896-3
|
Fat
intake
panel
|
|
81904-5
|
Protein
intake
panel
|
|
81912-8
|
Amino
acid
intake
panel
|
|
81913-6
|
Essential
amino
acid
intake
panel
|
|
81926-8
|
Fiber
intake
panel
|
|
81931-8
|
Nonessential
amino
acid
intake
panel
|
|
81940-9
|
Carbohydrate
intake
panel
|
|
81941-7
|
Micronutrient
intake
panel
|
|
81942-5
|
Vitamin
intake
panel
|
|
81943-3
|
Mineral
AndOr
trace
element
intake
panel
|
|
82159-5
|
Respiratory
pathogens
DNA
and
RNA
panel
-
Nasopharynx
by
Target
amplification
with
non-probe
based
detection
|
|
82180-1
|
Meningitis+Encephalitis
pathogens
DNA
and
RNA
panel
-
Cerebral
spinal
fluid
by
Target
amplification
with
non-probe
based
detection
|
|
82195-9
|
Gastrointestinal
pathogens
DNA
and
RNA
panel
-
Stool
by
Target
amplification
with
non-probe
based
detection
|
|
1003-3
|
Indirect
antiglobulin
test.complement
specific
reagent
[Presence]
in
Serum
or
Plasma
|
|
1004-1
|
Direct
antiglobulin
test.complement
specific
reagent
[Presence]
on
Red
Blood
Cells
|
|
1007-4
|
Direct
antiglobulin
test.poly
specific
reagent
[Presence]
on
Red
Blood
Cells
|
|
1015-7
|
Ew
Ag
[Presence]
on
Red
Blood
Cells
|
|
1021-5
|
E
Ag
[Presence]
on
Red
Blood
Cells
|
|
10226-9
|
Oxygen
content
in
Intravascular
space
|
|
10244-2
|
Oxygen
content
in
Left
pulmonary
artery
|
|
10245-9
|
Oxygen
content
in
Main
pulmonary
artery
|
|
10246-7
|
Oxygen
content
in
Right
pulmonary
artery
|
|
10247-5
|
Oxygen
content
in
Pulmonary
wedge
|
|
1027-2
|
Fy
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
1033-0
|
Fy
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
|
|
10331-7
|
Rh
[Type]
in
Blood
|
|
10334-1
|
Cancer
Ag
125
[Units/volume]
in
Serum
or
Plasma
|
|
10336-6
|
Gonadotropin
peptide
[Mass/volume]
in
Urine
|
|
10337-4
|
Procollagen
type
I
[Mass/volume]
in
Serum
|
|
10338-2
|
Barbiturates
[Mass/volume]
in
Serum
or
Plasma
|
|
10339-0
|
Fluoxetine+Norfluoxetine
[Mass/volume]
in
Serum
or
Plasma
|
|
10340-8
|
Molindone
[Mass/volume]
in
Serum
or
Plasma
|
|
10341-6
|
Norpropoxyphene
[Mass/volume]
in
Serum
or
Plasma
|
|
10342-4
|
Sulfamethoxazole
[Mass/volume]
in
Serum
or
Plasma
|
|
10343-2
|
Temazepam
[Mass/volume]
in
Serum
or
Plasma
|
|
10344-0
|
Tranylcypromine
[Mass/volume]
in
Serum
or
Plasma
|
|
10345-7
|
Trihexyphenidyl
[Mass/volume]
in
Urine
|
|
10347-3
|
Babesia
microti
identified
in
Blood
by
Light
microscopy
|
|
10348-1
|
Bordetella
parapertussis
Ab
[Presence]
in
Serum
|
|
10349-9
|
Brucella
sp
Ab
[Units/volume]
in
Serum
|
|
10350-7
|
Herpes
simplex
virus
IgM
Ab
[Titer]
in
Serum
by
Immunoassay
|
|
10351-5
|
HIV
1
RNA
[Units/volume]
(viral
load)
in
Serum
or
Plasma
by
Probe
with
amplification
|
|
10352-3
|
Bacteria
identified
in
Genital
specimen
by
Aerobe
culture
|
|
10353-1
|
Bacteria
identified
in
Nose
by
Aerobe
culture
|
|
10354-9
|
Bacteria
identified
in
Urethra
by
Culture
|
|
10355-6
|
Microscopic
observation
[Identifier]
in
Bone
marrow
by
Wright
Giemsa
stain
|
|
10357-2
|
Microscopic
observation
[Identifier]
in
Wound
by
Gram
stain
|
|
10358-0
|
Teichoate
Ab
[Titer]
in
Serum
by
Immune
diffusion
(ID)
|
|
10360-6
|
DNA
single
strand
IgG
Ab
[Units/volume]
in
Serum
|
|
10361-4
|
DNA
single
strand
IgM
Ab
[Units/volume]
in
Serum
|
|
10362-2
|
Endomysium
IgA
Ab
[Presence]
in
Serum
|
|
10363-0
|
Barbiturates
[Presence]
in
Unspecified
specimen
|
|
10364-8
|
Cotinine
[Mass/mass]
in
Hair
|
|
10365-5
|
Cotinine
[Mass/volume]
in
Serum
or
Plasma
|
|
10366-3
|
Cotinine
[Mass/volume]
in
Urine
|
|
10367-1
|
Ethanol
[Mass/volume]
in
Gastric
fluid
|
|
10368-9
|
Lead
[Mass/volume]
in
Capillary
blood
|
|
10369-7
|
Opiates
[Mass/mass]
in
Hair
|
|
10370-5
|
Phencyclidine
[Mass/mass]
in
Hair
|
|
10384-6
|
A,B
variant
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
10400-0
|
I
Ag
[Presence]
on
Red
Blood
Cells
|
|
10408-3
|
little
i
Ag
[Presence]
on
Red
Blood
Cells
|
|
1041-3
|
G
Ag
[Presence]
on
Red
Blood
Cells
|
|
10429-9
|
AE
1
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10430-7
|
AE
3
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10431-5
|
B-cell
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10432-3
|
CD30
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10433-1
|
BR-2
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10434-9
|
Complement
C3
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10435-6
|
C5B-9
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10436-4
|
CD15
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10437-2
|
CD16
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10438-0
|
CD20
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10439-8
|
CD3
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10441-4
|
CD34
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10442-2
|
CD56
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10443-0
|
CD43
T-cell
monocyte+myeloid
cell
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10444-8
|
CD57
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10445-5
|
CD11c
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10446-3
|
Leukocyte
common
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10447-1
|
M-5
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10448-9
|
T-cell
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10449-7
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
meal
|
|
10450-5
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--10
hours
fasting
|
|
10451-3
|
Proinsulin
[Moles/volume]
in
Serum
or
Plasma
--12
hours
fasting
|
|
10457-0
|
Actin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10458-8
|
Alkaline
phosphatase.placental
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10459-6
|
Alpha-1-Fetoprotein
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10460-4
|
Lactalbumin
alpha
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10461-2
|
Alpha-1-Antichymotrypsin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10462-0
|
Alpha
1
antitrypsin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10463-8
|
Amyloid
A
component
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10464-6
|
Amyloid
P
component
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10465-3
|
Amyloid.prealbumin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10467-9
|
Beta-2-Microglobulin
amyloid
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10468-7
|
Calcitonin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10469-5
|
Carcinoembryonic
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10470-3
|
Choriogonadotropin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10471-1
|
Chromogranin
A
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10472-9
|
Chromogranin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10473-7
|
Chymotrypsin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10474-5
|
Collagen
type
4
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10475-2
|
Corticotropin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10476-0
|
Desmin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10477-8
|
Enolase.neuron
specific
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10478-6
|
Eosinophil
major
basic
protein
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10479-4
|
CD227
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10480-2
|
Estrogen+Progesterone
receptor
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10481-0
|
Follitropin.alpha
subunit
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10482-8
|
Follitropin.beta
subunit
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10483-6
|
Gastrin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10484-4
|
Glial
fibrillary
acidic
protein
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10485-1
|
Glucagon
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10486-9
|
Hemoglobin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10487-7
|
HMB-45
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10488-5
|
IgA
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10489-3
|
IgA.heavy
chain
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10490-1
|
IgE
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10491-9
|
IgG
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10492-7
|
IgG.heavy
chain
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10493-5
|
IgM
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10494-3
|
IgM.heavy
chain
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10495-0
|
Insulin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10496-8
|
Immunoglobulin
light
chains.kappa
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10497-6
|
Immunoglobulin
light
chains.kappa
amyloid
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10498-4
|
Keratin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10499-2
|
Immunoglobulin
light
chains.lambda
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
1050-4
|
H
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
10500-7
|
Immunoglobulin
light
chains.lambda
amyloid
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10501-5
|
Lutropin
[Units/volume]
in
Serum
or
Plasma
|
|
10502-3
|
Lutropin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10503-1
|
Lysozyme
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10504-9
|
Myelin
basic
protein
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10505-6
|
Myoglobin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10506-4
|
Peanut
agglutinin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10507-2
|
Prolactin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10508-0
|
Prostate
specific
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10509-8
|
Prostatic
acid
phosphatase
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10510-6
|
S-100
Ag
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10511-4
|
Serotonin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10512-2
|
Somatostatin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10513-0
|
Somatotropin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10514-8
|
Synaptophysin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10515-5
|
Thyroglobulin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10516-3
|
Thyrotropin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10517-1
|
Trypsin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10518-9
|
Ulex
europaeus
I
lectin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10519-7
|
Vimentin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10520-5
|
Coagulation
factor
VI
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10521-3
|
Coagulation
factor
VIII
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10522-1
|
Coagulation
factor
XIII
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10523-9
|
Fibrinogen
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10524-7
|
Microscopic
observation
[Identifier]
in
Cervix
by
Cyto
stain
|
|
10525-4
|
Microscopic
observation
[Identifier]
in
Unspecified
specimen
by
Cyto
stain
|
|
10526-2
|
Microscopic
observation
[Identifier]
in
Sputum
by
Cyto
stain
|
|
10527-0
|
Microscopic
observation
[Identifier]
in
Tissue
by
Cyto
stain
|
|
10528-8
|
Acetophenazine
[Mass/volume]
in
Serum
or
Plasma
|
|
10529-6
|
Amoxapine
metabolite
[Mass/volume]
in
Serum
or
Plasma
|
|
10530-4
|
Aprobarbital
[Mass/volume]
in
Serum
or
Plasma
|
|
10531-2
|
Bretylium
[Mass/volume]
in
Serum
or
Plasma
|
|
10533-8
|
Propoxyphene+Acetaminophen
[Mass/volume]
in
Serum
or
Plasma
|
|
10534-6
|
Diazoxide
[Mass/volume]
in
Serum
or
Plasma
|
|
10535-3
|
Digoxin
[Mass/volume]
in
Serum
or
Plasma
|
|
10536-1
|
Dipyridamole
[Mass/volume]
in
Serum
or
Plasma
|
|
10539-5
|
Glipizide
[Mass/volume]
in
Serum
or
Plasma
|
|
10540-3
|
Glyburide
[Mass/volume]
in
Serum
or
Plasma
|
|
10541-1
|
Mepivacaine
[Mass/volume]
in
Serum
or
Plasma
|
|
10542-9
|
Metharbital
[Mass/volume]
in
Serum
or
Plasma
|
|
10543-7
|
Methsuximide+Normethsuximide
[Mass/volume]
in
Serum
or
Plasma
|
|
10544-5
|
Normeperidine
[Presence]
in
Serum
or
Plasma
|
|
10545-2
|
Normephenytoin
[Mass/volume]
in
Serum
or
Plasma
|
|
10546-0
|
Normethsuximide
[Mass/volume]
in
Serum
or
Plasma
|
|
10547-8
|
Primidone+Phenobarbital
[Mass/volume]
in
Serum
or
Plasma
|
|
10549-4
|
Pirmenol
[Mass/volume]
in
Serum
or
Plasma
|
|
10551-0
|
Triamterene
[Mass/volume]
in
Serum
or
Plasma
|
|
10552-8
|
Tricyclic
antidepressants
[Mass/volume]
in
Serum
or
Plasma
|
|
10553-6
|
Prostatic
acid
phosphatase
[Enzymatic
activity/volume]
in
Genital
fluid
|
|
10557-7
|
Adenosine
triphosphate
[Moles/volume]
in
Semen
|
|
10558-5
|
Albumin
[Moles/volume]
in
Semen
|
|
10560-1
|
Carcinoembryonic
Ag
[Units/volume]
in
Semen
|
|
10561-9
|
Carnitine
[Moles/volume]
in
Semen
|
|
10565-0
|
Choriogonadotropin
[Units/volume]
in
Semen
|
|
10567-6
|
Citrate
[Moles/volume]
in
Semen
|
|
10573-4
|
Ferning
[Type]
in
Cervical
mucus
|
|
10574-2
|
Fructose
[Moles/volume]
in
Semen
|
|
10577-5
|
Glucosidase
[Enzymatic
activity/volume]
in
Seminal
plasma
|
|
10582-5
|
pH
of
Cervical
mucus
|
|
10583-3
|
Prostaglandin
F1
alpha
[Moles/volume]
in
Semen
|
|
10596-5
|
Deprecated
Spermatozoa
Ab
in
cervical
mucosa
|
|
10597-3
|
Deprecated
Spermatozoa
Ab
in
semen
|
|
10598-1
|
Deprecated
Spermatozoa
Ab
in
serum
|
|
10599-9
|
Spermatozoa
penetration
[Presence]
in
Seminal
fluid
and
Cervical
mucosa
by
Kremer
test
|
|
10600-5
|
Spermatozoa
penetration
[Presence]
in
Seminal
fluid
and
Cervical
mucosa
|
|
10601-3
|
Spermatozoa
penetration
[Presence]
in
Seminal
fluid
and
Cervical
mucosa
--post
coitus
|
|
10630-2
|
Spinnbarkeit
[Length]
in
Cervical
mucus
|
|
10631-0
|
Testosterone
[Moles/volume]
in
Semen
|
|
10633-6
|
Zinc
[Moles/volume]
in
Semen
|
|
10635-1
|
Acanthamoeba
sp
identified
in
Eye
by
Organism
specific
culture
|
|
10636-9
|
Acanthamoeba
sp
identified
in
Eye
by
Wet
preparation
|
|
10637-7
|
Microscopic
observation
[Identifier]
in
Tissue
by
Night
blue
stain
|
|
10638-5
|
Thermophilic
Actinomycetes
colony
count
[#/volume]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
10639-3
|
Thermophilic
Actinomycetes
identified
in
Unspecified
specimen
by
Organism
specific
culture
|
|
10640-1
|
Deprecated
Adenovirus
40+41
[Identifier]
in
Stool
by
Electron
microscopy
|
|
10641-9
|
Amoeba
identified
in
Aspirate
by
Immune
stain
|
|
10642-7
|
Amoeba
identified
in
Aspirate
by
Wet
preparation
|
|
10643-5
|
Amoeba
identified
in
Stool
by
Organism
specific
culture
|
|
10644-3
|
Arthropod
identified
in
Unspecified
specimen
|
|
10645-0
|
Aspergillus
fumigatus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
10646-8
|
Astrovirus
[Identifier]
in
Stool
by
Electron
microscopy
|
|
10647-6
|
Babesia
sp
identified
in
Blood
by
Thick
film
|
|
10648-4
|
Babesia
sp
identified
in
Blood
by
Thin
film
|
|
10649-2
|
Calicivirus
[Identifier]
in
Stool
by
Electron
microscopy
|
|
10650-0
|
Candida
sp
DNA
[Presence]
in
Blood
by
Probe
with
amplification
|
|
10651-8
|
Chlamydophila
pneumoniae
Ag
[Presence]
in
Sputum
or
Bronchial
|
|
10652-6
|
Chlamydophila
pneumoniae
DNA
[Presence]
in
Sputum
or
Bronchial
by
Probe
with
amplification
|
|
10655-9
|
Coccidia
identified
in
Duodenal
fluid
by
Acid
fast
stain
|
|
10656-7
|
Coccidia
identified
in
Stool
by
Acid
fast
stain
|
|
10657-5
|
Deprecated
Cryptococcus
neoformans
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
10658-3
|
Cyanobacterium
identified
in
Water
by
Light
microscopy
|
|
10659-1
|
Cyclospora
sp
identified
in
Stool
by
Acid
fast
stain
|
|
1066-0
|
I
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
10660-9
|
Cytomegalovirus
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10661-7
|
Dinoflagellate
identified
in
Water
by
Light
microscopy
|
|
10662-5
|
Filaria
identified
in
Blood
by
Concentration
|
|
10663-3
|
Filaria
identified
in
Blood
by
Thick
film
|
|
10664-1
|
Filaria
identified
in
Blood
by
Thin
film
|
|
10665-8
|
Fungus
colony
count
[#/volume]
in
Unspecified
specimen
by
Environmental
culture
|
|
10666-6
|
Fungus
identified
in
Tissue
by
Fontana-Masson
stain
|
|
10667-4
|
Fungus
identified
in
Unspecified
specimen
by
Animal
inoculation
|
|
10668-2
|
Fungus
identified
in
Unspecified
specimen
by
Environmental
culture
|
|
10669-0
|
Fungus
identified
in
Unspecified
specimen
by
Sticky
tape
for
environmental
fungus
|
|
10670-8
|
Giardia
lamblia
[Presence]
in
Stool
by
Organism
specific
culture
|
|
10671-6
|
Helminth
identified
in
Unspecified
specimen
|
|
10672-4
|
Helminth+Arthropod
identified
in
Unspecified
specimen
|
|
10673-2
|
Hepatitis
B
virus
core
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10674-0
|
Hepatitis
B
virus
surface
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10675-7
|
Hepatitis
B
virus
surface
Ag
[Presence]
in
Tissue
by
Orcein
stain
|
|
10676-5
|
Hepatitis
C
virus
RNA
[Units/volume]
(viral
load)
in
Serum
or
Plasma
by
Probe
with
amplification
|
|
10677-3
|
Herpes
simplex
virus
1
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10678-1
|
Herpes
simplex
virus
1+2
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10679-9
|
Herpes
simplex
virus
2
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10680-7
|
Herpes
simplex
virus
identified
in
Cerebral
spinal
fluid
by
Electron
microscopy
|
|
10681-5
|
Herpes
simplex
virus
identified
in
Tissue
by
Electron
microscopy
|
|
10683-1
|
Hydatid
cyst
identified
in
Aspirate
by
Immune
stain
|
|
10684-9
|
Hydatid
cyst
identified
in
Liver
by
Wet
preparation
|
|
10685-6
|
Hydatid
cyst
identified
in
Lung
tissue
by
Wet
preparation
|
|
10686-4
|
Leishmania
sp
identified
in
Tissue
by
Giemsa
stain
|
|
10687-2
|
Leishmania
sp
identified
in
Tissue
by
Organism
specific
culture
|
|
10688-0
|
Microscopic
observation
[Identifier]
in
Hair
by
KOH
preparation
|
|
10689-8
|
Microscopic
observation
[Identifier]
in
Nail
by
KOH
preparation
|
|
10690-6
|
Microsporidia
identified
in
Duodenal
fluid
by
Trichrome
stain
modified
|
|
10691-4
|
Mushroom.toxic
identified
by
Inspection
|
|
10692-2
|
Mushroom.toxic
identified
in
Food
by
Light
microscopy
|
|
10693-0
|
Mushroom.toxic
identified
in
Vomitus
by
Light
microscopy
|
|
10694-8
|
Naegleria
sp
identified
in
Tissue
by
Organism
specific
culture
|
|
10695-5
|
Naegleria
sp
identified
in
Tissue
by
Wet
preparation
|
|
10696-3
|
Norovirus
[Identifier]
in
Stool
by
Electron
microscopy
|
|
10699-7
|
Onchocerca
sp
identified
in
Tissue
by
Wet
preparation
|
|
10700-3
|
Orthopoxvirus
[Identifier]
in
Skin
by
Electron
microscopy
|
|
10701-1
|
Ova
and
parasites
identified
in
Stool
by
Concentration
|
|
10702-9
|
Ova
and
parasites
identified
in
Stool
by
Immune
stain
|
|
10703-7
|
Ova
and
parasites
identified
in
Stool
by
Kinyoun
iron
hematoxylin
stain
|
|
10704-5
|
Ova
and
parasites
identified
in
Stool
by
Light
microscopy
|
|
10705-2
|
Human
papilloma
virus
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10706-0
|
Picornavirus
[Identifier]
in
Stool
by
Electron
microscopy
|
|
10707-8
|
Toxic
Plant
identified
in
plant
specimen
by
Inspection
|
|
10708-6
|
Toxic
Plant
identified
in
Vomitus
by
Light
microscopy
|
|
10709-4
|
Plasmodium
falciparum
Ag
[Units/volume]
in
Blood
by
Immunofluorescence
|
|
10710-2
|
Plasmodium
sp
identified
in
Blood
by
Thin
film
|
|
10711-0
|
Plasmodium
vivax
Ag
[Units/volume]
in
Blood
by
Immunofluorescence
|
|
10712-8
|
Pneumocystis
sp
identified
in
Lung
tissue
|
|
10713-6
|
Prototheca
identified
in
Unspecified
specimen
by
Culture
|
|
10714-4
|
Deprecated
Rotavirus
[Identifier]
in
Stool
by
Electron
microscopy
|
|
10715-1
|
Schistosoma
sp
identified
in
Urine
sediment
by
Light
microscopy
|
|
10716-9
|
Schistosoma
sp
identified
in
Unspecified
specimen
by
Organism
specific
culture
|
|
10717-7
|
Streptococcus
pneumoniae
Ab
[Units/volume]
in
Serum
by
Latex
agglutination
|
|
10718-5
|
Strongyloides
sp
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
10719-3
|
Taenia
solium
adult
Ab
[Units/volume]
in
Serum
by
Immunoblot
(IB)
|
|
1072-8
|
Jk
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
10722-7
|
Torovirus
[Identifier]
in
Stool
by
Electron
microscopy
|
|
10723-5
|
Toxoplasma
gondii
IgA
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
10724-3
|
Toxoplasma
gondii
IgE
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
10725-0
|
Toxoplasma
gondii
DNA
[Units/volume]
in
Body
fluid
by
Probe
with
amplification
|
|
10726-8
|
Toxoplasma
gondii
[Presence]
in
Tissue
by
Giemsa
stain
|
|
10727-6
|
Toxoplasma
gondii
identified
in
Tissue
|
|
10728-4
|
Trichomonas
sp
identified
in
Genital
specimen
by
Organism
specific
culture
|
|
10729-2
|
Trypanosoma
sp
identified
in
Blood
by
Light
microscopy
|
|
10730-0
|
Trypanosoma
sp
identified
in
Blood
by
Organism
specific
culture
|
|
10731-8
|
Trypanosoma
sp
identified
in
Blood
by
Thick
film
|
|
10732-6
|
Trypanosoma
sp
identified
in
Blood
by
Thin
film
|
|
10733-4
|
Trypanosoma
sp
identified
in
Blood
by
Wet
preparation
|
|
10734-2
|
Varicella
zoster
virus
identified
in
Skin
by
Electron
microscopy
|
|
10735-9
|
Viral
sequencing
[Identifier]
in
Serum
by
Sequencing
|
|
10736-7
|
Virus
identified
in
Cerebral
spinal
fluid
by
Electron
microscopy
|
|
10737-5
|
Virus
identified
in
Stool
by
Electron
microscopy
|
|
10738-3
|
Virus
identified
in
Tissue
by
Electron
microscopy
|
|
10739-1
|
Virus
identified
in
Unspecified
specimen
by
Electron
microscopy
|
|
10751-6
|
Copper.microscopic
observation
[Identifier]
in
Tissue
by
Rhodamine
stain
|
|
10753-2
|
Fat.microscopic
observation
[Identifier]
in
Stool
by
Sudan
IV
stain
|
|
10758-1
|
Iron.microscopic
observation
[Identifier]
in
Bone
by
Histomorphometry
stain
|
|
10759-9
|
Iron.microscopic
observation
[Identifier]
in
Sputum
by
Gomori
stain
|
|
10760-7
|
Iron.microscopic
observation
[Identifier]
in
Tissue
by
Gomori
stain
|
|
10761-5
|
Iron.microscopic
observation
[Identifier]
in
Tissue
by
Other
stain
|
|
10763-1
|
Microscopic
observation
[Identifier]
in
Body
fluid
by
Sudan
black
stain
|
|
10765-6
|
Microscopic
observation
[Identifier]
in
Tissue
by
Acetate
esterase
stain
|
|
10778-9
|
Microscopic
observation
[Identifier]
in
Tissue
by
Butyrate
esterase
stain
|
|
1078-5
|
Jk
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
|
|
10780-5
|
Microscopic
observation
[Identifier]
in
Tissue
by
Chloracetate
esterase
stain
|
|
10813-4
|
Microscopic
observation
[Identifier]
in
Tissue
by
Sudan
black
stain
|
|
10823-3
|
Mucopolysaccharides.microscopic
observation
[Identifier]
in
Tissue
by
Colloidal
ferric
oxide
stain.Hale
|
|
10829-0
|
Silicon
[Mass/volume]
in
Serum
or
Plasma
|
|
10834-0
|
Globulin
[Mass/volume]
in
Serum
by
calculation
|
|
10835-7
|
Lipoprotein
a
[Mass/volume]
in
Serum
or
Plasma
|
|
10836-5
|
Niacin
[Mass/volume]
in
Blood
|
|
10837-3
|
Organic
acids
[Presence]
in
Serum
or
Plasma
|
|
10839-9
|
Troponin
I.cardiac
[Mass/volume]
in
Serum
or
Plasma
|
|
1084-3
|
Js
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
10840-7
|
Atropine
[Mass/volume]
in
Urine
|
|
10841-5
|
Methazolamide
[Mass/volume]
in
Serum
or
Plasma
|
|
10846-4
|
Borrelia
burgdorferi
DNA
[Presence]
in
Blood
by
Probe
with
amplification
|
|
10847-2
|
Borrelia
burgdorferi
DNA
[Presence]
in
Body
fluid
by
Probe
with
amplification
|
|
10848-0
|
Chlamydia
sp
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
10849-8
|
Chlamydia
sp
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
10850-6
|
Cyclospora
cayetanensis
[Presence]
in
Unspecified
specimen
|
|
10851-4
|
Escherichia
coli
O157:H7
[Presence]
in
Stool
by
Organism
specific
culture
|
|
10853-0
|
Isospora
belli
[Presence]
in
Unspecified
specimen
by
Acid
fast
stain.Kinyoun
modified
|
|
10854-8
|
Deprecated
Midrofilaria
identified
in
Blood
by
Concentration
|
|
10855-5
|
Ova
and
parasites
identified
in
Duodenal
fluid
or
Gastric
fluid
by
Light
microscopy
|
|
10856-3
|
Microscopic
observation
[Identifier]
in
Genital
mucus
by
Gram
stain
|
|
10857-1
|
Microsporidia
identified
in
Unspecified
specimen
by
Light
microscopy
|
|
10858-9
|
Teichoate
Ab
[Presence]
in
Serum
|
|
10859-7
|
Trypanosoma
sp
[Identifier]
in
Blood
by
Acridine
Orange
+
Giemsa
Stain
|
|
10860-5
|
Varicella
zoster
virus
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
10861-3
|
Progesterone
receptor
[Mass/mass]
in
Tissue
|
|
10862-1
|
Basement
membrane
Ab
[Titer]
in
Serum
|
|
10863-9
|
Endomysium
IgA
Ab
[Titer]
in
Serum
|
|
10864-7
|
Immune
complex
[Units/volume]
in
Serum
or
Plasma
by
Raji
cell
assay
|
|
10865-4
|
Intercellular
substance
Ab
[Presence]
in
Serum
|
|
10866-2
|
Sulfatide
IgG
Ab
[Titer]
in
Serum
|
|
10867-0
|
Sulfatide
IgM
Ab
[Titer]
in
Serum
|
|
10873-8
|
Beta-2-Microglobulin
[Mass/time]
in
24
hour
Urine
|
|
10874-6
|
Bombesin
[Mass/volume]
in
Plasma
|
|
10875-3
|
Carnitine
esters
[Mass/volume]
in
Urine
|
|
10876-1
|
Carnitine
esters
[Mass/volume]
in
Serum
or
Plasma
|
|
10877-9
|
Carnitine
free
(C0)
[Mass/volume]
in
Urine
|
|
10878-7
|
Iodine.protein
bound
[Mass/volume]
in
Serum
or
Plasma
|
|
10880-3
|
Magnesium
[Mass/mass]
in
Stool
|
|
10883-7
|
Phenolphthalein
[Mass/mass]
in
Stool
|
|
10884-5
|
Phosphate
[Mass/mass]
in
Stool
|
|
10886-0
|
Prostate
Specific
Ag
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
10887-8
|
Pyridinoline
[Mass/time]
in
24
hour
Urine
|
|
10888-6
|
Lipase
[Enzymatic
activity/volume]
in
Urine
|
|
10889-4
|
Bisacodyl
[Mass/mass]
in
Stool
|
|
10891-0
|
Oxyphenisatin
[Mass/mass]
in
Stool
|
|
10892-8
|
Pentoxifylline
[Mass/volume]
in
Serum
or
Plasma
|
|
10893-6
|
Trenbolone
[Mass/volume]
in
Urine
|
|
10894-4
|
Aspergillus
niger
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
10895-1
|
Clostridium
difficile
toxin
B
[Presence]
in
Stool
|
|
10896-9
|
Eastern
equine
encephalitis
virus
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
10897-7
|
Eastern
equine
encephalitis
virus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
10898-5
|
Eastern
equine
encephalitis
virus
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
10899-3
|
Eastern
equine
encephalitis
virus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
1090-0
|
Js
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
|
|
10900-9
|
Hepatitis
B
virus
surface
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
10903-3
|
Hyaluronidase
Ab
[Titer]
in
Serum
|
|
10904-1
|
La
Crosse
virus
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
10905-8
|
La
Crosse
virus
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
10906-6
|
Saint
Louis
encephalitis
virus
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
10907-4
|
Saint
Louis
encephalitis
virus
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
10909-0
|
Benzidine
[Mass/volume]
in
Urine
|
|
10910-8
|
Borate
[Mass/volume]
in
Urine
|
|
10911-6
|
Dichlorobenzidine
[Mass/volume]
in
Urine
|
|
10912-4
|
Lead
[Mass/volume]
in
Serum
or
Plasma
|
|
10913-2
|
4,4'-Methylene
bis(2-Chloroaniline)
[Mass/volume]
in
Urine
|
|
10914-0
|
Methylenediamine
[Mass/volume]
in
Urine
|
|
10915-7
|
Phencyclidine
[Mass/volume]
in
Unspecified
specimen
|
|
10916-5
|
Platinum
[Mass/volume]
in
Blood
|
|
10917-3
|
Zinc
[Mass/mass]
in
Stool
|
|
10918-1
|
Zinc
[Mass/volume]
in
Unspecified
specimen
|
|
10919-9
|
Anisakis
IgE
Ab
[Units/volume]
in
Serum
|
|
10920-7
|
Bamboo
shoot
IgE
Ab
[Units/volume]
in
Serum
|
|
10921-5
|
Blomia
tropicalis
IgE
Ab
[Units/volume]
in
Serum
|
|
10922-3
|
Bovine
serum
albumin
(BSA)
IgE
Ab
[Units/volume]
in
Serum
|
|
10923-1
|
Bromelin
IgE
Ab
[Units/volume]
in
Serum
|
|
10924-9
|
Starfruit
IgE
Ab
[Units/volume]
in
Serum
|
|
10925-6
|
Chub
Mackerel
IgE
Ab
[Units/volume]
in
Serum
|
|
10926-4
|
Deer
epithelium
IgE
Ab
[Units/volume]
in
Serum
|
|
10927-2
|
Elk
or
Moose
Meat
IgE
Ab
[Units/volume]
in
Serum
|
|
10928-0
|
Fennel
Fresh
IgE
Ab
[Units/volume]
in
Serum
|
|
10929-8
|
Fennel
Seed
IgE
Ab
[Units/volume]
in
Serum
|
|
10930-6
|
Fish
Feed
IgE
Ab
[Units/volume]
in
Serum
|
|
10931-4
|
Daphnia
(fish
feed)
IgE
Ab
[Units/volume]
in
Serum
|
|
10932-2
|
Tetramin
IgE
Ab
[Units/volume]
in
Serum
|
|
10933-0
|
Guar
gum
IgE
Ab
[Units/volume]
in
Serum
|
|
10934-8
|
Guava
IgE
Ab
[Units/volume]
in
Serum
|
|
10935-5
|
Horse
serum
proteins
IgE
Ab
[Units/volume]
in
Serum
|
|
10936-3
|
Mare
milk
IgE
Ab
[Units/volume]
in
Serum
|
|
10937-1
|
Marjoram
IgE
Ab
[Units/volume]
in
Serum
|
|
10938-9
|
Mediterranean
flour
moth
IgE
Ab
[Units/volume]
in
Serum
|
|
10939-7
|
Whiff
IgE
Ab
[Units/volume]
in
Serum
|
|
10940-5
|
Cow
milk
boiled
IgE
Ab
[Units/volume]
in
Serum
|
|
10941-3
|
Milk
powder
IgE
Ab
[Units/volume]
in
Serum
|
|
10942-1
|
Cockspur
IgE
Ab
[Units/volume]
in
Serum
|
|
10943-9
|
Mink
epithelium
IgE
Ab
[Units/volume]
in
Serum
|
|
10944-7
|
Octopus
IgE
Ab
[Units/volume]
in
Serum
|
|
10945-4
|
Papain
IgE
Ab
[Units/volume]
in
Serum
|
|
10946-2
|
Passion
fruit
IgE
Ab
[Units/volume]
in
Serum
|
|
10947-0
|
Persimmon
IgE
Ab
[Units/volume]
in
Serum
|
|
10948-8
|
Pigeon
feather
IgE
Ab
[Units/volume]
in
Serum
|
|
10949-6
|
Malassezia
furfur
IgE
Ab
[Units/volume]
in
Serum
|
|
10950-4
|
Reindeer
epithelium
IgE
Ab
[Units/volume]
in
Serum
|
|
10951-2
|
Sericin
IgE
Ab
[Units/volume]
in
Serum
|
|
10952-0
|
Swine
urine
proteins
IgE
Ab
[Units/volume]
in
Serum
|
|
10953-8
|
Timothy
IgG
Ab
[Units/volume]
in
Serum
|
|
10954-6
|
Pine
Nut
IgE
Ab
[Units/volume]
in
Serum
|
|
10955-3
|
Long
Leaf
Pine
IgE
Ab
[Units/volume]
in
Serum
|
|
10956-1
|
Short
Leaf
Pine
IgE
Ab
[Units/volume]
in
Serum
|
|
10957-9
|
Slash
Pine
IgE
Ab
[Units/volume]
in
Serum
|
|
10958-7
|
Virginia
Scrub
Pine
IgE
Ab
[Units/volume]
in
Serum
|
|
10959-5
|
Plaice
IgE
Ab
[Units/volume]
in
Serum
|
|
1096-7
|
K
Ag
[Presence]
on
Red
Blood
Cells
|
|
10960-3
|
Rabbit
serum
proteins
IgE
Ab
[Units/volume]
in
Serum
|
|
10961-1
|
Rabbit
urine
proteins
IgE
Ab
[Units/volume]
in
Serum
|
|
10962-9
|
Deprecated
Sagebrush
tridenda
IgE
Ab
[Units/volume]
in
Serum
|
|
10963-7
|
Spondylocladium
citrovirens
IgE
Ab
[Units/volume]
in
Serum
|
|
10969-4
|
Cystine+Homocysteine
[Presence]
in
Urine
|
|
10970-2
|
Galactose
1
phosphate
uridyl
transferase
[Enzymatic
activity/volume]
in
Blood
|
|
10971-0
|
Lysozyme
[Mass/volume]
in
Urine
|
|
10972-8
|
Organic
acids
[Mass/volume]
in
Urine
|
|
10973-6
|
3
methoxy
O
desmethylencainide
[Mass/volume]
in
Serum
or
Plasma
|
|
10974-4
|
5-Fluorocytosine
[Mass/volume]
in
Urine
|
|
10975-1
|
6-Monoacetylmorphine
(6-MAM)
[Mass/volume]
in
Urine
|
|
10976-9
|
6-Monoacetylmorphine
(6-MAM)
[Presence]
in
Urine
|
|
10977-7
|
Alprazolam
[Mass/volume]
in
Blood
|
|
10978-5
|
Amitriptyline+Nortriptyline
[Mass/volume]
in
Urine
|
|
10979-3
|
Carisoprodol
[Mass/volume]
in
Urine
|
|
10980-1
|
Cephapirin
[Mass/volume]
in
Serum
or
Plasma
|
|
10981-9
|
Clonidine
[Mass/volume]
in
Urine
|
|
10982-7
|
Demeclocycline
[Mass/volume]
in
Serum
or
Plasma
|
|
10983-5
|
Norparamethadione
[Mass/volume]
in
Serum
or
Plasma
|
|
10984-3
|
Dicloxacillin
[Mass/volume]
in
Serum
or
Plasma
|
|
10985-0
|
Doxapram
[Mass/volume]
in
Serum
or
Plasma
|
|
10986-8
|
Doxycycline
[Mass/volume]
in
Serum
or
Plasma
|
|
10987-6
|
Fluconazole
[Mass/volume]
in
Serum
or
Plasma
|
|
10988-4
|
Fluvoxamine
[Mass/volume]
in
Serum
or
Plasma
|
|
10989-2
|
Itraconazole
[Mass/volume]
in
Serum
or
Plasma
|
|
10990-0
|
Ketoconazole
[Mass/volume]
in
Serum
or
Plasma
|
|
10991-8
|
Metronidazole
[Mass/volume]
in
Serum
or
Plasma
|
|
10992-6
|
Norclozapine
[Mass/volume]
in
Serum
or
Plasma
|
|
10993-4
|
Nafcillin
[Mass/volume]
in
Serum
or
Plasma
|
|
10994-2
|
Naltrexone
[Mass/volume]
in
Serum
or
Plasma
|
|
10995-9
|
Neomycin
[Mass/volume]
in
Serum
or
Plasma
|
|
10996-7
|
Normeperidine
[Mass/volume]
in
Serum
or
Plasma
|
|
10997-5
|
O-desmethylencainide
[Mass/volume]
in
Serum
or
Plasma
|
|
10998-3
|
Oxycodone
[Presence]
in
Urine
|
|
10999-1
|
Paramethadione
[Mass/volume]
in
Serum
or
Plasma
|
|
11000-7
|
Promethazine
[Presence]
in
Urine
|
|
11001-5
|
Pyrazinamide
[Mass/volume]
in
Serum
or
Plasma
|
|
11002-3
|
Scopolamine
[Presence]
in
Urine
|
|
11003-1
|
Ticlopidine
[Mass/volume]
in
Serum
or
Plasma
|
|
11004-9
|
Tricyclic
antidepressants
[Presence]
in
Urine
|
|
11005-6
|
Trimethoprim
[Mass/volume]
in
Serum
or
Plasma
|
|
11006-4
|
Borrelia
burgdorferi
Ab
[Presence]
in
Serum
|
|
11007-2
|
Borrelia
burgdorferi
Ag
[Units/volume]
in
Urine
|
|
11008-0
|
Cytomegalovirus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
11009-8
|
Epstein
Barr
virus
capsid
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
11010-6
|
Epstein
Barr
virus
capsid
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
11011-4
|
Hepatitis
C
virus
RNA
[Units/volume]
(viral
load)
in
Serum
or
Plasma
by
Probe
and
target
amplification
method
|
|
11012-2
|
Reovirus
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
11013-0
|
DNA
double
strand
Ab
[Titer]
in
Serum
|
|
11014-8
|
Somatotropin
Ab
[Titer]
in
Serum
or
Plasma
|
|
11015-5
|
Somatotropin
binding
protein
[Moles/volume]
in
Serum
or
Plasma
|
|
11017-1
|
Microscopic
observation
[Identifier]
in
Blood
or
Marrow
by
Chloracetate
esterase
stain
|
|
11018-9
|
Microscopic
observation
[Identifier]
in
Blood
or
Marrow
by
Peroxidase
stain
|
|
11019-7
|
Microscopic
observation
[Identifier]
in
Blood
or
Marrow
by
Sudan
black
B
stain
|
|
1102-3
|
Kp
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
11020-5
|
Microscopic
observation
[Identifier]
in
Blood
or
Marrow
by
Tartrate-resistant
acid
phosphatase
stain
|
|
11021-3
|
Microscopic
observation
[Identifier]
in
Blood
or
Marrow
by
Terminal
deoxynucleotidyl
transferase
stain
|
|
11022-1
|
Barbiturates
[Mass/volume]
in
Meconium
|
|
11023-9
|
Benzodiazepines
[Mass/volume]
in
Meconium
|
|
11024-7
|
Benzodiazepines
[Mass/volume]
in
Serum
or
Plasma
|
|
11025-4
|
Methadone
[Mass/volume]
in
Meconium
|
|
11026-2
|
Methaqualone
[Mass/volume]
in
Meconium
|
|
11027-0
|
Propoxyphene
[Mass/volume]
in
Meconium
|
|
11028-8
|
Zinc
[Mass/volume]
in
Body
fluid
|
|
11030-4
|
Aspergillus
fumigatus+Aspergillus
niger
IgE
Ab
[Units/volume]
in
Serum
|
|
11034-6
|
Acetylcholine
receptor
binding
Ab
[Moles/volume]
in
Serum
|
|
11035-3
|
Adenylate
kinase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11037-9
|
Alpha-N-acetylgalactosaminidase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
11038-7
|
Beta+gamma
tocopherol
[Mass/volume]
in
Serum
or
Plasma
|
|
11039-5
|
C
reactive
protein
[Presence]
in
Serum
or
Plasma
|
|
11040-3
|
Cortisol
Free
[Mass/volume]
in
Urine
|
|
11043-7
|
Cryofibrinogen
[Presence]
in
Plasma
|
|
11044-5
|
Diphosphoglycerate
mutase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11045-2
|
Enolase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11046-0
|
Epinephrine
[Mass/volume]
in
Urine
|
|
11047-8
|
Glucose
phosphate
isomerase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11048-6
|
Glyceraldehyde
3
phosphate
dehydrogenase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11050-2
|
Immunoglobulin
light
chains.kappa
[Mass/volume]
in
Serum
or
Plasma
|
|
11051-0
|
Immunoglobulin
light
chains.lambda
[Mass/volume]
in
Serum
or
Plasma
|
|
11052-8
|
Ketamine
[Mass/volume]
in
Urine
|
|
11053-6
|
Lactate
dehydrogenase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11055-1
|
Melatonin
[Mass/volume]
in
Serum
or
Plasma
|
|
11056-9
|
Melatonin
[Flow]
in
24
hour
Urine
|
|
11057-7
|
Monophosphoglyceromutase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11058-5
|
Phosphofructokinase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11059-3
|
Phosphoglycerate
kinase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11060-1
|
Reducing
substances
[Presence]
in
Stool
|
|
11061-9
|
Thromboxane
beta
2
[Mass/time]
in
24
hour
Urine
|
|
11062-7
|
Thyroxine
(T4).albumin
bound
[Mass/volume]
in
Serum
or
Plasma
|
|
11063-5
|
Triosephosphate
isomerase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11064-3
|
Urea
nitrogen
[Mass/volume]
in
Serum
or
Plasma
--post
dialysis
|
|
11065-0
|
Urea
nitrogen
[Mass/volume]
in
Serum
or
Plasma
--pre
dialysis
|
|
11066-8
|
Uroporphyrinogen
III
synthase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11067-6
|
Bleeding
time
|
|
11068-4
|
Microscopic
observation
[Identifier]
in
Body
fluid
by
Cyto
stain
|
|
11069-2
|
Microscopic
observation
[Identifier]
in
Gastric
fluid
by
Cyto
stain
|
|
11070-0
|
Microscopic
observation
[Identifier]
in
Urine
by
Cyto
stain
|
|
11071-8
|
Butalbital
[Mass/volume]
in
Urine
|
|
11072-6
|
Despropionylfentanyl
[Mass/volume]
in
Serum
or
Plasma
|
|
11073-4
|
Despropionylfentanyl
[Mass/volume]
in
Urine
|
|
11074-2
|
Norfentanyl
[Mass/volume]
in
Serum
or
Plasma
|
|
11075-9
|
Norfentanyl
[Mass/volume]
in
Urine
|
|
11077-5
|
Hepatitis
C
virus
superoxide
dismutase
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
1108-0
|
Kp
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
|
|
11083-3
|
Human
papilloma
virus
identified
in
Cervix
|
|
11084-1
|
Reagin
Ab
[Titer]
in
Serum
|
|
11085-8
|
Schistosoma
sp
identified
in
Stool
by
Concentration
|
|
11086-6
|
Streptococcus
pneumoniae
Ag
[Presence]
in
Serum
|
|
11087-4
|
Insulin
Ab
[Titer]
in
Serum
|
|
11088-2
|
Neuronal
nuclear
Ab
[Presence]
in
Serum
|
|
11089-0
|
Neuronal
nuclear
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
11090-8
|
Smith
extractable
nuclear
Ab
[Units/volume]
in
Serum
|
|
11091-6
|
Alpha
chlordane
[Mass/volume]
in
Serum
or
Plasma
|
|
11092-4
|
Barbiturates
[Mass/mass]
in
Hair
|
|
11093-2
|
Dichlorodiphenyldichloroethylene
[Mass/volume]
in
Serum
or
Plasma
|
|
11094-0
|
Dichlorodiphenyltrichloroethane
[Mass/volume]
in
Serum
or
Plasma
|
|
11095-7
|
Dieldrin
[Mass/volume]
in
Serum
or
Plasma
|
|
11096-5
|
Gamma
chlordane
[Mass/volume]
in
Serum
or
Plasma
|
|
11097-3
|
Lindane
[Mass/volume]
in
Serum
or
Plasma
|
|
11098-1
|
Malaoxon
[Mass/volume]
in
Serum
or
Plasma
|
|
11099-9
|
Methoxychlor
[Mass/volume]
in
Serum
or
Plasma
|
|
11100-5
|
Tetrachloroethylene
[Mass/volume]
in
Blood
|
|
11102-1
|
Charcot-leyden
crystals
[type]
in
Unspecified
specimen
by
Trichrome
stain
|
|
11133-6
|
Catecholamines
Free
[Mass/volume]
in
Urine
|
|
11139-3
|
Metanephrine
[Mass/volume]
in
Urine
|
|
11140-1
|
Metanephrine
[Moles/time]
in
24
hour
Urine
|
|
11144-3
|
Homovanillate
[Mass/volume]
in
Urine
|
|
11145-0
|
5-Hydroxyindoleacetate/Creatinine
[Mass
Ratio]
in
Urine
|
|
11146-8
|
Homovanillate/Creatinine
[Mass
Ratio]
in
Urine
|
|
11147-6
|
Myoglobin/Creatinine
[Mass
Ratio]
in
Urine
|
|
11148-4
|
Potassium/Creatinine
[Mass
Ratio]
in
Urine
|
|
11149-2
|
Sodium/Creatinine
[Mass
Ratio]
in
Urine
|
|
1115-5
|
Le
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
11151-8
|
Hematocrit
[Volume
Fraction]
of
Cord
blood
|
|
11153-4
|
Hematocrit
[Volume
Fraction]
of
Body
fluid
|
|
11154-2
|
Cholinesterase
[Enzymatic
activity/volume]
in
Blood
|
|
11155-9
|
Cortisol/Creatinine
[Mass
Ratio]
in
Urine
|
|
11159-1
|
Alkalase
IgE
Ab
[Units/volume]
in
Serum
|
|
11160-9
|
Beta
lactoglobulin
IgG
Ab
[Units/volume]
in
Serum
|
|
11161-7
|
Wheat
Bran
IgE
Ab
[Units/volume]
in
Serum
|
|
11162-5
|
Deprecated
Cocoa
IgE
Ab
[Units/volume]
in
Serum
|
|
11163-3
|
Carageenan
IgE
Ab
[Units/volume]
in
Serum
|
|
11164-1
|
Cream
Cheese
IgE
Ab
[Units/volume]
in
Serum
|
|
11165-8
|
Chinchilla
IgE
Ab
[Units/volume]
in
Serum
|
|
11166-6
|
Chortoglyphus
arcuatus
IgE
Ab
[Units/volume]
in
Serum
|
|
11167-4
|
Cockatiel
feather
IgE
Ab
[Units/volume]
in
Serum
|
|
11168-2
|
Arizona
Cypress
IgE
Ab
[Units/volume]
in
Serum
|
|
11169-0
|
Deer
hair
IgE
Ab
[Units/volume]
in
Serum
|
|
11170-8
|
Dematiaceae
IgE
Ab
[Units/volume]
in
Serum
|
|
11171-6
|
Erythromycin
IgE
Ab
[Units/volume]
in
Serum
|
|
11172-4
|
Ferret
epithelium
IgE
Ab
[Units/volume]
in
Serum
|
|
11173-2
|
Fig
IgE
Ab
[Units/volume]
in
Serum
|
|
11174-0
|
Grain
weevel
IgE
Ab
[Units/volume]
in
Serum
|
|
11175-7
|
Helminthosporium
sativum
IgE
Ab
[Units/volume]
in
Serum
|
|
11176-5
|
Lactalbumin
alpha
IgG
Ab
[Units/volume]
in
Serum
|
|
11177-3
|
Lactalbumin
beta
IgE
Ab
[Units/volume]
in
Serum
|
|
11178-1
|
Beta
galactosidase
IgE
Ab
[Units/volume]
in
Serum
|
|
11179-9
|
Linden
IgE
Ab
[Units/volume]
in
Serum
|
|
11180-7
|
Lupin
IgE
Ab
[Units/volume]
in
Serum
|
|
11181-5
|
Lycopodium
spp
IgE
Ab
[Units/volume]
in
Serum
|
|
11182-3
|
Lysozyme
IgE
Ab
[Units/volume]
in
Serum
|
|
11183-1
|
Macadamia
IgE
Ab
[Units/volume]
in
Serum
|
|
11184-9
|
Scad
IgE
Ab
[Units/volume]
in
Serum
|
|
11185-6
|
Maxatase
IgE
Ab
[Units/volume]
in
Serum
|
|
11186-4
|
Foxtail
Millet
IgE
Ab
[Units/volume]
in
Serum
|
|
11187-2
|
Penicillium
frequentans
IgE
Ab
[Units/volume]
in
Serum
|
|
11188-0
|
Cayenne
IgE
Ab
[Units/volume]
in
Serum
|
|
11189-8
|
Jalepeno
Pepper
IgE
Ab
[Units/volume]
in
Serum
|
|
11190-6
|
Mint
IgE
Ab
[Units/volume]
in
Serum
|
|
11191-4
|
Pollock
IgE
Ab
[Units/volume]
in
Serum
|
|
11192-2
|
Protamine
IgE
Ab
[Units/volume]
in
Serum
|
|
11193-0
|
Pumpkin
Seed
IgE
Ab
[Units/volume]
in
Serum
|
|
11194-8
|
Rape
Pollen
IgE
Ab
[Units/volume]
in
Serum
|
|
11195-5
|
Rapeseed
IgE
Ab
[Units/volume]
in
Serum
|
|
11196-3
|
Orange
roughy
IgE
Ab
[Units/volume]
in
Serum
|
|
11197-1
|
Sardine
(pilchard)
IgE
Ab
[Units/volume]
in
Serum
|
|
11198-9
|
Shark
IgE
Ab
[Units/volume]
in
Serum
|
|
11199-7
|
Silver
IgE
Ab
[Units/volume]
in
Serum
|
|
11200-3
|
Escargot
IgE
Ab
[Units/volume]
in
Serum
|
|
11201-1
|
Succinylcholine
IgE
Ab
[Units/volume]
in
Serum
|
|
11202-9
|
Tarragon
IgE
Ab
[Units/volume]
in
Serum
|
|
11203-7
|
Trichosporon
pullulans
IgE
Ab
[Units/volume]
in
Serum
|
|
11204-5
|
Ulocladium
chartarum
IgE
Ab
[Units/volume]
in
Serum
|
|
11205-2
|
Deprecated
Paper
Wasp
IgE
Ab
[Units/volume]
in
Serum
|
|
11206-0
|
18-Hydroxydeoxycorticosterone
[Mass/volume]
in
Serum
or
Plasma
|
|
11207-8
|
Alpha-1-Fetoprotein
[Mass/volume]
in
Body
fluid
|
|
11208-6
|
Atrial
natriuretic
factor
[Mass/volume]
in
Plasma
|
|
11209-4
|
Beta
glucuronidase
[Enzymatic
activity/volume]
in
Cerebral
spinal
fluid
|
|
1121-3
|
Le
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
|
|
11210-2
|
Cancer
Ag
125
[Units/volume]
in
Body
fluid
|
|
11211-0
|
Carbon
dioxide,
total
[Moles/volume]
in
Body
fluid
|
|
11213-6
|
Corticotropin
releasing
hormone
[Mass/volume]
in
Serum
or
Plasma
|
|
11214-4
|
Deprecated
Creatinine
|
|
11215-1
|
Delta
aminolevulinate
[Mass/volume]
in
Urine
|
|
11216-9
|
Deoxypyridinoline
[Mass/volume]
in
Urine
|
|
11218-5
|
Microalbumin
[Mass/volume]
in
Urine
by
Test
strip
|
|
11219-3
|
Immunoglobulin
light
chains
[Presence]
in
Serum
|
|
11220-1
|
Iodine
Free
[Mass/time]
in
24
hour
Urine
|
|
11226-8
|
Prorenin
[Units/volume]
in
Plasma
|
|
11227-6
|
Pyruvate
kinase
[Presence]
in
Blood
|
|
11229-2
|
3-O-Methyldopa
[Mass/volume]
in
Serum
or
Plasma
|
|
11230-0
|
Amobarbital
[Mass/volume]
in
Urine
|
|
11231-8
|
Astemizole
[Mass/volume]
in
Serum
or
Plasma
|
|
11232-6
|
Bromocriptine
[Mass/volume]
in
Serum
or
Plasma
|
|
11233-4
|
Brompheniramine
[Mass/volume]
in
Serum
or
Plasma
|
|
11234-2
|
Propoxyphene
[Mass/mass]
in
Hair
|
|
11235-9
|
Fentanyl
[Presence]
in
Urine
|
|
11236-7
|
Gemfibrozil
[Mass/volume]
in
Serum
or
Plasma
|
|
11237-5
|
Hydralazine
[Mass/volume]
in
Serum
or
Plasma
|
|
11238-3
|
Hydroxyalprazolam
[Mass/volume]
in
Urine
|
|
11240-9
|
Hydroxyzine
[Mass/volume]
in
Urine
|
|
11241-7
|
Hyoscyamine
[Mass/volume]
in
Serum
or
Plasma
|
|
11242-5
|
Mercaptopurine
[Mass/volume]
in
Serum
or
Plasma
|
|
11243-3
|
Methadone
[Mass/mass]
in
Hair
|
|
11244-1
|
Morphine
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
11246-6
|
Oxycodone
[Mass/volume]
in
Urine
|
|
11247-4
|
Oxymorphone
[Presence]
in
Urine
|
|
11248-2
|
Pergolide
[Mass/volume]
in
Serum
or
Plasma
|
|
11249-0
|
Phenacemide
[Mass/volume]
in
Serum
or
Plasma
|
|
11250-8
|
Phenylethylmalonate
[Mass/volume]
in
Serum
or
Plasma
|
|
11251-6
|
Piroxicam
[Mass/volume]
in
Serum
or
Plasma
|
|
11252-4
|
Scopolamine
[Mass/volume]
in
Serum
or
Plasma
|
|
11253-2
|
Tacrolimus
[Mass/volume]
in
Blood
|
|
11254-0
|
Chlamydophila
pneumoniae
Ab
[Titer]
in
Serum
|
|
11255-7
|
Haemophilus
ducreyi
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
11256-5
|
Haemophilus
influenzae
B
IgG
Ab
[Mass/volume]
in
Serum
|
|
11257-3
|
Haemophilus
influenzae
B
IgG
Ab
[Mass/volume]
in
Serum
by
Immunoassay
|
|
11258-1
|
Hepatitis
B
virus
DNA
[Units/volume]
in
Serum
|
|
11259-9
|
Hepatitis
C
virus
RNA
[Presence]
in
Serum
or
Plasma
by
Probe
and
target
amplification
method
|
|
11260-7
|
HTLV
I
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
11261-5
|
Bacteria
identified
in
Vaginal
fluid
by
Aerobe
culture
|
|
11262-3
|
Parainfluenza
virus
3
IgG
Ab
[Titer]
in
Serum
|
|
11263-1
|
Parainfluenza
virus
3
IgM
Ab
[Titer]
in
Serum
|
|
11264-9
|
Salmonella
paratyphi
A
Ab
[Presence]
in
Serum
by
Agglutination
|
|
11265-6
|
Salmonella
paratyphi
B
Ab
[Presence]
in
Serum
by
Agglutination
|
|
11266-4
|
Streptococcus
agalactiae
Ag
[Presence]
in
Unspecified
specimen
|
|
11267-2
|
Streptococcus.beta-hemolytic
[Presence]
in
Genital
specimen
by
Organism
specific
culture
|
|
11268-0
|
Streptococcus
pyogenes
[Presence]
in
Throat
by
Organism
specific
culture
|
|
11269-8
|
Streptococcus
pyogenes
Ag
[Presence]
in
Serum
by
Agglutination
|
|
1132-0
|
Le
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
1138-7
|
Lu
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
11467-8
|
Bacillus
anthracis
Ab
[Units/volume]
in
Serum
by
Immunoblot
(IB)
|
|
11468-6
|
Bacillus
anthracis
Ab
[Units/volume]
in
Unspecified
specimen
by
Immunofluorescence
|
|
11469-4
|
Bacillus
anthracis
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
1147-8
|
Lu
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
|
|
11470-2
|
Clostridium
botulinum
toxin
[Units/volume]
in
Stool
|
|
11471-0
|
Deprecated
Cryptococcus
neoformans
Ag
[Titer]
in
Unspecified
specimen
|
|
11472-8
|
Deprecated
Cryptococcus
neoformans
Ag
[Presence]
in
Unspecified
specimen
|
|
11473-6
|
Cryptococcus
sp
Ag
[Titer]
in
Unspecified
specimen
|
|
11474-4
|
Hydatid
cyst
identified
in
Unspecified
specimen
by
Wet
preparation
|
|
11475-1
|
Microorganism
identified
in
Unspecified
specimen
by
Culture
|
|
11476-9
|
Microscopic
observation
[Identifier]
in
Gastric
fluid
by
Acid
fast
stain
|
|
11477-7
|
Microscopic
observation
[Identifier]
in
Sputum
by
Acid
fast
stain
|
|
11478-5
|
Microscopic
observation
[Identifier]
in
Stool
by
Acid
fast
stain
|
|
11479-3
|
Microscopic
observation
[Identifier]
in
Tissue
by
Acid
fast
stain
|
|
11480-1
|
Microscopic
observation
[Identifier]
in
Urine
by
Acid
fast
stain
|
|
11481-9
|
Human
papilloma
virus
identified
in
Unspecified
specimen
|
|
11482-7
|
Rickettsia
rickettsii
RNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
11483-5
|
Varicella
zoster
virus
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
11484-3
|
Virus
identified
in
Amniotic
fluid
by
Culture
|
|
11488-4
|
Consult
note
|
|
11490-0
|
Physician
Discharge
summary
|
|
11492-6
|
Provider-unspecifed,
History
and
physical
note
|
|
11504-8
|
Provider-unspecified
Operation
note
|
|
11505-5
|
Physician
Procedure
note
|
|
11506-3
|
Provider-unspecified
Progress
note
|
|
11507-1
|
Occupational
therapy
Progress
note
|
|
11508-9
|
Physical
therapy
Progress
note
|
|
11509-7
|
Podiatry
Progress
note
|
|
11510-5
|
Psychology
Progress
note
|
|
11512-1
|
Speech-language
pathology
Progress
note
|
|
11522-0
|
Deprecated
Cardiac
echo
study
|
|
11523-8
|
EEG
study
|
|
11524-6
|
EKG
Study
|
|
11525-3
|
US
Pelvis
Fetus
for
pregnancy
|
|
11526-1
|
Pathology
study
|
|
11527-9
|
Psychiatry
study
|
|
11529-5
|
Surgical
pathology
study
|
|
1153-6
|
Lu
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
11536-0
|
Nurse
Notes
|
|
11541-0
|
Deprecated
MRI
Brain
study
|
|
11545-1
|
Microscopic
observation
[Identifier]
in
Unspecified
specimen
by
Acid
fast
stain
|
|
11546-9
|
Microscopic
observation
[Identifier]
in
Unspecified
specimen
by
Other
stain
|
|
11550-1
|
Borrelia
burgdorferi
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
11551-9
|
Borrelia
burgdorferi
DNA
[Presence]
in
Cerebral
spinal
fluid
by
Probe
with
amplification
|
|
11556-8
|
Oxygen
[Partial
pressure]
in
Blood
|
|
11557-6
|
Carbon
dioxide
[Partial
pressure]
in
Blood
|
|
11558-4
|
pH
of
Blood
|
|
11560-0
|
Acetylcholine
receptor
binding
Ab
[Units/volume]
in
Serum
|
|
11561-8
|
Acetylcholine
receptor
blocking
Ab
[Units/volume]
in
Serum
|
|
11562-6
|
Acetylcholine
receptor
modulation
Ab
[Units/volume]
in
Serum
|
|
11564-2
|
Intrinsic
factor
Ab
[Units/volume]
in
Serum
|
|
11565-9
|
Jo-1
extractable
nuclear
Ab
[Units/volume]
in
Serum
|
|
11566-7
|
Liver
kidney
microsomal
Ab
[Units/volume]
in
Serum
|
|
11568-3
|
Phosphatidylserine
IgG
Ab
[Presence]
in
Serum
|
|
11569-1
|
Phosphatidylserine
IgM
Ab
[Presence]
in
Serum
|
|
11570-9
|
Platelet
IgG
Ab
[Units/volume]
in
Serum
|
|
11571-7
|
Rheumatoid
arthritis
nuclear
Ab
[Units/volume]
in
Serum
|
|
11572-5
|
Rheumatoid
factor
[Units/volume]
in
Serum
or
Plasma
|
|
11573-3
|
Rheumatoid
factor
IgM
[Units/volume]
in
Serum
|
|
11574-1
|
Deprecated
Thyroperoxidase
Ab
[Units/volume]
in
Serum
|
|
11579-0
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
by
Detection
limit
<=
0.05
mIU/L
|
|
11580-8
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
by
Detection
limit
<=
0.005
mIU/L
|
|
11581-6
|
Ebola
virus
Ab
[Units/volume]
in
Serum
|
|
11582-4
|
Wuchereria
bancrofti
Ab
[Units/volume]
in
Serum
|
|
11583-2
|
Aspergillus
fumigatus
1
Ab
[Presence]
in
Serum
|
|
11584-0
|
Aureobasidium
pullulans
Ab
[Presence]
in
Serum
|
|
11585-7
|
Bordetella
pertussis
Ab
[Units/volume]
in
Serum
|
|
11586-5
|
Brucella
abortus
Ab
[Units/volume]
in
Serum
|
|
11587-3
|
Brucella
canis
Ab
[Units/volume]
in
Serum
|
|
11588-1
|
Brucella
melitensis
Ab
[Units/volume]
in
Serum
|
|
11589-9
|
Brucella
suis
Ab
[Units/volume]
in
Serum
|
|
1159-3
|
little
c
Ag
[Presence]
on
Red
Blood
Cells
|
|
11590-7
|
Coxsackievirus
A10
Ab
[Units/volume]
in
Serum
|
|
11591-5
|
Coxsackievirus
A2
Ab
[Units/volume]
in
Serum
|
|
11592-3
|
Aspergillus
fumigatus
6
Ab
[Presence]
in
Serum
|
|
11593-1
|
Coxsackievirus
A4
Ab
[Units/volume]
in
Serum
|
|
11594-9
|
Echovirus
16
Ab
[Units/volume]
in
Serum
|
|
11595-6
|
Echovirus
18
Ab
[Units/volume]
in
Serum
|
|
11596-4
|
Shigella
dysenteriae
Ab
[Units/volume]
in
Serum
|
|
11597-2
|
Treponema
pallidum
Ab
[Units/volume]
in
Serum
|
|
11598-0
|
Toxoplasma
gondii
Ab
[Units/volume]
in
Serum
|
|
11599-8
|
Coxsackievirus
A21
Ab
[Units/volume]
in
Serum
|
|
11600-4
|
Shigella
flexneri
Ab
[Units/volume]
in
Serum
|
|
11601-2
|
Echovirus
7
Ab
[Units/volume]
in
Serum
|
|
11602-0
|
Shigella
boydii
Ab
[Units/volume]
in
Serum
|
|
11603-8
|
Salmonella
sp
Ab
[Units/volume]
in
Serum
|
|
11604-6
|
Burkholderia
pseudomallei
Ab
[Units/volume]
in
Serum
|
|
11605-3
|
Lymphocytic
choriomeningitis
virus
Ab
[Units/volume]
in
Serum
|
|
11606-1
|
Leptospira
interrogans
Ab
[Units/volume]
in
Serum
|
|
11607-9
|
Junin
virus
Ab
[Units/volume]
in
Serum
|
|
11608-7
|
Japanese
encephalitis
virus
Ab
[Units/volume]
in
Serum
|
|
11609-5
|
HTLV
I
Ab
[Units/volume]
in
Serum
|
|
11610-3
|
Heterophile
Ab
[Units/volume]
in
Serum
|
|
11611-1
|
Shigella
sonnei
Ab
[Units/volume]
in
Serum
|
|
1165-0
|
little
e
Ag
[Presence]
on
Red
Blood
Cells
|
|
1171-8
|
little
f
Ag
[Presence]
on
Red
Blood
Cells
|
|
1189-0
|
little
i
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
1195-7
|
little
k
Ag
[Presence]
on
Red
Blood
Cells
|
|
1204-7
|
pk
Ag
[Presence]
on
Red
Blood
Cells
|
|
1207-0
|
little
p
Ag
[Presence]
on
Red
Blood
Cells
|
|
1213-8
|
little
s
Ag
[Presence]
on
Red
Blood
Cells
|
|
12172-3
|
5-Hydroxyindoleacetate
[Presence]
in
24
hour
Urine
|
|
12173-1
|
Non
prostatic
acid
phosphatase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
12176-4
|
Amino
acids
[Moles/volume]
in
Serum
or
Plasma
|
|
12177-2
|
Amino
acids/Creatinine
[Ratio]
in
Urine
|
|
12178-0
|
Bacteria
[Presence]
in
Genital
specimen
by
Wet
preparation
|
|
12180-6
|
Calcium.ionized
[Moles/volume]
in
Serum
or
Plasma
by
Ion-selective
membrane
electrode
(ISE)
|
|
12181-4
|
Calcium
[Moles/volume]
in
Body
fluid
|
|
12183-0
|
Cholesterol
[Mass/volume]
in
Body
fluid
|
|
12184-8
|
Choriogonadotropin
[Presence]
in
Body
fluid
|
|
12186-3
|
Colloid
oncotic
pressure
[Partial
pressure]
in
Plasma
|
|
1219-5
|
LW
Ag
[Presence]
on
Red
Blood
Cells
|
|
12190-5
|
Creatinine
[Mass/volume]
in
Body
fluid
|
|
12191-3
|
Creatinine
[Mass/volume]
in
Peritoneal
fluid
|
|
12196-2
|
Cryofibrinogen
[Presence]
in
Plasma
by
4
hour
cold
incubation
|
|
12197-0
|
Cryofibrinogen
[Presence]
in
Plasma
by
1
day
cold
incubation
|
|
12198-8
|
Cryofibrinogen
[Presence]
in
Plasma
by
2
day
cold
incubation
|
|
12199-6
|
Cryofibrinogen
[Presence]
in
Plasma
by
3
day
cold
incubation
|
|
12210-1
|
Eosinophils/100
leukocytes
in
Urine
sediment
by
Manual
count
|
|
12212-7
|
Epstein
Barr
virus
nuclear
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
12217-6
|
Globulin
[Mass/volume]
in
Body
fluid
|
|
12218-4
|
Glucose
[Mass/volume]
in
Peritoneal
fluid
--2
hours
post
peritoneal
dialysis
|
|
12220-0
|
Glucose
[Mass/volume]
in
Peritoneal
fluid
--12
hours
post
peritoneal
dialysis
|
|
12221-8
|
Heterophile
Ab
[Presence]
in
Serum
by
Sheep
Cell
Agglutination
|
|
12222-6
|
Human
papilloma
virus
Ag
[Presence]
in
Genital
specimen
|
|
12223-4
|
Human
papilloma
virus
16+18
Ag
[Presence]
in
Genital
specimen
|
|
12228-3
|
Triglyceride
[Mass/volume]
in
Body
fluid
|
|
12232-5
|
Measles
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
12237-4
|
Mumps
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
12239-0
|
Oligosaccharides
[Presence]
in
Urine
|
|
12240-8
|
Orotidine
[Moles/volume]
in
Urine
|
|
12242-4
|
Phosphate
[Mass/volume]
in
Body
fluid
|
|
12245-7
|
Porphobilinogen
[Presence]
in
24
hour
Urine
|
|
12247-3
|
Pyruvate
[Mass/volume]
in
Serum
or
Plasma
|
|
1225-2
|
Mg
Ag
[Presence]
on
Red
Blood
Cells
|
|
12251-5
|
Rubella
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
12256-4
|
Spermatozoa
[#/area]
in
Semen
by
Microscopy
high
power
field
--post
vasectomy
|
|
12259-8
|
Streptococcus
pyogenes
enzyme
Ab
[Presence]
in
Serum
by
Sheep
Cell
Agglutination
|
|
12260-6
|
Sucrose
hemolysis
[Presence]
of
Red
Blood
Cells
|
|
12261-4
|
Toxoplasma
gondii
IgG
Ab
[Titer]
in
Serum
by
Immunoassay
|
|
12262-2
|
Toxoplasma
gondii
IgM
Ab
[Titer]
in
Serum
by
Immunoassay
|
|
12263-0
|
Deprecated
EBV
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
12264-8
|
Deprecated
Epstein
Barr
virus
early
restricted
Ab
[Mass/volume]
in
Body
fluid
|
|
12265-5
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
fluid
|
|
12266-3
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
fluid
--2
hours
post
peritoneal
dialysis
|
|
12267-1
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
fluid
--4
hours
post
peritoneal
dialysis
|
|
12268-9
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
fluid
--12
hours
post
peritoneal
dialysis
|
|
12269-7
|
Urobilinogen
[Presence]
in
24
hour
Urine
|
|
12271-3
|
Varicella
zoster
virus
Ab
[Presence]
in
Serum
by
Latex
agglutination
|
|
12272-1
|
Virus
identified
in
Unspecified
specimen
by
Immunofluorescence
|
|
12274-7
|
Xylose
[Mass/time]
in
5
hour
Urine
|
|
12275-4
|
Yeast
[Presence]
in
Genital
specimen
by
Wet
preparation
|
|
12276-2
|
Deprecated
Escherichia
coli
O157:H7
identified
in
Stool
by
Organism
specific
culture
|
|
12277-0
|
DNA
double
strand
Ab
[Presence]
in
Serum
by
Farr
method
|
|
12281-2
|
Bacteria
identified
in
Cervix
by
Anaerobe
culture
|
|
12282-0
|
Warfarin
[Presence]
in
Urine
|
|
12283-8
|
Corticotropin
releasing
hormone
[Units/volume]
in
Serum
or
Plasma
|
|
12284-6
|
Growth
hormone-releasing
hormone
[Units/volume]
in
Serum
or
Plasma
|
|
12286-1
|
Drugs
identified
in
Urine
by
Screen
method
|
|
12287-9
|
Drugs
identified
in
Gastric
fluid
by
Screen
method
|
|
12288-7
|
Diuretics
[Identifier]
in
Urine
|
|
12289-5
|
Drugs
identified
in
Vitreous
fluid
by
Screen
method
|
|
12290-3
|
Procyclidine
[Presence]
in
Urine
|
|
12291-1
|
Mephentermine
[Presence]
in
Urine
|
|
12292-9
|
Dimethyltryptamine
[Presence]
in
Urine
|
|
12293-7
|
Cotinine
[Presence]
in
Urine
|
|
12294-5
|
Nicotine
[Presence]
in
Urine
|
|
12295-2
|
Hallucinogens
[Identifier]
in
Urine
|
|
12296-0
|
Mescaline
[Presence]
in
Urine
|
|
12297-8
|
Chlorate
[Presence]
in
Blood
|
|
12298-6
|
Erythromycin
[Presence]
in
Urine
|
|
12299-4
|
Ethinamate
[Presence]
in
Urine
|
|
12300-0
|
Polythiazide
[Presence]
in
Urine
|
|
12301-8
|
Procaine
[Presence]
in
Urine
|
|
12302-6
|
Theobromine
[Presence]
in
Serum
or
Plasma
|
|
12303-4
|
Theobromine
[Presence]
in
Urine
|
|
12304-2
|
Benzyl
alcohol
[Presence]
in
Serum
or
Plasma
|
|
12305-9
|
Chlordecone
[Presence]
in
Blood
|
|
12306-7
|
Cyclohexane
[Mass/volume]
in
Blood
|
|
12307-5
|
Dichloroethane
[Mass/volume]
in
Blood
|
|
12308-3
|
Hydrocodone
[Presence]
in
Urine
|
|
12309-1
|
Naltrexone
[Presence]
in
Urine
|
|
1231-0
|
M
Ag
[Presence]
on
Red
Blood
Cells
|
|
12310-9
|
Phenytoin
[Presence]
in
Urine
|
|
12311-7
|
Prazepam
[Mass/volume]
in
Urine
|
|
12312-5
|
Cyclopropane
[Mass/volume]
in
Blood
|
|
12313-3
|
Aprobarbital
[Presence]
in
Urine
|
|
12314-1
|
Clorazepate
[Presence]
in
Urine
|
|
12315-8
|
Mephobarbital
[Presence]
in
Urine
|
|
12317-4
|
Phenolphthalein
[Presence]
in
Urine
|
|
12318-2
|
Spironolactone
[Presence]
in
Urine
|
|
12319-0
|
Thioridazine
[Presence]
in
Urine
|
|
12320-8
|
Thiothixene
[Presence]
in
Urine
|
|
12321-6
|
Trifluoperazine
[Presence]
in
Urine
|
|
12322-4
|
Triflupromazine
[Presence]
in
Urine
|
|
12323-2
|
Trimeprazine
[Presence]
in
Urine
|
|
12324-0
|
Hydroxyzine
[Presence]
in
Urine
|
|
12325-7
|
Tetrahydrocortisone
[Presence]
in
Urine
|
|
12326-5
|
Diamorphine
[Presence]
in
Unknown
substance
|
|
12327-3
|
Ketamine
[Presence]
in
Urine
|
|
12328-1
|
Beta
blockers
[Identifier]
in
Urine
|
|
12329-9
|
Chlorpropamide
[Presence]
in
Urine
|
|
12330-7
|
Hypoglycemics.oral
[Identifier]
in
Urine
|
|
12331-5
|
Phenethylamine
[Presence]
in
Urine
|
|
12332-3
|
Antihistamines
[Identifier]
in
Urine
|
|
12333-1
|
Butorphanol
[Presence]
in
Urine
|
|
12334-9
|
Para
aminophenol
[Mass/volume]
in
Urine
|
|
12335-6
|
Halothane
[Presence]
in
Blood
|
|
12336-4
|
Hydralazine
[Presence]
in
Serum
or
Plasma
|
|
12337-2
|
Dimethylsulfoxide
[Presence]
in
Serum
or
Plasma
|
|
12338-0
|
Pentachlorophenol
[Presence]
in
Serum
or
Plasma
|
|
12339-8
|
Diquat
[Presence]
in
Urine
|
|
1234-4
|
Mi
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
12340-6
|
Ethylene
[Presence]
in
Blood
|
|
12341-4
|
Mazindol
[Presence]
in
Serum
or
Plasma
|
|
12342-2
|
Oxymorphone
[Presence]
in
Serum
or
Plasma
|
|
12343-0
|
Thiazides
[Identifier]
in
Urine
|
|
12344-8
|
Antipsychotics
[Identifier]
in
Serum
or
Plasma
|
|
12345-5
|
Cyclothiazide
[Presence]
in
Urine
|
|
12346-3
|
Methyclothiazide
[Presence]
in
Urine
|
|
12347-1
|
Metolazone
[Presence]
in
Urine
|
|
12348-9
|
Quinethazone
[Presence]
in
Urine
|
|
12349-7
|
Trichlormethiazide
[Presence]
in
Urine
|
|
12350-5
|
Amphetamines
[Presence]
in
Stool
|
|
12351-3
|
Tetrahydrocannabinol
[Presence]
in
Stool
|
|
12352-1
|
Benzoylecgonine
[Presence]
in
Stool
|
|
12353-9
|
Methaqualone
[Presence]
in
Stool
|
|
12354-7
|
Opiates
[Presence]
in
Stool
|
|
12355-4
|
Phencyclidine
[Presence]
in
Stool
|
|
12356-2
|
Methadone
[Presence]
in
Stool
|
|
12357-0
|
Propoxyphene
[Presence]
in
Stool
|
|
12358-8
|
Barbiturates
[Presence]
in
Stool
|
|
12359-6
|
Benzodiazepines
[Presence]
in
Stool
|
|
12360-4
|
Barbital
[Presence]
in
Urine
|
|
12361-2
|
Oxazepam
[Presence]
in
Urine
|
|
12362-0
|
Oxazepam
[Presence]
in
Serum
or
Plasma
|
|
12363-8
|
Carbamazepine
[Presence]
in
Urine
|
|
12364-6
|
Benzodiazepines
[Presence]
in
Gastric
fluid
|
|
12365-3
|
Dimenhydrinate
[Presence]
in
Urine
|
|
12366-1
|
Disopyramide
[Presence]
in
Urine
|
|
12367-9
|
Mesoridazine
[Presence]
in
Urine
|
|
12368-7
|
Phenacetin
[Presence]
in
Urine
|
|
12369-5
|
Sympathomimetics
[Identifier]
in
Urine
|
|
12370-3
|
Thiopental
[Mass/volume]
in
Urine
|
|
12371-1
|
Isopropyl
ether
[Mass/volume]
in
Blood
|
|
12372-9
|
Dimethylacetamide
[Mass/volume]
in
Urine
|
|
12374-5
|
Clobazam
[Mass/volume]
in
Urine
|
|
12375-2
|
Clozapine+Norclozapine
[Mass/volume]
in
Serum
or
Plasma
|
|
12377-8
|
Demoxepam
[Mass/volume]
in
Serum
or
Plasma
|
|
12378-6
|
Diazepam
[Presence]
in
Stool
|
|
12379-4
|
Halazepam
[Mass/volume]
in
Serum
or
Plasma
|
|
12380-2
|
Lorazepam
[Presence]
in
Stool
|
|
12381-0
|
Oxazepam
[Presence]
in
Stool
|
|
12382-8
|
Temazepam
[Mass/volume]
in
Urine
|
|
12383-6
|
Hydroxytriazolam
[Presence]
in
Stool
|
|
12384-4
|
Triazolam
[Presence]
in
Stool
|
|
12386-9
|
Nordoxepin
[Mass/volume]
in
Urine
|
|
12387-7
|
Primidone
[Mass/volume]
in
Urine
|
|
12388-5
|
Phenylethylmalonamide
[Mass/volume]
in
Serum
or
Plasma
|
|
12389-3
|
Olanzapine
[Mass/volume]
in
Serum
or
Plasma
|
|
12390-1
|
Sulfasalazine
[Mass/volume]
in
Serum
or
Plasma
|
|
12391-9
|
Dimenhydrinate
[Mass/volume]
in
Serum
or
Plasma
|
|
12394-3
|
Butorphanol
[Mass/volume]
in
Serum
or
Plasma
|
|
12395-0
|
Butorphanol
[Mass/volume]
in
Urine
|
|
12396-8
|
Chlorpropamide
[Mass/volume]
in
Urine
|
|
12397-6
|
Colchicine
[Mass/volume]
in
Serum
or
Plasma
|
|
12398-4
|
Diphenoxylate
[Mass/volume]
in
Serum
or
Plasma
|
|
12399-2
|
Emetine
[Mass/volume]
in
Serum
or
Plasma
|
|
12400-8
|
Emetine
[Mass/volume]
in
Urine
|
|
12401-6
|
Ethinamate
[Mass/volume]
in
Serum
or
Plasma
|
|
12402-4
|
Griseofulvin
[Mass/volume]
in
Serum
or
Plasma
|
|
12403-2
|
Mephentermine
[Mass/volume]
in
Blood
|
|
12404-0
|
Nitroglycerin
[Mass/volume]
in
Serum
or
Plasma
|
|
12405-7
|
Nabumetone
[Mass/volume]
in
Serum
or
Plasma
|
|
12406-5
|
Nadolol
[Mass/volume]
in
Serum
or
Plasma
|
|
12407-3
|
6-Beta
naltrexone
[Mass/volume]
in
Serum
or
Plasma
|
|
12408-1
|
Oxybutynin
[Mass/volume]
in
Serum
or
Plasma
|
|
12410-7
|
Pimozide
[Mass/volume]
in
Serum
or
Plasma
|
|
12411-5
|
Promazine
[Mass/volume]
in
Serum
or
Plasma
|
|
12412-3
|
Pyridine
[Mass/volume]
in
Serum
or
Plasma
|
|
12413-1
|
Resperine
[Mass/volume]
in
Serum
or
Plasma
|
|
12414-9
|
Resperine
[Mass/volume]
in
Urine
|
|
12415-6
|
Selegiline
[Mass/volume]
in
Serum
or
Plasma
|
|
12416-4
|
Sotalol
[Mass/volume]
in
Serum
or
Plasma
|
|
12417-2
|
Sulindac
[Mass/volume]
in
Serum
or
Plasma
|
|
12418-0
|
Terfenadine
[Mass/volume]
in
Serum
or
Plasma
|
|
12419-8
|
Terfenadine
[Mass/volume]
in
Urine
|
|
12420-6
|
Thiosulfate
[Mass/volume]
in
Urine
|
|
12421-4
|
Thiosulfate/Creatinine
[Mass
Ratio]
in
Urine
|
|
12422-2
|
Triflupromazine
[Mass/volume]
in
Serum
or
Plasma
|
|
12423-0
|
Trimeprazine
[Mass/volume]
in
Serum
or
Plasma
|
|
12424-8
|
Triprolidine
[Mass/volume]
in
Serum
or
Plasma
|
|
12425-5
|
Chlorzoxazone
[Mass/volume]
in
Serum
or
Plasma
|
|
12426-3
|
Brodifacoum
[Mass/volume]
in
Serum
or
Plasma
|
|
12427-1
|
Chlormezanone
[Mass/volume]
in
Serum
or
Plasma
|
|
12428-9
|
Flurbiprofen
[Mass/volume]
in
Serum
or
Plasma
|
|
12429-7
|
Succinylcholine
[Mass/volume]
in
Urine
|
|
1243-5
|
M
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
12430-5
|
Cumene
[Mass/volume]
in
Serum
or
Plasma
|
|
12431-3
|
Norfenfluramine
[Mass/volume]
in
Serum
or
Plasma
|
|
12432-1
|
Hydroxytriazolam
[Mass/volume]
in
Urine
|
|
12433-9
|
Bufotenine
[Mass/volume]
in
Serum
or
Plasma
|
|
12434-7
|
Prednisone
[Mass/volume]
in
Serum
or
Plasma
|
|
12435-4
|
Naphthalene
[Mass/volume]
in
Serum
or
Plasma
|
|
12436-2
|
Naphthol
[Mass/volume]
in
Serum
or
Plasma
|
|
12437-0
|
Tramadol
[Mass/volume]
in
Serum
or
Plasma
|
|
12438-8
|
Nortramadol
[Mass/volume]
in
Serum
or
Plasma
|
|
12439-6
|
Fluoxetine
[Mass/volume]
in
Urine
|
|
12440-4
|
Midazolam
[Presence]
in
Stool
|
|
12441-2
|
Tolmetin
[Mass/volume]
in
Serum
or
Plasma
|
|
12442-0
|
Acetaminophen
[Mass/volume]
in
Unspecified
specimen
|
|
12443-8
|
Trimipramine
[Mass/volume]
in
Urine
|
|
12444-6
|
Nortrimipramine
[Mass/volume]
in
Urine
|
|
12445-3
|
Norfluoxetine
[Mass/volume]
in
Urine
|
|
12446-1
|
Halogenated
organic
molecules
[Identifier]
in
Urine
|
|
12448-7
|
Ketones
[Mass/volume]
in
Urine
by
Test
strip
--fasting
|
|
12455-2
|
Histoplasma
capsulatum
yeast
phase
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
12456-0
|
Histoplasma
capsulatum
mycelial
phase
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
12465-1
|
Ethanol
[Mass/volume]
in
Vitreous
fluid
|
|
12466-9
|
Alpha
1
antitrypsin
[Mass/volume]
in
Amniotic
fluid
by
Nephelometry
|
|
12467-7
|
Amino
acids
[Identifier]
in
Urine
|
|
12468-5
|
Amino
acids
[Identifier]
in
Serum
or
Plasma
|
|
12470-1
|
Homocysteine
[Mass/volume]
in
Urine
|
|
12471-9
|
Amino
beta
guanidinopropionate
[Mass/volume]
in
Urine
|
|
12472-7
|
Amino
beta
guanidinopropionate
[Mass/volume]
in
24
hour
Urine
|
|
12475-0
|
Delta
aminolevulinate
[Mass/time]
in
Urine
|
|
12476-8
|
Bilirubin.total
[Mass/volume]
in
Amniotic
fluid
by
Spectrophotometry
direct
|
|
12477-6
|
Dextromethamphetamine
[Mass/volume]
in
Urine
|
|
12478-4
|
Levomethamphetamine
[Mass/volume]
in
Urine
|
|
12479-2
|
Androsterone
[Mass/time]
in
Urine
|
|
12480-0
|
Angiotensin
converting
enzyme
[Enzymatic
activity/volume]
in
Cerebral
spinal
fluid
|
|
12481-8
|
Arsenic.inorganic
[Mass/volume]
in
Urine
|
|
12482-6
|
Ascorbate
[Mass/volume]
in
Leukocytes
|
|
12483-4
|
Tungsten
[Presence]
in
Serum
or
Plasma
|
|
12484-2
|
Phenobarbital
[Presence]
in
Gastric
fluid
|
|
12485-9
|
Amobarbital
[Presence]
in
Gastric
fluid
|
|
12486-7
|
Butabarbital
[Presence]
in
Gastric
fluid
|
|
12487-5
|
Butalbital
[Presence]
in
Gastric
fluid
|
|
12488-3
|
Pentobarbital
[Presence]
in
Gastric
fluid
|
|
12489-1
|
Secobarbital
[Presence]
in
Gastric
fluid
|
|
1249-2
|
M1
Ag
[Presence]
on
Red
Blood
Cells
|
|
12490-9
|
Allyl-sec-butyl-barbiturate
[Mass/volume]
in
Serum
or
Plasma
|
|
12491-7
|
Methohexital
[Presence]
in
Serum
or
Plasma
|
|
12492-5
|
Thiamylal
[Presence]
in
Serum
or
Plasma
|
|
12493-3
|
Hexobarbital
[Mass/volume]
in
Serum
or
Plasma
|
|
12494-1
|
Amobarbital
[Presence]
in
Stool
|
|
12495-8
|
Barbital
[Presence]
in
Stool
|
|
12496-6
|
Butabarbital
[Presence]
in
Stool
|
|
12497-4
|
Butalbital
[Presence]
in
Stool
|
|
12498-2
|
Metharbital
[Presence]
in
Stool
|
|
12499-0
|
Pentobarbital
[Presence]
in
Stool
|
|
12500-5
|
Secobarbital
[Presence]
in
Stool
|
|
12501-3
|
Phenobarbital
[Presence]
in
Stool
|
|
12502-1
|
Allobarbital
[Presence]
in
Stool
|
|
12505-4
|
Cadmium
[Mass/volume]
in
Red
Blood
Cells
|
|
12511-2
|
Calcium
[Mass/volume]
in
4
hour
Urine
|
|
12513-8
|
Bicarbonate
[Moles/volume]
in
Water
|
|
12514-6
|
Bicarbonate
[Moles/volume]
in
Dialysis
fluid
|
|
12515-3
|
Carcinoembryonic
Ag
[Mass/volume]
in
Body
fluid
|
|
12530-2
|
Chloride
[Moles/volume]
in
Water
|
|
12532-8
|
Meclizine
[Presence]
in
Serum
or
Plasma
|
|
12533-6
|
Thiazolidine-2-Thione-4-Carboxylic
acid
[Mass/volume]
in
Urine
|
|
12534-4
|
Thiazolidine-2-Thione-4-Carboxylic
acid/Creatinine
[Mass
Ratio]
in
Urine
|
|
12535-1
|
Amyl
nitrite
[Presence]
in
Blood
|
|
12536-9
|
Butyl
nitrate
[Presence]
in
Blood
|
|
12537-7
|
Phenylglyoxylate
[Mass/volume]
in
Urine
|
|
12538-5
|
Nitrate
[Mass/volume]
in
Blood
|
|
12541-9
|
Meta
methylhippurate+Para
methylhippurate
[Mass/volume]
in
Urine
|
|
12542-7
|
N-methylacetamide
[Mass/volume]
in
Urine
|
|
12543-5
|
Methyl
formamide
[Mass/volume]
in
Urine
|
|
12544-3
|
Nefazodone
[Mass/volume]
in
Serum
or
Plasma
|
|
12545-0
|
Zomepirac
[Mass/volume]
in
Serum
or
Plasma
|
|
12546-8
|
Quinethazone
[Presence]
in
Serum
or
Plasma
|
|
12547-6
|
Phorate
[Mass/volume]
in
Serum
or
Plasma
|
|
12548-4
|
Tybamate
[Mass/volume]
in
Serum
or
Plasma
|
|
12549-2
|
Turpentine
[Mass/volume]
in
Serum
or
Plasma
|
|
12550-0
|
Papaverine
[Mass/volume]
in
Serum
or
Plasma
|
|
12551-8
|
Isocarboxazid
[Mass/volume]
in
Serum
or
Plasma
|
|
12552-6
|
Propylene
glycol
[Mass/volume]
in
Serum
or
Plasma
|
|
12553-4
|
Stimulants
[Identifier]
in
Urine
|
|
12554-2
|
Narcotics
and
opioids
[Identifier]
in
Urine
|
|
12555-9
|
Turpentine
[Mass/volume]
in
Urine
|
|
12556-7
|
Copper
[Mass/volume]
in
Blood
|
|
12584-9
|
Creatinine
[Mass/volume]
in
Vitreous
fluid
|
|
12585-6
|
Creatinine
[Mass/time]
in
2
hour
Urine
|
|
12586-4
|
Creatinine
[Mass/time]
in
4
hour
Urine
|
|
12587-2
|
Creatinine
[Mass/time]
in
6
hour
Urine
|
|
12588-0
|
Creatinine
[Mass/time]
in
8
hour
Urine
|
|
12589-8
|
Creatinine
[Mass/time]
in
12
hour
Urine
|
|
12595-5
|
Estradiol
(E2)
[Mass/volume]
in
Urine
|
|
12598-9
|
Fat.neutral
[Presence]
in
Stool
|
|
12601-1
|
Fluoride
[Mass/volume]
in
Dialysis
fluid
|
|
12602-9
|
Hydroxyethylflurazepam
[Mass/volume]
in
Urine
|
|
12603-7
|
N-desalkylflurazepam
[Presence]
in
Stool
|
|
12604-5
|
Hydroxyethylflurazepam
[Presence]
in
Stool
|
|
12605-2
|
Flurazepam
[Presence]
in
Stool
|
|
1261-7
|
N
Ag
[Presence]
on
Red
Blood
Cells
|
|
12610-2
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
XXX
challenge
|
|
12614-4
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--7
hours
post
meal
|
|
12628-4
|
Glucose
[Mass/volume]
in
Peritoneal
dialysis
fluid
|
|
12629-2
|
Glucose
[Mass/volume]
in
24
hour
Peritoneal
dialysis
fluid
|
|
12646-6
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
XXX
challenge
|
|
12647-4
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--12
hours
post
XXX
challenge
|
|
1267-4
|
N
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
12702-7
|
Antimony
[Presence]
in
Serum
or
Plasma
|
|
12703-5
|
Gallium
[Mass/volume]
in
Serum
or
Plasma
|
|
12705-0
|
Strontium
[Mass/volume]
in
Urine
|
|
12706-8
|
Tellurium
[Mass/volume]
in
Serum
or
Plasma
|
|
12707-6
|
Thorium
[Mass/volume]
in
Serum
or
Plasma
|
|
12708-4
|
Tin
[Mass/volume]
in
Urine
|
|
12709-2
|
Norastemizole
[Mass/volume]
in
Serum
or
Plasma
|
|
12714-2
|
N-methylhistamine
[Mass/volume]
in
Urine
|
|
12715-9
|
Homovanillate
[Mass/time]
in
Urine
|
|
12720-9
|
Hydroxyproline
[Mass/volume]
in
2
hour
Urine
|
|
12721-7
|
Melatonin
[Units/volume]
in
Serum
or
Plasma
|
|
12722-5
|
Insulin-like
growth
factor
binding
protein
1
[Mass/volume]
in
Serum
or
Plasma
|
|
12723-3
|
Insulin-like
growth
factor
binding
protein
2
[Mass/volume]
in
Serum
or
Plasma
|
|
12724-1
|
Voltage-gated
calcium
channel
IgG
Ab
[Units/volume]
in
Serum
|
|
12725-8
|
IgA.secretory
[Units/volume]
in
Serum
or
Plasma
|
|
12726-6
|
Leucine-enkephalin
[Units/volume]
in
Serum
or
Plasma
|
|
12727-4
|
Prednisolone
[Mass/volume]
in
Serum
or
Plasma
|
|
12728-2
|
Alpha
subunit
[Units/volume]
in
Serum
or
Plasma
|
|
12729-0
|
Interferon
gamma
[Units/volume]
in
Serum
or
Plasma
|
|
12730-8
|
Interferon
beta
[Units/volume]
in
Serum
or
Plasma
|
|
12731-6
|
Interferon
alpha
[Units/volume]
in
Serum
or
Plasma
|
|
12732-4
|
Interleukin
12
[Units/volume]
in
Serum
or
Plasma
|
|
12733-2
|
Tryptase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
12734-0
|
Cytokeratin
Ab
[Units/volume]
in
Serum
|
|
12735-7
|
Collagen
Ab
[Units/volume]
in
Urine
|
|
12736-5
|
Hyaluronate
[Mass/volume]
in
Serum
or
Plasma
|
|
12737-3
|
Endothelin
[Units/volume]
in
Serum
or
Plasma
|
|
12769-6
|
17-Ketosteroids.total
neutral
[Mass/time]
in
24
hour
Urine
|
|
12770-4
|
Lead
[Mass/mass]
in
Tissue
|
|
12774-6
|
Mercury
[Mass/volume]
in
Red
Blood
Cells
|
|
12775-3
|
Mercury
[Mass/volume]
in
Dentin
|
|
12776-1
|
Mucin-like
carcinoma
associated
Ag
[Units/volume]
in
Serum
or
Plasma
|
|
12777-9
|
Immunoglobulin
light
chains.kappa.free
[Units/volume]
in
Urine
|
|
12778-7
|
Immunoglobulin
light
chains.lambda.free
[Units/volume]
in
Urine
|
|
12779-5
|
Nickel
[Mass/time]
in
Urine
|
|
12780-3
|
Nickel
[Mass/volume]
in
Red
Blood
Cells
|
|
12784-5
|
Codeine
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
12785-2
|
Dihydrocodeine
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
12786-0
|
Hydrocodone
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
12787-8
|
Hydromorphone
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
12788-6
|
6-Monoacetylmorphine
(6-MAM)
[Mass/volume]
in
Serum
or
Plasma
|
|
12789-4
|
Oxycodone
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
12799-3
|
Parathyrin
Ab
[Units/volume]
in
Serum
|
|
12801-7
|
Methdilazine
[Mass/volume]
in
Serum
or
Plasma
|
|
12802-5
|
Propiomazine
[Mass/volume]
in
Serum
or
Plasma
|
|
12803-3
|
Phenylalanine
[Presence]
in
Blood
by
Guthrie
test
|
|
12804-1
|
Acid
phosphatase
[Enzymatic
activity/volume]
in
Body
fluid
|
|
12805-8
|
Alkaline
phosphatase
isoenzyme
[Units/volume]
in
Serum
or
Plasma
|
|
12810-8
|
Porphobilinogen
deaminase
[Enzymatic
activity/volume]
in
Blood
|
|
12811-6
|
Uroporphyrinogen
III
synthase
[Enzymatic
activity/volume]
in
Blood
|
|
12814-0
|
Potassium
[Moles/volume]
in
Vitreous
fluid
|
|
12820-7
|
Progesterone
[Mass/volume]
in
24
hour
Urine
|
|
12836-3
|
Prostaglandin
E2
[Mass/volume]
in
24
hour
Urine
|
|
12837-1
|
Prostaglandin
E1
[Mass/volume]
in
24
hour
Urine
|
|
12838-9
|
Prostaglandin
D2
[Mass/volume]
in
Urine
|
|
12839-7
|
Prostaglandin
D2
[Mass/volume]
in
Serum
or
Plasma
|
|
12840-5
|
Prostaglandin
F2
alpha
[Moles/volume]
in
Urine
|
|
12842-1
|
Protein
[Mass/volume]
in
12
hour
Urine
|
|
12843-9
|
Protein
[Mass/volume]
in
Peritoneal
dialysis
fluid
|
|
1285-6
|
P
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
12852-0
|
Bovine
inner
ear
Ag
[Presence]
in
Serum
or
Plasma
by
Immunoblot
(IB)
|
|
12853-8
|
Purkinje
cells
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12854-6
|
Neuronal
nuclear
type
1
Ab
[Units/volume]
in
Serum
|
|
12897-5
|
Myelin
associated
glycoprotein
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
12898-3
|
Chloride
[Moles/volume]
in
Vitreous
fluid
|
|
12899-1
|
Acetylene
[Mass/volume]
in
Serum
or
Plasma
|
|
12907-2
|
Sodium
[Moles/volume]
in
Red
Blood
Cells
|
|
12908-0
|
Sodium
[Moles/volume]
in
Vitreous
fluid
|
|
1291-4
|
P1
Ag
[Presence]
on
Red
Blood
Cells
|
|
12912-2
|
Lipids
[Mass/volume]
in
Body
fluid
|
|
12913-0
|
Beta-N-acetylhexosaminidase
[Enzymatic
activity/volume]
in
Leukocytes
|
|
12915-5
|
Beta
galactosidase
[Enzymatic
activity/volume]
in
Leukocytes
|
|
12916-3
|
Porphobilinogen
synthase
[Enzymatic
activity/volume]
in
Blood
|
|
12917-1
|
Porphobilinogen
synthase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
12918-9
|
Monoamine
oxidase
[Enzymatic
activity/volume]
in
Platelet
rich
plasma
|
|
12919-7
|
Monoamine
oxidase
[Enzymatic
activity/volume]
in
Blood
|
|
12920-5
|
Sulfate
[Mass/volume]
in
24
hour
Urine
|
|
12949-4
|
Transferrin.carbohydrate
deficient
[Mass/volume]
in
Serum
or
Plasma
|
|
12960-1
|
Alpha
1
antitrypsin
fecal
clearance
|
|
12961-9
|
Urea
nitrogen
[Mass/volume]
in
Arterial
blood
|
|
12962-7
|
Urea
nitrogen
[Mass/volume]
in
Venous
blood
|
|
12963-5
|
Urea
nitrogen
[Mass/volume]
in
Peripheral
blood
|
|
12967-6
|
Urea
nitrogen
[Mass/volume]
in
24
hour
Urine
|
|
1297-1
|
P2
Ag
[Presence]
on
Red
Blood
Cells
|
|
12983-3
|
Volatiles
and
gases
[Identifier]
in
Urine
|
|
12987-4
|
Acetonitrile
[Mass/volume]
in
Urine
|
|
12988-2
|
Acrylamide
[Mass/volume]
in
Blood
|
|
12989-0
|
Allyl
alcohol
[Mass/volume]
in
Serum
or
Plasma
|
|
12990-8
|
Polychlorinated
biphenyl.Aroclor
1260
[Mass/volume]
in
Serum
or
Plasma
|
|
12991-6
|
Polychlorinated
biphenyl.Aroclor
1254
[Mass/volume]
in
Serum
or
Plasma
|
|
12992-4
|
Isobutane
[Mass/volume]
in
Blood
|
|
12993-2
|
Hydrocarbons.chlorinated
[Identifier]
in
Blood
|
|
12994-0
|
Oxychlordane
[Mass/volume]
in
Blood
|
|
12995-7
|
Cyclohexanone
[Mass/volume]
in
Blood
|
|
12996-5
|
Dichlorodifluoroethane
[Mass/volume]
in
Blood
|
|
12997-3
|
1,4-Dioxane
[Mass/volume]
in
Serum
or
Plasma
|
|
12998-1
|
Methylene
chloride
[Mass/volume]
in
Blood
|
|
12999-9
|
Epichlorohydrin
[Mass/volume]
in
Serum
or
Plasma
|
|
13000-5
|
Mandelate
[Mass/volume]
in
Urine
|
|
13001-3
|
Mandelate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13002-1
|
Mesityl
oxide
[Mass/volume]
in
Blood
|
|
13003-9
|
Halogenated
organic
molecules
[Identifier]
in
Blood
|
|
13004-7
|
Hydrocarbons.halogenated.volatile
[Identifier]
in
Blood
|
|
13007-0
|
Ethane
[Mass/volume]
in
Blood
|
|
13008-8
|
Methyl
propyl
ketone
[Mass/volume]
in
Blood
|
|
13009-6
|
Methyl
ethyl
ketone
[Mass/volume]
in
Urine
|
|
13010-4
|
Methyl
amyl
ketone
[Mass/volume]
in
Blood
|
|
13011-2
|
Methyl
ethyl
ketone
[Mass/volume]
in
Blood
|
|
13012-0
|
Methyl
isoamyl
ketone
[Mass/volume]
in
Blood
|
|
13013-8
|
Methyl
isobutyl
ketone
[Mass/volume]
in
Blood
|
|
13014-6
|
Methyl
butyl
ketone
[Mass/volume]
in
Blood
|
|
13015-3
|
Diisobutylketone
[Mass/volume]
in
Blood
|
|
13016-1
|
Nitrophenol
[Units/volume]
in
Blood
|
|
13018-7
|
Pesticides
[Identifier]
in
Urine
|
|
13019-5
|
Pesticides
[Identifier]
in
Serum
or
Plasma
|
|
13020-3
|
Pesticides
[Identifier]
in
Blood
|
|
13021-1
|
Pesticides
[Identifier]
in
Gastric
fluid
|
|
13022-9
|
Propane
[Mass/volume]
in
Blood
|
|
13023-7
|
Trichlorofluoromethane
[Mass/volume]
in
Blood
|
|
13024-5
|
Trichlorofluoroethane
[Mass/volume]
in
Blood
|
|
13025-2
|
Trichlorotrifluoroethane
[Mass/volume]
in
Blood
|
|
13026-0
|
Orthocresol
[Mass/volume]
in
Urine
|
|
13027-8
|
Ethyl
acetate
[Mass/volume]
in
Serum
or
Plasma
|
|
13037-7
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--fasting
|
|
13050-0
|
Protein
C/Coagulation
factor
IX
[Mass
Ratio]
in
Platelet
poor
plasma
|
|
13051-8
|
Deprecated
Protein
S
[Units/volume]
in
Platelet
poor
plasma
|
|
13052-6
|
Protein
S/Coagulation
factor
IX
[Mass
Ratio]
in
Platelet
poor
plasma
by
Coagulation
assay
|
|
13053-4
|
Kaolin
activated
time
[Units/volume]
in
Platelet
poor
plasma
|
|
13054-2
|
Fibrin+Fibrinogen
fragments
[Units/volume]
in
Urine
|
|
13055-9
|
Heparin
[Units/volume]
in
Platelet
poor
plasma
|
|
13056-7
|
Platelets
[#/volume]
in
Plasma
by
Automated
count
|
|
13061-7
|
Platelet
IgM
Ab
[Units/volume]
in
Serum
|
|
13062-5
|
Platelet
IgA
Ab
[Units/volume]
in
Serum
|
|
13063-3
|
Drug
induced
platelet
Ab
[Units/volume]
in
Serum
|
|
13064-1
|
Platelet
associated
IgA
Ab
[Units/volume]
in
Blood
|
|
13065-8
|
Deprecated
Platelet
Ab
[Units/volume]
in
Serum
|
|
13066-6
|
Nuclear
Ab
[Units/volume]
in
Body
fluid
by
Immunofluorescence
|
|
13069-0
|
Phosphatidylserine
IgA
Ab
[Units/volume]
in
Serum
|
|
13070-8
|
Phosphatidate
IgG
Ab
[Units/volume]
in
Serum
|
|
13071-6
|
Phosphatidate
IgM
Ab
[Units/volume]
in
Serum
|
|
13072-4
|
Phosphatidate
IgA
Ab
[Units/volume]
in
Serum
|
|
13073-2
|
Phosphatidylcholine
IgG
Ab
[Units/volume]
in
Serum
|
|
13074-0
|
Phosphatidylcholine
IgM
Ab
[Units/volume]
in
Serum
|
|
13075-7
|
Phosphatidylcholine
IgA
Ab
[Units/volume]
in
Serum
|
|
13076-5
|
Phosphatidylethanolamine
IgG
Ab
[Units/volume]
in
Serum
|
|
13077-3
|
Phosphatidylethanolamine
IgM
Ab
[Units/volume]
in
Serum
|
|
13078-1
|
Phosphatidylethanolamine
IgA
Ab
[Units/volume]
in
Serum
|
|
13079-9
|
Phosphatidylglycerol
IgG
Ab
[Units/volume]
in
Serum
|
|
13080-7
|
Phosphatidylglycerol
IgM
Ab
[Units/volume]
in
Serum
|
|
13081-5
|
Phosphatidylglycerol
IgA
Ab
[Units/volume]
in
Serum
|
|
13082-3
|
Phosphatidylinositol
IgG
Ab
[Units/volume]
in
Serum
|
|
13083-1
|
Phosphatidylinositol
IgM
Ab
[Units/volume]
in
Serum
|
|
13084-9
|
Phosphatidylinositol
IgA
Ab
[Units/volume]
in
Serum
|
|
13085-6
|
Complement
C4
Nephritic
[Mass/volume]
in
Serum
or
Plasma
|
|
13086-4
|
Complement
C3
Nephritic
[Mass/volume]
in
Serum
or
Plasma
|
|
13087-2
|
Complement
alternate
pathway
AH50
[Units/volume]
in
Serum
or
Plasma
|
|
13088-0
|
Complement
total
hemolytic
CH100
[Units/volume]
in
Serum
or
Plasma
|
|
13091-4
|
Deoxyribonucleoprotein
Ab
[Units/volume]
in
Serum
|
|
13092-2
|
Endomysium
Ab
[Units/volume]
in
Serum
|
|
13096-3
|
Deprecated
Myelin
associated
glycoprotein
Ab.IgM
in
serum
|
|
13097-1
|
Deprecated
PM-SCL
extractable
nuclear
Ab
|
|
13098-9
|
Deprecated
Sulfatide
Ab.IgG
|
|
13099-7
|
Deprecated
Sulfatide
Ab.IgM
in
serum
|
|
131-3
|
Cefsulodin
[Mass/volume]
in
Serum
or
Plasma
|
|
13100-3
|
Deprecated
Sulfate-3-Glucuronyl
paragloboside
Ab.IgM
in
serum
|
|
13101-1
|
Deprecated
Sulfate-3-Glucuronyl
paragloboside
Ab.IgM
in
CSF
|
|
13110-2
|
Deprecated
Beta
tubulin
Ab.IgM
|
|
13111-0
|
Deprecated
Nuclear
Ab
by
Immunofluorescence
|
|
13112-8
|
Deprecated
Nuclear
Ab
Immunofluorescence
(rat
kidney
substrate)
|
|
13114-4
|
Deprecated
Neuronal
nuclear
type
2
Ab
|
|
13115-1
|
Deprecated
Neuronal
nuclear
type
1
Ab
|
|
13116-9
|
Deprecated
Reticulin
Ab.IgG
|
|
13117-7
|
Complement
Sc5b-9
Ab
[Units/volume]
in
Serum
or
Plasma
|
|
13118-5
|
Deprecated
Myelin
associated
glycoprotein
Ab
|
|
13119-3
|
Myelin
associated
glycoprotein
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
1312-8
|
D
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
13120-1
|
Ovary
Ab
[Units/volume]
in
Serum
|
|
13121-9
|
Deprecated
Ribosomal
P
protein
Ab
|
|
13123-5
|
Deprecated
Sulfate-3-Glucuronyl
paragloboside
Ab
in
serum
|
|
13126-8
|
Deprecated
Hepatitis
B
virus
DNA
[Presence]
in
Blood
by
Immunoblot
(IB)
|
|
13127-6
|
Cancer
Ag
DM/70K
[Units/volume]
in
Serum
or
Plasma
|
|
13129-2
|
Pancreatic
oncofetal
Ag
[Units/volume]
in
Serum
or
Plasma
|
|
13130-0
|
Motilin
[Units/volume]
in
Serum
or
Plasma
|
|
1314-4
|
Rh
immune
globulin
screen
[interpretation]
|
|
13164-9
|
Human
antimouse
Ab
[Units/volume]
in
Serum
|
|
13170-6
|
Immune
complex
[Units/volume]
in
Serum
or
Plasma
by
Conglutinin
assay
|
|
13171-4
|
Immune
complex
[Units/volume]
in
Serum
or
Plasma
by
Polyethylene
glycol
(PEG)
assay
|
|
13172-2
|
Complement
C1q
Ag
[Units/volume]
in
Serum
or
Plasma
by
Raji
cell
assay
|
|
13173-0
|
Fibronectin
aggregate
IgA
Ab
[Units/volume]
in
Serum
|
|
13175-5
|
Liver
cytosol
Ab
[Presence]
in
Serum
|
|
13176-3
|
Wasp
venom
IgE
Ab
[Units/volume]
in
Serum
|
|
13177-1
|
Russian
olive
IgE
Ab
[Units/volume]
in
Serum
|
|
13178-9
|
Wasp
venom
IgG
Ab
[Units/volume]
in
Serum
|
|
13179-7
|
English
Walnut
IgG
Ab
[Units/volume]
in
Serum
|
|
13180-5
|
Formaldehyde
IgG
Ab
[Units/volume]
in
Serum
|
|
13181-3
|
Bahia
grass
IgG
Ab
[Units/volume]
in
Serum
|
|
13182-1
|
Mesquite
IgG
Ab
[Units/volume]
in
Serum
|
|
13183-9
|
White
Elm
IgG
Ab
[Units/volume]
in
Serum
|
|
13184-7
|
Cottonwood
IgG
Ab
[Units/volume]
in
Serum
|
|
13185-4
|
Nettle
IgG
Ab
[Units/volume]
in
Serum
|
|
13186-2
|
Yellow
Dock
IgG
Ab
[Units/volume]
in
Serum
|
|
13187-0
|
False
ragweed
IgG
Ab
[Units/volume]
in
Serum
|
|
13188-8
|
Mugwort
IgG
Ab
[Units/volume]
in
Serum
|
|
13189-6
|
English
plantain
IgG
Ab
[Units/volume]
in
Serum
|
|
13190-4
|
Formaldehyde
IgM
Ab
[Units/volume]
in
Serum
or
Plasma
|
|
13192-0
|
Adenovirus
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13193-8
|
Aspergillus
flavus
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13194-6
|
Aspergillus
glaucus
Ab
[Units/volume]
in
Serum
|
|
13195-3
|
Ehrlichia
chaffeensis
Ab
[Units/volume]
in
Serum
|
|
13196-1
|
Ehrlichia
sp
IgG
Ab
[Presence]
in
Serum
|
|
13197-9
|
Ehrlichia
sp
IgM
Ab
[Presence]
in
Serum
|
|
13198-7
|
Thermoactinomyces
Ab
[Units/volume]
in
Serum
|
|
13199-5
|
Rickettsia
conorii
IgG
Ab
[Units/volume]
in
Serum
|
|
1320-1
|
S
Ag
[Presence]
on
Red
Blood
Cells
|
|
13200-1
|
Rickettsia
conorii
IgM
Ab
[Units/volume]
in
Serum
|
|
13201-9
|
Blastomyces
dermatitidis
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13202-7
|
Borrelia
burgdorferi
IgG
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
13203-5
|
Borrelia
burgdorferi
IgM
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
13204-3
|
Borrelia
burgdorferi
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
13205-0
|
Borrelia
burgdorferi
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
13206-8
|
Borrelia
burgdorferi
IgG
Ab
[Presence]
in
Synovial
fluid
by
Immunoblot
(IB)
|
|
13207-6
|
Borrelia
burgdorferi
IgM
Ab
[Presence]
in
Synovial
fluid
by
Immunoblot
(IB)
|
|
13208-4
|
Borrelia
hermsii
IgG
Ab
[Units/volume]
in
Serum
|
|
13209-2
|
Borrelia
hermsii
IgM
Ab
[Units/volume]
in
Serum
|
|
13210-0
|
Brucella
sp
IgG
Ab
[Units/volume]
in
Serum
|
|
13211-8
|
Brucella
sp
IgA
Ab
[Units/volume]
in
Serum
|
|
13212-6
|
Brucella
abortus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13213-4
|
Brucella
abortus
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13214-2
|
Brucella
canis
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13215-9
|
Brucella
canis
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13216-7
|
Candida
albicans
immune
complex
[Units/volume]
in
Serum
or
Plasma
|
|
13217-5
|
Chlamydia
trachomatis
B
Ab
[Units/volume]
in
Serum
|
|
13218-3
|
Chlamydia
trachomatis
C
Ab
[Units/volume]
in
Serum
|
|
13219-1
|
Chlamydia
trachomatis
G+F+K
Ab
[Units/volume]
in
Serum
|
|
13220-9
|
Chlamydia
trachomatis
C
IgM
Ab
[Units/volume]
in
Serum
|
|
13221-7
|
Chlamydia
trachomatis
G+F+K
IgM
Ab
[Units/volume]
in
Serum
|
|
13225-8
|
Cytomegalovirus
IgG
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
13226-6
|
Cytomegalovirus
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13227-4
|
Corynebacterium
diphtheriae
IgG
Ab
[Units/volume]
in
Serum
|
|
13228-2
|
Eastern
equine
encephalitis
virus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13229-0
|
Eastern
equine
encephalitis
virus
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13230-8
|
Saint
Louis
encephalitis
virus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13231-6
|
Saint
Louis
encephalitis
virus
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13232-4
|
Coxsackievirus
A
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13233-2
|
Coxsackievirus
A2
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13234-0
|
Coxsackievirus
A4
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13235-7
|
Coxsackievirus
A16
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13236-5
|
Epstein
Barr
virus
early
diffuse
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
13237-3
|
Epstein
Barr
virus
early
restricted
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
13238-1
|
Epstein
Barr
virus
Ab
[Units/volume]
in
Serum
|
|
13240-7
|
Phoma
herbarum
IgE
Ab
[Units/volume]
in
Serum
|
|
13241-5
|
Sporothrix
schenckii
IgG
Ab
[Units/volume]
in
Serum
|
|
13242-3
|
Sporothrix
schenckii
IgM
Ab
[Units/volume]
in
Serum
|
|
13243-1
|
Sporothrix
schenckii
IgA
Ab
[Units/volume]
in
Serum
|
|
13244-9
|
Filaria
IgG
Ab
[Units/volume]
in
Serum
|
|
13245-6
|
Filaria
IgM
Ab
[Units/volume]
in
Serum
|
|
13246-4
|
Haemophilus
influenzae
B
Ab
[Units/volume]
in
Serum
|
|
13247-2
|
HTLV
I+II
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13248-0
|
Hepatitis
D
virus
Ab
[Presence]
in
Serum
|
|
13249-8
|
Herpes
simplex
virus
1+2
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13250-6
|
Herpes
virus
6
IgG+IgM
Ab
[Units/volume]
in
Serum
|
|
13251-4
|
Herpes
simplex
virus
1
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13252-2
|
Herpes
simplex
virus
2
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13253-0
|
Legionella
non-pneumophila
Ab
[Presence]
in
Serum
|
|
13254-8
|
Legionella
pneumophila
atypical
Ab
[Presence]
in
Serum
|
|
13255-5
|
Legionella
longbeachae
1+2
Ab
[Presence]
in
Serum
|
|
13256-3
|
Leishmania
donovani
IgG
Ab
[Units/volume]
in
Serum
|
|
13257-1
|
Leishmania
donovani
IgM
Ab
[Units/volume]
in
Serum
|
|
13258-9
|
Leishmania
brasilensis
IgG
Ab
[Units/volume]
in
Serum
|
|
13259-7
|
Leishmania
brasilensis
IgM
Ab
[Units/volume]
in
Serum
|
|
13260-5
|
Leishmania
mexicana
IgG
Ab
[Units/volume]
in
Serum
|
|
13261-3
|
Leishmania
mexicana
IgM
Ab
[Units/volume]
in
Serum
|
|
13262-1
|
Leishmania
tropica
IgG
Ab
[Units/volume]
in
Serum
|
|
13263-9
|
Leishmania
tropica
IgM
Ab
[Units/volume]
in
Serum
|
|
13264-7
|
Leptospira
sp
IgG
Ab
[Titer]
in
Serum
|
|
13265-4
|
Leptospira
sp
IgM
Ab
[Titer]
in
Serum
|
|
13266-2
|
Mumps
virus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13267-0
|
Mumps
virus
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13268-8
|
Mycoplasma
pneumoniae
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
13269-6
|
Mycoplasma
pneumoniae
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
13270-4
|
Mycoplasma
pneumoniae
IgA
Ab
[Units/volume]
in
Serum
|
|
13271-2
|
Neisseria
meningitidis
A
Ab
[Units/volume]
in
Serum
|
|
13272-0
|
Neisseria
meningitidis
C
Ab
[Units/volume]
in
Serum
|
|
13273-8
|
Sporothrix
schenckii
Ab
[Presence]
in
Serum
|
|
13274-6
|
Toxocara
canis
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13275-3
|
Toxocara
canis
IgM
Ab
[Units/volume]
in
Serum
|
|
13276-1
|
Toxocara
canis
IgA
Ab
[Units/volume]
in
Serum
|
|
13277-9
|
Schistosoma
sp
IgG
Ab
[Units/volume]
in
Serum
|
|
13278-7
|
Schistosoma
sp
IgM
Ab
[Units/volume]
in
Serum
|
|
13279-5
|
Rubella
virus
IgG
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
1328-4
|
U
Ag
[Presence]
on
Red
Blood
Cells
|
|
13280-3
|
Rubella
virus
IgG
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
13281-1
|
Rubella
virus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13282-9
|
Rubella
virus
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13283-7
|
Measles
virus
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13284-5
|
Salmonella
typhi
H
D
Ab
[Presence]
in
Serum
|
|
13285-2
|
Salmonella
typhi
O
D
Ab
[Presence]
in
Serum
|
|
13286-0
|
Toxoplasma
gondii
IgG
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
13287-8
|
Toxoplasma
gondii
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13288-6
|
Treponema
pallidum
Ab
[Units/volume]
in
Blood
by
Immunofluorescence
|
|
13289-4
|
Hantavirus
hantaan
Ab
[Units/volume]
in
Serum
|
|
13290-2
|
Trypanosoma
cruzi
IgM
Ab
[Units/volume]
in
Serum
|
|
13291-0
|
Trypanosoma
cruzi
IgG
Ab
[Units/volume]
in
Serum
|
|
13292-8
|
Colorado
tick
fever
virus
IgG
Ab
[Units/volume]
in
Serum
|
|
13293-6
|
Colorado
tick
fever
virus
IgM
Ab
[Units/volume]
in
Serum
|
|
13294-4
|
Hepatitis
E
virus
Ab
[Presence]
in
Serum
|
|
13295-1
|
Coxsackievirus
A10
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13297-7
|
Coxsackievirus
A1
Ab
[Units/volume]
in
Serum
|
|
13308-2
|
Deprecated
DNA
|
|
13309-0
|
Duffy
group
Ag
[Type]
on
Red
Blood
Cells
|
|
13310-8
|
Kell
group
Ag
[Type]
on
Red
Blood
Cells
|
|
13311-6
|
MNS
group
Ag
[Type]
on
Red
Blood
Cells
|
|
13312-4
|
IgA
IgG
Ab
[Units/volume]
in
Serum
or
Plasma
|
|
13313-2
|
IgM
IgM
Ab
[Units/volume]
in
Serum
or
Plasma
|
|
13314-0
|
Bacteria
identified
in
Semen
|
|
13315-7
|
Bacteria
identified
in
24
hour
Urine
by
Culture
|
|
13316-5
|
Vancomycin
resistant
enterococcus
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
13317-3
|
Methicillin
resistant
Staphylococcus
aureus
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
13318-1
|
Escherichia
coli
enteroinvasive
identified
in
Stool
by
Organism
specific
culture
|
|
13319-9
|
Ova
and
parasites
identified
in
Stool
by
Light
microscopy--2nd
specimen
|
|
13320-7
|
Ova
and
parasites
identified
in
Stool
by
Light
microscopy--3rd
specimen
|
|
13321-5
|
Human
papilloma
virus
IgG
Ab
[Presence]
in
Serum
|
|
13322-3
|
Human
papilloma
virus
IgM
Ab
[Presence]
in
Serum
|
|
13323-1
|
Herpes
simplex
virus
2
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
13324-9
|
Herpes
simplex
virus
1
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
13325-6
|
Bartonella
sp
identified
in
Blood
by
Light
microscopy
|
|
13326-4
|
Pneumocystis
sp
identified
in
Unspecified
specimen
by
Light
microscopy
|
|
13327-2
|
Parainfluenza
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
13328-0
|
Measles
virus
Ag
[Presence]
in
Serum
or
Plasma
by
Immunofluorescence
|
|
13329-8
|
Escherichia
coli
labile
toxin
[Presence]
in
Unspecified
specimen
|
|
1334-2
|
V
Ag
[Presence]
on
Red
Blood
Cells
|
|
13347-0
|
RNA
polymerase
I+II+III
Ab
[Presence]
in
Serum
|
|
13348-8
|
Monoclonal
band
observed
[Identifier]
in
Serum
or
Plasma
|
|
13349-6
|
Leukocytes
[#/volume]
in
Stool
by
Manual
count
|
|
13356-1
|
Fat
[Presence]
in
Body
fluid
|
|
13364-5
|
Amino
beta
guanidinopropionate
[Mass/volume]
in
Plasma
|
|
13365-2
|
Amino
beta
guanidinopropionate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13374-4
|
Hydroxyproline
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13382-7
|
Amino
beta
guanidinopropionate
[Mass/volume]
in
Amniotic
fluid
|
|
13401-5
|
Hydroxyproline
[Mass/volume]
in
Amniotic
fluid
|
|
13409-8
|
Phenylalanine
[Mass/volume]
in
Amniotic
fluid
|
|
1341-7
|
Xg
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
13441-1
|
Creatinine
renal
clearance
in
4
hour
|
|
13442-9
|
Creatinine
renal
clearance
in
6
hour
|
|
13443-7
|
Creatinine
renal
clearance
in
8
hour
|
|
13451-0
|
Creatinine
dialysis
fluid
clearance
|
|
13456-9
|
IgG
synthesis
rate
[Units/volume]
in
Serum
and
CSF
|
|
13461-9
|
Monoacetyldapsone/Dapsone
[Mass
Ratio]
in
Serum
or
Plasma
|
|
13463-5
|
Arsenic/Creatinine
[Mass
Ratio]
in
Urine
|
|
13464-3
|
Chromium/Creatinine
[Mass
Ratio]
in
Urine
|
|
13465-0
|
Mercury/Creatinine
[Mass
Ratio]
in
Urine
|
|
13466-8
|
Lead/Creatinine
[Mass
Ratio]
in
Urine
|
|
13467-6
|
Selenium/Creatinine
[Mass
Ratio]
in
Urine
|
|
13468-4
|
Cobalt/Creatinine
[Mass
Ratio]
in
Urine
|
|
13469-2
|
Thallium/Creatinine
[Mass
Ratio]
in
Urine
|
|
1347-4
|
Yt
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
13470-0
|
Aluminum/Creatinine
[Mass
Ratio]
in
Urine
|
|
13471-8
|
Cadmium/Creatinine
[Mass
Ratio]
in
Urine
|
|
13472-6
|
Nickel/Creatinine
[Mass
Ratio]
in
Urine
|
|
13473-4
|
Zinc/Creatinine
[Mass
Ratio]
in
Urine
|
|
13474-2
|
Magnesium/Creatinine
[Mass
Ratio]
in
Urine
|
|
13475-9
|
Fluoride/Creatinine
[Mass
Ratio]
in
Urine
|
|
13476-7
|
Silver/Creatinine
[Mass
Ratio]
in
Urine
|
|
13477-5
|
Orthocresol/Creatinine
[Mass
Ratio]
in
Urine
|
|
13478-3
|
Tetrahydrocannabinol/Creatinine
[Mass
Ratio]
in
Urine
|
|
13479-1
|
Benzoylecgonine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13481-7
|
Gonadotropin
peptide/Creatinine
[Mass
Ratio]
in
Urine
|
|
13482-5
|
Aldosterone/Creatinine
[Mass
Ratio]
in
Urine
|
|
13483-3
|
Oxalate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13484-1
|
Creatine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13485-8
|
Beta-2-Microglobulin/Creatinine
[Mass
Ratio]
in
Urine
|
|
13486-6
|
Testosterone/Creatinine
[Mass
Ratio]
in
Urine
|
|
13487-4
|
Phenol/Creatinine
[Mass
Ratio]
in
Urine
|
|
13489-0
|
Follitropin/Creatinine
[Mass
Ratio]
in
Urine
|
|
13490-8
|
Lutropin/Creatinine
[Mass
Ratio]
in
Urine
|
|
13506-1
|
Urea
nitrogen
renal
clearance
|
|
13508-7
|
Hematocrit
[Volume
Fraction]
of
Cerebral
spinal
fluid
by
Centrifugation
|
|
13509-5
|
Microscopic
observation
[Identifier]
in
Blood
by
Crystal
violet
stain
|
|
13510-3
|
Microscopic
observation
[Identifier]
in
Bone
marrow
by
Myeloperoxidase
stain
|
|
13511-1
|
Cyanide
ascorbate
screen
[Presence]
in
Blood
|
|
13512-9
|
Microscopic
observation
[Identifier]
in
Bone
marrow
by
Butyrate
esterase
stain
|
|
13513-7
|
Iron.microscopic
observation
[Identifier]
in
Bone
marrow
by
Potassium
ferrocyanide
stain
|
|
1353-2
|
Yt
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
|
|
13533-5
|
Acid
hemolysis
[Presence]
of
Blood
|
|
13534-3
|
Sucrose
hemolysis
[Presence]
of
Blood
|
|
13536-8
|
Globulin
[Mass/volume]
in
Plasma
|
|
13538-4
|
Carbon
dioxide,
total
[Moles/volume]
in
Urine
|
|
13539-2
|
Phosphate
[Moles/volume]
in
Urine
|
|
13540-0
|
Carbon
dioxide,
total
[Moles/volume]
in
Cerebral
spinal
fluid
|
|
13542-6
|
Phosphate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13544-2
|
4-Hydroxyglutethimide
[Presence]
in
Serum
or
Plasma
|
|
13545-9
|
Alprazolam
[Presence]
in
Serum
or
Plasma
|
|
13546-7
|
Amikacin
[Mass/volume]
in
Body
fluid
|
|
13547-5
|
Butriptyline
[Presence]
in
Serum
or
Plasma
|
|
13548-3
|
Chlorpromazine
[Presence]
in
Serum
or
Plasma
|
|
13549-1
|
Clomipramine
[Presence]
in
Serum
or
Plasma
|
|
13550-9
|
Clonazepam
[Presence]
in
Serum
or
Plasma
|
|
13551-7
|
Clorazepate
[Presence]
in
Serum
or
Plasma
|
|
13552-5
|
Clozapine
[Presence]
in
Serum
or
Plasma
|
|
13553-3
|
Cocaethylene
[Presence]
in
Serum
or
Plasma
|
|
13554-1
|
Cyclobenzaprine
[Presence]
in
Serum
or
Plasma
|
|
13555-8
|
D-pseudoephedrine
[Presence]
in
Serum
or
Plasma
|
|
13556-6
|
Demoxepam
[Presence]
in
Serum
or
Plasma
|
|
13557-4
|
Norsertraline
[Presence]
in
Serum
or
Plasma
|
|
13558-2
|
Disopyramide
[Presence]
in
Serum
or
Plasma
|
|
13559-0
|
Flecainide
[Presence]
in
Serum
or
Plasma
|
|
13560-8
|
Fluvoxamine
[Presence]
in
Serum
or
Plasma
|
|
13561-6
|
Gentamicin
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13562-4
|
Gentamicin
[Mass/volume]
in
Body
fluid
|
|
13563-2
|
Glutethimide
[Presence]
in
Serum
or
Plasma
|
|
13564-0
|
Ibuprofen
[Presence]
in
Serum
or
Plasma
|
|
13565-7
|
Lorazepam
[Presence]
in
Serum
or
Plasma
|
|
13566-5
|
Mesoridazine
[Presence]
in
Serum
or
Plasma
|
|
13567-3
|
Mexiletine
[Presence]
in
Serum
or
Plasma
|
|
13568-1
|
N-desalkylflurazepam
[Presence]
in
Serum
or
Plasma
|
|
13569-9
|
Norchlordiazepoxide
[Presence]
in
Serum
or
Plasma
|
|
13570-7
|
Norclomipramine
[Presence]
in
Serum
or
Plasma
|
|
13571-5
|
Norclozapine
[Presence]
in
Serum
or
Plasma
|
|
13572-3
|
Nordiazepam
[Presence]
in
Serum
or
Plasma
|
|
13573-1
|
Nordoxepin
[Presence]
in
Serum
or
Plasma
|
|
13574-9
|
Norfluoxetine
[Presence]
in
Serum
or
Plasma
|
|
13575-6
|
Normaprotiline
[Presence]
in
Serum
or
Plasma
|
|
13576-4
|
Oxycodone
[Presence]
in
Serum
or
Plasma
|
|
13577-2
|
Paroxetine
[Presence]
in
Serum
or
Plasma
|
|
13578-0
|
Promazine
[Presence]
in
Serum
or
Plasma
|
|
13579-8
|
Sertraline
[Presence]
in
Serum
or
Plasma
|
|
13580-6
|
Temazepam
[Presence]
in
Serum
or
Plasma
|
|
13581-4
|
Theophylline
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13582-2
|
Theophylline
[Mass/volume]
in
Body
fluid
|
|
13583-0
|
Thioridazine
[Presence]
in
Serum
or
Plasma
|
|
13584-8
|
Tobramycin
[Mass/volume]
in
Body
fluid
|
|
13585-5
|
Trifluoperazine
[Presence]
in
Serum
or
Plasma
|
|
13586-3
|
Vancomycin
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13587-1
|
Vancomycin
[Mass/volume]
in
Body
fluid
|
|
13588-9
|
Venlafaxine
[Presence]
in
Serum
or
Plasma
|
|
13589-7
|
Activated
protein
C
resistance
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
13590-5
|
Activated
protein
C
resistance
[Time
Ratio]
in
Platelet
poor
plasma
by
Coagulation
assay
|
|
13591-3
|
Factor
inhibitor
XXX
[Units/volume]
in
Platelet
poor
plasma
by
Coagulation
assay
|
|
13594-7
|
Prekallikrein
(Fletcher
Factor)
[Presence]
in
Platelet
poor
plasma
|
|
13610-1
|
3-Beta-Androstanediol
[Mass/volume]
in
Serum
or
Plasma
|
|
13611-9
|
6-Beta-Hydroxycortisol
[Mass/time]
in
24
hour
Urine
|
|
13612-7
|
Dehydroepiandrosterone
(DHEA)
[Mass/time]
in
24
hour
Urine
|
|
13614-3
|
Etiocholanolone
[Mass/volume]
in
Serum
or
Plasma
|
|
13618-4
|
Tetrahydroaldosterone
[Mass/time]
in
24
hour
Urine
|
|
13622-6
|
Acetaminophen
[Mass/volume]
in
Urine
|
|
13623-4
|
Dextromethorphan
[Mass/volume]
in
Serum
or
Plasma
|
|
13624-2
|
Doxorubicin
[Mass/volume]
in
Serum
or
Plasma
|
|
13625-9
|
Methoxsalen
[Mass/volume]
in
Serum
or
Plasma
|
|
13626-7
|
Mitotane
[Mass/volume]
in
Serum
or
Plasma
|
|
13629-1
|
Interleukin
1
beta
[Mass/volume]
in
Serum
or
Plasma
|
|
13630-9
|
Deprecated
Immune
complex
[Units/volume]
in
Serum
or
Plasma
by
Conglutinin
assay
|
|
13631-7
|
Immune
complex
[Mass/volume]
in
Serum
or
Plasma
by
Polyethylene
glycol
(PEG)
assay
|
|
13632-5
|
Insulin
receptor
Ab
[Titer]
in
Serum
|
|
13633-3
|
Insulin
receptor
Ab
[Presence]
in
Serum
|
|
13634-1
|
Rheumatoid
factor
[Units/volume]
in
Synovial
fluid
|
|
13635-8
|
Ribosomal
Ab
[Titer]
in
Serum
|
|
13636-6
|
Ribosomal
P
Ab
[Units/volume]
in
Serum
|
|
13637-4
|
Trichloroethane
[Mass/volume]
in
Serum
or
Plasma
|
|
13638-2
|
Chlordecone
[Mass/volume]
in
Blood
|
|
13639-0
|
Chlordecone
[Mass/volume]
in
Serum
or
Plasma
|
|
13640-8
|
Vinyl
chloride
[Mass/volume]
in
Urine
|
|
13641-6
|
Codeine
[Presence]
in
Urine
by
SAMHSA
confirm
method
|
|
13643-2
|
Lindane
[Mass/volume]
in
Urine
|
|
13644-0
|
1,3-Dimethylbenzene
[Mass/volume]
in
Blood
|
|
13646-5
|
Methaqualone
[Mass/mass]
in
Hair
|
|
13648-1
|
Morphine
[Presence]
in
Urine
by
SAMHSA
confirm
method
|
|
13649-9
|
Nickel
[Mass/volume]
in
Water
|
|
13650-7
|
1,2-Dimethylbenzene
[Mass/volume]
in
Blood
|
|
13651-5
|
1,4-Dimethylbenzene
[Mass/volume]
in
Blood
|
|
13652-3
|
Zinc
[Mass/mass]
in
Hair
|
|
13655-6
|
Leukocytes
[Presence]
in
Stool
by
Light
microscopy
|
|
13658-0
|
Urobilinogen
[Presence]
in
Urine
|
|
13659-8
|
Epidermal
growth
factor
receptor
[Mass/mass]
in
Tissue
|
|
13660-6
|
Gonadotropin
releasing
hormone
[Mass/volume]
in
Serum
or
Plasma
|
|
13664-8
|
Myelin
associated
glycoprotein/Sulfated
glucuronic
paragloboside
IgM
Ab
[Titer]
in
Serum
|
|
13671-3
|
Alpha
hydroxybutyrate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13676-2
|
2-Oxo,3-Methylvalerate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13678-8
|
Alpha
ketoglutarate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13682-0
|
3-Hydroxy,3-Methylglutarate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13696-0
|
4-Hydroxyphenylacetate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13701-8
|
Acetoacetate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13702-6
|
Aconitate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13703-4
|
Adipate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13705-9
|
Albumin/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13709-1
|
Argininosuccinate/Creatinine
[Mass
Ratio]
in
Urine
|
|
1371-4
|
Bromsulphthalein
[Mass/volume]
in
Serum
or
Plasma
|
|
13712-5
|
Azelate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13713-3
|
Benzoate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13715-8
|
C
peptide/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13716-6
|
C
peptide/Creatinine
[Mass
Ratio]
in
Urine
|
|
13717-4
|
Calcium/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13718-2
|
Carnitine
free
(C0)/Creatinine
[Mass
Ratio]
in
Urine
|
|
13721-6
|
Chloride/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13722-4
|
Citrate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13725-7
|
Cystine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13728-1
|
Delta
aminolevulinate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13729-9
|
Deoxypyridinoline/Creatinine
[Mass
Ratio]
in
Urine
|
|
13730-7
|
Deoxypyridinoline/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13731-5
|
Deoxypyridinoline/Creatinine
[Mass
Ratio]
in
2
hour
Urine
|
|
13733-1
|
Dopamine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13734-9
|
Epinephrine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13735-6
|
Epinephrine+Norepinephrine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13736-4
|
Estradiol
(E2)/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13737-2
|
Estriol
(E3)/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13738-0
|
Estrogen/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13739-8
|
Estrone
(E1)/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13741-4
|
Ethylmalonate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13742-2
|
Formate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13743-0
|
Fumarate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13744-8
|
Galactose/Creatinine
[Mass
Ratio]
in
Urine
|
|
13745-5
|
Glutaconate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13748-9
|
Glutarate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13749-7
|
Glycerate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13751-3
|
Glycolate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13752-1
|
Glyoxylate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13753-9
|
Hexanoylglycine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13754-7
|
Hippurate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13755-4
|
Histamine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13756-2
|
Histamine/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13758-8
|
Homocysteine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13760-4
|
Homovanillate/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13763-8
|
Hydroxyproline/Creatinine
[Mass
Ratio]
in
Urine
|
|
13764-6
|
Isocitrate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13767-9
|
Lactate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13770-3
|
Malate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13771-1
|
Metanephrines/Creatinine
[Mass
Ratio]
in
Urine
|
|
13774-5
|
Methylhippurate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13775-2
|
Methylmalonate/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13776-0
|
Methylmalonate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13777-8
|
Methylsuccinate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13778-6
|
Mevalonate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13779-4
|
N-acetyl-L-aspartate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13780-2
|
N-acetyltyrosine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13781-0
|
N-methylhistamine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13782-8
|
Norepinephrine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13783-6
|
Normetanephrine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13787-7
|
Orotate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13788-5
|
Oxalate/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13790-1
|
Para
nitrophenol/Creatinine
[Mass
Ratio]
in
Urine
|
|
13791-9
|
Phenylacetate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13792-7
|
Phenyllactate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13793-5
|
Phenylpropionylglycine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13794-3
|
Phenylpyruvate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13797-6
|
Porphobilinogen/Creatinine
[Mass
Ratio]
in
Urine
|
|
13798-4
|
Potassium/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13800-8
|
Propionylglycine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13801-6
|
Protein/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13802-4
|
Pyridinoline/Creatinine
[Mass
Ratio]
in
Urine
|
|
13803-2
|
Pyridinoline/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13804-0
|
Pyridinoline/Creatinine
[Mass
Ratio]
in
2
hour
Urine
|
|
13805-7
|
Pyruvate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13809-9
|
Sodium/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13810-7
|
Suberate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13812-3
|
Succinate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13816-4
|
Tiglylglycine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13819-8
|
Uracil/Creatinine
[Mass
Ratio]
in
Urine
|
|
13820-6
|
Urate/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13821-4
|
Urea
nitrogen/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13823-0
|
Antimony/Creatinine
[Mass
Ratio]
in
Urine
|
|
13824-8
|
Arsenic/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13825-5
|
Arsenic.inorganic/Creatinine
[Mass
Ratio]
in
Urine
|
|
13826-3
|
Barium/Creatinine
[Mass
Ratio]
in
Urine
|
|
13827-1
|
Beryllium/Creatinine
[Mass
Ratio]
in
Urine
|
|
13828-9
|
Cadmium/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13829-7
|
Copper/Creatinine
[Mass
Ratio]
in
Urine
|
|
13830-5
|
Phenylglyoxylate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13831-3
|
Vanadium/Creatinine
[Mass
Ratio]
in
Urine
|
|
13832-1
|
Dimethylbenzene/Creatinine
[Mass
Ratio]
in
Urine
|
|
13833-9
|
Finch
feather
IgE
Ab
[Units/volume]
in
Serum
|
|
13834-7
|
Total
IgE
[Units/volume]
in
Serum
by
Radioallergosorbent
test
(RAST)
|
|
13840-4
|
CD19
blasts/100
blasts
in
Blood
|
|
13872-7
|
11-Deoxycortisol
[Mass/time]
in
24
hour
Urine
|
|
13876-8
|
Beta-2
transferrin
[Presence]
in
Body
fluid
|
|
13877-6
|
Bilirubin.total
[Presence]
in
Amniotic
fluid
|
|
13878-4
|
Collagen
type
1
IgG
Ab
[Units/volume]
in
Serum
|
|
13879-2
|
Collagen
type
2
IgG
Ab
[Units/volume]
in
Serum
|
|
13880-0
|
Collagen
type
4
IgG
Ab
[Units/volume]
in
Serum
|
|
13881-8
|
Deoxypyridinoline
Free/Creatinine
[Molar
ratio]
in
Urine
|
|
13884-2
|
Estradiol
(E2).bioavailable
[Mass/volume]
in
Serum
or
Plasma
|
|
13891-7
|
Motilin
[Mass/volume]
in
Serum
or
Plasma
|
|
13892-5
|
Nitrosonaphthol
[Presence]
in
Urine
|
|
13894-1
|
Pregnenolone
[Mass/time]
in
24
hour
Urine
|
|
13895-8
|
Sodium
[Moles/volume]
in
Milk
|
|
13896-6
|
Insulin-like
growth
factor-I
[Units/volume]
in
Blood
|
|
13897-4
|
Thyrotropin.beta
subunit
[Mass/volume]
in
Serum
or
Plasma
|
|
13898-2
|
Trichloroacetate
[Mass/volume]
in
Serum
or
Plasma
|
|
13900-6
|
Deprecated
Tumor
necrosis
factor.alpha
[Mass/volume]
in
Serum
or
Plasma
|
|
13902-2
|
Urate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13903-0
|
Vasopressin
[Mass/volume]
in
Urine
|
|
13904-8
|
Meclizine
[Mass/volume]
in
Serum
or
Plasma
|
|
13905-5
|
Meclofenamate
[Mass/volume]
in
Serum
or
Plasma
|
|
13907-1
|
Norethindrone
[Mass/volume]
in
Serum
or
Plasma
|
|
13908-9
|
Oxipurinol
[Mass/volume]
in
Serum
or
Plasma
|
|
13909-7
|
Tamoxifen
[Mass/volume]
in
Serum
or
Plasma
|
|
13913-9
|
Adenovirus
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
13914-7
|
Adenovirus
IgG
Ab
[Units/volume]
in
Serum
|
|
13915-4
|
Adenovirus
IgM
Ab
[Titer]
in
Serum
|
|
13916-2
|
Bordetella
parapertussis
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
13917-0
|
Coccidioides
immitis
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Complement
fixation
|
|
13918-8
|
Eastern
equine
encephalitis
virus
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
13919-6
|
Hepatitis
B
virus
core
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
13921-2
|
Mumps
virus
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
13922-0
|
Trichinella
spiralis
IgA
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
13923-8
|
Trichinella
spiralis
IgM
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
13924-6
|
Calcitonin
Ab
[Presence]
in
Serum
|
|
13925-3
|
Cytokeratin
Ab
[Presence]
in
Serum
|
|
13926-1
|
Glutamate
decarboxylase
65
Ab
[Units/volume]
in
Serum
|
|
13927-9
|
Pancreatic
islet
cell
Ab
[Titer]
in
Serum
|
|
13928-7
|
Parathyrin
Ab
[Presence]
in
Serum
|
|
13929-5
|
Rheumatoid
factor
[Titer]
in
Synovial
fluid
by
Sheep
Cell
Agglutination
|
|
13930-3
|
Rheumatoid
factor
[Titer]
in
Synovial
fluid
by
Agglutination
|
|
13931-1
|
Striated
muscle
Ab
[Presence]
in
Serum
|
|
13932-9
|
Testes
IgG
Ab
[Titer]
in
Serum
|
|
13933-7
|
Benzodiazepines
[Mass/mass]
in
Hair
|
|
13934-5
|
Butanol
[Mass/volume]
in
Blood
|
|
13935-2
|
Dichlorodifluoromethane
[Mass/volume]
in
Blood
|
|
13936-0
|
Diethyl
ether
[Mass/volume]
in
Blood
|
|
13937-8
|
Ethyl
acetate
[Mass/volume]
in
Blood
|
|
13938-6
|
Trichloroethane
[Mass/volume]
in
Blood
|
|
13940-2
|
Dimethylbenzene
[Mass/volume]
in
Blood
|
|
13943-6
|
Fructose
[Presence]
in
Semen
|
|
13946-9
|
Complement+Immunoglobulin
[Presence]
in
Red
Blood
Cells
|
|
13947-7
|
Coccidioides
immitis
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
13948-5
|
Coccidioides
immitis
IgM
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
13949-3
|
Cytomegalovirus
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
13950-1
|
Hepatitis
A
virus
IgM
Ab
[Presence]
in
Serum
or
Plasma
by
Immunoassay
|
|
13951-9
|
Hepatitis
A
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
13952-7
|
Hepatitis
B
virus
core
Ab
[Presence]
in
Serum
or
Plasma
by
Immunoassay
|
|
13953-5
|
Hepatitis
B
virus
e
Ab
[Presence]
in
Serum
or
Plasma
by
Immunoassay
|
|
13954-3
|
Hepatitis
B
virus
e
Ag
[Presence]
in
Serum
or
Plasma
by
Immunoassay
|
|
13955-0
|
Hepatitis
C
virus
Ab
[Presence]
in
Serum
or
Plasma
by
Immunoassay
|
|
13956-8
|
Mycobacterium
tuberculosis
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
13957-6
|
Clostridium
difficile
toxin
A
[Presence]
in
Stool
by
Immunoassay
|
|
13958-4
|
Arsenic
[Presence]
in
24
hour
Urine
|
|
13959-2
|
Calcium.ionized
[Moles/volume]
in
Serum
or
Plasma
by
calculation
|
|
13961-8
|
Mercury
[Presence]
in
24
hour
Urine
|
|
13962-6
|
Beta
glucuronidase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
13963-4
|
Orotate
[Moles/volume]
in
Urine
|
|
13964-2
|
Methylmalonate
[Moles/volume]
in
Serum
or
Plasma
|
|
13965-9
|
Homocysteine
[Moles/volume]
in
Serum
or
Plasma
|
|
13966-7
|
Cystine
[Moles/time]
in
24
hour
Urine
|
|
13967-5
|
Sex
hormone
binding
globulin
[Moles/volume]
in
Serum
or
Plasma
|
|
13969-1
|
Creatine
kinase.MB
[Mass/volume]
in
Serum
or
Plasma
|
|
1397-9
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
0.05-0.15
U
insulin/kg
IV
12
hours
fasting
|
|
13970-9
|
Delta
tocopherol
[Mass/volume]
in
Serum
or
Plasma
|
|
13971-7
|
Histoplasma
capsulatum
Ag
[Units/volume]
in
Urine
by
Immunoassay
|
|
1399-5
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
0.05-0.15
U
insulin/kg
IV
post
12H
CFst
|
|
13996-4
|
Hydroxyproline/Creatinine
[Molar
ratio]
in
24
hour
Urine
|
|
13997-2
|
Neuronal
nuclear
type
1
Ab
[Titer]
in
Serum
|
|
13998-0
|
Neuronal
nuclear
type
2
Ab
[Titer]
in
Serum
|
|
13999-8
|
Transferrin.carbohydrate
deficient
[Units/volume]
in
Serum
or
Plasma
|
|
14000-4
|
Urea
nitrogen
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
14001-2
|
IgE
[Units/volume]
in
Cord
blood
|
|
14002-0
|
IgM
[Units/volume]
in
Cord
blood
|
|
14003-8
|
Carbon
dioxide
[Partial
pressure]
in
Cord
blood
|
|
14004-6
|
Prostaglandin
A
[Mass/time]
in
24
hour
Urine
|
|
14005-3
|
Prostaglandin
E1
[Mass/time]
in
24
hour
Urine
|
|
14006-1
|
Prostaglandin
E2
[Mass/time]
in
24
hour
Urine
|
|
14007-9
|
Prostaglandin
F2
alpha
[Mass/time]
in
24
hour
Urine
|
|
14008-7
|
Phosphatidylcholine
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
14009-5
|
Phosphatidylcholine
IgM
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
14010-3
|
Phosphatidylcholine
IgA
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
14011-1
|
Deprecated
Platelet
associated
IgA
Ab
[Units/volume]
in
Blood
|
|
14012-9
|
Platelet
associated
IgG
Ab
[Units/volume]
in
Blood
by
Flow
cytometry
(FC)
|
|
14013-7
|
Platelet
associated
IgM
Ab
[Units/volume]
in
Blood
by
Flow
cytometry
(FC)
|
|
14014-5
|
Thyroxine
(T4).prealbumin
bound
[Mass/volume]
in
Serum
or
Plasma
|
|
14016-0
|
Thyroxine.thyroxine
binding
globulin
bound
[Mass/volume]
in
Serum
or
Plasma
|
|
14027-7
|
HTLV
I+II
rgp21
Ab
[Presence]
in
Serum
or
Plasma
by
Immunoblot
(IB)
|
|
14028-5
|
Deprecated
HTLV
I+II
rgp46-I
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
14029-3
|
Deprecated
HTLV
I+II
rgp46-II
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
14030-1
|
Smith
extractable
nuclear
Ab+Ribonucleoprotein
extractable
nuclear
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
14031-9
|
Ciprofloxacin
[Mass/volume]
in
Serum
or
Plasma
--peak
|
|
14032-7
|
Ciprofloxacin
[Mass/volume]
in
Serum
or
Plasma
--trough
|
|
14033-5
|
1,4-Dioxane
[Mass/volume]
in
Blood
by
Gas
chromatography
|
|
14034-3
|
Rheumatoid
factor
[Units/volume]
in
Cerebral
spinal
fluid
|
|
14035-0
|
Japanese
Cedar
IgE
Ab
[Units/volume]
in
Serum
|
|
14036-8
|
Dermatophagoides
microceras
IgE
Ab
[Units/volume]
in
Serum
|
|
14037-6
|
Fox
IgE
Ab
[Units/volume]
in
Serum
|
|
14038-4
|
Pacific
Squid
IgE
Ab
[Units/volume]
in
Serum
|
|
14040-0
|
Carbon
dioxide,
total
[Moles/volume]
in
Stool
|
|
14041-8
|
Choriogonadotropin.beta
subunit
[Units/volume]
in
Cerebral
spinal
fluid
|
|
14042-6
|
Corticosterone
[Mass/time]
in
24
hour
Urine
|
|
14043-4
|
Cortisol
Free
[Mass/time]
in
12
hour
Urine
|
|
14044-2
|
Cortisone
[Mass/time]
in
24
hour
Urine
|
|
14045-9
|
D-Lactate
[Moles/volume]
in
Serum
or
Plasma
|
|
14046-7
|
D-Lactate
[Moles/volume]
in
Urine
|
|
14047-5
|
Androstanolone
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
14048-3
|
Elastase.pancreatic
[Mass/volume]
in
Serum
|
|
14049-1
|
Epidermal
growth
factor
[Mass/volume]
in
Serum
or
Plasma
|
|
14050-9
|
Epidermal
growth
factor
receptor
[Moles/mass]
in
Tissue
|
|
14051-7
|
Estrogen
binding
protein
[Mass/volume]
in
Serum
or
Plasma
|
|
14052-5
|
Formate
[Mass/volume]
in
Urine
|
|
14054-1
|
Prostaglandin
D2
[Mass/time]
in
24
hour
Urine
|
|
14055-8
|
Sodium
[Moles/mass]
in
Stool
|
|
14056-6
|
Carbamazepine
10,11-epoxide
free
[Mass/volume]
in
Serum
or
Plasma
|
|
14057-4
|
Carbamazepine
free
[Mass/volume]
in
Saliva
(oral
fluid)
|
|
14060-8
|
Cyclobenzaprine
[Presence]
in
Urine
|
|
14061-6
|
Cyclobenzaprine
[Mass/volume]
in
Urine
|
|
14062-4
|
Dexamethasone
[Mass/volume]
in
Serum
or
Plasma
|
|
14063-2
|
Dezocine
[Presence]
in
Urine
|
|
14064-0
|
Diethylstilbestrol
[Mass/volume]
in
Serum
or
Plasma
|
|
14065-7
|
Diflunisal
[Mass/volume]
in
Serum
or
Plasma
|
|
14066-5
|
Dihydrocodeine
[Presence]
in
Urine
|
|
14067-3
|
Dihydrocodeine
[Mass/volume]
in
Blood
|
|
14068-1
|
Triamterene+Hydrochlorothiazide
[Mass/volume]
in
Serum
or
Plasma
|
|
14069-9
|
Estazolam
[Mass/volume]
in
Serum
or
Plasma
|
|
14070-7
|
Fluphenazine
[Presence]
in
Urine
|
|
14071-5
|
Ibuprofen
[Presence]
in
Urine
|
|
14072-3
|
Monoacetyldapsone
[Mass/volume]
in
Serum
or
Plasma
|
|
14073-1
|
Phenytoin
[Mass/volume]
in
Saliva
(oral
fluid)
|
|
14074-9
|
Spironolactone
[Mass/volume]
in
Serum
or
Plasma
|
|
14075-6
|
Sulfapyridine
[Mass/volume]
in
Serum
or
Plasma
|
|
14076-4
|
Complement
total
hemolytic
CH100
[Presence]
in
Serum
or
Plasma
by
Immune
diffusion
(ID)
|
|
14077-2
|
Borrelia
burgdorferi
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunoassay
|
|
14078-0
|
Borrelia
burgdorferi
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunoassay
|
|
14079-8
|
Brucella
canis
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14080-6
|
Brucella
canis
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14081-4
|
Coliform
bacteria
[Presence]
in
Water
|
|
14082-2
|
Echinococcus
sp
IgG
Ab
[Units/volume]
in
Serum
by
Immunoblot
(IB)
|
|
14083-0
|
Epstein
Barr
virus
early
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14084-8
|
Herpes
simplex
virus
1
[Presence]
in
Isolate
by
Immunofluorescence
|
|
14085-5
|
Herpes
simplex
virus
2
[Presence]
in
Isolate
by
Immunofluorescence
|
|
14086-3
|
Herpes
simplex
virus
1
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14087-1
|
Herpes
simplex
virus
1
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14088-9
|
Deprecated
Herpes
simplex
virus
1
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14089-7
|
Herpes
simplex
virus
2
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14090-5
|
Herpes
simplex
virus
2
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14091-3
|
Deprecated
Herpes
simplex
virus
2
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14092-1
|
HIV
1
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
14093-9
|
Bacteria
identified
in
Water
by
Culture
|
|
14094-7
|
Trypanosoma
cruzi
IgG
Ab
[Titer]
in
Serum
|
|
14095-4
|
Fibronectin
aggregate
IgG
Ab
[Units/volume]
in
Serum
|
|
14096-2
|
Intercalated
disk
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14097-0
|
Antimony
[Mass/time]
in
24
hour
Urine
|
|
14098-8
|
Dimethylsulfoxide
[Mass/volume]
in
Serum
or
Plasma
|
|
14099-6
|
Nickel
[Mass/volume]
in
Urine
|
|
14100-2
|
Strontium
[Presence]
in
Urine
|
|
14101-0
|
Strychnine
[Mass/volume]
in
Gastric
fluid
|
|
14102-8
|
Strychnine
[Mass/volume]
in
Blood
|
|
14104-4
|
Barley
smut+Wheat
smut
IgE
Ab
[Units/volume]
in
Serum
|
|
14115-0
|
Collagen
crosslinked
N-telopeptide/Creatinine
[Molar
ratio]
in
Urine
|
|
14116-8
|
IgG
synthesis
rate
[Mass/time]
in
Serum
and
CSF
by
calculation
|
|
14118-4
|
Lactate
[Mass/volume]
in
Serum
or
Plasma
|
|
14121-8
|
Pyruvate
[Moles/volume]
in
Blood
|
|
14122-6
|
Pyruvate
[Moles/volume]
in
Cerebral
spinal
fluid
|
|
14125-9
|
Entamoeba
histolytica
[Presence]
in
Stool
by
Trichrome
stain
|
|
14127-5
|
Neisseria
gonorrhoeae
[Presence]
in
Anal
by
Organism
specific
culture
|
|
14128-3
|
Rabies
virus
Ab
[Titer]
in
Serum
|
|
14129-1
|
Respiratory
syncytial
virus
[Presence]
in
Nose
by
Organism
specific
culture
|
|
14130-9
|
Estrogen
receptor
[Moles/mass]
in
Tissue
|
|
14131-7
|
PM-1
Ab
[Presence]
in
Serum
|
|
14133-3
|
Silver
Maple
IgE
Ab
[Units/volume]
in
Serum
|
|
14134-1
|
Deprecated
Free
Hemoglobin
[Mass/volume]
in
Serum
|
|
1414-2
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
0.05-0.15
U
insulin/kg
IV
post
12H
CFst
|
|
14148-1
|
18-Hydroxycortisol
[Mass/time]
in
24
hour
Urine
|
|
14149-9
|
Corticotropin
Big
Fragment
[Mass/volume]
in
Serum
or
Plasma
|
|
14151-5
|
Bicarbonate
[Moles/volume]
in
Cord
blood
|
|
14152-3
|
Bilirubin.direct
[Mass/volume]
in
Body
fluid
|
|
14153-1
|
Carnitine
esters/Creatinine
[Mass
Ratio]
in
Urine
|
|
14154-9
|
Cholesterol
sulfate
[Mass/volume]
in
Serum
|
|
14158-0
|
Cortisol
[Mass/time]
in
24
hour
Urine
|
|
14159-8
|
Cortisone
[Mass/volume]
in
Serum
or
Plasma
|
|
14162-2
|
Gamma
melanocyte
stimulating
hormone
[Mass/volume]
in
Serum
or
Plasma
|
|
14163-0
|
IgA.secretory
[Mass/volume]
in
Serum
or
Plasma
|
|
14164-8
|
Immunosuppressive
acidic
protein
[Mass/volume]
in
Serum
or
Plasma
|
|
14165-5
|
Lactate
[Moles/volume]
in
Body
fluid
|
|
14166-3
|
Methane
[Mass/volume]
in
Blood
|
|
14167-1
|
N-methylimidazoleacetate
[Mass/time]
in
24
hour
Urine
|
|
14168-9
|
Palatinase
[Enzymatic
activity/mass]
in
Tissue
|
|
14169-7
|
Peptide
histidine
isoleucine
[Mass/volume]
in
Plasma
|
|
14170-5
|
Pituitary
glucoprotein
hormone.alpha
subunit
[Mass/volume]
in
Serum
|
|
14172-1
|
Potassium
[Moles/volume]
in
Synovial
fluid
|
|
14173-9
|
Progesterone
Free
[Mass/time]
in
24
hour
Urine
|
|
14174-7
|
Prostaglandin
F2
alpha
[Mass/volume]
in
Serum
or
Plasma
|
|
14176-2
|
Pyrroles
[Mass/volume]
in
Urine
|
|
14177-0
|
Growth
hormone-releasing
hormone
[Mass/volume]
in
Serum
or
Plasma
|
|
14178-8
|
Sucrase
[Enzymatic
activity/mass]
in
Tissue
|
|
14179-6
|
Tissue
polypeptide
Ag
[Mass/volume]
in
Serum
or
Plasma
|
|
14182-0
|
Thrombin
antithrombin
complex
Ag
[Mass/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
14183-8
|
Aprobarbital
[Mass/volume]
in
Urine
|
|
14184-6
|
Atropine
[Presence]
in
Urine
|
|
14185-3
|
Methimazole
[Mass/volume]
in
Serum
or
Plasma
|
|
14186-1
|
Methylprednisolone
[Mass/volume]
in
Serum
or
Plasma
|
|
14187-9
|
OKT3
[Mass/volume]
in
Serum
or
Plasma
|
|
14188-7
|
Omeprazole
[Mass/volume]
in
Serum
or
Plasma
|
|
14189-5
|
Phenyltoloxamine
[Mass/volume]
in
Urine
|
|
14190-3
|
Phenytoin
Free
[Mass/volume]
in
Saliva
(oral
fluid)
|
|
14191-1
|
Prazosin
[Mass/volume]
in
Serum
or
Plasma
|
|
14192-9
|
Triazolam
[Presence]
in
Urine
|
|
14193-7
|
Tripelennamine
[Presence]
in
Urine
|
|
14195-2
|
Complement
C3b
Inactive
[Mass/volume]
in
Plasma
|
|
14197-8
|
Blastomyces
dermatitidis
exoantigen
[Identifier]
in
Isolate
|
|
14198-6
|
Chlamydophila
psittaci
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14199-4
|
Chlamydia
trachomatis
B
IgA
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14200-0
|
Chlamydia
trachomatis
B
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14201-8
|
Chlamydia
trachomatis
B
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14202-6
|
Chlamydia
trachomatis
C
IgA
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14203-4
|
Chlamydia
trachomatis
C
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14204-2
|
Chlamydia
trachomatis
C
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14205-9
|
Coccidioides
immitis
Ag
[Presence]
in
Isolate
by
Immune
diffusion
(ID)
|
|
14206-7
|
Coccidioides
immitis
exoantigen
[Identifier]
in
Isolate
|
|
14207-5
|
Streptococcal
DNAse
B
[Titer]
in
Serum
|
|
14208-3
|
Filaria
IgG4
Ab
[Units/volume]
in
Serum
|
|
14209-1
|
Francisella
tularensis
IgA
Ab
[Presence]
in
Serum
|
|
14210-9
|
Giardia
lamblia
Ag
[Presence]
in
Stool
by
Immunofluorescence
|
|
14211-7
|
Hepatitis
E
virus
IgG
Ab
[Presence]
in
Serum
|
|
14212-5
|
Hepatitis
E
virus
IgM
Ab
[Presence]
in
Serum
|
|
14213-3
|
Herpes
simplex
virus
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14214-1
|
Histoplasma
capsulatum
exoantigen
[Identifier]
in
Isolate
|
|
14215-8
|
HTLV
I
g46
Ab
[Presence]
in
Serum
|
|
14224-0
|
HTLV
I
rgp21
Ab
[Presence]
in
Serum
|
|
14225-7
|
HTLV
II
g46
Ab
[Presence]
in
Serum
|
|
14226-5
|
Nocardia
sp
identified
in
Isolate
by
Organism
specific
culture
|
|
14227-3
|
Salmonella
typhi
H
D
Ab
[Titer]
in
Serum
|
|
14228-1
|
Estrogen
receptor/100
cells
in
Tissue
by
Immune
stain
|
|
14229-9
|
P53
protein
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
14230-7
|
Progesterone
receptor/100
cells
in
Tissue
by
Immune
stain
|
|
14231-5
|
H2a-H2b
DNA
IgG
Ab
[Units/volume]
in
Serum
|
|
14232-3
|
Adrenal
Ab
[Presence]
in
Serum
|
|
14233-1
|
Beta
tubulin
IgG
Ab
[Titer]
in
Serum
|
|
14234-9
|
Beta
tubulin
IgM
Ab
[Titer]
in
Serum
|
|
14235-6
|
Jo-1
extractable
nuclear
Ab
[Titer]
in
Serum
|
|
14236-4
|
Mitochondria
Ab
[Presence]
in
Serum
|
|
14237-2
|
Myelin
basic
protein
IgA
Ab
[Units/volume]
in
Serum
|
|
14238-0
|
Myelin
basic
protein
IgG
Ab
[Units/volume]
in
Serum
|
|
14239-8
|
Myelin
basic
protein
IgM
Ab
[Units/volume]
in
Serum
|
|
14240-6
|
Neuronal
nuclear
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
14241-4
|
Parietal
cell
Ab
[Presence]
in
Serum
|
|
14242-2
|
Phosphatidylcholine
IgA
Ab
[Presence]
in
Serum
|
|
14243-0
|
Phosphatidylcholine
IgG
Ab
[Presence]
in
Serum
|
|
14244-8
|
Phosphatidylcholine
IgM
Ab
[Presence]
in
Serum
|
|
14245-5
|
Phosphatidylserine
IgG
Ab
[Units/volume]
in
Serum
|
|
14246-3
|
Phosphatidylserine
IgM
Ab
[Units/volume]
in
Serum
|
|
14247-1
|
Purkinje
cells
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14248-9
|
Purkinje
cells
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14249-7
|
Purkinje
cells
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
14250-5
|
Purkinje
cells
IgG
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
14251-3
|
Mitochondria
M2
IgG
Ab
[Units/volume]
in
Serum
|
|
14252-1
|
Smooth
muscle
Ab
[Presence]
in
Serum
|
|
14253-9
|
Somatotropin
Ab
[Presence]
in
Serum
or
Plasma
|
|
14255-4
|
Thyrotropin
blocking
Ab
[Units/volume]
in
Serum
|
|
14256-2
|
Tetrachlorodiphenylethane
[Mass/mass]
in
Tissue
|
|
14257-0
|
Tetrachlorodiphenylethane
[Mass/volume]
in
Serum
or
Plasma
|
|
14258-8
|
1,4-Dioxane
[Mass/volume]
in
Blood
|
|
14259-6
|
1-Pentanol
[Mass/volume]
in
Blood
|
|
14260-4
|
Bromoform
[Mass/volume]
in
Blood
|
|
14261-2
|
Codeine
[Presence]
in
Gastric
fluid
|
|
14262-0
|
Dichlorodiphenyldichloroethylene
[Mass/mass]
in
Tissue
|
|
14263-8
|
Dichlorodiphenyltrichloroethane
[Mass/mass]
in
Tissue
|
|
14264-6
|
Enflurane
[Mass/volume]
in
Blood
|
|
14265-3
|
Isobutyl
acetate
[Mass/volume]
in
Blood
|
|
14266-1
|
Methoxyflurane
[Mass/volume]
in
Blood
|
|
14267-9
|
Methylenedioxymethamphetamine
[Presence]
in
Urine
|
|
14268-7
|
Butyl
acetate
[Mass/volume]
in
Blood
|
|
14269-5
|
Sec-butyl
acetate
[Mass/volume]
in
Blood
|
|
14270-3
|
Tert-butyl
acetate
[Mass/volume]
in
Blood
|
|
14272-9
|
Liver
kidney
microsomal
Ab
[Presence]
in
Serum
|
|
14273-7
|
Reticulin
IgA
Ab
[Presence]
in
Serum
|
|
14275-2
|
Immune
complex
[Units/volume]
in
Serum
or
Plasma
by
C3b
binding
assay
|
|
14277-8
|
Neutrophil
cytoplasmic
Ab.classic
[Titer]
in
Serum
by
Immunofluorescence
|
|
14278-6
|
Neutrophil
cytoplasmic
Ab.perinuclear
[Titer]
in
Serum
by
Immunofluorescence
|
|
14282-8
|
Acylcarnitine
[Moles/volume]
in
Serum
or
Plasma
|
|
14284-4
|
Beta
glucuronidase
[Moles/volume]
in
Serum
or
Plasma
|
|
14285-1
|
Carnitine
free
(C0)
[Moles/volume]
in
Urine
|
|
14286-9
|
Carnitine
free
(C0)
[Moles/volume]
in
Serum
or
Plasma
|
|
14287-7
|
Carnitine
[Moles/volume]
in
Urine
|
|
14288-5
|
Carnitine
[Moles/volume]
in
Serum
or
Plasma
|
|
14292-7
|
IgE
[Moles/volume]
in
Serum
|
|
14294-3
|
Lysosomal
enzymes
screen
[Identifier]
in
Plasma
and
Urine
|
|
14295-0
|
Organic
acids/Creatinine
[Molar
ratio]
in
Urine
|
|
14296-8
|
Thyroperoxidase
Ab
[Moles/volume]
in
Serum
or
Plasma
|
|
14297-6
|
Thyrotropin
[Moles/volume]
in
Serum
or
Plasma
|
|
14304-0
|
Measles
virus
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
--1st
specimen
|
|
14305-7
|
Measles
virus
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
--2nd
specimen
|
|
14306-5
|
Varicella
zoster
virus
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
--1st
specimen
|
|
14307-3
|
Varicella
zoster
virus
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
--2nd
specimen
|
|
14308-1
|
Amphetamines
[Presence]
in
Urine
by
Screen
method
>1000
ng/mL
|
|
14309-9
|
Amphetamines
[Presence]
in
Urine
by
Confirm
method
>200
ng/mL
|
|
14310-7
|
Phencyclidine
[Presence]
in
Urine
by
Screen
method
>25
ng/mL
|
|
14311-5
|
Phencyclidine
[Presence]
in
Urine
by
Confirm
method
>20
ng/mL
|
|
14312-3
|
Tetrahydrocannabinol
[Presence]
in
Urine
by
Screen
method
>50
ng/mL
|
|
14313-1
|
Tetrahydrocannabinol
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
14314-9
|
Benzoylecgonine
[Presence]
in
Urine
by
Screen
method
|
|
14315-6
|
Benzoylecgonine
[Presence]
in
Urine
by
Confirmatory
method
|
|
14316-4
|
Benzodiazepines
[Presence]
in
Urine
by
Screen
method
|
|
14317-2
|
Microscopic
observation
[Identifier]
in
Genital
specimen
by
Wet
preparation
|
|
14318-0
|
Microscopic
observation
[Identifier]
in
Cervix
by
Wet
preparation
|
|
14319-8
|
Microscopic
observation
[Identifier]
in
Vaginal
fluid
by
Wet
preparation
|
|
14320-6
|
Deprecated
Bacteria
identified
in
Urine
by
Culture
@1:100
|
|
14321-4
|
Haemophilus
influenzae
B
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Latex
agglutination
|
|
14322-2
|
Streptococcus
pneumoniae
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Latex
agglutination
|
|
14323-0
|
Streptococcus
agalactiae
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Latex
agglutination
|
|
14324-8
|
Escherichia
coli
K1
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Latex
agglutination
|
|
14325-5
|
Bacteria
identified
in
Unspecified
specimen
by
Environmental
culture
|
|
14333-9
|
Lead
[Presence]
in
24
hour
Urine
|
|
14334-7
|
Lithium
[Moles/volume]
in
Serum
or
Plasma
|
|
14335-4
|
Optical
density
of
Amniotic
fluid
by
Spectrophotometry
|
|
14336-2
|
Ethanol
[Mass/volume]
in
Serum
or
Plasma
by
Gas
chromatography
|
|
14338-8
|
Prealbumin
[Mass/volume]
in
Serum
or
Plasma
|
|
14345-3
|
Specific
gravity
of
Amniotic
fluid
by
Refractometry
|
|
14346-1
|
Specific
gravity
of
Cerebral
spinal
fluid
by
Refractometry
|
|
14347-9
|
Specific
gravity
of
Gastric
fluid
by
Refractometry
|
|
14348-7
|
Specific
gravity
of
Peritoneal
fluid
by
Refractometry
|
|
14349-5
|
Specific
gravity
of
Pleural
fluid
by
Refractometry
|
|
14350-3
|
Specific
gravity
of
Synovial
fluid
by
Refractometry
|
|
14351-1
|
Specific
gravity
of
Stool
by
Refractometry
|
|
14352-9
|
Specific
gravity
of
Water
by
Refractometry
|
|
14353-7
|
Microscopic
observation
[Identifier]
in
Pleural
fluid
by
Acid
fast
stain.Kinyoun
modified
|
|
14354-5
|
Microscopic
observation
[Identifier]
in
Wound
by
Acid
fast
stain.Kinyoun
modified
|
|
14355-2
|
Microscopic
observation
[Identifier]
in
Cervix
by
KOH
preparation
|
|
14356-0
|
Microscopic
observation
[Identifier]
in
Vaginal
fluid
by
KOH
preparation
|
|
14357-8
|
Microscopic
observation
[Identifier]
in
Cerebral
spinal
fluid
by
Gram
stain
|
|
14358-6
|
Microscopic
observation
[Identifier]
in
Aspirate
by
Gram
stain
|
|
14359-4
|
Microscopic
observation
[Identifier]
in
Peritoneal
fluid
by
Gram
stain
|
|
14360-2
|
Microscopic
observation
[Identifier]
in
Pleural
fluid
by
Gram
stain
|
|
14361-0
|
Microscopic
observation
[Identifier]
in
Vaginal
fluid
by
Gram
stain
|
|
14362-8
|
Microscopic
observation
[Identifier]
in
Throat
by
Gram
stain
|
|
14363-6
|
Microscopic
observation
[Identifier]
in
Synovial
fluid
by
Gram
stain
|
|
14364-4
|
Microscopic
observation
[Identifier]
in
Eye
by
Gram
stain
|
|
14365-1
|
Microscopic
observation
[Identifier]
in
Ear
by
Gram
stain
|
|
14366-9
|
Trichomonas
vaginalis
[Presence]
in
Cervix
by
Wet
preparation
|
|
14367-7
|
Trichomonas
vaginalis
[Presence]
in
Vaginal
fluid
by
Wet
preparation
|
|
14368-5
|
Trichomonas
vaginalis
[Presence]
in
Urethra
by
Wet
preparation
|
|
14369-3
|
Yeast
[Presence]
in
Cervix
by
Wet
preparation
|
|
14370-1
|
Yeast
[Presence]
in
Vaginal
fluid
by
Wet
preparation
|
|
14371-9
|
Yeast
[Presence]
in
Urethra
by
Wet
preparation
|
|
14386-7
|
Glucose
[Mass/volume]
in
Gastric
fluid
|
|
14387-5
|
Protein
[Mass/volume]
in
Gastric
fluid
|
|
14388-3
|
Amylase
[Enzymatic
activity/volume]
in
Synovial
fluid
|
|
14389-1
|
Amylase
[Enzymatic
activity/volume]
in
Cerebral
spinal
fluid
|
|
14390-9
|
Amylase
[Enzymatic
activity/volume]
in
Dialysis
fluid
|
|
14391-7
|
Amylase
[Enzymatic
activity/volume]
in
Gastric
fluid
|
|
14392-5
|
Amylase
[Enzymatic
activity/volume]
in
Amniotic
fluid
|
|
14393-3
|
Urea
nitrogen
[Mass/volume]
in
Amniotic
fluid
|
|
14394-1
|
Urea
nitrogen
[Mass/volume]
in
Pleural
fluid
|
|
14396-6
|
Urea
nitrogen
[Mass/volume]
in
Synovial
fluid
|
|
14397-4
|
Urea
nitrogen
[Mass/volume]
in
Gastric
fluid
|
|
14398-2
|
Creatinine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
14399-0
|
Creatinine
[Mass/volume]
in
Pleural
fluid
|
|
14401-4
|
Creatinine
[Mass/volume]
in
Synovial
fluid
|
|
14402-2
|
Creatinine
[Mass/volume]
in
Gastric
fluid
|
|
14403-0
|
Lactate
dehydrogenase
[Enzymatic
activity/volume]
in
Gastric
fluid
|
|
14404-8
|
Phosphate
[Mass/volume]
in
Pleural
fluid
|
|
14405-5
|
Phosphate
[Mass/volume]
in
Peritoneal
fluid
|
|
14406-3
|
Phosphate
[Mass/volume]
in
Synovial
fluid
|
|
14407-1
|
Phosphate
[Mass/volume]
in
Gastric
fluid
|
|
14408-9
|
Phosphate
[Mass/volume]
in
Amniotic
fluid
|
|
14409-7
|
Aspartate
aminotransferase
[Enzymatic
activity/volume]
in
Pleural
fluid
|
|
14410-5
|
Aspartate
aminotransferase
[Enzymatic
activity/volume]
in
Peritoneal
fluid
|
|
14411-3
|
Aspartate
aminotransferase
[Enzymatic
activity/volume]
in
Synovial
fluid
|
|
14412-1
|
Aspartate
aminotransferase
[Enzymatic
activity/volume]
in
Gastric
fluid
|
|
14413-9
|
Aspartate
aminotransferase
[Enzymatic
activity/volume]
in
Urine
|
|
14414-7
|
Aspartate
aminotransferase
[Enzymatic
activity/volume]
in
Dialysis
fluid
|
|
14415-4
|
Calcium
[Moles/volume]
in
Amniotic
fluid
|
|
14416-2
|
Calcium
[Moles/volume]
in
Pleural
fluid
|
|
14417-0
|
Calcium
[Moles/volume]
in
Peritoneal
fluid
|
|
14418-8
|
Calcium
[Moles/volume]
in
Synovial
fluid
|
|
14419-6
|
Calcium
[Moles/volume]
in
Gastric
fluid
|
|
14420-4
|
Bilirubin.total
[Mass/volume]
in
Dialysis
fluid
|
|
14421-2
|
Bilirubin.total
[Mass/volume]
in
Pleural
fluid
|
|
14422-0
|
Bilirubin.total
[Mass/volume]
in
Peritoneal
fluid
|
|
14423-8
|
Bilirubin.total
[Mass/volume]
in
Synovial
fluid
|
|
14424-6
|
Bilirubin.total
[Mass/volume]
in
Gastric
fluid
|
|
14425-3
|
Globulin
[Mass/volume]
in
Amniotic
fluid
|
|
14426-1
|
Globulin
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
14427-9
|
Globulin
[Mass/volume]
in
Pleural
fluid
|
|
14428-7
|
Globulin
[Mass/volume]
in
Peritoneal
fluid
|
|
14429-5
|
Globulin
[Mass/volume]
in
Semen
|
|
14430-3
|
Globulin
[Mass/volume]
in
Synovial
fluid
|
|
14431-1
|
Globulin
[Mass/volume]
in
Urine
|
|
14438-6
|
Cholesterol
[Mass/volume]
in
Amniotic
fluid
|
|
14439-4
|
Cholesterol
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
1444-9
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--pre
12
hour
fast
|
|
14441-0
|
Cholesterol
[Mass/volume]
in
Peritoneal
fluid
|
|
14442-8
|
Cholesterol
[Mass/volume]
in
Semen
|
|
14443-6
|
Cholesterol
[Mass/volume]
in
Synovial
fluid
|
|
14444-4
|
Cholesterol
[Mass/volume]
in
Urine
|
|
14445-1
|
Triglyceride
[Mass/volume]
in
Amniotic
fluid
|
|
14446-9
|
Triglyceride
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
14447-7
|
Triglyceride
[Mass/volume]
in
Peritoneal
fluid
|
|
14448-5
|
Triglyceride
[Mass/volume]
in
Semen
|
|
14449-3
|
Triglyceride
[Mass/volume]
in
Synovial
fluid
|
|
14450-1
|
Triglyceride
[Mass/volume]
in
Urine
|
|
14451-9
|
Virus
identified
in
Eye
by
Culture
|
|
14452-7
|
Virus
identified
in
Cervix
by
Culture
|
|
14453-5
|
Virus
identified
in
Vaginal
fluid
by
Culture
|
|
14454-3
|
Virus
identified
in
Nose
by
Culture
|
|
14455-0
|
Virus
identified
in
Pleural
fluid
by
Culture
|
|
14456-8
|
Virus
identified
in
Peritoneal
fluid
by
Culture
|
|
14457-6
|
Virus
identified
in
Urine
by
Culture
|
|
14458-4
|
Virus
identified
in
Sputum
by
Culture
|
|
14459-2
|
Virus
identified
in
Penis
by
Culture
|
|
14460-0
|
Virus
identified
in
Urethra
by
Culture
|
|
14461-8
|
Chlamydia
trachomatis
[Presence]
in
Blood
by
Organism
specific
culture
|
|
14462-6
|
Chlamydia
trachomatis
[Presence]
in
Cerebral
spinal
fluid
by
Organism
specific
culture
|
|
14463-4
|
Chlamydia
trachomatis
[Presence]
in
Cervix
by
Organism
specific
culture
|
|
14464-2
|
Chlamydia
trachomatis
[Presence]
in
Vaginal
fluid
by
Organism
specific
culture
|
|
14465-9
|
Chlamydia
trachomatis
[Presence]
in
Urethra
by
Organism
specific
culture
|
|
14466-7
|
Deprecated
Chlamydia
trachomatis
[Presence]
in
Penis
by
Organism
specific
culture
|
|
14467-5
|
Chlamydia
trachomatis
[Presence]
in
Urine
sediment
by
Organism
specific
culture
|
|
14468-3
|
Chlamydia
trachomatis
Ag
[Presence]
in
Blood
by
Immunoassay
|
|
14469-1
|
Chlamydia
trachomatis
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Immunoassay
|
|
14470-9
|
Chlamydia
trachomatis
Ag
[Presence]
in
Cervix
by
Immunoassay
|
|
14471-7
|
Chlamydia
trachomatis
Ag
[Presence]
in
Vaginal
fluid
by
Immunoassay
|
|
14472-5
|
Chlamydia
trachomatis
Ag
[Presence]
in
Urethra
by
Immunoassay
|
|
14473-3
|
Deprecated
Chlamydia
trachomatis
Ag
[Presence]
in
Penis
by
Immunoassay
|
|
14474-1
|
Chlamydia
trachomatis
Ag
[Presence]
in
Urine
sediment
by
Immunoassay
|
|
14475-8
|
Bacteria
identified
in
Cervix
by
Aerobe
culture
|
|
14477-4
|
Bacteria
identified
in
Urethra
by
Aerobe
culture
|
|
14478-2
|
Bacteria
identified
in
Penis
by
Aerobe
culture
|
|
14479-0
|
Diphtheria
identified
in
Throat
by
Organism
specific
culture
|
|
14480-8
|
Diphtheria
identified
in
Sputum
by
Organism
specific
culture
|
|
14481-6
|
Diphtheria
identified
in
Nose
by
Organism
specific
culture
|
|
14482-4
|
Diphtheria
identified
in
Skin
by
Organism
specific
culture
|
|
14483-2
|
Diphtheria
identified
in
Bronchial
specimen
by
Organism
specific
culture
|
|
14484-0
|
Mycoplasma
sp
and
Ureaplasma
sp
[Identifier]
in
Cervix
by
Organism
specific
culture
|
|
14485-7
|
Mycoplasma
sp
and
Ureaplasma
sp
[Identifier]
in
Vaginal
fluid
by
Organism
specific
culture
|
|
14486-5
|
Mycoplasma
sp
and
Ureaplasma
sp
[Identifier]
in
Penis
by
Organism
specific
culture
|
|
14487-3
|
Mycoplasma
sp
and
Ureaplasma
sp
[Identifier]
in
Urethra
by
Organism
specific
culture
|
|
14488-1
|
Virus
identified
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14489-9
|
Virus
identified
in
Blood
by
Immunofluorescence
|
|
14490-7
|
Virus
identified
in
Semen
by
Immunofluorescence
|
|
14491-5
|
Virus
identified
in
Throat
by
Immunofluorescence
|
|
14492-3
|
Virus
identified
in
Eye
by
Immunofluorescence
|
|
14493-1
|
Virus
identified
in
Cervix
by
Immunofluorescence
|
|
14494-9
|
Virus
identified
in
Vaginal
fluid
by
Immunofluorescence
|
|
14495-6
|
Virus
identified
in
Urine
sediment
by
Immunofluorescence
|
|
14496-4
|
Virus
identified
in
Sputum
by
Immunofluorescence
|
|
14497-2
|
Virus
identified
in
Penis
by
Immunofluorescence
|
|
14498-0
|
Virus
identified
in
Urethra
by
Immunofluorescence
|
|
14499-8
|
Human
papilloma
virus
Ag
[Presence]
in
Cervix
|
|
14500-3
|
Human
papilloma
virus
Ag
[Presence]
in
Vaginal
fluid
|
|
14501-1
|
Human
papilloma
virus
Ag
[Presence]
in
Penis
|
|
14502-9
|
Human
papilloma
virus
Ag
[Presence]
in
Urethra
|
|
14503-7
|
Human
papilloma
virus
16+18
Ag
[Presence]
in
Cervix
|
|
14504-5
|
Human
papilloma
virus
16+18
Ag
[Presence]
in
Vaginal
fluid
|
|
14505-2
|
Human
papilloma
virus
16+18
Ag
[Presence]
in
Penis
|
|
14506-0
|
Human
papilloma
virus
16+18
Ag
[Presence]
in
Urethra
|
|
14507-8
|
Chlamydia
trachomatis
Ag
[Presence]
in
Blood
by
Immunofluorescence
|
|
14508-6
|
Chlamydia
trachomatis
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14509-4
|
Chlamydia
trachomatis
Ag
[Presence]
in
Cervix
by
Immunofluorescence
|
|
14510-2
|
Chlamydia
trachomatis
Ag
[Presence]
in
Vaginal
fluid
by
Immunofluorescence
|
|
14511-0
|
Chlamydia
trachomatis
Ag
[Presence]
in
Urethra
by
Immunofluorescence
|
|
14512-8
|
Deprecated
Chlamydia
trachomatis
Ag
[Presence]
in
Penis
by
Immunofluorescence
|
|
14513-6
|
Chlamydia
trachomatis
Ag
[Presence]
in
Urine
sediment
by
Immunofluorescence
|
|
14514-4
|
Pneumocystis
jiroveci
Ag
[Presence]
in
Blood
by
Immunofluorescence
|
|
14515-1
|
Pneumocystis
jiroveci
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14516-9
|
Pneumocystis
jiroveci
Ag
[Presence]
in
Semen
by
Immunofluorescence
|
|
14517-7
|
Pneumocystis
jiroveci
Ag
[Presence]
in
Stool
by
Immunofluorescence
|
|
14518-5
|
Pneumocystis
jiroveci
Ag
[Presence]
in
Throat
by
Immunofluorescence
|
|
14519-3
|
Pneumocystis
jiroveci
Ag
[Presence]
in
Eye
by
Immunofluorescence
|
|
14520-1
|
Pneumocystis
jiroveci
Ag
[Presence]
in
Nose
by
Immunofluorescence
|
|
14521-9
|
Pneumocystis
jiroveci
Ag
[Presence]
in
Urine
by
Immunofluorescence
|
|
14522-7
|
Pneumocystis
jiroveci
Ag
[Presence]
in
Bronchial
specimen
by
Immunofluorescence
|
|
14523-5
|
Rubella
virus
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14524-3
|
Rubella
virus
Ag
[Presence]
in
Throat
by
Immunofluorescence
|
|
14525-0
|
Rubella
virus
Ag
[Presence]
in
Skin
by
Immunofluorescence
|
|
14526-8
|
Rubella
virus
Ag
[Presence]
in
Eye
by
Immunofluorescence
|
|
14527-6
|
Rubella
virus
Ag
[Presence]
in
Nose
by
Immunofluorescence
|
|
14528-4
|
Rubella
virus
Ag
[Presence]
in
Sputum
by
Immunofluorescence
|
|
14529-2
|
Rubella
virus
Ag
[Presence]
in
Cervix
by
Immunofluorescence
|
|
14530-0
|
Rubella
virus
Ag
[Presence]
in
Vaginal
fluid
by
Immunofluorescence
|
|
14531-8
|
Rubella
virus
Ag
[Presence]
in
Urine
sediment
by
Immunofluorescence
|
|
14532-6
|
Rubella
virus
Ag
[Presence]
in
Penis
by
Immunofluorescence
|
|
14533-4
|
Rubella
virus
Ag
[Presence]
in
Urethra
by
Immunofluorescence
|
|
14534-2
|
Measles
virus
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14535-9
|
Measles
virus
Ag
[Presence]
in
Throat
by
Immunofluorescence
|
|
14536-7
|
Measles
virus
Ag
[Presence]
in
Skin
by
Immunofluorescence
|
|
14537-5
|
Measles
virus
Ag
[Presence]
in
Eye
by
Immunofluorescence
|
|
14538-3
|
Measles
virus
Ag
[Presence]
in
Nose
by
Immunofluorescence
|
|
14539-1
|
Measles
virus
Ag
[Presence]
in
Sputum
by
Immunofluorescence
|
|
14540-9
|
Measles
virus
Ag
[Presence]
in
Cervix
by
Immunofluorescence
|
|
14541-7
|
Measles
virus
Ag
[Presence]
in
Vaginal
fluid
by
Immunofluorescence
|
|
14542-5
|
Measles
virus
Ag
[Presence]
in
Urine
sediment
by
Immunofluorescence
|
|
14543-3
|
Measles
virus
Ag
[Presence]
in
Penis
by
Immunofluorescence
|
|
14544-1
|
Measles
virus
Ag
[Presence]
in
Urethra
by
Immunofluorescence
|
|
14545-8
|
Mumps
virus
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14546-6
|
Mumps
virus
Ag
[Presence]
in
Throat
by
Immunofluorescence
|
|
14547-4
|
Mumps
virus
Ag
[Presence]
in
Skin
by
Immunofluorescence
|
|
14548-2
|
Mumps
virus
Ag
[Presence]
in
Eye
by
Immunofluorescence
|
|
14549-0
|
Mumps
virus
Ag
[Presence]
in
Nose
by
Immunofluorescence
|
|
14550-8
|
Mumps
virus
Ag
[Presence]
in
Sputum
by
Immunofluorescence
|
|
14551-6
|
Mumps
virus
Ag
[Presence]
in
Cervix
by
Immunofluorescence
|
|
14552-4
|
Mumps
virus
Ag
[Presence]
in
Vaginal
fluid
by
Immunofluorescence
|
|
14553-2
|
Mumps
virus
Ag
[Presence]
in
Urine
sediment
by
Immunofluorescence
|
|
14554-0
|
Mumps
virus
Ag
[Presence]
in
Penis
by
Immunofluorescence
|
|
14555-7
|
Mumps
virus
Ag
[Presence]
in
Urethra
by
Immunofluorescence
|
|
14556-5
|
Mycobacterium
tuberculosis
DNA
[Presence]
in
Sputum
by
Probe
and
target
amplification
method
|
|
14557-3
|
Mycobacterium
tuberculosis
DNA
[Presence]
in
Bronchial
specimen
by
Probe
and
target
amplification
method
|
|
14558-1
|
Mycobacterium
tuberculosis
DNA
[Presence]
in
Gastric
fluid
by
Probe
and
target
amplification
method
|
|
14559-9
|
Mycobacterium
tuberculosis
DNA
[Presence]
in
Pleural
fluid
by
Probe
and
target
amplification
method
|
|
14560-7
|
Mycobacterium
tuberculosis
DNA
[Presence]
in
Urine
by
Probe
and
target
amplification
method
|
|
14561-5
|
Mycobacterium
tuberculosis
DNA
[Presence]
in
Cerebral
spinal
fluid
by
Probe
and
target
amplification
method
|
|
14562-3
|
Mycobacterium
tuberculosis
DNA
[Presence]
in
Semen
by
Probe
and
target
amplification
method
|
|
14566-4
|
Calcitriol
[Moles/volume]
in
Serum
or
Plasma
|
|
14567-2
|
11-Deoxycortisol
[Moles/volume]
in
Serum
or
Plasma
|
|
14568-0
|
17-Hydroxycorticosteroids
[Moles/time]
in
24
hour
Urine
|
|
14569-8
|
17-Hydroxyprogesterone
[Moles/volume]
in
Serum
or
Plasma
|
|
14570-6
|
17-Hydroxyprogesterone
[Moles/volume]
in
Urine
|
|
14571-4
|
17-Hydroxyprogesterone
[Moles/time]
in
24
hour
Urine
|
|
14572-2
|
17-Ketosteroids
[Moles/time]
in
24
hour
Urine
|
|
14573-0
|
5-Hydroxyindoleacetate
[Moles/time]
in
24
hour
Urine
|
|
14574-8
|
8-Hydroxyamoxapine
[Moles/volume]
in
Serum
or
Plasma
|
|
14580-5
|
ABO
group
[Type]
in
Blood
from
newborn
|
|
14581-3
|
Acetaminophen
[Moles/volume]
in
Serum
or
Plasma
|
|
14582-1
|
Acetone
[Moles/volume]
in
Serum
or
Plasma
|
|
14583-9
|
Acidity.titratable
[Mass/volume]
in
Gastric
fluid
|
|
14584-7
|
Adenosine
monophosphate.cyclic
[Moles/time]
in
24
hour
Urine
|
|
14585-4
|
Albumin/Creatinine
[Molar
ratio]
in
Urine
|
|
14586-2
|
Aldosterone
[Moles/volume]
in
Serum
or
Plasma
|
|
14587-0
|
Aldosterone
[Moles/time]
in
24
hour
Urine
|
|
14590-4
|
Alpha
tocopherol
[Moles/volume]
in
Serum
or
Plasma
|
|
14591-2
|
Alprazolam
[Moles/volume]
in
Serum
or
Plasma
|
|
14592-0
|
Aluminum
[Moles/volume]
in
24
hour
Urine
|
|
14593-8
|
Aluminum
[Moles/volume]
in
Serum
or
Plasma
|
|
14594-6
|
Amitriptyline+Nortriptyline
[Presence]
in
Gastric
fluid
|
|
14595-3
|
Amitriptyline+Nortriptyline
[Presence]
in
Serum
or
Plasma
|
|
14596-1
|
Amitriptyline+Nortriptyline
[Presence]
in
Urine
|
|
14597-9
|
Amitriptyline
[Moles/volume]
in
Serum
or
Plasma
|
|
14598-7
|
Amitriptyline+Nortriptyline
[Moles/volume]
in
Serum
or
Plasma
|
|
14599-5
|
Ammonium
[Presence]
in
Stone
|
|
14600-1
|
Amoxapine
[Moles/volume]
in
Serum
or
Plasma
|
|
14601-9
|
Amoxapine+8-Hydroxyamoxapine
[Moles/volume]
in
Serum
or
Plasma
|
|
14603-5
|
Androstenedione
[Moles/volume]
in
Serum
or
Plasma
|
|
14607-6
|
Nuclear
Ab
[Presence]
in
Body
fluid
|
|
14608-4
|
Nuclear
Ab
[Presence]
in
Pleural
fluid
|
|
14609-2
|
Nuclear
Ab
[Presence]
in
Peritoneal
fluid
|
|
14610-0
|
Nuclear
Ab
[Presence]
in
Synovial
fluid
|
|
14612-6
|
Nuclear
Ab
[Titer]
in
Pericardial
fluid
|
|
14613-4
|
Nuclear
Ab
[Titer]
in
Body
fluid
|
|
14614-2
|
Nuclear
Ab
[Titer]
in
Pleural
fluid
|
|
14615-9
|
Nuclear
Ab
[Titer]
in
Peritoneal
fluid
|
|
14616-7
|
Nuclear
Ab
[Titer]
in
Synovial
fluid
|
|
14622-5
|
Ascorbate
[Moles/volume]
in
Serum
or
Plasma
|
|
14623-3
|
Barbital
[Presence]
in
Serum
or
Plasma
|
|
14624-1
|
Barbiturates
[Presence]
in
Gastric
fluid
|
|
14626-6
|
Beta-2-Microglobulin
[Moles/volume]
in
Serum
|
|
14627-4
|
Bicarbonate
[Moles/volume]
in
Venous
blood
|
|
14628-2
|
Bile
acid
[Moles/volume]
in
Serum
|
|
14629-0
|
Bilirubin.direct
[Moles/volume]
in
Serum
or
Plasma
|
|
14630-8
|
Bilirubin.indirect
[Moles/volume]
in
Serum
or
Plasma
|
|
14631-6
|
Bilirubin.total
[Moles/volume]
in
Serum
or
Plasma
|
|
14633-2
|
C
peptide
[Moles/volume]
in
Serum
or
Plasma
|
|
14634-0
|
C
reactive
protein
[Titer]
in
Serum
or
Plasma
|
|
14635-7
|
Calcidiol
[Moles/volume]
in
Serum
or
Plasma
|
|
14636-5
|
Calcium
[Presence]
in
Stone
|
|
14637-3
|
Calcium
[Moles/time]
in
24
hour
Urine
|
|
14639-9
|
Carbamazepine
[Moles/volume]
in
Serum
or
Plasma
|
|
14640-7
|
Carbon
dioxide,
total
[Moles/volume]
in
Dialysis
fluid
|
|
14641-5
|
Carbonate
[Presence]
in
Stone
|
|
14642-3
|
Carotene
[Moles/volume]
in
Serum
|
|
14643-1
|
Catecholamines
Free
[Moles/time]
in
24
hour
Urine
|
|
14644-9
|
Chlorpromazine
[Presence]
in
Gastric
fluid
|
|
14645-6
|
Chlorpromazine
[Moles/volume]
in
Serum
or
Plasma
|
|
14646-4
|
Cholesterol
in
HDL
[Moles/volume]
in
Serum
or
Plasma
|
|
14647-2
|
Cholesterol
[Moles/volume]
in
Serum
or
Plasma
|
|
14648-0
|
Chylomicrons
[Moles/volume]
in
Serum
or
Plasma
|
|
14649-8
|
Cimetidine
[Presence]
in
Gastric
fluid
|
|
1465-4
|
Epinephrine
[Mass/volume]
in
Plasma
--supine
|
|
14650-6
|
Citrate
[Moles/time]
in
24
hour
Urine
|
|
14651-4
|
Clobazam
[Moles/volume]
in
Serum
or
Plasma
|
|
14652-2
|
Clomipramine
[Moles/volume]
in
Serum
or
Plasma
|
|
14653-0
|
Clomipramine
[Moles/volume]
in
Urine
|
|
14655-5
|
Clonazepam
[Moles/volume]
in
Serum
or
Plasma
|
|
14656-3
|
Clozapine
[Moles/volume]
in
Serum
or
Plasma
|
|
14657-1
|
Clozapine+Norclozapine
[Moles/volume]
in
Serum
or
Plasma
|
|
14658-9
|
Cold
agglutinin
[Titer]
in
Serum
or
Plasma
|
|
14665-4
|
Copper
[Moles/volume]
in
Serum
or
Plasma
|
|
14666-2
|
Copper
[Moles/time]
in
24
hour
Urine
|
|
14674-6
|
Corticotropin
[Moles/volume]
in
Plasma
|
|
14675-3
|
Cortisol
[Moles/volume]
in
Serum
or
Plasma
|
|
14676-1
|
Cortisol
Free
[Moles/time]
in
24
hour
Urine
|
|
14678-7
|
Cortisol
[Moles/volume]
in
Serum
or
Plasma
--PM
trough
specimen
|
|
14679-5
|
Cortisol
[Moles/volume]
in
Serum
or
Plasma
--AM
peak
specimen
|
|
14681-1
|
Creatinine
[Moles/volume]
in
Peritoneal
dialysis
fluid
|
|
14682-9
|
Creatinine
[Moles/volume]
in
Serum
or
Plasma
|
|
14683-7
|
Creatinine
[Moles/volume]
in
Urine
|
|
14684-5
|
Creatinine
[Moles/time]
in
24
hour
Urine
|
|
14685-2
|
Cobalamin
(Vitamin
B12)
[Moles/volume]
in
Serum
or
Plasma
|
|
14688-6
|
Dehydroepiandrosterone
sulfate
(DHEA-S)
[Moles/volume]
in
Serum
or
Plasma
|
|
14689-4
|
Delta
aminolevulinate
[Moles/time]
in
24
hour
Urine
|
|
14690-2
|
N-desalkylflurazepam
[Moles/volume]
in
Serum
or
Plasma
|
|
14691-0
|
Desipramine
[Moles/volume]
in
Serum
or
Plasma
|
|
14692-8
|
Desipramine
[Moles/volume]
in
Urine
|
|
14693-6
|
Norclobazam
[Moles/volume]
in
Serum
or
Plasma
|
|
14694-4
|
Norclomipramine
[Moles/volume]
in
Serum
or
Plasma
|
|
14695-1
|
Nordoxepin
[Moles/volume]
in
Serum
or
Plasma
|
|
14697-7
|
Diazepam
[Moles/volume]
in
Serum
or
Plasma
|
|
14698-5
|
Digoxin
[Moles/volume]
in
Serum
or
Plasma
|
|
14699-3
|
Diphenhydramine+Dimenhydrinate
[Presence]
in
Gastric
fluid
|
|
14700-9
|
Diphenhydramine+Dimenhydrinate
[Presence]
in
Serum
or
Plasma
|
|
14701-7
|
Diphenhydramine+Dimenhydrinate
[Presence]
in
Urine
|
|
14702-5
|
Disopyramide
[Moles/volume]
in
Serum
or
Plasma
|
|
14703-3
|
Dopamine
[Moles/volume]
in
Serum
or
Plasma
|
|
14704-1
|
Doxepin
[Presence]
in
Gastric
fluid
|
|
14705-8
|
Doxepin
[Moles/volume]
in
Serum
or
Plasma
|
|
14706-6
|
Doxepin
[Moles/volume]
in
Urine
|
|
14707-4
|
Doxepin+Nordoxepin
[Moles/volume]
in
Serum
or
Plasma
|
|
14708-2
|
Endomysium
Ab
[Titer]
in
Serum
|
|
14710-8
|
Ephedrine+Pseudoephedrine
[Presence]
in
Gastric
fluid
|
|
14711-6
|
Epinephrine
[Moles/volume]
in
Plasma
|
|
14712-4
|
Epinephrine
[Moles/time]
in
24
hour
Urine
|
|
14714-0
|
Erythropoietin
(EPO)
[Moles/volume]
in
Serum
or
Plasma
|
|
14715-7
|
Estradiol
(E2)
[Moles/volume]
in
Serum
or
Plasma
|
|
14716-5
|
Estriol
(E3)
[Moles/volume]
in
Serum
or
Plasma
|
|
14717-3
|
Estriol
(E3)
[Moles/volume]
in
Urine
|
|
14718-1
|
Estriol
(E3)
[Moles/time]
in
24
hour
Urine
|
|
14719-9
|
Ethanol
[Moles/volume]
in
Serum
or
Plasma
|
|
14720-7
|
Ethosuximide
[Moles/volume]
in
Serum
or
Plasma
|
|
14721-5
|
Ethylene
glycol
[Moles/volume]
in
Serum
or
Plasma
|
|
14722-3
|
Extractable
nuclear
Ab
[Presence]
in
Serum
|
|
14723-1
|
Ferritin
[Moles/volume]
in
Serum
or
Plasma
|
|
14726-4
|
Fluoride
[Moles/volume]
in
Serum
or
Plasma
|
|
14727-2
|
Fluoxetine
[Presence]
in
Gastric
fluid
|
|
14728-0
|
Fluoxetine
[Moles/volume]
in
Serum
or
Plasma
|
|
14729-8
|
Flurazepam
[Moles/volume]
in
Serum
or
Plasma
|
|
14730-6
|
Flurazepam+N-desalkylflurazepam
[Moles/volume]
in
Serum
or
Plasma
|
|
14731-4
|
Folate
[Moles/volume]
in
Red
Blood
Cells
|
|
14732-2
|
Folate
[Moles/volume]
in
Serum
or
Plasma
|
|
14734-8
|
Follitropin
[Moles/time]
in
24
hour
Urine
|
|
14743-9
|
Glucose
[Moles/volume]
in
Capillary
blood
by
Glucometer
|
|
14744-7
|
Glucose
[Moles/volume]
in
Cerebral
spinal
fluid
|
|
14745-4
|
Glucose
[Moles/volume]
in
Body
fluid
|
|
14746-2
|
Glucose
[Moles/volume]
in
Peritoneal
dialysis
fluid
|
|
14747-0
|
Glucose
[Moles/volume]
in
Pleural
fluid
|
|
14748-8
|
Glucose
[Moles/volume]
in
Peritoneal
fluid
|
|
14749-6
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
|
|
14750-4
|
Glucose
[Moles/volume]
in
Synovial
fluid
|
|
14753-8
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--1
hour
post
100
g
glucose
PO
|
|
14754-6
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--1
hour
post
50
g
glucose
PO
|
|
14755-3
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--1
hour
post
50
g
lactose
PO
|
|
14756-1
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--1
hour
post
dose
glucose
|
|
14757-9
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--2
hours
post
100
g
glucose
PO
|
|
14758-7
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--2
hours
post
50
g
lactose
PO
|
|
14759-5
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--2
hours
post
dose
glucose
|
|
14760-3
|
Glucose
[Moles/volume]
in
Capillary
blood
--2
hours
post
meal
|
|
14761-1
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--2
hours
post
meal
|
|
14769-4
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--pre
12
hour
fast
|
|
14770-2
|
Fasting
glucose
[Moles/volume]
in
Capillary
blood
by
Glucometer
|
|
14771-0
|
Fasting
glucose
[Moles/volume]
in
Serum
or
Plasma
|
|
14772-8
|
Gold
[Moles/volume]
in
Serum
or
Plasma
|
|
14774-4
|
Haloperidol
[Moles/volume]
in
Serum
or
Plasma
|
|
14775-1
|
Hemoglobin
[Mass/volume]
in
Arterial
blood
by
Oximetry
|
|
14776-9
|
Heptacarboxylate
[Moles/volume]
in
Plasma
|
|
14777-7
|
Heptacarboxylate
[Moles/volume]
in
Stool
|
|
14778-5
|
Heptacarboxylate
[Moles/volume]
in
Urine
|
|
14779-3
|
Hexacarboxylate
[Moles/volume]
in
Plasma
|
|
14780-1
|
Hexacarboxylate
[Moles/volume]
in
Stool
|
|
14781-9
|
Hexacarboxylate
[Moles/volume]
in
Urine
|
|
14782-7
|
Homovanillate
[Moles/volume]
in
Urine
|
|
14783-5
|
Homovanillate
[Moles/time]
in
24
hour
Urine
|
|
14784-3
|
Hydroxyproline
Free
[Moles/time]
in
24
hour
Urine
|
|
14785-0
|
Hydroxyproline
[Moles/time]
in
24
hour
Urine
|
|
14787-6
|
Arthropod
identified
in
Unspecified
specimen
by
Permanent
mount
|
|
14788-4
|
Helminth+Arthropod
identified
in
Unspecified
specimen
by
Rearing/Culture
|
|
14789-2
|
Helminth
identified
in
Unspecified
specimen
by
Macro/micro
identification
|
|
14790-0
|
Helminth
identified
in
Unspecified
specimen
by
Permanent
mount
|
|
14791-8
|
Imipramine+Desipramine
[Presence]
in
Gastric
fluid
|
|
14792-6
|
Imipramine+Desipramine
[Presence]
in
Serum
or
Plasma
|
|
14793-4
|
Imipramine+Desipramine
[Presence]
in
Urine
|
|
14794-2
|
Imipramine+Desipramine
[Moles/volume]
in
Serum
or
Plasma
|
|
14796-7
|
Insulin
[Moles/volume]
in
Serum
or
Plasma
|
|
14798-3
|
Iron
[Moles/volume]
in
Serum
or
Plasma
|
|
14799-1
|
Iron
[Moles/time]
in
24
hour
Urine
|
|
14800-7
|
Iron
binding
capacity
[Moles/volume]
in
Serum
or
Plasma
|
|
14801-5
|
Iron
saturation
[Molar
fraction]
in
Serum
or
Plasma
|
|
14802-3
|
Isopropanol
[Moles/volume]
in
Serum
or
Plasma
|
|
14803-1
|
Lactate
dehydrogenase
[Enzymatic
activity/volume]
in
Body
fluid
by
Lactate
to
pyruvate
reaction
|
|
14807-2
|
Lead
[Moles/volume]
in
Blood
|
|
14808-0
|
Lead
[Moles/volume]
in
Urine
|
|
14809-8
|
Lead
[Moles/time]
in
24
hour
Urine
|
|
14812-2
|
Lidocaine
[Moles/volume]
in
Serum
or
Plasma
|
|
14817-1
|
Lorazepam
[Moles/volume]
in
Serum
or
Plasma
|
|
14825-4
|
Maprotiline
[Moles/volume]
in
Serum
or
Plasma
|
|
14826-2
|
Meperidine
[Presence]
in
Gastric
fluid
|
|
14832-0
|
Metanephrines
[Moles/volume]
in
Urine
|
|
14833-8
|
Metanephrines
[Moles/time]
in
24
hour
Urine
|
|
14834-6
|
Methamphetamine
[Presence]
in
Gastric
fluid
|
|
14835-3
|
Methanol
[Moles/volume]
in
Serum
or
Plasma
|
|
14836-1
|
Methotrexate
[Moles/volume]
in
Serum
or
Plasma
|
|
14837-9
|
Methsuximide
[Moles/volume]
in
Serum
or
Plasma
|
|
14838-7
|
Toxoplasma
gondii
[Presence]
in
Tissue
by
Organism
specific
culture
|
|
14839-5
|
Trypanosoma
sp
identified
in
Buffy
Coat
by
Light
microscopy
|
|
14840-3
|
Trypanosoma
sp
identified
in
Cerebral
spinal
fluid
by
Wet
preparation
|
|
14841-1
|
Microscopic
observation
[Identifier]
in
Unspecified
specimen
by
Iron
hematoxylin
stain
|
|
14842-9
|
Microscopic
observation
[Identifier]
in
Unspecified
specimen
by
Kinyoun
iron
hematoxylin
stain
|
|
14843-7
|
6-Monoacetylmorphine
(6-MAM)
[Presence]
in
Gastric
fluid
|
|
14844-5
|
6-Monoacetylmorphine
(6-MAM)
[Presence]
in
Serum
or
Plasma
|
|
14846-0
|
N-acetylprocainamide
[Moles/volume]
in
Serum
or
Plasma
|
|
14849-4
|
Nitrazepam
[Moles/volume]
in
Serum
or
Plasma
|
|
14850-2
|
Nitrazepam
[Moles/volume]
in
Urine
|
|
14851-0
|
Norclozapine
[Moles/volume]
in
Serum
or
Plasma
|
|
14852-8
|
Norepinephrine
[Moles/volume]
in
Plasma
|
|
14853-6
|
Norepinephrine
[Moles/volume]
in
Urine
|
|
14854-4
|
Norepinephrine
[Moles/time]
in
24
hour
Urine
|
|
14855-1
|
Norfluoxetine
[Moles/volume]
in
Serum
or
Plasma
|
|
14856-9
|
Nortriptyline
[Moles/volume]
in
Serum
or
Plasma
|
|
14862-7
|
Oxalate
[Moles/time]
in
24
hour
Urine
|
|
14863-5
|
Oxycodone
[Presence]
in
Gastric
fluid
|
|
14864-3
|
Oxygen
[Partial
pressure]
in
Cord
blood
|
|
14866-8
|
Parathyrin.intact
[Moles/volume]
in
Serum
or
Plasma
|
|
14867-6
|
Paroxetine
[Moles/volume]
in
Serum
or
Plasma
|
|
14870-0
|
Pentacarboxylate
[Moles/volume]
in
Plasma
|
|
14871-8
|
Pentacarboxylate
[Moles/volume]
in
Stool
|
|
14872-6
|
Pentacarboxylate
[Moles/volume]
in
Urine
|
|
14873-4
|
pH
of
Cord
blood
|
|
14874-2
|
Phenobarbital
[Moles/volume]
in
Serum
or
Plasma
|
|
14875-9
|
Phenylalanine
[Moles/volume]
in
Serum
or
Plasma
|
|
14876-7
|
Phenylpropanolamine
[Presence]
in
Gastric
fluid
|
|
14877-5
|
Phenytoin
[Moles/volume]
in
Serum
or
Plasma
|
|
14878-3
|
Phosphate
[Presence]
in
Stone
|
|
14879-1
|
Phosphate
[Moles/volume]
in
Serum
or
Plasma
|
|
14881-7
|
Phosphate
[Moles/time]
in
24
hour
Urine
|
|
14882-5
|
Porphobilinogen
[Moles/time]
in
24
hour
Urine
|
|
14885-8
|
Pregnanediol
[Moles/time]
in
24
hour
Urine
|
|
14886-6
|
Pregnanetriol
[Moles/time]
in
24
hour
Urine
|
|
14887-4
|
Primidone
[Moles/volume]
in
Serum
or
Plasma
|
|
14888-2
|
Procainamide
[Moles/volume]
in
Serum
or
Plasma
|
|
14889-0
|
Procainamide+N-acetylprocainamide
[Moles/volume]
in
Serum
or
Plasma
|
|
14890-8
|
Progesterone
[Moles/volume]
in
Serum
or
Plasma
|
|
14891-6
|
Propranolol
[Moles/volume]
in
Serum
or
Plasma
|
|
14892-4
|
Propranolol
[Moles/volume]
in
Urine
|
|
14893-2
|
Propranolol
[Moles/time]
in
24
hour
Urine
|
|
14894-0
|
Propylene
glycol
[Presence]
in
Serum
or
Plasma
|
|
14898-1
|
Protriptyline
[Moles/volume]
in
Serum
or
Plasma
|
|
14899-9
|
Quinidine
[Moles/volume]
in
Serum
or
Plasma
|
|
14900-5
|
Ranitidine
[Presence]
in
Gastric
fluid
|
|
14901-3
|
Ranitidine
[Presence]
in
Serum
or
Plasma
|
|
14902-1
|
Ranitidine
[Presence]
in
Urine
|
|
14904-7
|
Reagin
Ab
[Presence]
in
Unspecified
specimen
by
VDRL
|
|
14905-4
|
Retinol
[Moles/volume]
in
Serum
or
Plasma
|
|
14906-2
|
Rh
[Type]
in
Cord
blood
|
|
14908-8
|
Rh
[Type]
in
Blood
from
newborn
|
|
14909-6
|
Salicylates
[Moles/volume]
in
Serum
or
Plasma
|
|
14910-4
|
Serotonin
[Moles/volume]
in
Serum
|
|
14911-2
|
Sertraline
[Moles/volume]
in
Serum
or
Plasma
|
|
14913-8
|
Testosterone
[Moles/volume]
in
Serum
or
Plasma
|
|
14914-6
|
Testosterone
Free
[Moles/volume]
in
Serum
or
Plasma
|
|
14915-3
|
Theophylline
[Moles/volume]
in
Serum
or
Plasma
|
|
14916-1
|
Thiocyanate
[Moles/volume]
in
Serum
or
Plasma
|
|
14917-9
|
Thioridazine
[Moles/volume]
in
Serum
or
Plasma
|
|
14918-7
|
Thyroglobulin
[Moles/volume]
in
Serum
or
Plasma
|
|
14919-5
|
Thyrotropin
binding
inhibitory
immunoglobulins
[Presence]
in
Serum
|
|
14920-3
|
Thyroxine
(T4)
free
[Moles/volume]
in
Serum
or
Plasma
|
|
14921-1
|
Thyroxine
(T4)
[Moles/volume]
in
Serum
or
Plasma
|
|
14922-9
|
Toxoplasma
gondii
IgA+IgE
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
14923-7
|
Toxoplasma
gondii
Ab
[Units/volume]
in
Unspecified
specimen
|
|
14925-2
|
Trazodone
[Moles/volume]
in
Serum
or
Plasma
|
|
14926-0
|
Triazolam
[Moles/volume]
in
Serum
or
Plasma
|
|
14927-8
|
Triglyceride
[Moles/volume]
in
Serum
or
Plasma
|
|
14928-6
|
Triiodothyronine
(T3)
Free
[Moles/volume]
in
Serum
or
Plasma
|
|
14929-4
|
Triiodothyronine
(T3).reverse
[Moles/volume]
in
Serum
or
Plasma
|
|
1493-6
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
0.05-0.15
U
insulin/kg
IV
12
hours
fasting
|
|
14930-2
|
Triiodothyronine
(T3)
[Moles/volume]
in
Serum
or
Plasma
|
|
14931-0
|
Trimipramine
[Moles/volume]
in
Serum
or
Plasma
|
|
14932-8
|
Urate
[Presence]
in
Stone
|
|
14933-6
|
Urate
[Moles/volume]
in
Serum
or
Plasma
|
|
14934-4
|
Urate
[Moles/volume]
in
Urine
|
|
14935-1
|
Urate
[Moles/time]
in
24
hour
Urine
|
|
14936-9
|
Urea
nitrogen
[Moles/volume]
in
Peritoneal
dialysis
fluid
|
|
14937-7
|
Urea
nitrogen
[Moles/volume]
in
Serum
or
Plasma
|
|
14938-5
|
Urea
nitrogen
[Moles/volume]
in
Urine
|
|
14939-3
|
Urea
nitrogen
[Moles/time]
in
24
hour
Urine
|
|
14946-8
|
Valproate
[Moles/volume]
in
Serum
or
Plasma
|
|
14947-6
|
Vanillylmandelate
[Moles/time]
in
24
hour
Urine
|
|
14948-4
|
Vanillylmandelate/Creatinine
[Molar
ratio]
in
Urine
|
|
14949-2
|
Vasopressin
[Moles/volume]
in
Plasma
|
|
14950-0
|
Viscosity
of
Synovial
fluid
Qualitative
|
|
14951-8
|
Volatile
drugs
positive
[Identifier]
in
Serum
or
Plasma
by
Screen
method
|
|
14955-9
|
Zinc
[Moles/volume]
in
Serum
or
Plasma
|
|
14956-7
|
Microalbumin
[Mass/time]
in
24
hour
Urine
|
|
14957-5
|
Microalbumin
[Mass/volume]
in
Urine
|
|
14958-3
|
Microalbumin/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
14959-1
|
Microalbumin/Creatinine
[Mass
Ratio]
in
Urine
|
|
14964-1
|
CD19
Abnormal
blood
cells/Abnormal
blood
cells.total
in
Blood
|
|
14970-8
|
Estrone
(E1).bioavailable
[Mass/volume]
in
Serum
or
Plasma
|
|
14972-4
|
Mycobacterium
sp
DNA
[Presence]
in
Cerebral
spinal
fluid
by
Probe
and
target
amplification
method
|
|
14973-2
|
Mycobacterium
sp
DNA
[Presence]
in
Sputum
by
Probe
and
target
amplification
method
|
|
14974-0
|
Mycobacterium
sp
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
14975-7
|
Human
antimouse
Ab
[Mass/volume]
in
Serum
|
|
14976-5
|
Lecithin/Sphingomyelin
[Ratio]
in
Amniotic
fluid
|
|
14977-3
|
Immunoglobulin
light
chains.free
[Type]
in
Urine
|
|
14978-1
|
Cyclosporine
[Mass/volume]
in
Blood
by
Immunoassay
|
|
14979-9
|
aPTT
in
Platelet
poor
plasma
by
Coagulation
assay
|
|
1499-3
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
0.5
g/kg
glucose
IV
|
|
14994-8
|
O
group
[Presence]
on
Red
Blood
Cells
|
|
14995-5
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--2
hours
post
75
g
glucose
PO
|
|
1500-8
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
0.05-0.15
U
insulin/kg
IV
post
12H
CFst
|
|
15003-7
|
11-Hydroxyandrosterone
[Moles/time]
in
24
hour
Urine
|
|
15004-5
|
11-Hydroxyetiocholanolone
[Moles/time]
in
24
hour
Urine
|
|
15005-2
|
11-Ketoandrosterone
[Moles/time]
in
24
hour
Urine
|
|
15006-0
|
11-Ketoetiocholanolone
[Moles/time]
in
24
hour
Urine
|
|
15007-8
|
2,3-Diphosphoglycerate
[Moles/volume]
in
Red
Blood
Cells
|
|
15008-6
|
3-Alpha-Androstanediol
glucuronide
[Moles/volume]
in
Serum
|
|
15009-4
|
5-Hydroxyindoleacetate
[Moles/volume]
in
Urine
|
|
1501-6
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
100
g
glucose
PO
|
|
15010-2
|
Aldosterone
[Moles/volume]
in
Urine
|
|
15011-0
|
Aldosterone
[Moles/volume]
in
Serum
or
Plasma
--supine
|
|
15012-8
|
Aldosterone
[Moles/volume]
in
Serum
or
Plasma
--upright
|
|
15019-3
|
Alpha-1-Fetoprotein
[Moles/volume]
in
Amniotic
fluid
|
|
15026-8
|
Androstanediol
[Moles/volume]
in
Serum
or
Plasma
|
|
15027-6
|
Androstenedione
[Moles/volume]
in
Urine
|
|
15028-4
|
Androstenedione
[Moles/time]
in
24
hour
Urine
|
|
15029-2
|
Androsterone
[Moles/volume]
in
Serum
or
Plasma
|
|
1503-2
|
Glucose
[Mass/volume]
in
Urine
--1
hour
post
100
g
glucose
PO
|
|
15030-0
|
Androsterone
[Moles/time]
in
24
hour
Urine
|
|
15031-8
|
Angiotensin
I
[Moles/volume]
in
Plasma
|
|
15032-6
|
Angiotensin
II
[Moles/volume]
in
Plasma
|
|
15033-4
|
Ascorbate
[Moles/time]
in
24
hour
Urine
|
|
15034-2
|
Bromide
[Moles/volume]
in
Serum
or
Plasma
|
|
15035-9
|
Calcitonin
[Moles/volume]
in
Serum
or
Plasma
|
|
15036-7
|
Catecholamines
[Moles/time]
in
24
hour
Urine
|
|
15037-5
|
Chymotrypsin
[Moles/mass]
in
Stool
|
|
15038-3
|
Citrate
[Moles/volume]
in
Serum
or
Plasma
|
|
1504-0
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
50
g
glucose
PO
|
|
15042-5
|
Corticotropin
[Units/volume]
in
Serum
|
|
15043-3
|
Cortisol
[Moles/volume]
in
Urine
|
|
15044-1
|
Cortisol
Free
[Moles/volume]
in
Serum
or
Plasma
|
|
15045-8
|
Creatine
[Moles/volume]
in
Serum
or
Plasma
|
|
15046-6
|
Creatine
[Moles/volume]
in
Urine
|
|
15047-4
|
Creatine
[Moles/time]
in
24
hour
Urine
|
|
1505-7
|
Glucose
[Mass/volume]
in
Urine
--1
hour
post
50
g
glucose
PO
|
|
15050-8
|
Creatinine
[Moles/volume]
in
Amniotic
fluid
|
|
15051-6
|
Creatinine
[Moles/volume]
in
Dialysis
fluid
|
|
15052-4
|
Cobalamin
(Vitamin
B12).unsaturated
Binding
Capacity
[Moles/volume]
in
Serum
or
Plasma
|
|
15053-2
|
Dehydroepiandrosterone
sulfate
(DHEA-S)
[Moles/time]
in
24
hour
Urine
|
|
15054-0
|
Dehydroepiandrosterone
(DHEA)
[Moles/volume]
in
Serum
or
Plasma
|
|
15055-7
|
Deoxypyridinoline
[Moles/time]
in
24
hour
Urine
|
|
15057-3
|
Androstanolone
[Moles/volume]
in
Serum
or
Plasma
|
|
15058-1
|
Dopamine
[Moles/volume]
in
Urine
|
|
15059-9
|
Dopamine
[Moles/time]
in
24
hour
Urine
|
|
1506-5
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
50
g
lactose
PO
|
|
15060-7
|
Enolase.neuron
specific
[Mass/volume]
in
Serum
or
Plasma
|
|
15061-5
|
Erythropoietin
(EPO)
[Units/volume]
in
Serum
or
Plasma
|
|
15062-3
|
Estradiol
(E2).unconjugated
[Moles/time]
in
24
hour
Urine
|
|
15063-1
|
Estriol
(E3).conjugated
[Moles/volume]
in
Serum
or
Plasma
|
|
15064-9
|
Estriol
(E3).unconjugated
[Moles/volume]
in
Serum
or
Plasma
|
|
15065-6
|
Etiocholanolone
[Moles/time]
in
24
hour
Urine
|
|
15066-4
|
Fatty
acids.nonesterified
[Moles/volume]
in
Serum
or
Plasma
|
|
15067-2
|
Follitropin
[Units/volume]
in
Serum
or
Plasma
|
|
15068-0
|
Follitropin
[Units]
in
24
hour
Urine
|
|
15069-8
|
Fructosamine
[Moles/volume]
in
Serum
or
Plasma
|
|
1507-3
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
75
g
glucose
PO
|
|
15070-6
|
Fructose
[Moles/time]
in
24
hour
Urine
|
|
15071-4
|
Galactose
[Moles/time]
in
24
hour
Urine
|
|
15072-2
|
Gastrin
[Moles/volume]
in
Serum
or
Plasma
|
|
15073-0
|
Glucagon
[Moles/volume]
in
Serum
or
Plasma
|
|
15074-8
|
Glucose
[Moles/volume]
in
Blood
|
|
15075-5
|
Glucose
[Moles/volume]
in
Dialysis
fluid
|
|
15076-3
|
Glucose
[Moles/volume]
in
Urine
|
|
15077-1
|
Glucose
[Moles/time]
in
24
hour
Urine
|
|
15078-9
|
Lactate
[Moles/time]
in
24
hour
Urine
|
|
15079-7
|
Lutropin
[Units/volume]
in
Urine
|
|
15080-5
|
Lutropin
[Units]
in
24
hour
Urine
|
|
15081-3
|
Prolactin
[Units/volume]
in
Serum
or
Plasma
|
|
15082-1
|
Methemoglobin
[Mass/volume]
in
Blood
|
|
15083-9
|
Normetanephrine
[Moles/time]
in
24
hour
Urine
|
|
15084-7
|
Osteocalcin
[Moles/volume]
in
Serum
or
Plasma
|
|
15085-4
|
Oxalate
[Moles/volume]
in
Serum
or
Plasma
|
|
15086-2
|
Oxalate
[Moles/volume]
in
Urine
|
|
15087-0
|
Parathyrin
related
protein
[Moles/volume]
in
Serum
or
Plasma
|
|
15088-8
|
Parathyrin.C-terminal
[Moles/volume]
in
Serum
or
Plasma
|
|
15089-6
|
Phospholipid
[Moles/volume]
in
Serum
or
Plasma
|
|
1509-9
|
Glucose
[Mass/volume]
in
Urine
--1
hour
post
75
g
glucose
PO
|
|
15091-2
|
Pregnanediol
[Moles/volume]
in
Urine
|
|
15092-0
|
Pregnanetriol
[Moles/volume]
in
Urine
|
|
15094-6
|
Testosterone
[Moles/volume]
in
Urine
|
|
15095-3
|
Testosterone
[Moles/time]
in
24
hour
Urine
|
|
15097-9
|
Vanillylmandelate
[Moles/volume]
in
Urine
|
|
15098-7
|
Amikacin
[Moles/volume]
in
Serum
or
Plasma
--random
|
|
15099-5
|
Amiodarone
[Moles/volume]
in
Serum
or
Plasma
|
|
1510-7
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
dose
insulin
IV
|
|
15100-1
|
Barbiturates
[Moles/volume]
in
Serum
or
Plasma
|
|
15101-9
|
Chloramphenicol
[Moles/volume]
in
Serum
or
Plasma
|
|
15102-7
|
Codeine
[Moles/volume]
in
Serum
or
Plasma
|
|
15103-5
|
Cyclosporine
[Moles/volume]
in
Serum
|
|
15104-3
|
Digitoxin
[Moles/volume]
in
Serum
or
Plasma
|
|
15105-0
|
Flecainide
[Moles/volume]
in
Serum
or
Plasma
|
|
15106-8
|
Gentamicin
[Moles/volume]
in
Serum
or
Plasma
--random
|
|
15107-6
|
Imipramine
[Moles/volume]
in
Serum
or
Plasma
|
|
15108-4
|
Methadone
[Moles/volume]
in
Serum
or
Plasma
|
|
15109-2
|
Midazolam
[Moles/volume]
in
Serum
or
Plasma
|
|
15110-0
|
Morphine
[Moles/volume]
in
Serum
or
Plasma
|
|
15111-8
|
Tricyclic
antidepressants
[Moles/volume]
in
Serum
or
Plasma
|
|
15112-6
|
Leukocyte
phosphatase
[Units/volume]
in
Leukocytes
|
|
15113-4
|
Aluminum
[Moles/volume]
in
Dialysis
fluid
|
|
15114-2
|
Arsenic
[Moles/volume]
in
Blood
|
|
15115-9
|
Arsenic
[Moles/volume]
in
Urine
|
|
15117-5
|
Cadmium
[Moles/volume]
in
Blood
|
|
15118-3
|
Chromium
[Moles/volume]
in
Blood
|
|
15119-1
|
Cobalt
[Moles/volume]
in
Blood
|
|
15120-9
|
Ethanol
[Moles/volume]
in
Blood
|
|
15130-8
|
Methionine+Tryptophan
[Presence]
in
Serum
or
Plasma
|
|
15131-6
|
Isoleucine+Leucine
[Presence]
in
Serum
or
Plasma
|
|
15133-2
|
Anserine+Carnosine+Cysteine+Histidine+Ornithine
[Presence]
in
Serum
or
Plasma
|
|
15134-0
|
Glutamate+Glutamine+Threonine
[Presence]
in
Serum
or
Plasma
|
|
15135-7
|
Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline
[Presence]
in
Serum
or
Plasma
|
|
15136-5
|
Arginine+Argininosuccinate+Lysine+Serine+Taurine
[Presence]
in
Serum
or
Plasma
|
|
15137-3
|
Alanine+Ethanolamine
[Presence]
in
Serum
or
Plasma
|
|
15138-1
|
Isoleucine+Leucine
[Presence]
in
Urine
|
|
15139-9
|
Anserine+Carnosine+Cysteine+Histidine+Ornithine
[Presence]
in
Urine
|
|
1514-9
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
100
g
glucose
PO
|
|
15140-7
|
Arginine+Argininosuccinate+Lysine+Serine+Taurine
[Presence]
in
Urine
|
|
15142-3
|
Alanine+Ethanolamine
[Presence]
in
Urine
|
|
15143-1
|
Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline
[Presence]
in
Urine
|
|
15144-9
|
Glutamate+Glutamine+Threonine
[Presence]
in
Urine
|
|
15145-6
|
Methionine+Tryptophan
[Presence]
in
Urine
|
|
15146-4
|
Acetone
[Units/volume]
in
Body
fluid
|
|
15147-2
|
Deprecated
Acetone
[Units]
in
24
hour
Urine
Qualitative
|
|
15148-0
|
Alkaline
phosphatase
[Enzymatic
activity/volume]
in
Body
fluid
|
|
15149-8
|
Ammonia
[Moles/volume]
in
Body
fluid
|
|
15151-4
|
Aspergillus
fumigatus
3
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15152-2
|
Bilirubin.conjugated
[Mass/volume]
in
Serum
or
Plasma
|
|
15155-5
|
Calcium
[Mass/volume]
in
Body
fluid
|
|
15158-9
|
Chloride
[Moles/volume]
in
Stool
|
|
1516-4
|
Glucose
[Mass/volume]
in
Urine
--2
hours
post
100
g
glucose
PO
|
|
15161-3
|
Complement
C1
esterase
inhibitor.functional
[Presence]
in
Serum
or
Plasma
|
|
15162-1
|
Complement
C1q
[Mass/volume]
in
Body
fluid
|
|
15163-9
|
Complement
C2
[Mass/volume]
in
Body
fluid
|
|
15164-7
|
Complement
C3
[Mass/volume]
in
Synovial
fluid
|
|
15165-4
|
Complement
C4
[Mass/volume]
in
Synovial
fluid
|
|
15166-2
|
Complement
C5
[Mass/volume]
in
Body
fluid
|
|
15167-0
|
Complement
C6
[Mass/volume]
in
Body
fluid
|
|
15168-8
|
Complement
total
hemolytic
C50
[Units/volume]
in
Body
fluid
by
Immunoassay
|
|
15169-6
|
Complement
total
hemolytic
C50
[Units/volume]
in
Serum
or
Plasma
by
Immunoassay
|
|
1517-2
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
50
g
lactose
PO
|
|
15170-4
|
Complement
total
hemolytic
C50
[Units/volume]
in
Synovial
fluid
by
Immunoassay
|
|
15171-2
|
Cryoglobulin.IgA
[Units/volume]
in
Serum
|
|
15172-0
|
Cryoglobulin.IgG
[Units/volume]
in
Serum
|
|
15173-8
|
Cryoglobulin.IgM
[Units/volume]
in
Serum
|
|
15174-6
|
Cryocrit
of
Serum
by
Spun
Westergren
|
|
15176-1
|
Cryoproteins
identified
in
Serum
or
Plasma
|
|
15177-9
|
DNA
double
strand
Ab
[Units/volume]
in
Body
fluid
|
|
15178-7
|
Complement
factor
B
[Mass/volume]
in
Body
fluid
|
|
15179-5
|
Fibrin
D-dimer
[Presence]
in
Platelet
poor
plasma
|
|
1518-0
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
75
g
glucose
PO
|
|
15181-1
|
IgA
[Mass/volume]
in
Body
fluid
|
|
15183-7
|
IgG
[Mass/volume]
in
Body
fluid
|
|
15185-2
|
IgM
[Mass/volume]
in
Body
fluid
|
|
15187-8
|
Immunoglobulin
light
chains.lambda
[Mass/volume]
in
24
hour
Urine
|
|
15188-6
|
Immunoglobulin
light
chains.kappa
[Mass/volume]
in
24
hour
Urine
|
|
15191-0
|
Lupus
anticoagulant
neutralization
dilute
phospholipid
[Presence]
in
Platelet
poor
plasma
|
|
1520-6
|
Glucose
[Mass/volume]
in
Urine
--2
hours
post
75
g
glucose
PO
|
|
15200-9
|
Osmolality
of
Body
fluid
|
|
15202-5
|
Potassium
[Moles/volume]
in
Stool
|
|
15203-3
|
Rheumatoid
factor
[Units/volume]
in
Body
fluid
by
Nephelometry
|
|
15204-1
|
Rheumatoid
factor
[Titer]
in
Serum
by
Nephelometry
|
|
15205-8
|
Rheumatoid
factor
[Units/volume]
in
Serum
by
Nephelometry
|
|
15206-6
|
Rheumatoid
factor
[Units/volume]
in
Synovial
fluid
by
Nephelometry
|
|
15207-4
|
Sodium
[Moles/volume]
in
Stool
|
|
15209-0
|
Saccharomonospora
viridis
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
1521-4
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
meal
|
|
15210-8
|
Thyroglobulin
Ab
[Presence]
in
Serum
|
|
15212-4
|
Lipase
[Enzymatic
activity/volume]
in
Body
fluid
|
|
15213-2
|
Epidermal
Allergen
Mix
2
(Cat
dander+Dog
dander+Guinea
pig
epithelium+Mouse+Rat)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15214-0
|
Epidermal
Allergen
Mix
70
(Guinea
pig
epithelium+Hamster
epithelium+Mouse+Rabbit
epithelium+Rat)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15215-7
|
Epidermal
Allergen
Mix
71
(Chicken
feather+Duck
feather+Goose
feather+Turkey
feather)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15216-5
|
Epidermal
Allergen
Mix
72
(Budgerigar
feather+Canary
feather+Finch
feather+Parakeet
feather+Parrot
feather)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15217-3
|
Food
Allergen
Mix
1
(Peanut+Brazil
nut+Coconut+Hazelnut+Almond)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15218-1
|
Food
Allergen
Mix
2
(Cod+Blue
Mussel+Shrimp+Salmon+Tuna)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15219-9
|
Food
Allergen
Mix
3
(Oat+Buckwheat+Sesame
seed+Wheat+Corn)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15220-7
|
Food
Allergen
Mix
A
(Peanut+Cow
milk+Egg
white+Soybean+Wheat)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15221-5
|
Food
Allergen
Mix
F
(Buckwheat+Soybean+Rice+Sesame
seed+Wheat)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15222-3
|
Food
Allergen
Mix
E
(Crab+Buckwheat+Shrimp+Sesame
seed+Corn)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15223-1
|
Food
Allergen
Mix
B
(Tarragon+Lovage+Marjoram)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15224-9
|
Food
Allergen
Mix
71
(Caraway+Cardamon+Mace+Clove)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15225-6
|
Food
Allergen
Mix
72
(Fennel
seed+Basil+Anise+Ginger)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15226-4
|
Food
Allergen
Mix
G
(Beef+Chicken
meat+Pork+Plaice)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15227-2
|
Food
Allergen
Mix
74
(Herring+Cod+Plaice+Mackerel)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15228-0
|
Grass
Allergen
Mix
4
(Sweet
vernal
grass+Velvet
grass+Perennial
rye
grass+Common
reed+Rye)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15229-8
|
Grass
Allergen
Mix
3
(Sweet
vernal
grass+Perennial
rye
grass+Timothy+Rye+Velvet
grass)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
1523-0
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
0.05-0.15
U
insulin/kg
IV
post
12H
CFst
|
|
15230-6
|
Grass
Allergen
Mix
C
(Brome+Bermuda
grass+Velvet
grass+Bahia
grass+Timothy+Johnson
grass)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15231-4
|
Dust
Allergen
Mix
A
(Cockroach+American
house
dust
mite+European
house
dust
mite+House
dust
Greer)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15232-2
|
Regional
Allergen
Mix
A
(Common
ragweed+Mugwort+Japenese
cedar+Orchard
grass+Timothy)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15233-0
|
Mold
Allergen
Mix
A
(Alternaria
alternata+Aspergillus
fumigatus+Candida
albicans+Setomelanomma
rostrata+Penicillium
notatum)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15234-8
|
Mold
Allergen
Mix
2
(Alternaria
alternata+Aspergillus
fumigatus+Candida
albicans+Cladosporium
herbarum+Setomelanomma
rostrata+Penicillium
notatum)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15235-5
|
Occupational
Allergen
Mix
1
(Chicken
feather+Cow
dander+Goose
feather+Horse
dander)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15236-3
|
Occupational
Allergen
Mix
2
(Acarus
siro+Lepidoglyphus
destructor+Horse
bot
fly+Grain
weevel)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15237-1
|
Occupational
Allergen
Mix
3
(Alternaria
alternata+Aspergillus
fumigatus+rye
pollen+wheat
pollen)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15238-9
|
Occupational
Allergen
Mix
4
(Amylase+Soybean+Grain
weevel+Wheat)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15239-7
|
Occupational
Allergen
Mix
5
(Isocyanate
HDI+MDI+TDI+Phthalic
anhydride)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15240-5
|
Occupational
Allergen
Mix
6
(Chloramin
T+Ethylene
oxide+Formaldehyde+Phthalic
anhydride)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15241-3
|
Food
Allergen
Mix
10
(Beef+Chicken
meat+Egg
yolk+Pork+Turkey
meat)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15242-1
|
Food
Allergen
Mix
11
(Broccoli+Carrot+White
bean+Peas+Corn)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15243-9
|
Food
Allergen
Mix
12
(Mushroom+Pumpkin+Rice+Rye+Potato)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15244-7
|
Food
Allergen
Mix
13
(Carrot+White
bean+Peas+Potato)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15245-4
|
Food
Allergen
Mix
14
(Cabbage+Paprika+Tomato+Spinach)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15246-2
|
Food
Allergen
Mix
15
(Orange+Apple+Banana+Peach)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15247-0
|
Food
Allergen
Mix
H
(Pineapple+Lemon+Strawberry+Avocado)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15248-8
|
Food
Allergen
Mix
18
(Peanut+Soybean+Peas)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15249-6
|
Food
Allergen
Mix
19
(Cucumber+Carrot+Potato+Spinach)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15250-4
|
Food
Allergen
Mix
20
(Barley+Rice+Rye+Wheat)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15251-2
|
Food
Allergen
Mix
21
(Kiwi+Pineapple+Melon+Banana+Peach)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15252-0
|
Food
Allergen
Mix
22
(Cashew+Pecan
or
Hickory
nut+Walnut+Pistachio)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15253-8
|
Food
Allergen
Mix
7
(Onion+Garlic+Celery+Tomato+Yeast)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15254-6
|
Food
Allergen
Mix
8
(Brazil
nut+Orange+Hazelnut+Apple+Cocoa)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15255-3
|
Food
Allergen
Mix
9
(Kiwi+Melon+Banana+Almond+Grape)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15256-1
|
Regional
Allergen
Mix
1
(Mugwort+Silver
birch+Pellitory+Timothy+English
plantain)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15257-9
|
Regional
Allergen
Mix
2
(Alternaria
alternata+Cat
dander+American
house
dust
mite+Dog
dander+Horse
dander)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15258-7
|
Regional
Allergen
Mix
B
(Common
ragweed+Goosefoot
or
Lambs
quarters+Bermuda
grass+Perennial
rye
grass+Bahia
grass)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15259-5
|
Regional
Allergen
Mix
4
(Bermuda
grass+Perennial
rye
grass+Brome+Common
ragweed+Mugwort+English
plantain)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15260-3
|
Tree
Allergen
Mix
10
(Grey
alder+Silver
birch+Hazelnut+White
ash)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15261-1
|
Weed
Allergen
Mix
209
(Common
ragweed+Western
ragweed+Giant
ragweed)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15262-9
|
Tree
Allergen
Mix
1
(Boxelder+Silver
birch+White
oak+White
elm+California
walnut)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15263-7
|
Tree
Allergen
Mix
D
(Cottonwood+Elm+Maple+Oak+Pecan
tree)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15264-5
|
Tree
Allergen
Mix
3
(Mountain
juniper+White
oak+White
elm+Cottonwood+Mesquite)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15265-2
|
Tree
Allergen
Mix
E
(American
sycamore+Cottonwood+White
oak+Willow+White
elm)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15266-0
|
Tree
Allergen
Mix
5
(Grey
alder+Hazelnut+White
elm+Willow+Cottonwood)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15267-8
|
Tree
Allergen
Mix
6
(Boxelder+Silver
birch+American
beech+White
oak+California
walnut)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15268-6
|
Tree
Allergen
Mix
7
(Olive+Willow+Eastern
white
pine+Eucalyptus
spp+Wattle+Cajeput)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15269-4
|
Tree
Allergen
Mix
9
(Grey
alder+Silver
birch+Hazelnut+White
oak+Willow)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15270-2
|
Tree
Allergen
Mix
8
(Boxelder+Silver
birch+Hazelnut+White
oak+London
plane
or
Maple
leaf
sycamore)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15271-0
|
Weed
Allergen
Mix
1
(Common
ragweed+Mugwort+Goosefoot
or
Lambs
quarters+English
plantain+Saltwort)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15272-8
|
Weed
Allergen
Mix
2
(Western
ragweed+Mugwort+Lenscale+Goosefoot
or
Lambs
quarters+English
plantain)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15273-6
|
Weed
Allergen
Mix
3
(Mugwort+Goosefoot
or
Lambs
quarters+English
plantain+Goldenrod+Nettle)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15274-4
|
Weed
Allergen
Mix
5
(Common
ragweed+Mugwort+Ox-eye
daisy+Dandelion+Goldenrod)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15275-1
|
Weed
Allergen
Mix
6
(English
plantain+Goosefoot
or
Lambs
quarters+Saltwort+Sheep
sorrel)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15276-9
|
Weed
Allergen
Mix
7
(Ox-eye
daisy+Dandelion+English
plantain+Goosefoot
or
Lambs
quarters+Goldenrod)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15277-7
|
Deprecated
Turkey
feather
IgE
Ab
[Units/volume]
in
Serum
|
|
15278-5
|
Lovage
IgE
Ab
[Units/volume]
in
Serum
|
|
15279-3
|
Cardamon
IgE
Ab
[Units/volume]
in
Serum
|
|
15280-1
|
Mace
IgE
Ab
[Units/volume]
in
Serum
|
|
15281-9
|
Horse
Bot
Fly
IgE
Ab
[Units/volume]
in
Serum
|
|
15282-7
|
Deprecated
Cultivated
Rye
IgE
Ab
[Units/volume]
in
Serum
|
|
15283-5
|
Silver
Birch
IgE
Ab
[Units/volume]
in
Serum
|
|
15284-3
|
Grey
Alder
IgE
Ab
[Units/volume]
in
Serum
|
|
15285-0
|
London
Plane
IgE
Ab
[Units/volume]
in
Serum
|
|
15339-5
|
Berlin
Beetle
IgE
Ab
[Units/volume]
in
Serum
|
|
15340-3
|
Italian
Cedar
IgE
Ab
[Units/volume]
in
Serum
|
|
15341-1
|
Black
Fly
IgE
Ab
[Units/volume]
in
Serum
|
|
15342-9
|
European
Hornet
IgE
Ab
[Units/volume]
in
Serum
|
|
15343-7
|
Blood
group
antibody
screen
[Titer]
in
Serum
or
Plasma
|
|
15350-2
|
Amylase
[Enzymatic
activity/time]
in
2
hour
Urine
|
|
15351-0
|
Apolipoprotein
E2
[Presence]
in
Blood
|
|
15352-8
|
Apolipoprotein
E3
[Presence]
in
Blood
|
|
15353-6
|
Apolipoprotein
E4
[Presence]
in
Blood
|
|
15354-4
|
Bombesin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
15355-1
|
Estrone
sulfate
[Mass/volume]
in
Serum
or
Plasma
|
|
15356-9
|
Globulin
[Mass/time]
in
24
hour
Urine
|
|
15357-7
|
Iron
[Mass/mass]
in
Tissue
|
|
15358-5
|
Macroamylase
[Presence]
in
Serum
or
Plasma
|
|
15360-1
|
dRVVT
actual/normal
[Presence]
in
Platelet
poor
plasma
by
Coagulation
assay
|
|
15362-7
|
aPTT.inhibitor
sensitive
in
Platelet
poor
plasma
by
Coagulation
assay
|
|
15363-5
|
Busulfan
[Mass/volume]
in
Serum
or
Plasma
|
|
15364-3
|
Codeine
[Mass/volume]
in
Meconium
|
|
15366-8
|
Dextroamphetamine
[Mass/volume]
in
Urine
|
|
15367-6
|
Ganciclovir
[Mass/volume]
in
Serum
or
Plasma
|
|
15368-4
|
Hypoglycemics.sulfonyluric
[Identifier]
in
Serum
or
Plasma
|
|
15370-0
|
Morphine
[Mass/volume]
in
Meconium
|
|
15372-6
|
Nordiazepam
[Mass/volume]
in
Urine
|
|
15373-4
|
Phenyltoloxamine
[Mass/volume]
in
Blood
|
|
15374-2
|
Sulfonylurea
[Presence]
in
Serum
or
Plasma
|
|
15375-9
|
Valproate
Free
[Mass/volume]
in
Saliva
(oral
fluid)
|
|
15377-5
|
Cytomegalovirus
Ab
[Presence]
in
Serum
by
Latex
agglutination
|
|
15378-3
|
Fungus
identified
in
Isolate
by
Culture
|
|
15379-1
|
Haemophilus
influenzae
B
Ag
[Presence]
in
Urine
|
|
15380-9
|
Leishmania
brasilensis
IgG
Ab
[Titer]
in
Serum
|
|
15381-7
|
Leishmania
brasilensis
IgM
Ab
[Titer]
in
Serum
|
|
15382-5
|
Leishmania
donovani
IgG
Ab
[Titer]
in
Serum
|
|
15383-3
|
Leishmania
donovani
IgM
Ab
[Titer]
in
Serum
|
|
15384-1
|
Leishmania
mexicana
IgG
Ab
[Titer]
in
Serum
|
|
15385-8
|
Leishmania
mexicana
IgM
Ab
[Titer]
in
Serum
|
|
15386-6
|
Leishmania
tropica
IgG
Ab
[Titer]
in
Serum
|
|
15387-4
|
Leishmania
tropica
IgM
Ab
[Titer]
in
Serum
|
|
15388-2
|
Mycoplasma
hominis
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
15389-0
|
Parainfluenza
virus
1
IgG
Ab
[Presence]
in
Serum
|
|
15390-8
|
Parainfluenza
virus
1
IgM
Ab
[Presence]
in
Serum
|
|
15391-6
|
Parainfluenza
virus
1
IgM
Ab
[Titer]
in
Serum
|
|
15392-4
|
Parainfluenza
virus
2
IgG
Ab
[Presence]
in
Serum
|
|
15393-2
|
Parainfluenza
virus
2
IgM
Ab
[Titer]
in
Serum
|
|
15394-0
|
Parainfluenza
virus
3
IgG
Ab
[Presence]
in
Serum
|
|
15395-7
|
Parainfluenza
virus
3
IgM
Ab
[Presence]
in
Serum
|
|
15396-5
|
Deprecated
Toxoplasma
gondii
IgG
Ab
[Units/volume]
in
Serum
|
|
15397-3
|
Trypanosoma
cruzi
IgM
Ab
[Titer]
in
Serum
|
|
15398-1
|
Neuronal
nuclear
Ab
[Titer]
in
Serum
|
|
15399-9
|
Neuronal
nuclear
IgG
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
15400-5
|
Platelet
IgG
Ab
[Presence]
in
Serum
|
|
15401-3
|
Drugs
identified
in
Blood
by
Screen
method
|
|
15402-1
|
Ethanol
[Presence]
in
Meconium
|
|
15403-9
|
Isopropanol
[Presence]
in
Meconium
|
|
15405-4
|
Methamphetamine
[Mass/volume]
in
Meconium
|
|
15407-0
|
Methanol
[Presence]
in
Meconium
|
|
15408-8
|
Thallium
[Mass/mass]
in
Hair
|
|
15409-6
|
Thallium
[Mass/mass]
in
Nail
|
|
15410-4
|
Varicella
zoster
virus
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15411-2
|
Ergosterol
[Mass/volume]
in
Serum
or
Plasma
|
|
15433-6
|
Anaplasma
marginale
Ab
[Presence]
in
Serum
by
Agglutination
|
|
15434-4
|
Avian
adenovirus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15435-1
|
Avian
adenovirus
2
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15436-9
|
Avian
encephalomyelitis
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15437-7
|
Avian
encephalomyelitis
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15438-5
|
Avian
hemorrhagic
enteritis
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15439-3
|
Infectious
bronchitis
virus
Ark-99
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
15440-1
|
Infectious
bronchitis
virus
Mass-41
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
15441-9
|
Infectious
bronchitis
virus
Conn-42
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
15442-7
|
Avian
infectious
laryngotracheitis
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15443-5
|
Avian
infectious
laryngotracheitis
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15444-3
|
Influenza
virus
A
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15445-0
|
Avian
leukosis
virus
Ag
[Titer]
in
Serum
by
Immunoassay
|
|
15446-8
|
Avian
leukosis
virus
Ag
[Titer]
in
Egg
yolk
by
Immunoassay
|
|
15447-6
|
Avian
paramyxovirus
1
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15448-4
|
Avian
paramyxovirus
1
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
15449-2
|
Avian
paramyxovirus
2
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
15450-0
|
Avian
paramyxovirus
3
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
15451-8
|
Avian
pox
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15452-6
|
Avian
reovirus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15453-4
|
Avian
reovirus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15454-2
|
Reticuloendotheliosis
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15455-9
|
Bluetongue
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15456-7
|
Bluetongue
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15457-5
|
Bordetella
avium
Ab
[Titer]
in
Serum
by
Agglutination
|
|
15458-3
|
Bordetella
avium
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15459-1
|
Bovine
herpesvirus
1
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
15460-9
|
Bovine
leukemia
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15461-7
|
Bovine
leukemia
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15462-5
|
Bovine
diarrhea
virus
1
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
15463-3
|
Bovine
diarrhea
virus
2
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
15464-1
|
Caprine
arthritis
encephalitis
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15465-8
|
Caprine
arthritis
encephalitis
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15466-6
|
Epizootic
hemorrhagic
disease
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15467-4
|
Equine
herpesvirus
1
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
15468-2
|
Equine
infectious
anemia
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15469-0
|
Equine
influenza
virus
A1
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
15470-8
|
Equine
influenza
virus
A2
Ab
[Presence]
in
Serum
|
|
15471-6
|
Equine
influenza
virus
A2
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
15472-4
|
Equine
influenza
virus
Ag
[Presence]
in
Nose
by
Immunoassay
|
|
15473-2
|
Equine
arteritis
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
15474-0
|
Infectious
bursal
disease
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15475-7
|
Infectious
bursal
disease
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15476-5
|
Leptospira
interrogans
sv
Bratislava
Ab
[Titer]
in
Serum
by
Agglutination
|
|
15477-3
|
Leptospira
interrogans
sv
Canicola
Ab
[Titer]
in
Serum
by
Agglutination
|
|
15478-1
|
Leptospira
interrogans
sv
Grippotyphosa
Ab
[Titer]
in
Serum
by
Agglutination
|
|
15479-9
|
Leptospira
interrogans
sv
Hardjo
Ab
[Titer]
in
Serum
by
Agglutination
|
|
15480-7
|
Leptospira
interrogans
sv
Icterohaemorrhagiae
Ab
[Titer]
in
Serum
by
Agglutination
|
|
15481-5
|
Leptospira
interrogans
sv
Pomona
Ab
[Titer]
in
Serum
by
Agglutination
|
|
15482-3
|
Mycobacterium
avium
ss
paratuberculosis
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15483-1
|
Mycobacterium
avium
ss
paratuberculosis
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15484-9
|
Mycoplasma
gallisepticum
Ab
[Presence]
in
Serum
by
Agglutination
|
|
15485-6
|
Mycoplasma
gallisepticum
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15486-4
|
Mycoplasma
gallisepticum
rRNA
[Presence]
in
Nose
or
Trachea
by
DNA
probe
|
|
15487-2
|
Mycoplasma
meleagridis
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15488-0
|
Mycoplasma
meleagridis
Ab
[Presence]
in
Serum
by
Agglutination
|
|
15489-8
|
Mycoplasma
synoviae
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15490-6
|
Mycoplasma
synoviae
Ab
[Presence]
in
Serum
by
Agglutination
|
|
15491-4
|
Mycoplasma
synoviae
rRNA
[Presence]
in
Serum
by
DNA
probe
|
|
15492-2
|
Neospora
caninum
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15493-0
|
Parainfluenza
virus
3
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
15494-8
|
Pasteurella
multocida
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15495-5
|
Porcine
reproductive
and
respiratory
syndrome
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15496-3
|
Porcine
reproductive
and
respiratory
syndrome
virus
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
15497-1
|
Pseudorabies
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15498-9
|
Pseudorabies
virus
Ab
[Presence]
in
Serum
by
Latex
agglutination
|
|
15499-7
|
Pseudorabies
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
1550-3
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--pre
12
hour
fast
|
|
15500-2
|
Pseudorabies
virus
Clinease
gene
deletion
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15501-0
|
Pseudorabies
virus
Herdcheck
gene
deletion
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15502-8
|
Pseudorabies
virus
Omnimark
gene
deletion
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15503-6
|
Pseudorabies
virus
Tolvid
gene
deletion
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15504-4
|
Salmonella
arizonae
Ab
[Presence]
in
Serum
by
Agglutination
|
|
15505-1
|
Salmonella
pullorum
Ab
[Presence]
in
Serum
by
Agglutination
|
|
15506-9
|
Salmonella
typhimurium
Ab
[Presence]
in
Serum
by
Agglutination
|
|
15507-7
|
Provider-unspecified
ED
Progress
note
|
|
1554-5
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--12
hours
fasting
|
|
1555-2
|
Glucose
[Mass/volume]
in
Urine
--12
hours
fasting
|
|
1556-0
|
Fasting
glucose
[Mass/volume]
in
Capillary
blood
|
|
1557-8
|
Fasting
glucose
[Mass/volume]
in
Venous
blood
|
|
1558-6
|
Fasting
glucose
[Mass/volume]
in
Serum
or
Plasma
|
|
1573-5
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--12
hours
fasting
|
|
1585-9
|
Lactose
[Mass/volume]
in
Serum
or
Plasma
--pre
12
hour
fast
|
|
16101-8
|
Cumin
IgE
Ab
[Units/volume]
in
Serum
|
|
16102-6
|
Bovine
Gelatin
IgE
Ab
[Units/volume]
in
Serum
|
|
16103-4
|
Porcine
Gelatin
IgE
Ab
[Units/volume]
in
Serum
|
|
16104-2
|
Paper
Mulberry
IgE
Ab
[Units/volume]
in
Serum
|
|
16105-9
|
Pheasant
IgE
Ab
[Units/volume]
in
Serum
|
|
16110-9
|
11-Deoxycorticosterone
[Mass/time]
in
24
hour
Urine
|
|
16111-7
|
Epinephrine+Norepinephrine
[Mass/time]
in
24
hour
Urine
|
|
16114-1
|
Amitriptyline
[Mass/volume]
in
Urine
|
|
16115-8
|
Doxepin
[Mass/mass]
in
Tissue
|
|
16116-6
|
Tetrahydrocortisone
[Mass/time]
in
24
hour
Urine
|
|
16117-4
|
Babesia
microti
IgG
Ab
[Titer]
in
Serum
|
|
16118-2
|
Babesia
microti
IgM
Ab
[Titer]
in
Serum
|
|
16119-0
|
Brucella
abortus
IgG
Ab
[Titer]
in
Serum
|
|
16120-8
|
Brucella
abortus
IgM
Ab
[Titer]
in
Serum
|
|
16121-6
|
Colorado
tick
fever
virus
IgG
Ab
[Titer]
in
Serum
|
|
16122-4
|
Colorado
tick
fever
virus
IgM
Ab
[Titer]
in
Serum
|
|
16123-2
|
Cryptococcus
sp
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
16124-0
|
Cryptococcus
sp
Ab
[Titer]
in
Serum
|
|
16125-7
|
Helicobacter
pylori
IgA
Ab
[Presence]
in
Serum
|
|
16126-5
|
Helicobacter
pylori
IgG
Ab
[Presence]
in
Serum
|
|
16127-3
|
Helicobacter
pylori
IgM
Ab
[Presence]
in
Serum
|
|
16128-1
|
Hepatitis
C
virus
Ab
[Presence]
in
Serum
|
|
16129-9
|
Hepatitis
C
virus
IgG
Ab
[Presence]
in
Serum
|
|
16130-7
|
Herpes
simplex
virus
1
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
16131-5
|
Herpes
simplex
virus
2
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
16133-1
|
Legionella
pneumophila
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
16134-9
|
Neisseria
meningitidis
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
16135-6
|
Beta
2
glycoprotein
1
IgG
Ab
[Units/volume]
in
Serum
|
|
16136-4
|
Beta
2
glycoprotein
1
IgM
Ab
[Units/volume]
in
Serum
|
|
16137-2
|
Centromere
Ab
[Presence]
in
Serum
|
|
16139-8
|
Neuronal
nuclear
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
16140-6
|
Tellurium
[Mass/volume]
in
Blood
|
|
16141-4
|
Nitrogen
[Mass/time]
in
24
hour
Stool
|
|
16142-2
|
Fat
[Mass/time]
in
24
hour
Stool
|
|
16144-8
|
Droperidol
[Presence]
in
Serum
or
Plasma
|
|
16145-5
|
Mescaline
[Mass/volume]
in
Serum
or
Plasma
|
|
16146-3
|
Psilocin
[Mass/volume]
in
Serum
or
Plasma
|
|
16150-5
|
Carboxy
tetrahydrocannabinol
[Mass/volume]
in
Serum
or
Plasma
|
|
16151-3
|
Dechlorane
[Presence]
in
Serum
or
Plasma
|
|
16171-1
|
Cocaethylene
[Mass/mass]
in
Hair
|
|
16172-9
|
Magnesium
[Mass/mass]
in
Hair
|
|
16173-7
|
Amyl
ether
[Mass/volume]
in
Blood
|
|
16174-5
|
Bartonella
henselae
IgG
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
16175-2
|
Bartonella
henselae
IgM
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
16176-0
|
Bartonella
quintana
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16177-8
|
Bartonella
quintana
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16178-6
|
Beryllium
[Mass/mass]
in
Tissue
|
|
16179-4
|
Polychlorinated
biphenyl
(PCB)
[Mass/mass]
in
Tissue
|
|
16180-2
|
Zinc
[Mass/mass]
in
Tissue
|
|
16181-0
|
Tricyclic
antidepressants
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16182-8
|
Alkaline
phosphatase
isoenzymes
[Enzymatic
activity/volume]
in
Serum
or
Plasma
by
Heat
stability
|
|
16183-6
|
Phenolphthalein
[Mass/volume]
in
Stool
|
|
16184-4
|
Temazepam
[Mass/volume]
in
Stool
|
|
16185-1
|
Chlordiazepoxide
[Mass/volume]
in
Stool
|
|
16186-9
|
Hydroxyalprazolam
[Mass/volume]
in
Stool
|
|
16187-7
|
Alprazolam
[Mass/volume]
in
Stool
|
|
16190-1
|
Amobarbital
[Presence]
in
Urine
by
Confirmatory
method
|
|
16191-9
|
Butabarbital
[Presence]
in
Urine
by
Confirmatory
method
|
|
16192-7
|
Phenobarbital
[Presence]
in
Urine
by
Confirmatory
method
|
|
16193-5
|
Pentobarbital
[Presence]
in
Urine
by
Confirmatory
method
|
|
16194-3
|
Secobarbital
[Presence]
in
Urine
by
Confirmatory
method
|
|
16195-0
|
Benzodiazepines
[Presence]
in
Urine
by
Confirmatory
method
|
|
16196-8
|
Morphine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16197-6
|
Codeine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16198-4
|
Diamorphine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16199-2
|
Methadone
[Presence]
in
Urine
by
Confirmatory
method
|
|
16200-8
|
Propoxyphene
[Presence]
in
Urine
by
Confirmatory
method
|
|
16201-6
|
Oxazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16202-4
|
Nordiazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
16203-2
|
Alprazolam
[Presence]
in
Urine
by
Confirmatory
method
|
|
16204-0
|
Clonazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
16205-7
|
Lorazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
16206-5
|
Temazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
16207-3
|
Meperidine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16208-1
|
Buprenorphine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16209-9
|
Chlorpheniramine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16210-7
|
Diethylpropion
[Presence]
in
Urine
by
Confirmatory
method
|
|
16211-5
|
Dihydrocodeine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16212-3
|
Ethylamphetamine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16213-1
|
Levorphanol
[Presence]
in
Urine
by
Confirmatory
method
|
|
16214-9
|
Lysergate
diethylamide
[Presence]
in
Urine
by
Confirmatory
method
|
|
16215-6
|
Mephobarbital
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16216-4
|
Methylephedrine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16217-2
|
Methyprylon
[Presence]
in
Urine
by
Confirmatory
method
|
|
16218-0
|
Nalbuphine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16219-8
|
Pentazocine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16220-6
|
Phenmetrazine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16221-4
|
Phenothiazines
[Presence]
in
Urine
by
Confirmatory
method
|
|
16222-2
|
Phentermine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16223-0
|
Thiopental
[Presence]
in
Urine
by
Confirmatory
method
|
|
16224-8
|
Triazolam
[Presence]
in
Urine
by
Confirmatory
method
|
|
16225-5
|
Amitriptyline
[Presence]
in
Urine
by
Confirmatory
method
|
|
16226-3
|
Benzoylecgonine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16227-1
|
Diazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16228-9
|
Nordiazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16229-7
|
Clonazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16230-5
|
N-desalkylflurazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16231-3
|
Flurazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16232-1
|
Triazolam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16233-9
|
Midazolam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16234-7
|
Amphetamine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16235-4
|
Methamphetamine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16236-2
|
Butabarbital
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16237-0
|
Butalbital
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16238-8
|
Secobarbital
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16239-6
|
Amobarbital
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16240-4
|
Pentobarbital
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16241-2
|
Phenobarbital
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16242-0
|
Propoxyphene
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16243-8
|
Cannabinoids
[Mass/volume]
in
Blood
by
Confirmatory
method
|
|
16244-6
|
Methaqualone
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16245-3
|
Hydroxyethylflurazepam
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16246-1
|
Methadone
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16247-9
|
Dextromethorphan
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16249-5
|
Oxycodone
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16250-3
|
Codeine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16251-1
|
Morphine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16252-9
|
Hydrocodone
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16253-7
|
Meperidine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16254-5
|
Phencyclidine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16255-2
|
Troponin
I.cardiac
[Units/volume]
in
Serum
or
Plasma
|
|
16273-5
|
Calcium
[Mass/mass]
in
Red
Blood
Cells
|
|
16275-0
|
Bartonella
sp
DNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
16276-8
|
Bartonella
henselae
DNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
16277-6
|
Bartonella
quintana
DNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
16278-4
|
Mycobacterium
tuberculosis
DNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
16279-2
|
Toxoplasma
gondii
DNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
16280-0
|
Human
papilloma
virus
DNA
[Presence]
in
Unspecified
specimen
by
Probe
with
amplification
|
|
16281-8
|
Trazodone
[Units/volume]
in
Urine
|
|
16282-6
|
Acetaminophen
[Units/volume]
in
Urine
|
|
16283-4
|
Escherichia
coli
verotoxin
[Presence]
in
Unspecified
specimen
|
|
16284-2
|
Polio
virus
Ab
[Units/volume]
in
Serum
|
|
16287-5
|
Deprecated
Sulfatide
Ab
|
|
16291-7
|
Herpes
simplex
virus
1
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
16292-5
|
1,4-Dioxane
[Mass/volume]
in
Urine
|
|
16293-3
|
11-Deoxycorticosteroids
[Mass/volume]
in
Plasma
|
|
16296-6
|
11-Hydroxyandrosterone
[Mass/volume]
in
Serum
or
Plasma
|
|
16297-4
|
17-Hydroxypregnenolone
[Mass/volume]
in
Urine
|
|
16300-6
|
17-Ketogenic
steroids
[Mass/time]
in
72
hour
Urine
|
|
16305-5
|
2-Methoxyethanol
[Mass/volume]
in
Blood
|
|
16307-1
|
Acetate
[Mass/volume]
in
Dialysis
fluid
|
|
16308-9
|
Acetazolamide
[Units/volume]
in
Serum
or
Plasma
|
|
16309-7
|
Acetazolamide
[Units/volume]
in
Urine
|
|
16310-5
|
Acetone
[Presence]
in
Body
fluid
|
|
16311-3
|
Acetone
[Mass/volume]
in
Body
fluid
|
|
16312-1
|
Acetonitrile
[Mass/volume]
in
Serum
or
Plasma
|
|
16313-9
|
Acetylene
[Mass/volume]
in
Blood
|
|
16314-7
|
Acetylsalicylate
[Presence]
in
Urine
|
|
16315-4
|
Acid
phosphatase
[Enzymatic
activity/volume]
in
Blood
by
Tartrate
inhibited
|
|
16316-2
|
Acid
phosphatase
tartrate
resistant
[Enzymatic
activity/volume]
in
Blood
|
|
16317-0
|
Prostatic
acid
phosphatase
[Presence]
in
Vaginal
fluid
|
|
16318-8
|
Acrylamide
[Mass/volume]
in
Urine
|
|
16319-6
|
Acrylamide
[Mass/volume]
in
Serum
or
Plasma
|
|
16322-0
|
Biperiden
[Mass/volume]
in
Serum
or
Plasma
|
|
16324-6
|
Alanine
aminotransferase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
16327-9
|
Allyl
alcohol
[Mass/volume]
in
Blood
|
|
16328-7
|
Benzyl
alcohol
[Presence]
in
Blood
|
|
16333-7
|
Aldrin
[Mass/volume]
in
Blood
|
|
16334-5
|
Alfentanil
[Mass/volume]
in
Urine
|
|
16335-2
|
Hydrocarbons
Aliphatic
[Identifier]
in
Blood
|
|
16337-8
|
Alkaline
phosphatase
[Enzymatic
activity/volume]
in
Urine
|
|
16346-9
|
Alpha
chlordane
[Mass/volume]
in
Urine
|
|
16347-7
|
Alpha
chlordane
[Mass/volume]
in
Blood
|
|
16348-5
|
Alpha
hydroxyalprazolam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16349-3
|
Aluminum
[Mass/volume]
in
Body
fluid
|
|
16351-9
|
Amiloride
[Units/volume]
in
Serum
or
Plasma
|
|
16352-7
|
Amiloride
[Units/volume]
in
Urine
|
|
16353-5
|
Amino
beta
guanidinopropionate
[Presence]
in
Urine
|
|
16355-0
|
Amino
beta
guanidinopropionate
[Presence]
in
Plasma
|
|
16360-0
|
Amitriptyline
[Mass/volume]
in
Serum
or
Plasma
--peak
|
|
16361-8
|
Amitriptyline
[Mass/volume]
in
Serum
or
Plasma
--trough
|
|
16362-6
|
Ammonia
[Moles/volume]
in
Plasma
|
|
16363-4
|
Ammonia
[Moles/mass]
in
Tissue
|
|
16364-2
|
Amobarbital
[Mass/volume]
in
Gastric
fluid
|
|
16365-9
|
Amoxicillin+Clavulanate
[Mass/volume]
in
Serum
or
Plasma
|
|
16366-7
|
Diethylpropion
[Mass/volume]
in
Serum
or
Plasma
|
|
16367-5
|
Deprecated
Amphetamine/Methamphetamine
[Mass
ratio]
in
Urine
Qualitative
|
|
16369-1
|
Amphetamines
[Presence]
in
Urine
by
Confirmatory
method
|
|
16370-9
|
Amphotericin
B
[Mass/volume]
in
Urine
|
|
16373-3
|
Amyl
ether
[Presence]
in
Blood
|
|
16374-1
|
Amyl
nitrite
[Mass/volume]
in
Serum
or
Plasma
|
|
16388-1
|
Anticonvulsants
[Identifier]
in
Urine
|
|
16389-9
|
Antidepressants
[Identifier]
in
Serum
or
Plasma
|
|
16390-7
|
Antidiuretics
[Identifier]
in
Urine
|
|
16391-5
|
Antimony
[Presence]
in
Urine
|
|
16392-3
|
Nuclear
Ab
[Presence]
in
Serum
by
Rodent
substrate
|
|
16393-1
|
Nuclear
Ab
[Units/volume]
in
Serum
by
Rodent
substrate
|
|
16394-9
|
Nuclear
Ab
[Presence]
in
Body
fluid
by
Immunofluorescence
|
|
16395-6
|
Antipsychotics
[Identifier]
in
Urine
|
|
16402-0
|
Aromatic
solvents
[Identifier]
in
Blood
|
|
16403-8
|
Arsenic
[Presence]
in
Serum
or
Plasma
|
|
16404-6
|
Arsenic
[Presence]
in
Urine
|
|
16405-3
|
Arylamidase
[Presence]
in
Urine
|
|
16406-1
|
Arylamidase
[Enzymatic
activity/volume]
in
Urine
|
|
16407-9
|
Asbestos
identified
in
Sputum
by
Light
microscopy
|
|
16408-7
|
Ascorbate
[Mass/volume]
in
Urine
|
|
16412-9
|
Aspartate
aminotransferase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
16414-5
|
Aspergillus
amstelodami
Ab
[Units/volume]
in
Serum
|
|
16415-2
|
Aspergillus
flavus
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
16416-0
|
Aspergillus
terreus
Ab
[Units/volume]
in
Serum
|
|
16417-8
|
Aspergillus
versicolor
Ab
[Units/volume]
in
Serum
|
|
16418-6
|
Azatadine
[Presence]
in
Urine
|
|
16419-4
|
Azathioprine
[Mass/volume]
in
Serum
or
Plasma
|
|
16420-2
|
Azithromycin
[Mass/volume]
in
Serum
or
Plasma
|
|
16422-8
|
Azlocillin
[Mass/volume]
in
Urine
|
|
16423-6
|
Aztreonam
[Mass/volume]
in
Urine
|
|
16425-1
|
Babesia
sp
IgM
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
16426-9
|
Babesia
sp
IgM
Ab
[Titer]
in
Serum
|
|
16427-7
|
Babesia
microti
Ab
[Titer]
in
Serum
|
|
16428-5
|
Bacitracin
[Mass/volume]
in
Serum
or
Plasma
|
|
16429-3
|
Barbiturates
[Presence]
in
Urine
by
Confirmatory
method
|
|
16430-1
|
Barbiturates
[Units/volume]
in
Urine
|
|
16431-9
|
Barium
[Presence]
in
Urine
|
|
16432-7
|
Barium
[Mass/volume]
in
Blood
|
|
16433-5
|
Basement
membrane
Ab
[Presence]
in
Serum
|
|
16434-3
|
Basement
membrane
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
16435-0
|
Deprecated
White
Bean
IgE
Ab
[Units/volume]
in
Serum
|
|
16436-8
|
Deprecated
Bean
string
IgE
Ab
[Units/volume]
in
Serum
|
|
16437-6
|
Bendroflumethiazide
[Units/volume]
in
Urine
|
|
16438-4
|
Benzaldehyde
[Presence]
in
Urine
|
|
16439-2
|
Benzene
[Presence]
in
Blood
|
|
1644-4
|
Triglyceride
[Mass/volume]
in
Serum
or
Plasma
--12
hours
fasting
|
|
16440-0
|
Benzene
ring
IgE
Ab
[Units/volume]
in
Serum
|
|
16441-8
|
Benzene
ring
IgG
Ab
[Units/volume]
in
Serum
|
|
16442-6
|
Benzene
ring
IgM
Ab
[Units/volume]
in
Serum
|
|
16443-4
|
Benzonatate
[Mass/volume]
in
Serum
|
|
16444-2
|
Benzophenone
[Mass/volume]
in
Serum
or
Plasma
|
|
16446-7
|
Benzoylecgonine
[Presence]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16447-5
|
Cocaine
[Units/volume]
in
Serum
or
Plasma
|
|
16448-3
|
Cocaine
[Units/volume]
in
Urine
|
|
16449-1
|
Benzthiazide
[Mass/volume]
in
Serum
or
Plasma
|
|
16450-9
|
Benzylhydrazine
[Mass/volume]
in
Serum
or
Plasma
|
|
16451-7
|
Beryllium
[Presence]
in
Urine
|
|
16454-1
|
Beta
galactosidase
[Enzymatic
activity/volume]
in
Blood
|
|
16455-8
|
Beta
hydroxybutyrate
[Moles/volume]
in
Cerebral
spinal
fluid
|
|
16456-6
|
Beta
hydroxybutyrate
[Moles/volume]
in
Urine
|
|
16457-4
|
Beta-N-acetylhexosaminidase.A
[Enzymatic
activity/volume]
in
Leukocytes
|
|
16458-2
|
Bethanechol
[Mass/volume]
in
Serum
or
Plasma
|
|
16459-0
|
Bicarbonate
[Moles/volume]
in
Body
fluid
|
|
16460-8
|
Bicarbonate
[Moles/volume]
in
Cerebral
spinal
fluid
|
|
16461-6
|
Bicarbonate
[Moles/volume]
in
Red
Blood
Cells
|
|
16462-4
|
Bicarbonate
[Moles/volume]
in
Amniotic
fluid
|
|
16463-2
|
Bile
acid.dihydroxy
[Mass/volume]
in
Serum
|
|
16464-0
|
Bile
acid
[Units/volume]
in
Exhaled
gas
|
|
16465-7
|
Bile
acid
[Mass/volume]
in
Urine
|
|
16466-5
|
Bile
acid.trihydroxy
[Mass/volume]
in
Serum
|
|
16467-3
|
Bismuth
[Presence]
in
Blood
|
|
16468-1
|
Bismuth
[Presence]
in
Urine
|
|
16469-9
|
Bismuth/Creatinine
[Mass
Ratio]
in
Urine
|
|
16470-7
|
Blastomyces
dermatitidis
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
16471-5
|
Blastomyces
dermatitidis
Ab
[Units/volume]
in
Serum
|
|
16472-3
|
Blastomyces
dermatitidis
rRNA
[Presence]
in
Serum
by
DNA
probe
|
|
16473-1
|
Bordetella
parapertussis
Ab
[Units/volume]
in
Serum
|
|
16474-9
|
Bordetella
pertussis
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16475-6
|
Borrelia
burgdorferi
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoassay
|
|
16476-4
|
Borrelia
burgdorferi
Ab
[Presence]
in
Body
fluid
by
Immunoassay
|
|
16477-2
|
Borrelia
burgdorferi
Ab
[Presence]
in
Body
fluid
|
|
16478-0
|
Borrelia
burgdorferi
IgA
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
16479-8
|
Borrelia
burgdorferi
IgA
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoassay
|
|
16480-6
|
Borrelia
burgdorferi
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
16481-4
|
Borrelia
burgdorferi
IgG
Ab
[Units/volume]
in
Body
fluid
by
Immunoassay
|
|
16482-2
|
Borrelia
burgdorferi
IgM
Ab
[Units/volume]
in
Body
fluid
by
Immunoassay
|
|
16483-0
|
Borrelia
hermsii
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
16484-8
|
Boysenberry
IgE
Ab
[Units/volume]
in
Serum
|
|
16485-5
|
Bromodiphenhydramine
[Mass/volume]
in
Urine
|
|
16486-3
|
Brucella
abortus
IgA+IgG+IgM
Ab
[Units/volume]
in
Serum
|
|
16487-1
|
Brucella
abortus
IgG
Ab
[Units/volume]
in
Serum
by
Agglutination
|
|
16488-9
|
Brucella
abortus
IgG
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16489-7
|
Brucella
melitensis
Ab
[Units/volume]
in
Serum
by
Latex
agglutination
|
|
1649-3
|
Calcitriol
[Mass/volume]
in
Serum
or
Plasma
|
|
16490-5
|
Brucella
suis
Ab
[Units/volume]
in
Serum
by
Latex
agglutination
|
|
16491-3
|
Brush
border
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
16492-1
|
Bufotenine
[Units/volume]
in
Urine
|
|
16493-9
|
Bufotenine
[Units/volume]
in
Serum
or
Plasma
|
|
16494-7
|
Bumetanide
[Units/volume]
in
Urine
|
|
16495-4
|
Buprenorphine
[Units/volume]
in
Serum
or
Plasma
|
|
16496-2
|
Buprenorphine
[Units/volume]
in
Urine
|
|
16497-0
|
Butabarbital
[Mass/volume]
in
Gastric
fluid
|
|
16498-8
|
Butalbital
[Units/volume]
in
Gastric
fluid
|
|
16499-6
|
Butorphanol
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
1650-1
|
1,4-Alpha
glucan
branching
enzyme
[Enzymatic
activity/volume]
in
Leukocytes
|
|
16503-5
|
C
reactive
protein
[Mass/volume]
in
Body
fluid
|
|
16518-3
|
Calcium
[Mass/time]
in
2
hour
Urine
|
|
16528-2
|
Campylobacter
coli
rRNA
[Units/volume]
in
Serum
by
DNA
probe
|
|
16529-0
|
Campylobacter
jejuni
rRNA
[Units/volume]
in
Serum
by
DNA
probe
|
|
16530-8
|
Campylobacter
jejuni
rRNA
[Presence]
in
Serum
by
DNA
probe
|
|
16531-6
|
Campylobacter
lari
rRNA
[Units/volume]
in
Serum
by
DNA
probe
|
|
16532-4
|
Campylobacter
lari
rRNA
[Presence]
in
Serum
by
DNA
probe
|
|
16533-2
|
Helicobacter
pylori
Ab
[Titer]
in
Serum
|
|
16534-0
|
Campylobacter
sp
rRNA
[Presence]
in
Serum
by
DNA
probe
|
|
16535-7
|
Canary
droppings
IgE
Ab
[Units/volume]
in
Serum
|
|
16536-5
|
Canary
serum
proteins
Ab
[Units/volume]
in
Serum
|
|
16537-3
|
Candida
albicans
Ab
[Units/volume]
in
Serum
by
Immune
diffusion
(ID)
|
|
16538-1
|
Candida
sp
IgA
Ab
[Units/volume]
in
Saliva
(oral
fluid)
|
|
16539-9
|
Candida
sp
Ag
[Presence]
in
Serum
|
|
1654-3
|
1-Naphthalene
[Mass/volume]
in
Urine
|
|
16542-3
|
Cannabinoids
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16543-1
|
Cannabinoids
[Mass/volume]
in
Unknown
substance
by
Confirmatory
method
|
|
16544-9
|
Canrenone
[Units/volume]
in
Urine
|
|
16545-6
|
Capreomycin
[Mass/volume]
in
Serum
or
Plasma
|
|
16546-4
|
Captopril
[Mass/volume]
in
Serum
or
Plasma
|
|
16547-2
|
Carbamate
pesticides
[Type]
in
Urine
|
|
16548-0
|
Carbamazepine
[Mass/volume]
in
Urine
|
|
16549-8
|
Carbinoxamine
[Presence]
in
Urine
|
|
16550-6
|
Carbohydrates
[Identifier]
in
Urine
|
|
16551-4
|
Carbon
dioxide,
total
[Moles/volume]
in
Capillary
blood
|
|
16553-0
|
Carnitine
[Mass/mass]
in
Tissue
|
|
16555-5
|
Carnitine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
16556-3
|
Carnitine
[Mass/volume]
in
Amniotic
fluid
|
|
1656-8
|
11-Deoxycorticosterone
[Mass/volume]
in
Serum
or
Plasma
|
|
16562-1
|
Cathartic
laxatives
[Identifier]
in
Urine
|
|
16564-7
|
Cefaclor
[Mass/volume]
in
Serum
or
Plasma
|
|
16565-4
|
Cefadroxil
[Mass/volume]
in
Serum
or
Plasma
|
|
16566-2
|
Cefazolin
[Mass/volume]
in
Urine
|
|
16567-0
|
Cefixime
[Mass/volume]
in
Serum
or
Plasma
|
|
16568-8
|
Cefuroxime
IgE
Ab
[Units/volume]
in
Serum
|
|
16569-6
|
Ceftriaxone
IgE
Ab
[Mass/volume]
in
Serum
|
|
1657-6
|
11-Deoxycortisol
[Mass/volume]
in
Serum
or
Plasma
|
|
16570-4
|
Centromere
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
16571-2
|
Cephadrine
[Mass/volume]
in
Serum
or
Plasma
|
|
16572-0
|
Cephaloridine
[Mass/volume]
in
Serum
or
Plasma
|
|
1658-4
|
11-Hydroxyandrostenedione
[Mass/volume]
in
Serum
or
Plasma
|
|
16581-1
|
Chlamydophila
pneumoniae
IgA
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16582-9
|
Chlamydophila
pneumoniae
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16583-7
|
Chlamydophila
pneumoniae
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16584-5
|
Chlamydophila
pneumoniae
rRNA
[Presence]
in
Sputum
by
DNA
probe
|
|
16585-2
|
Chlamydophila
pneumoniae
rRNA
[Presence]
in
Serum
or
Plasma
by
DNA
probe
|
|
16586-0
|
Chlamydophila
psittaci
IgA
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16587-8
|
Chlamydophila
psittaci
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16588-6
|
Chlamydophila
psittaci
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16589-4
|
Chlamydia
sp
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
1659-2
|
11-Hydroxyandrosterone
[Mass/volume]
in
Urine
|
|
16590-2
|
Chlamydia
sp
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16591-0
|
Chlamydia
sp
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16592-8
|
Chlamydia
sp
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16593-6
|
Chlamydia
sp
Ag
[Presence]
in
Urine
|
|
16594-4
|
Chlamydia
trachomatis
IgA
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16595-1
|
Chlamydia
trachomatis
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16596-9
|
Chlamydia
trachomatis
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16597-7
|
Chlamydia
trachomatis
B
IgG
Ab
[Units/volume]
in
Serum
|
|
16598-5
|
Chlamydia
trachomatis
C
IgG
Ab
[Units/volume]
in
Serum
|
|
16599-3
|
Chlamydia
trachomatis
DNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
1660-0
|
11-Hydroxyetiocholanolone
[Mass/volume]
in
Serum
|
|
16600-9
|
Chlamydia
trachomatis
rRNA
[Presence]
in
Genital
specimen
by
DNA
probe
|
|
16601-7
|
Chlamydia
trachomatis
rRNA
[Presence]
in
Urine
by
DNA
probe
|
|
16602-5
|
Deprecated
Chlamydia
trachomatis
rRNA
[Presence]
in
Urine
by
DNA
probe
|
|
16603-3
|
Chloramphenicol
[Mass/volume]
in
Serum
or
Plasma
--peak
|
|
16604-1
|
Chloramphenicol
[Mass/volume]
in
Serum
or
Plasma
--trough
|
|
16605-8
|
Chlorocycline
[Mass/volume]
in
Urine
|
|
16606-6
|
Chlorine
[Mass/volume]
in
Dialysis
fluid
|
|
16608-2
|
Chlorpheniramine
[Units/volume]
in
Urine
|
|
16609-0
|
Chlorphentermine
[Units/volume]
in
Blood
|
|
1661-8
|
11-Ketoandrosterone
[Mass/volume]
in
Serum
|
|
16610-8
|
Chlorphentermine
[Units/volume]
in
Urine
|
|
16611-6
|
Chlorpyrifos
[Mass/volume]
in
Urine
|
|
16612-4
|
Chlorthalidone
[Mass/volume]
in
Serum
or
Plasma
|
|
16617-3
|
Choriogonadotropin.intact
[Moles/volume]
in
Semen
|
|
16618-1
|
Cladosporium
herbarum
Ab
[Units/volume]
in
Serum
|
|
16619-9
|
Clarithromycin
[Mass/volume]
in
Serum
or
Plasma
|
|
1662-6
|
11-Ketoetiocholanolone
[Mass/volume]
in
Serum
|
|
16621-5
|
Clindamycin
[Mass/volume]
in
Serum
or
Plasma
--peak
|
|
16622-3
|
Clindamycin
[Mass/volume]
in
Serum
or
Plasma
--trough
|
|
16624-9
|
Clomipramine
[Units/volume]
in
Milk
|
|
16625-6
|
Clomipramine
[Mass/volume]
in
Milk
|
|
16626-4
|
Clostridium
tetani
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
16627-2
|
Clostridium
tetani
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
16628-0
|
Cloxacillin
[Mass/volume]
in
Serum
or
Plasma
|
|
1663-4
|
11-Oxycorticosterone
[Mass/volume]
in
Serum
|
|
16631-4
|
aPTT
in
Blood
by
Coagulation
1:1
saline
|
|
16632-2
|
Cocaethylene
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16633-0
|
Cocaine
[Presence]
in
Blood
|
|
16634-8
|
Coccidioides
immitis
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16635-5
|
Coccidioides
immitis
IgA
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
16636-3
|
Coccidioides
immitis
IgA
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16637-1
|
Coccidioides
immitis
IgE
Ab
[Units/volume]
in
Serum
|
|
16638-9
|
Coccidioides
immitis
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16639-7
|
Coccidioides
immitis
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
1664-2
|
17-Hydroxycorticosteroids
[Mass/volume]
in
Amniotic
fluid
|
|
16641-3
|
Cockatiel
droppings
Ab
[Units/volume]
in
Serum
|
|
16642-1
|
Cockatiel
droppings
IgG
Ab
[Units/volume]
in
Serum
|
|
16643-9
|
Cockatoo
droppings
Ab
[Units/volume]
in
Serum
|
|
16644-7
|
Codeine
Free
[Presence]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16645-4
|
Colistin
[Mass/volume]
in
Serum
or
Plasma
|
|
16647-0
|
Collagen
Ab
[Units/volume]
in
Serum
|
|
16648-8
|
Copper
[Mass/volume]
in
Body
fluid
|
|
16649-6
|
Coproporphyrinogen
oxidase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
1665-9
|
17-Hydroxycorticosteroids
[Mass/volume]
in
Plasma
|
|
16650-4
|
Cilantro
IgE
Ab
[Units/volume]
in
Serum
|
|
16652-0
|
Corticotropin
[Mass/volume]
in
Amniotic
fluid
by
Radioimmunoassay
(RIA)
|
|
16653-8
|
Corticotropin
Canine
[Mass/volume]
in
Plasma
|
|
1666-7
|
17-Hydroxycorticosteroids
[Mass/volume]
in
Urine
|
|
16667-8
|
Cortisol
Free
[Mass/time]
in
48
hour
Urine
|
|
16668-6
|
Cortisol
Free
[Mass/time]
in
72
hour
Urine
|
|
1667-5
|
17-Hydroxyketosteroids
[Mass/volume]
in
Urine
|
|
16676-9
|
Corynebacterium
diphtheriae
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
16677-7
|
Coxiella
burnetii
IgG
Ab
[Units/volume]
in
Serum
|
|
16678-5
|
Coxiella
burnetii
IgM
Ab
[Units/volume]
in
Serum
|
|
16679-3
|
Coxsackievirus
A
Ab
[Units/volume]
in
Serum
|
|
1668-3
|
17-Hydroxyprogesterone
[Mass/volume]
in
Serum
or
Plasma
|
|
16680-1
|
Coxsackievirus
A
IgG
Ab
[Units/volume]
in
Serum
|
|
16681-9
|
Coxsackievirus
A
IgM
Ab
[Units/volume]
in
Serum
|
|
16682-7
|
Coxsackievirus
A2
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
16683-5
|
Coxsackievirus
A4
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
16684-3
|
Coxsackievirus
B
Ab
[Units/volume]
in
Serum
|
|
16685-0
|
Coxsackievirus
B
IgG
Ab
[Units/volume]
in
Serum
by
Neutralization
test
|
|
16686-8
|
Coxsackievirus
B
IgM
Ab
[Units/volume]
in
Serum
by
Neutralization
test
|
|
16687-6
|
Creatine
[Mass/volume]
in
Vitreous
fluid
|
|
16688-4
|
Creatine
kinase
[Enzymatic
activity/volume]
in
Body
fluid
|
|
16689-2
|
Creatinine
[Mass/time]
in
48
hour
Urine
|
|
16690-0
|
Creatinine
[Mass/time]
in
72
hour
Urine
|
|
16691-8
|
Cresols
[Identifier]
in
Unspecified
specimen
|
|
16692-6
|
Cryptococcus
sp
Ag
[Presence]
in
Body
fluid
|
|
16693-4
|
Cryptococcus
sp
Ag
[Presence]
in
Urine
|
|
16694-2
|
Cumene
[Presence]
in
Blood
|
|
16695-9
|
Cobalamin
(Vitamin
B12)
[Mass/volume]
in
Blood
|
|
16697-5
|
Cyclohexane
[Presence]
in
Blood
|
|
16698-3
|
Cyclohexanol
[Mass/volume]
in
Blood
|
|
16699-1
|
Cyclohexanol
[Mass/volume]
in
Urine
|
|
1670-9
|
17-Hydroxyprogesterone
[Mass/volume]
in
Urine
|
|
16700-7
|
Cyclohexanol/Creatinine
[Mass
Ratio]
in
Urine
|
|
16701-5
|
Cyclopropane
[Presence]
in
Blood
|
|
16702-3
|
Cycloserine
[Mass/volume]
in
Urine
|
|
16703-1
|
Cyclosporine
[Mass/volume]
in
Plasma
|
|
16704-9
|
Cyproheptadine
[Mass/volume]
in
Serum
or
Plasma
|
|
16706-4
|
Taenia
solium
larva
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16707-2
|
Taenia
solium
larva
IgM
Ab
[Units/volume]
in
Serum
|
|
16708-0
|
Taenia
solium
larva
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16709-8
|
Cystine
[Units/volume]
in
Urine
|
|
1671-7
|
17-Ketogenic
steroids
[Mass/volume]
in
Blood
|
|
16711-4
|
Cystine+Homocystine
[Presence]
in
Urine
|
|
16712-2
|
Cytomegalovirus
Ab
[Units/volume]
in
Body
fluid
|
|
16713-0
|
Cytomegalovirus
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16714-8
|
Cytomegalovirus
Ab
[Units/volume]
in
Serum
by
Latex
agglutination
|
|
16715-5
|
Cytomegalovirus
IgG
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
16716-3
|
Cytomegalovirus
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
--2nd
specimen
|
|
16717-1
|
Cytomegalovirus
Ag
[Presence]
in
Urine
by
Immunoassay
|
|
16718-9
|
Cytomegalovirus
Ag
[Presence]
in
Blood
|
|
16719-7
|
Cytomegalovirus
inclusion
bodies
[Presence]
in
Urine
by
Microscopic
observation
|
|
16720-5
|
Dechlorane
[Presence]
in
Blood
|
|
16721-3
|
Dehydroepiandrosterone
sulfate
(DHEA-S)
[Mass/volume]
in
Saliva
(oral
fluid)
|
|
1673-3
|
17-Ketogenic
steroids
[Mass/time]
in
24
hour
Urine
|
|
16731-2
|
Deprecated
Dehydroepiandrosterone.unconjugated
[Mass/volume]
in
Serum
or
Plasma
|
|
16736-1
|
Dengue
virus
1
Ab
[Titer]
in
Serum
|
|
16737-9
|
Dengue
virus
2
Ab
[Titer]
in
Serum
|
|
16738-7
|
Dengue
virus
3
Ab
[Titer]
in
Serum
|
|
16739-5
|
Dengue
virus
4
Ab
[Titer]
in
Serum
|
|
1674-1
|
18-Hydroxycorticosterone
[Mass/volume]
in
Serum
or
Plasma
|
|
16740-3
|
Dengue
virus
Ab
[Presence]
in
Serum
|
|
16741-1
|
American
house
dust
mite
IgG
Ab
[Presence]
in
Blood
|
|
16742-9
|
European
house
dust
mite
IgG
Ab
[Presence]
in
Blood
|
|
16746-0
|
Nortrimipramine
[Mass/volume]
in
Serum
or
Plasma
|
|
16747-8
|
Dextromoramide
[Presence]
in
Serum
or
Plasma
|
|
16748-6
|
Propoxyphene
[Presence]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16749-4
|
Propoxyphene
+
Norpropoxyphene
[Units/volume]
in
Urine
|
|
1675-8
|
2,3-Diphosphoglycerate
[Mass/volume]
in
Red
Blood
Cells
|
|
16750-2
|
Dezocine
[Mass/volume]
in
Serum
or
Plasma
|
|
16751-0
|
Dezocine
[Mass/volume]
in
Blood
|
|
16752-8
|
Deprecated
Diacetate
[Presence]
in
Urine
|
|
16754-4
|
Diamorphine
[Mass/volume]
in
Unknown
substance
|
|
16755-1
|
Diamorphine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16756-9
|
Diamorphine
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16757-7
|
Diazepam+Nordiazepam
[Mass/volume]
in
Serum
or
Plasma
|
|
16758-5
|
Dicamba
[Mass/volume]
in
Serum
or
Plasma
|
|
16759-3
|
Dicamba
[Mass/volume]
in
Urine
|
|
1676-6
|
2,3-Diphosphoglycerate
[Mass/volume]
in
Serum
|
|
16762-7
|
Dichlorobenzene
[Mass/volume]
in
Blood
|
|
16763-5
|
Dichlorodiphenyldichloroethylene
[Mass/volume]
in
Urine
|
|
16764-3
|
Dichlorodiphenyldichloroethylene
[Mass/volume]
in
Blood
|
|
16765-0
|
Dichlorodiphenyltrichloroethane
[Mass/volume]
in
Milk
|
|
16766-8
|
Dichloroethane
[Presence]
in
Blood
|
|
16767-6
|
Deprecated
2,4-Dichlorophenoxyacetate
[Mass/volume]
in
Urine
|
|
16768-4
|
Dichlorvos
[Mass/volume]
in
Urine
|
|
16769-2
|
Dicloxacillin
[Mass/volume]
in
Urine
|
|
1677-4
|
Alpha
hydroxybutyrate
dehydrogenase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
16770-0
|
Dicoumarol
[Mass/volume]
in
Urine
|
|
16771-8
|
Dicyclomine
[Mass/volume]
in
Serum
or
Plasma
|
|
16772-6
|
Dieldrin
[Mass/volume]
in
Urine
|
|
16773-4
|
Dieldrin
[Mass/volume]
in
Blood
|
|
16774-2
|
Diethylcarbamazepine
[Mass/volume]
in
Serum
or
Plasma
|
|
16775-9
|
Dihydrocodeine
Free
[Presence]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16776-7
|
Diltiazem
[Mass/volume]
in
Urine
|
|
16777-5
|
Dimethylacetamide
[Presence]
in
Urine
|
|
16778-3
|
Dinitrophenol
[Presence]
in
Serum
or
Plasma
|
|
16779-1
|
Dinitrophenol
[Mass/volume]
in
Urine
|
|
1678-2
|
20-Hydroxyprogesterone
[Mass/volume]
in
Serum
|
|
16780-9
|
Disopyramide
[Mass/volume]
in
Urine
|
|
16781-7
|
Disulfiram
[Presence]
in
Urine
|
|
1679-0
|
24r-Hydroxycalcidiol
[Mass/volume]
in
Serum
or
Plasma
|
|
16791-6
|
Doxylamine
[Mass/volume]
in
Serum
or
Plasma
|
|
16792-4
|
Doxylamine
[Mass/volume]
in
Urine
|
|
16793-2
|
Drugs
identified
in
Unknown
substance
by
Screen
method
|
|
16794-0
|
Echinococcus
sp
IgM
Ab
[Units/volume]
in
Serum
|
|
16795-7
|
Echovirus
Ab
[Units/volume]
in
Serum
|
|
16796-5
|
Echovirus
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16797-3
|
Echovirus
1
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16798-1
|
Echovirus
14
Ab
[Units/volume]
in
Serum
|
|
16799-9
|
Deprecated
Echovirus
140
Ab
by
complement
fixation
|
|
1680-8
|
3-Alpha-Androstanediol
glucuronide
[Mass/volume]
in
Serum
|
|
16800-5
|
Echovirus
19
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16801-3
|
Echovirus
3
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16802-1
|
Echovirus
30
Ab
[Units/volume]
in
Serum
|
|
16803-9
|
Echovirus
4
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16804-7
|
Echovirus
40
Ab
[Units/volume]
in
Serum
|
|
16805-4
|
Echovirus
6
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16806-2
|
Echovirus
6+18+30
Ab
[Units/volume]
in
Serum
|
|
16807-0
|
Echovirus
9
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16808-8
|
Anaplasma
phagocytophilum
IgG
Ab
[Units/volume]
in
Serum
|
|
16809-6
|
Anaplasma
phagocytophilum
IgM
Ab
[Units/volume]
in
Serum
|
|
1681-6
|
Beta
hydroxybutyrate
dehydrogenase
[Enzymatic
activity/volume]
in
Blood
|
|
16812-0
|
Emetine
[Presence]
in
Serum
or
Plasma
|
|
16813-8
|
Emetine
[Units/volume]
in
Serum
or
Plasma
|
|
16814-6
|
Endomysium
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
16815-3
|
Endomysium
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
16816-1
|
Enoxacin
[Mass/volume]
in
Urine
|
|
16817-9
|
Entamoeba
histolytica
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
16818-7
|
Entamoeba
histolytica
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16819-5
|
Entamoeba
histolytica
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
1682-4
|
Beta
hydroxybutyrate
dehydrogenase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
16820-3
|
Entamoeba
histolytica
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16823-7
|
Epstein
Barr
virus
early
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
16824-5
|
Epstein
Barr
virus
nuclear
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
16825-2
|
Epstein
Barr
virus
nuclear
IgG
Ab
[Presence]
in
Body
fluid
|
|
16826-0
|
Epstein
Barr
virus
capsid
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16827-8
|
Epstein
Barr
virus
capsid
IgG
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
16829-4
|
Erythromycin
[Mass/volume]
in
Urine
|
|
16832-8
|
Escherichia
coli
enterotoxic
identified
in
Stool
by
Organism
specific
culture
|
|
16833-6
|
Escherichia
coli
K1
Ag
[Presence]
in
Unspecified
specimen
by
Immunoassay
|
|
16834-4
|
Escherichia
coli
K1
Ag
[Presence]
in
Unspecified
specimen
by
Latex
agglutination
|
|
16835-1
|
Escherichia
coli
shiga-like
identified
in
Stool
by
Organism
specific
culture
|
|
16836-9
|
Escherichia
coli
verotoxic
identified
in
Stool
by
Organism
specific
culture
|
|
16838-5
|
Estriol
(E3)
[Mass/volume]
in
Body
fluid
|
|
1684-0
|
3-Methoxy-4-Hydroxyphenylglycol
[Mass/volume]
in
Urine
|
|
16840-1
|
Ethacrynate
[Mass/volume]
in
Serum
or
Plasma
|
|
16842-7
|
Ethanol
[Mass/volume]
in
Unknown
substance
|
|
16843-5
|
Ethanol
[Mass/volume]
in
Body
fluid
|
|
16844-3
|
Ethinamate
[Presence]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16845-0
|
Ethionamide
[Mass/volume]
in
Serum
or
Plasma
|
|
16847-6
|
Ethoheptazine
[Presence]
in
Serum
or
Plasma
|
|
16848-4
|
Ethoheptazine
[Mass/volume]
in
Serum
or
Plasma
|
|
16849-2
|
Ethyl
benzene
[Mass/volume]
in
Urine
|
|
16850-0
|
Ethylene
oxide
[Mass/volume]
in
Blood
|
|
16851-8
|
Ethylmorphine
[Units/volume]
in
Urine
|
|
16852-6
|
Etodolac
[Mass/volume]
in
Serum
or
Plasma
|
|
16853-4
|
Fat
[Mass]
in
Stool
|
|
16855-9
|
Fat
[Mass/time]
in
48
hour
Stool
|
|
16857-5
|
Fenclorvos
[Presence]
in
Blood
|
|
16858-3
|
Fentanyl
[Mass/volume]
in
Body
fluid
|
|
16859-1
|
Fibrinogen
[Presence]
in
Platelet
poor
plasma
|
|
16860-9
|
Fibrinopeptide
A
Ag
[Units/volume]
in
Peritoneal
fluid
by
Immunologic
method
|
|
16861-7
|
Fibrinopeptide
A
Ag
[Units/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
16862-5
|
Fibrinopeptide
B
Ag
[Units/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
16863-3
|
Fibrinopeptide
B
beta
(1-14)
Ag
[Units/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
16864-1
|
Fibrinopeptide
B
beta
(1-42)
Ag
[Units/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
16865-8
|
Fibrinopeptide
B
beta
(15-42)
Ag
[Units/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
16866-6
|
Fibrinopeptide
B
beta
(43-47)
Ag
[Units/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
16867-4
|
Fibronectin
aggregate
IgG
Ab
[Mass/volume]
in
Serum
|
|
16868-2
|
Finch
droppings
IgE
Ab
[Presence]
in
Serum
|
|
16870-8
|
Fluconazole
[Mass/volume]
in
Urine
|
|
16871-6
|
Fluoride
[Units/volume]
in
Bone
|
|
16872-4
|
Fluorocarbons
[Identifier]
in
Serum
or
Plasma
|
|
16874-0
|
Formate+Formaldehyde
[Mass/volume]
in
Blood
|
|
16875-7
|
Francisella
tularensis
Ab
[Titer]
in
Serum
|
|
16876-5
|
Francisella
tularensis
IgA
Ab
[Presence]
in
Serum
by
Latex
agglutination
|
|
16877-3
|
Francisella
tularensis
IgG
Ab
[Presence]
in
Serum
by
Latex
agglutination
|
|
16878-1
|
Francisella
tularensis
IgM
Ab
[Units/volume]
in
Serum
|
|
16879-9
|
Francisella
tularensis
Ag
[Presence]
in
Serum
by
Immunofluorescence
|
|
1688-1
|
4-Pyridoxate
[Mass/volume]
in
Serum
or
Plasma
|
|
16881-5
|
Gallium
[Mass/volume]
in
Blood
|
|
16888-0
|
Gamma
chlordane
[Mass/volume]
in
Urine
|
|
1689-9
|
5'-Nucleotidase
[Enzymatic
activity/volume]
in
Amniotic
fluid
|
|
16898-9
|
Giardia
lamblia
65
Ag
[Presence]
in
Stool
|
|
16899-7
|
Giardia
lamblia
Ag
[Presence]
in
Unspecified
specimen
|
|
1690-7
|
5'-Nucleotidase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
16900-3
|
Gliadin
Ab
[Units/volume]
in
Saliva
(oral
fluid)
|
|
16901-1
|
Gliadin
IgA
Ab
[Presence]
in
Serum
|
|
16902-9
|
Gliadin
IgG
Ab
[Presence]
in
Serum
|
|
16903-7
|
Glucose
[Mass/volume]
in
Vitreous
fluid
|
|
1691-5
|
5,10-Methylenetetrahydrofolate
reductase
[Enzymatic
activity/volume]
in
Serum
|
|
16913-6
|
Fasting
glucose
[Presence]
in
Urine
|
|
16915-1
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--post
meal
|
|
16918-5
|
Glutathione
[Mass/volume]
in
Serum
or
Plasma
|
|
1692-3
|
5-Hydroxyindoleacetate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
16920-1
|
Glycoproteins
[Presence]
in
Serum
or
Plasma
|
|
16921-9
|
St.
Augustine
grass
IgE
Ab
[Units/volume]
in
Serum
|
|
16922-7
|
Wild
rye
grass
IgE
Ab
[Units/volume]
in
Serum
|
|
16923-5
|
Guaifenesin
[Mass/volume]
in
Serum
or
Plasma
|
|
16924-3
|
Haemophilus
influenzae
IgG
Ab
[Units/volume]
in
Serum
|
|
16925-0
|
Haemophilus
influenzae
A
Ag
[Presence]
in
Urine
|
|
16926-8
|
Haemophilus
influenzae
A
Ag
[Presence]
in
Cerebral
spinal
fluid
|
|
16927-6
|
Haemophilus
influenzae
B
IgG
Ab
[Units/volume]
in
Serum
|
|
16928-4
|
Hantavirus
puumala
IgG+IgM
Ab
[Units/volume]
in
Serum
|
|
16929-2
|
Helicobacter
pylori
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
1693-1
|
5-Hydroxyindoleacetate
[Mass/volume]
in
Serum
|
|
16930-0
|
Helminth
IgE
Ab
[Units/volume]
in
Serum
|
|
16933-4
|
Hepatitis
B
virus
core
Ab
[Presence]
in
Serum
|
|
16934-2
|
Hepatitis
B
virus
polymerase
DNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
16935-9
|
Hepatitis
B
virus
surface
Ab
[Units/volume]
in
Serum
|
|
16936-7
|
Hepatitis
C
virus
IgG
Ab
[Units/volume]
in
Serum
|
|
16937-5
|
Hepatitis
G
virus
RNA
[Presence]
in
Serum
by
Probe
and
target
amplification
method
|
|
16939-1
|
Heptachlor
[Mass/volume]
in
Urine
|
|
1694-9
|
5-Hydroxyindoleacetate
[Mass/volume]
in
Urine
|
|
16940-9
|
Heptachlorepoxide
[Mass/volume]
in
Urine
|
|
16941-7
|
Herbicide
[Identifier]
in
Unspecified
specimen
|
|
16942-5
|
Herpes
simplex
virus
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
16943-3
|
Herpes
simplex
virus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16944-1
|
Herpes
simplex
virus
IgM
Ab
[Units/volume]
in
Serum
|
|
16945-8
|
Herpes
simplex
virus
Ag
[Presence]
in
Unspecified
specimen
|
|
16947-4
|
Herpes
simplex
virus
1
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
16948-2
|
Herpes
simplex
virus
1
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16949-0
|
Herpes
simplex
virus
1
IgG
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
1695-6
|
5-Hydroxyindoleacetate
[Mass/time]
in
24
hour
Urine
|
|
16950-8
|
Herpes
simplex
virus
1
IgG
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
16952-4
|
Herpes
simplex
virus
1
DNA
[Presence]
in
Cerebral
spinal
fluid
by
Probe
and
target
amplification
method
|
|
16953-2
|
Herpes
simplex
virus
1
DNA
[Presence]
in
Serum
or
Plasma
by
Probe
and
target
amplification
method
|
|
16954-0
|
Herpes
simplex
virus
2
Ab
[Presence]
in
Serum
|
|
16955-7
|
Herpes
simplex
virus
2
IgG
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
16956-5
|
Herpes
simplex
virus
2
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16957-3
|
Herpes
simplex
virus
2
IgG
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
16958-1
|
Herpes
simplex
virus
2
IgG
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
16959-9
|
Herpes
simplex
virus
2
DNA
[Presence]
in
Serum
or
Plasma
by
Probe
and
target
amplification
method
|
|
1696-4
|
5-Methyltetrahydrofolate
homocysteine
methyltransferase
[Enzymatic
activity/volume]
in
Serum
|
|
16960-7
|
Herpes
simplex
virus
2
DNA
[Presence]
in
Cerebral
spinal
fluid
by
Probe
and
target
amplification
method
|
|
16962-3
|
Heterophile
Ab
[Presence]
in
Synovial
fluid
by
Latex
agglutination
|
|
16965-6
|
Lindane
[Mass/volume]
in
Blood
|
|
16966-4
|
Hexachloroethane
[Mass/volume]
in
Blood
|
|
16967-2
|
Hexokinase
1
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
16968-0
|
Hexokinase
3
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
16969-8
|
Histone
H2a+H2b
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
1697-2
|
6-Phosphogluconate
dehydrogenase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
16970-6
|
Histoplasma
capsulatum
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
16971-4
|
Histoplasma
capsulatum
IgA
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
16972-2
|
Histoplasma
capsulatum
IgE
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
16973-0
|
Histoplasma
capsulatum
IgM
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
16974-8
|
HIV
1
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
16975-5
|
HIV
1
IgG
Ab
[Presence]
in
Serum
|
|
16976-3
|
HIV
1
Ag
[Units/volume]
in
Serum
|
|
16977-1
|
HIV
1
Ag
[Presence]
in
Cerebral
spinal
fluid
|
|
1698-0
|
8-Hydroxyamoxapine
[Mass/volume]
in
Serum
or
Plasma
|
|
16980-5
|
HTLV
II
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
16981-3
|
HTLV
I
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
16982-1
|
HTLV
I+II
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
16983-9
|
Hydralazine
[Presence]
in
Urine
|
|
16984-7
|
Hydrastine
[Presence]
in
Urine
|
|
1699-8
|
Alpha-L-iduronidase
[Enzymatic
activity/mass]
in
Tissue
|
|
16998-7
|
Hydromorphone
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16999-5
|
Hydroquinone
[Mass/volume]
in
Urine
|
|
1700-4
|
Acetaldehyde
[Mass/volume]
in
Blood
|
|
17001-9
|
Hydroxyproline
[Presence]
in
Urine
|
|
17002-7
|
Hydroxytriazolam
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
17003-5
|
Serotonin
[Mass/volume]
in
Urine
|
|
17004-3
|
Hypoxanthine
[Mass/volume]
in
Urine
|
|
17005-0
|
IgA
subclass
1
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
17006-8
|
IgA
subclass
2
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
17007-6
|
IgG
[Presence]
in
Serum
|
|
17009-2
|
IgM
[Presence]
in
Serum
|
|
1701-2
|
Acetaldehyde
[Mass/volume]
in
Serum
or
Plasma
|
|
17010-0
|
Imipenem
[Mass/volume]
in
Serum
or
Plasma
|
|
17012-6
|
Influenza
virus
A
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
17013-4
|
Influenza
virus
A+B
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17014-2
|
Influenza
virus
B
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
17015-9
|
Influenza
virus
B
IgG
Ab
[Units/volume]
in
Serum
|
|
17016-7
|
Influenza
virus
B
IgM
Ab
[Units/volume]
in
Serum
|
|
1702-0
|
Acetoacetate
[Mass/volume]
in
Urine
|
|
17020-9
|
Intercellular
substance
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17021-7
|
Intercellular
substance
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17022-5
|
Interleukin
1+2
[Units/volume]
in
Serum
or
Plasma
|
|
17024-1
|
Iodine.inorganic
[Mass/volume]
in
Serum
or
Plasma
|
|
17026-6
|
Isocyanate
IgE
Ab
[Units/volume]
in
Serum
|
|
17027-4
|
Isocyanate
IgG
Ab
[Units/volume]
in
Serum
|
|
17028-2
|
Isocyanate
IgM
Ab
[Units/volume]
in
Serum
|
|
1703-8
|
Acetoacetate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
17030-8
|
Isopropyl
ether
[Presence]
in
Blood
|
|
17031-6
|
Jo-1
extractable
nuclear
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17032-4
|
Jo-1
extractable
nuclear
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17033-2
|
Ketamine
[Presence]
in
Urine
by
Confirmatory
method
|
|
17034-0
|
Ketoprofen
[Mass/volume]
in
Serum
or
Plasma
|
|
17035-7
|
Ketorolac
[Mass/volume]
in
Serum
or
Plasma
|
|
17036-5
|
La
Crosse
virus
Ab
[Titer]
in
Serum
|
|
17037-3
|
La
Crosse
virus
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
17038-1
|
La
Crosse
virus
IgG
Ab
[Titer]
in
Serum
|
|
17039-9
|
La
Crosse
virus
IgM
Ab
[Titer]
in
Serum
|
|
1704-6
|
Acetoacetate
[Presence]
in
Serum
or
Plasma
|
|
17040-7
|
Labetalol
[Presence]
in
Serum
or
Plasma
|
|
17041-5
|
Lactate
dehydrogenase
[Presence]
in
Urine
|
|
17042-3
|
Lactoglobulin
IgE
Ab
[Units/volume]
in
Serum
|
|
17043-1
|
Lactose
[Mass/volume]
in
Urine
|
|
17044-9
|
Lamellar
bodies
[Presence]
in
Amniotic
fluid
|
|
17045-6
|
Latex
IgE
Ab
[Units/volume]
in
Blood
|
|
17046-4
|
Latex
IgG
Ab
[Units/volume]
in
Serum
|
|
17047-2
|
Latex
Bencard
IgE
Ab
[Units/volume]
in
Serum
|
|
17048-0
|
Latex
glove
extract
IgE
Ab
[Units/volume]
in
Blood
|
|
17049-8
|
Latex
glove
extract
ammoniated
IgE
Ab
[Units/volume]
in
Blood
|
|
1705-3
|
Acetoacetate
[Mass/volume]
in
Serum
or
Plasma
|
|
17050-6
|
Latex
glove
extract
buffered
IgE
Ab
[Units/volume]
in
Blood
|
|
17051-4
|
Laxatives
[Identifier]
in
Urine
|
|
17052-2
|
Lead
[Presence]
in
Blood
|
|
17053-0
|
Legionella
longbeachae
1
IgG
Ab
[Presence]
in
Serum
|
|
17054-8
|
Legionella
longbeachae
1
IgM
Ab
[Presence]
in
Serum
|
|
17055-5
|
Legionella
longbeachae
2
IgG
Ab
[Presence]
in
Serum
|
|
17056-3
|
Legionella
longbeachae
2
IgM
Ab
[Presence]
in
Serum
|
|
17057-1
|
Legionella
pneumophila
Ag
[Presence]
in
Unspecified
specimen
|
|
17058-9
|
Legionella
pneumophila
Ag
[Presence]
in
Urine
by
Latex
agglutination
|
|
17059-7
|
Legionella
pneumophila
Ag
[Presence]
in
Urine
by
Immunofluorescence
|
|
1706-1
|
Acetonitrile
[Mass/volume]
in
Blood
|
|
17060-5
|
Legionella
pneumophila
1
Ab
[Titer]
in
Serum
|
|
17061-3
|
Legionella
pneumophila
1
IgM
Ab
[Units/volume]
in
Serum
|
|
17062-1
|
Legionella
pneumophila
2
Ab
[Titer]
in
Serum
|
|
17063-9
|
Legionella
pneumophila
2
IgM
Ab
[Units/volume]
in
Serum
|
|
17064-7
|
Legionella
pneumophila
3
Ab
[Titer]
in
Serum
|
|
17065-4
|
Legionella
pneumophila
3
IgM
Ab
[Units/volume]
in
Serum
|
|
17066-2
|
Legionella
pneumophila
4
Ab
[Titer]
in
Serum
|
|
17067-0
|
Legionella
pneumophila
4
IgM
Ab
[Units/volume]
in
Serum
|
|
17068-8
|
Legionella
pneumophila
5
Ab
[Titer]
in
Serum
|
|
17069-6
|
Legionella
pneumophila
5
IgM
Ab
[Units/volume]
in
Serum
|
|
1707-9
|
Acetylcholine
[Mass/volume]
in
Serum
|
|
17070-4
|
Legionella
pneumophila
6
Ab
[Titer]
in
Serum
|
|
17071-2
|
Legionella
pneumophila
7
Ab
[Presence]
in
Serum
|
|
17072-0
|
Legionella
pneumophila
8
Ab
[Presence]
in
Serum
|
|
17073-8
|
Legionella
pneumophila
9
Ab
[Presence]
in
Serum
|
|
17075-3
|
Lidocaine
[Mass/volume]
in
Urine
|
|
17076-1
|
Lidocaine
[Mass/volume]
in
Body
fluid
|
|
1708-7
|
Acetylcholinesterase
[Enzymatic
activity/volume]
in
Amniotic
fluid
|
|
17086-0
|
Lithium
[Mass/volume]
in
Body
fluid
|
|
17087-8
|
Loperamide
[Mass/volume]
in
Serum
or
Plasma
|
|
17088-6
|
Lorazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
17089-4
|
Lorcainide
[Mass/volume]
in
Serum
or
Plasma
|
|
1709-5
|
Acetylcholinesterase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
17090-2
|
Loxapine+8-Hydroxyloxapine
[Mass/volume]
in
Serum
or
Plasma
|
|
17091-0
|
Lumpfish
roe
IgE
Ab
[Units/volume]
in
Serum
|
|
17092-8
|
Lupus
erythematosus
factor
[Presence]
in
Serum
by
Latex
agglutination
|
|
1710-3
|
Acetylcholinesterase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
17100-9
|
CD103
cells/100
cells
in
Blood
|
|
1711-1
|
Acid
phosphatase
[Enzymatic
activity/volume]
in
Blood
|
|
1712-9
|
Prostatic
acid
phosphatase
[Enzymatic
activity/volume]
in
Vaginal
fluid
|
|
1713-7
|
Prostatic
acid
phosphatase
[Enzymatic
activity/volume]
in
Semen
|
|
1714-5
|
Prostatic
acid
phosphatase
[Enzymatic
activity/volume]
in
Serum
|
|
17148-8
|
CD41
cells/100
cells
in
Blood
|
|
1715-2
|
Acid
phosphatase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
1716-0
|
Acidity.titratable
[Mass/volume]
in
Urine
|
|
1718-6
|
Acyl
CoA
dehydrogenase
[Enzymatic
activity/volume]
in
Serum
|
|
1719-4
|
Adenine
[Mass/volume]
in
Serum
|
|
1720-2
|
Adenine
phosphoribosyltransferase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
1721-0
|
Adenosine
triphosphate
[Mass/volume]
in
Blood
|
|
1722-8
|
Adenosine
deaminase
[Enzymatic
activity/volume]
in
Blood
|
|
17228-8
|
Lymphocytic
choriomeningitis
virus
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
17229-6
|
Lymphocytic
choriomeningitis
virus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
1723-6
|
Adenosine
deaminase
binding
protein
[Mass/volume]
in
Urine
|
|
17231-2
|
Lysosomal
enzymes
[Identifier]
in
Plasma
|
|
17232-0
|
Lysozyme
[Enzymatic
activity/volume]
in
Tear
|
|
17235-3
|
Magnesium
[Moles/volume]
in
Leukocytes
|
|
17236-1
|
Magnesium
[Moles/volume]
in
Stool
|
|
17237-9
|
Magnesium
[Moles/mass]
in
Hair
|
|
17238-7
|
Malignin
Ab
[Units/volume]
in
Serum
|
|
1724-4
|
Adenosine
diphosphate
[Mass/volume]
in
Serum
|
|
17244-5
|
Manganese
[Mass/mass]
in
Hair
|
|
17246-0
|
Mefenamate
[Mass/volume]
in
Serum
or
Plasma
|
|
17247-8
|
Melanin
[Units/volume]
in
Urine
|
|
17248-6
|
Melanin
[Units/volume]
in
Serum
or
Plasma
|
|
17249-4
|
Menthol
[Mass/volume]
in
Blood
|
|
1725-1
|
Adenosine
monophosphate
deaminase
[Enzymatic
activity/volume]
in
Serum
|
|
17250-2
|
Mephobarbital
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
17251-0
|
Mepivacaine
[Presence]
in
Serum
or
Plasma
|
|
17252-8
|
Mercaptopurine
[Presence]
in
Serum
or
Plasma
|
|
17253-6
|
Mercury
[Mass/volume]
in
Milk
|
|
17254-4
|
Mercury
[Mass/volume]
in
Food
|
|
17255-1
|
Mercury
[Mass/volume]
in
Dialysis
fluid
|
|
17256-9
|
Mesoridazine
[Mass/volume]
in
Urine
|
|
17258-5
|
Metandienone
[Mass/volume]
in
Serum
or
Plasma
|
|
17259-3
|
Methadone.long
acting
metabolite
[Mass/volume]
in
Serum
or
Plasma
|
|
1726-9
|
Adenosine
monophosphate.cyclic
[Mass/volume]
in
Serum
or
Plasma
|
|
17260-1
|
Methamphetamine
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
17261-9
|
Methapyrilene
[Mass/volume]
in
Urine
|
|
17263-5
|
Methemalbumin
[Presence]
in
Serum
or
Plasma
|
|
17265-0
|
Methocarbamol
[Units/volume]
in
Serum
or
Plasma
|
|
17266-8
|
Methotrexate
[Mass/volume]
in
Urine
|
|
17267-6
|
Methoxychlor
[Mass/volume]
in
Urine
|
|
17269-2
|
Methyl
isobutyl
ketone
[Mass/volume]
in
Urine
|
|
1727-7
|
Adenosine
monophosphate.cyclic
[Mass/time]
in
24
hour
Urine
|
|
17270-0
|
Methylacrylate
[Mass/volume]
in
Serum
or
Plasma
|
|
17272-6
|
Methylenedianiline
[Mass/volume]
in
Blood
|
|
17273-4
|
Methylephedrine
[Units/volume]
in
Urine
|
|
17274-2
|
Methylergonovine
[Mass/volume]
in
Serum
or
Plasma
|
|
17275-9
|
Methylfentanyl
[Mass/volume]
in
Serum
or
Plasma
|
|
17276-7
|
2-Methylpentane
[Mass/volume]
in
Blood
|
|
17277-5
|
Metolazone
[Mass/volume]
in
Serum
or
Plasma
|
|
17278-3
|
Miconazole
[Mass/volume]
in
Serum
or
Plasma
|
|
17279-1
|
Bacteria
identified
in
Pleural
fluid
by
Aerobe
culture
|
|
1728-5
|
Adenosine
monophosphate.cyclic/Creatinine
[Mass
Ratio]
in
Serum
or
Plasma
|
|
17280-9
|
Microscopic
observation
[Identifier]
in
Tissue
by
Malaria
thick
smear
|
|
17281-7
|
Microscopic
observation
[Identifier]
in
Sputum
by
KOH
preparation
|
|
17282-5
|
Minoxidil
[Mass/volume]
in
Serum
or
Plasma
|
|
17283-3
|
Mirtazapine
[Mass/volume]
in
Serum
or
Plasma
|
|
17284-1
|
Mitochondria
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17285-8
|
Mitochondria
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17289-0
|
Monosodium
glutamate
(MSG)
IgE
Ab
[Units/volume]
in
Serum
|
|
1729-3
|
Adenosine
triphosphatase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
17290-8
|
Morphine
[Presence]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
17291-6
|
Deprecated
Mulberry
tree
IgE
Ab
[Units/volume]
in
Serum
|
|
17292-4
|
Mumps
virus
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
17293-2
|
Mumps
virus
IgG+IgM
Ab
[Units/volume]
in
Serum
|
|
17294-0
|
Mushroom
toxins
[Identifier]
in
Urine
|
|
17296-5
|
Mycobacterium
tuberculosis
complex
rRNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
17297-3
|
Deprecated
Mycobacterium
tuberculosum
rRNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
17299-9
|
Mycoplasma
fermentans
Ab
[Presence]
in
Serum
|
|
1730-1
|
Adenosine
triphosphatase
[Enzymatic
activity/volume]
in
Semen
|
|
17300-5
|
Mycoplasma
hominis
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
17301-3
|
Mycoplasma
hominis
Ab
[Presence]
in
Serum
|
|
17302-1
|
Mycoplasma
pneumoniae
Ab
[Presence]
in
Serum
|
|
17303-9
|
Mycoplasma
pneumoniae
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
17304-7
|
Mycoplasma
pneumoniae
IgG+IgM
Ab
[Units/volume]
in
Serum
|
|
17305-4
|
Myelin
IgA
Ab
[Presence]
in
Serum
|
|
17306-2
|
Myelin
IgG
Ab
[Presence]
in
Serum
|
|
17307-0
|
Myelin
IgM
Ab
[Presence]
in
Serum
|
|
17308-8
|
Myelin
associated
glycoprotein
Ab
[Units/volume]
in
Serum
by
Immunoblot
(IB)
|
|
1731-9
|
Adenylate
kinase
[Enzymatic
activity/volume]
in
Serum
|
|
17310-4
|
Myelin
associated
glycoprotein
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17311-2
|
Myelin
associated
glycoprotein
IgA
Ab
[Units/volume]
in
Serum
|
|
17312-0
|
Myelin
associated
glycoprotein
IgG
Ab
[Units/volume]
in
Serum
|
|
17313-8
|
Myelin
associated
glycoprotein
IgG
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17314-6
|
Myelin
associated
glycoprotein
IgM
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
17315-3
|
Myelin
basic
protein
Ab
[Mass/volume]
in
Serum
|
|
17316-1
|
Myeloperoxidase
Ab
[Presence]
in
Serum
|
|
17317-9
|
N-acetylprocainamide
[Mass/volume]
in
Urine
|
|
17318-7
|
Nalbuphine
[Mass/volume]
in
Serum
or
Plasma
|
|
17319-5
|
Nalidixate
[Mass/volume]
in
Serum
or
Plasma
|
|
1732-7
|
Adenylosuccinate
lyase
[Enzymatic
activity/volume]
in
Serum
|
|
17320-3
|
Nefazodone
[Mass/volume]
in
Urine
|
|
17321-1
|
Neisseria
meningitidis
A+Y
Ag
[Presence]
in
Urine
|
|
17322-9
|
Neisseria
meningitidis
Ab
[Presence]
in
Serum
|
|
17323-7
|
Neisseria
meningitidis
Ag
[Presence]
in
Urine
|
|
17324-5
|
Neisseria
meningitidis
Ag
[Units/volume]
in
Cerebral
spinal
fluid
by
Latex
agglutination
|
|
17325-2
|
Neisseria
meningitidis
C+w135
Ag
[Presence]
in
Urine
|
|
17326-0
|
Neisseria
meningitidis
A
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
17327-8
|
Neisseria
meningitidis
B
Ab
[Units/volume]
in
Serum
|
|
17328-6
|
Neisseria
meningitidis
B
Ag
[Presence]
in
Urine
by
Latex
agglutination
|
|
17329-4
|
Neisseria
meningitidis
C
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
1733-5
|
Adipate
[Mass/volume]
in
Urine
|
|
17330-2
|
Neisseria
meningitidis
Y
Ag
[Presence]
in
Cerebral
spinal
fluid
|
|
17331-0
|
Neisseria
meningitidis
polyvalent
Ab
[Units/volume]
in
Serum
|
|
17332-8
|
Neisseria
meningitidis
polyvalent
Ag
[Presence]
in
Cerebral
spinal
fluid
|
|
17333-6
|
Neisseria
meningitidis
w135
Ag
[Presence]
in
Serum
or
Plasma
by
Latex
agglutination
|
|
17334-4
|
Neopterin/Creatinine
[Mass
Ratio]
in
Urine
|
|
17335-1
|
Neostigmine
[Mass/volume]
in
Serum
or
Plasma
|
|
17336-9
|
Neuronal
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17337-7
|
Neuronal
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
17338-5
|
Neuronal
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17339-3
|
Neuronal
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
1734-3
|
Aldosterone
renal
clearance
in
24
hour
|
|
17340-1
|
Neuronal
IgG
Ab
[Presence]
in
Body
fluid
by
Immunoassay
|
|
17341-9
|
Neuronal
nuclear
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
17342-7
|
Neuronal
nuclear
type
2
Ab
[Units/volume]
in
Serum
|
|
17343-5
|
Neuronal
nuclear
type
2
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
17344-3
|
Neuronal
nuclear
type
2
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17346-8
|
Neutrophil
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17347-6
|
Neutrophil
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17348-4
|
Neutrophil
IgA
Ab
[Units/volume]
in
Serum
|
|
17349-2
|
Neutrophil
IgG
Ab
[Units/volume]
in
Serum
|
|
17350-0
|
Neutrophil
IgM
Ab
[Units/volume]
in
Serum
|
|
17351-8
|
Neutrophil
cytoplasmic
Ab
[Presence]
in
Serum
|
|
17353-4
|
Neutrophil
cytoplasmic
Ab.classic
[Presence]
in
Serum
by
Immunofluorescence
|
|
17354-2
|
Neutrophil
cytoplasmic
IgA
Ab
[Presence]
in
Serum
|
|
17355-9
|
Neutrophil
cytoplasmic
IgG
Ab
[Presence]
in
Serum
|
|
17356-7
|
Neutrophil
cytoplasmic
IgM
Ab
[Presence]
in
Serum
|
|
17357-5
|
Neutrophil
cytoplasmic
Ab.perinuclear
[Presence]
in
Serum
by
Immunofluorescence
|
|
17358-3
|
Neutrophil
Cytoplasmic
Ab
atypical
[Units/volume]
in
Serum
|
|
17360-9
|
Heptane
[Mass/volume]
in
Blood
|
|
17362-5
|
Nicotinamide
[Presence]
in
Urine
|
|
17363-3
|
Nitrazepam
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
17364-1
|
Nitrophenol
[Presence]
in
Urine
|
|
17365-8
|
Nitroprusside
[Mass/volume]
in
Serum
or
Plasma
|
|
17366-6
|
Nizatidine
[Mass/volume]
in
Serum
or
Plasma
|
|
17367-4
|
Nomifensine
[Mass/volume]
in
Serum
or
Plasma
|
|
17375-7
|
Norflunitrazepam
[Mass/volume]
in
Blood
|
|
17376-5
|
Norpropoxyphene
[Presence]
in
Urine
by
Confirmatory
method
|
|
17377-3
|
Norpropoxyphene
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
17378-1
|
Novobiocin
[Mass/volume]
in
Serum
or
Plasma
|
|
17379-9
|
Propanol
[Mass/volume]
in
Blood
|
|
17380-7
|
Nuclear
Ab.histone
reactive
[Presence]
in
Serum
|
|
17384-9
|
Opiates
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
17385-6
|
Organic
acids
[Units/volume]
in
Urine
|
|
17386-4
|
Organic
acids
[Units/volume]
in
Blood
|
|
17387-2
|
Organic
acids
[Units/volume]
in
Serum
or
Plasma
|
|
17388-0
|
Organochlorine
pesticides
[Type]
in
Urine
|
|
17390-6
|
Orphenadrine
[Mass/volume]
in
Urine
|
|
17391-4
|
Orthocresol
[Mass/volume]
in
Blood
|
|
17392-2
|
Osmium
[Mass/volume]
in
Urine
|
|
17393-0
|
Ovary
Ab
[Presence]
in
Serum
|
|
17394-8
|
Oxychlordane
[Mass/volume]
in
Urine
|
|
17395-5
|
Oxymorphone
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
17396-3
|
Oxytetracycline
[Mass/volume]
in
Serum
or
Plasma
|
|
17397-1
|
Oxytriphylline
[Mass/volume]
in
Serum
or
Plasma
|
|
17398-9
|
Human
papilloma
virus
11
Ag
[Presence]
in
Unspecified
specimen
|
|
17399-7
|
Human
papilloma
virus
16
Ag
[Presence]
in
Unspecified
specimen
|
|
1740-0
|
Alanine
aminopeptidase
[Mass/volume]
in
Serum
|
|
17400-3
|
Human
papilloma
virus
16+18
Ag
[Presence]
in
Unspecified
specimen
|
|
17401-1
|
Human
papilloma
virus
18
Ag
[Presence]
in
Unspecified
specimen
|
|
17402-9
|
Human
papilloma
virus
31
Ag
[Presence]
in
Unspecified
specimen
|
|
17403-7
|
Human
papilloma
virus
31+33+35
Ag
[Presence]
in
Unspecified
specimen
|
|
17404-5
|
Human
papilloma
virus
33
Ag
[Presence]
in
Unspecified
specimen
|
|
17405-2
|
Human
papilloma
virus
42
Ag
[Presence]
in
Unspecified
specimen
|
|
17406-0
|
Human
papilloma
virus
43
Ag
[Presence]
in
Unspecified
specimen
|
|
17407-8
|
Human
papilloma
virus
44
Ag
[Presence]
in
Unspecified
specimen
|
|
17408-6
|
Human
papilloma
virus
45
Ag
[Presence]
in
Unspecified
specimen
|
|
17409-4
|
Human
papilloma
virus
5
Ag
[Presence]
in
Unspecified
specimen
|
|
1741-8
|
Alanine
aminotransferase
[Enzymatic
activity/volume]
in
Amniotic
fluid
|
|
17410-2
|
Human
papilloma
virus
51
Ag
[Presence]
in
Unspecified
specimen
|
|
17411-0
|
Human
papilloma
virus
6
Ag
[Presence]
in
Unspecified
specimen
|
|
17412-8
|
Human
papilloma
virus
6+11
Ag
[Presence]
in
Unspecified
specimen
|
|
17413-6
|
Papova
virus
SV
40
Ab
[Units/volume]
in
Serum
|
|
17414-4
|
Parainfluenza
virus
1+2+3
Ag
[Presence]
in
Unspecified
specimen
|
|
17415-1
|
Parainfluenza
virus
A
Ab
[Units/volume]
in
Serum
|
|
17416-9
|
Parakeet
droppings
Ab
[Units/volume]
in
Serum
|
|
17417-7
|
Parakeet
droppings
IgG
Ab
[Units/volume]
in
Serum
|
|
17418-5
|
Parakeet
serum
Ab
[Units/volume]
in
Serum
|
|
17419-3
|
Parathion
[Mass/volume]
in
Urine
|
|
1742-6
|
Alanine
aminotransferase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
17420-1
|
Parrot
droppings
Ab
[Units/volume]
in
Serum
|
|
17421-9
|
Parrot
serum
Ab
[Units/volume]
in
Serum
|
|
17422-7
|
Parvovirus
B19
IgG+IgM
Ab
[Units/volume]
in
Serum
|
|
17426-8
|
Penicillium
roqueforti
IgE
Ab
[Units/volume]
in
Serum
|
|
17427-6
|
Penicillium
sp
Ab
[Units/volume]
in
Serum
|
|
17429-2
|
Pentachlorophenol
[Mass/volume]
in
Blood
|
|
1743-4
|
Alanine
aminotransferase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
by
With
P-5'-P
|
|
17430-0
|
Pentane
[Mass/volume]
in
Blood
|
|
17431-8
|
Pentobarbital
[Mass/volume]
in
Gastric
fluid
|
|
17432-6
|
Tetrachloroethylene
[Mass/volume]
in
Serum
or
Plasma
|
|
17433-4
|
pH
of
Unspecified
specimen
|
|
17434-2
|
Phenazopyridine
[Mass/volume]
in
Serum
or
Plasma
|
|
17435-9
|
Pheniramine
[Mass/volume]
in
Urine
|
|
17436-7
|
Phenobarbital
[Mass/volume]
in
Gastric
fluid
|
|
17437-5
|
Phenolphthalein
[Mass/volume]
in
Urine
|
|
17438-3
|
Phenolphthalein
[Mass/volume]
in
Blood
|
|
17439-1
|
Phenols
[Mass/volume]
in
Blood
|
|
1744-2
|
Alanine
aminotransferase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
by
Without
P-5'-P
|
|
17440-9
|
Phenothiazines
[Units/volume]
in
Serum
or
Plasma
|
|
17441-7
|
Phenothiazines
[Units/volume]
in
Urine
|
|
17442-5
|
Phenylephrine
[Mass/volume]
in
Serum
or
Plasma
|
|
17443-3
|
Phenylpropanolamine
[Mass/volume]
in
Urine
|
|
17444-1
|
Phenytoin
[Mass/volume]
in
Urine
|
|
17445-8
|
Phoma
herbarum
IgG
Ab
[Units/volume]
in
Serum
|
|
17446-6
|
Phoma
sp
IgE
Ab
[Units/volume]
in
Serum
|
|
17447-4
|
Phosphate
[Presence]
in
Stool
|
|
17448-2
|
Phosphatidylethanolamine
IgA
Ab
[Presence]
in
Serum
|
|
17449-0
|
Phosphatidylethanolamine
IgG
Ab
[Presence]
in
Serum
|
|
1745-9
|
Albumin
[Mass/volume]
in
Amniotic
fluid
|
|
17450-8
|
Phosphatidylethanolamine
IgM
Ab
[Presence]
in
Serum
|
|
17451-6
|
Phosphatidylglycerol
IgA
Ab
[Presence]
in
Serum
|
|
17452-4
|
Phosphatidylglycerol
IgG
Ab
[Presence]
in
Serum
|
|
17453-2
|
Phosphatidylglycerol
IgM
Ab
[Presence]
in
Serum
|
|
17454-0
|
Phosphatidylinositol
IgA
Ab
[Presence]
in
Serum
|
|
17455-7
|
Phosphatidylinositol
IgG
Ab
[Presence]
in
Serum
|
|
17456-5
|
Phosphatidylinositol
IgM
Ab
[Presence]
in
Serum
|
|
17459-9
|
Phospholipid
IgA
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
1746-7
|
Albumin
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
17462-3
|
Picloram
[Mass/volume]
in
Urine
|
|
17463-1
|
Pigeon
droppings
Ab
[Units/volume]
in
Serum
|
|
17464-9
|
Pigeon
feather
IgE
Ab
[Presence]
in
Serum
|
|
17465-6
|
Pigeon
serum
IgE
Ab
[Presence]
in
Serum
|
|
17466-4
|
Deprecated
Plasminogen
activator
inhibitor
1
Ag
[Units/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
17467-2
|
Plasminogen
activator
inhibitor
2
Ag
[Units/volume]
in
Platelet
poor
plasma
by
Immunoassay
|
|
17468-0
|
Plutonium
[Mass/volume]
in
Urine
|
|
17469-8
|
PM-1
Ab
[Units/volume]
in
Serum
|
|
1747-5
|
Albumin
[Mass/volume]
in
Body
fluid
|
|
17470-6
|
PM-1
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17471-4
|
PM-1
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17472-2
|
Polybrominated
biphenyl
[Mass/volume]
in
Serum
or
Plasma
|
|
17473-0
|
Polymyxin
B
[Mass/volume]
in
Serum
or
Plasma
|
|
17476-3
|
Porphyrins
[Units/volume]
in
Red
Blood
Cells
|
|
17479-7
|
Prazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
1748-3
|
Albumin
[Mass/volume]
in
Pleural
fluid
|
|
17480-5
|
Pregnenolone
[Mass/volume]
in
Urine
|
|
17481-3
|
Probenecid
[Units/volume]
in
Urine
|
|
17482-1
|
Procainamide
[Mass/volume]
in
Urine
|
|
17483-9
|
Progesterone
[Mass/volume]
in
Urine
|
|
1749-1
|
Albumin
[Mass/volume]
in
Peritoneal
fluid
|
|
17493-8
|
Prostaglandin
E
[Mass/volume]
in
Serum
or
Plasma
|
|
17494-6
|
Prostaglandin
F2
alpha
[Mass/volume]
in
Urine
|
|
17495-3
|
Prostaglandins
[Mass/volume]
in
Urine
|
|
1750-9
|
Albumin
[Mass/volume]
in
Semen
|
|
17502-6
|
Pseudomonas
aeruginosa
Ab
[Units/volume]
in
Serum
|
|
17504-2
|
Psilocybin
[Presence]
in
Urine
|
|
17505-9
|
Psilocybin/Psilocin
[Mass
Ratio]
in
Serum
or
Plasma
|
|
17506-7
|
Quinacrine
[Mass/volume]
in
Serum
or
Plasma
|
|
17507-5
|
Quinidine
[Mass/volume]
in
Urine
|
|
17508-3
|
Quinine
[Units/volume]
in
Urine
|
|
17509-1
|
Marsh
Ragweed
IgE
Ab
[Units/volume]
in
Serum
|
|
1751-7
|
Albumin
[Mass/volume]
in
Serum
or
Plasma
|
|
17510-9
|
Raisin
IgE
Ab
[Units/volume]
in
Serum
|
|
17511-7
|
Red
dye
IgE
Ab
[Units/volume]
in
Serum
|
|
17512-5
|
Redfish
IgE
Ab
[Units/volume]
in
Serum
|
|
17516-6
|
Renin
[Enzymatic
activity/volume]
in
Plasma
--supine
|
|
17517-4
|
Respiratory
syncytial
virus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
17518-2
|
Respiratory
syncytial
virus
IgG
Ab
[Titer]
in
Serum
|
|
17519-0
|
Respiratory
syncytial
virus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
1752-5
|
Albumin
[Mass/volume]
in
Synovial
fluid
|
|
17520-8
|
Respiratory
syncytial
virus
identified
in
Unspecified
specimen
by
Organism
specific
culture
|
|
17521-6
|
Reticulin
Ab
[Presence]
in
Serum
|
|
17522-4
|
Reticulin
IgA
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
17523-2
|
Reticulin
IgG
Ab
[Titer]
in
Serum
|
|
17524-0
|
Reticulin
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
17525-7
|
Retinoate
esters
[Mass/volume]
in
Serum
or
Plasma
|
|
17526-5
|
Retinyl
esters
[Mass/volume]
in
Serum
or
Plasma
|
|
17527-3
|
Retinol
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
1753-3
|
Albumin
[Presence]
in
Urine
|
|
17530-7
|
Retrovirus
identified
in
Unspecified
specimen
by
Organism
specific
culture
|
|
17531-5
|
Rh
[Type]
in
Amniotic
fluid
|
|
17532-3
|
Rheumatoid
arthritis
nuclear
Ab
[Presence]
in
Serum
|
|
17533-1
|
Rheumatoid
arthritis
nuclear
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17534-9
|
Rheumatoid
factor
[Units/volume]
in
Body
fluid
by
Immunoassay
|
|
17535-6
|
Ribonucleoprotein
extractable
nuclear
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17536-4
|
Ribonucleoprotein
extractable
nuclear
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17537-2
|
Rickettsia
spotted
fever
group
RNA
[Presence]
in
Serum
by
Probe
and
target
amplification
method
|
|
17538-0
|
Rickettsia
spotted
fever
group
RNA
[Presence]
in
Serum
by
DNA
probe
|
|
17539-8
|
Rickettsia
typhi
Ab
[Units/volume]
in
Serum
by
Latex
agglutination
|
|
1754-1
|
Albumin
[Mass/volume]
in
Urine
|
|
17540-6
|
Rickettsia
typhi
IgA
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17541-4
|
Rickettsia
typhi
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
17544-8
|
Bartonella
quintana
IgG
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
17545-5
|
Bartonella
quintana
IgM
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
17546-3
|
Bartonella
quintana
rRNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
17547-1
|
Rotavirus
Ag
[Presence]
in
Stool
|
|
17548-9
|
Rotavirus
RNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
17549-7
|
Rubella
virus
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
17550-5
|
Rubella
virus
Ab
[Units/volume]
in
Serum
by
Latex
agglutination
|
|
17551-3
|
Rubella
virus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunoassay
|
|
17552-1
|
Rubella
virus
IgM
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
17553-9
|
Measles
virus
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
17554-7
|
Measles
virus
IgA
Ab
[Units/volume]
in
Serum
|
|
17555-4
|
Measles
virus
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
17556-2
|
Measles
virus
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
17557-0
|
Saccharomonospora
viridis
IgG
Ab
[Units/volume]
in
Serum
|
|
17558-8
|
Saint
Louis
encephalitis
virus
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
17559-6
|
Salicylates
[Presence]
in
Blood
|
|
1756-6
|
Albumin
in
CSF/Albumin
in
Serum
or
Plasma
|
|
17560-4
|
Salicylates
[Presence]
in
Gastric
fluid
|
|
17561-2
|
Salmon
roe
IgE
Ab
[Units/volume]
in
Serum
|
|
17562-0
|
Salmonella
sp
Ab
[Presence]
in
Serum
|
|
17563-8
|
Salmonella
sp
identified
in
Unspecified
specimen
by
Organism
specific
culture
|
|
17564-6
|
Salmonella
typhi
O
D
Ab
[Presence]
in
Serum
by
Latex
agglutination
|
|
17565-3
|
Salmonella
typhi
H
D
Ab
[Presence]
in
Serum
by
Latex
agglutination
|
|
17566-1
|
Salmonella
typhi
O
Ab
[Presence]
in
Serum
|
|
17567-9
|
Sasapyrine
[Mass/volume]
in
Serum
or
Plasma
|
|
17569-5
|
SCL-70
extractable
nuclear
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
1757-4
|
Albumin
renal
clearance
in
24
hour
|
|
17570-3
|
SCL-70
extractable
nuclear
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
17571-1
|
Scopolamine
[Mass/volume]
in
Urine
|
|
17573-7
|
Secobarbital
[Mass/volume]
in
Gastric
fluid
|
|
17574-5
|
Selenium
[Mass/volume]
in
Body
fluid
|
|
17576-0
|
Shigella
sp
identified
in
Unspecified
specimen
by
Organism
specific
culture
|
|
1758-2
|
Albumin.glycated
[Mass/volume]
in
Serum
or
Plasma
|
|
17582-8
|
Silver
[Mass/volume]
in
Dialysis
fluid
|
|
17583-6
|
Sjogrens
syndrome-A
extractable
nuclear
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17584-4
|
Sjogrens
syndrome-A
extractable
nuclear
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17585-1
|
Sjogrens
syndrome-A
extractable
nuclear
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
17586-9
|
Sjogrens
syndrome-B
extractable
nuclear
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17587-7
|
Sjogrens
syndrome-B
extractable
nuclear
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17588-5
|
Sjogrens
syndrome-B
extractable
nuclear
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
17589-3
|
Smith
extractable
nuclear
Ab
[Titer]
in
Serum
by
Immune
diffusion
(ID)
|
|
17590-1
|
Smith
extractable
nuclear
Ab
[Titer]
in
Serum
by
Immunoassay
|
|
17591-9
|
Smith
extractable
nuclear
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17592-7
|
Smith
extractable
nuclear
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17593-5
|
Smooth
muscle
Ab
[Presence]
in
Sweat
|
|
17598-4
|
Specific
gravity
of
Synovial
fluid
|
|
1760-8
|
Alcohol
dehydrogenase
[Enzymatic
activity/volume]
in
Serum
|
|
1761-6
|
Aldolase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
17611-5
|
Stimulants
[Identifier]
in
Serum
or
Plasma
|
|
1762-4
|
Aldosterone
[Mass/volume]
in
Blood
|
|
1763-2
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
|
|
1764-0
|
Aldosterone
[Mass/volume]
in
Urine
|
|
17647-9
|
Streptococcus
pneumoniae
Ab
[Units/volume]
in
Serum
|
|
17648-7
|
Streptococcus
pneumoniae
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
1765-7
|
Aldosterone
[Mass/time]
in
24
hour
Urine
|
|
17650-3
|
Streptococcus
pneumoniae
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
--1st
specimen
|
|
17651-1
|
Streptococcus
pneumoniae
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
--2nd
specimen
|
|
17652-9
|
Streptococcus
pneumoniae
Ag
[Presence]
in
Unspecified
specimen
by
Latex
agglutination
|
|
17656-0
|
Streptococcus
pyogenes
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
17657-8
|
Streptolysin
O
Ab
[Units/volume]
in
Synovial
fluid
|
|
17658-6
|
Strontium/Creatinine
[Mass
Ratio]
in
Urine
|
|
17659-4
|
Strychnine
[Units/volume]
in
Serum
or
Plasma
|
|
1766-5
|
Aldosterone
receptors
[#]
in
Leukocytes
|
|
17660-2
|
Strychnine
[Units/volume]
in
Urine
|
|
17661-0
|
Succinylcholine
[Mass/volume]
in
Serum
or
Plasma
|
|
17662-8
|
Succinylpurines
[Presence]
in
Urine
|
|
17663-6
|
Sulfadiazine
IgE
Ab
[Units/volume]
in
Serum
|
|
17664-4
|
Sulfalazine
IgE
Ab
[Units/volume]
in
Serum
|
|
17665-1
|
Sulfamedraxozole
IgE
Ab
[Units/volume]
in
Serum
|
|
17666-9
|
Sulfate
[Mass/volume]
in
Dialysis
fluid
|
|
17668-5
|
Sulfatide
IgG
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17669-3
|
Sulfatide
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
1767-3
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
--supine
|
|
17670-1
|
Sulfatide
IgM
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17671-9
|
Sulfatide
IgM
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
17672-7
|
Sulfide
[Mass/volume]
in
Urine
|
|
17673-5
|
Sulfisoxazole
IgE
Ab
[Units/volume]
in
Serum
|
|
17674-3
|
Sulfonamide
[Units/volume]
in
Serum
or
Plasma
|
|
17675-0
|
Sulfonamide
[Units/volume]
in
Urine
|
|
17676-8
|
Sulindac
sulfide
metabolite
[Mass/volume]
in
Serum
or
Plasma
|
|
17677-6
|
Deprecated
Helianthus
annuus
Ab.IgE
|
|
1768-1
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
--upright
|
|
17681-8
|
Tellurium
[Presence]
in
Urine
|
|
17682-6
|
Terpineol
[Presence]
in
Blood
|
|
17683-4
|
2-Methyl-2-Propanol
[Mass/volume]
in
Blood
|
|
17685-9
|
Testosterone
Free
[Mass/volume]
in
Dialysis
fluid
|
|
17686-7
|
Testosterone.weakly
bound
[Mass/volume]
in
Serum
or
Plasma
|
|
17687-5
|
Testosterone/Epitestosterone
[Mass
Ratio]
in
Serum
or
Plasma
|
|
1769-9
|
Fatty
acids.nonesterified
[Mass/volume]
in
Serum
or
Plasma
|
|
17695-8
|
Tetrachlorodiphenylethane
[Mass/volume]
in
Blood
|
|
17696-6
|
Tetrachlorodiphenylethane
[Mass/volume]
in
Urine
|
|
17697-4
|
Tetrachloroethane
[Mass/volume]
in
Blood
|
|
17698-2
|
Tetraethyl
lead
[Mass/volume]
in
Blood
|
|
17699-0
|
Thebaine
[Mass/volume]
in
Serum
or
Plasma
|
|
17700-6
|
Theophylline
[Mass/volume]
in
Urine
|
|
17701-4
|
Thiazides
[Mass/volume]
in
Urine
|
|
17703-0
|
Thorium
[Mass/volume]
in
Urine
|
|
17705-5
|
Thyroglobulin
IgM
Ab
[Units/volume]
in
Serum
|
|
17706-3
|
Thyroperoxidase
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Latex
agglutination
|
|
17707-1
|
Thyroperoxidase
IgM
Ab
[Units/volume]
in
Serum
or
Plasma
|
|
17708-9
|
Thyroid
stimulating
immunoglobulins
[Presence]
in
Serum
|
|
17709-7
|
Ticlopidine
[Presence]
in
Urine
|
|
17710-5
|
Tin/Creatinine
[Mass
Ratio]
in
Urine
|
|
17712-1
|
Toluene
diisocyanate
[Mass/volume]
in
Blood
|
|
17713-9
|
Topiramate
[Mass/volume]
in
Serum
or
Plasma
|
|
17714-7
|
Toxaphene
[Mass/volume]
in
Serum
or
Plasma
|
|
17715-4
|
Toxocara
canis
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunoassay
|
|
17716-2
|
Toxoplasma
gondii
IgE
Ab
[Units/volume]
in
Serum
|
|
17717-0
|
Toxoplasma
gondii
IgG+IgM
Ab
[Presence]
in
Serum
|
|
17718-8
|
Tramadol
[Presence]
in
Urine
by
Confirmatory
method
|
|
17719-6
|
Tramadol
[Mass/volume]
in
Urine
|
|
17720-4
|
Trans
nonachlor
[Mass/volume]
in
Urine
|
|
17721-2
|
Trans
nonachlor
[Mass/volume]
in
Blood
|
|
17723-8
|
Treponema
pallidum
Ab
[Presence]
in
Serum
by
Immobilization
|
|
17724-6
|
Treponema
pallidum
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17725-3
|
Treponema
pallidum
Ab
[Units/volume]
in
Serum
by
Latex
agglutination
|
|
17726-1
|
Treponema
pallidum
IgG
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17727-9
|
Treponema
pallidum
IgG
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17728-7
|
Treponema
pallidum
IgM
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17729-5
|
Treponema
pallidum
IgM
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17730-3
|
Triamterene
[Units/volume]
in
Urine
|
|
17732-9
|
Trichinella
spiralis
Ab
[Presence]
in
Serum
by
Latex
agglutination
|
|
17733-7
|
Trichinella
spiralis
IgA
Ab
[Presence]
in
Serum
|
|
17734-5
|
Trichinella
spiralis
IgG
Ab
[Units/volume]
in
Serum
|
|
17735-2
|
Trichinella
spiralis
IgM
Ab
[Presence]
in
Serum
|
|
17736-0
|
Trichloroacetate
[Mass/volume]
in
Blood
|
|
17737-8
|
Trichloroethane
[Mass/volume]
in
Urine
|
|
17738-6
|
Chloral
hydrate
[Presence]
in
Urine
|
|
17739-4
|
Chloral
hydrate
[Presence]
in
Urine
by
Confirmatory
method
|
|
17740-2
|
Trichlorophenoxyacetate
[Presence]
in
Blood
|
|
17741-0
|
Trichlorophenoxyacetate
[Mass/volume]
in
Serum
or
Plasma
|
|
17742-8
|
Trichlorothiazide
[Presence]
in
Urine
|
|
17744-4
|
Trimellitic
anhydride
(TMA)
IgG
Ab
[Units/volume]
in
Serum
|
|
17745-1
|
Trimellitic
anhydride
(TMA)
IgM
Ab
[Units/volume]
in
Serum
|
|
17746-9
|
Trimeprazine
[Presence]
in
Serum
or
Plasma
|
|
17747-7
|
Trimethoprim
[Mass/volume]
in
Urine
|
|
17748-5
|
Trimethylamine
[Presence]
in
Urine
|
|
17749-3
|
Tromethamine
[Mass/volume]
in
Serum
or
Plasma
|
|
1775-6
|
Alkaline
phosphatase
[Mass/volume]
in
Body
fluid
|
|
17750-1
|
Trypsinogen
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
17751-9
|
Tryptamine
[Mass/volume]
in
Serum
or
Plasma
|
|
17753-5
|
Tungsten
[Mass/volume]
in
Serum
or
Plasma
|
|
17755-0
|
Urate
[Mass/time]
in
2
hour
Urine
|
|
17756-8
|
Urate
[Mass/time]
in
4
hour
Urine
|
|
17757-6
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
dialysis
fluid
|
|
17758-4
|
Urea
nitrogen
[Mass/volume]
in
Vitreous
fluid
|
|
17759-2
|
Urea
nitrogen
[Mass/volume]
in
Arterial
blood
--post
dialysis
|
|
1776-4
|
Alkaline
phosphatase
[Mass/volume]
in
Urine
|
|
17760-0
|
Urea
nitrogen
[Mass/volume]
in
Venous
blood
--pre
dialysis
|
|
17761-8
|
Urobilinogen
[Mass/time]
in
48
hour
Stool
|
|
17762-6
|
Valproate
[Mass/volume]
in
Urine
|
|
17763-4
|
Varicella
zoster
virus
IgG
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17764-2
|
Varicella
zoster
virus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
17765-9
|
Varicella
zoster
virus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
17766-7
|
Varicella
zoster
virus
IgM
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17767-5
|
Verapamil
[Mass/volume]
in
Urine
|
|
17768-3
|
Vinyl
chloride
[Mass/volume]
in
Blood
|
|
17769-1
|
Western
equine
encephalitis
virus
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
1777-2
|
Alkaline
phosphatase.bone
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
17770-9
|
Western
equine
encephalitis
virus
Ab
[Titer]
in
Serum
|
|
17771-7
|
Whitefish
roe
IgE
Ab
[Units/volume]
in
Serum
|
|
17772-5
|
Dimethylbenzene
[Mass/volume]
in
Urine
|
|
17774-1
|
Yellow
dye
IgE
Ab
[Units/volume]
in
Serum
|
|
17775-8
|
Yersinia
sp
IgA
Ab
[Units/volume]
in
Serum
|
|
17776-6
|
Yersinia
sp
IgG
Ab
[Units/volume]
in
Serum
|
|
17777-4
|
Yersinia
sp
IgM
Ab
[Units/volume]
in
Serum
|
|
17778-2
|
Zinc
[Mass/volume]
in
Leukocytes
|
|
17780-8
|
Helicobacter
pylori
Ag
[Presence]
in
Stool
by
Immunoassay
|
|
17781-6
|
21-Hydroxylase
Ab
[Units/volume]
in
Serum
|
|
17784-0
|
Parasites
in
Blood
by
Light
microscopy
|
|
17791-5
|
Sjogrens
syndrome-B
extractable
nuclear
Ab
[Units/volume]
in
Serum
|
|
17792-3
|
Sjogrens
syndrome-A
extractable
nuclear
Ab
[Units/volume]
in
Serum
|
|
17793-1
|
Immunoglobulin
light
chains
[Mass/volume]
in
24
hour
Urine
|
|
17794-9
|
Osmolality
of
Hyperal
solution
|
|
17795-6
|
Potassium
[Moles/volume]
in
Hyperal
solution
|
|
17796-4
|
Sodium
[Moles/volume]
in
Hyperal
solution
|
|
17797-2
|
Thyroid
colloidal
Ab
[Units/volume]
in
Serum
|
|
17798-0
|
Amikacin
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
17805-3
|
Procainamide
[Mass/volume]
in
Body
fluid
|
|
17806-1
|
N-acetylprocainamide
[Mass/volume]
in
Body
fluid
|
|
17807-9
|
Cyclosporine
[Mass/volume]
in
Body
fluid
|
|
17808-7
|
Tobramycin
[Mass/volume]
in
Urine
|
|
17809-5
|
Hematocrit
[Volume
Fraction]
of
Urine
|
|
17824-4
|
CD3+CD8+
(T8
suppressor
cells)
cells/100
cells
in
Body
fluid
|
|
17829-3
|
CD19
cells/100
cells
in
Body
fluid
|
|
1783-0
|
Alkaline
phosphatase
[Enzymatic
activity/volume]
in
Blood
|
|
17830-1
|
Centromere
Ab
[Units/volume]
in
Body
fluid
|
|
17837-6
|
Acid
phosphatase
tartrate
resistant
[Enzymatic
activity/volume]
in
Serum
|
|
17838-4
|
Alkaline
phosphatase.bone
[Mass/volume]
in
Serum
or
Plasma
|
|
17839-2
|
Alpha
fucosidase
[Enzymatic
activity/volume]
in
Blood
|
|
1784-8
|
Alpha
amino
acid
nitrogen
[Mass/volume]
in
Plasma
|
|
17840-0
|
Alpha-L-iduronidase
[Enzymatic
activity/volume]
in
Blood
|
|
17841-8
|
Amylase
[Enzymatic
activity/time]
in
12
hour
Urine
|
|
17842-6
|
Cancer
Ag
27-29
[Units/volume]
in
Serum
or
Plasma
|
|
17843-4
|
Cancer
Ag
72-4
[Units/volume]
in
Serum
or
Plasma
|
|
17844-2
|
Estradiol
(E2).albumin
bound
[Mass/volume]
in
Serum
or
Plasma
|
|
17849-1
|
Reticulocytes/100
erythrocytes
in
Blood
by
Automated
count
|
|
1785-5
|
Alpha
amino
acid
nitrogen
[Mass/time]
in
24
hour
Urine
|
|
17850-9
|
Herpes
simplex
virus
1
IgG
Ab
[Presence]
in
Serum
|
|
17851-7
|
Herpes
simplex
virus
2
IgG
Ab
[Presence]
in
Serum
|
|
17852-5
|
Ureaplasma
urealyticum
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
17855-8
|
Hemoglobin
A1c/Hemoglobin.total
in
Blood
by
calculation
|
|
17856-6
|
Hemoglobin
A1c/Hemoglobin.total
in
Blood
by
HPLC
|
|
17857-4
|
Rheumatoid
factor
[Titer]
in
Serum
|
|
17858-2
|
Gamma
glutamyl
transferase
[Enzymatic
activity/volume]
in
Body
fluid
|
|
17859-0
|
Helicobacter
pylori
IgG
Ab
[Presence]
in
Serum
or
Plasma
by
Immunoassay
|
|
17861-6
|
Calcium
[Mass/volume]
in
Serum
or
Plasma
|
|
17862-4
|
Calcium
[Mass/volume]
in
Urine
|
|
17863-2
|
Calcium.ionized
[Mass/volume]
in
Serum
or
Plasma
|
|
17864-0
|
Calcium.ionized
[Mass/volume]
in
Serum
or
Plasma
by
Ion-selective
membrane
electrode
(ISE)
|
|
17865-7
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--8
hours
fasting
|
|
17867-3
|
Carnitine
free
(C0)/Creatinine
[Ratio]
in
Urine
|
|
17869-9
|
Orotate/Creatinine
[Molar
ratio]
in
Urine
|
|
17870-7
|
Orotidine/Creatinine
[Molar
ratio]
in
Urine
|
|
17871-5
|
Hemoglobin
H
[Presence]
in
Blood
by
Heat
denaturation
|
|
17872-3
|
Tetrahydrocannabinol
[Presence]
in
Urine
by
Confirm
method
>25
ng/mL
|
|
17898-8
|
Bacteria
identified
in
Throat
by
Aerobe
culture
|
|
17909-3
|
Bacteria
identified
in
Wound
deep
by
Aerobe
culture
|
|
17915-0
|
Bacteria
identified
in
Wound
shallow
by
Aerobe
culture
|
|
17925-9
|
Bacteria
identified
in
Wound
deep
by
Anaerobe
culture
|
|
17928-3
|
Bacteria
identified
in
Blood
by
Aerobe
culture
|
|
17934-1
|
Bacteria
identified
in
Blood
by
Anaerobe
culture
|
|
1794-7
|
Amylase
[Enzymatic
activity/volume]
in
Duodenal
fluid
|
|
1795-4
|
Amylase
[Enzymatic
activity/volume]
in
Body
fluid
|
|
17950-7
|
Deprecated
Bacteria
identified
in
Body
fluid
by
Aerobe
culture
|
|
17956-4
|
Bacteria
identified
in
Body
fluid
by
Anaerobe
culture
|
|
1796-2
|
Amylase
[Enzymatic
activity/volume]
in
Pleural
fluid
|
|
17969-7
|
Deprecated
Bacteria
identified
in
Urine
by
Aerobe
culture
|
|
1797-0
|
Amylase
[Enzymatic
activity/volume]
in
Peritoneal
fluid
|
|
1798-8
|
Amylase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
1799-6
|
Amylase
[Enzymatic
activity/volume]
in
Urine
|
|
1800-2
|
Amylase
[Enzymatic
activity/time]
in
24
hour
Urine
|
|
1812-7
|
Alpha
fucosidase
[Enzymatic
activity/mass]
in
Tissue
|
|
1813-5
|
Alpha
galactosidase
A
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
1814-3
|
Acid
alpha
glucosidase
[Enzymatic
activity/volume]
in
Semen
|
|
1815-0
|
Acid
alpha
glucosidase
[Enzymatic
activity/mass]
in
Tissue
|
|
1816-8
|
Acid
alpha
glucosidase
[Enzymatic
activity/volume]
in
Leukocytes
|
|
1817-6
|
Alpha
ketoglutarate
[Mass/volume]
in
Serum
or
Plasma
|
|
1818-4
|
Alpha
mannosidase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
18183-4
|
Melatonin
[Mass/time]
in
24
hour
Urine
|
|
18184-2
|
Erythrocyte
sedimentation
rate
by
2H
Westergren
method
|
|
18186-7
|
Calcium
[Mass/time]
in
12
hour
Urine
|
|
18187-5
|
Lorazepam
[Presence]
in
Urine
|
|
18188-3
|
Acebutolol
[Mass/volume]
in
Unspecified
specimen
|
|
18189-1
|
Acetone
[Mass/time]
in
24
hour
Urine
|
|
1819-2
|
Alpha
mannosidase
[Enzymatic
activity/mass]
in
Tissue
|
|
18190-9
|
Acid
phosphatase
tartrate
resistant
[Presence]
in
Unspecified
specimen
|
|
18191-7
|
Amino
acids
[Identifier]
in
24
hour
Urine
|
|
18192-5
|
Bacteria
[Presence]
in
Nose
by
Light
microscopy
|
|
18194-1
|
Barium
[Mass/time]
in
24
hour
Urine
|
|
18195-8
|
Acid
beta
glucosidase
[Presence]
in
Tissue
|
|
18196-6
|
Beta-N-acetylhexosaminidase.A
[Presence]
in
Tissue
|
|
18197-4
|
Blastomyces
dermatitidis
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
18198-2
|
Blastomyces
dermatitidis
IgE
Ab
[Presence]
in
Serum
|
|
18199-0
|
Blastomyces
dermatitidis
IgG
Ab
[Presence]
in
Serum
|
|
1820-0
|
Alpha
melanocyte
stimulating
hormone
[Mass/volume]
in
Serum
or
Plasma
|
|
18200-6
|
Blastomyces
dermatitidis
IgM
Ab
[Presence]
in
Serum
|
|
18201-4
|
Borrelia
burgdorferi
IgA
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
18202-2
|
Borrelia
burgdorferi
IgA
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
18203-0
|
Borrelia
burgdorferi
IgG+IgM
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
18204-8
|
Caffeine
renal
clearance
in
24
hour
|
|
18205-5
|
Carbon
disulfide
[Presence]
in
Urine
|
|
18208-9
|
Cocaine
[Mass/volume]
in
Unspecified
specimen
|
|
18209-7
|
Coenzyme
Q10
[Units/volume]
in
Serum
or
Plasma
|
|
1821-8
|
Alpha
naphthylesterase
[Enzymatic
activity/volume]
in
Serum
|
|
18210-5
|
Complement
C1
esterase
inhibitor
bound
IgG
Ab
[Mass/volume]
in
Serum
or
Plasma
|
|
18211-3
|
Complement
C1
esterase
inhibitor
bound
IgM
Ab
[Mass/volume]
in
Serum
or
Plasma
|
|
18212-1
|
Complement
C1
esterase
inhibitor
free
IgG
Ab
[Mass/volume]
in
Serum
or
Plasma
|
|
18213-9
|
Complement
C1
esterase
inhibitor
free
IgM
Ab
[Mass/volume]
in
Serum
or
Plasma
|
|
18214-7
|
Delta
5-Pregnanetriol
[Mass/volume]
in
Urine
|
|
18215-4
|
Delta
alanine
[Mass/volume]
in
Urine
|
|
18216-2
|
Dezocine
[Presence]
in
Urine
by
Confirmatory
method
|
|
18217-0
|
Epidermis
IgA
Ab
[Presence]
in
Tissue
|
|
18218-8
|
Epidermis
IgM
Ab
[Presence]
in
Tissue
|
|
1822-6
|
Alpha
thymosin
[Mass/volume]
in
Serum
|
|
18227-9
|
Glucose
[Mass/time]
in
6
hour
Urine
|
|
18228-7
|
Glucose-6-Phosphate
dehydrogenase
[Presence]
in
Tissue
|
|
18229-5
|
Heparan
sulfate
[Presence]
in
Serum
or
Plasma
|
|
1823-4
|
Alpha
tocopherol
[Mass/volume]
in
Serum
or
Plasma
|
|
18230-3
|
Histone
H2a+H2b
Ab
[Units/volume]
in
Serum
|
|
18231-1
|
Histone
H2a+H2b
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
18232-9
|
Hydrocorticosterone
[Presence]
in
Urine
|
|
18233-7
|
Influenza
virus
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
18234-5
|
Insulin
[Presence]
in
Unknown
substance
|
|
18235-2
|
Ketone
solvents
[Identifier]
in
Blood
|
|
18236-0
|
Lead
[Presence]
in
Tissue
|
|
18237-8
|
Legionella
pneumophila
atypical
IgM
Ab
[Presence]
in
Serum
|
|
18238-6
|
Lithium
[Mass/mass]
in
Tissue
|
|
18239-4
|
Lupus
erythematosus
factor
[Mass/volume]
in
Blood
by
Latex
agglutination
|
|
1824-2
|
Alpha-1-Antichymotrypsin
[Mass/volume]
in
Serum
|
|
18241-0
|
Cefoxitin
IgE
Ab
[Units/volume]
in
Serum
|
|
18242-8
|
Methyprylon
[Mass/time]
in
24
hour
Urine
|
|
18243-6
|
Mycoplasma
pneumoniae
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
18244-4
|
Niacin
[Mass/volume]
in
Serum
or
Plasma
|
|
18245-1
|
Nickel
[Mass/volume]
in
Unspecified
specimen
|
|
18246-9
|
Nitrogen
[Mass/volume]
in
Stool
|
|
18247-7
|
Nitrogen
[Mass/volume]
in
Dialysis
fluid
|
|
18248-5
|
Nordiazepam
[Mass/volume]
in
Stool
|
|
18249-3
|
Para
aminobenzoate
[Mass/volume]
in
Serum
or
Plasma
|
|
1825-9
|
Alpha
1
antitrypsin
[Mass/volume]
in
Serum
or
Plasma
|
|
18251-9
|
Polychlorinated
biphenyl
(PCB)
[Presence]
in
Tissue
|
|
18252-7
|
Prednisone
[Mass/time]
in
24
hour
Urine
|
|
18253-5
|
Serotonin
[Mass/time]
in
24
hour
Urine
|
|
18254-3
|
Silicate
[Mass/volume]
in
Body
fluid
|
|
18255-0
|
Sulfonylurea
[Mass/volume]
in
Serum
or
Plasma
|
|
18256-8
|
Sulfonylurea
[Mass/volume]
in
Urine
|
|
18258-4
|
Trimethoprim
IgE
Ab
[Units/volume]
in
Serum
|
|
18259-2
|
Vasoactive
intestinal
peptide
[Mass/time]
in
24
hour
Urine
|
|
18260-0
|
Zinc
[Presence]
in
Tissue
|
|
18262-6
|
Cholesterol
in
LDL
[Mass/volume]
in
Serum
or
Plasma
by
Direct
assay
|
|
18265-9
|
Acetaminophen
[Presence]
in
Body
fluid
|
|
18267-5
|
CD16+CD56+
cells/100
cells
in
Blood
|
|
18268-3
|
CD16+CD56+
cells/100
cells
in
Body
fluid
|
|
18269-1
|
Immune
complex
[Units/volume]
in
Body
fluid
|
|
18270-9
|
Carbamazepine
10,11-Epoxide
[Moles/volume]
in
Serum
or
Plasma
|
|
18271-7
|
Alpha
1
antitrypsin
fecal
clearance
in
24
hour
|
|
18272-5
|
RNA
Ab
[Units/volume]
in
Serum
|
|
18273-3
|
Blood
group
antibody
screen
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
18274-1
|
Blood
group
antibody
screen
[Presence]
in
Serum
or
Plasma
from
donor
|
|
18277-4
|
Hemoglobin
F
[Presence]
in
Gastric
fluid
by
Apt-Downey
method
|
|
18278-2
|
Hemoglobin
F
[Presence]
in
Meconium
by
Apt-Downey
method
|
|
18279-0
|
Deprecated
Hemoglobin
F
[Presence]
in
Stool
by
Apt-Downey
method
|
|
18282-4
|
Cannabinoids
[Presence]
in
Urine
by
Screen
method
|
|
18286-5
|
Donath
Landsteiner
Ab
[Presence]
in
Blood
|
|
18297-2
|
Acid
hemolysis
[Mass/volume]
of
Red
Blood
Cells
|
|
18305-3
|
Amoeba
identified
in
Aspirate
by
Iron
hematoxylin
stain
|
|
18306-1
|
Hydatid
cyst
identified
in
Aspirate
by
Iron
hematoxylin
stain
|
|
18307-9
|
Ova
and
parasites
identified
in
Stool
by
Iron
hematoxylin
stain
|
|
18308-7
|
Pneumocystis
sp
identified
in
Lung
tissue
by
Immunohistochemical
|
|
1832-5
|
Alpha-1-Fetoprotein
[Mass/volume]
in
Amniotic
fluid
|
|
18320-2
|
Globulin
[Mass/volume]
in
Urine
by
calculation
|
|
18321-0
|
Benzidine
[Mass/volume]
in
Serum
or
Plasma
|
|
18322-8
|
Norketamine
[Mass/volume]
in
Urine
|
|
18323-6
|
Smith
extractable
nuclear
IgG
Ab
[Units/volume]
in
Serum
|
|
18324-4
|
Cockatiel
serum
IgE
Ab
[Units/volume]
in
Serum
|
|
18325-1
|
Oxymorphone
[Presence]
in
Urine
by
Confirmatory
method
|
|
18326-9
|
Microscopic
observation
[Identifier]
in
Cervix
by
Other
stain
|
|
18327-7
|
Microscopic
observation
[Identifier]
in
Duodenal
fluid
by
Other
stain
|
|
18328-5
|
Microscopic
observation
[Identifier]
in
Body
fluid
by
Other
stain
|
|
18329-3
|
Neutrophil
cytoplasmic
IgA
Ab
[Units/volume]
in
Serum
|
|
1833-3
|
Alpha-1-Fetoprotein
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
18330-1
|
Neutrophil
cytoplasmic
IgG
Ab
[Units/volume]
in
Serum
|
|
18331-9
|
Neutrophil
cytoplasmic
IgM
Ab
[Units/volume]
in
Serum
|
|
18332-7
|
Thyroperoxidase
IgG
Ab
[Units/volume]
in
Serum
or
Plasma
|
|
18333-5
|
Echovirus
7
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
18334-3
|
Naltrexone
[Presence]
in
Urine
by
Confirmatory
method
|
|
18335-0
|
Antihistamines
[Presence]
in
Urine
by
Confirmatory
method
|
|
18336-8
|
Methyl
tert-butyl
ether
[Mass/volume]
in
Blood
|
|
18337-6
|
Hydroxyitraconazole
[Mass/volume]
in
Serum
or
Plasma
|
|
18338-4
|
Nortramadol
[Mass/volume]
in
Urine
|
|
18339-2
|
Nortramadol
[Presence]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
1834-1
|
Alpha-1-Fetoprotein
[Mass/volume]
in
Serum
or
Plasma
|
|
18340-0
|
Nortramadol
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
18341-8
|
Propylene
glycol
[Mass/volume]
in
Urine
|
|
18343-4
|
6-Monoacetylmorphine
(6-MAM)
[Presence]
in
Serum
or
Plasma
by
Screen
method
|
|
18344-2
|
Beta-N-acetylhexosaminidase
[Enzymatic
activity/volume]
in
Platelets
|
|
18345-9
|
Protein
S
Ag/Coagulation
factor
VII
Ag
Ag
[Mass
Ratio]
in
Platelet
poor
plasma
by
Coagulation
assay
|
|
18348-3
|
Toxoplasma
gondii
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
1835-8
|
Alpha-2-Macroglobulin
[Mass/volume]
in
Serum
or
Plasma
|
|
18354-1
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--12
hours
post
50
g
lactose
PO
|
|
18355-8
|
Methylenedioxyamphetamine
[Mass/volume]
in
Urine
|
|
18356-6
|
Methylenedioxymethamphetamine
[Mass/volume]
in
Serum
or
Plasma
|
|
18357-4
|
Methylenedioxymethamphetamine
[Mass/volume]
in
Blood
|
|
18358-2
|
Methylenedioxymethamphetamine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
18359-0
|
Methylenedioxyamphetamine
[Mass/volume]
in
Blood
|
|
1836-6
|
Alpha-2-Retinol
binding
protein
[Mass/volume]
in
Serum
or
Plasma
|
|
18360-8
|
8-Hydroxyamoxapine
[Mass/volume]
in
Urine
|
|
18361-6
|
Adenosine
monophosphate.cyclic/Creatinine
[Mass
Ratio]
in
Urine
|
|
18362-4
|
Alpha-2-Retinol
binding
protein
[Mass/time]
in
24
hour
Urine
|
|
18363-2
|
Carnitine
free
(C0)
[Units/mass]
in
Tissue
|
|
18364-0
|
Chondroitin
sulfate
[Mass/volume]
in
Serum
|
|
18365-7
|
Cortisol
Free
[Mass/volume]
in
Saliva
(oral
fluid)
|
|
18366-5
|
Cytochrome
C
oxidase
[Enzymatic
activity/mass]
in
Tissue
|
|
18367-3
|
Iodine
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
18368-1
|
Magnesium
[Moles/time]
in
2
hour
Urine
|
|
18369-9
|
Magnesium
[Moles/time]
in
4
hour
Urine
|
|
1837-4
|
Alpha-N-acetylglucosaminidase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
18371-5
|
Methyl
parathion
[Mass/volume]
in
Urine
|
|
18372-3
|
Potassium
[Moles/time]
in
6
hour
Urine
|
|
18373-1
|
Protein
[Mass/time]
in
6
hour
Urine
|
|
18374-9
|
Riboflavin
[Mass/volume]
in
24
hour
Urine
|
|
18376-4
|
Sodium
[Moles/time]
in
6
hour
Urine
|
|
18377-2
|
Sodium
[Moles/time]
in
12
hour
Urine
|
|
18378-0
|
Transcortin
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
18379-8
|
Urate
[Mass/time]
in
6
hour
Urine
|
|
1838-2
|
Alpha-N-acetylglucosaminidase
[Enzymatic
activity/mass]
in
Tissue
|
|
18380-6
|
Uroporphyrinogen
decarboxylase
[Entitic
Catalytic
Activity]
in
Red
Blood
Cells
|
|
18381-4
|
Uroporphyrinogen
decarboxylase
[Enzymatic
activity/volume]
in
Blood
|
|
18383-0
|
Alfentanil
[Presence]
in
Urine
|
|
18384-8
|
Butabarbital
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
18385-5
|
Butalbital
[Presence]
in
Urine
by
Confirmatory
method
|
|
18386-3
|
Chlorothiazide
[Presence]
in
Serum
or
Plasma
|
|
18387-1
|
Diamorphine
[Mass/volume]
in
Serum
or
Plasma
|
|
18388-9
|
Diazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
18389-7
|
Methaqualone
[Presence]
in
Urine
by
Confirmatory
method
|
|
1839-0
|
Ammonia
[Moles/volume]
in
Blood
|
|
18390-5
|
Opiates
[Presence]
in
Urine
by
Confirmatory
method
|
|
18391-3
|
Paraldehyde
[Mass/volume]
in
Urine
|
|
18392-1
|
Phencyclidine
[Presence]
in
Urine
by
Confirmatory
method
|
|
18393-9
|
Quinidine+Quinine
[Presence]
in
Urine
|
|
18395-4
|
Aspergillus
niger
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
18397-0
|
Polio
virus
1
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Complement
fixation
|
|
18398-8
|
Polio
virus
2
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Complement
fixation
|
|
18399-6
|
Polio
virus
3
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Complement
fixation
|
|
1840-8
|
Ammonia
[Moles/volume]
in
Cerebral
spinal
fluid
|
|
18400-2
|
Spermatozoa
IgA
Ab
[Units/volume]
in
Cervical
mucus
|
|
18401-0
|
Spermatozoa
IgG
Ab
[Units/volume]
in
Cervical
mucus
|
|
18402-8
|
Spermatozoa
IgA
Ab
[Units/volume]
in
Semen
|
|
18403-6
|
Spermatozoa
IgG
Ab
[Units/volume]
in
Semen
|
|
18404-4
|
Spermatozoa
IgM
Ab
[Units/volume]
in
Semen
|
|
18405-1
|
Arsenate
[Mass/volume]
in
Urine
|
|
18406-9
|
Arsenic
trioxide
[Mass/volume]
in
Urine
|
|
18409-3
|
Curvularia
lunata
IgG
Ab
[Units/volume]
in
Serum
|
|
1841-6
|
Ammonia
[Moles/volume]
in
Serum
|
|
18410-1
|
Epicoccum
purpurascens
IgG
Ab
[Units/volume]
in
Serum
|
|
18411-9
|
Rhizopus
nigricans
IgG
Ab
[Units/volume]
in
Serum
|
|
18412-7
|
Stemphylium
botryosum
IgG
Ab
[Units/volume]
in
Serum
|
|
18414-3
|
Psilocin
[Presence]
in
Urine
|
|
18415-0
|
Psilocin
[Mass/volume]
in
Urine
|
|
18416-8
|
Aspergillus
nidulans
IgG
Ab
[Units/volume]
in
Serum
|
|
18417-6
|
Black
Bean
IgG
Ab
[Units/volume]
in
Serum
|
|
18418-4
|
Casein
IgA
Ab
[Units/volume]
in
Serum
|
|
18419-2
|
Cephalosporine
mold
IgG
Ab
[Units/volume]
in
Serum
|
|
1842-4
|
Ammonia
[Moles/volume]
in
Urine
|
|
18420-0
|
Chaetomium
globosum
IgG
Ab
[Units/volume]
in
Serum
|
|
18421-8
|
Fusarium
oxysporum
IgG
Ab
[Units/volume]
in
Serum
|
|
18423-4
|
Phthalic
anhydride
IgG
Ab
[Units/volume]
in
Serum
|
|
18424-2
|
Phthalic
anhydride
IgM
Ab
[Units/volume]
in
Serum
|
|
18425-9
|
Zucchini
IgG
Ab
[Units/volume]
in
Serum
|
|
18426-7
|
Aspergillus
sp
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
18427-5
|
Epstein
Barr
virus
early
Ab
[Presence]
in
Body
fluid
|
|
18428-3
|
Epstein
Barr
virus
nuclear
IgG
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
18429-1
|
Rickettsia
rickettsii
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
1843-2
|
Ammonia
nitrogen
[Mass/time]
in
24
hour
Urine
|
|
18430-9
|
Rickettsia
rickettsii
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
18431-7
|
Amphetamines
[Presence]
in
Stool
by
Screen
method
|
|
18432-5
|
Tetrahydrocannabinol
[Presence]
in
Stool
by
Screen
method
|
|
18435-8
|
Sufentanil
[Presence]
in
Urine
|
|
18436-6
|
Acetylcarnitine
(C2)
[Mass/volume]
in
Serum
or
Plasma
|
|
1844-0
|
Ammonium
ion
[Moles/volume]
in
Arterial
blood
|
|
1845-7
|
Ammonium
ion
[Moles/volume]
in
Plasma
|
|
1846-5
|
Amylo-alpha-1,6-glucosidase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
18467-1
|
Venlafaxine
[Mass/volume]
in
Urine
|
|
18468-9
|
Aspergillus
fumigatus
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
18469-7
|
Methyclothiazide
[Mass/volume]
in
Serum
or
Plasma
|
|
1847-3
|
Amyloid
associated
protein
[Mass/volume]
in
Serum
|
|
18470-5
|
Norclomipramine
[Mass/volume]
in
Urine
|
|
18471-3
|
Metoclopramide
[Mass/volume]
in
Urine
|
|
18472-1
|
Organophosphate
pesticides
[Identifier]
in
Urine
|
|
18473-9
|
Hydromorphone
[Presence]
in
Urine
by
Confirmatory
method
|
|
18474-7
|
HER2
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
18476-2
|
Uroporphyrinogen
decarboxylase
[Presence]
in
Red
Blood
Cells
|
|
18477-0
|
Lithium
[Moles/time]
in
24
hour
Urine
|
|
18478-8
|
Human
papilloma
virus
16+18
DNA
[Presence]
in
Tissue
by
DNA
probe
|
|
18479-6
|
Human
papilloma
virus
31+35+51
DNA
[Presence]
in
Tissue
by
DNA
probe
|
|
1848-1
|
Androstanolone
[Mass/volume]
in
Serum
or
Plasma
|
|
18480-4
|
Human
papilloma
virus
6+11
DNA
[Presence]
in
Tissue
by
DNA
probe
|
|
18481-2
|
Streptococcus
pyogenes
Ag
[Presence]
in
Throat
|
|
18482-0
|
Yeast
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
18483-8
|
Yeast
[Presence]
in
Genital
specimen
by
Organism
specific
culture
|
|
18484-6
|
Ku
Ab
[Presence]
in
Serum
|
|
18485-3
|
Mi-2
Ab
[Presence]
in
Serum
|
|
18486-1
|
Methylenediamine
[Presence]
in
Urine
|
|
18488-7
|
Calcium
[Mass/volume]
in
24
hour
Urine
|
|
18489-5
|
Valproate.protein
bound
[Mass/volume]
in
Serum
or
Plasma
|
|
1849-9
|
Androstanolone
[Mass/volume]
in
Semen
|
|
18490-3
|
Chlamydia
trachomatis
G+F+K
IgA
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
18491-1
|
Chlamydia
trachomatis
G+F+K
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
18492-9
|
Chlamydia
trachomatis
G+F+K
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
18493-7
|
Ova
and
parasites
identified
in
Stool
by
Concentration--3rd
specimen
|
|
18494-5
|
Ova
and
parasites
identified
in
Stool
by
Concentration--2nd
specimen
|
|
18495-2
|
Ova
and
parasites
identified
in
Stool
by
Trichrome
stain--3rd
specimen
|
|
18496-0
|
Ova
and
parasites
identified
in
Stool
by
Trichrome
stain--2nd
specimen
|
|
18497-8
|
Microscopic
observation
[Identifier]
in
Thyroid
fine
needle
aspirate
by
Cyto
stain
|
|
18498-6
|
Microscopic
observation
[Identifier]
in
Breast
fine
needle
aspirate
by
Cyto
stain
|
|
18499-4
|
Microscopic
observation
[Identifier]
in
Nipple
discharge
by
Cyto
stain
|
|
1850-7
|
Androstanediol
[Mass/volume]
in
Urine
|
|
18500-9
|
Microscopic
observation
[Identifier]
in
Cervix
by
Cyto
stain.thin
prep
|
|
18501-7
|
Microscopic
observation
[Identifier]
in
Buccal
smear
by
Cyto
stain
|
|
18502-5
|
Microscopic
observation
[Identifier]
in
Deep
tissue
fine
needle
aspirate
by
Cyto
stain
|
|
18503-3
|
Microscopic
observation
[Identifier]
in
Superficial
tissue
fine
needle
aspirate
by
Cyto
stain
|
|
1851-5
|
Androstenedione
[Mass/volume]
in
Amniotic
fluid
|
|
1852-3
|
Androstenedione
[Mass/volume]
in
Capillary
blood
|
|
1853-1
|
Androstenedione
[Mass/volume]
in
Semen
|
|
1854-9
|
Androstenedione
[Mass/volume]
in
Serum
or
Plasma
|
|
1855-6
|
Androstenedione
[Mass/volume]
in
Urine
|
|
1856-4
|
Androsterone
[Mass/volume]
in
Serum
or
Plasma
|
|
1857-2
|
Angiotensin
converting
enzyme
[Enzymatic
activity/volume]
in
Blood
|
|
1858-0
|
Angiotensin
I
[Mass/volume]
in
Plasma
|
|
1859-8
|
Angiotensin
II
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
1860-6
|
Angiotensin
II
[Mass/volume]
in
Plasma
|
|
1861-4
|
Angiotensinogen
[Mass/volume]
in
Plasma
|
|
1862-2
|
Aniline
[Mass/volume]
in
Serum
or
Plasma
|
|
1868-9
|
Antithrombin
Ag
[Mass/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
1869-7
|
Apolipoprotein
A-I
[Mass/volume]
in
Serum
or
Plasma
|
|
1870-5
|
Apolipoprotein
A-II
[Mass/volume]
in
Serum
or
Plasma
|
|
1871-3
|
Apolipoprotein
B-100
[Mass/volume]
in
Serum
or
Plasma
|
|
18733-6
|
Physician
attending
Progress
note
|
|
18734-4
|
Occupational
therapy
Initial
evaluation
note
|
|
18735-1
|
Physical
therapy
Initial
evaluation
note
|
|
18736-9
|
Physician
Initial
evaluation
note
|
|
18737-7
|
Podiatry
Initial
evaluation
note
|
|
18738-5
|
Psychology
Initial
evaluation
note
|
|
18739-3
|
Social
work
Initial
evaluation
note
|
|
18740-1
|
Speech-language
pathology
Initial
evaluation
note
|
|
18742-7
|
Arthroscopy
study
|
|
18743-5
|
Autopsy
report
|
|
18744-3
|
Bronchoscopy
study
|
|
18745-0
|
Cardiac
catheterization
study
|
|
18746-8
|
Colonoscopy
Study
|
|
18747-6
|
Deprecated
CT
Unspecified
system
Study
|
|
18748-4
|
Diagnostic
imaging
study
|
|
18749-2
|
Electromyogram
study
|
|
1875-4
|
Apolipoprotein
C-I
[Mass/volume]
in
Serum
or
Plasma
|
|
18750-0
|
Electrophysiology
study
|
|
18751-8
|
Endoscopy
study
|
|
18752-6
|
Exercise
stress
test
study
|
|
18753-4
|
Flexible
sigmoidoscopy
study
|
|
18754-2
|
Holter
monitor
study
|
|
18755-9
|
Deprecated
MRI
Unspecified
site
study
|
|
18756-7
|
MR
Spine
study
|
|
18757-5
|
Deprecated
Nuclear
medicine
study
|
|
18758-3
|
Deprecated
PET
scan
Unspecified
system
Study
|
|
18759-1
|
Spirometry
study
|
|
1876-2
|
Apolipoprotein
C-II
[Mass/volume]
in
Serum
or
Plasma
|
|
18760-9
|
Deprecated
US
Unspecified
system
Study
|
|
18761-7
|
Provider-unspecified
Transfer
summary
|
|
18762-5
|
Deprecated
Chiropractor
Progress
note
|
|
18763-3
|
Physician
consulting
Initial
evaluation
note
|
|
18764-1
|
Deprecated
Nurse
practitioner
Progress
note
|
|
1877-0
|
Apolipoprotein
C-III
[Mass/volume]
in
Serum
or
Plasma
|
|
1878-8
|
Apolipoprotein
A-III
[Mass/volume]
in
Serum
or
Plasma
|
|
1879-6
|
Apolipoprotein
E2
[Mass/volume]
in
Serum
or
Plasma
|
|
1880-4
|
Beta
2
glycoprotein
1
[Mass/volume]
in
Serum
or
Plasma
|
|
1881-2
|
Apolipoprotein
LPA
[Mass/volume]
in
Serum
or
Plasma
|
|
1882-0
|
Apolipoprotein
LPQ
[Mass/volume]
in
Serum
or
Plasma
|
|
1883-8
|
Apolipoprotein
A
[Mass/volume]
in
Serum
or
Plasma
|
|
18836-7
|
Cardiac
stress
study
Procedure
|
|
1884-6
|
Apolipoprotein
B
[Mass/volume]
in
Serum
or
Plasma
|
|
18841-7
|
Hospital
consultations
Document
|
|
18842-5
|
Discharge
summary
|
|
1885-3
|
Apolipoprotein
C
[Mass/volume]
in
Serum
or
Plasma
|
|
1886-1
|
Apolipoprotein
E
[Mass/volume]
in
Serum
or
Plasma
|
|
1888-7
|
Aquacobalamin
[Mass/volume]
in
Serum
or
Plasma
|
|
1890-3
|
Arginase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
1896-0
|
Argininosuccinate
[Mass/volume]
in
Serum
or
Plasma
|
|
1897-8
|
Argininosuccinate
[Mass/volume]
in
Urine
|
|
1898-6
|
Argininosuccinate
lyase
[Enzymatic
activity/volume]
in
Serum
|
|
1899-4
|
Argininosuccinate
synthase
[Enzymatic
activity/mass]
in
Tissue
|
|
1900-0
|
Arylamidase
[Enzymatic
activity/volume]
in
Serum
|
|
1901-8
|
Arylsulfatase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
1902-6
|
Ascorbate
[Mass/volume]
in
Blood
|
|
19022-3
|
Neisseria
meningitidis
C+w135
Ag
[Presence]
in
Cerebral
spinal
fluid
|
|
1903-4
|
Ascorbate
[Mass/volume]
in
Serum
or
Plasma
|
|
1904-2
|
Ascorbate
[Presence]
in
Urine
|
|
19049-6
|
Metanephrine
[Mass/time]
in
24
hour
Urine
|
|
1905-9
|
Ascorbate
[Mass/time]
in
24
hour
Urine
|
|
19050-4
|
Metanephrines
[Mass/volume]
in
24
hour
Urine
|
|
19051-2
|
Saquinavir
[Mass/volume]
in
Serum
or
Plasma
|
|
19052-0
|
Borrelia
burgdorferi
DNA
[Presence]
in
Urine
by
Probe
with
amplification
|
|
19053-8
|
Brucella
sp
Ab
[Titer]
in
Serum
by
Agglutination
|
|
19054-6
|
Mycoplasma
pneumoniae
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
19055-3
|
Carboxy
tetrahydrocannabinol/Creatinine
[Mass
Ratio]
in
Urine
|
|
19056-1
|
Mercury
[Presence]
in
Urine
|
|
19057-9
|
ABO
and
Rh
group
[Type]
in
Blood
from
newborn
|
|
19058-7
|
Allergens
identified
in
Serum
|
|
19074-4
|
Carnitine
esters
[Moles/volume]
in
Serum
or
Plasma
|
|
19080-1
|
Choriogonadotropin
[Units/volume]
in
Serum
or
Plasma
|
|
19090-0
|
Colony
count
[#/volume]
in
Urine
|
|
19091-8
|
Colony
count
[#]
in
Urine
by
Visual
count
|
|
19101-5
|
Fungus
colony
count
[#/volume]
in
Unspecified
specimen
by
Culture
|
|
19102-3
|
Genetic
screen
in
Unspecified
specimen
by
Molecular
genetics
method
Narrative
|
|
19106-4
|
Herpes
simplex
virus
IgG
Ab
[Presence]
in
Serum
|
|
19107-2
|
Histoplasma
capsulatum
Ag
[Units/volume]
in
Serum
by
Radioimmunoassay
(RIA)
|
|
19108-0
|
Histoplasma
capsulatum
Ag
[Presence]
in
Serum
|
|
19109-8
|
Histoplasma
capsulatum
Ag
[Presence]
in
Unspecified
specimen
|
|
19113-0
|
IgE
[Units/volume]
in
Serum
or
Plasma
|
|
19122-1
|
CD42
cells/100
cells
in
Blood
|
|
19123-9
|
Magnesium
[Mass/volume]
in
Serum
or
Plasma
|
|
19124-7
|
Magnesium
[Mass/volume]
in
Urine
|
|
19126-2
|
Bacteria
identified
in
Bone
marrow
by
Aerobe
culture
|
|
19127-0
|
Bacteria
identified
in
Sputum
by
Acute
Respiratoy
Distress
(ARDS)
culture
|
|
19128-8
|
Bacteria
identified
in
Catheter
tip
by
Culture
|
|
19129-6
|
Microscopic
observation
[Identifier]
in
Tissue
by
Biopsy
culture
|
|
19133-8
|
Neisseria
meningitidis
A+C+w135+Y
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Latex
agglutination
|
|
19134-6
|
Neisseria
meningitidis
B+Escherichia
coli
K1
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Latex
agglutination
|
|
19137-9
|
Neuronal
nuclear
Ab
[Units/volume]
in
Serum
by
Immunoblot
(IB)
|
|
19140-3
|
Phospholipid
Ab
[Presence]
in
Serum
|
|
19141-1
|
Propoxyphene
[Presence]
in
Urine
|
|
19161-9
|
Urobilinogen
[Units/volume]
in
Urine
by
Test
strip
|
|
19162-7
|
Varicella
zoster
virus
IgG
Ab
[Presence]
in
Serum
|
|
19163-5
|
Cancer
Ag
19-9
[Units/volume]
in
Pleural
fluid
|
|
19164-3
|
Cancer
Ag
72-4
[Units/volume]
in
Pleural
fluid
|
|
19165-0
|
Cancer
Ag
125
[Units/volume]
in
Pleural
fluid
|
|
19166-8
|
Carcinoembryonic
Ag
[Units/volume]
in
Serum
or
Plasma
|
|
19167-6
|
Carcinoembryonic
Ag
[Moles/volume]
in
Serum
or
Plasma
|
|
19168-4
|
Carcinoembryonic
Ag
[Units/volume]
in
Pleural
fluid
|
|
19169-2
|
Carcinoembryonic
Ag
[Mass/volume]
in
Pleural
fluid
|
|
1917-4
|
Aspartate
aminotransferase
[Enzymatic
activity/volume]
in
Amniotic
fluid
|
|
19170-0
|
Carcinoembryonic
Ag
[Moles/volume]
in
Pleural
fluid
|
|
19171-8
|
Alpha-1-Fetoprotein
[Units/volume]
in
Amniotic
fluid
|
|
19172-6
|
Alpha-1-Fetoprotein
[Units/volume]
in
Pleural
fluid
|
|
19173-4
|
Alpha-1-Fetoprotein
[Moles/volume]
in
Pleural
fluid
|
|
19174-2
|
Choriogonadotropin.beta
subunit
[Units/volume]
in
Amniotic
fluid
|
|
19175-9
|
Choriogonadotropin.beta
subunit
[Moles/volume]
in
Amniotic
fluid
|
|
19176-7
|
Alpha-1-Fetoprotein
[Units/volume]
in
Serum
or
Plasma
|
|
19177-5
|
Alpha-1-Fetoprotein
[Moles/volume]
in
Serum
or
Plasma
|
|
19178-3
|
Choriogonadotropin.beta
subunit
free
[Units/volume]
in
Amniotic
fluid
|
|
19179-1
|
Choriogonadotropin.beta
subunit
free
[Moles/volume]
in
Amniotic
fluid
|
|
1918-2
|
Aspartate
aminotransferase
[Enzymatic
activity/volume]
in
Cerebral
spinal
fluid
|
|
19180-9
|
Choriogonadotropin.beta
subunit
free
[Units/volume]
in
Serum
or
Plasma
|
|
19182-5
|
Cytokeratin
19
[Units/volume]
in
Serum
or
Plasma
|
|
19183-3
|
Cytokeratin
19
[Units/volume]
in
Pleural
fluid
|
|
19184-1
|
Tissue
polypeptide
specific
Ag
[Units/volume]
in
Serum
or
Plasma
|
|
19185-8
|
Tissue
polypeptide
specific
Ag
[Units/volume]
in
Pleural
fluid
|
|
19186-6
|
Cancer
Ag
15-3
[Units/volume]
in
Pleural
fluid
|
|
19187-4
|
Cancer
Ag
27-29
[Units/volume]
in
Pleural
fluid
|
|
19188-2
|
Mucin-like
carcinoma
associated
Ag
[Units/volume]
in
Pleural
fluid
|
|
19189-0
|
Cancer
Ag
549
[Units/volume]
in
Serum
or
Plasma
|
|
1919-0
|
Aspartate
aminotransferase
[Enzymatic
activity/volume]
in
Body
fluid
|
|
19190-8
|
Cancer
Ag
549
[Units/volume]
in
Pleural
fluid
|
|
19193-2
|
Enolase.neuron
specific
[Units/volume]
in
Serum
or
Plasma
|
|
19194-0
|
Enolase.neuron
specific
[Units/volume]
in
Pleural
fluid
|
|
19195-7
|
Prostate
specific
Ag
[Units/volume]
in
Serum
or
Plasma
|
|
19197-3
|
Prostate
specific
Ag
[Moles/volume]
in
Serum
or
Plasma
|
|
19198-1
|
Prostate
specific
Ag
[Units/volume]
in
Semen
|
|
19199-9
|
Prostate
specific
Ag
[Mass/volume]
in
Semen
|
|
1920-8
|
Aspartate
aminotransferase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
19200-5
|
Prostate
specific
Ag
[Moles/volume]
in
Semen
|
|
19201-3
|
Prostate
Specific
Ag
Free
[Units/volume]
in
Serum
or
Plasma
|
|
19203-9
|
Prostate
Specific
Ag
Free
[Moles/volume]
in
Serum
or
Plasma
|
|
19204-7
|
Prostate
Specific
Ag
Free
[Units/volume]
in
Semen
|
|
19205-4
|
Prostate
Specific
Ag
Free
[Mass/volume]
in
Semen
|
|
19206-2
|
Prostate
Specific
Ag
Free
[Moles/volume]
in
Semen
|
|
19207-0
|
Squamous
cell
carcinoma
Ag
[Units/volume]
in
Serum
or
Plasma
|
|
19208-8
|
Squamous
cell
carcinoma
Ag
[Moles/volume]
in
Serum
or
Plasma
|
|
19209-6
|
Squamous
cell
carcinoma
Ag
[Units/volume]
in
Pleural
fluid
|
|
1921-6
|
Atrial
natriuretic
factor
[Mass/volume]
in
Arterial
blood
|
|
19210-4
|
Squamous
cell
carcinoma
Ag
[Moles/volume]
in
Pleural
fluid
|
|
19211-2
|
Oxygen
[Partial
pressure]
in
Mixed
venous
blood
|
|
19212-0
|
Carbon
dioxide
[Partial
pressure]
in
Mixed
venous
blood
|
|
19213-8
|
pH
of
Mixed
venous
blood
|
|
19223-7
|
Carbon
dioxide,
total
[Moles/volume]
in
Mixed
venous
blood
|
|
19229-4
|
Bicarbonate
[Moles/volume]
in
Mixed
venous
blood
|
|
19239-3
|
Lactate
[Moles/volume]
in
Capillary
blood
|
|
19240-1
|
Lactate
[Moles/volume]
in
Mixed
venous
blood
|
|
19243-5
|
Brucella
abortus
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
19245-0
|
Clonazepam
[Presence]
in
Urine
|
|
19247-6
|
Doxepin+Metabolites
[Mass/volume]
in
Urine
|
|
19253-4
|
Trichinella
spiralis
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
19259-1
|
Neisseria
meningitidis
A+C+w135+Y
Ag
[Presence]
in
Unspecified
specimen
by
Latex
agglutination
|
|
19260-9
|
Neisseria
meningitidis
B+Escherichia
coli
K1
Ag
[Presence]
in
Unspecified
specimen
by
Latex
agglutination
|
|
19261-7
|
Amphetamines
[Presence]
in
Urine
by
Screen
method
|
|
19270-8
|
Barbiturates
[Presence]
in
Urine
by
Screen
method
|
|
1928-1
|
Immunoglobulin
light
chains
[Presence]
in
Urine
|
|
19289-8
|
Cannabinoids
[Presence]
in
Urine
by
Confirmatory
method
|
|
1929-9
|
Immunoglobulin
light
chains
[Mass/volume]
in
Urine
|
|
19290-6
|
Cannabinoids
positive
[Identifier]
in
Urine
by
Confirmatory
method
|
|
19295-5
|
Opiates
[Presence]
in
Urine
by
Screen
method
|
|
19298-9
|
Opiates
positive
[Identifier]
in
Urine
by
Confirmatory
method
|
|
1930-7
|
Benzoate
[Mass/volume]
in
Serum
or
Plasma
|
|
19303-7
|
Thiazides
[Presence]
in
Urine
by
Screen
method
|
|
19306-0
|
Thiazides
[Presence]
in
Urine
by
Confirmatory
method
|
|
19312-8
|
Tricyclic
antidepressants
[Presence]
in
Urine
by
Screen
method
|
|
19315-1
|
Tricyclic
antidepressants
[Presence]
in
Urine
by
Confirmatory
method
|
|
19321-9
|
6-Monoacetylmorphine
(6-MAM)
[Presence]
in
Urine
by
Screen
method
|
|
19322-7
|
6-Monoacetylmorphine
(6-MAM)
[Presence]
in
Urine
by
Confirmatory
method
|
|
19325-0
|
Alpha
hydroxyalprazolam
[Presence]
in
Urine
by
Screen
method
|
|
19326-8
|
Alpha
hydroxyalprazolam
[Presence]
in
Urine
by
Confirmatory
method
|
|
19328-4
|
Alpha
hydroxyalprazolam
[Mass/volume]
in
Urine
|
|
19331-8
|
Amitriptyline
[Presence]
in
Urine
by
Screen
method
|
|
19335-9
|
Amitriptyline+Nortriptyline
[Presence]
in
Urine
by
Screen
method
|
|
19336-7
|
Amitriptyline+Nortriptyline
[Presence]
in
Urine
by
Confirmatory
method
|
|
19339-1
|
Amobarbital
[Presence]
in
Urine
by
Screen
method
|
|
19341-7
|
Amobarbital
cutoff
[Mass/volume]
in
Urine
for
Screen
method
|
|
19343-3
|
Amphetamine
[Presence]
in
Urine
by
Screen
method
|
|
19344-1
|
Amphetamine
[Presence]
in
Urine
by
Confirmatory
method
|
|
19346-6
|
Amphetamine
[Mass/volume]
in
Urine
|
|
19349-0
|
Aprobarbital
[Presence]
in
Urine
by
Screen
method
|
|
19350-8
|
Aprobarbital
[Presence]
in
Urine
by
Confirmatory
method
|
|
19353-2
|
Barbital
[Presence]
in
Urine
by
Screen
method
|
|
19354-0
|
Barbital
[Presence]
in
Urine
by
Confirmatory
method
|
|
19359-9
|
Cocaine
[Presence]
in
Urine
by
Screen
method
|
|
19360-7
|
Cocaine
[Presence]
in
Urine
by
Confirmatory
method
|
|
19364-9
|
Bromazepam
[Presence]
in
Urine
by
Screen
method
|
|
19365-6
|
Bromazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
19368-0
|
Butabarbital
[Presence]
in
Urine
by
Screen
method
|
|
1937-2
|
Beta
endorphin
[Mass/volume]
in
Serum
or
Plasma
|
|
19370-6
|
Butabarbital
[Mass/volume]
in
Urine
|
|
19373-0
|
Butalbital
[Presence]
in
Urine
by
Screen
method
|
|
19377-1
|
Butorphanol
[Presence]
in
Urine
by
Screen
method
|
|
19378-9
|
Butorphanol
[Presence]
in
Urine
by
Confirmatory
method
|
|
1938-0
|
Beta
fructofuranosidase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
19381-3
|
Carboxy
tetrahydrocannabinol
[Presence]
in
Urine
by
Screen
method
|
|
19382-1
|
Carboxy
tetrahydrocannabinol
[Presence]
in
Urine
by
Confirmatory
method
|
|
19385-4
|
Chlordiazepoxide
[Presence]
in
Urine
by
Screen
method
|
|
19386-2
|
Chlordiazepoxide
[Presence]
in
Urine
by
Confirmatory
method
|
|
19389-6
|
Chlorpheniramine
[Presence]
in
Urine
by
Screen
method
|
|
1939-8
|
Beta
fructofuranosidase
[Enzymatic
activity/volume]
in
Serum
|
|
19391-2
|
Chlorpheniramine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
19392-0
|
Chlorpheniramine
[Mass/volume]
in
Urine
|
|
19395-3
|
Chlorpromazine
[Presence]
in
Urine
by
Screen
method
|
|
19396-1
|
Chlorpromazine
[Presence]
in
Urine
by
Confirmatory
method
|
|
19399-5
|
Clonazepam
[Presence]
in
Urine
by
Screen
method
|
|
1940-6
|
Beta
galactosidase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
19402-7
|
Clonazepam
[Mass/volume]
in
Urine
|
|
19405-0
|
Cocaethylene
[Presence]
in
Urine
by
Screen
method
|
|
19406-8
|
Cocaethylene
[Presence]
in
Urine
by
Confirmatory
method
|
|
19408-4
|
Cocaethylene
[Mass/volume]
in
Urine
|
|
1941-4
|
Beta
galactosidase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
19411-8
|
Codeine
[Presence]
in
Urine
by
Screen
method
|
|
19415-9
|
Tetrahydrocannabinol
[Presence]
in
Urine
by
Screen
method
|
|
19416-7
|
Tetrahydrocannabinol
[Presence]
in
Urine
by
Confirmatory
method
|
|
19419-1
|
Dextroamphetamine
[Presence]
in
Urine
by
Screen
method
|
|
1942-2
|
Beta
galactosidase
[Enzymatic
activity/mass]
in
Tissue
|
|
19420-9
|
Dextroamphetamine
[Presence]
in
Urine
by
Confirmatory
method
|
|
19423-3
|
Dextromethamphetamine
[Presence]
in
Urine
by
Screen
method
|
|
19424-1
|
Dextromethamphetamine
[Presence]
in
Urine
by
Confirmatory
method
|
|
19425-8
|
Dextromethamphetamine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
19429-0
|
Propoxyphene
[Presence]
in
Urine
by
Screen
method
|
|
1943-0
|
Acid
beta
glucosidase
[Enzymatic
activity/volume]
in
Leukocytes
|
|
19433-2
|
Propoxyphene
+
Norpropoxyphene
[Presence]
in
Urine
by
Screen
method
|
|
19434-0
|
Propoxyphene
+
Norpropoxyphene
[Presence]
in
Urine
by
Confirmatory
method
|
|
19435-7
|
Propoxyphene
+
Norpropoxyphene
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
19436-5
|
Propoxyphene
+
Norpropoxyphene
[Mass/volume]
in
Urine
|
|
19439-9
|
Diamorphine
[Presence]
in
Urine
by
Screen
method
|
|
1944-8
|
Beta
glucuronidase
[Enzymatic
activity/mass]
in
Tissue
|
|
19443-1
|
Diazepam
[Presence]
in
Urine
by
Screen
method
|
|
19446-4
|
Dihydrocodeine
[Presence]
in
Urine
by
Screen
method
|
|
19448-0
|
Dihydrocodeine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
19449-8
|
Dihydrocodeine
[Mass/volume]
in
Urine
|
|
1945-5
|
Beta
glucuronidase
[Enzymatic
activity/volume]
in
Urine
|
|
19452-2
|
Dimetamphetamine
[Presence]
in
Urine
by
Screen
method
|
|
19453-0
|
Dimetamphetamine
[Presence]
in
Urine
by
Confirmatory
method
|
|
19456-3
|
Ethylamphetamine
[Presence]
in
Urine
by
Screen
method
|
|
19458-9
|
Ethylamphetamine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
19459-7
|
Ethylamphetamine
[Mass/volume]
in
Urine
|
|
1946-3
|
Beta
hydroxybutyrate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
19462-1
|
Ethylmorphine
[Presence]
in
Urine
by
Screen
method
|
|
19463-9
|
Ethylmorphine
[Presence]
in
Urine
by
Confirmatory
method
|
|
19466-2
|
Flunitrazepam
[Presence]
in
Urine
by
Screen
method
|
|
19467-0
|
Flunitrazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
1947-1
|
Beta
hydroxybutyrate
[Mass/volume]
in
Urine
|
|
19470-4
|
Fluoxetine
[Presence]
in
Urine
by
Screen
method
|
|
19471-2
|
Fluoxetine
[Presence]
in
Urine
by
Confirmatory
method
|
|
19474-6
|
Flurazepam
[Presence]
in
Urine
by
Screen
method
|
|
19475-3
|
Flurazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
19478-7
|
Haloperidol
[Presence]
in
Urine
by
Screen
method
|
|
19479-5
|
Haloperidol
[Presence]
in
Urine
by
Confirmatory
method
|
|
19482-9
|
Hydrocodone
[Presence]
in
Urine
by
Screen
method
|
|
19483-7
|
Hydrocodone
[Presence]
in
Urine
by
Confirmatory
method
|
|
19486-0
|
Hydromorphone
[Presence]
in
Urine
by
Screen
method
|
|
19489-4
|
Hydroxyalprazolam
[Presence]
in
Urine
by
Screen
method
|
|
1949-7
|
Beta
lipotropin
[Mass/volume]
in
Serum
or
Plasma
|
|
19490-2
|
Hydroxyalprazolam
[Presence]
in
Urine
by
Confirmatory
method
|
|
19493-6
|
Hydroxyethylflurazepam
[Presence]
in
Urine
by
Screen
method
|
|
19494-4
|
Hydroxyethylflurazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
19497-7
|
Hydroxytriazolam
[Presence]
in
Urine
by
Screen
method
|
|
19499-3
|
Ketamine
[Mass/volume]
in
Urine
by
Screen
method
|
|
1950-5
|
Beta
melanocyte
stimulating
hormone
[Mass/volume]
in
Serum
or
Plasma
|
|
19502-4
|
Methotrimeprazine
[Presence]
in
Urine
by
Screen
method
|
|
19503-2
|
Methotrimeprazine
[Presence]
in
Urine
by
Confirmatory
method
|
|
19506-5
|
Deprecated
Levomepromazine
[Presence]
in
Urine
by
Screen
method
|
|
19507-3
|
Deprecated
Levomepromazine
[Presence]
in
Urine
by
Confirm
method
|
|
1951-3
|
Beta-2-Microglobulin
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
19510-7
|
Levomethamphetamine
[Presence]
in
Urine
by
Screen
method
|
|
19511-5
|
Levomethamphetamine
[Presence]
in
Urine
by
Confirmatory
method
|
|
19512-3
|
Levomethamphetamine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
19516-4
|
Levorphanol
[Presence]
in
Urine
by
Screen
method
|
|
1952-1
|
Beta-2-Microglobulin
[Mass/volume]
in
Serum
or
Plasma
|
|
19520-6
|
Lorazepam
[Presence]
in
Urine
by
Screen
method
|
|
19524-8
|
Lormetazepam
[Presence]
in
Urine
by
Screen
method
|
|
19525-5
|
Lormetazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
19528-9
|
Lysergate
diethylamide
[Presence]
in
Urine
by
Screen
method
|
|
1953-9
|
Beta-2-Microglobulin
[Mass/volume]
in
Urine
|
|
19532-1
|
Meperidine
[Presence]
in
Urine
by
Screen
method
|
|
19536-2
|
Mephobarbital
[Presence]
in
Urine
by
Screen
method
|
|
19537-0
|
Mephobarbital
[Presence]
in
Urine
by
Confirmatory
method
|
|
19539-6
|
Mephobarbital
[Mass/volume]
in
Urine
|
|
1954-7
|
Beta-N-acetylhexosaminidase
[Enzymatic
activity/volume]
in
Serum
|
|
19542-0
|
Mescaline
[Presence]
in
Urine
by
Screen
method
|
|
19543-8
|
Mescaline
[Presence]
in
Urine
by
Confirmatory
method
|
|
19546-1
|
Mesoridazine
[Presence]
in
Urine
by
Screen
method
|
|
19547-9
|
Mesoridazine
[Presence]
in
Urine
by
Confirmatory
method
|
|
1955-4
|
Beta-N-acetylhexosaminidase
[Enzymatic
activity/mass]
in
Tissue
|
|
19550-3
|
Methadone
[Presence]
in
Urine
by
Screen
method
|
|
19554-5
|
Methamphetamine
[Presence]
in
Urine
by
Screen
method
|
|
19555-2
|
Methamphetamine
[Presence]
in
Urine
by
Confirmatory
method
|
|
19558-6
|
Methaqualone
[Presence]
in
Urine
by
Screen
method
|
|
1956-2
|
Beta-N-acetylhexosaminidase.A
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
19561-0
|
Methylenediamine
[Presence]
in
Urine
by
Screen
method
|
|
19562-8
|
Methylenediamine
[Presence]
in
Urine
by
Confirmatory
method
|
|
19565-1
|
Methylenedioxyamphetamine
[Presence]
in
Urine
by
Screen
method
|
|
19566-9
|
Methylenedioxyamphetamine
[Presence]
in
Urine
by
Confirmatory
method
|
|
19568-5
|
Methylenedioxymethamphetamine
[Presence]
in
Urine
by
Screen
method
|
|
19569-3
|
Methylenedioxymethamphetamine
[Presence]
in
Urine
by
Confirmatory
method
|
|
1957-0
|
Beta-N-acetylhexosaminidase.B
[Enzymatic
activity/volume]
in
Serum
|
|
19570-1
|
Methylenedioxymethamphetamine
[Mass/volume]
in
Urine
|
|
19573-5
|
Methylephedrine
[Presence]
in
Urine
by
Screen
method
|
|
19577-6
|
Methylphenidate
[Presence]
in
Urine
by
Screen
method
|
|
19578-4
|
Methylphenidate
[Presence]
in
Urine
by
Confirmatory
method
|
|
1958-8
|
Beta-N-acetylhexosaminidase.I
[Enzymatic
activity/volume]
in
Serum
|
|
19581-8
|
Methyprylon
[Presence]
in
Urine
by
Screen
method
|
|
19585-9
|
Midazolam
[Presence]
in
Urine
by
Screen
method
|
|
19586-7
|
Midazolam
[Presence]
in
Urine
by
Confirmatory
method
|
|
19588-3
|
Midazolam
[Mass/volume]
in
Urine
|
|
1959-6
|
Bicarbonate
[Moles/volume]
in
Blood
|
|
19593-3
|
6-Monoacetylmorphine
(6-MAM)
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
19597-4
|
Morphine
[Presence]
in
Urine
by
Screen
method
|
|
1960-4
|
Bicarbonate
[Moles/volume]
in
Arterial
blood
|
|
19601-4
|
Morphine
Free
[Presence]
in
Urine
by
Screen
method
|
|
19602-2
|
Morphine
Free
[Presence]
in
Urine
by
Confirmatory
method
|
|
19605-5
|
Nalbuphine
[Presence]
in
Urine
by
Screen
method
|
|
19609-7
|
Naltrexone
[Presence]
in
Urine
by
Screen
method
|
|
1961-2
|
Bicarbonate
[Moles/volume]
in
Capillary
blood
|
|
19610-5
|
Naltrexone
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
19611-3
|
Naltrexone
[Mass/volume]
in
Urine
|
|
19614-7
|
N-desalkylflurazepam
[Presence]
in
Urine
by
Screen
method
|
|
19615-4
|
N-desalkylflurazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
19617-0
|
N-desalkylflurazepam
[Mass/volume]
in
Urine
|
|
1962-0
|
Bicarbonate
[Moles/volume]
in
Plasma
|
|
19620-4
|
Nitrazepam
[Presence]
in
Urine
by
Screen
method
|
|
19621-2
|
Nitrazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
19624-6
|
Nordiazepam
[Presence]
in
Urine
by
Screen
method
|
|
19628-7
|
Norfluoxetine
[Presence]
in
Urine
by
Screen
method
|
|
19629-5
|
Norfluoxetine
[Presence]
in
Urine
by
Confirmatory
method
|
|
1963-8
|
Bicarbonate
[Moles/volume]
in
Serum
|
|
19632-9
|
Norpropoxyphene
[Presence]
in
Urine
by
Screen
method
|
|
19635-2
|
Norpropoxyphene
[Mass/volume]
in
Urine
|
|
19638-6
|
Oxazepam
[Presence]
in
Urine
by
Screen
method
|
|
19639-4
|
Oxazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
1964-6
|
Bicarbonate
[Moles/volume]
in
Urine
|
|
19642-8
|
Oxycodone
[Presence]
in
Urine
by
Screen
method
|
|
19643-6
|
Oxycodone
[Presence]
in
Urine
by
Confirmatory
method
|
|
19646-9
|
Oxymorphone
[Presence]
in
Urine
by
Screen
method
|
|
19648-5
|
Oxymorphone
[Mass/volume]
in
Urine
|
|
1965-3
|
Bile
[Presence]
in
Stool
|
|
19651-9
|
Para
hydroxyamphetamine
[Presence]
in
Urine
by
Screen
method
|
|
19652-7
|
Para
hydroxyamphetamine
[Presence]
in
Urine
by
Confirmatory
method
|
|
19655-0
|
Pentobarbital
[Presence]
in
Urine
by
Screen
method
|
|
19659-2
|
Phencyclidine
[Presence]
in
Urine
by
Screen
method
|
|
1966-1
|
Bile
acid
[Mass/volume]
in
Exhaled
gas
|
|
19662-6
|
Phenmetrazine
[Presence]
in
Urine
by
Screen
method
|
|
19666-7
|
Phenobarbital
[Presence]
in
Urine
by
Screen
method
|
|
1967-9
|
Bile
acid
[Mass/volume]
in
Serum
|
|
19670-9
|
Phenothiazines
[Presence]
in
Urine
by
Screen
method
|
|
19674-1
|
Phentermine
[Presence]
in
Urine
by
Screen
method
|
|
19678-2
|
Prazepam
[Presence]
in
Urine
by
Screen
method
|
|
19679-0
|
Prazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
1968-7
|
Bilirubin.direct
[Mass/volume]
in
Serum
or
Plasma
|
|
19682-4
|
Psilocin
[Presence]
in
Urine
by
Screen
method
|
|
19683-2
|
Psilocin
[Presence]
in
Urine
by
Confirmatory
method
|
|
19686-5
|
Psilocybin
[Presence]
in
Urine
by
Screen
method
|
|
19687-3
|
Psilocybin
[Presence]
in
Urine
by
Confirmatory
method
|
|
19688-1
|
Psilocybin
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
1969-5
|
Bilirubin.total
renal
clearance
in
24
hour
|
|
19692-3
|
Secobarbital
[Presence]
in
Urine
by
Screen
method
|
|
19695-6
|
Secobarbital
[Mass/volume]
in
Urine
|
|
19698-0
|
Temazepam
[Presence]
in
Urine
by
Screen
method
|
|
1970-3
|
Bilirubin.delta
[Mass/volume]
in
Serum
or
Plasma
|
|
19702-0
|
Deprecated
Tetrahydrocannabinol
[Presence]
in
Urine
by
Screen
method
|
|
19703-8
|
Deprecated
Tetrahydrocannabinol
[Presence]
in
Urine
by
Confirm
method
|
|
19706-1
|
Thioridazine
[Presence]
in
Urine
by
Screen
method
|
|
19707-9
|
Thioridazine
[Presence]
in
Urine
by
Confirmatory
method
|
|
1971-1
|
Bilirubin.indirect
[Mass/volume]
in
Serum
or
Plasma
|
|
19710-3
|
Tramadol
[Presence]
in
Urine
by
Screen
method
|
|
19714-5
|
Triazolam
[Presence]
in
Urine
by
Screen
method
|
|
19718-6
|
Trichlorothiazide
[Presence]
in
Urine
by
Screen
method
|
|
19719-4
|
Trichlorothiazide
[Presence]
in
Urine
by
Confirmatory
method
|
|
1972-9
|
Bilirubin.total
[Mass/volume]
in
Amniotic
fluid
|
|
19720-2
|
Trichlorothiazide
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
19721-0
|
Trichlorothiazide
[Mass/volume]
in
Urine
|
|
19724-4
|
Abachi
Wood
Dust
IgE
Ab
[Units/volume]
in
Serum
|
|
19725-1
|
Aspergillus
flavus
IgG
Ab
[Presence]
in
Serum
|
|
19726-9
|
Aspergillus
fumigatus
IgG
Ab
[Presence]
in
Serum
|
|
19727-7
|
Aspergillus
niger
IgG
Ab
[Presence]
in
Serum
|
|
19728-5
|
Beet
IgE
Ab
[Units/volume]
in
Serum
|
|
19729-3
|
Blue
vetch
IgE
Ab
[Units/volume]
in
Serum
|
|
1973-7
|
Bilirubin.total
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
19730-1
|
Deprecated
Budgerigar
droppings
IgE
Ab
[Units/volume]
in
Serum
|
|
19731-9
|
Deprecated
Budgerigar
serum
proteins
IgE
Ab
[Units/volume]
in
Serum
|
|
19732-7
|
Cat
serum
albumin
IgE
Ab
[Units/volume]
in
Serum
|
|
19733-5
|
Cefaclor
IgE
Ab
[Units/volume]
in
Serum
|
|
19734-3
|
Chicken
droppings
IgE
Ab
[Units/volume]
in
Serum
|
|
19735-0
|
Deprecated
Cocksfoot
IgE
Ab
[Units/volume]
in
Serum
|
|
19736-8
|
Coralbumin
IgE
Ab
[Units/volume]
in
Serum
|
|
19737-6
|
Cotton
fibers
IgE
Ab
[Units/volume]
in
Serum
|
|
19738-4
|
Dog
serum
albumin
IgE
Ab
[Units/volume]
in
Serum
|
|
19739-2
|
Fenugreek
IgE
Ab
[Units/volume]
in
Serum
|
|
1974-5
|
Bilirubin.total
[Mass/volume]
in
Body
fluid
|
|
19740-0
|
Fox
epithelium
IgE
Ab
[Units/volume]
in
Serum
|
|
19741-8
|
Hake
IgE
Ab
[Units/volume]
in
Serum
|
|
19742-6
|
Hexahydrophthalic
anhydride
(HHPA)
IgE
Ab
[Units/volume]
in
Serum
|
|
19743-4
|
Horse
meat
IgE
Ab
[Units/volume]
in
Serum
|
|
19744-2
|
Jackfruit
IgE
Ab
[Units/volume]
in
Serum
|
|
19745-9
|
Deprecated
Flax
IgE
Ab
[Units/volume]
in
Serum
|
|
19746-7
|
Maleic
anhydride
IgE
Ab
[Units/volume]
in
Serum
|
|
19747-5
|
Mealworm
IgE
Ab
[Units/volume]
in
Serum
|
|
19748-3
|
Methyltetrahydrophthalic
anhydride
(MTHPA)
IgE
Ab
[Units/volume]
in
Serum
|
|
19749-1
|
Saccharopolyspora
rectivirgula
IgG
Ab
[Presence]
in
Serum
|
|
1975-2
|
Bilirubin.total
[Mass/volume]
in
Serum
or
Plasma
|
|
19750-9
|
Deprecated
Mint
IgE
Ab
[Units/volume]
in
Serum
|
|
19751-7
|
Mouse
epithelium,
serum
proteins
+
urine
proteins
IgE
Ab
[Units/volume]
in
Serum
|
|
19752-5
|
Pigeon
serum
IgG
Ab
[Presence]
in
Serum
|
|
19753-3
|
Rat
epithelium,
serum
proteins
+
urine
proteins
IgE
Ab
[Units/volume]
in
Serum
|
|
19754-1
|
Red
Currant
IgE
Ab
[Units/volume]
in
Serum
|
|
19755-8
|
Saffron
IgE
Ab
[Units/volume]
in
Serum
|
|
19756-6
|
Sheep
milk
IgE
Ab
[Units/volume]
in
Serum
|
|
19757-4
|
Sheep
whey
IgE
Ab
[Units/volume]
in
Serum
|
|
19758-2
|
Silk
waste
IgE
Ab
[Units/volume]
in
Serum
|
|
19759-0
|
Swine
serum
albumin
IgE
Ab
[Units/volume]
in
Serum
|
|
1976-0
|
Bilirubin.total
[Presence]
in
Stool
|
|
19760-8
|
Clostridium
tetani
toxoid
IgE
Ab
[Units/volume]
in
Serum
|
|
19761-6
|
Thermoactinomyces
vulgaris
IgG
Ab
[Presence]
in
Serum
|
|
19765-7
|
Microscopic
observation
[Identifier]
in
Cervical
or
vaginal
smear
or
scraping
by
Cyto
stain
|
|
19766-5
|
Microscopic
observation
[Identifier]
in
Cervical
or
vaginal
smear
or
scraping
by
Cyto
stain
Narrative
|
|
1977-8
|
Bilirubin.total
[Presence]
in
Urine
|
|
1978-6
|
Bilirubin.total
[Mass/volume]
in
Urine
|
|
1979-4
|
Biopterin
[Mass/volume]
in
24
hour
Urine
|
|
1980-2
|
Biotin
[Mass/volume]
in
Serum
or
Plasma
|
|
1981-0
|
Biotinidase
[Presence]
in
Blood
|
|
1982-8
|
Biotinidase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
1983-6
|
Bradykinin
[Mass/volume]
in
Serum
or
Plasma
|
|
1984-4
|
Bromide
[Mass/volume]
in
Serum
or
Plasma
|
|
1985-1
|
Bromide
[Mass/volume]
in
Urine
|
|
1986-9
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
|
|
1987-7
|
C
peptide
[Mass/volume]
in
Urine
|
|
1988-5
|
C
reactive
protein
[Mass/volume]
in
Serum
or
Plasma
|
|
1989-3
|
Calcidiol
[Mass/volume]
in
Serum
or
Plasma
|
|
1990-1
|
Cholecalciferol
(Vit
D3)
[Mass/volume]
in
Serum
or
Plasma
|
|
1991-9
|
Calciferol
binding
proteins
[Mass/volume]
in
Serum
|
|
1992-7
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
|
|
1993-5
|
Calcium
renal
clearance
in
24
hour
|
|
1994-3
|
Calcium.ionized
[Moles/volume]
in
Blood
|
|
1995-0
|
Calcium.ionized
[Moles/volume]
in
Serum
or
Plasma
|
|
1996-8
|
Calcium
[Moles/volume]
in
Blood
|
|
1997-6
|
Calcium
[Moles/volume]
in
Cerebral
spinal
fluid
|
|
1998-4
|
Calcium
[Moles/volume]
in
Dialysis
fluid
|
|
1999-2
|
Calcium
[Moles/volume]
in
Semen
|
|
2000-8
|
Calcium
[Moles/volume]
in
Serum
or
Plasma
|
|
2001-6
|
Calcium
[Moles/volume]
in
24
hour
Stool
|
|
2002-4
|
Calcium
[Moles/volume]
in
Stool
|
|
2004-0
|
Calcium
[Moles/volume]
in
Urine
|
|
2005-7
|
Calcium
[Moles/time]
in
2
hour
Urine
--12
hours
fasting
|
|
2006-5
|
Cancer
Ag
125
[Presence]
in
Serum
or
Plasma
|
|
2007-3
|
Cancer
Ag
15-3
[Presence]
in
Serum
or
Plasma
|
|
2009-9
|
Cancer
Ag
19-9
[Presence]
in
Serum
or
Plasma
|
|
2011-5
|
Cancer
Ag
242
[Presence]
in
Serum
or
Plasma
|
|
2012-3
|
Cancer
Ag
27-29
[Presence]
in
Serum
or
Plasma
|
|
2013-1
|
Cancer
Ag
50
[Presence]
in
Serum
or
Plasma
|
|
2014-9
|
Cancer
Ag
549
[Presence]
in
Serum
or
Plasma
|
|
2015-6
|
Cancer
Ag
72-4
[Presence]
in
Serum
or
Plasma
|
|
2016-4
|
Carbamoyl
phosphate
synthetase
[Enzymatic
activity/volume]
in
Serum
|
|
2017-2
|
Carbamoyl
phosphate
synthetase
(ammonia)
[Enzymatic
activity/mass]
in
Tissue
|
|
2018-0
|
Carbon
dioxide
[Partial
pressure]
in
Amniotic
fluid
|
|
2019-8
|
Carbon
dioxide
[Partial
pressure]
in
Arterial
blood
|
|
2020-6
|
Carbon
dioxide
[Partial
pressure]
in
Capillary
blood
|
|
2021-4
|
Carbon
dioxide
[Partial
pressure]
in
Venous
blood
|
|
2022-2
|
Carbon
dioxide
[Partial
pressure]
in
Cerebral
spinal
fluid
|
|
2023-0
|
Carbon
dioxide
[Partial
pressure]
in
Body
fluid
|
|
2024-8
|
Carbon
dioxide
dissolved
[Moles/volume]
in
Plasma
|
|
2025-5
|
Carbon
dioxide
dissolved
[Moles/volume]
in
Red
Blood
Cells
|
|
2026-3
|
Carbon
dioxide,
total
[Moles/volume]
in
Arterial
blood
|
|
2027-1
|
Carbon
dioxide,
total
[Moles/volume]
in
Venous
blood
|
|
2028-9
|
Carbon
dioxide,
total
[Moles/volume]
in
Serum
or
Plasma
|
|
2033-9
|
Carbonate
[Mass/volume]
in
Arterial
blood
|
|
2034-7
|
Carbonate
[Mass/volume]
in
Venous
blood
|
|
2035-4
|
Carbonate
[Mass/volume]
in
Plasma
|
|
2036-2
|
Carbonate
dehydratase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
2037-0
|
Carcinoembryonic
Ag
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
2038-8
|
Carcinoembryonic
Ag
[Mass/volume]
in
Semen
|
|
2039-6
|
Carcinoembryonic
Ag
[Mass/volume]
in
Serum
or
Plasma
|
|
20398-4
|
Nuclear
Ab
Pattern
Homogenous
[Titer]
in
Serum
|
|
20399-2
|
Nuclear
Ab
pattern.nucleolar
[Titer]
in
Serum
|
|
2040-4
|
Cardiolipin
[Mass/volume]
in
Serum
|
|
20400-8
|
Nuclear
Ab
pattern.rim
[Titer]
in
Serum
|
|
20401-6
|
Nuclear
Ab
pattern.speckled
[Titer]
in
Serum
|
|
20402-4
|
CD16+CD56+
cells
[#/volume]
in
Blood
|
|
20403-2
|
Fibronectin.fetal
[Mass/volume]
in
Vaginal
fluid
|
|
20404-0
|
Fibronectin.fetal
[Presence]
in
Vaginal
fluid
|
|
20405-7
|
Urobilinogen
[Mass/volume]
in
Urine
by
Test
strip
|
|
20406-5
|
Deprecated
Glucose
[Mass/volume]
in
Urine
by
Test
strip
|
|
2041-2
|
Carnitine
acyltransferase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
20410-7
|
Amphetamines
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20411-5
|
Barbiturates
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20412-3
|
Benzodiazepines
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20413-1
|
Cannabinoids
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20414-9
|
Thiazides
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20415-6
|
Choriogonadotropin.beta
subunit
[Units/volume]
in
Serum
or
Plasma
by
Immunoassay
(EIA)
3rd
IS
|
|
20416-4
|
Hepatitis
C
virus
RNA
[#/volume]
(viral
load)
in
Serum
or
Plasma
by
Probe
and
target
amplification
method
|
|
20417-2
|
Histoplasma
capsulatum
mycelial
phase
Ab
[Titer]
in
Serum
|
|
20418-0
|
Histoplasma
capsulatum
yeast
phase
Ab
[Titer]
in
Serum
|
|
20419-8
|
Lutropin
[Units/volume]
in
Serum
or
Plasma
by
1st
IRP
|
|
2042-0
|
Carnitine
free
(C0)
[Presence]
in
Serum
or
Plasma
|
|
20420-6
|
Prostatic
acid
phosphatase
[Mass/volume]
in
Serum
|
|
20421-4
|
Barbiturates
[Presence]
in
Serum
or
Plasma
by
Screen
method
|
|
20423-0
|
Beta
lactamase
organism
identified
in
Isolate
|
|
20427-1
|
Acetylcholine
receptor
Ab
[Moles/volume]
in
Serum
|
|
20428-9
|
Phospholipid
IgG
Ab
[Presence]
in
Serum
|
|
20429-7
|
Phospholipid
IgM
Ab
[Presence]
in
Serum
|
|
2043-8
|
Carnitine
free
(C0)
[Mass/volume]
in
Serum
or
Plasma
|
|
20430-5
|
Culture
medium
[Type]
in
Isolate
|
|
20431-3
|
Microscopic
observation
[Identifier]
in
Unspecified
specimen
by
Smear
|
|
20432-1
|
Epstein
Barr
virus
nuclear
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
20433-9
|
Follitropin
[Units/volume]
in
Serum
or
Plasma
by
2nd
IRP
|
|
20434-7
|
Prolactin
[Units/volume]
in
Serum
or
Plasma
by
3rd
IS
|
|
20435-4
|
Unidentified
extractable
nuclear
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
20436-2
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
dose
glucose
|
|
20438-8
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
dose
glucose
|
|
2044-6
|
Carnitine
[Mass/volume]
in
Semen
|
|
20442-0
|
Hepatitis
B
virus
DNA
[#/volume]
(viral
load)
in
Serum
by
Probe
and
signal
amplification
method
|
|
20444-6
|
Herpes
simplex
virus
1+2
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
20445-3
|
Herpes
virus
identified
in
Unspecified
specimen
by
Organism
specific
culture
|
|
20447-9
|
HIV
1
RNA
[#/volume]
(viral
load)
in
Serum
or
Plasma
by
Probe
and
target
amplification
method
|
|
20448-7
|
Insulin
[Units/volume]
in
Serum
or
Plasma
|
|
20449-5
|
Borrelia
burgdorferi
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
2045-3
|
Carnitine
[Presence]
in
Serum
or
Plasma
|
|
20451-1
|
Thyroxine
(T4)
[Presence]
in
Blood
|
|
20452-9
|
Thyrotropin
[Presence]
in
Blood
|
|
20459-4
|
Streptococcus
agalactiae
Ag
[Presence]
in
Unspecified
specimen
by
Latex
agglutination
|
|
2046-1
|
Carnitine
[Mass/volume]
in
Serum
or
Plasma
|
|
20463-6
|
Mycobacterium
avium
complex
rRNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
20468-5
|
Thiamine
[Moles/volume]
in
Serum
or
Plasma
|
|
20469-3
|
Acetone
[Presence]
in
Serum
or
Plasma
by
Screen
method
|
|
2047-9
|
Carnitine
[Mass/volume]
in
Urine
|
|
20470-1
|
Ethanol
[Presence]
in
Serum
or
Plasma
by
Screen
method
|
|
20471-9
|
Isopropanol
[Presence]
in
Serum
or
Plasma
by
Screen
method
|
|
20474-3
|
Bacteria
identified
in
Tissue
by
Biopsy
culture
|
|
20479-2
|
Measles
virus
IgG
Ab
[Presence]
in
Serum
|
|
20483-4
|
Mitochondria
Ab
[Titer]
in
Serum
|
|
20484-2
|
Cardiolipin
IgG
Ab
[Titer]
in
Serum
|
|
20485-9
|
Cardiolipin
IgM
Ab
[Titer]
in
Serum
|
|
20486-7
|
Haemophilus
influenzae
B
Ag
[Units/volume]
in
Cerebral
spinal
fluid
|
|
20487-5
|
Neisseria
meningitidis
A+Y
Ag
[Presence]
in
Cerebral
spinal
fluid
|
|
20488-3
|
Streptococcus
agalactiae
Ag
[Presence]
in
Cerebral
spinal
fluid
|
|
20489-1
|
Streptococcus
pneumoniae
Ag
[Presence]
in
Cerebral
spinal
fluid
|
|
20490-9
|
Epstein
Barr
virus
capsid
IgG
Ab
[Titer]
in
Serum
|
|
20491-7
|
Epstein
Barr
virus
capsid
IgM
Ab
[Titer]
in
Serum
|
|
20495-8
|
Gliadin
IgA
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
20496-6
|
Gliadin
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
20497-4
|
Histoplasma
capsulatum
mycelial
phase
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
20498-2
|
Histoplasma
capsulatum
yeast
phase
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
20500-5
|
Hydroxyalprazolam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20501-3
|
Hydroxytriazolam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20502-1
|
Clue
cells
[Presence]
in
Vaginal
fluid
by
Wet
preparation
|
|
20507-0
|
Reagin
Ab
[Presence]
in
Serum
by
RPR
|
|
20508-8
|
Reagin
Ab
[Units/volume]
in
Serum
by
RPR
|
|
20514-6
|
Deprecated
6-Monoacetylmorphine
[Mass/volume]
in
Urine
Confirm
|
|
20515-3
|
Amitriptyline
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20516-1
|
Amitriptyline+Nortriptyline
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20517-9
|
Aprobarbital
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20518-7
|
Barbital
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20519-5
|
Cocaine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
2052-9
|
Carotene
[Mass/volume]
in
Blood
|
|
20520-3
|
Bromazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20521-1
|
Carboxy
tetrahydrocannabinol
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20522-9
|
Chlordiazepoxide
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20523-7
|
Chlorpromazine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20524-5
|
Deprecated
Tetrahydrocannabinol
[Mass/volume]
in
Urine
by
Confirm
method
|
|
20525-2
|
Dextroamphetamine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20526-0
|
Dimetamphetamine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20527-8
|
Ethylmorphine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20528-6
|
Flunitrazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20529-4
|
Fluoxetine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
2053-7
|
Carotene
[Mass/volume]
in
Serum
|
|
20530-2
|
Haloperidol
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20532-8
|
Hydroxyethylflurazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20533-6
|
Hydroxytriazolam
[Presence]
in
Urine
by
Confirmatory
method
|
|
20537-7
|
Ketamine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20538-5
|
Methotrimeprazine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20539-3
|
Deprecated
Levomepromazine
[Mass/volume]
in
Urine
by
Confirm
method
|
|
2054-5
|
Catalase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
20540-1
|
Levorphanol
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20541-9
|
Lormetazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20542-7
|
Lysergate
diethylamide
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20543-5
|
Mescaline
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20544-3
|
Mesoridazine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20545-0
|
Methylenedioxyamphetamine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20547-6
|
Methylephedrine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20548-4
|
Methylphenidate
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20549-2
|
Methyprylon
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
2055-2
|
Catecholamines
[Mass/volume]
in
Blood
|
|
20550-0
|
Morphine
Free
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20551-8
|
Nalbuphine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20552-6
|
Nitrazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20553-4
|
Norfluoxetine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20554-2
|
Para
hydroxyamphetamine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20555-9
|
Phenmetrazine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20556-7
|
Phenothiazines
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20557-5
|
Phentermine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20558-3
|
Psilocin
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20559-1
|
Temazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
2056-0
|
Catecholamines
[Mass/volume]
in
Plasma
|
|
20560-9
|
Thioridazine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20561-7
|
Tramadol
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
20563-3
|
Carboxyhemoglobin/Hemoglobin.total
in
Blood
|
|
20565-8
|
Carbon
dioxide,
total
[Moles/volume]
in
Blood
|
|
20566-6
|
Colony
count
[#/volume]
in
Catheter
tip
by
Culture
|
|
20567-4
|
Ferritin
[Mass/volume]
in
Serum
or
Plasma
by
Immunoassay
|
|
20568-2
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
by
Immunoassay
|
|
2057-8
|
Catecholamines
[Mass/volume]
in
Urine
|
|
20570-8
|
Hematocrit
[Volume
Fraction]
of
Blood
|
|
20571-6
|
Hepatitis
C
virus
RNA
[#/volume]
(viral
load)
in
Serum
or
Plasma
by
Probe
and
signal
amplification
method
|
|
20573-2
|
Histoplasma
capsulatum
mycelial
phase
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
20574-0
|
Histoplasma
capsulatum
yeast
phase
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
20575-7
|
Hepatitis
A
virus
Ab
[Presence]
in
Serum
|
|
20576-5
|
Galactose
1
phosphate
uridyl
transferase
[Presence]
in
Blood
|
|
20578-1
|
Vancomycin
[Mass/volume]
in
Serum
or
Plasma
|
|
20579-9
|
Methanol
[Presence]
in
Serum
or
Plasma
by
Screen
method
|
|
2058-6
|
Catecholamines
[Mass/time]
in
24
hour
Urine
|
|
2059-4
|
Cerebroside
sulfatase
[Presence]
in
Serum
or
Plasma
|
|
20592-2
|
CD19
cells
[#/volume]
in
Unspecified
specimen
|
|
20593-0
|
CD19
cells/100
cells
in
Unspecified
specimen
|
|
20598-9
|
CD3
cells
[#/volume]
in
Unspecified
specimen
|
|
2060-2
|
Cerebroside
sulfatase
[Enzymatic
activity/mass]
in
Tissue
|
|
20603-7
|
CD38
cells/100
cells
in
Unspecified
specimen
|
|
20605-2
|
Deprecated
CD4
cells
[#/volume]
in
Unspecified
specimen
|
|
20608-6
|
CD41
cells/100
cells
in
Unspecified
specimen
|
|
20609-4
|
CD42
cells/100
cells
in
Unspecified
specimen
|
|
2061-0
|
Cerebroside
sulfatase
[Enzymatic
activity/volume]
in
Urine
|
|
20613-6
|
Deprecated
CD8
cells
[#/volume]
in
Unspecified
specimen
|
|
20614-4
|
Deprecated
CD8
cells/100
cells
in
Unspecified
specimen
|
|
2062-8
|
Cerebroside
sulfatase
[Presence]
in
Leukocytes
|
|
20620-1
|
CD16+CD56+
cells/100
cells
in
Unspecified
specimen
|
|
20621-9
|
Albumin/Creatinine
[Presence]
in
Urine
by
Test
strip
|
|
20622-7
|
Cortisol
[Mass/volume]
in
24
hour
Urine
|
|
20624-3
|
Creatinine
[Mass/volume]
in
24
hour
Urine
|
|
20625-0
|
Lead
[Mass/volume]
in
24
hour
Urine
|
|
2063-6
|
Cerebroside
sulfatase
[Enzymatic
activity/volume]
in
Leukocytes
|
|
2064-4
|
Ceruloplasmin
[Mass/volume]
in
Serum
or
Plasma
|
|
20647-4
|
Hydroxyproline
[Moles/volume]
in
Serum
or
Plasma
|
|
20660-7
|
Tyrosine
[Moles/volume]
in
Serum
or
Plasma
|
|
20662-3
|
Allergens
tested
for
in
Serum
|
|
20663-1
|
Tricyclic
antidepressants
[Mass/volume]
in
Urine
by
Screen
method
|
|
20664-9
|
Barbiturates
[Mass/volume]
in
Urine
by
Screen
method
|
|
20665-6
|
Echovirus
14
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
20669-8
|
Cardiolipin
IgA
Ab
[Titer]
in
Serum
|
|
20672-2
|
Actinobacillus
pleuropneumoniae
serotype
[Identifier]
in
Isolate
|
|
20673-0
|
Actinobacillus
pleuropneumoniae
Ab
[Presence]
in
Serum
|
|
20674-8
|
Avian
adenovirus
2
Ag
[Presence]
in
Tissue
by
Immune
diffusion
(ID)
|
|
20675-5
|
Bovine
adenovirus
3
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20676-3
|
Bovine
adenovirus
5
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20677-1
|
Equine
adenovirus
Ag
[Presence]
in
Lung
by
Immunofluorescence
|
|
20678-9
|
Alkaloid
identified
in
Urine
by
Thin
layer
chromatography
(TLC)
|
|
20679-7
|
Alkaloid
identified
in
Plant
by
Thin
layer
chromatography
(TLC)
|
|
2068-5
|
Chloride
[Moles/volume]
in
Amniotic
fluid
|
|
20680-5
|
Alkaloid
identified
in
Ingesta
by
Thin
layer
chromatography
(TLC)
|
|
20681-3
|
Alpha
tocopherol
[Mass/mass]
in
Tissue
|
|
20682-1
|
Ammonia
[Mass/volume]
in
Urine
|
|
20683-9
|
Ammonia
[Mass/volume]
in
Ingesta
|
|
20684-7
|
Ammonia
[Mass/volume]
in
Serum
|
|
20685-4
|
Anaplasma
marginale
Ab
[Presence]
in
Serum
by
Card
agglutination
|
|
20686-2
|
Anaplasma
marginale
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
20687-0
|
Arsenic
[Mass/volume]
in
Gastric
fluid
|
|
20688-8
|
Aspergillus
sp
identified
in
Litter
by
Organism
specific
culture
|
|
20689-6
|
Babesia
caballi
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
2069-3
|
Chloride
[Moles/volume]
in
Blood
|
|
20690-4
|
Theileria
equi
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
20692-0
|
Bacillus
cereus
[Presence]
in
Food
by
Culture
FDA
method
|
|
20693-8
|
Bacteria
identified
in
Litter
by
Aerobe
culture
|
|
20694-6
|
Bacteria
identified
in
embryo
by
Aerobe
culture
|
|
20695-3
|
Bacteria
[#/volume]
in
Mother's
milk
|
|
20696-1
|
Bifidobacterium
sp
[#/volume]
in
Milk
by
Organism
specific
culture
|
|
20697-9
|
Amines.biogenic
[Mass/mass]
in
Feed
|
|
20698-7
|
Bluetongue
virus
serotype
[Identifier]
in
Isolate
|
|
20699-5
|
Bluetongue
virus
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
2070-1
|
Chloride
[Moles/volume]
in
Cerebral
spinal
fluid
|
|
20700-1
|
Bluetongue
virus
RNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
20701-9
|
Bluetongue
virus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20702-7
|
Bluetongue
virus
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
20703-5
|
Border
disease
virus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20704-3
|
Border
disease
virus
Ag
[Presence]
in
Blood
by
Immunofluorescence
|
|
20705-0
|
Clostridium
botulinum
toxin
[Identifier]
in
Serum
by
Animal
inoculation
|
|
20706-8
|
Clostridium
botulinum
toxin
[Identifier]
in
Unspecified
specimen
by
Animal
inoculation
|
|
20708-4
|
Bovine
papular
stomatitis
virus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20709-2
|
Bovine
diarrhea
virus
RNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
2071-9
|
Chloride
[Moles/volume]
in
Dialysis
fluid
|
|
20710-0
|
Bovine
diarrhea
virus
RNA
[Presence]
in
Serum
by
Probe
and
target
amplification
method
|
|
20711-8
|
Bovine
diarrhea
virus
Ag
[Presence]
in
Nose
by
Immunofluorescence
|
|
20712-6
|
Bovine
diarrhea
virus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20713-4
|
Bovine
diarrhea
virus
Ag
[Presence]
in
Blood
by
Immunofluorescence
|
|
20714-2
|
Bovine
diarrhea
virus
Ag
[Presence]
in
Stool
by
Immunofluorescence
|
|
20715-9
|
Bovine
diarrhea
virus
Ag
[Presence]
in
Serum
by
Immune
stain
|
|
20716-7
|
Bovine
diarrhea
virus
[Presence]
in
Serum
by
Organism
specific
culture
|
|
20717-5
|
Bovine
diarrhea
virus
2
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20718-3
|
Bromide
[Mass/volume]
in
Ocular
fluid
|
|
20719-1
|
Brucella
abortus
Ab
[Titer]
in
Serum
by
Tube
agglutination
|
|
2072-7
|
Chloride
[Moles/volume]
in
Body
fluid
|
|
20720-9
|
Brucella
abortus
Ab
[Presence]
in
Milk
by
Serial
ring
agglutination
|
|
20721-7
|
Brucella
abortus
Ab
[Presence]
in
Semen
by
Agglutination
|
|
20722-5
|
Brucella
abortus
Ab
[Titer]
in
Serum
by
Rivanol
agglutination
|
|
20723-3
|
Brucella
abortus
Ab
[Presence]
in
Serum
by
Rapid
agglutination
|
|
20724-1
|
Brucella
abortus
Ab
[Presence]
in
Whey
by
Ring
agglutination
|
|
20725-8
|
Brucella
abortus
Ab
[Presence]
in
Milk
by
Ring
agglutination
|
|
20726-6
|
Brucella
abortus
Ab
[Presence]
in
Serum
by
Card
agglutination
|
|
20727-4
|
Brucella
abortus
Ab
[Presence]
in
Serum
by
Acidified
buffered
plate
agglutination
|
|
20728-2
|
Brucella
abortus
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
20729-0
|
Brucella
abortus
Ab
[Titer]
in
Serum
by
Plate
agglutination
|
|
2073-5
|
Chloride
[Moles/volume]
in
Red
Blood
Cells
|
|
20730-8
|
Brucella
abortus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
20731-6
|
Brucella
abortus
Ab
[Presence]
in
Serum
by
Immunoassay
(EIA)
RST
|
|
20732-4
|
Brucella
ovis
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
20733-2
|
Brucella
ovis
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
20734-0
|
Brucella
sp
identified
in
Tissue
by
Organism
specific
culture
|
|
20735-7
|
Brucella
sp
identified
in
Milk
by
Organism
specific
culture
|
|
20736-5
|
Cache
valley
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
20737-3
|
Cadmium
[Mass/mass]
in
Tissue
|
|
20738-1
|
Campylobacter
sp
identified
in
Isolate
by
Organism
specific
culture
|
|
20739-9
|
Campylobacter
sp
identified
in
Body
fluid
by
Organism
specific
culture
|
|
2074-3
|
Chloride
[Moles/volume]
in
Saliva
(oral
fluid)
|
|
20740-7
|
Campylobacter
sp
identified
in
Tissue
by
Organism
specific
culture
|
|
20741-5
|
Canarypox
virus
Ag
[Presence]
in
Serum
by
Immunofluorescence
|
|
20742-3
|
Canine
distemper
virus
Ag
[Presence]
in
Conjunctival
specimen
by
Immunofluorescence
|
|
20745-6
|
Carbamates
[Presence]
in
Gastric
fluid
by
Screen
method
|
|
20746-4
|
Carbamates
[Presence]
in
Unspecified
specimen
by
Screen
method
|
|
20747-2
|
Carbamates
[Presence]
in
Ingesta
by
Screen
method
|
|
20748-0
|
Carbamates
[Presence]
in
Tissue
by
Screen
method
|
|
20749-8
|
Carbamates
[Presence]
in
Feed
by
Screen
method
|
|
2075-0
|
Chloride
[Moles/volume]
in
Serum
or
Plasma
|
|
20750-6
|
Chicken
anemia
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
20751-4
|
Chicken
anemia
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
20752-2
|
Chlamydophila
psittaci
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
20753-0
|
Chlamydophila
psittaci
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20754-8
|
Chlamydophila
psittaci
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
20755-5
|
Chlamydia
sp
Ag
[Presence]
in
Body
fluid
by
Immunoassay
|
|
20756-3
|
Chlamydia
sp
Ag
[Presence]
in
Stool
by
Immunoassay
|
|
20757-1
|
Chlamydia
sp
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20758-9
|
Cholinesterase
[Enzymatic
activity/mass]
in
Brain
|
|
20759-7
|
Chromium
[Mass/mass]
in
Tissue
|
|
2076-8
|
Chloride
[Moles/mass]
in
Stool
|
|
20760-5
|
Clostridium
chauvoei
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20761-3
|
Clostridium
difficile
[Presence]
in
Stool
by
Agglutination
|
|
20762-1
|
Clostridium
difficile
[Presence]
in
Stool
by
Aerobe
culture
|
|
20763-9
|
Clostridium
novyii
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20764-7
|
Clostridium
perfringens
genotype
[Identifier]
in
Isolate
|
|
20765-4
|
Clostridium
septicum
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20766-2
|
Clostridium
sordellii
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20767-0
|
Coccidioides
immitis
[Presence]
in
Isolate
|
|
20768-8
|
Coccidioides
immitis
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
20769-6
|
Coliform
bacteria
[#/volume]
in
Water
by
Viability
count
|
|
2077-6
|
Chloride
[Moles/volume]
in
Sweat
|
|
20770-4
|
Coliform
bacteria
[#/volume]
by
Viability
count
|
|
20771-2
|
Coliform
bacteria
[#/mass]
in
Egg
by
Viability
count
|
|
20772-0
|
Coliform
colony
count
[#/volume]
in
Milk
|
|
20773-8
|
Colony
count
[#/volume]
in
Milk
by
Culture
Standard
Plate
Count
|
|
20774-6
|
Colony
count
[Units/volume]
in
Unspecified
specimen
by
Visual
count
|
|
20775-3
|
Colony
count
[Units/volume]
in
Unspecified
specimen
by
Viability
count
FDA
method
|
|
20776-1
|
Caprine
parapoxvirus
Ab
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20777-9
|
Caprine
parapoxvirus
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
20778-7
|
Copper
[Mass/volume]
in
Unspecified
specimen
|
|
20779-5
|
Bovine
coronavirus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
2078-4
|
Chloride
[Moles/volume]
in
Urine
|
|
20780-3
|
Cryptosporidium
sp
[Presence]
in
Large
intestine
or
small
intestine
Tissue
by
Acid
fast
stain
|
|
20781-1
|
Cryptosporidium
sp
[Presence]
in
Stool
by
Acid
fast
stain
|
|
20782-9
|
Cyanide
[Mass/mass]
in
Plant
|
|
20783-7
|
Cyanide
[Units/mass]
in
Plant
Qualitative
|
|
20784-5
|
Cyanide
[Mass/volume]
in
Unspecified
specimen
|
|
20785-2
|
Drugs
identified
in
Serum
or
Plasma
by
Screen
method
|
|
20786-0
|
Drugs
identified
in
Tissue
by
Screen
method
|
|
20787-8
|
Drugs
identified
in
Unspecified
specimen
by
Screen
method
|
|
20788-6
|
Duck
enteritis
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
20789-4
|
Escherichia
coli
serotype
[Identifier]
in
Isolate
|
|
2079-2
|
Chloride
[Moles/time]
in
24
hour
Urine
|
|
20790-2
|
Eastern
equine
encephalitis
virus
Ab
[Presence]
in
Serum
by
Hemagglutination
inhibition
|
|
20791-0
|
Eastern
equine
encephalitis
virus
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
20792-8
|
Eastern
equine
encephalitis
virus
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
20793-6
|
Eastern
equine
encephalitis
virus
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
20794-4
|
Eastern
equine
encephalitis
virus
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Complement
fixation
|
|
20795-1
|
Eastern
equine
encephalitis
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
20796-9
|
Endophyte
identified
in
Plant
|
|
20797-7
|
Endotoxin
identified
in
Unspecified
specimen
|
|
20798-5
|
Clostridium
perfringens
enterotoxin
[Presence]
in
Tissue
|
|
20799-3
|
Clostridium
perfringens
enterotoxin
[Presence]
in
Body
fluid
|
|
2080-0
|
Cholate
[Mass/volume]
in
Serum
|
|
20800-9
|
Clostridium
perfringens
enterotoxin
[Presence]
in
Small
intestine
Fixed
|
|
20801-7
|
Encephalitozoon
cuniculi
Ab
[Presence]
in
Serum
|
|
20802-5
|
Epizootic
hemorrhagic
disease
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
20803-3
|
Epizootic
hemorrhagic
disease
virus
Ab
[Presence]
in
Serum
|
|
20804-1
|
Epizootic
hemorrhagic
disease
virus
Ag
[Presence]
in
Blood
by
Immunofluorescence
|
|
20805-8
|
Epizootic
hemorrhagic
disease
virus
Ag
[Units/mass]
in
Lung
Qualitative
by
Immunofluorescence
|
|
20806-6
|
Saint
Louis
encephalitis
virus
Ab
[Presence]
in
Serum
|
|
20807-4
|
Equine
arteritis
virus
[Presence]
in
Blood
by
Organism
specific
culture
|
|
20808-2
|
Ergot
alkaloid
[Mass/volume]
in
Unspecified
specimen
|
|
20809-0
|
Ergot
alkaloid
[Mass/mass]
in
Feed
|
|
2081-8
|
Cholecystokinin
[Mass/volume]
in
Plasma
|
|
20811-6
|
Escherichia
coli
[Presence]
in
Unspecified
specimen
by
Culture
FDA
method
|
|
20812-4
|
Escherichia
coli
987P
[Presence]
in
Small
intestine
Tissue
by
Immunofluorescence
|
|
20813-2
|
Escherichia
coli
F41
[Presence]
in
Isolate
by
Agglutination
|
|
20814-0
|
Escherichia
coli
F41
[Presence]
in
Small
intestine
Tissue
by
Immunofluorescence
|
|
20815-7
|
Escherichia
coli
K88
[Presence]
in
Small
intestine
Tissue
by
Agglutination
|
|
20816-5
|
Escherichia
coli
K88
[Presence]
in
Isolate
by
Agglutination
|
|
20817-3
|
Escherichia
coli
K88
[Presence]
in
Small
intestine
Tissue
by
Immunofluorescence
|
|
20818-1
|
Escherichia
coli
K99
[Presence]
in
Small
intestine
Tissue
by
Agglutination
|
|
20819-9
|
Escherichia
coli
K99
[Presence]
in
Isolate
by
Agglutination
|
|
2082-6
|
Cholestanol
[Mass/volume]
in
Serum
or
Plasma
|
|
20821-5
|
Escherichia
coli
K99
[Presence]
in
Stool
by
Agglutination
|
|
20822-3
|
Escherichia
coli
K99
[Presence]
in
Small
intestine
Tissue
by
Immunofluorescence
|
|
20823-1
|
Escherichia
coli
O157:H7
[Presence]
in
Raw
milk
by
Organism
specific
culture
|
|
20825-6
|
Fumonisin
[Mass/mass]
in
Feed
|
|
20826-4
|
Gallotannin
[Mass/volume]
in
Serum
or
Plasma
|
|
20827-2
|
Gallotannin
[Mass/mass]
in
Gastric
fluid
|
|
20828-0
|
Gallotannin
[Mass/mass]
in
Plant
|
|
20829-8
|
Glycol
[Mass/mass]
in
Tissue
|
|
2083-4
|
Cholesterol
esterase
[Enzymatic
activity/volume]
in
Serum
|
|
20830-6
|
Glycol
[Mass/volume]
in
Urine
|
|
20831-4
|
Glycolate
[Mass/mass]
in
Tissue
|
|
20832-2
|
Gossypol
[Mass/mass]
in
Feed
|
|
20833-0
|
Haemophilus
paragallinarum
serotype
[Identifier]
in
Isolate
|
|
20834-8
|
Deprecated
Herbicide
[Identifier]
in
Unspecified
specimen
|
|
20835-5
|
Herbicide
[Identifier]
in
Ingesta
|
|
20836-3
|
Herbicide
[Identifier]
in
Tissue
|
|
20837-1
|
Herbicide
[Identifier]
in
Feed
|
|
20838-9
|
Herbicide
[Presence]
in
Gastric
fluid
by
Screen
method
|
|
20839-7
|
Herbicide
[Presence]
in
Unspecified
specimen
by
Screen
method
|
|
2084-2
|
Cholesterol
esters
[Mass/volume]
in
Serum
or
Plasma
|
|
20840-5
|
Herbicide
[Presence]
in
Ingesta
by
Screen
method
|
|
20841-3
|
Herbicide
[Presence]
in
Tissue
by
Screen
method
|
|
20842-1
|
Herbicide
[Presence]
in
Feed
by
Screen
method
|
|
20843-9
|
Avian
infectious
laryngotracheitis
virus
Ag
[Presence]
in
Trachea
by
Immunofluorescence
|
|
20844-7
|
Avian
infectious
laryngotracheitis
virus
Ag
[Presence]
in
Lung
tissue
by
Immunofluorescence
|
|
20845-4
|
Bovine
herpesvirus
1
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
20846-2
|
Bovine
herpesvirus
1
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20847-0
|
Bovine
herpesvirus
2
Ag
[Presence]
in
Exudate
by
Immunofluorescence
|
|
20848-8
|
Bovine
herpesvirus
2
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20849-6
|
Bovine
herpesvirus
4
Ag
[Presence]
in
Body
fluid
by
Immunofluorescence
|
|
2085-9
|
Cholesterol
in
HDL
[Mass/volume]
in
Serum
or
Plasma
|
|
20850-4
|
Bovine
herpesvirus
4
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20851-2
|
Bovine
herpesvirus
5
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20852-0
|
Duck
enteritis
virus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20853-8
|
Equine
herpesvirus
1
Ag
[Presence]
in
Tracheal
swab
by
Immunofluorescence
|
|
20854-6
|
Equine
herpesvirus
1
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20855-3
|
IgG.bovine
[Mass/volume]
in
Serum
by
Immune
diffusion
(ID)
|
|
20856-1
|
IgG.equine
[Mass/volume]
in
Body
fluid
from
Fetus
by
Immune
diffusion
(ID)
|
|
20857-9
|
IgG.equine
[Mass/volume]
in
Colostrum
by
Immune
diffusion
(ID)
|
|
20858-7
|
Infectious
bronchitis
virus
genotype
[Identifier]
in
Isolate
by
Polyacrylamide
gel
electrophoresis
(PAGE)
|
|
20859-5
|
Infectious
bronchitis
virus
serotype
[Identifier]
in
Isolate
by
Neutralization
test
|
|
20860-3
|
Infectious
bronchitis
virus
[Presence]
in
Tissue
by
Organism
specific
culture
|
|
20861-1
|
Infectious
bronchitis
virus
genotype
[Identifier]
in
Isolate
by
Probe
and
target
amplification
method
|
|
20862-9
|
Influenza
virus
A
Ab
[Presence]
in
Serum
by
Hemagglutination
inhibition
|
|
20864-5
|
Iodine
[Mass/volume]
in
Milk
|
|
20865-2
|
Iodine
[Mass/mass]
in
Liver
|
|
20866-0
|
Lactobacillus
acidophilus
colony
count
[#/volume]
in
Milk
by
Organism
specific
culture
|
|
20867-8
|
Lead
[Mass/mass]
in
Bone
|
|
20868-6
|
Leptospira
sp
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20869-4
|
Leptospira
sp
[Presence]
in
Tissue
by
Organism
specific
culture
|
|
20870-2
|
Listeria
sp
[Presence]
in
Milk
by
Organism
specific
culture
|
|
20871-0
|
Listeria
sp
[Presence]
in
Cheese
by
Organism
specific
culture
|
|
20872-8
|
Magnesium
[Mass/volume]
in
Ocular
fluid
|
|
20873-6
|
Alcelaphine
herpesvirus
1
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
20874-4
|
Manganese
[Mass/mass]
in
Tissue
|
|
20875-1
|
Manganese
[Mass/mass]
in
Feed
|
|
20876-9
|
Mercury
[Mass/mass]
in
Feed
|
|
20877-7
|
Bacteria
identified
in
Isolate
by
Animal
inoculation
|
|
20878-5
|
Bacteria
identified
in
Isolate
by
Anaerobe
culture
|
|
20879-3
|
Bacteria
identified
in
Milk
by
Aerobe
culture
|
|
20881-9
|
Microscopic
observation
[Identifier]
in
Tissue
by
Electron
microscopy
thin
sectiion
|
|
20882-7
|
Microscopic
observation
[Identifier]
in
Stool
by
Electron
microscopy
negative
stain
|
|
20883-5
|
Microscopic
observation
[Identifier]
in
Urine
by
Dark
field
examination
|
|
20884-3
|
Microscopic
observation
[Identifier]
in
Stool
by
Dark
field
examination
|
|
20885-0
|
Microscopic
observation
[Identifier]
in
Gastric
fluid
by
Dark
field
examination
|
|
20886-8
|
Molybdenum
[Mass/volume]
in
Unspecified
specimen
|
|
20887-6
|
Molybdenum
[Mass/mass]
in
Tissue
|
|
20888-4
|
Molybdenum
[Mass/mass]
in
Feed
|
|
20889-2
|
Monensin
[Mass/mass]
in
Gastric
fluid
|
|
2089-1
|
Cholesterol
in
LDL
[Mass/volume]
in
Serum
or
Plasma
|
|
20890-0
|
Monensin
[Mass/mass]
in
Feed
|
|
20891-8
|
Mushroom
identified
|
|
20892-6
|
Mycobacterium
avium
ss
paratuberculosis
[Presence]
in
Tissue
by
Organism
specific
culture
|
|
20893-4
|
Mycobacterium
avium
ss
paratuberculosis
[Presence]
in
Stool
by
Organism
specific
culture
|
|
20894-2
|
Mycobacterium
avium
ss
paratuberculosis
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
20895-9
|
Mycoplasma
gallisepticum
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
20896-7
|
Mycoplasma
sp
[Presence]
in
Tissue
by
Culture
NPIP
(National
Poultry
Improvement
Plan)
|
|
20897-5
|
Mycoplasma
sp
serotype
[Identifier]
in
Isolate
|
|
20898-3
|
Mycoplasma
sp
[Presence]
in
Milk
by
Organism
specific
culture
|
|
20899-1
|
Mycoplasma
sp
[Presence]
in
Exudate
by
Organism
specific
culture
|
|
20900-7
|
Mycoplasma
sp
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
20901-5
|
Mycoplasma
sp
Ag
[Presence]
in
Isolate
by
Immune
stain
|
|
20902-3
|
Mycoplasma
sp+Ureaplasma
sp
[Presence]
in
Tissue
by
Organism
specific
culture
|
|
20903-1
|
Mycotoxin
identified
in
Feed
|
|
20904-9
|
Neospora
caninum
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
20905-6
|
Oleandrin
[Mass/volume]
in
Urine
|
|
20906-4
|
Oleandrin
[Mass/volume]
in
Ingesta
|
|
20907-2
|
Organochlorine
pesticides
[Identifier]
in
Blood
|
|
20908-0
|
Organochlorine
pesticides
[Identifier]
in
Unspecified
specimen
|
|
20909-8
|
Organochlorine
pesticides
[Identifier]
in
Gastric
fluid
|
|
20910-6
|
Organochlorine
pesticides
[Identifier]
in
Milk
|
|
20911-4
|
Organochlorine
pesticides
[Identifier]
in
Tissue
|
|
20912-2
|
Organochlorine
pesticides
[Presence]
in
Blood
by
Screen
method
|
|
20913-0
|
Organochlorine
pesticides
[Presence]
in
Unspecified
specimen
by
Screen
method
|
|
20914-8
|
Organochlorine
pesticides
[Presence]
in
Gastric
fluid
by
Screen
method
|
|
20915-5
|
Organochlorine
pesticides
[Presence]
in
Milk
by
Screen
method
|
|
20916-3
|
Organochlorine
pesticides
[Presence]
in
Tissue
by
Screen
method
|
|
20917-1
|
Organophosphate
pesticides
[Presence]
in
Blood
by
Screen
method
|
|
20918-9
|
Organophosphate
pesticides
[Presence]
in
Unspecified
specimen
by
Screen
method
|
|
20919-7
|
Organophosphate
pesticides
[Presence]
in
Gastric
fluid
by
Screen
method
|
|
20920-5
|
Organophosphate
pesticides
[Presence]
in
Tissue
by
Screen
method
|
|
20921-3
|
Organophosphate
pesticides
[Identifier]
in
Unspecified
specimen
|
|
20922-1
|
Organophosphate
pesticides
[Identifier]
in
Gastric
fluid
|
|
20923-9
|
Organophosphate
pesticides
[Identifier]
in
Tissue
|
|
20924-7
|
Ova
and
parasites
identified
in
Stool
by
Parasite
sedimentation
|
|
20925-4
|
Ova
and
parasites
identified
in
Stool
by
McMaster
concentration
|
|
20926-2
|
Ova
and
parasites
identified
in
Stool
by
Baerman
concentration
|
|
20927-0
|
Oxalate
[Mass/mass]
in
Tissue
|
|
20928-8
|
Oxalate
[Mass/mass]
in
Plant
|
|
20929-6
|
Paraquat
[Mass/volume]
in
Gastric
fluid
|
|
2093-3
|
Cholesterol
[Mass/volume]
in
Serum
or
Plasma
|
|
20930-4
|
Paraquat
[Mass/mass]
in
Tissue
|
|
20931-2
|
Parasites
[#/volume]
in
Gastric
fluid
|
|
20932-0
|
Parasite
identified
in
Unspecified
specimen
by
Inspection
|
|
20933-8
|
Parasite
identified
in
Serum
by
Light
microscopy
|
|
20934-6
|
Bovine
parvovirus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20935-3
|
Pasteurella
multocida
serotype
[Identifier]
in
Isolate
by
Immune
diffusion
(ID)
|
|
20936-1
|
Pentachlorophenol
[Mass/mass]
in
Tissue
|
|
20937-9
|
Pentachlorophenol
[Mass/mass]
in
Fat
|
|
20938-7
|
Phenols
[Mass/volume]
in
Gastric
fluid
|
|
20939-5
|
Phosphide
[Mass/mass]
in
Gastrointestinal
content
|
|
2094-1
|
Cholesterol.non-esterified
[Mass/volume]
in
Serum
or
Plasma
|
|
20940-3
|
Phosphide
[Mass/mass]
in
Feed
|
|
20942-9
|
Plant
identified
[Type]
in
Plant
|
|
20943-7
|
Bovine
respiratory
syncytial
virus
Ag
[Presence]
in
Lung
by
Immune
stain
|
|
20944-5
|
Bovine
respiratory
syncytial
virus
Ag
[Presence]
in
Lung
by
Immunoassay
|
|
20945-2
|
Bovine
respiratory
syncytial
virus
Ag
[Presence]
in
Lung
by
Immunofluorescence
|
|
20946-0
|
Retinol
[Mass/mass]
in
Liver
|
|
20947-8
|
Retinol
[Mass/mass]
in
Feed
|
|
20948-6
|
Retinol
[Mass/mass]
in
Tissue
|
|
20949-4
|
Rickettsia
sp
[Presence]
in
Blood
by
Light
microscopy
|
|
20950-2
|
Bovine
rotavirus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
20951-0
|
Salmonella
sp
serotype
[Identifier]
in
Isolate
by
Agglutination
|
|
20952-8
|
Salmonella
sp
identified
in
Egg
by
Organism
specific
culture
|
|
20953-6
|
Salmonella
sp
identified
in
Tissue
by
Organism
specific
culture
|
|
20955-1
|
Salmonella
sp
identified
in
Stool
by
Organism
specific
culture
|
|
20956-9
|
Sarcocystis
neurona
Ab
[Presence]
in
Body
fluid
by
Immunoblot
(IB)
|
|
20957-7
|
Sarcocystis
neurona
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
20958-5
|
Sarcocystis
neurona
Ab
[Presence]
in
Blood
by
Immunoblot
(IB)
|
|
20959-3
|
Sarcocystis
neurona
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
20960-1
|
Selenium
[Mass/mass]
in
Gastric
fluid
|
|
20961-9
|
Selenium
[Mass/mass]
in
Feed
|
|
20962-7
|
Serpulina
hyodysenteria
[Presence]
in
Spiral
colon
by
Organism
specific
culture
|
|
20963-5
|
Serpulina
hyodysenteria
[Presence]
in
Stool
by
Organism
specific
culture
|
|
20964-3
|
Shigella
sp
identified
in
Feed
by
Organism
specific
culture
|
|
20965-0
|
Somatic
cells
[#/volume]
in
Milk
|
|
20966-8
|
Staphylococcus
sp
identified
in
Unspecified
specimen
by
Organism
specific
culture
|
|
20967-6
|
Staphylococcus
sp
identified
in
Milk
by
Organism
specific
culture
|
|
20968-4
|
Staphylococcus
sp
identified
in
Cheese
by
Organism
specific
culture
|
|
20969-2
|
Strychnine
[Presence]
in
Gastric
fluid
|
|
2097-4
|
Cholinesterase
[Enzymatic
activity/volume]
in
Amniotic
fluid
|
|
20970-0
|
Strychnine
[Presence]
in
Unspecified
specimen
|
|
20972-6
|
Strychnine
[Mass/mass]
in
Tissue
|
|
20973-4
|
Sulfate
[Mass/volume]
in
Gastric
fluid
|
|
20974-2
|
Sulfate
[Mass/volume]
in
Serum
or
Plasma
|
|
20975-9
|
Thallium
[Mass/mass]
in
Tissue
|
|
20976-7
|
Tritrichomonas
foetus
[Presence]
in
Preputial
wash
by
Organism
specific
culture
|
|
20977-5
|
Urea
[Mass/volume]
in
Blood
|
|
20978-3
|
Urea
[Mass/volume]
in
Gastric
fluid
|
|
20979-1
|
Urea
[Mass/mass]
in
Feed
|
|
2098-2
|
Cholinesterase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
20980-9
|
Venezuelan
equine
encephalitis
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
20981-7
|
Verotoxin
identified
in
Isolate
|
|
20982-5
|
Western
equine
encephalitis
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
20983-3
|
Western
equine
encephalitis
virus
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
20984-1
|
Western
equine
encephalitis
virus
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
20985-8
|
Western
equine
encephalitis
virus
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
20986-6
|
Western
equine
encephalitis
virus
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Complement
fixation
|
|
20987-4
|
Yersinia
sp
identified
in
Dairy
product
by
Organism
specific
culture
|
|
20988-2
|
Zinc
phosphide
[Mass/mass]
in
Gastrointestinal
content
|
|
20989-0
|
Zinc
phosphide
[Mass/mass]
in
Unspecified
specimen
|
|
2099-0
|
Cholinesterase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
20990-8
|
APC
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
20992-4
|
Bordetella
pertussis
Ab
[Presence]
in
Unspecified
specimen
|
|
20993-2
|
Deprecated
Chlamydia
trachomatis
DNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
2100-6
|
Cholylglycine
[Mass/volume]
in
Serum
|
|
21003-9
|
Fungus
identified
in
Unspecified
specimen
by
Fungus
stain
|
|
21005-4
|
Hepatitis
B
virus
core
Ab
[Units/volume]
in
Serum
from
donor
by
Immunoassay
|
|
21006-2
|
Hepatitis
B
virus
surface
Ab
[Units/volume]
in
Serum
from
donor
by
Immunoassay
|
|
21007-0
|
HIV
1
Ab
[Presence]
in
Serum
from
donor
|
|
21008-8
|
HIV
1
RNA
[#/volume]
(viral
load)
in
Serum
or
Plasma
by
DNA
probe
|
|
2101-4
|
Cholylglycine.conjugated
[Mass/volume]
in
Serum
|
|
21016-1
|
CD41
cells
[#/volume]
in
Blood
|
|
21019-5
|
Metanephrine
[Mass/volume]
in
24
hour
Urine
|
|
2102-2
|
Chondroitin
sulfate
[Mass/volume]
in
Urine
|
|
21020-3
|
Bacteria
identified
in
Unspecified
specimen
by
Anaerobe+Aerobe
culture
|
|
21021-1
|
Microscopic
observation
[Identifier]
in
Bronchial
specimen
by
Gram
stain
|
|
21022-9
|
Microscopic
observation
[Identifier]
in
Dialysis
fluid
by
Gram
stain
|
|
21023-7
|
Neutrophil
cytoplasmic
Ab
[Titer]
in
Serum
|
|
2103-0
|
Choriomammotropin
[Mass/volume]
in
Amniotic
fluid
|
|
21030-2
|
Reagin
Ab
[Presence]
in
Serum
from
donor
by
VDRL
|
|
21034-4
|
11-Deoxycortisol
[Mass/volume]
in
Serum
or
Plasma
--evening
specimen
|
|
21035-1
|
11-Deoxycortisol
[Mass/volume]
in
Serum
or
Plasma
--morning
specimen
|
|
21036-9
|
17-Hydroxycorticosteroids
[Mass/time]
in
24
hour
Urine
|
|
21037-7
|
17-Hydroxypregnenolone
[Mass/time]
in
24
hour
Urine
|
|
21038-5
|
17-Ketosteroids
[Mass/volume]
in
24
hour
Urine
|
|
21039-3
|
18-Hydroxycortisol
[Mass/volume]
in
24
hour
Urine
|
|
2104-8
|
Choriomammotropin
[Mass/volume]
in
Serum
|
|
21043-5
|
3-Methoxy-4-Hydroxyphenylglycol
[Mass/volume]
in
24
hour
Urine
|
|
21044-3
|
5-Alpha
tetrahydrocortisol
[Mass/time]
in
24
hour
Urine
|
|
21045-0
|
5-Hydroxytryptophan
[Mass/time]
in
24
hour
Urine
|
|
21046-8
|
7-Aminoflunitrazepam
[Mass/volume]
in
Serum
or
Plasma
|
|
21047-6
|
8-Hydroxyloxapine
[Mass/volume]
in
Urine
|
|
21048-4
|
Acetaldehyde
[Mass/volume]
in
Urine
|
|
21049-2
|
Acetone
[Mass/mass]
in
Tissue
|
|
2105-5
|
Choriogonadotropin
[Moles/volume]
in
Semen
|
|
21051-8
|
Acrylaldehyde
[Mass/volume]
in
Serum
or
Plasma
|
|
21052-6
|
Adenosine
monophosphate.cyclic.nephrogenous
[Moles/volume]
in
Urine
and
Serum
or
Plasma
|
|
21053-4
|
Adenovirus
IgG
Ab
[Titer]
in
Serum
|
|
21054-2
|
Adenovirus
IgM
Ab
[Presence]
in
Serum
|
|
21055-9
|
Adenovirus
DNA
[Presence]
in
Serum
or
Plasma
by
Probe
and
target
amplification
method
|
|
21056-7
|
Alanine+Cystine+Histidine+Homocysteine+Leucine+Phenylalanine+Tyrosine
[Presence]
in
Urine
|
|
21057-5
|
Alanine+Histidine+Leucine+Phenylalanine+Tyrosine
[Presence]
in
Serum
or
Plasma
|
|
21059-1
|
Albumin
[Mass/volume]
in
24
hour
Urine
|
|
2106-3
|
Choriogonadotropin
(pregnancy
test)
[Presence]
in
Urine
|
|
21062-5
|
Allobarbital
[Mass/volume]
in
Serum
or
Plasma
|
|
21064-1
|
Acid
alpha
glucosidase
[Enzymatic
activity/volume]
in
Amniotic
fluid
|
|
21066-6
|
Ampicillin
[Mass/volume]
in
Unspecified
specimen
|
|
2107-1
|
Choriogonadotropin
[Moles/volume]
in
Urine
|
|
21071-6
|
Antimony
[Mass/volume]
in
24
hour
Urine
|
|
21074-0
|
Arsenic
[Mass/volume]
in
24
hour
Urine
|
|
21075-7
|
Ascaris
lumbricoides
IgE
Ab
[Units/volume]
in
Serum
|
|
21077-3
|
Black
Ash
IgE
Ab
[Units/volume]
in
Serum
|
|
21078-1
|
Green
Ash
IgE
Ab
[Units/volume]
in
Serum
|
|
2108-9
|
Choriogonadotropin.alpha
subunit
[Presence]
in
Serum
or
Plasma
|
|
21081-5
|
ASPA
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21084-9
|
Aspergillus
flavus
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immune
diffusion
(ID)
|
|
21085-6
|
Aspergillus
fumigatus
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immune
diffusion
(ID)
|
|
21086-4
|
Aspergillus
niger
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immune
diffusion
(ID)
|
|
21088-0
|
Azinphos-methyl
[Mass/volume]
in
Urine
|
|
21089-8
|
Babesia
microti
DNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
2109-7
|
Choriogonadotropin.alpha
subunit
[Moles/volume]
in
Serum
or
Plasma
|
|
21095-5
|
BCL2
gene
rearrangements
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21096-3
|
Black
Bean
IgE
Ab
[Units/volume]
in
Serum
|
|
2110-5
|
Choriogonadotropin.beta
subunit
(pregnancy
test)
[Presence]
in
Serum
or
Plasma
|
|
21107-8
|
Bendiocarb
[Mass/volume]
in
Urine
|
|
21108-6
|
Beta
2
glycoprotein
1
IgA
Ab
[Units/volume]
in
Serum
|
|
2111-3
|
Choriogonadotropin.beta
subunit
[Moles/volume]
in
Serum
or
Plasma
|
|
21113-6
|
Bismuth
[Mass/volume]
in
24
hour
Urine
|
|
21118-5
|
Borrelia
burgdorferi
IgG
Ab
[Presence]
in
Synovial
fluid
by
Immunoassay
|
|
21119-3
|
Borrelia
burgdorferi
IgM
Ab
[Presence]
in
Synovial
fluid
by
Immunoassay
|
|
2112-1
|
Choriogonadotropin.beta
subunit
(pregnancy
test)
[Presence]
in
Urine
|
|
21120-1
|
Borrelia
burgdorferi
DNA
[Presence]
in
Urine
by
Probe
and
target
amplification
method
|
|
21121-9
|
Borrelia
hermsii
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
21122-7
|
Borrelia
hermsii
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
21125-0
|
Brush
border
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
21128-4
|
Cadmium
[Mass/mass]
in
Nail
|
|
21129-2
|
Cadmium
[Mass/volume]
in
Serum
or
Plasma
|
|
2113-9
|
Choriogonadotropin.beta
subunit
[Mass/time]
in
24
hour
Urine
|
|
21130-0
|
Cadmium
[Mass/volume]
in
24
hour
Urine
|
|
21135-9
|
Canrenone
[Mass/volume]
in
Serum
or
Plasma
|
|
21139-1
|
Carbofuran
[Mass/volume]
in
Urine
|
|
2114-7
|
Choriogonadotropin.beta
subunit
[Moles/volume]
in
Urine
|
|
21140-9
|
Carbophenothion
[Mass/volume]
in
Urine
|
|
21142-5
|
Carisoprodol
[Presence]
in
Urine
|
|
21143-3
|
Carp
IgE
Ab
[Units/volume]
in
Serum
|
|
21148-2
|
White
Cedar
IgE
Ab
[Units/volume]
in
Serum
|
|
2115-4
|
Choriogonadotropin.beta
subunit
free
[Moles/volume]
in
Serum
or
Plasma
|
|
21151-6
|
Ceftazidime
[Mass/volume]
in
Unspecified
specimen
|
|
2116-2
|
Choriogonadotropin.intact
[Presence]
in
Serum
or
Plasma
|
|
2117-0
|
Choriogonadotropin.intact
[Moles/volume]
in
Serum
or
Plasma
|
|
21173-0
|
Cephaeline
[Mass/volume]
in
Serum
or
Plasma
|
|
21174-8
|
Cephaeline
[Mass/volume]
in
Urine
|
|
21175-5
|
Cephalexin
[Mass/volume]
in
Unspecified
specimen
|
|
2118-8
|
Choriogonadotropin
(pregnancy
test)
[Presence]
in
Serum
or
Plasma
|
|
21184-7
|
Chlamydophila
pneumoniae
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
21185-4
|
Chlamydia
sp
IgG
Ab
[Presence]
in
Serum
|
|
21186-2
|
Chlamydia
sp
IgM
Ab
[Presence]
in
Serum
|
|
21187-0
|
Chlamydia
trachomatis
DNA
[Presence]
in
Conjunctival
specimen
by
Probe
and
target
amplification
method
|
|
21188-8
|
Chlamydia
trachomatis
rRNA
[Presence]
in
Conjunctival
specimen
by
DNA
probe
|
|
21189-6
|
Chlamydia
trachomatis
DNA
[Presence]
in
Cervical
mucus
by
Probe
and
target
amplification
method
|
|
2119-6
|
Choriogonadotropin
[Moles/volume]
in
Serum
or
Plasma
|
|
21190-4
|
Chlamydia
trachomatis
DNA
[Presence]
in
Cervix
by
Probe
and
target
amplification
method
|
|
21191-2
|
Chlamydia
trachomatis
DNA
[Presence]
in
Urethra
by
Probe
and
target
amplification
method
|
|
21192-0
|
Chlamydia
trachomatis
rRNA
[Presence]
in
Urethra
by
DNA
probe
|
|
21193-8
|
Chlordiazepoxide+Norchlordiazepoxide
[Mass/volume]
in
Serum
or
Plasma
|
|
21194-6
|
Chloride
[Moles/volume]
in
24
hour
Urine
|
|
21195-3
|
Chlorzoxazone
[Mass/volume]
in
Urine
|
|
21198-7
|
Choriogonadotropin.beta
subunit
[Units/volume]
in
Serum
or
Plasma
|
|
21199-5
|
Chromium
[Mass/volume]
in
Body
fluid
|
|
2120-4
|
Chylomicrons
[Mass/volume]
in
Serum
or
Plasma
|
|
21200-1
|
Chromium
[Mass/mass]
in
Nail
|
|
21201-9
|
Chromium
[Mass/volume]
in
24
hour
Urine
|
|
21203-5
|
Citrate
[Mass/volume]
in
24
hour
Urine
|
|
21206-8
|
Sweet
Clover
IgE
Ab
[Units/volume]
in
Serum
|
|
21207-6
|
CCR5
gene
mutations
found
[Identifier]
in
Blood
by
Molecular
genetics
method
Nominal
|
|
21208-4
|
Cobalt
[Mass/volume]
in
24
hour
Urine
|
|
21209-2
|
Coccidioides
immitis
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immune
diffusion
(ID)
|
|
2121-2
|
Chylomicrons
[Presence]
in
Serum
or
Plasma
|
|
21215-9
|
Collagen
crosslinked
N-telopeptide
[Moles/volume]
in
Serum
|
|
21216-7
|
Collagen
crosslinked
N-telopeptide/Creatinine
[Molar
ratio]
in
24
hour
Urine
|
|
21217-5
|
Complement
C4d
[Mass/volume]
in
Plasma
|
|
21218-3
|
Complement
total
hemolytic
CH50
[Units/volume]
in
Cerebral
spinal
fluid
|
|
21219-1
|
Copper
[Mass/volume]
in
24
hour
Urine
|
|
2122-0
|
Chymopapain
[Mass/volume]
in
Serum
|
|
21229-0
|
Coumaphos
[Mass/volume]
in
Urine
|
|
2123-8
|
Chymotrypsin
[Enzymatic
activity/volume]
in
Body
fluid
|
|
21232-4
|
Creatinine
[Mass/volume]
in
Arterial
blood
|
|
21233-2
|
Cryptosporidium
sp
Ag
[Presence]
in
Stool
|
|
21236-5
|
Cyclohexanone
[Mass/volume]
in
Urine
|
|
21237-3
|
Cytomegalovirus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
21239-9
|
Desalkylhalazepam
[Mass/volume]
in
Serum
or
Plasma
|
|
2124-6
|
Chymotrypsin
[Mass/volume]
in
Serum
or
Plasma
|
|
21240-7
|
Dextromethorphan
[Mass/volume]
in
Urine
|
|
21241-5
|
Diazepam+Nordiazepam
[Mass/volume]
in
Urine
|
|
21243-1
|
Diethyl
ether
[Mass/volume]
in
Urine
|
|
21245-6
|
Diisobutylketone
[Mass/volume]
in
Urine
|
|
21246-4
|
Dimethoate
[Mass/volume]
in
Urine
|
|
21247-2
|
DMD
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21248-0
|
Dobutamine
[Mass/volume]
in
Serum
or
Plasma
|
|
2125-3
|
Chymotrypsin
[Mass/mass]
in
Stool
|
|
21250-6
|
Doxycycline
[Mass/volume]
in
Unspecified
specimen
|
|
21252-2
|
Echinococcus
granulosus
IgG
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
21259-7
|
Entamoeba
histolytica
Ab
[Titer]
in
Serum
by
Hemagglutination
|
|
2126-1
|
Citrate
[Mass/volume]
in
Semen
|
|
21260-5
|
Epstein
Barr
virus
nuclear
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
21262-1
|
Escherichia
coli
shiga-like
[Presence]
in
Stool
by
Immunoassay
|
|
21263-9
|
Estradiol
(E2)
[Mass/time]
in
24
hour
Urine
|
|
21266-2
|
Ethion
[Mass/volume]
in
Urine
|
|
21267-0
|
Ethyl
O-(P-nitrophenyl)
phenylphosphonothionate
[Mass/volume]
in
Urine
|
|
21268-8
|
Fenchlorphos
[Mass/volume]
in
Urine
|
|
21269-6
|
Fenthion
[Mass/volume]
in
Urine
|
|
2127-9
|
Citrate
[Mass/volume]
in
Serum
or
Plasma
|
|
21271-2
|
Fireweed
IgE
Ab
[Units/volume]
in
Serum
|
|
2128-7
|
Citrate
[Mass/volume]
in
Urine
|
|
21280-3
|
Fonofos
[Mass/volume]
in
Urine
|
|
21284-5
|
Gardnerella
vaginalis
[Presence]
in
Genital
specimen
by
Organism
specific
culture
|
|
21300-9
|
Giardia
lamblia
IgA
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
21301-7
|
Giardia
lamblia
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
21302-5
|
Giardia
lamblia
Ag
[Presence]
in
Stool
by
Immunoassay
--2nd
specimen
|
|
21303-3
|
Giardia
lamblia
Ag
[Presence]
in
Stool
by
Immunoassay
--3rd
specimen
|
|
21305-8
|
Glucose
[Mass/volume]
in
24
hour
Urine
|
|
21306-6
|
Glucose
[Mass/time]
in
8
hour
Urine
|
|
21307-4
|
Glucose
[Mass/time]
in
10
hour
Urine
|
|
21312-4
|
Gold
[Mass/volume]
in
Body
fluid
|
|
21317-3
|
Deprecated
Groundsel
Tree
IgE
Ab
[Units/volume]
in
Serum
|
|
2132-9
|
Cobalamin
(Vitamin
B12)
[Mass/volume]
in
Serum
or
Plasma
|
|
21320-7
|
Haemophilus
influenzae
B
Ag
[Presence]
in
Unspecified
specimen
by
Latex
agglutination
|
|
21322-3
|
Hantavirus
puumala
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
21323-1
|
Hantavirus
puumala
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
21326-4
|
Herpes
simplex
virus
1
IgM
Ab
[Titer]
in
Serum
|
|
21327-2
|
Herpes
simplex
virus
2
IgM
Ab
[Titer]
in
Serum
|
|
2133-7
|
Collagenase
[Enzymatic
activity/volume]
in
Serum
|
|
21330-6
|
Histoplasma
capsulatum
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immune
diffusion
(ID)
|
|
21333-0
|
HIV
1
RNA
[#/volume]
in
Serum
|
|
21345-4
|
HTLV
I+II
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
21348-8
|
HTLV
I+II
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
21361-1
|
Laxatives
present
[Identifier]
in
Stool
by
Screen
method
|
|
21362-9
|
Legionella
pneumophila
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
21363-7
|
Legionella
pneumophila
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
21365-2
|
Leptin
[Mass/volume]
in
Serum
or
Plasma
|
|
21368-6
|
Levofloxacin
[Mass/volume]
in
Serum
or
Plasma
|
|
21377-7
|
Magnesium
[Mass/volume]
in
Blood
|
|
21378-5
|
Malathion
[Mass/volume]
in
Urine
|
|
2138-6
|
Coproporphyrinogen
oxidase
[Enzymatic
activity/volume]
in
Serum
|
|
21380-1
|
Prolactin
[Mass/time]
in
24
hour
Urine
|
|
21382-7
|
Manganese
[Mass/volume]
in
24
hour
Urine
|
|
21383-5
|
Mercury
[Mass/volume]
in
24
hour
Urine
|
|
21385-0
|
Metasystox
[Mass/volume]
in
Urine
|
|
21386-8
|
Methamphetamine
[Presence]
in
Urine
by
SAMHSA
confirm
method
|
|
21387-6
|
Methylhippurate
[Mass/volume]
in
Urine
|
|
21388-4
|
Mevinphos
[Mass/volume]
in
Urine
|
|
21389-2
|
Saccharopolyspora
rectivirgula
IgE
Ab
[Units/volume]
in
Serum
|
|
2139-4
|
Corticosterone
[Mass/volume]
in
Serum
or
Plasma
|
|
21391-8
|
Microscopic
observation
[Identifier]
in
Bone
by
Acid
phosphatase
stain
|
|
2140-2
|
Corticotropin
[Mass/volume]
in
Amniotic
fluid
|
|
21401-5
|
Mumps
virus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
21402-3
|
Mumps
virus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
21405-6
|
Mycobacterium
sp
DNA
[Presence]
in
Bronchial
specimen
by
Probe
and
target
amplification
method
|
|
21406-4
|
Mycoplasma
pneumoniae
IgM
Ab
[Presence]
in
Serum
|
|
21407-2
|
Myelin
IgA
Ab
[Titer]
in
Serum
|
|
21408-0
|
Myelin
IgG
Ab
[Titer]
in
Serum
|
|
21409-8
|
Myelin
IgM
Ab
[Titer]
in
Serum
|
|
2141-0
|
Corticotropin
[Mass/volume]
in
Plasma
|
|
21410-6
|
Myelin
associated
glycoprotein
IgM
Ab
[Titer]
in
Serum
|
|
21411-4
|
Myelin
associated
glycoprotein
IgM
Ab
[Units/volume]
in
Serum
|
|
21413-0
|
N-Acetylgalactosamine-4-Sulfatase
[Enzymatic
activity/volume]
in
Urine
|
|
21414-8
|
Neisseria
gonorrhoeae
DNA
[Presence]
in
Cervical
mucus
by
Probe
and
target
amplification
method
|
|
21415-5
|
Neisseria
gonorrhoeae
DNA
[Presence]
in
Urethra
by
Probe
and
target
amplification
method
|
|
21416-3
|
Neisseria
gonorrhoeae
DNA
[Presence]
in
Urine
by
Probe
and
target
amplification
method
|
|
21417-1
|
Neurokinin
A
[Units/volume]
in
Serum
or
Plasma
|
|
21418-9
|
Neutrophil
Ab
[Presence]
in
Serum
|
|
2142-8
|
Cortisol
[Mass/volume]
in
Saliva
(oral
fluid)
|
|
21420-5
|
Nitrate
[Mass/volume]
in
Urine
|
|
21421-3
|
Norketamine
[Mass/volume]
in
Serum
or
Plasma
|
|
21422-1
|
Normetanephrine
[Mass/volume]
in
24
hour
Urine
|
|
21423-9
|
Nuclear
Ab
[Titer]
in
Serum
by
Immunofluorescence
(IF)
rat
liver
|
|
21424-7
|
Nuclear
IgG
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
21428-8
|
Olive
IgE
Ab
[Units/volume]
in
Serum
|
|
2143-6
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
|
|
21431-2
|
Opiates
[Presence]
in
Urine
by
Screen
method
>2000
ng/mL
|
|
21435-3
|
Osteocalcin.bovine
[Mass/volume]
in
Serum
or
Plasma
|
|
21436-1
|
Ovary
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
21437-9
|
Oxychlordane
[Mass/volume]
in
Serum
or
Plasma
|
|
2144-4
|
Cortisol
[Mass/volume]
in
Urine
|
|
21440-3
|
Human
papilloma
virus
16+18+31+33+35+45+51+52+56
DNA
[Presence]
in
Cervix
by
DNA
probe
|
|
21441-1
|
Human
papilloma
virus
6+11+42+43+44
DNA
[Presence]
in
Cervix
by
DNA
probe
|
|
21442-9
|
Parainfluenza
virus
identified
in
Nose
by
Organism
specific
culture
|
|
21443-7
|
Paraoxon
[Mass/volume]
in
Urine
|
|
2145-1
|
Cortisol
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
21457-7
|
Phorate
[Mass/volume]
in
Urine
|
|
21458-5
|
Phosphate
[Mass/volume]
in
24
hour
Urine
|
|
21461-9
|
Lodgepole
Pine+Pondersosa
Pine
IgE
Ab
[Units/volume]
in
Serum
|
|
21464-3
|
Plasminogen
activator
urokinase
type
[Presence]
in
Tissue
|
|
21465-0
|
Plasmodium
falciparum
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
21466-8
|
Plasmodium
malariae
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
21467-6
|
Plasmodium
ovale
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
21468-4
|
Plasmodium
vivax
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
2147-7
|
Cortisol
Free
[Mass/time]
in
24
hour
Urine
|
|
21471-8
|
Pomegranate
IgE
Ab
[Units/volume]
in
Serum
|
|
21473-4
|
White
Poplar
IgE
Ab
[Units/volume]
in
Serum
|
|
21476-7
|
Potassium
[Moles/volume]
in
24
hour
Urine
|
|
21477-5
|
Deprecated
Potato
IgE
Ab
[Units/volume]
in
Serum
|
|
2148-5
|
Creatine
[Mass/volume]
in
Serum
or
Plasma
|
|
21480-9
|
Propoxur
[Mass/volume]
in
Urine
|
|
21481-7
|
Propranolol
[Mass/volume]
in
Gastric
fluid
|
|
21482-5
|
Protein
[Mass/volume]
in
24
hour
Urine
|
|
21483-3
|
Quinidine
[Mass/volume]
in
Serum
or
Plasma
--peak
|
|
21487-4
|
Ribosomal
P
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
21489-0
|
Rickettsia
(Proteus
OX19)
Ab
[Titer]
in
Serum
by
Latex
agglutination
|
|
2149-3
|
Creatine
[Mass/volume]
in
Urine
|
|
21490-8
|
Rickettsia
(Proteus
OX2)
Ab
[Titer]
in
Serum
by
Latex
agglutination
|
|
21491-6
|
Rickettsia
(Proteus
OXK)
Ab
[Titer]
in
Serum
by
Latex
agglutination
|
|
21492-4
|
Rickettsia
conorii
IgG
Ab
[Titer]
in
Serum
|
|
21493-2
|
Rickettsia
conorii
IgM
Ab
[Titer]
in
Serum
|
|
21494-0
|
Rickettsia
spotted
fever
group
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
21495-7
|
Rickettsia
spotted
fever
group
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
21496-5
|
Rickettsia
typhus
group
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
21497-3
|
Rickettsia
typhus
group
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
21498-1
|
Orientia
tsutsugamushi
IgG
Ab
[Titer]
in
Serum
|
|
2150-1
|
Creatine
[Mass/time]
in
24
hour
Urine
|
|
21500-4
|
Measles
virus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
21501-2
|
Measles
virus
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
21502-0
|
Measles
virus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
21503-8
|
Measles
virus
IgM
Ab
[Presence]
in
Serum
|
|
21509-5
|
Saint
Louis
encephalitis
virus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
2151-9
|
Creatine
kinase
[Enzymatic
activity/volume]
in
Cerebral
spinal
fluid
|
|
21510-3
|
Saint
Louis
encephalitis
virus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
21511-1
|
Salmonella
paratyphi
A
H
Ab
[Titer]
in
Serum
by
Agglutination
|
|
21512-9
|
Salmonella
paratyphi
A
H
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
21513-7
|
Salmonella
paratyphi
B
H
Ab
[Titer]
in
Serum
by
Agglutination
|
|
21514-5
|
Salmonella
paratyphi
B
H
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
21518-6
|
SCL-70
extractable
nuclear
IgG
Ab
[Presence]
in
Serum
|
|
2152-7
|
Creatine
kinase.BB
[Enzymatic
activity/volume]
in
Serum
or
Plasma
by
Electrophoresis
|
|
21522-8
|
Smith
extractable
nuclear
Ab+Ribonucleoprotein
extractable
nuclear
IgG
Ab
[Units/volume]
in
Serum
|
|
21523-6
|
Smith
extractable
nuclear
IgG
Ab
[Presence]
in
Serum
|
|
21525-1
|
Sodium
[Moles/volume]
in
24
hour
Urine
|
|
21526-9
|
Sodium
[Mass/volume]
in
24
hour
Urine
|
|
21527-7
|
Sodium
[Mass/time]
in
24
hour
Urine
|
|
2153-5
|
Creatine
kinase.macromolecular
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
21536-8
|
Acid
sphingomyelinase
[Enzymatic
activity/volume]
in
Blood
|
|
2154-3
|
Creatine
kinase.MB
[Enzymatic
activity/volume]
in
Serum
or
Plasma
by
Electrophoresis
|
|
21545-9
|
Sulfatide
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
21546-7
|
Sulfatide
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
2155-0
|
Creatine
kinase.MM
[Enzymatic
activity/volume]
in
Serum
or
Plasma
by
Electrophoresis
|
|
21554-1
|
Terbufos
[Mass/volume]
in
Urine
|
|
21556-6
|
Tetrahydrocannabinol
[Presence]
in
Urine
by
Screen
method
>20
ng/mL
|
|
21557-4
|
Tetrahydrocannabinol
[Presence]
in
Urine
by
Screen
method
>100
ng/mL
|
|
21558-2
|
Thallium
[Mass/volume]
in
24
hour
Urine
|
|
21559-0
|
Theophylline
[Mass/volume]
in
Gastric
fluid
|
|
2156-8
|
Creatine
kinase
[Enzymatic
activity/volume]
in
Amniotic
fluid
|
|
21560-8
|
Thermoactinomyces
candidus
Ab
[Presence]
in
Serum
|
|
21561-6
|
Thermoactinomyces
sacchari
Ab
[Presence]
in
Serum
|
|
21562-4
|
Thiocyanate/Creatinine
[Mass
Ratio]
in
Urine
|
|
21563-2
|
Thiopurine
methyltransferase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
21564-0
|
Thiosulfate
[Mass/volume]
in
Serum
or
Plasma
|
|
21565-7
|
Tiagabine
[Mass/volume]
in
Serum
or
Plasma
|
|
21566-5
|
Tolazamide
[Presence]
in
Serum
or
Plasma
|
|
21567-3
|
Tolbutamide
[Presence]
in
Serum
or
Plasma
|
|
21569-9
|
Toxoplasma
gondii
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
2157-6
|
Creatine
kinase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
21570-7
|
Toxoplasma
gondii
IgG
Ab
[Presence]
in
Serum
by
Sabin
dye
test
|
|
21571-5
|
Toxoplasma
gondii
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
21579-8
|
Trichloroethylene
[Mass/volume]
in
Blood
|
|
21580-6
|
Trimethobenzamide
[Mass/volume]
in
Unspecified
specimen
|
|
21582-2
|
Tryptase
[Mass/volume]
in
Serum
or
Plasma
|
|
21585-5
|
Uranium
[Mass/volume]
in
24
hour
Urine
|
|
21586-3
|
Uranium
[Mass/time]
in
24
hour
Urine
|
|
21587-1
|
Urate
[Mass/volume]
in
24
hour
Urine
|
|
21588-9
|
Urobilinogen
[Mass/mass]
in
Stool
|
|
2159-2
|
Creatinine
[Mass/volume]
in
Amniotic
fluid
|
|
21592-1
|
Varicella
zoster
virus
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
21594-7
|
Varicella
zoster
virus
Ab
[Titer]
in
Serum
|
|
21595-4
|
Varicella
zoster
virus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
21596-2
|
Varicella
zoster
virus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
21597-0
|
Varicella
zoster
virus
IgM
Ab
[Presence]
in
Serum
|
|
21598-8
|
Varicella
zoster
virus
DNA
[Presence]
in
Cerebral
spinal
fluid
by
Probe
and
target
amplification
method
|
|
2160-0
|
Creatinine
[Mass/volume]
in
Serum
or
Plasma
|
|
21603-6
|
Wheat
dust
IgE
Ab
[Units/volume]
in
Serum
|
|
2161-8
|
Creatinine
[Mass/volume]
in
Urine
|
|
21610-1
|
Zinc
[Mass/volume]
in
24
hour
Urine
|
|
21613-5
|
Chlamydia
trachomatis
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
21614-3
|
CDKN2A
gene
deletion
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21615-0
|
CDKN2B
gene
deletion
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21617-6
|
APC
gene
p.Ile1307Lys
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21619-2
|
APOE
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
2162-6
|
Creatinine
[Mass/time]
in
24
hour
Urine
|
|
21620-0
|
STS
gene
deletion
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21622-6
|
ASPA
gene
p.Glu285Ala
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21624-2
|
ATM
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21626-7
|
ATP7B
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21627-5
|
ATP7B
gene
c.2010_2016del
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21628-3
|
ATP7B
gene
c.2337delC
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21629-1
|
ATP7B
gene
c.2487insT
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
2163-4
|
Creatinine
renal
clearance
in
12
hour
|
|
21630-9
|
ATP7B
gene
c.1711G>C
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21631-7
|
ATP7B
gene
p.Gly1267Arg
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21632-5
|
ATP7B
gene
p.His1070Gln
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21633-3
|
ATP7B
gene
p.His714Gln
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21634-1
|
ATP7B
gene
p.Asn915Ser
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21635-8
|
ATP7B
gene
p.Arg778Leu
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21636-6
|
BRCA1
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21637-4
|
BRCA1
gene.c.185
del
AG
[presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21638-2
|
BRCA1
gene
c.5382insC
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
2164-2
|
Creatinine
renal
clearance
in
24
hour
|
|
21640-8
|
BRCA2
gene
c.6174delT
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21641-6
|
CACNA1S
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21642-4
|
CACNA1S
gene
p.Arg1239Gly
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21643-2
|
CACNA1S
gene
p.Arg1239His
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21644-0
|
CACNA1S
gene
p.Arg528His
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21646-5
|
CBS
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21647-3
|
Deprecated
CBS
gene
p.G307S
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21648-1
|
Deprecated
CBS
gene
p.I278T
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
2165-9
|
Cryofibrinogen
[Mass/volume]
in
Blood
|
|
21652-3
|
CDH1
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21654-9
|
CFTR
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21655-6
|
CFTR
gene.p.Phe508del
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21657-2
|
COL2A1
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21659-8
|
CTNNB1
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
2166-7
|
Cryoglobulin
[Mass/volume]
in
Blood
|
|
21661-4
|
CYP2D6
gene
deletion
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21662-2
|
CYP2D6
gene
c.2637delA
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21663-0
|
CYP2D6
gene
G-A
NT1
X4
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21664-8
|
CYP2D6
gene
p.Gly169Ter
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21665-5
|
EGFR
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21667-1
|
F5
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21668-9
|
F5
gene
p.Arg506Gln
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
2167-5
|
Cryoglobulin
[Presence]
in
Serum
or
Plasma
|
|
21670-5
|
F7
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21672-1
|
F8
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21674-7
|
FGFR2
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21676-2
|
FGFR3
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21677-0
|
FGFR3
gene
p.Gly375Cys
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21678-8
|
FGFR3
gene
p.Gly380Arg
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21679-6
|
FGFR3
gene
p.Lys650Glu
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
2168-3
|
Cryoglobulin
[Mass/volume]
in
Serum
or
Plasma
|
|
21680-4
|
G6PD
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21685-3
|
HADHB
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21687-9
|
HBA1
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21689-5
|
HBB
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
2169-1
|
Cobalamin
(Vitamin
B12)
renal
clearance
in
24
hour
|
|
21690-3
|
HBB
gene
p.Glu6Val
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21692-9
|
PRSS1
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21694-5
|
HFE
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21695-2
|
HFE
gene.p.Cys282Tyr
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21696-0
|
HFE
gene
p.His63Asp
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21698-6
|
HRAS
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21700-0
|
Kallman
syndrome
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21702-6
|
KRAS
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21704-2
|
MT-ATP6
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21705-9
|
MT-ND4
gene
m.11696G>A
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21706-7
|
Deprecated
MT-ND4
gene
p.R304H
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21707-5
|
MT-ND4
gene
p.Thr109Ala
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21708-3
|
Deprecated
MT-ATP6
gene
p.L156R
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21709-1
|
MTHFR
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
2171-7
|
Cobalamin
(Vitamin
B12).unsaturated
Binding
Capacity
[Mass/volume]
in
Serum
or
Plasma
|
|
21710-9
|
MTHFR
gene
p.Ala677Val
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21711-7
|
MTHFR
gene
p.Cys677Glu
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21713-3
|
MT-TK
gene
m.8344A>G
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21714-1
|
MT-TL1
gene
m.3243A>G
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21715-8
|
MXI1
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21716-6
|
NB
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21717-4
|
NF1
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21719-0
|
NRAS
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21721-6
|
OTC
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21723-2
|
SERPINA1
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21724-0
|
SERPINA1
gene
p.Glu264Val
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21725-7
|
SERPINA1
gene
p.Glu342Lys
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21727-3
|
PMP22
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21729-9
|
PSAP
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21731-5
|
RB1
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21733-1
|
RET
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21735-6
|
SNCA
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21736-4
|
SNCA
gene
p.Ala30Pro
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21737-2
|
SNCA
gene
p.Ala53Thr
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21739-8
|
TP53
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21740-6
|
TRAF3
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21742-2
|
WT1
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
21744-8
|
CCND1
gene
rearrangements
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21746-3
|
BCL6
gene
rearrangements
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21747-1
|
HC
gene
rearrangements
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21748-9
|
Kappa
LC
gene
rearrangements
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21749-7
|
Lambda
LC
gene
rearrangements
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21750-5
|
MYC
gene
rearrangements
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21751-3
|
TCRB
gene
rearrangements
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21752-1
|
TCRD
gene
rearrangements
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21753-9
|
TCRG
gene
rearrangements
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21754-7
|
AR
gene
CAG
repeats
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21755-4
|
CACNA1A
gene
CAG
repeats
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21756-2
|
ATN1
gene
CAG
repeats
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21757-0
|
DMPK
gene
CTG
repeats
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21759-6
|
FMR1
gene
CGG
repeats
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21760-4
|
FRAXE
gene
CGG
repeats
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21761-2
|
Deprecated
FRAXE
gene
CGG
repeats
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21762-0
|
FXN
gene
GAA
repeats
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21763-8
|
HTT
gene
CAG
repeats
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21764-6
|
MJD
gene
CAG
repeats
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21765-3
|
SCA1
gene
CAG
repeats
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21766-1
|
SCA2
gene
CAG
repeats
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21767-9
|
SCA7
gene
CAG
repeats
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21769-5
|
SCA
genes
CAG
repeats
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21770-3
|
Chromosome
12
trisomy
[Presence]
in
Blood
or
Tissue
by
Cytogenetics
|
|
21771-1
|
Chromosome
21
trisomy
[Presence]
in
Blood
or
Tissue
by
Cytogenetics
|
|
21772-9
|
Chromosome
7
trisomy
[Presence]
in
Blood
or
Tissue
by
Cytogenetics
|
|
21773-7
|
Chromosome
8
trisomy
[Presence]
in
Blood
or
Tissue
by
Cytogenetics
|
|
21774-5
|
Chromosome
9
trisomy
[Presence]
in
Blood
or
Tissue
by
Cytogenetics
|
|
2178-2
|
Cystine
[Mass/volume]
in
Urine
|
|
2179-0
|
Cystine
[Mass/time]
in
24
hour
Urine
|
|
2180-8
|
Cystine+Cysteine
[Mass/volume]
in
Serum
or
Plasma
|
|
21809-9
|
t(14;18)(q32;q21.3)(IGH,BCL2)
fusion
transcript
major
break
points
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
2181-6
|
Cystinyl
aminopeptidase
[Enzymatic
activity/volume]
in
Serum
|
|
21810-7
|
t(14;18)(q32;q21.3)(IGH,BCL2)
fusion
transcript
minor
break
points
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
21819-8
|
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1)
fusion
transcript
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
2182-4
|
Cytochrome
B
reductase
[Enzymatic
activity/volume]
in
Amniotic
fluid
|
|
2183-2
|
Cytochrome
B5
reductase
[Enzymatic
activity/volume]
in
Serum
|
|
2184-0
|
Cytochrome
C
oxidase
[Enzymatic
activity/volume]
in
Plasma
|
|
2185-7
|
Cytochrome
C
oxidase
[Enzymatic
activity/volume]
in
Platelets
|
|
2186-5
|
Cytochrome
C
oxidase
[Enzymatic
activity/volume]
in
Leukocytes
|
|
2187-3
|
Cytosol
aminopeptidase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
2188-1
|
Cytosol
aminopeptidase
[Presence]
in
Urine
|
|
2189-9
|
Cytosol
aminopeptidase
[Enzymatic
activity/volume]
in
Urine
|
|
2190-7
|
Dehydroepiandrosterone
sulfate
(DHEA-S)
[Mass/volume]
in
Amniotic
fluid
|
|
2191-5
|
Dehydroepiandrosterone
sulfate
(DHEA-S)
[Mass/volume]
in
Serum
or
Plasma
|
|
2192-3
|
Dehydroepiandrosterone
sulfate
(DHEA-S)
[Mass/time]
in
24
hour
Urine
|
|
2193-1
|
Dehydroepiandrosterone
(DHEA)
[Mass/volume]
in
Serum
or
Plasma
|
|
2194-9
|
Dehydroepiandrosterone
(DHEA)
[Presence]
in
Urine
|
|
2195-6
|
Dehydroepiandrosterone
(DHEA)
[Mass/volume]
in
Urine
|
|
2196-4
|
Dehydroepiandrosterone
(DHEA).unconjugated
[Mass/volume]
in
Serum
or
Plasma
|
|
2197-2
|
Dehydroepiandrosterone
(DHEA).unconjugated
[Mass/time]
in
24
hour
Urine
|
|
2198-0
|
Delta
aminolevulinate
[Mass/volume]
in
Plasma
|
|
2199-8
|
Delta
aminolevulinate
[Mass/volume]
in
Serum
|
|
2200-4
|
Delta
aminolevulinate
[Mass/time]
in
24
hour
Urine
|
|
2201-2
|
Deoxycholate
[Mass/volume]
in
Serum
|
|
2202-0
|
Deoxycholylglycine
[Mass/volume]
in
Serum
|
|
2203-8
|
Dermatan
sulfate
[Mass/volume]
in
Serum
or
Plasma
|
|
2204-6
|
Dermatan
sulfate
[Mass/volume]
in
Urine
|
|
2205-3
|
Deprecated
Diacetate
[Mass/volume]
in
Serum
|
|
2206-1
|
Dicarboxylate,
C6-C8-C10
[Mass/volume]
in
Serum
|
|
2207-9
|
Dicarboxylate,
C6-C8-C10
[Mass/volume]
in
Urine
|
|
22070-7
|
HP
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
22071-5
|
Gaucher
3
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
22072-3
|
Gaucher
2
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
22073-1
|
Gaucher
1
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
22077-2
|
Acanthamoeba
sp
Ab
[Presence]
in
Cornea
|
|
22078-0
|
Acanthamoeba
sp
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
22079-8
|
Actinomyces
sp
Ab
[Titer]
in
Serum
|
|
2208-7
|
Diethyl
ether
[Mass/volume]
in
Serum
or
Plasma
|
|
22080-6
|
Adenovirus
Ab
[Titer]
in
Serum
|
|
22081-4
|
Afipia
felis
IgG
Ab
[Titer]
in
Serum
|
|
22082-2
|
Afipia
felis
IgM
Ab
[Titer]
in
Serum
|
|
22083-0
|
Alcelaphine
herpesvirus
1
Ab
[Presence]
in
Serum
|
|
22084-8
|
Anaplasma
marginale
Ab
[Presence]
in
Serum
|
|
22085-5
|
Aspergillus
fumigatus
3
Ab
[Presence]
in
Serum
|
|
22086-3
|
Aspergillus
niger
Ab
[Presence]
in
Serum
|
|
22087-1
|
Aspergillus
sp
Ab
[Titer]
in
Serum
|
|
22088-9
|
Avian
adenovirus
2
Ab
[Presence]
in
Serum
|
|
22089-7
|
Avian
adenovirus
Ab
[Presence]
in
Serum
|
|
2209-5
|
Dihydrofolate
[Mass/volume]
in
Serum
|
|
22090-5
|
Avian
encephalomyelitis
virus
Ab
[Presence]
in
Serum
|
|
22091-3
|
Avian
hemorrhagic
enteritis
virus
Ab
[Presence]
in
Serum
|
|
22092-1
|
Infectious
bronchitis
virus
Ark-99
Ab
[Titer]
in
Serum
|
|
22093-9
|
Infectious
bronchitis
virus
Conn-42
Ab
[Titer]
in
Serum
|
|
22094-7
|
Infectious
bronchitis
virus
Mass-41
Ab
[Titer]
in
Serum
|
|
22095-4
|
Avian
infectious
laryngotracheitis
virus
Ab
[Presence]
in
Serum
|
|
22096-2
|
Influenza
virus
A
Ab
[Presence]
in
Serum
|
|
22097-0
|
Avian
paramyxovirus
1
Ab
[Presence]
in
Serum
|
|
22098-8
|
Avian
paramyxovirus
1
Ab
[Titer]
in
Serum
|
|
22099-6
|
Avian
paramyxovirus
2
Ab
[Titer]
in
Serum
|
|
2210-3
|
Dihydrolipoamide
acetyl
transferase
[Enzymatic
activity/mass]
in
Tissue
|
|
22100-2
|
Avian
paramyxovirus
3
Ab
[Titer]
in
Serum
|
|
22101-0
|
Avian
pox
virus
Ab
[Presence]
in
Serum
|
|
22102-8
|
Avian
reovirus
Ab
[Presence]
in
Serum
|
|
22103-6
|
Reticuloendotheliosis
virus
Ab
[Presence]
in
Serum
|
|
22104-4
|
Babesia
caballi
Ab
[Presence]
in
Serum
|
|
22105-1
|
Theileria
equi
Ab
[Presence]
in
Serum
|
|
22106-9
|
Babesia
sp
Ab
[Titer]
in
Serum
|
|
22107-7
|
Babesia
sp
IgG
Ab
[Titer]
in
Serum
|
|
22108-5
|
Babesia
sp
IgM
Ab
[Units/volume]
in
Serum
|
|
22109-3
|
Bacillus
anthracis
Ab
[Units/volume]
in
Unspecified
specimen
|
|
2211-1
|
Dihydrolipoamide
dehydrogenase
[Enzymatic
activity/mass]
in
Tissue
|
|
22110-1
|
Bartonella
henselae
IgG
Ab
[Titer]
in
Serum
|
|
22111-9
|
Bartonella
henselae
IgM
Ab
[Titer]
in
Serum
|
|
22112-7
|
Blastomyces
dermatitidis
Ab
[Titer]
in
Serum
|
|
22113-5
|
Bluetongue
virus
Ab
[Presence]
in
Serum
|
|
22114-3
|
Bordetella
avium
Ab
[Presence]
in
Serum
|
|
22115-0
|
Bordetella
avium
Ab
[Titer]
in
Serum
|
|
22116-8
|
Bordetella
pertussis
Ab
[Titer]
in
Serum
|
|
22117-6
|
Bordetella
pertussis
Ab
[Titer]
in
Unspecified
specimen
|
|
22118-4
|
Borrelia
burgdorferi
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
22119-2
|
Borrelia
burgdorferi
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
2212-9
|
Dihydropteridine
reductase
[Enzymatic
activity/volume]
in
Serum
|
|
22120-0
|
Borrelia
burgdorferi
Ab
[Units/volume]
in
Body
fluid
|
|
22121-8
|
Borrelia
burgdorferi
Ab
[Units/volume]
in
Serum
|
|
22122-6
|
Borrelia
burgdorferi
Ab
[Titer]
in
Serum
|
|
22123-4
|
Borrelia
burgdorferi
IgA
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
22124-2
|
Borrelia
burgdorferi
IgA
Ab
[Presence]
in
Serum
|
|
22125-9
|
Borrelia
burgdorferi
IgG
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
22126-7
|
Borrelia
burgdorferi
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
22127-5
|
Borrelia
burgdorferi
IgG
Ab
[Units/volume]
in
Body
fluid
|
|
22128-3
|
Borrelia
burgdorferi
IgG
Ab
[Presence]
in
Serum
|
|
22129-1
|
Borrelia
burgdorferi
IgG
Ab
[Presence]
in
Synovial
fluid
|
|
2213-7
|
Dimethadione
[Mass/volume]
in
Serum
or
Plasma
|
|
22130-9
|
Borrelia
burgdorferi
IgG
Ab
[Titer]
in
Serum
|
|
22131-7
|
Borrelia
burgdorferi
IgG+IgM
Ab
[Presence]
in
Serum
|
|
22132-5
|
Borrelia
burgdorferi
IgM
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
22133-3
|
Borrelia
burgdorferi
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
22134-1
|
Borrelia
burgdorferi
IgM
Ab
[Units/volume]
in
Body
fluid
|
|
22135-8
|
Borrelia
burgdorferi
IgM
Ab
[Presence]
in
Serum
|
|
22136-6
|
Borrelia
burgdorferi
IgM
Ab
[Presence]
in
Synovial
fluid
|
|
22137-4
|
Borrelia
burgdorferi
IgM
Ab
[Titer]
in
Serum
|
|
22138-2
|
Borrelia
hermsii
IgG
Ab
[Titer]
in
Serum
|
|
22139-0
|
Borrelia
hermsii
IgM
Ab
[Titer]
in
Serum
|
|
2214-5
|
Dinitrobenzene
[Mass/volume]
in
Urine
|
|
22140-8
|
Bovine
diarrhea
virus
1
Ab
[Titer]
in
Serum
|
|
22141-6
|
Bovine
diarrhea
virus
2
Ab
[Titer]
in
Serum
|
|
22142-4
|
Bovine
herpesvirus
1
Ab
[Presence]
in
Serum
|
|
22143-2
|
Bovine
herpesvirus
1
Ab
[Titer]
in
Serum
|
|
22144-0
|
Bovine
leukemia
virus
Ab
[Presence]
in
Serum
|
|
22146-5
|
Brucella
abortus
Ab
[Presence]
in
Milk
|
|
22147-3
|
Brucella
abortus
Ab
[Presence]
in
Serum
|
|
22148-1
|
Brucella
abortus
Ab
[Presence]
in
Semen
|
|
22149-9
|
Brucella
abortus
Ab
[Presence]
in
Whey
|
|
2215-2
|
Dipalmitoylphosphatidylcholine
[Mass/volume]
in
Serum
|
|
22150-7
|
Brucella
abortus
Ab
[Titer]
in
Serum
|
|
22151-5
|
Brucella
abortus
IgM
Ab
[Units/volume]
in
Serum
|
|
22152-3
|
Brucella
canis
Ab
[Titer]
in
Serum
|
|
22153-1
|
Brucella
canis
IgG
Ab
[Units/volume]
in
Serum
|
|
22154-9
|
Brucella
canis
IgG
Ab
[Titer]
in
Serum
|
|
22155-6
|
Brucella
canis
IgM
Ab
[Units/volume]
in
Serum
|
|
22156-4
|
Brucella
canis
IgM
Ab
[Titer]
in
Serum
|
|
22157-2
|
Brucella
melitensis
Ab
[Titer]
in
Serum
|
|
22158-0
|
Brucella
ovis
Ab
[Presence]
in
Serum
|
|
22159-8
|
Brucella
sp
Ab
[Titer]
in
Serum
|
|
2216-0
|
Dopamine
[Mass/volume]
in
Serum
or
Plasma
|
|
22160-6
|
Brucella
suis
Ab
[Titer]
in
Serum
|
|
22161-4
|
Cache
valley
virus
Ab
[Presence]
in
Serum
|
|
22162-2
|
Candida
albicans
Ab
[Presence]
in
Serum
|
|
22163-0
|
Candida
albicans
Ab
[Units/volume]
in
Serum
|
|
22164-8
|
Caprine
arthritis
encephalitis
virus
Ab
[Presence]
in
Serum
|
|
22166-3
|
Caprine
parapoxvirus
Ab
[Presence]
in
Serum
|
|
22167-1
|
Caprine
parapoxvirus
Ab
[Presence]
in
Tissue
|
|
22168-9
|
Chicken
anemia
virus
Ab
[Presence]
in
Serum
|
|
22169-7
|
Chlamydophila
pneumoniae
IgA
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
2217-8
|
Dopamine
[Mass/volume]
in
Urine
|
|
22170-5
|
Chlamydophila
pneumoniae
IgA
Ab
[Titer]
in
Serum
|
|
22171-3
|
Chlamydophila
pneumoniae
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22172-1
|
Chlamydophila
pneumoniae
IgG
Ab
[Titer]
in
Serum
|
|
22173-9
|
Chlamydophila
pneumoniae
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22174-7
|
Chlamydophila
pneumoniae
IgM
Ab
[Titer]
in
Serum
|
|
22175-4
|
Chlamydophila
psittaci
Ab
[Presence]
in
Serum
|
|
22176-2
|
Chlamydophila
psittaci
Ab
[Titer]
in
Serum
|
|
22177-0
|
Chlamydophila
psittaci
IgA
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22178-8
|
Chlamydophila
psittaci
IgA
Ab
[Titer]
in
Serum
|
|
22179-6
|
Chlamydophila
psittaci
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
2218-6
|
Dopamine
[Mass/time]
in
24
hour
Urine
|
|
22180-4
|
Chlamydophila
psittaci
IgG
Ab
[Titer]
in
Serum
|
|
22181-2
|
Chlamydophila
psittaci
IgM
Ab
[Titer]
in
Serum
|
|
22182-0
|
Chlamydia
sp
Ab
[Titer]
in
Serum
|
|
22183-8
|
Chlamydia
sp
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
22184-6
|
Chlamydia
sp
IgG
Ab
[Titer]
in
Serum
|
|
22185-3
|
Chlamydia
sp
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
22186-1
|
Chlamydia
sp
IgM
Ab
[Titer]
in
Serum
|
|
22187-9
|
Chlamydia
trachomatis
Ab
[Titer]
in
Serum
|
|
22188-7
|
Chlamydia
trachomatis
IgA
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22189-5
|
Chlamydia
trachomatis
IgA
Ab
[Titer]
in
Serum
|
|
2219-4
|
Dopamine
beta-hydroxylase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
22190-3
|
Chlamydia
trachomatis
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
22191-1
|
Chlamydia
trachomatis
IgG
Ab
[Titer]
in
Serum
|
|
22192-9
|
Chlamydia
trachomatis
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
22193-7
|
Chlamydia
trachomatis
IgM
Ab
[Titer]
in
Serum
|
|
22194-5
|
Chlamydia
trachomatis
B
IgA
Ab
[Titer]
in
Serum
|
|
22195-2
|
Chlamydia
trachomatis
B
IgG
Ab
[Titer]
in
Serum
|
|
22196-0
|
Chlamydia
trachomatis
B
IgM
Ab
[Titer]
in
Serum
|
|
22197-8
|
Chlamydia
trachomatis
C
IgA
Ab
[Titer]
in
Serum
|
|
22198-6
|
Chlamydia
trachomatis
C
IgG
Ab
[Titer]
in
Serum
|
|
22199-4
|
Chlamydia
trachomatis
C
IgM
Ab
[Titer]
in
Serum
|
|
2220-2
|
Elastase.pancreatic
Free
[Enzymatic
activity/volume]
in
Serum
|
|
22200-0
|
Chlamydia
trachomatis
G+F+K
IgA
Ab
[Titer]
in
Serum
|
|
22201-8
|
Chlamydia
trachomatis
G+F+K
IgG
Ab
[Titer]
in
Serum
|
|
22202-6
|
Chlamydia
trachomatis
G+F+K
IgM
Ab
[Titer]
in
Serum
|
|
22203-4
|
Clostridium
tetani
IgG
Ab
[Units/volume]
in
Serum
|
|
22204-2
|
Coccidioides
immitis
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
22205-9
|
Coccidioides
immitis
Ab
[Presence]
in
Serum
|
|
22206-7
|
Coccidioides
immitis
Ab
[Units/volume]
in
Serum
|
|
22207-5
|
Coccidioides
immitis
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22208-3
|
Coccidioides
immitis
Ab
[Titer]
in
Serum
|
|
22209-1
|
Coccidioides
immitis
IgG
Ab
[Presence]
in
Serum
|
|
2221-0
|
Elastase.pancreatic
[Enzymatic
activity/volume]
in
Serum
|
|
22210-9
|
Coccidioides
immitis
IgM
Ab
[Presence]
in
Serum
|
|
22211-7
|
Coxiella
burnetii
Ab
[Titer]
in
Serum
|
|
22212-5
|
Coxsackievirus
A10
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22213-3
|
Coxsackievirus
A10
Ab
[Titer]
in
Serum
|
|
22214-1
|
Coxsackievirus
A16
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22215-8
|
Coxsackievirus
A16
Ab
[Titer]
in
Serum
|
|
22216-6
|
Coxsackievirus
A2
Ab
[Titer]
in
Serum
|
|
22217-4
|
Coxsackievirus
A21
Ab
[Titer]
in
Serum
|
|
22218-2
|
Coxsackievirus
A4
Ab
[Titer]
in
Serum
|
|
22219-0
|
Coxsackievirus
A7
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
2222-8
|
Elastase.pancreatic
2
[Enzymatic
activity/volume]
in
Serum
|
|
22220-8
|
Coxsackievirus
A7
Ab
[Titer]
in
Serum
|
|
22221-6
|
Coxsackievirus
A9
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22222-4
|
Coxsackievirus
A9
Ab
[Titer]
in
Serum
|
|
22223-2
|
Coxsackievirus
B
IgG
Ab
[Units/volume]
in
Serum
|
|
22224-0
|
Coxsackievirus
B
IgM
Ab
[Units/volume]
in
Serum
|
|
22225-7
|
Coxsackievirus
B1
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22226-5
|
Coxsackievirus
B1
Ab
[Titer]
in
Serum
|
|
22227-3
|
Coxsackievirus
B2
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22228-1
|
Coxsackievirus
B2
Ab
[Titer]
in
Serum
|
|
22229-9
|
Coxsackievirus
B3
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
2223-6
|
Elastase.leukocytary
[Enzymatic
activity/volume]
in
Plasma
|
|
22230-7
|
Coxsackievirus
B3
Ab
[Titer]
in
Serum
|
|
22231-5
|
Coxsackievirus
B4
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22232-3
|
Coxsackievirus
B4
Ab
[Titer]
in
Serum
|
|
22233-1
|
Coxsackievirus
B5
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22234-9
|
Coxsackievirus
B5
Ab
[Titer]
in
Serum
|
|
22235-6
|
Coxsackievirus
B6
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22236-4
|
Coxsackievirus
B6
Ab
[Titer]
in
Serum
|
|
22237-2
|
Cryptococcus
neoformans
Ab
[Titer]
in
Serum
|
|
22238-0
|
Taenia
solium
larva
Ab
[Presence]
in
Serum
|
|
22239-8
|
Cytomegalovirus
Ab
[Presence]
in
Serum
|
|
2224-4
|
Enolase
[Enzymatic
activity/volume]
in
Serum
|
|
22240-6
|
Cytomegalovirus
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22241-4
|
Cytomegalovirus
Ab
[Titer]
in
Serum
|
|
22243-0
|
Cytomegalovirus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
22244-8
|
Cytomegalovirus
IgG
Ab
[Presence]
in
Serum
|
|
22245-5
|
Cytomegalovirus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22246-3
|
Cytomegalovirus
IgG
Ab
[Titer]
in
Serum
|
|
22247-1
|
Cytomegalovirus
IgG
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
22248-9
|
Cytomegalovirus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22249-7
|
Cytomegalovirus
IgM
Ab
[Titer]
in
Serum
|
|
2225-1
|
Enolase.neuron
specific
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
22250-5
|
Dengue
virus
1
Ab
[Presence]
in
Serum
|
|
22251-3
|
Dengue
virus
2
Ab
[Presence]
in
Serum
|
|
22252-1
|
Dengue
virus
3
Ab
[Presence]
in
Serum
|
|
22253-9
|
Dengue
virus
4
Ab
[Presence]
in
Serum
|
|
22254-7
|
Duck
enteritis
virus
Ab
[Presence]
in
Serum
|
|
22255-4
|
Eastern
equine
encephalitis
virus
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
22256-2
|
Eastern
equine
encephalitis
virus
Ab
[Presence]
in
Serum
|
|
22257-0
|
Eastern
equine
encephalitis
virus
Ab
[Titer]
in
Serum
|
|
22258-8
|
Eastern
equine
encephalitis
virus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22259-6
|
Eastern
equine
encephalitis
virus
IgG
Ab
[Titer]
in
Serum
|
|
2226-9
|
Enteroglucagon
[Mass/volume]
in
Serum
|
|
22260-4
|
Eastern
equine
encephalitis
virus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22261-2
|
Eastern
equine
encephalitis
virus
IgM
Ab
[Titer]
in
Serum
|
|
22263-8
|
Ebola
virus
Ab
[Titer]
in
Serum
|
|
22264-6
|
Echinococcus
granulosus
IgG
Ab
[Presence]
in
Serum
|
|
22265-3
|
Echinococcus
sp
IgG
Ab
[Units/volume]
in
Serum
|
|
22266-1
|
Echovirus
1
Ab
[Titer]
in
Serum
|
|
22267-9
|
Echovirus
11
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22268-7
|
Echovirus
11
Ab
[Titer]
in
Serum
|
|
22269-5
|
Echovirus
14
Ab
[Titer]
in
Serum
|
|
2227-7
|
Enteropeptidase
[Enzymatic
activity/volume]
in
Plasma
|
|
22270-3
|
Deprecated
Echovirus
140
Ab
|
|
22271-1
|
Echovirus
16
Ab
[Titer]
in
Serum
|
|
22272-9
|
Echovirus
18
Ab
[Titer]
in
Serum
|
|
22273-7
|
Echovirus
19
Ab
[Titer]
in
Serum
|
|
22274-5
|
Echovirus
3
Ab
[Titer]
in
Serum
|
|
22275-2
|
Echovirus
30
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22276-0
|
Echovirus
4
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22277-8
|
Echovirus
4
Ab
[Titer]
in
Serum
|
|
22278-6
|
Echovirus
6
Ab
[Titer]
in
Serum
|
|
22279-4
|
Echovirus
7
Ab
[Titer]
in
Serum
|
|
2228-5
|
Enterotoxin
[Mass/volume]
in
Serum
|
|
22280-2
|
Echovirus
9
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22281-0
|
Echovirus
9
Ab
[Titer]
in
Serum
|
|
22282-8
|
Echovirus
NOS
Ab
[Titer]
in
Serum
|
|
22283-6
|
Ehrlichia
chaffeensis
IgG
Ab
[Presence]
in
Serum
|
|
22284-4
|
Ehrlichia
chaffeensis
IgG
Ab
[Units/volume]
in
Serum
|
|
22285-1
|
Entamoeba
histolytica
Ab
[Presence]
in
Serum
|
|
22286-9
|
Entamoeba
histolytica
Ab
[Titer]
in
Serum
|
|
22287-7
|
Entamoeba
histolytica
IgA
Ab
[Units/volume]
in
Serum
|
|
22288-5
|
Entamoeba
histolytica
IgG
Ab
[Units/volume]
in
Serum
|
|
22289-3
|
Entamoeba
histolytica
IgM
Ab
[Units/volume]
in
Serum
|
|
2229-3
|
Epiandrosterone
[Mass/volume]
in
Serum
or
Plasma
|
|
22290-1
|
Epstein
Barr
virus
capsid
IgA
Ab
[Titer]
in
Serum
|
|
22291-9
|
Epstein
Barr
virus
capsid
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22292-7
|
Epstein
Barr
virus
capsid
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22293-5
|
Epstein
Barr
virus
early
Ab
[Units/volume]
in
Serum
|
|
22294-3
|
Epstein
Barr
virus
early
Ab
[Titer]
in
Serum
|
|
22295-0
|
Epstein
Barr
virus
early
IgG
Ab
[Presence]
in
Serum
|
|
22296-8
|
Epstein
Barr
virus
nuclear
Ab
[Presence]
in
Serum
|
|
22297-6
|
Epstein
Barr
virus
nuclear
Ab
[Titer]
in
Serum
|
|
22298-4
|
Epstein
Barr
virus
nuclear
IgG
Ab
[Titer]
in
Serum
|
|
22299-2
|
Equine
arteritis
virus
Ab
[Titer]
in
Serum
|
|
2230-1
|
Epinephrine
[Mass/volume]
in
Plasma
|
|
22300-8
|
Equine
herpesvirus
1
Ab
[Titer]
in
Serum
|
|
22301-6
|
Equine
infectious
anemia
virus
Ab
[Presence]
in
Serum
|
|
22302-4
|
Equine
influenza
virus
A1
Ab
[Titer]
in
Serum
|
|
22303-2
|
Equine
influenza
virus
A2
Ab
[Titer]
in
Serum
|
|
22304-0
|
Giardia
lamblia
Ab
[Titer]
in
Serum
|
|
22305-7
|
Giardia
lamblia
IgA
Ab
[Titer]
in
Serum
|
|
22306-5
|
Giardia
lamblia
IgG
Ab
[Titer]
in
Serum
|
|
22307-3
|
Giardia
lamblia
IgM
Ab
[Titer]
in
Serum
|
|
22308-1
|
Hantavirus
puumala
IgG
Ab
[Titer]
in
Serum
|
|
22309-9
|
Hantavirus
puumala
IgM
Ab
[Titer]
in
Serum
|
|
2231-9
|
Deprecated
Epinephrine
[Mass/volume]
in
Plasma
|
|
22310-7
|
Helicobacter
pylori
Ab
[Presence]
in
Serum
|
|
22312-3
|
Hepatitis
A
virus
Ab
[Units/volume]
in
Serum
|
|
22313-1
|
Hepatitis
A
virus
IgG
Ab
[Units/volume]
in
Serum
|
|
22314-9
|
Hepatitis
A
virus
IgM
Ab
[Presence]
in
Serum
|
|
22315-6
|
Hepatitis
A
virus
IgM
Ab
[Units/volume]
in
Serum
|
|
22316-4
|
Hepatitis
B
virus
core
Ab
[Units/volume]
in
Serum
|
|
22317-2
|
Hepatitis
B
virus
core
Ab
[Units/volume]
in
Serum
from
donor
|
|
22318-0
|
Hepatitis
B
virus
core
IgG
Ab
[Units/volume]
in
Serum
|
|
22319-8
|
Hepatitis
B
virus
core
IgM
Ab
[Units/volume]
in
Serum
|
|
2232-7
|
Epinephrine
[Mass/time]
in
24
hour
Urine
|
|
22320-6
|
Hepatitis
B
virus
e
Ab
[Presence]
in
Serum
|
|
22321-4
|
Hepatitis
B
virus
e
Ab
[Units/volume]
in
Serum
|
|
22322-2
|
Hepatitis
B
virus
surface
Ab
[Presence]
in
Serum
|
|
22323-0
|
Hepatitis
B
virus
surface
Ab
[Units/volume]
in
Serum
from
donor
|
|
22327-1
|
Hepatitis
C
virus
Ab
[Units/volume]
in
Serum
|
|
22328-9
|
Hepatitis
C
virus
superoxide
dismutase
Ab
[Presence]
in
Serum
|
|
2233-5
|
Epitestosterone
[Mass/volume]
in
Serum
or
Plasma
|
|
22330-5
|
Hepatitis
D
virus
Ab
[Units/volume]
in
Serum
|
|
22331-3
|
Herpes
simplex
virus
1
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
22333-9
|
Herpes
simplex
virus
1
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22334-7
|
Herpes
simplex
virus
1
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22337-0
|
Herpes
simplex
virus
2
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22338-8
|
Herpes
simplex
virus
2
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22339-6
|
Herpes
simplex
virus
Ab
[Presence]
in
Serum
|
|
2234-3
|
Epitestosterone
[Presence]
in
Urine
|
|
22340-4
|
Herpes
simplex
virus
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22341-2
|
Herpes
simplex
virus
Ab
[Titer]
in
Serum
|
|
22343-8
|
Herpes
simplex
virus
IgM
Ab
[Titer]
in
Serum
|
|
22344-6
|
Heterophile
Ab
after
absorption
[Titer]
in
Serum
|
|
22345-3
|
Histoplasma
capsulatum
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
22346-1
|
Histoplasma
capsulatum
Ab
[Presence]
in
Serum
|
|
22347-9
|
Histoplasma
capsulatum
Ab
[Titer]
in
Serum
|
|
22348-7
|
Histoplasma
capsulatum
IgA
Ab
[Presence]
in
Serum
|
|
22349-5
|
Histoplasma
capsulatum
IgA
Ab
[Units/volume]
in
Serum
|
|
2235-0
|
Epitestosterone
[Mass/volume]
in
Urine
|
|
22350-3
|
Histoplasma
capsulatum
IgE
Ab
[Presence]
in
Serum
|
|
22351-1
|
Histoplasma
capsulatum
IgG
Ab
[Units/volume]
in
Serum
|
|
22352-9
|
Histoplasma
capsulatum
IgM
Ab
[Presence]
in
Serum
|
|
22353-7
|
Histoplasma
capsulatum
IgM
Ab
[Units/volume]
in
Serum
|
|
22354-5
|
Histoplasma
capsulatum
mycelial
phase
Ab
[Units/volume]
in
Serum
|
|
22355-2
|
Histoplasma
capsulatum
yeast
phase
Ab
[Units/volume]
in
Serum
|
|
22356-0
|
HIV
1
Ab
[Units/volume]
in
Serum
|
|
22357-8
|
HIV
1+2
Ab
[Units/volume]
in
Serum
|
|
22358-6
|
HIV
2
Ab
[Units/volume]
in
Serum
|
|
22359-4
|
HTLV
I
Ab
[Presence]
in
Serum
|
|
2236-8
|
Calciferol
(Vit
D2)
[Mass/volume]
in
Serum
or
Plasma
|
|
22360-2
|
HTLV
I
IgG
Ab
[Presence]
in
Serum
|
|
22361-0
|
HTLV
I+II
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
22362-8
|
HTLV
I+II
Ab
[Presence]
in
Serum
|
|
22363-6
|
HTLV
I+II
Ab
[Units/volume]
in
Serum
|
|
22364-4
|
Infectious
bursal
disease
virus
Ab
[Presence]
in
Serum
|
|
22365-1
|
Influenza
virus
A
Ab
[Titer]
in
Serum
|
|
22366-9
|
Influenza
virus
A+B
Ab
[Titer]
in
Serum
|
|
22367-7
|
Influenza
virus
B
Ab
[Titer]
in
Serum
|
|
22368-5
|
Influenza
virus
C
Ab
[Titer]
in
Serum
|
|
22369-3
|
Japanese
encephalitis
virus
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
2237-6
|
Erythropoietin
(EPO)
[Mass/volume]
in
Serum
or
Plasma
|
|
22370-1
|
Japanese
encephalitis
virus
Ab
[Presence]
in
Serum
|
|
22371-9
|
Junin
virus
Ab
[Presence]
in
Serum
|
|
22372-7
|
Deprecated
La
Crosse
virus
Ab
|
|
22373-5
|
La
Crosse
virus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22375-0
|
La
Crosse
virus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22377-6
|
Lassa
virus
IgG
Ab
[Presence]
in
Serum
|
|
22378-4
|
Lassa
virus
IgG
Ab
[Titer]
in
Serum
|
|
22379-2
|
Lassa
virus
IgM
Ab
[Presence]
in
Serum
|
|
2238-4
|
Estradiol
(E2)
[Mass/volume]
in
Saliva
(oral
fluid)
|
|
22380-0
|
Lassa
virus
IgM
Ab
[Titer]
in
Serum
|
|
22381-8
|
Legionella
pneumophila
1
IgG
Ab
[Titer]
in
Serum
|
|
22382-6
|
Legionella
pneumophila
1
IgM
Ab
[Titer]
in
Serum
|
|
22383-4
|
Legionella
pneumophila
2
IgG
Ab
[Titer]
in
Serum
|
|
22384-2
|
Legionella
pneumophila
2
IgM
Ab
[Titer]
in
Serum
|
|
22385-9
|
Legionella
pneumophila
3
IgG
Ab
[Titer]
in
Serum
|
|
22386-7
|
Legionella
pneumophila
3
IgM
Ab
[Titer]
in
Serum
|
|
22387-5
|
Legionella
pneumophila
4
IgG
Ab
[Titer]
in
Serum
|
|
22388-3
|
Legionella
pneumophila
4
IgM
Ab
[Titer]
in
Serum
|
|
22389-1
|
Legionella
pneumophila
5
IgG
Ab
[Titer]
in
Serum
|
|
2239-2
|
Estradiol
(E2)
[Mass/volume]
in
Semen
|
|
22390-9
|
Legionella
pneumophila
5
IgM
Ab
[Titer]
in
Serum
|
|
22391-7
|
Legionella
pneumophila
6
IgG
Ab
[Titer]
in
Serum
|
|
22392-5
|
Legionella
pneumophila
6
IgM
Ab
[Titer]
in
Serum
|
|
22393-3
|
Legionella
pneumophila
7
Ab
[Titer]
in
Serum
|
|
22394-1
|
Legionella
pneumophila
8
Ab
[Titer]
in
Serum
|
|
22395-8
|
Legionella
pneumophila
9
Ab
[Titer]
in
Serum
|
|
22396-6
|
Legionella
pneumophila
Ab
[Titer]
in
Serum
|
|
22397-4
|
Legionella
pneumophila
IgG
Ab
[Titer]
in
Serum
|
|
22398-2
|
Legionella
pneumophila
IgM
Ab
[Titer]
in
Serum
|
|
22399-0
|
Legionella
sp
Ab
[Titer]
in
Serum
|
|
2240-0
|
Estradiol
(E2)
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
22400-6
|
Leptospira
interrogans
sv
Bratislava
Ab
[Titer]
in
Serum
|
|
22401-4
|
Leptospira
interrogans
sv
Canicola
Ab
[Titer]
in
Serum
|
|
22402-2
|
Leptospira
interrogans
sv
Grippotyphosa
Ab
[Titer]
in
Serum
|
|
22403-0
|
Leptospira
interrogans
sv
Hardjo
Ab
[Titer]
in
Serum
|
|
22404-8
|
Leptospira
interrogans
sv
Icterohaemorrhagiae
Ab
[Titer]
in
Serum
|
|
22405-5
|
Leptospira
interrogans
sv
Pomona
Ab
[Titer]
in
Serum
|
|
22406-3
|
Listeria
monocytogenes
Ab
[Titer]
in
Serum
|
|
22408-9
|
Lymphocytic
choriomeningitis
virus
Ab
[Titer]
in
Serum
|
|
22409-7
|
Lymphocytic
choriomeningitis
virus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
2241-8
|
Estradiol
(E2)
Free
[Moles/mass]
in
Tissue
|
|
22410-5
|
Lymphocytic
choriomeningitis
virus
IgG
Ab
[Titer]
in
Serum
|
|
22411-3
|
Lymphocytic
choriomeningitis
virus
IgM
Ab
[Titer]
in
Serum
|
|
22412-1
|
Saccharopolyspora
rectivirgula
Ab
[Presence]
in
Serum
|
|
22413-9
|
Mumps
virus
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22414-7
|
Mumps
virus
Ab
[Titer]
in
Serum
|
|
22415-4
|
Mumps
virus
IgG
Ab
[Presence]
in
Serum
|
|
22416-2
|
Mumps
virus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22417-0
|
Mumps
virus
IgG
Ab
[Titer]
in
Serum
|
|
22418-8
|
Mumps
virus
IgM
Ab
[Presence]
in
Serum
|
|
22419-6
|
Mumps
virus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
2242-6
|
Deprecated
Estradiol
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
22420-4
|
Mumps
virus
IgM
Ab
[Titer]
in
Serum
|
|
22421-2
|
Mycobacterium
avium
ss
paratuberculosis
Ab
[Presence]
in
Serum
|
|
22422-0
|
Mycoplasma
gallisepticum
Ab
[Presence]
in
Serum
|
|
22423-8
|
Mycoplasma
hominis
Ab
[Titer]
in
Serum
|
|
22424-6
|
Mycoplasma
meleagridis
Ab
[Presence]
in
Serum
|
|
22425-3
|
Mycoplasma
pneumoniae
Ab
[Titer]
in
Serum
|
|
22426-1
|
Mycoplasma
pneumoniae
IgG
Ab
[Titer]
in
Serum
|
|
22427-9
|
Mycoplasma
pneumoniae
IgM
Ab
[Titer]
in
Serum
|
|
22428-7
|
Mycoplasma
sp
Ab
[Presence]
in
Serum
|
|
22429-5
|
Mycoplasma
synoviae
Ab
[Presence]
in
Serum
|
|
2243-4
|
Estradiol
(E2)
[Mass/volume]
in
Serum
or
Plasma
|
|
22430-3
|
Neisseria
gonorrhoeae
Ab
[Titer]
in
Serum
|
|
22431-1
|
Neisseria
meningitidis
Y
Ab
[Titer]
in
Unspecified
specimen
|
|
22432-9
|
Neospora
caninum
Ab
[Presence]
in
Serum
|
|
22434-5
|
Human
papilloma
virus
Ab
[Presence]
in
Tissue
|
|
22435-2
|
Paracoccidioides
brasiliensis
Ab
[Titer]
in
Serum
|
|
22436-0
|
Paragonimus
sp
Ab
[Titer]
in
Serum
|
|
22437-8
|
Parainfluenza
virus
1
Ab
[Titer]
in
Serum
|
|
22438-6
|
Parainfluenza
virus
2
Ab
[Titer]
in
Serum
|
|
22439-4
|
Parainfluenza
virus
3
Ab
[Titer]
in
Serum
|
|
22440-2
|
Pasteurella
multocida
Ab
[Presence]
in
Serum
|
|
22441-0
|
Plasmodium
falciparum
Ab
[Titer]
in
Serum
|
|
22442-8
|
Plasmodium
malariae
Ab
[Titer]
in
Serum
|
|
22443-6
|
Plasmodium
ovale
Ab
[Titer]
in
Serum
|
|
22444-4
|
Plasmodium
vivax
Ab
[Titer]
in
Serum
|
|
22445-1
|
Polio
virus
1
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22446-9
|
Polio
virus
1
Ab
[Titer]
in
Serum
|
|
22447-7
|
Polio
virus
2
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22448-5
|
Polio
virus
2
Ab
[Titer]
in
Serum
|
|
22449-3
|
Polio
virus
3
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
2245-9
|
Estradiol
(E2)
[Moles/mass]
in
Tissue
|
|
22450-1
|
Polio
virus
3
Ab
[Titer]
in
Serum
|
|
22451-9
|
Porcine
reproductive
and
respiratory
syndrome
virus
Ab
[Presence]
in
Serum
|
|
22452-7
|
Pseudorabies
virus
Ab
[Presence]
in
Serum
|
|
22453-5
|
Pseudorabies
virus
Ab
[Titer]
in
Serum
|
|
22454-3
|
Pseudorabies
virus
Clinease
gene
deletion
Ab
[Presence]
in
Serum
|
|
22455-0
|
Pseudorabies
virus
Herdcheck
gene
deletion
Ab
[Presence]
in
Serum
|
|
22456-8
|
Pseudorabies
virus
Omnimark
gene
deletion
Ab
[Presence]
in
Serum
|
|
22457-6
|
Pseudorabies
virus
Tolvid
gene
deletion
Ab
[Presence]
in
Serum
|
|
22458-4
|
Rabies
virus
Ab
[Units/volume]
in
Tissue
|
|
22459-2
|
Reagin
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
2246-7
|
Estradiol
(E2).unconjugated
[Mass/time]
in
24
hour
Urine
|
|
22460-0
|
Reagin
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
22461-8
|
Reagin
Ab
[Presence]
in
Serum
|
|
22462-6
|
Reagin
Ab
[Units/volume]
in
Serum
|
|
22463-4
|
Reagin
Ab
[Presence]
in
Serum
from
donor
|
|
22464-2
|
Reagin
Ab
[Presence]
in
Unspecified
specimen
|
|
22465-9
|
Reovirus
Ab
[Titer]
in
Serum
|
|
22466-7
|
Respiratory
syncytial
virus
Ab
[Titer]
in
Serum
|
|
22467-5
|
Respiratory
syncytial
virus
IgM
Ab
[Titer]
in
Serum
|
|
22468-3
|
Rickettsia
(Proteus
OX19)
Ab
[Presence]
in
Serum
|
|
22469-1
|
Rickettsia
(Proteus
OX19)
Ab
[Titer]
in
Serum
|
|
2247-5
|
Estriol
(E3).conjugated
[Mass/volume]
in
Serum
or
Plasma
|
|
22470-9
|
Rickettsia
(Proteus
OX2)
Ab
[Presence]
in
Serum
|
|
22471-7
|
Rickettsia
(Proteus
OX2)
Ab
[Titer]
in
Serum
|
|
22472-5
|
Rickettsia
(Proteus
OXK)
Ab
[Presence]
in
Serum
|
|
22473-3
|
Rickettsia
(Proteus
OXK)
Ab
[Titer]
in
Serum
|
|
22474-1
|
Rickettsia
spotted
fever
group
Ab
[Presence]
in
Serum
|
|
22475-8
|
Rickettsia
spotted
fever
group
Ab
[Titer]
in
Serum
|
|
22476-6
|
Rickettsia
spotted
fever
group
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22477-4
|
Rickettsia
spotted
fever
group
IgG
Ab
[Titer]
in
Serum
|
|
22478-2
|
Rickettsia
spotted
fever
group
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22479-0
|
Rickettsia
spotted
fever
group
IgM
Ab
[Titer]
in
Serum
|
|
2248-3
|
Estriol
(E3)
[Mass/volume]
in
Amniotic
fluid
|
|
22480-8
|
Rickettsia
typhus
group
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22481-6
|
Rickettsia
typhus
group
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22482-4
|
Rickettsia
rickettsii
IgG
Ab
[Titer]
in
Serum
|
|
22483-2
|
Rickettsia
rickettsii
IgM
Ab
[Titer]
in
Serum
|
|
22484-0
|
Rickettsia
sp
Ab
[Titer]
in
Serum
|
|
22485-7
|
Orientia
tsutsugamushi
Ab
[Titer]
in
Serum
|
|
22486-5
|
Rickettsia
typhi
Ab
[Units/volume]
in
Serum
|
|
22487-3
|
Rickettsia
typhi
IgA
Ab
[Units/volume]
in
Serum
|
|
22488-1
|
Rickettsia
typhi
IgG
Ab
[Presence]
in
Serum
|
|
22489-9
|
Rickettsia
typhi
IgG
Ab
[Titer]
in
Serum
|
|
2249-1
|
Estriol
(E3).unconjugated
[Mass/volume]
in
Amniotic
fluid
|
|
22490-7
|
Rickettsia
typhi
IgM
Ab
[Titer]
in
Serum
|
|
22491-5
|
Rickettsia
typhus
group
Ab
[Presence]
in
Serum
|
|
22492-3
|
Rickettsia
typhus
group
Ab
[Titer]
in
Serum
|
|
22493-1
|
Rickettsia
typhus
group
IgG
Ab
[Titer]
in
Serum
|
|
22494-9
|
Rickettsia
typhus
group
IgM
Ab
[Titer]
in
Serum
|
|
22495-6
|
Rotavirus
Ab
[Titer]
in
Serum
|
|
22496-4
|
Rubella
virus
Ab
[Presence]
in
Serum
|
|
22497-2
|
Rubella
virus
Ab
[Titer]
in
Serum
|
|
22498-0
|
Measles
virus
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22499-8
|
Measles
virus
Ab
[Titer]
in
Serum
|
|
2250-9
|
Estriol
(E3).unconjugated
[Mass/volume]
in
Serum
or
Plasma
|
|
22500-3
|
Measles
virus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
22501-1
|
Measles
virus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22502-9
|
Measles
virus
IgG
Ab
[Titer]
in
Serum
|
|
22503-7
|
Measles
virus
IgG
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
22504-5
|
Measles
virus
IgG
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
22505-2
|
Measles
virus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22506-0
|
Measles
virus
IgM
Ab
[Titer]
in
Serum
|
|
22507-8
|
Saint
Louis
encephalitis
virus
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
22509-4
|
Saint
Louis
encephalitis
virus
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
2251-7
|
Estriol
(E3)
[Mass/volume]
in
Serum
or
Plasma
|
|
22510-2
|
Saint
Louis
encephalitis
virus
Ab
[Titer]
in
Serum
|
|
22511-0
|
Saint
Louis
encephalitis
virus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22512-8
|
Saint
Louis
encephalitis
virus
IgG
Ab
[Titer]
in
Serum
|
|
22513-6
|
Saint
Louis
encephalitis
virus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22514-4
|
Saint
Louis
encephalitis
virus
IgM
Ab
[Titer]
in
Serum
|
|
22515-1
|
Salmonella
arizonae
Ab
[Presence]
in
Serum
|
|
22516-9
|
Salmonella
paratyphi
A
Ab
[Presence]
in
Serum
|
|
22517-7
|
Salmonella
paratyphi
A
H
Ab
[Presence]
in
Serum
|
|
22518-5
|
Salmonella
paratyphi
A
H
Ab
[Titer]
in
Serum
|
|
22519-3
|
Salmonella
paratyphi
A
O
Ab
[Presence]
in
Serum
|
|
2252-5
|
Estriol
(E3)
[Mass/volume]
in
Urine
|
|
22520-1
|
Salmonella
paratyphi
B
Ab
[Presence]
in
Serum
|
|
22521-9
|
Salmonella
paratyphi
B
H
Ab
[Presence]
in
Serum
|
|
22522-7
|
Salmonella
paratyphi
B
H
Ab
[Titer]
in
Serum
|
|
22523-5
|
Salmonella
paratyphi
B
O
Ab
[Presence]
in
Serum
|
|
22524-3
|
Salmonella
paratyphi
C
H
Ab
[Presence]
in
Serum
|
|
22525-0
|
Salmonella
paratyphi
C
O
Ab
[Presence]
in
Serum
|
|
22526-8
|
Salmonella
pullorum
Ab
[Presence]
in
Serum
|
|
22527-6
|
Salmonella
sp
Ab
[Titer]
in
Serum
|
|
22529-2
|
Salmonella
typhi
H
Ab
[Presence]
in
Serum
|
|
2253-3
|
Estriol
(E3)
[Mass/time]
in
24
hour
Urine
|
|
22531-8
|
Salmonella
typhimurium
Ab
[Presence]
in
Serum
|
|
22532-6
|
Sarcocystis
neurona
Ab
[Presence]
in
Blood
|
|
22533-4
|
Sarcocystis
neurona
Ab
[Presence]
in
Body
fluid
|
|
22534-2
|
Sarcocystis
neurona
Ab
[Presence]
in
Serum
|
|
22535-9
|
Schistosoma
japonicum
Ab
[Titer]
in
Serum
|
|
22536-7
|
Schistosoma
mansoni
Ab
[Presence]
in
Serum
|
|
22537-5
|
Shigella
boydii
Ab
[Titer]
in
Serum
|
|
22538-3
|
Shigella
dysenteriae
Ab
[Titer]
in
Serum
|
|
22539-1
|
Shigella
flexneri
Ab
[Titer]
in
Serum
|
|
2254-1
|
Estrogen
[Mass/volume]
in
Serum
or
Plasma
|
|
22540-9
|
Shigella
sonnei
Ab
[Titer]
in
Serum
|
|
2255-8
|
Estrogen
[Mass/volume]
in
Urine
|
|
2256-6
|
Estrogen
[Mass/time]
in
24
hour
Urine
|
|
22562-3
|
Streptococcus
pneumoniae
IgG
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
22564-9
|
Streptococcus
pneumoniae
IgG
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
22566-4
|
Streptococcus
pyogenes
enzyme
Ab
[Presence]
in
Serum
|
|
22567-2
|
Streptococcus
pyogenes
enzyme
Ab
[Titer]
in
Serum
|
|
22568-0
|
Streptolysin
O
Ab
[Titer]
in
Serum
|
|
2257-4
|
Estrone
(E1)
[Mass/volume]
in
Semen
|
|
22571-4
|
Teichoate
Ab
[Titer]
in
Serum
|
|
22572-2
|
Saccharomonospora
viridis
Ab
[Presence]
in
Serum
|
|
22573-0
|
Thermoactinomyces
vulgaris
Ab
[Presence]
in
Serum
|
|
22575-5
|
Toxocara
canis
IgG
Ab
[Units/volume]
in
Serum
|
|
22577-1
|
Toxoplasma
gondii
Ab
[Presence]
in
Serum
|
|
22578-9
|
Toxoplasma
gondii
IgA
Ab
[Units/volume]
in
Serum
|
|
22579-7
|
Toxoplasma
gondii
IgA+IgE
Ab
[Units/volume]
in
Serum
|
|
2258-2
|
Estrone
(E1)
[Mass/volume]
in
Serum
or
Plasma
|
|
22580-5
|
Toxoplasma
gondii
IgG
Ab
[Presence]
in
Serum
|
|
22581-3
|
Toxoplasma
gondii
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22582-1
|
Toxoplasma
gondii
IgG
Ab
[Titer]
in
Serum
|
|
22583-9
|
Toxoplasma
gondii
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22584-7
|
Toxoplasma
gondii
IgM
Ab
[Titer]
in
Serum
|
|
22585-4
|
Treponema
pallidum
Ab
[Units/volume]
in
Blood
|
|
22586-2
|
Treponema
pallidum
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
22587-0
|
Treponema
pallidum
Ab
[Presence]
in
Serum
|
|
2259-0
|
Estrone
(E1)
[Mass/volume]
in
Urine
|
|
22590-4
|
Treponema
pallidum
Ab
[Titer]
in
Serum
|
|
22592-0
|
Treponema
pallidum
IgG
Ab
[Units/volume]
in
Serum
|
|
22594-6
|
Treponema
pallidum
IgM
Ab
[Units/volume]
in
Serum
|
|
22595-3
|
Trichinella
spiralis
Ab
[Presence]
in
Serum
|
|
22596-1
|
Trichinella
spiralis
Ab
[Titer]
in
Serum
|
|
22599-5
|
Trypanosoma
cruzi
Ab
[Titer]
in
Serum
|
|
2260-8
|
Estrone
(E1).unconjugated
[Mass/volume]
in
Amniotic
fluid
|
|
22600-1
|
Varicella
zoster
virus
Ab
[Presence]
in
Serum
|
|
22601-9
|
Varicella
zoster
virus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22602-7
|
Varicella
zoster
virus
IgG
Ab
[Titer]
in
Serum
|
|
22603-5
|
Varicella
zoster
virus
IgG
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
22604-3
|
Varicella
zoster
virus
IgG
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
22605-0
|
Varicella
zoster
virus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22606-8
|
Varicella
zoster
virus
IgM
Ab
[Titer]
in
Serum
|
|
22607-6
|
Venezuelan
equine
encephalitis
virus
Ab
[Titer]
in
Serum
|
|
22608-4
|
Escherichia
coli
verotoxin
1
Ab
[Titer]
in
Stool
|
|
22609-2
|
Escherichia
coli
verotoxin
2
Ab
[Titer]
in
Stool
|
|
2261-6
|
Estrone
(E1).unconjugated
[Mass/volume]
in
Serum
or
Plasma
|
|
22610-0
|
Western
equine
encephalitis
virus
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
22611-8
|
Western
equine
encephalitis
virus
Ab
[Presence]
in
Serum
|
|
22613-4
|
Western
equine
encephalitis
virus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22614-2
|
Western
equine
encephalitis
virus
IgG
Ab
[Titer]
in
Serum
|
|
22615-9
|
Western
equine
encephalitis
virus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
22616-7
|
Western
equine
encephalitis
virus
IgM
Ab
[Titer]
in
Serum
|
|
22617-5
|
Wuchereria
bancrofti
Ab
[Presence]
in
Serum
|
|
22618-3
|
Yellow
fever
virus
Ab
[Titer]
in
Serum
|
|
22619-1
|
Yersinia
enterocolitica
IgA
Ab
[Units/volume]
in
Serum
|
|
2262-4
|
Estrone
(E1).unconjugated
[Mass/time]
in
24
hour
Urine
|
|
22620-9
|
Yersinia
enterocolitica
IgG
Ab
[Units/volume]
in
Serum
|
|
22621-7
|
Yersinia
enterocolitica
IgM
Ab
[Units/volume]
in
Serum
|
|
2265-7
|
Ethylmalonate
[Mass/volume]
in
Urine
|
|
2266-5
|
Etiocholanolone
[Presence]
in
Urine
|
|
22663-9
|
Estrone
(E1)
[Moles/volume]
in
Serum
or
Plasma
|
|
22664-7
|
Urea
[Moles/volume]
in
Serum
or
Plasma
|
|
22665-4
|
Bilirubin.delta
[Moles/volume]
in
Serum
or
Plasma
|
|
22666-2
|
Busulfan
[Moles/volume]
in
Serum
or
Plasma
|
|
22668-8
|
Propylene
glycol
[Moles/volume]
in
Serum
or
Plasma
|
|
2267-3
|
Etiocholanolone
[Mass/volume]
in
Urine
|
|
22674-6
|
Transferrin
[Moles/volume]
in
Serum
or
Plasma
|
|
22675-3
|
Deprecated
Angiotensin
converting
enzyme
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
22676-1
|
7-Dehydrocholesterol
[Presence]
in
Serum
or
Plasma
|
|
22678-7
|
Ethylene
glycol
[Moles/volume]
in
Urine
|
|
2268-1
|
Etiocholanolone
[Mass/time]
in
24
hour
Urine
|
|
22680-3
|
Mercury/Creatinine
[Molar
ratio]
in
Urine
|
|
22687-8
|
Cystine/Creatinine
[Molar
ratio]
in
Urine
|
|
22689-4
|
Zinc
[Moles/time]
in
24
hour
Urine
|
|
2269-9
|
Complement
factor
B
[Mass/volume]
in
Serum
or
Plasma
|
|
22696-9
|
Cadmium/Creatinine
[Molar
ratio]
in
Urine
|
|
2270-7
|
Fat
[Presence]
in
Stool
|
|
22700-9
|
Urea
[Moles/volume]
in
Urine
|
|
22701-7
|
Salicylates
[Moles/volume]
in
Urine
|
|
22702-5
|
Ketones
[Moles/volume]
in
Urine
by
Test
strip
|
|
22704-1
|
Carnitine
free
(C0)/Creatinine
[Molar
ratio]
in
Urine
|
|
22705-8
|
Glucose
[Moles/volume]
in
Urine
by
Test
strip
|
|
22708-2
|
Homovanillate/Creatinine
[Molar
ratio]
in
Urine
|
|
2271-5
|
Fat
[Mass/time]
in
72
hour
Stool
|
|
22712-4
|
Adenosine
monophosphate.cyclic
[Moles/volume]
in
Urine
|
|
2272-3
|
Fat
[Presence]
in
Urine
|
|
22726-4
|
Creatinine
[Moles/volume]
in
Unspecified
specimen
|
|
22731-4
|
Triglyceride
[Moles/volume]
in
Unspecified
specimen
|
|
22732-2
|
Salicylates
[Moles/volume]
in
Unspecified
specimen
|
|
22733-0
|
Phosphate
[Moles/volume]
in
Unspecified
specimen
|
|
22734-8
|
Ethylene
glycol
[Moles/volume]
in
Unspecified
specimen
|
|
22735-5
|
Bicarbonate
[Moles/volume]
in
Unspecified
specimen
|
|
22736-3
|
Acetaminophen
[Moles/volume]
in
Unspecified
specimen
|
|
22738-9
|
Urea
[Moles/volume]
in
Unspecified
specimen
|
|
22742-1
|
Propylene
glycol
[Moles/volume]
in
Unspecified
specimen
|
|
22744-7
|
Copper
[Moles/volume]
in
Unspecified
specimen
|
|
22745-4
|
Ethanol
[Moles/volume]
in
Urine
|
|
22746-2
|
Gentamicin
[Moles/volume]
in
Serum
or
Plasma
--peak
|
|
22747-0
|
Gentamicin
[Moles/volume]
in
Serum
or
Plasma
--trough
|
|
22748-8
|
Cholesterol
in
LDL
[Moles/volume]
in
Serum
or
Plasma
|
|
22750-4
|
Tobramycin
[Moles/volume]
in
Serum
or
Plasma
--random
|
|
22751-2
|
Tobramycin
[Moles/volume]
in
Serum
or
Plasma
--peak
|
|
22752-0
|
Tobramycin
[Moles/volume]
in
Serum
or
Plasma
--trough
|
|
22753-8
|
Iron
binding
capacity.unsaturated
[Moles/volume]
in
Serum
or
Plasma
|
|
22755-3
|
Haemophilus
influenzae
B
Ab
[Mass/volume]
in
Serum
|
|
22758-7
|
Plasminogen
activator
inhibitor
1
Ag
[Mass/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
22759-5
|
Platelet
Ab
[Titer]
in
Serum
|
|
2276-4
|
Ferritin
[Mass/volume]
in
Serum
or
Plasma
|
|
22760-3
|
Potassium
[Mass/volume]
in
Serum
or
Plasma
|
|
22763-7
|
Ammonia
[Mass/volume]
in
Plasma
|
|
22764-5
|
Actinobacillus
pleuropneumoniae
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
22765-2
|
Adult
fly
identified
in
Unspecified
specimen
|
|
22766-0
|
African
horse
sickness
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
22767-8
|
African
horse
sickness
virus
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
22768-6
|
African
horse
sickness
virus
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
22769-4
|
African
horse
sickness
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
2277-2
|
Ferrochelatase
[Enzymatic
activity/volume]
in
Serum
|
|
22770-2
|
African
horse
sickness
virus
Ab
[Titer]
in
Serum
|
|
22771-0
|
African
horse
sickness
virus
Ab
[Presence]
in
Serum
|
|
22772-8
|
African
horse
sickness
virus
Ag
[Presence]
in
Tissue
by
Immunoassay
|
|
22773-6
|
African
horse
sickness
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunoassay
|
|
22774-4
|
African
horse
sickness
virus
RNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
22775-1
|
African
horse
sickness
virus
serotype
[Identifier]
in
Serum
by
Neutralization
test
|
|
22776-9
|
African
horse
sickness
virus
serotype
[Identifier]
in
Unspecified
specimen
by
Neutralization
test
|
|
22777-7
|
African
swine
fever
virus
Ab
[Presence]
in
Body
fluid
by
Immunoassay
|
|
22778-5
|
African
swine
fever
virus
Ab
[Presence]
in
Body
fluid
|
|
22779-3
|
African
swine
fever
virus
Ab
[Presence]
in
Serum
|
|
2278-0
|
Fibrinopeptide
B
[Mass/volume]
in
Serum
|
|
22780-1
|
African
swine
fever
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
22781-9
|
African
swine
fever
virus
Ag
[Presence]
in
Unspecified
specimen
by
Agglutination
|
|
22782-7
|
African
swine
fever
virus
Ag
[Presence]
in
Tissue
by
Agglutination
|
|
22783-5
|
African
swine
fever
virus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
22784-3
|
African
swine
fever
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
22785-0
|
African
swine
fever
virus
DNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
22786-8
|
Alcelaphine
herpesvirus
1
Ab
[Titer]
in
Serum
|
|
22787-6
|
Alcelaphine
herpesvirus
1
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
22788-4
|
Alcelaphine
herpesvirus
1
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
22789-2
|
Alcelaphine
herpesvirus
1
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
2279-8
|
Fibrinopeptide
A
[Mass/volume]
in
Peritoneal
fluid
|
|
22790-0
|
Alcelaphine
herpesvirus
1
Ag
[Presence]
in
Unspecified
specimen
by
Immune
stain
|
|
22791-8
|
Alcelaphine
herpesvirus
1
DNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
22792-6
|
Aleutian
disease
virus
Ab
[Presence]
in
Serum
by
Counterimmunoelectrophoresis
(CIE)
|
|
22793-4
|
Aleutian
disease
virus
Ab
[Presence]
in
Serum
|
|
22794-2
|
Anaplasma
marginale
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
22795-9
|
Anaplasma
marginale
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
22796-7
|
Anaplasma
marginale
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
22797-5
|
Anaplasma
marginale
DNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
22798-3
|
Anaplasma
marginale
rRNA
[Presence]
in
Tissue
by
DNA
probe
|
|
22799-1
|
Anaplasma
sp
identified
in
Tissue
by
Modified
Giemsa
stain
|
|
2280-6
|
Fibronectin
[Mass/volume]
in
Plasma
|
|
22800-7
|
Anaplasma
sp
identified
in
Blood
by
Modified
Giemsa
stain
|
|
22801-5
|
Infectious
bronchitis
virus
Ab
[Titer]
in
Serum
|
|
22802-3
|
Infectious
bronchitis
virus
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
22803-1
|
Infectious
bronchitis
virus
Ab
[Titer]
in
Serum
by
Immunoassay
|
|
22804-9
|
Infectious
bronchitis
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
22805-6
|
Infectious
bronchitis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Neutralization
test
|
|
22806-4
|
Infectious
bronchitis
virus
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
22807-2
|
Infectious
bronchitis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
22808-0
|
Infectious
bronchitis
virus
[Presence]
in
Unspecified
specimen
by
Electron
microscopy
|
|
22809-8
|
Infectious
bronchitis
virus
RNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
2281-4
|
Flavin
adenine
dinucleotide
[Mass/volume]
in
Serum
|
|
22810-6
|
Infectious
bronchitis
virus
RNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
22811-4
|
Avian
infectious
laryngotracheitis
virus
[Presence]
in
Unspecified
specimen
by
Electron
microscopy
|
|
22813-0
|
Avian
infectious
laryngotracheitis
virus
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
22814-8
|
Avian
infectious
laryngotracheitis
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
22815-5
|
Avian
infectious
laryngotracheitis
virus
Ab
[Titer]
in
Serum
|
|
22816-3
|
Avian
infectious
laryngotracheitis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Neutralization
test
|
|
22817-1
|
Avian
infectious
laryngotracheitis
virus
Ag
[Presence]
in
Trachea
by
Immune
diffusion
(ID)
|
|
22818-9
|
Avian
infectious
laryngotracheitis
virus
Ag
[Presence]
in
Trachea
by
Immunoassay
|
|
22819-7
|
Avian
infectious
laryngotracheitis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immune
diffusion
(ID)
|
|
2282-2
|
Folate
[Mass/volume]
in
Blood
|
|
22820-5
|
Avian
orthoreovirus
Ag
[Presence]
in
Unspecified
specimen
|
|
22821-3
|
Deprecated
Influenza
virus
A
Ab
[Titer]
in
Serum
|
|
22822-1
|
Influenza
virus
A
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
22823-9
|
Influenza
virus
A
Ab
[Titer]
in
Serum
by
Agglutination
|
|
22824-7
|
Influenza
virus
A
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
22825-4
|
Influenza
virus
A
Ag
[Presence]
in
Unspecified
specimen
by
Immune
diffusion
(ID)
|
|
22826-2
|
Influenza
virus
A
identified
in
Unspecified
specimen
by
Bioassay
|
|
22827-0
|
Influenza
virus
A
subtype
[Identifier]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
22828-8
|
Influenza
virus
A
subtype
[Identifier]
in
Unspecified
specimen
by
Immune
diffusion
(ID)
|
|
22829-6
|
Avian
paramyxovirus
1
Ab
[Presence]
in
Serum
by
Hemagglutination
inhibition
|
|
2283-0
|
Folate
[Mass/volume]
in
Red
Blood
Cells
|
|
22830-4
|
Avian
paramyxovirus
1
Ab
[Titer]
in
Serum
by
Agglutination
|
|
22831-2
|
Avian
paramyxovirus
1
Ag
[Presence]
in
Unspecified
specimen
by
Hemagglutination
inhibition
|
|
22832-0
|
Avian
paramyxovirus
1
identified
in
Unspecified
specimen
by
Bioassay
|
|
22833-8
|
Avian
paramyxovirus
1
[Units/volume]
in
Unspecified
specimen
by
Bioassay
|
|
22834-6
|
Avian
pneumovirus
Ab
[Presence]
in
Serum
|
|
22836-1
|
Avian
pox
virus
[Presence]
in
Tissue
by
Electron
microscopy
|
|
22837-9
|
Avian
pox
virus
Ab
[Presence]
in
Serum
by
Agglutination
|
|
22838-7
|
Avian
pox
virus
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
22839-5
|
Avian
pox
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
2284-8
|
Folate
[Mass/volume]
in
Serum
or
Plasma
|
|
22840-3
|
Avian
pox
virus
Ab
[Presence]
in
Serum
by
Immune
stain
|
|
22841-1
|
Avian
pox
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
22842-9
|
Avian
pox
virus
DNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
22843-7
|
Avian
pox
virus
DNA
[Presence]
in
Tissue
by
DNA
probe
|
|
22844-5
|
Babesia
bigemina
Ab
[Presence]
in
Serum
|
|
22845-2
|
Babesia
bigemina
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
22846-0
|
Babesia
bigemina
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
22847-8
|
Babesia
bovis
Ab
[Presence]
in
Serum
|
|
22848-6
|
Babesia
bovis
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
22849-4
|
Babesia
bovis
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
2285-5
|
Follitropin
[Moles/volume]
in
Semen
|
|
22850-2
|
Babesia
caballi
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
22851-0
|
Babesia
caballi
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
22853-6
|
Babesia
caballi
rRNA
[Presence]
in
Blood
by
DNA
probe
|
|
22854-4
|
Babesia
divergens
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
22855-1
|
Babesia
divergens
Ab
[Presence]
in
Serum
|
|
22856-9
|
Babesia
sp
rRNA
[Presence]
in
Tissue
by
DNA
probe
|
|
22857-7
|
Babesia
sp
DNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
22858-5
|
Babesia
sp
identified
in
Tissue
by
Giemsa
stain
|
|
22859-3
|
Bacillus
anthracis
Ab
[Titer]
in
Serum
|
|
2286-3
|
Follitropin
[Moles/volume]
in
Serum
or
Plasma
|
|
22860-1
|
Bacillus
anthracis
Ab
[Presence]
in
Serum
|
|
22861-9
|
Bacillus
anthracis
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
22862-7
|
Bacillus
anthracis
Ab
[Presence]
in
Serum
by
Agglutination
|
|
22863-5
|
Bacillus
anthracis
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
22864-3
|
Bacillus
anthracis
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
22865-0
|
Bacillus
anthracis
Ab
[Titer]
in
Serum
by
Immune
diffusion
(ID)
|
|
22866-8
|
Bacillus
anthracis
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
22867-6
|
Bacillus
anthracis
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
22868-4
|
Bluetongue
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
22869-2
|
Bluetongue
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
2287-1
|
Follitropin
[Mass/time]
in
24
hour
Urine
|
|
22870-0
|
Bluetongue
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunoassay
|
|
22871-8
|
Bluetongue
virus
Ag
[Presence]
in
Unspecified
specimen
by
Neutralization
test
|
|
22872-6
|
Bluetongue
virus
Ag
[Presence]
in
Blood
|
|
22873-4
|
Bluetongue
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immune
stain
|
|
22874-2
|
Bluetongue
virus
serotype
[Identifier]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
22875-9
|
Border
disease
virus
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
22876-7
|
Border
disease
virus
Ab
[Units/volume]
in
Serum
|
|
22877-5
|
Border
disease
virus
Ab
[Titer]
in
Serum
|
|
22878-3
|
Border
disease
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
22879-1
|
Border
disease
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
2288-9
|
Follitropin.alpha
subunit
[Moles/volume]
in
Serum
or
Plasma
|
|
22880-9
|
Border
disease
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immune
stain
|
|
22881-7
|
Border
disease
virus
Ag
[Presence]
in
Tissue
by
Immunoassay
|
|
22882-5
|
Border
disease
virus
Ag
[Presence]
in
Blood
by
Immunoassay
|
|
22883-3
|
Border
disease
virus
RNA
[Presence]
in
Tissue
from
Fetus
by
Probe
and
target
amplification
method
|
|
22884-1
|
Border
disease
virus
RNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
22885-8
|
Border
disease
virus
RNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
22886-6
|
Bordetella
bronchiseptica
Ab
[Presence]
in
Serum
|
|
22887-4
|
Bordetella
bronchiseptica
Ab
[Presence]
in
Serum
by
Agglutination
|
|
22888-2
|
Bordetella
bronchiseptica
Ag
[Presence]
in
Unspecified
specimen
by
Agglutination
|
|
22889-0
|
Bovine
diarrhea
virus
Ab
[Presence]
in
Milk
|
|
2289-7
|
Follitropin.beta
subunit
[Moles/volume]
in
Serum
or
Plasma
|
|
22890-8
|
Bovine
diarrhea
virus
Ab
[Presence]
in
Milk
by
Immunoassay
|
|
22891-6
|
Bovine
diarrhea
virus
Ab
[Titer]
in
Serum
|
|
22892-4
|
Bovine
diarrhea
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
22893-2
|
Bovine
diarrhea
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
22894-0
|
Bovine
diarrhea
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
22895-7
|
Bovine
diarrhea
virus
Ab
[Presence]
in
Serum
|
|
22896-5
|
Bovine
diarrhea
virus
Ag
[Presence]
in
Blood
by
Immunoassay
|
|
22897-3
|
Bovine
diarrhea
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immune
stain
|
|
22898-1
|
Bovine
diarrhea
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
22899-9
|
Bovine
diarrhea
virus
RNA
[Presence]
in
Tissue
by
DNA
probe
|
|
22900-5
|
Bovine
diarrhea
virus
RNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
22901-3
|
Bovine
herpesvirus
1
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
22902-1
|
Bovine
herpesvirus
1
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
22903-9
|
Bovine
herpesvirus
1
Ab
[Presence]
in
Milk
by
Immunoassay
|
|
22904-7
|
Bovine
herpesvirus
1
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
22905-4
|
Bovine
herpesvirus
1
Ab
[Presence]
in
Milk
|
|
22906-2
|
Bovine
herpesvirus
1
Ag
[Presence]
in
Unspecified
specimen
by
Immunoassay
|
|
22907-0
|
Bovine
herpesvirus
1
Ag
[Presence]
in
Nose
by
Immunofluorescence
|
|
22908-8
|
Bovine
herpesvirus
1
Ag
[Units/volume]
in
Unspecified
specimen
by
Neutralization
test
|
|
22909-6
|
Bovine
herpesvirus
1
Ag
[Presence]
in
Unspecified
specimen
by
Immune
stain
|
|
2291-3
|
Formate
[Mass/volume]
in
Blood
|
|
22910-4
|
Bovine
herpesvirus
1
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
22911-2
|
Bovine
herpesvirus
1
Ag
[Presence]
in
Genital
specimen
by
Immunofluorescence
|
|
22912-0
|
Bovine
herpesvirus
1
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
22913-8
|
Bovine
herpesvirus
1
DNA
[Presence]
in
Semen
by
Probe
and
target
amplification
method
|
|
22914-6
|
Bovine
herpesvirus
1
DNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
22915-3
|
Bovine
leukemia
virus
Ab
[Presence]
in
Milk
|
|
22916-1
|
Bovine
leukemia
virus
Ab
[Presence]
in
Milk
by
Immunoassay
|
|
22917-9
|
Bovine
leukemia
virus
Ag
[Presence]
in
Unspecified
specimen
|
|
22918-7
|
Bovine
leukemia
virus
RNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
22919-5
|
Bovine
leukemia
virus
RNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
2292-1
|
Formate
[Mass/volume]
in
Serum
or
Plasma
|
|
22920-3
|
Brucella
abortus
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
22921-1
|
Brucella
abortus
Ab
[Units/volume]
in
Serum
by
Agglutination
|
|
22922-9
|
Brucella
abortus
IgG1
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
22923-7
|
Brucella
abortus
IgG1
Ab
[Presence]
in
Milk
by
Immunoassay
|
|
22924-5
|
Brucella
abortus
IgG1
Ab
[Presence]
in
Serum
|
|
22925-2
|
Brucella
abortus
IgG1
Ab
[Presence]
in
Milk
|
|
22926-0
|
Brucella
abortus
rRNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
22927-8
|
Brucella
abortus
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
22928-6
|
Brucella
canis
Ab
[Presence]
in
Serum
|
|
22929-4
|
Brucella
canis
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
2293-9
|
Fructokinase
[Enzymatic
activity/volume]
in
Serum
|
|
22930-2
|
Brucella
canis
Ab
[Presence]
in
Serum
by
Agglutination
|
|
22931-0
|
Brucella
melitensis
Ab
[Presence]
in
Serum
|
|
22932-8
|
Brucella
melitensis
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
22933-6
|
Brucella
melitensis
Ab
[Presence]
in
Serum
by
Agglutination
|
|
22934-4
|
Brucella
melitensis
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
22935-1
|
Brucella
melitensis
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
22936-9
|
Brucella
melitensis
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
22937-7
|
Brucella
ovis
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
22938-5
|
Brucella
ovis
Ab
[Presence]
in
Serum
by
Agglutination
|
|
22939-3
|
Brucella
ovis
Ab
[Units/volume]
in
Serum
|
|
2294-7
|
Deprecated
Fructosamine
|
|
22940-1
|
Brucella
ovis
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
22943-5
|
Brucella
sp
Ag
[Presence]
in
Placenta
by
Immunofluorescence
|
|
22944-3
|
Brucella
sp
Ag
[Presence]
in
Vaginal
fluid
by
Immune
stain
|
|
22945-0
|
Brucella
sp
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
22946-8
|
Brucella
sp
Ag
[Presence]
in
Tissue
from
Fetus
by
Immunofluorescence
|
|
22947-6
|
Brucella
sp
Ag
[Presence]
in
Vaginal
fluid
by
Immunofluorescence
|
|
22948-4
|
Brucella
sp
Ag
[Presence]
in
Tissue
from
Fetus
by
Immune
stain
|
|
22949-2
|
Brucella
sp
Ag
[Presence]
in
Placenta
by
Immune
stain
|
|
2295-4
|
Fructose
[Mass/volume]
in
Semen
|
|
22950-0
|
Brucella
suis
Ab
[Presence]
in
Serum
by
Plate
agglutination
|
|
22951-8
|
Brucella
suis
Ab
[Presence]
in
Serum
|
|
22952-6
|
Brucella
suis
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
22953-4
|
Brucella
suis
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
22954-2
|
Brucella
suis
rRNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
22955-9
|
Brucella
suis
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
22956-7
|
Burkholderia
mallei
Ab
[Presence]
in
Serum
|
|
22958-3
|
Burkholderia
mallei
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
22959-1
|
Burkholderia
mallei
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
2296-2
|
Fructose
[Mass/volume]
in
Serum
|
|
22962-5
|
Campylobacter
fetus
Ab
[Presence]
in
Genital
mucus
|
|
22963-3
|
Campylobacter
fetus
Ab
[Presence]
in
Genital
mucus
by
Agglutination
|
|
22964-1
|
Campylobacter
fetus
Ag
[Presence]
in
Genital
fluid
by
Immunofluorescence
|
|
22965-8
|
Campylobacter
fetus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
22966-6
|
Campylobacter
fetus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
22967-4
|
Campylobacter
fetus
ss
venerealis
Ab
[Presence]
in
Genital
mucus
|
|
22968-2
|
Campylobacter
fetus
ss
venerealis
Ab
[Presence]
in
Genital
mucus
by
Agglutination
|
|
22969-0
|
Campylobacter
fetus
ss
venerealis
IgA
Ab
[Presence]
in
Genital
mucus
by
Immunoassay
|
|
2297-0
|
Fructose
[Mass/time]
in
24
hour
Urine
|
|
22970-8
|
Campylobacter
fetus
ss
venerealis
IgA
Ab
[Presence]
in
Genital
mucus
|
|
22971-6
|
Caprine
arthritis
encephalitis
virus
[Presence]
in
Unspecified
specimen
by
Electron
microscopy
|
|
22972-4
|
Caprine
arthritis
encephalitis
virus
Ab
[Presence]
in
Milk
|
|
22973-2
|
Caprine
arthritis
encephalitis
virus
Ab
[Presence]
in
Milk
by
Immunoassay
|
|
22974-0
|
Caprine
arthritis
encephalitis
virus
Ab
[Presence]
in
Serum
by
Agglutination
|
|
22975-7
|
Caprine
arthritis
encephalitis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immune
stain
|
|
22976-5
|
Caprine
arthritis
encephalitis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
22977-3
|
Caprine
arthritis
encephalitis
virus
DNA
[Presence]
in
Unspecified
specimen
by
Polyacrylamide
gel
electrophoresis
(PAGE)
|
|
22978-1
|
Caprine
arthritis
encephalitis
virus
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
22979-9
|
Caprine
herpesvirus
1
Ab
[Presence]
in
Serum
|
|
22980-7
|
Caprine
herpesvirus
1
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
22981-5
|
Capripox
virus
[Presence]
in
Tissue
by
Animal
inoculation
|
|
22982-3
|
Capripox
virus
Ab
[Presence]
in
Serum
|
|
22983-1
|
Capripox
virus
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
22984-9
|
Capripox
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
22986-4
|
Capripox
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immune
diffusion
(ID)
|
|
22987-2
|
Capripox
virus
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
22988-0
|
Capripox
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunoassay
|
|
22989-8
|
Capripox
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
2299-6
|
Aldolase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
22990-6
|
Capripox
virus
Ag
[Presence]
in
Tissue
by
Immunoassay
|
|
22991-4
|
Capripox
virus
DNA
[Presence]
in
Unspecified
specimen
by
Restriction
Fragment
Length
Polymorphysm
(RFLP)
|
|
22992-2
|
Chlamydophila
psittaci
[Presence]
in
Unspecified
specimen
by
Giemsa
stain
|
|
22993-0
|
Chlamydophila
psittaci
[Presence]
in
Placenta
by
Electron
microscopy
|
|
22994-8
|
Chlamydophila
psittaci
Ab
[Presence]
in
Serum
by
Agglutination
|
|
22995-5
|
Chlamydophila
psittaci
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
22996-3
|
Chlamydophila
psittaci
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
22997-1
|
Chlamydophila
psittaci
Ag
[Presence]
in
Unspecified
specimen
by
Immune
stain
|
|
22998-9
|
Chlamydophila
psittaci
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
22999-7
|
Chlamydophila
psittaci
Ag
[Presence]
in
Stool
by
Immune
stain
|
|
23000-3
|
Chlamydophila
psittaci
Ag
[Presence]
in
Exudate
by
Immune
stain
|
|
23001-1
|
Chlamydophila
psittaci
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23002-9
|
Classical
swine
fever
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23003-7
|
Classical
swine
fever
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23004-5
|
Classical
swine
fever
virus
Ab
[Presence]
in
Serum
|
|
23005-2
|
Classical
swine
fever
virus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23006-0
|
Classical
swine
fever
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23007-8
|
Classical
swine
fever
virus
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
23008-6
|
Classical
swine
fever
virus
RNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23009-4
|
Cowdria
ruminantium
[Presence]
in
Brain
by
Giemsa
stain
|
|
23010-2
|
Cowdria
ruminantium
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23011-0
|
Cowdria
ruminantium
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23012-8
|
Cowdria
ruminantium
Ab
[Presence]
in
Serum
|
|
23013-6
|
Cowdria
ruminantium
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
23014-4
|
Cowdria
ruminantium
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23015-1
|
Cowdria
ruminantium
rRNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
23016-9
|
Coxiella
burnetii
[Presence]
in
Placenta
by
Light
microscopy
|
|
23017-7
|
Coxiella
burnetii
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23018-5
|
Coxiella
burnetii
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23019-3
|
Coxiella
burnetii
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
2302-8
|
Fumarase
[Enzymatic
activity/volume]
in
Serum
|
|
23020-1
|
Coxiella
burnetii
Ab
[Presence]
in
Serum
|
|
23021-9
|
Coxiella
burnetii
Ag
[Presence]
in
Tissue
by
Immunoassay
|
|
23022-7
|
Coxiella
burnetii
Ag
[Presence]
in
Placenta
by
Immunofluorescence
|
|
23023-5
|
Coxiella
burnetii
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23024-3
|
Coxiella
burnetii
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23025-0
|
Dermatophilus
congolensis
[Presence]
in
Skin
by
Giemsa
stain
|
|
23026-8
|
Dermatophilus
congolensis
Ab
[Presence]
in
Serum
|
|
23027-6
|
Dermatophilus
congolensis
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23028-4
|
Dermatophilus
congolensis
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23029-2
|
Dirofilaria
immitis
Ag
[Presence]
in
Blood
|
|
2303-6
|
Fumarate
[Mass/volume]
in
Urine
|
|
23030-0
|
Duck
enteritis
virus
[Presence]
in
Tissue
by
Electron
microscopy
|
|
23031-8
|
Duck
enteritis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Neutralization
test
|
|
23032-6
|
Duck
enteritis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Agglutination
|
|
23033-4
|
Duck
hepatitis
virus
1
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23034-2
|
Duck
hepatitis
virus
1
Ab
[Presence]
in
Serum
|
|
23035-9
|
Duck
hepatitis
virus
1
Ag
[Presence]
in
Unspecified
specimen
by
Neutralization
test
|
|
23036-7
|
Duck
hepatitis
virus
2
Ab
[Presence]
in
Serum
|
|
23037-5
|
Duck
hepatitis
virus
2
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23038-3
|
Duck
hepatitis
virus
2
Ag
[Presence]
in
Unspecified
specimen
by
Neutralization
test
|
|
23039-1
|
Duck
hepatitis
virus
3
Ab
[Presence]
in
Serum
|
|
2304-4
|
Fumarylacetoacetate
[Mass/volume]
in
Serum
|
|
23040-9
|
Duck
hepatitis
virus
3
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23041-7
|
Duck
hepatitis
virus
3
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23042-5
|
Eastern
equine
encephalitis
virus
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
23043-3
|
Eastern
equine
encephalitis
virus
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23044-1
|
Eastern
equine
encephalitis
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23045-8
|
Eastern
equine
encephalitis
virus
IgM
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23046-6
|
Eastern
equine
encephalitis
virus
IgM
Ab
[Presence]
in
Serum
|
|
23047-4
|
Eastern
equine
encephalitis
virus
Ag
[Presence]
in
Brain
by
Complement
fixation
|
|
23048-2
|
Eastern
equine
encephalitis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23049-0
|
Eastern
equine
encephalitis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Complement
fixation
|
|
2305-1
|
Galactokinase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
23050-8
|
Eastern
equine
encephalitis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Neutralization
test
|
|
23051-6
|
Eastern
equine
encephalitis
virus
RNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
23052-4
|
Eastern
equine
encephalitis
virus
RNA
[Presence]
in
Tissue
by
DNA
probe
|
|
23053-2
|
Echinococcus
sp
Ag
[Presence]
in
Stool
by
Immunoassay
|
|
23054-0
|
Ehrlichia
canis
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23055-7
|
Ehrlichia
risticii
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23056-5
|
Ehrlichia
risticii
Ab
[Presence]
in
Serum
|
|
23057-3
|
Ephemeral
fever
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23058-1
|
Ephemeral
fever
virus
Ab
[Presence]
in
Serum
|
|
23059-9
|
Epizootic
hemorrhagic
disease
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
2306-9
|
Galactose
[Presence]
in
Blood
|
|
23060-7
|
Epizootic
hemorrhagic
disease
virus
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23061-5
|
Epizootic
hemorrhagic
disease
virus
Ag
[Presence]
in
Unspecified
specimen
|
|
23062-3
|
Epizootic
hemorrhagic
disease
virus
Ag
[Presence]
in
Blood
|
|
23063-1
|
Epizootic
hemorrhagic
disease
virus
Alberta
Ab
[Presence]
in
Serum
|
|
23064-9
|
Epizootic
hemorrhagic
disease
virus
Alberta
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
23065-6
|
Epizootic
hemorrhagic
disease
virus
New
Jersey
Ab
[Presence]
in
Serum
|
|
23066-4
|
Epizootic
hemorrhagic
disease
virus
New
Jersey
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
23067-2
|
Epizootic
hemorrhagic
disease
virus
RNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
23068-0
|
Equine
arteritis
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
23069-8
|
Equine
arteritis
virus
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
2307-7
|
Galactose
[Mass/volume]
in
Blood
|
|
23070-6
|
Equine
arteritis
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23071-4
|
Equine
arteritis
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23072-2
|
Equine
arteritis
virus
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23073-0
|
Equine
arteritis
virus
Ab
[Presence]
in
Serum
|
|
23074-8
|
Equine
arteritis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23075-5
|
Equine
arteritis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immune
stain
|
|
23076-3
|
Equine
arteritis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Neutralization
test
|
|
23077-1
|
Equine
arteritis
virus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23078-9
|
Equine
arteritis
virus
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
23079-7
|
Equine
arteritis
virus
RNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
2308-5
|
Galactose
[Mass/volume]
in
Serum
or
Plasma
|
|
23080-5
|
Equine
herpesvirus
1
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23081-3
|
Equine
herpesvirus
1
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
23082-1
|
Equine
herpesvirus
1
DNA
[Presence]
in
Nose
by
Probe
and
target
amplification
method
|
|
23083-9
|
Equine
herpesvirus
1
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23084-7
|
Equine
herpesvirus
1
DNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
23085-4
|
Equine
herpesvirus
1+4
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23086-2
|
Equine
herpesvirus
1+4
Ab
[Titer]
in
Serum
by
Immunoassay
|
|
23087-0
|
Equine
herpesvirus
1+4
Ab
[Presence]
in
Serum
|
|
23088-8
|
Equine
herpesvirus
1+4
Ab
[Titer]
in
Serum
|
|
23089-6
|
Equine
herpesvirus
1+4
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
2309-3
|
Galactose
[Presence]
in
Urine
|
|
23090-4
|
Equine
herpesvirus
1+4
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
23091-2
|
Equine
herpesvirus
1+4
Ag
[Presence]
in
Body
fluid
by
Immunofluorescence
|
|
23092-0
|
Equine
herpesvirus
4
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23093-8
|
Equine
herpesvirus
4
DNA
[Presence]
in
Nose
by
Probe
and
target
amplification
method
|
|
23094-6
|
Equine
herpesvirus
4
DNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
23095-3
|
Equine
herpesvirus
4
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23096-1
|
Equine
infectious
anemia
virus
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
23097-9
|
Equine
infectious
anemia
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23098-7
|
Equine
infectious
anemia
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23099-5
|
Equine
infectious
anemia
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunoassay
|
|
2310-1
|
Galactose
[Mass/volume]
in
Urine
|
|
23100-1
|
Equine
influenza
virus
A1
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23101-9
|
Equine
influenza
virus
A1
Ab
[Presence]
in
Serum
|
|
23102-7
|
Equine
influenza
virus
A1
Ag
[Titer]
in
Unspecified
specimen
by
Hemagglutination
inhibition
|
|
23103-5
|
Equine
influenza
virus
A2
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23104-3
|
Equine
influenza
virus
A2
Ag
[Titer]
in
Unspecified
specimen
by
Hemagglutination
inhibition
|
|
23105-0
|
Fly
larvae
identified
in
Unspecified
specimen
|
|
23106-8
|
Foot
and
mouth
disease
virus
Ab
[Presence]
in
Serum
|
|
23107-6
|
Foot
and
mouth
disease
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23108-4
|
Foot
and
mouth
disease
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23109-2
|
Foot
and
mouth
disease
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
2311-9
|
Galactose
renal
clearance
in
24
hour
|
|
23110-0
|
Foot
and
mouth
disease
virus
Ag
[Presence]
in
Tissue
by
Immunoassay
|
|
23111-8
|
Foot
and
mouth
disease
virus
Ag
[Presence]
in
Throat
by
Immunoassay
|
|
23112-6
|
Foot
and
mouth
disease
virus
Ag
[Presence]
in
Tissue
by
Complement
fixation
|
|
23113-4
|
Foot
and
mouth
disease
virus
Ag
[Presence]
in
Throat
by
Complement
fixation
|
|
23114-2
|
Foot
and
mouth
disease
virus
RNA
[Presence]
in
Tissue
by
DNA
probe
|
|
23115-9
|
Foot
and
mouth
disease
virus
serotype
[Identifier]
in
Unspecified
specimen
by
Complement
fixation
|
|
23116-7
|
Foot
and
mouth
disease
virus
serotype
[Identifier]
in
Tissue
by
Immunoassay
|
|
23117-5
|
Foot
and
mouth
disease
virus
serotype
[Identifier]
in
Serum
by
Immunoassay
|
|
23118-3
|
Foot
and
mouth
disease
virus
serotype
[Identifier]
in
Serum
by
Neutralization
test
|
|
23119-1
|
Foot
and
mouth
disease
virus
serotype
[Identifier]
in
Tissue
by
Complement
fixation
|
|
2312-7
|
Galactose
1
phosphate
[Mass/volume]
in
Red
Blood
Cells
|
|
23120-9
|
Foot
and
mouth
disease
virus
serotype
[Identifier]
in
Unspecified
specimen
by
Immunoassay
|
|
23121-7
|
Foot
and
mouth
disease
virus
serotype
[Identifier]
in
Tissue
by
Probe
and
target
amplification
method
|
|
23122-5
|
Francisella
tularensis
A
DNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
23123-3
|
Francisella
tularensis
A
rRNA
[Presence]
in
Tissue
by
DNA
probe
|
|
23124-1
|
Francisella
tularensis
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23125-8
|
Francisella
tularensis
Ab
[Titer]
in
Serum
by
Agglutination
|
|
23126-6
|
Francisella
tularensis
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
23127-4
|
Francisella
tularensis
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23128-2
|
Francisella
tularensis
B
DNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
23129-0
|
Francisella
tularensis
B
rRNA
[Presence]
in
Tissue
by
DNA
probe
|
|
2313-5
|
Galactose
1
phosphate
uridyl
transferase
[Presence]
in
Red
Blood
Cells
|
|
23130-8
|
Francisella
tularensis
DNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
23131-6
|
Francisella
tularensis
rRNA
[Presence]
in
Tissue
by
DNA
probe
|
|
23132-4
|
Histoplasma
farciminosum
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23133-2
|
Histoplasma
farciminosum
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23134-0
|
Histoplasma
farciminosum
Ab
[Presence]
in
Serum
by
Hemagglutination
|
|
23135-7
|
Histoplasma
farciminosum
Ab
[Presence]
in
Serum
|
|
23139-9
|
Infectious
bursal
disease
virus
Ab
[Titer]
in
Serum
|
|
2314-3
|
Galactose
1
phosphate
uridyl
transferase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
23140-7
|
Infectious
bursal
disease
virus
Ab
[Titer]
in
Serum
by
Immune
diffusion
(ID)
|
|
23141-5
|
Infectious
bursal
disease
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
23142-3
|
Infectious
bursal
disease
virus
Ag
[Presence]
in
Unspecified
specimen
by
Neutralization
test
|
|
23143-1
|
Infectious
bursal
disease
virus
Ag
[Presence]
in
Bursa
of
Fabricius
by
Immune
diffusion
(ID)
|
|
23144-9
|
Japanese
encephalitis
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
23145-6
|
Japanese
encephalitis
virus
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
23146-4
|
Japanese
encephalitis
virus
Ab
[Presence]
in
Serum
by
Hemagglutination
inhibition
|
|
23147-2
|
Japanese
encephalitis
virus
Ab
[Titer]
in
Serum
|
|
23148-0
|
Japanese
encephalitis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23149-8
|
Japanese
encephalitis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Hemagglutination
inhibition
|
|
2315-0
|
Galactosylceramidase
[Enzymatic
activity/mass]
in
Tissue
|
|
23150-6
|
Leishmania
donovani
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
23152-2
|
Leishmania
sp
Ab
[Titer]
in
Serum
|
|
23153-0
|
Leishmania
sp
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23154-8
|
Leishmania
sp
Ab
[Titer]
in
Serum
by
Hemagglutination
|
|
23155-5
|
Leishmania
sp
Ab
[Presence]
in
Serum
by
Immunoelectrophoresis
|
|
23156-3
|
Leishmania
sp
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
23157-1
|
Leishmania
sp
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23158-9
|
Leishmania
sp
rRNA
[Identifier]
in
Unspecified
specimen
by
DNA
probe
|
|
23159-7
|
Leishmania
sp
DNA
[Identifier]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
2316-8
|
Galactosylgalactosylglucosylceramidase
[Enzymatic
activity/mass]
in
Tissue
|
|
23160-5
|
Leishmania
sp
identified
in
Tissue
by
Immunofluorescence
|
|
23161-3
|
Leishmania
sp
identified
in
Tissue
by
Electrophoresis
|
|
23162-1
|
Leishmania
sp
identified
in
Tissue
by
Polyacrylamide
gel
electrophoresis
(PAGE)
|
|
23163-9
|
Leptospira
interrogans
sv
Australis
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23164-7
|
Leptospira
interrogans
sv
Australis
Ab
[Presence]
in
Serum
|
|
23165-4
|
Leptospira
interrogans
sv
Autumnalis
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23166-2
|
Leptospira
interrogans
sv
Autumnalis
Ab
[Presence]
in
Serum
|
|
23167-0
|
Leptospira
borgpetersenii
sv
Ballum
Ab
[Presence]
in
Serum
|
|
23168-8
|
Leptospira
borgpetersenii
sv
Ballum
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23169-6
|
Leptospira
interrogans
sv
Bataviae
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23170-4
|
Leptospira
interrogans
sv
Bataviae
Ab
[Presence]
in
Serum
|
|
23171-2
|
Leptospira
interrogans
sv
Bratislava
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23172-0
|
Leptospira
interrogans
sv
Bratislava
Ab
[Presence]
in
Serum
|
|
23173-8
|
Leptospira
interrogans
sv
Canicola
Ab
[Presence]
in
Serum
|
|
23174-6
|
Leptospira
interrogans
sv
Canicola
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23175-3
|
Leptospira
interrogans
sv
Copenhageni
Ab
[Presence]
in
Serum
|
|
23176-1
|
Leptospira
interrogans
sv
Copenhageni
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23177-9
|
Leptospira
interrogans
sv
Grippotyphosa
Ab
[Presence]
in
Serum
|
|
23178-7
|
Leptospira
interrogans
sv
Grippotyphosa
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23179-5
|
Leptospira
interrogans
sv
Hardjo
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23180-3
|
Leptospira
interrogans
sv
Hardjo
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23181-1
|
Leptospira
interrogans
sv
Hardjo
Ab
[Presence]
in
Serum
|
|
23182-9
|
Leptospira
interrogans
sv
Hebdomadis
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23183-7
|
Leptospira
interrogans
sv
Hebdomadis
Ab
[Presence]
in
Serum
|
|
23184-5
|
Leptospira
interrogans
sv
Icterohaemorrhagiae
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23185-2
|
Leptospira
interrogans
sv
Icterohaemorrhagiae
Ab
[Presence]
in
Serum
|
|
23186-0
|
Leptospira
interrogans
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23187-8
|
Leptospira
interrogans
Ab
[Presence]
in
Serum
|
|
23188-6
|
Leptospira
interrogans
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23189-4
|
Leptospira
interrogans
sv
Mitis
Ab
[Presence]
in
Serum
|
|
23190-2
|
Leptospira
interrogans
sv
Mitis
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23191-0
|
Leptospira
interrogans
sv
Pomona
Ab
[Presence]
in
Serum
|
|
23192-8
|
Leptospira
interrogans
sv
Pomona
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23193-6
|
Leptospira
borgpetersenii
sv
Sejroe
Ab
[Presence]
in
Serum
|
|
23194-4
|
Leptospira
borgpetersenii
sv
Sejroe
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23195-1
|
Leptospira
sp
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23196-9
|
Leptospira
sp
Ab
[Presence]
in
Serum
|
|
23197-7
|
Leptospira
sp
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23198-5
|
Leptospira
sp
Ab
[Titer]
in
Serum
by
Agglutination
|
|
23199-3
|
Leptospira
sp
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
2320-0
|
Gamma
glutamyl
cysteine
synthetase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
23200-9
|
Leptospira
sp
IgG
Ab
[Presence]
in
Serum
|
|
23201-7
|
Leptospira
sp
IgM
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23202-5
|
Leptospira
sp
IgM
Ab
[Presence]
in
Serum
|
|
23203-3
|
Leptospira
sp
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23204-1
|
Leptospira
sp
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
23205-8
|
Leptospira
sp
DNA
[Presence]
in
Body
fluid
by
Probe
and
target
amplification
method
|
|
23206-6
|
Leptospira
sp
DNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
23207-4
|
Leptospira
subtype
[Identifier]
in
Unspecified
specimen
|
|
23208-2
|
Leptospira
borgpetersenii
sv
Tarrasovi
Ab
[Presence]
in
Serum
|
|
23209-0
|
Leptospira
borgpetersenii
sv
Tarrasovi
Ab
[Presence]
in
Serum
by
Agglutination
|
|
2321-8
|
Gamma
glutamyl
cysteine
synthetase
[Enzymatic
activity/volume]
in
Serum
|
|
23210-8
|
Listeria
sp
Ab
[Presence]
in
Serum
|
|
23211-6
|
Listeria
sp
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23212-4
|
Lumpy
skin
disease
virus
[Presence]
in
Tissue
by
Electron
microscopy
|
|
23213-2
|
Lumpy
skin
disease
virus
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
23214-0
|
Lumpy
skin
disease
virus
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
23215-7
|
Lumpy
skin
disease
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23216-5
|
Lumpy
skin
disease
virus
Ab
[Presence]
in
Serum
|
|
23217-3
|
Lumpy
skin
disease
virus
Ab
[Titer]
in
Serum
|
|
23218-1
|
Lumpy
skin
disease
virus
Ag
[Presence]
in
Tissue
by
Immunoassay
|
|
23219-9
|
Lumpy
skin
disease
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunoassay
|
|
2322-6
|
Gamma
glutamyl
transferase
[Enzymatic
activity/volume]
in
Amniotic
fluid
|
|
23220-7
|
Lumpy
skin
disease
virus
Ag
[Presence]
in
Unspecified
specimen
|
|
23221-5
|
Lumpy
skin
disease
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23222-3
|
Lumpy
skin
disease
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immune
diffusion
(ID)
|
|
23223-1
|
Lumpy
skin
disease
virus
DNA
[Presence]
in
Unspecified
specimen
by
Restriction
Fragment
Length
Polymorphysm
(RFLP)
|
|
23224-9
|
Mareks
disease
virus
Ab
[Presence]
in
Serum
|
|
23225-6
|
Mareks
disease
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23226-4
|
Mareks
disease
virus
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23227-2
|
Mareks
disease
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23228-0
|
Mareks
disease
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
23229-8
|
Mareks
disease
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
2323-4
|
Gamma
glutamyl
transferase
[Enzymatic
activity/volume]
in
Semen
|
|
23230-6
|
Mareks
disease
virus
Ag
[Presence]
in
Feather
by
Immune
diffusion
(ID)
|
|
23231-4
|
Mareks
disease
virus
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23232-2
|
Mite
identified
in
Skin
by
Flotation
|
|
23233-0
|
Mite
identified
in
Skin
by
Parasite
sedimentation
|
|
23234-8
|
Mycobacterium
avium
ss
avium
Ab
[Presence]
in
Blood
|
|
23235-5
|
Mycobacterium
avium
ss
avium
Ab
[Presence]
in
Blood
by
Agglutination
|
|
23236-3
|
Mycobacterium
avium
ss
avium
rRNA
[Presence]
in
Tissue
by
DNA
probe
|
|
23237-1
|
Mycobacterium
avium
ss
avium
identified
in
Unspecified
specimen
by
Bioassay
|
|
23238-9
|
Mycobacterium
avium
ss
avium
serotype
[Identifier]
in
Unspecified
specimen
|
|
23239-7
|
Mycobacterium
bovis
Ab
[Presence]
in
Serum
|
|
2324-2
|
Gamma
glutamyl
transferase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
23240-5
|
Mycobacterium
bovis
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23241-3
|
Mycobacterium
bovis
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
23242-1
|
Mycobacterium
bovis
Ag
[Presence]
in
Blood
|
|
23243-9
|
Mycobacterium
avium
ss
paratuberculosis
[Presence]
in
Stool
by
Acid
fast
stain.Ziehl-Neelsen
|
|
23244-7
|
Mycobacterium
avium
ss
paratuberculosis
[Presence]
in
Tissue
by
Acid
fast
stain.Ziehl-Neelsen
|
|
23245-4
|
Mycobacterium
avium
ss
paratuberculosis
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23246-2
|
Mycobacterium
avium
ss
paratuberculosis
DNA
[Presence]
in
Stool
by
Probe
and
target
amplification
method
|
|
23247-0
|
Mycobacterium
sp
DNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
23248-8
|
Mycoplasma
agalactiae
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23249-6
|
Mycoplasma
agalactiae
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23250-4
|
Mycoplasma
agalactiae
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23251-2
|
Mycoplasma
agalactiae
Ab
[Presence]
in
Serum
|
|
23252-0
|
Mycoplasma
agalactiae
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23253-8
|
Mycoplasma
arginini
Ab
[Presence]
in
Serum
|
|
23254-6
|
Mycoplasma
arginini
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23255-3
|
Mycoplasma
bovis
Ab
[Presence]
in
Serum
|
|
23256-1
|
Mycoplasma
bovis
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23257-9
|
Mycoplasma
capricolum
ss
capricolum
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23258-7
|
Mycoplasma
capricolum
ss
capricolum
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23259-5
|
Mycoplasma
capricolum
ss
capricolum
Ab
[Presence]
in
Serum
|
|
2326-7
|
Gastric
inhibitory
polypeptide
[Mass/volume]
in
Plasma
|
|
23260-3
|
Mycoplasma
capricolum
ss
capripneumonia
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23262-9
|
Mycoplasma
capricolum
ss
capripneumonia
Ab
[Titer]
in
Serum
|
|
23263-7
|
Mycoplasma
capricolum
ss
capripneumonia
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23264-5
|
Mycoplasma
capricolum
ss
capripneumonia
Ab
[Presence]
in
Blood
by
Agglutination
|
|
23265-2
|
Mycoplasma
capricolum
ss
capripneumonia
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
23266-0
|
Mycoplasma
capricolum
ss
capripneumonia
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23267-8
|
Mycoplasma
capricolum
ss
capripneumonia
Ag
[Presence]
in
Unspecified
specimen
by
Neutralization
test
|
|
23268-6
|
Mycoplasma
capricolum
ss
capripneumonia
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23269-4
|
Mycoplasma
capricolum
ss
capripneumonia
Ag
[Presence]
in
Unspecified
specimen
|
|
2327-5
|
Gastrin
releasing
polypeptide
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
23270-2
|
Mycoplasma
capricolum
ss
capripneumonia
Ag
[Presence]
in
Tissue
|
|
23271-0
|
Mycoplasma
capricolum
ss
capripneumonia
rRNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
23272-8
|
Mycoplasma
capricolum
ss
capripneumonia
rRNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23273-6
|
Mycoplasma
gallisepticum
Ab
[Presence]
in
Serum
by
Hemagglutination
|
|
23274-4
|
Mycoplasma
gallisepticum
Ab
[Titer]
in
Serum
by
Hemagglutination
|
|
23275-1
|
Mycoplasma
gallisepticum
Ab
[Titer]
in
Serum
|
|
23276-9
|
Mycoplasma
gallisepticum
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23277-7
|
Mycoplasma
gallisepticum
Ag
[Presence]
in
Unspecified
specimen
by
Immune
stain
|
|
23278-5
|
Mycoplasma
gallisepticum
Ag
[Presence]
in
Unspecified
specimen
by
Neutralization
test
|
|
23279-3
|
Mycoplasma
gallisepticum
DNA
[Presence]
in
Nose
or
Trachea
by
Probe
and
target
amplification
method
|
|
2328-3
|
Gastrin
releasing
polypeptide
[Moles/volume]
in
Cerebral
spinal
fluid
|
|
23280-1
|
Mycoplasma
meleagridis
Ab
[Presence]
in
Serum
by
Hemagglutination
|
|
23281-9
|
Mycoplasma
mycoides
ss
capri
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23282-7
|
Mycoplasma
mycoides
ss
capri
Ab
[Presence]
in
Serum
|
|
23283-5
|
Mycoplasma
mycoides
ss
mycoides
large
colony
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23284-3
|
Mycoplasma
mycoides
ss
mycoides
large
colony
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23285-0
|
Mycoplasma
mycoides
ss
mycoides
small
colony
Ab
[Presence]
in
Serum
|
|
23286-8
|
Mycoplasma
mycoides
ss
mycoides
small
colony
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
23287-6
|
Mycoplasma
mycoides
ss
mycoides
small
colony
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23288-4
|
Mycoplasma
mycoides
ss
mycoides
small
colony
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23289-2
|
Mycoplasma
mycoides
ss
mycoides
small
colony
Ab
[Presence]
in
Serum
by
Agglutination
|
|
2329-1
|
Gastrin
releasing
polypeptide
[Mass/volume]
in
Serum
or
Plasma
|
|
23290-0
|
Mycoplasma
mycoides
ss
mycoides
small
colony
Ag
[Presence]
in
Unspecified
specimen
by
Immune
diffusion
(ID)
|
|
23291-8
|
Mycoplasma
mycoides
ss
mycoides
small
colony
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23292-6
|
Mycoplasma
mycoides
ss
mycoides
small
colony
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
23293-4
|
Mycoplasma
mycoides
ss
mycoides
small
colony
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23294-2
|
Mycoplasma
putrefaciens
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23295-9
|
Mycoplasma
putrefaciens
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23296-7
|
Mycoplasma
putrefaciens
Ab
[Presence]
in
Serum
|
|
23297-5
|
Mycoplasma
sp
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23298-3
|
Mycoplasma
sp
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23299-1
|
Mycoplasma
sp
Ag
[Presence]
in
Unspecified
specimen
|
|
2330-9
|
Gastrin.34
residue
fragment
[Mass/volume]
in
Serum
or
Plasma
|
|
23300-7
|
Mycoplasma
sp
rRNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
23301-5
|
Mycoplasma
sp
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23302-3
|
Mycoplasma
synoviae
Ab
[Presence]
in
Serum
by
Hemagglutination
|
|
23303-1
|
Myxoma
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
23304-9
|
Myxoma
virus
Ab
[Presence]
in
Serum
|
|
23305-6
|
Myxoma
virus
Ab
[Titer]
in
Serum
|
|
23306-4
|
Myxoma
virus
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
23307-2
|
Myxoma
virus
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23308-0
|
Myxoma
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23309-8
|
Myxoma
virus
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
2331-7
|
Gastrin.17
residue
fragment
[Mass/volume]
in
Serum
or
Plasma
|
|
23310-6
|
Myxoma
virus
Ag
[Presence]
in
Skin
by
Immune
diffusion
(ID)
|
|
23311-4
|
Myxoma
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23313-0
|
Nairobi
sheep
disease
virus
Ab
[Titer]
in
Serum
|
|
23314-8
|
Nairobi
sheep
disease
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
23315-5
|
Nairobi
sheep
disease
virus
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23316-3
|
Nairobi
sheep
disease
virus
Ab
[Presence]
in
Serum
|
|
23318-9
|
Nairobi
sheep
disease
virus
Ag
[Presence]
in
Unspecified
specimen
by
Complement
fixation
|
|
23319-7
|
Nairobi
sheep
disease
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
2332-5
|
Gastrin.14
residue
fragment
[Mass/volume]
in
Serum
or
Plasma
|
|
23320-5
|
Nairobi
sheep
disease
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunoassay
|
|
23321-3
|
Ovine
herpesvirus
2
Ab
[Presence]
in
Serum
|
|
23322-1
|
Ovine
herpesvirus
2
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23324-7
|
Ovine
herpesvirus
2
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23325-4
|
Ovine
herpesvirus
2
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23326-2
|
Ovine
herpesvirus
2
Ab
[Presence]
in
Serum
by
Immune
stain
|
|
23327-0
|
Ovine
herpesvirus
2
DNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
23328-8
|
Ovine
progressive
pneumonia
virus
Ab
[Presence]
in
Milk
|
|
23329-6
|
Ovine
progressive
pneumonia
virus
Ab
[Presence]
in
Serum
|
|
2333-3
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
|
|
23330-4
|
Ovine
progressive
pneumonia
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23332-0
|
Ovine
progressive
pneumonia
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
23333-8
|
Ovine
progressive
pneumonia
virus
Ab
[Presence]
in
Milk
by
Immunoassay
|
|
23334-6
|
Ovine
progressive
pneumonia
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23335-3
|
Ovine
progressive
pneumonia
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immune
stain
|
|
23336-1
|
Ovine
progressive
pneumonia
virus
DNA
[Presence]
in
Unspecified
specimen
by
Polyacrylamide
gel
electrophoresis
(PAGE)
|
|
23337-9
|
Ovine
progressive
pneumonia
virus
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23338-7
|
Ovine
pulmonary
adenomatosis
retrovirus
RNA
[Presence]
in
Lung
tissue
by
Probe
and
target
amplification
method
|
|
2334-1
|
Hemoglobin.gastrointestinal
[Presence]
in
Gastric
fluid
|
|
23341-1
|
Pasteurella
multocida
Ab
[Titer]
in
Serum
by
Immunoassay
|
|
23342-9
|
Pasteurella
multocida
Ab
[Titer]
in
Serum
|
|
23343-7
|
Pasteurella
multocida
Ag
[Titer]
in
Unspecified
specimen
by
Agglutination
|
|
23344-5
|
Pasteurella
multocida
rRNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
23345-2
|
Pasteurella
multocida
serotype
[Identifier]
in
Unspecified
specimen
by
Agglutination
|
|
23346-0
|
Pasteurella
multocida
serotype
[Identifier]
in
Unspecified
specimen
by
Immunoelectrophoresis
|
|
23347-8
|
Pasteurella
multocida
serotype
[Identifier]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23349-4
|
Pasteurella
multocida
toxin
[Presence]
in
Unspecified
specimen
by
Immunoassay
|
|
2335-8
|
Hemoglobin.gastrointestinal
[Presence]
in
Stool
|
|
23350-2
|
Peste
des
petits
ruminants
virus
Ab
[Titer]
in
Serum
|
|
23351-0
|
Peste
des
petits
ruminants
virus
Ab
[Presence]
in
Serum
|
|
23352-8
|
Peste
des
petits
ruminants
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
23354-4
|
Peste
des
petits
ruminants
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23355-1
|
Peste
des
petits
ruminants
virus
Ag
[Presence]
in
Tissue
by
Immunoassay
|
|
23356-9
|
Peste
des
petits
ruminants
virus
Ag
[Presence]
in
Tissue
by
Immunoelectrophoresis
|
|
23357-7
|
Peste
des
petits
ruminants
virus
Ag
[Presence]
in
Tissue
by
Immune
diffusion
(ID)
|
|
23358-5
|
Peste
des
petits
ruminants
virus
RNA
[Presence]
in
Tissue
by
DNA
probe
|
|
23359-3
|
Peste
des
petits
ruminants
virus
RNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
2336-6
|
Globulin
[Mass/volume]
in
Serum
|
|
23360-1
|
Porcine
enterovirus
Ag
[Presence]
in
Unspecified
specimen
by
Neutralization
test
|
|
23361-9
|
Porcine
enterovirus
Ab
[Presence]
in
Serum
|
|
23362-7
|
Porcine
enterovirus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23363-5
|
Porcine
enterovirus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23364-3
|
Porcine
enterovirus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23365-0
|
Porcine
parvovirus
Ab
[Presence]
in
Serum
by
Hemagglutination
inhibition
|
|
23366-8
|
Porcine
parvovirus
Ab
[Presence]
in
Serum
|
|
23367-6
|
Porcine
reproductive
and
respiratory
syndrome
virus
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23368-4
|
Porcine
reproductive
and
respiratory
syndrome
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23369-2
|
Porcine
reproductive
and
respiratory
syndrome
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immune
stain
|
|
2337-4
|
Glucagon
[Mass/volume]
in
Amniotic
fluid
|
|
23370-0
|
Porcine
reproductive
and
respiratory
syndrome
virus
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
23371-8
|
Porcine
reproductive
and
respiratory
syndrome
virus
RNA
[Presence]
in
Semen
by
Probe
and
target
amplification
method
|
|
23372-6
|
Porcine
respiratory
coronavirus
Ab
[Presence]
in
Serum
|
|
23373-4
|
Porcine
respiratory
coronavirus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23374-2
|
Porcine
respiratory
coronavirus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23376-7
|
Porcine
respiratory
coronavirus
Ag
[Presence]
in
Unspecified
specimen
by
Immune
stain
|
|
23377-5
|
Porcine
respiratory
coronavirus
Ag
[Presence]
in
Small
intestine
Tissue
by
Immune
stain
|
|
23378-3
|
Porcine
respiratory
coronavirus
RNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
23379-1
|
Abnormal
Prion
Protein
[Presence]
in
Brain
by
Immunoblot
(IB)
|
|
2338-2
|
Glucagon
[Mass/volume]
in
Serum
or
Plasma
|
|
23380-9
|
Abnormal
Prion
Protein
[Presence]
in
Brain
by
Immune
stain
|
|
23381-7
|
Abnormal
Prion
Protein
[Presence]
in
Brain
by
Electron
microscopy
|
|
23382-5
|
Pseudorabies
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23383-3
|
Pseudorabies
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immune
stain
|
|
23384-1
|
Pseudorabies
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunoassay
|
|
23385-8
|
Pseudorabies
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23386-6
|
Pseudorabies
virus
Ag
[Presence]
in
Unspecified
specimen
by
Neutralization
test
|
|
23387-4
|
Pseudorabies
virus
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23388-2
|
Rabies
virus
[Presence]
in
Brain
by
Light
microscopy
|
|
23389-0
|
Rabies
virus
Ag
[Presence]
in
Brain
by
Immunoassay
|
|
2339-0
|
Glucose
[Mass/volume]
in
Blood
|
|
23390-8
|
Rabies
virus
Ag
[Presence]
in
Brain
by
Immune
stain
|
|
23391-6
|
Rabies
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immune
stain
|
|
23392-4
|
Deprecated
Rabies
virus
DNA
by
probe
|
|
23393-2
|
Deprecated
Rabies
virus
DNA
by
amplified
target
|
|
23396-5
|
Rift
valley
fever
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
23397-3
|
Rift
valley
fever
virus
Ab
[Presence]
in
Serum
|
|
23398-1
|
Rift
valley
fever
virus
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
23399-9
|
Rift
valley
fever
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
2340-8
|
Glucose
[Mass/volume]
in
Blood
by
Automated
test
strip
|
|
23400-5
|
Rift
valley
fever
virus
Ab
[Titer]
in
Serum
|
|
23401-3
|
Rift
valley
fever
virus
Ag
[Presence]
in
Tissue
by
Neutralization
test
|
|
23402-1
|
Rift
valley
fever
virus
Ag
[Presence]
in
Blood
by
Neutralization
test
|
|
23403-9
|
Rift
valley
fever
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23404-7
|
Rift
valley
fever
virus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23405-4
|
Rift
valley
fever
virus
Ag
[Presence]
in
Tissue
by
Immune
diffusion
(ID)
|
|
23406-2
|
Rift
valley
fever
virus
Ag
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
23407-0
|
Rinderpest
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23408-8
|
Rinderpest
virus
Ab
[Titer]
in
Serum
|
|
23409-6
|
Rinderpest
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
2341-6
|
Glucose
[Mass/volume]
in
Blood
by
Test
strip
manual
|
|
23410-4
|
Rinderpest
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23411-2
|
Rinderpest
virus
Ab
[Presence]
in
Serum
|
|
23412-0
|
Rinderpest
virus
Ag
[Units/volume]
in
Tissue
by
Immunoassay
|
|
23413-8
|
Rinderpest
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23414-6
|
Rinderpest
virus
Ag
[Presence]
in
Exudate
by
Immunoelectrophoresis
|
|
23415-3
|
Rinderpest
virus
Ag
[Presence]
in
Exudate
by
Immune
diffusion
(ID)
|
|
23416-1
|
Rinderpest
virus
Ag
[Units/volume]
in
Unspecified
specimen
by
Immunoassay
|
|
23417-9
|
Rinderpest
virus
RNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23418-7
|
Salmonella
abortus
equi
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23419-5
|
Salmonella
abortus
equi
Ab
[Presence]
in
Serum
|
|
2342-4
|
Glucose
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
23420-3
|
Salmonella
abortus
ovis
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23421-1
|
Salmonella
abortus
ovis
Ab
[Presence]
in
Serum
|
|
23422-9
|
Salmonella
enteritidis
IgG
Ab
[Presence]
in
Serum
|
|
23423-7
|
Salmonella
enteritidis
IgG
Ab
[Presence]
in
Egg
yolk
by
Immunoassay
|
|
23424-5
|
Salmonella
enteritidis
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23425-2
|
Salmonella
enteritidis
IgG
Ab
[Presence]
in
Egg
yolk
|
|
23426-0
|
Salmonella
gallinarum
Ab
[Presence]
in
Blood
by
Agglutination
|
|
23427-8
|
Salmonella
gallinarum
Ab
[Presence]
in
Serum
|
|
23428-6
|
Salmonella
gallinarum
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23429-4
|
Salmonella
gallinarum
Ab
[Presence]
in
Serum
by
Agglutination
|
|
2343-2
|
Glucose
[Mass/volume]
in
Dialysis
fluid
|
|
23431-0
|
Salmonella
gallinarum
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23432-8
|
Salmonella
gallinarum
rRNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
23433-6
|
Salmonella
pullorum
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
23434-4
|
Salmonella
pullorum
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23435-1
|
Salmonella
pullorum
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23436-9
|
Salmonella
pullorum
rRNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
23437-7
|
Swine
influenza
virus
Ab
[Presence]
in
Serum
|
|
23438-5
|
Swine
influenza
virus
Ab
[Presence]
in
Serum
by
Hemagglutination
inhibition
|
|
2344-0
|
Glucose
[Mass/volume]
in
Body
fluid
|
|
23440-1
|
Swine
vesicular
disease
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23441-9
|
Swine
vesicular
disease
virus
Ab
[Presence]
in
Serum
|
|
23442-7
|
Swine
vesicular
disease
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23443-5
|
Swine
vesicular
disease
virus
Ab
[Presence]
in
Serum
by
Immunoelectrophoresis
|
|
23444-3
|
Swine
vesicular
disease
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunoassay
|
|
23445-0
|
Swine
vesicular
disease
virus
Ag
[Presence]
in
Skin
by
Complement
fixation
|
|
23446-8
|
Swine
vesicular
disease
virus
Ag
[Presence]
in
Unspecified
specimen
by
Complement
fixation
|
|
23447-6
|
Swine
vesicular
disease
virus
Ag
[Presence]
in
Skin
by
Immunoassay
|
|
23448-4
|
Swine
vesicular
disease
virus
RNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
23449-2
|
Taenia
hydatigena
Ag
[Presence]
in
Stool
by
Immunoassay
|
|
2345-7
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
|
|
23450-0
|
Taenia
sp
Ag
[Presence]
in
Stool
by
Immunoassay
|
|
23451-8
|
Taenia
sp
eggs
[Presence]
in
Stool
by
DNA
probe
|
|
23452-6
|
Taenia
sp
eggs
[Presence]
in
Stool
by
Probe
and
target
amplification
method
|
|
23453-4
|
Taylorella
equigenitalis
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23454-2
|
Taylorella
equigenitalis
Ab
[Presence]
in
Serum
|
|
23455-9
|
Taylorella
equigenitalis
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23456-7
|
Taylorella
equigenitalis
Ag
[Presence]
in
Unspecified
specimen
by
Agglutination
|
|
23458-3
|
Taylorella
equigenitalis
DNA
[Presence]
in
Genital
specimen
by
Probe
and
target
amplification
method
|
|
23459-1
|
Theileria
annulata
Ab
[Presence]
in
Serum
|
|
2346-5
|
Glucose
[Mass/volume]
in
Pleural
fluid
|
|
23460-9
|
Theileria
annulata
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23461-7
|
Theileria
annulata
Ab
[Titer]
in
Serum
|
|
23462-5
|
Theileria
annulata
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
23463-3
|
Theileria
annulata
rRNA
[Presence]
in
Serum
by
DNA
probe
|
|
23464-1
|
Theileria
equi
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23465-8
|
Theileria
equi
rRNA
[Presence]
in
Blood
by
DNA
probe
|
|
23466-6
|
Theileria
equi
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23467-4
|
Theileria
mutans
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
23468-2
|
Theileria
mutans
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23469-0
|
Theileria
mutans
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
2347-3
|
Glucose
[Mass/volume]
in
Peritoneal
fluid
|
|
23470-8
|
Theileria
mutans
Ab
[Presence]
in
Serum
|
|
23471-6
|
Theileria
mutans
Ab
[Titer]
in
Serum
|
|
23472-4
|
Theileria
mutans
rRNA
[Presence]
in
Serum
by
DNA
probe
|
|
23473-2
|
Theileria
mutans
DNA
[Presence]
in
Serum
by
Probe
and
target
amplification
method
|
|
23474-0
|
Theileria
parva
Ab
[Presence]
in
Serum
|
|
23475-7
|
Theileria
parva
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23476-5
|
Theileria
parva
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
23477-3
|
Theileria
parva
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23478-1
|
Theileria
parva
Ab
[Titer]
in
Serum
|
|
23479-9
|
Theileria
parva
rRNA
[Presence]
in
Serum
by
DNA
probe
|
|
2348-1
|
Glucose
[Mass/volume]
in
Synovial
fluid
|
|
23480-7
|
Theileria
parva
DNA
[Presence]
in
Serum
by
Probe
and
target
amplification
method
|
|
23481-5
|
Deprecated
Theileria
parva
rRNA
[Presence]
in
Serum
by
DNA
probe
|
|
23482-3
|
Theileria
sp
[Presence]
in
Blood
by
Giemsa
stain
|
|
23483-1
|
Theileria
sp
[Presence]
in
Tissue
by
Giemsa
stain
|
|
23484-9
|
Deprecated
Toxoplasma
gondii
Ab
[Presence]
in
Serum
|
|
23485-6
|
Toxoplasma
gondii
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23486-4
|
Toxoplasma
gondii
Ab
[Presence]
in
Serum
by
Latex
agglutination
|
|
23487-2
|
Transmissible
gastroenteritis
virus
Ab
[Presence]
in
Serum
|
|
23488-0
|
Transmissible
gastroenteritis
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23489-8
|
Transmissible
gastroenteritis
virus
Ab
[Titer]
in
Serum
|
|
2349-9
|
Glucose
[Presence]
in
Urine
|
|
23491-4
|
Transmissible
gastroenteritis
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23492-2
|
Transmissible
gastroenteritis
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
23493-0
|
Transmissible
gastroenteritis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Neutralization
test
|
|
23494-8
|
Transmissible
gastroenteritis
virus
Ag
[Presence]
in
Stool
by
Immunoassay
|
|
23495-5
|
Transmissible
gastroenteritis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immune
stain
|
|
23496-3
|
Transmissible
gastroenteritis
virus
Ag
[Presence]
in
Small
intestine
Tissue
by
Immune
stain
|
|
23497-1
|
Transmissible
gastroenteritis
virus
Ag
[Presence]
in
Small
intestine
Tissue
by
Immunofluorescence
|
|
23498-9
|
Transmissible
gastroenteritis
virus
RNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
23499-7
|
Trichinella
spiralis
[Presence]
in
Tissue
by
Light
microscopy
|
|
2350-7
|
Glucose
[Mass/volume]
in
Urine
|
|
23500-2
|
Tritrichomonas
foetus
Ab
[Presence]
in
Genital
mucus
|
|
23501-0
|
Tritrichomonas
foetus
Ab
[Presence]
in
Genital
mucus
by
Agglutination
|
|
23502-8
|
Tritrichomonas
foetus
Ag
[Presence]
in
Tissue
from
Fetus
by
Immune
stain
|
|
23503-6
|
Tritrichomonas
foetus
Ag
[Presence]
in
Placenta
by
Immune
stain
|
|
23504-4
|
Tritrichomonas
foetus
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23505-1
|
Tritrichomonas
foetus
DNA
[Presence]
in
Genital
fluid
by
Probe
and
target
amplification
method
|
|
23507-7
|
Trypanosoma
brucei
DNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
23508-5
|
Trypanosoma
congolense
DNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
23509-3
|
Trypanosoma
equiperdum
[Presence]
in
Body
fluid
by
Light
microscopy
|
|
2351-5
|
Glucose
[Mass/time]
in
24
hour
Urine
|
|
23510-1
|
Trypanosoma
equiperdum
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
23511-9
|
Trypanosoma
equiperdum
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23512-7
|
Trypanosoma
equiperdum
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23513-5
|
Trypanosoma
equiperdum
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23514-3
|
Trypanosoma
equiperdum
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
23515-0
|
Trypanosoma
equiperdum
Ab
[Presence]
in
Serum
|
|
23517-6
|
Trypanosoma
equiperdum
Ab
[Titer]
in
Serum
|
|
23518-4
|
Trypanosoma
evansi
[Presence]
in
Aspirate
by
Thick
film
|
|
23519-2
|
Trypanosoma
evansi
[Presence]
in
Aspirate
by
Thin
film
|
|
23520-0
|
Trypanosoma
evansi
[Presence]
in
Aspirate
by
Wet
preparation
|
|
23521-8
|
Trypanosoma
evansi
Ab
[Units/volume]
in
Serum
|
|
23522-6
|
Trypanosoma
evansi
Ab
[Presence]
in
Serum
|
|
23523-4
|
Trypanosoma
evansi
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23524-2
|
Trypanosoma
evansi
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
23526-7
|
Trypanosoma
evansi
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23528-3
|
Trypanosoma
evansi
Ag
[Presence]
in
Blood
by
Immunoassay
|
|
23529-1
|
Trypanosoma
evansi
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
2353-1
|
Glucose
phosphate
isomerase
[Enzymatic
activity/volume]
in
Serum
|
|
23530-9
|
Trypanosoma
evansi
rRNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
23531-7
|
Trypanosoma
sp
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23532-5
|
Trypanosoma
sp
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23533-3
|
Trypanosoma
sp
Ab
[Presence]
in
Serum
|
|
23534-1
|
Trypanosoma
sp
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23535-8
|
Trypanosoma
sp
Ag
[Presence]
in
Blood
by
Immunoassay
|
|
23536-6
|
Trypanosoma
sp
identified
in
Blood
by
Concentration
|
|
2354-9
|
Glucose-6-Phosphatase
[Enzymatic
activity/volume]
in
Serum
|
|
23540-8
|
Turkey
enteritis
coronavirus
[Presence]
in
Serum
by
Immunofluorescence
|
|
23541-6
|
Venezuelan
equine
encephalitis
virus
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23542-4
|
Venezuelan
equine
encephalitis
virus
Ab
[Presence]
in
Serum
by
Hemagglutination
inhibition
|
|
23543-2
|
Venezuelan
equine
encephalitis
virus
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
23544-0
|
Venezuelan
equine
encephalitis
virus
Ab
[Presence]
in
Serum
|
|
23545-7
|
Venezuelan
equine
encephalitis
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23546-5
|
Venezuelan
equine
encephalitis
virus
IgM
Ab
[Presence]
in
Serum
|
|
23547-3
|
Venezuelan
equine
encephalitis
virus
IgM
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23548-1
|
Venezuelan
equine
encephalitis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Neutralization
test
|
|
23549-9
|
Venezuelan
equine
encephalitis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
2355-6
|
Glucose-6-Phosphatase
[Enzymatic
activity/mass]
in
Tissue
|
|
23550-7
|
Venezuelan
equine
encephalitis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Hemagglutination
inhibition
|
|
23551-5
|
Venezuelan
equine
encephalitis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Complement
fixation
|
|
23552-3
|
Venezuelan
equine
encephalitis
virus
subtype
[Identifier]
in
Unspecified
specimen
by
Neutralization
test
|
|
23553-1
|
Venezuelan
equine
encephalitis
virus
subtype
[Identifier]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23554-9
|
Venezuelan
equine
encephalitis
virus
subtype
[Identifier]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23555-6
|
Vesicular
stomatitis
virus
Ab
[Presence]
in
Serum
|
|
23557-2
|
Vesicular
stomatitis
virus
Ag
[Presence]
in
Skin
by
Immunoassay
|
|
23558-0
|
Vesicular
stomatitis
virus
Ag
[Presence]
in
Throat
by
Immunoassay
|
|
23559-8
|
Vesicular
stomatitis
virus
Ag
[Presence]
in
Skin
by
Complement
fixation
|
|
2356-4
|
Glucose-6-Phosphate
dehydrogenase
[Presence]
in
Red
Blood
Cells
|
|
23560-6
|
Vesicular
stomatitis
virus
Ag
[Presence]
in
Throat
by
Complement
fixation
|
|
23561-4
|
Vesicular
stomatitis
Indiana
virus
Ab
[Presence]
in
Serum
|
|
23562-2
|
Vesicular
stomatitis
Indiana
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23563-0
|
Vesicular
stomatitis
Indiana
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23564-8
|
Vesicular
stomatitis
Indiana
virus
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23565-5
|
Vesicular
stomatitis
New
Jersey
virus
Ab
[Presence]
in
Serum
|
|
23566-3
|
Vesicular
stomatitis
New
Jersey
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23567-1
|
Vesicular
stomatitis
New
Jersey
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23568-9
|
Vesicular
stomatitis
New
Jersey
virus
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23569-7
|
Vesicular
stomatitis
virus
serotype
[Identifier]
in
Unspecified
specimen
by
Complement
fixation
|
|
2357-2
|
Glucose-6-Phosphate
dehydrogenase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
23570-5
|
Vesicular
stomatitis
virus
serotype
[Identifier]
in
Tissue
by
Complement
fixation
|
|
23571-3
|
Vesicular
stomatitis
virus
serotype
[Identifier]
in
Tissue
by
Immunoassay
|
|
23572-1
|
Vesicular
stomatitis
virus
serotype
[Identifier]
in
Unspecified
specimen
by
Immunoassay
|
|
23573-9
|
Viral
hemorrhagic
disease
virus
[Presence]
in
Tissue
by
Electron
microscopy
|
|
23574-7
|
Viral
hemorrhagic
disease
virus
Ab
[Presence]
in
Serum
|
|
23575-4
|
Viral
hemorrhagic
disease
virus
Ab
[Titer]
in
Serum
|
|
23576-2
|
Viral
hemorrhagic
disease
virus
Ab
[Titer]
in
Serum
by
Immunoassay
|
|
23577-0
|
Viral
hemorrhagic
disease
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23578-8
|
Viral
hemorrhagic
disease
virus
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
23579-6
|
Viral
hemorrhagic
disease
virus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
2358-0
|
Glucose-6-Phosphate
dehydrogenase
[Presence]
in
Serum
|
|
23580-4
|
Viral
hemorrhagic
disease
virus
Ag
[Presence]
in
Tissue
by
Immunoassay
|
|
23581-2
|
Viral
hemorrhagic
disease
virus
Ag
[Presence]
in
Tissue
by
Agglutination
|
|
23582-0
|
Viral
hemorrhagic
disease
virus
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
23583-8
|
Western
equine
encephalitis
virus
Ab
[Presence]
in
Serum
by
Agglutination
|
|
23584-6
|
Western
equine
encephalitis
virus
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
23585-3
|
Western
equine
encephalitis
virus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23586-1
|
Western
equine
encephalitis
virus
Ab
[Presence]
in
Serum
by
Hemagglutination
inhibition
|
|
23587-9
|
Western
equine
encephalitis
virus
IgM
Ab
[Presence]
in
Serum
|
|
23588-7
|
Western
equine
encephalitis
virus
IgM
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23589-5
|
Western
equine
encephalitis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Neutralization
test
|
|
2359-8
|
Glucose-6-Phosphate
dehydrogenase
[Enzymatic
activity/volume]
in
Serum
|
|
23590-3
|
Western
equine
encephalitis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23591-1
|
Western
equine
encephalitis
virus
Ag
[Presence]
in
Unspecified
specimen
by
Complement
fixation
|
|
23592-9
|
African
swine
fever
virus
Ab
[Presence]
in
Serum
by
Immune
stain
|
|
23593-7
|
Bovine
leukemia
virus
[Presence]
in
Blood
by
Organism
specific
culture
|
|
23594-5
|
Brucella
sp
identified
in
Semen
by
Organism
specific
culture
|
|
23595-2
|
Dermatophilus
congolensis
[Presence]
in
Exudate
by
Giemsa
stain
|
|
23596-0
|
Dermatophilus
congolensis
[Presence]
in
Exudate
by
Carbol-fuchsin
stain
|
|
23597-8
|
Dermatophilus
congolensis
[Presence]
in
Exudate
by
Methylene
blue
stain
|
|
23598-6
|
Dermatophilus
congolensis
Ag
[Presence]
in
Exudate
by
Immunofluorescence
|
|
23599-4
|
Leptospira
sp
identified
in
Tissue
by
Organism
specific
culture
|
|
2360-6
|
Glucose-6-Phosphate
dehydrogenase
[Enzymatic
activity/volume]
in
Leukocytes
|
|
23600-0
|
Leptospira
sp
identified
in
Milk
by
Organism
specific
culture
|
|
23601-8
|
Mareks
disease
virus
serotype
[Identifier]
in
Tissue
by
Organism
specific
culture
|
|
23602-6
|
Salmonella
enteritidis
[Presence]
in
Stool
by
Organism
specific
culture
|
|
23603-4
|
Taylorella
equigenitalis
[Presence]
in
Genital
specimen
by
Organism
specific
culture
|
|
23604-2
|
Tritrichomonas
foetus
[Presence]
in
Body
fluid
by
Organism
specific
culture
|
|
23605-9
|
Tritrichomonas
foetus
[Presence]
in
Placenta
by
Organism
specific
culture
|
|
23606-7
|
Tritrichomonas
foetus
[Presence]
in
Genital
fluid
by
Organism
specific
culture
|
|
2361-4
|
Glucosylceramidase
[Enzymatic
activity/mass]
in
Tissue
|
|
23644-8
|
Actinobacillus
pleuropneumoniae
1
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23645-5
|
Actinobacillus
pleuropneumoniae
3
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23646-3
|
Actinobacillus
pleuropneumoniae
5
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23647-1
|
Actinobacillus
pleuropneumoniae
7
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23648-9
|
Actinobacillus
pleuropneumoniae
Ab
[Titer]
in
Serum
|
|
23649-7
|
Actinobacillus
pleuropneumoniae
biovar
2
serotype
[Identifier]
in
Unspecified
specimen
by
Agglutination
|
|
23650-5
|
Actinobacillus
pleuropneumoniae
serotype
[Identifier]
in
Unspecified
specimen
by
Agglutination
|
|
23651-3
|
Actinobacillus
suis
serotype
[Identifier]
in
Isolate
by
Agglutination
|
|
23652-1
|
Aeromonas
salmonicida
DNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
23653-9
|
Aflatoxin
[Mass/volume]
in
Unspecified
specimen
|
|
23654-7
|
Aflatoxin
[Mass/mass]
in
Feed
|
|
23655-4
|
Aflatoxin
[Mass/mass]
in
Tissue
|
|
23656-2
|
Ammonia
[Mass/volume]
in
Unspecified
specimen
|
|
23657-0
|
Anaplasma
marginale
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
23660-4
|
Aspergillus
sp
Ab
[Titer]
in
Serum
by
Immunoassay
|
|
23661-2
|
Avian
paramyxovirus
1
Ab
[Titer]
in
Serum
by
Immunoassay
|
|
23662-0
|
Babesia
bigemina
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23663-8
|
Babesia
bovis
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23664-6
|
Babesia
canis
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
23665-3
|
Babesia
divergens
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
23666-1
|
Babesia
sp
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
23667-9
|
Bacteria
identified
in
Unspecified
specimen
|
|
23668-7
|
Bartonella
henselae
Ab
[Titer]
in
Serum
|
|
23669-5
|
Biochanin
A
[Mass/volume]
in
Serum
or
Plasma
|
|
2367-1
|
Glutamate
dehydrogenase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
23670-3
|
Deprecated
Blastomyces
dermatitidis
Ab
[Presence]
in
Serum
|
|
23671-1
|
Bluetongue
virus
10
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
23672-9
|
Bluetongue
virus
11
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
23673-7
|
Bluetongue
virus
13
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
23674-5
|
Bluetongue
virus
17
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
23675-2
|
Bluetongue
virus
2
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
23676-0
|
Borrelia
burgdorferi
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23677-8
|
Bovine
leukemia
virus
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
23678-6
|
Bovine
parainfluenza
virus
3
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23679-4
|
Bovine
respiratory
syncytial
virus
Ag
[Presence]
in
Unspecified
specimen
|
|
2368-9
|
Glutamate
dehydrogenase.NAD
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
23680-2
|
Bromide
[Mass/volume]
in
Unspecified
specimen
|
|
23681-0
|
Brucella
canis
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23682-8
|
Brucella
canis
Ab
[Titer]
in
Serum
by
Agglutination
|
|
23683-6
|
Brucella
canis
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
23684-4
|
Brucella
ovis
Ab
[Titer]
in
Serum
|
|
23685-1
|
Canine
adenovirus
1
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23686-9
|
Canine
adenovirus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23687-7
|
Canine
coronavirus
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23688-5
|
Canine
coronavirus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23689-3
|
Canine
distemper
virus
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
2369-7
|
Glutamate
dehydrogenase.NADP
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
23690-1
|
Canine
distemper
virus
Ab
[Titer]
in
Serum
|
|
23691-9
|
Canine
distemper
virus
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
23692-7
|
Canine
distemper
virus
IgG
Ab
[Titer]
in
Serum
|
|
23693-5
|
Canine
distemper
virus
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
23694-3
|
Canine
distemper
virus
IgM
Ab
[Titer]
in
Serum
|
|
23695-0
|
Canine
distemper
virus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23696-8
|
Canine
distemper
virus
Ag
[Presence]
in
Conjunctival
specimen
|
|
23697-6
|
Canine
herpesvirus
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23698-4
|
Canine
herpesvirus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23699-2
|
Canine
parainfluenza
virus
2
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23700-8
|
Canine
parvovirus
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23701-6
|
Canine
parvovirus
Ab
[Presence]
in
Serum
|
|
23702-4
|
Canine
parvovirus
Ab
[Titer]
in
Serum
|
|
23703-2
|
Canine
parvovirus
IgG
Ab
[Titer]
in
Serum
|
|
23704-0
|
Canine
parvovirus
IgM
Ab
[Titer]
in
Serum
|
|
23705-7
|
Canine
parvovirus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23706-5
|
Canine
parvovirus
Ag
[Presence]
in
Stool
by
Immunofluorescence
|
|
23707-3
|
Canine
parvovirus
DNA
[Presence]
in
Stool
by
DNA
probe
|
|
23708-1
|
Caprine
arthritis
encephalitis
virus
Ag
[Presence]
in
Unspecified
specimen
|
|
23710-7
|
Dirofilaria
immitis
Ag
[Presence]
in
Serum
by
Immunoassay
|
|
23711-5
|
Ehrlichia
canis
Ab
[Titer]
in
Serum
|
|
23713-1
|
Ethylene
glycol
[Presence]
in
Serum
or
Plasma
|
|
23714-9
|
Fat
[Mass/volume]
in
Milk
|
|
23715-6
|
Feline
calicivirus
Ab
[Titer]
in
Serum
|
|
23716-4
|
Feline
coronavirus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23717-2
|
Feline
coronavirus
Ab
[Presence]
in
Serum
|
|
23718-0
|
Feline
coronavirus
Ab
[Titer]
in
Serum
|
|
23719-8
|
Feline
herpesvirus
1
Ab
[Presence]
in
Serum
by
Neutralization
test
|
|
23720-6
|
Feline
herpesvirus
1
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23721-4
|
Feline
herpesvirus
1
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23722-2
|
Feline
herpesvirus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
23723-0
|
Feline
immunodeficiency
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23724-8
|
Feline
immunodeficiency
virus
Ab
[Presence]
in
Serum
|
|
23725-5
|
Feline
immunodeficiency
virus
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
23726-3
|
Feline
infectious
peritonitis
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23727-1
|
Feline
infectious
peritonitis
virus
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23728-9
|
Feline
infectious
peritonitis
virus
Ab
[Presence]
in
Serum
|
|
23729-7
|
Feline
infectious
peritonitis
virus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23730-5
|
Feline
infectious
peritonitis
virus
Ag
[Presence]
in
Small
intestine
Tissue
by
Immunofluorescence
|
|
23731-3
|
Feline
leukemia
provirus
[Presence]
in
Unspecified
specimen
|
|
23732-1
|
Feline
leukemia
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
23733-9
|
Feline
leukemia
virus
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23734-7
|
Feline
leukemia
virus
Ab
[Presence]
in
Serum
|
|
23735-4
|
Feline
leukemia
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
23736-2
|
Feline
leukemia
virus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23737-0
|
Feline
panleukopenia
virus
Ab
[Titer]
in
Serum
|
|
23738-8
|
Feline
herpesvirus
1
Ab
[Titer]
in
Serum
|
|
23739-6
|
Feline
syncytial
virus
Ab
[Titer]
in
Serum
|
|
23741-2
|
Francisella
tularensis
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
23742-0
|
Fumonisin
[Mass/volume]
in
Unspecified
specimen
|
|
23743-8
|
Genistein
[Units/volume]
in
Serum
or
Plasma
|
|
23744-6
|
Giardia
lamblia
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23745-3
|
Gossypol
[Mass/volume]
in
Unspecified
specimen
|
|
23746-1
|
Gossypol
Free
[Mass/volume]
in
Unspecified
specimen
|
|
23747-9
|
Heavy
metals
[Presence]
in
Unspecified
specimen
|
|
23748-7
|
Deprecated
Histoplasma
capsulatum
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
23749-5
|
Lead
[Mass/volume]
in
Unspecified
specimen
|
|
2375-4
|
Glutaryl
CoA
dehydrogenase
[Enzymatic
activity/mass]
in
Tissue
|
|
23750-3
|
Leptospira
sp
Ag
[Presence]
in
Urine
by
Immunofluorescence
|
|
23751-1
|
Metaldehyde
[Mass/volume]
in
Unspecified
specimen
|
|
23752-9
|
Mite
identified
in
Skin
|
|
23753-7
|
Mycoplasma
hyopneumoniae
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23754-5
|
Mycoplasma
sp
Ab
[Titer]
in
Serum
|
|
23755-2
|
Mycoplasma
synoviae
Ab
[Titer]
in
Serum
by
Hemagglutination
|
|
23756-0
|
Neospora
caninum
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
23757-8
|
Neospora
caninum
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
23758-6
|
Neospora
caninum
Ab
[Titer]
in
Serum
|
|
23759-4
|
Neospora
caninum
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
2376-2
|
Glutathione
peroxidase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
23760-2
|
Neospora
caninum
Ag
[Presence]
in
Fixed
tissue
by
Immune
stain
|
|
23762-8
|
Nitrate+Nitrite
[Mass/volume]
in
Unspecified
specimen
|
|
23763-6
|
Pasteurella
multocida
serotype
[Identifier]
in
Isolate
|
|
23764-4
|
Pesticides
[Identifier]
in
Unspecified
specimen
|
|
23765-1
|
Porcine
adenovirus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23766-9
|
Porcine
circovirus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23767-7
|
Porcine
circovirus
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
23768-5
|
Porcine
influenza
virus
A
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
23769-3
|
Porcine
influenza
virus
A
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
2377-0
|
Glutathione
peroxidase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
23770-1
|
Porcine
parvovirus
Ab
[Titer]
in
Serum
|
|
23771-9
|
Porcine
parvovirus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23772-7
|
Porcine
reproductive
and
respiratory
syndrome
virus
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
23773-5
|
Porcine
rotavirus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23774-3
|
Pseudorabies
virus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23775-0
|
Rhodococcus
equi
Ab
[Titer]
in
Serum
|
|
23776-8
|
Rickettsia
spotted
fever
group
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
23777-6
|
Salmonella
pullorum
Ab
[Titer]
in
Serum
by
Agglutination
|
|
23778-4
|
Salmonella
typhimurium
Ab
[Titer]
in
Serum
by
Agglutination
|
|
23779-2
|
Selenium
[Mass/volume]
in
Unspecified
specimen
|
|
2378-8
|
Glutathione
reductase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
23780-0
|
Strychnine
[Mass/volume]
in
Unspecified
specimen
|
|
23781-8
|
Swine
influenza
virus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
23782-6
|
Swine
influenza
virus
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
23783-4
|
Taylorella
equigenitalis
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
23784-2
|
Toxoplasma
gondii
Ab
[Titer]
in
Serum
by
Hemagglutination
|
|
23785-9
|
Trypanosoma
cruzi
Ab
[Presence]
in
Serum
|
|
23786-7
|
Urea
[Mass/volume]
in
Unspecified
specimen
|
|
23787-5
|
Venezuelan
equine
encephalitis
virus
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
23788-3
|
Vesicular
stomatitis
Indiana
virus
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
23789-1
|
Vesicular
stomatitis
Indiana
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
2379-6
|
Glutathione
S-transferase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
23790-9
|
Vesicular
stomatitis
New
Jersey
virus
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
23791-7
|
Vesicular
stomatitis
New
Jersey
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
23792-5
|
Western
equine
encephalitis
virus
Ab
[Presence]
in
Unspecified
specimen
|
|
23793-3
|
Canine
parvovirus
Ag
[Presence]
in
Stool
by
Immunoassay
|
|
23794-1
|
Food
Allergen
Mix
C
(Oat+Barley+Rice+Rye+Wheat+Corn)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
23795-8
|
Dust
Allergen
Mix
2
(Cockroach+American
house
dust
mite+European
house
dust
mite+House
dust
Hollister
Stier)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
23796-6
|
Deprecated
Tree
Allergen
Mix
1
(Boxelder+Silver
birch+White
oak+White
elm+California
walnut)
IgE
Ab
[Presence]
in
Serum
by
Multiple
allergens
|
|
23797-4
|
Tree
Allergen
Mix
2
(Boxelder+White
oak+White
elm+Cottonwood+Pecan/Hickory)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
23798-2
|
Epidermal
Allergen
Mix
1
(Cat
dander+Cow
dander+Dog
dander+Horse
dander)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
23799-0
|
Epidermal
Allergen
Mix
73
(Chicken
feather+Duck
feather+Goose
feather+Parrot
feather)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
2380-4
|
Glutathione
synthase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
23800-6
|
Mold
Allergen
Mix
1
(Alternaria
alternata+Aspergillus
fumigatus+Cladosporium
herbarum+Penicillium
notatum)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
23801-4
|
Food
Allergen
Mix
5
(Peanut+Cow
milk+Egg
white+Cod+Soybean+Wheat)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
23802-2
|
Grass
Allergen
Mix
D
(Bermuda
grass+Perennial
rye
grass+Timothy+Kentucky
blue
grass+Johnson
grass)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
23803-0
|
Grass
Allergen
Mix
1
(Orchard
grass+Meadow
Fescue+Perennial
rye
grass+Timothy+Kentucky
blue
grass)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
23804-8
|
Deprecated
Food
Allergen
Mix
2
(Cod+Blue
Mussel+Shrimp+Salmon+Tuna)
IgE
Ab
[Presence]
in
Serum
by
Multiple
allergens
|
|
23805-5
|
5-Fluorocytosine
[Mass/volume]
in
Unspecified
specimen
|
|
23808-9
|
Aldosterone
free
[Mass/time]
in
24
hour
Urine
|
|
2381-2
|
Glutathione.oxidized
[Mass/volume]
in
Red
Blood
Cells
|
|
23810-5
|
Alpha
fucosidase
[Units/volume]
in
Leukocytes
|
|
23814-7
|
Amantadine
[Mass/volume]
in
Urine
|
|
23815-4
|
Androstanediol
[Mass/time]
in
24
hour
Urine
|
|
23816-2
|
Other
Antibiotic
[Mass/volume]
in
Serum
or
Plasma
|
|
23819-6
|
Antibody
coated
bacteria
[Presence]
in
Urine
by
Immunofluorescence
|
|
2382-0
|
Glutathione.reduced
[Mass/volume]
in
Red
Blood
Cells
|
|
23820-4
|
Aspergillus
flavus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
23821-2
|
Aspergillus
fumigatus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
23822-0
|
Azinphos-methyl
[Mass/volume]
in
Blood
|
|
23826-1
|
Bordetella
pertussis
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
23827-9
|
Bordetella
pertussis
filamentous
hemagglutinin
IgA
Ab
[Units/volume]
in
Serum
|
|
23828-7
|
Bordetella
pertussis
filamentous
hemagglutinin
IgG
Ab
[Units/volume]
in
Serum
|
|
23829-5
|
Bordetella
pertussis
filamentous
hemagglutinin
IgM
Ab
[Units/volume]
in
Serum
|
|
2383-8
|
Glutathione
[Mass/volume]
in
Red
Blood
Cells
|
|
23830-3
|
Bordetella
pertussis
toxin
IgA
Ab
[Units/volume]
in
Serum
|
|
23831-1
|
Bordetella
pertussis
toxin
IgG
Ab
[Units/volume]
in
Serum
|
|
23832-9
|
Bordetella
pertussis
toxin
IgM
Ab
[Units/volume]
in
Serum
|
|
23833-7
|
Borrelia
burgdorferi
Ab
index
[Presence]
in
Serum
and
CSF
|
|
23835-2
|
Carbon
disulfide
[Mass/volume]
in
Urine
|
|
23836-0
|
Carbon
disulfide
[Mass/volume]
in
Serum
or
Plasma
|
|
23838-6
|
Chlamydia
trachomatis
rRNA
[Presence]
in
Genital
fluid
by
DNA
probe
|
|
23839-4
|
Deprecated
Cholinesterase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
2384-6
|
Glyceraldehyde
3
phosphate
dehydrogenase
[Enzymatic
activity/volume]
in
Serum
|
|
23842-8
|
Cobalt
[Mass/volume]
in
Synovial
fluid
|
|
23843-6
|
Cockatiel
droppings
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
23844-4
|
Complement
C3
Nephritic
[Units/volume]
in
Serum
or
Plasma
|
|
23847-7
|
Deprecated
Cotton
fibers
IgE
Ab
[Units/volume]
in
Serum
|
|
23848-5
|
Creosol
[Mass/volume]
in
Unspecified
specimen
|
|
23849-3
|
Creosol
[Mass/volume]
in
Serum
or
Plasma
|
|
2385-3
|
Glycerate
[Mass/volume]
in
Serum
|
|
23850-1
|
Creosol
[Mass/volume]
in
Urine
|
|
23851-9
|
Cyclohexanone
[Mass/volume]
in
Serum
or
Plasma
|
|
23853-5
|
Dimethylformamide/Creatinine
[Mass
Ratio]
in
Urine
|
|
23854-3
|
Dioxin
[Mass/volume]
in
Serum
or
Plasma
|
|
23855-0
|
Echinococcus
granulosus
IgE
Ab
[Units/volume]
in
Serum
|
|
23856-8
|
Endrin
[Mass/volume]
in
Serum
or
Plasma
|
|
23858-4
|
Epstein
Barr
virus
DNA
[Presence]
in
Cerebral
spinal
fluid
by
Probe
and
target
amplification
method
|
|
2386-1
|
Glycerate
[Mass/volume]
in
Urine
|
|
23861-8
|
Ethanol
[Mass/mass]
in
Tissue
|
|
23862-6
|
Famotidine
[Mass/volume]
in
Serum
or
Plasma
|
|
23864-2
|
Flunitrazepam
[Mass/volume]
in
Serum
or
Plasma
|
|
23865-9
|
Fluoxetine+Norfluoxetine
[Presence]
in
Urine
|
|
23866-7
|
Glutaraldehyde
[Presence]
in
Urine
|
|
23867-5
|
Hantavirus
sin
nombre
IgG
Ab
[Titer]
in
Serum
|
|
23868-3
|
Hantavirus
sin
nombre
IgM
Ab
[Titer]
in
Serum
|
|
23869-1
|
Hepatitis
B
virus
DNA
[Mass/volume]
(viral
load)
in
Serum
by
DNA
probe
|
|
23876-6
|
HIV
1
RNA
[Units/volume]
(viral
load)
in
Plasma
by
Probe
and
signal
amplification
method
|
|
23877-4
|
Anaplasma
phagocytophilum
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
23878-2
|
Anaplasma
phagocytophilum
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
23879-0
|
Immune
complex
[Units/volume]
in
Body
fluid
by
C1q
binding
assay
|
|
23880-8
|
Immune
complex
[Units/volume]
in
Body
fluid
by
Raji
cell
assay
|
|
23881-6
|
Immune
complex
[Mass/volume]
in
Body
fluid
by
Polyethylene
glycol
(PEG)
assay
|
|
23882-4
|
Immune
complex
[Units/volume]
in
Body
fluid
by
Conglutinin
assay
|
|
23883-2
|
Inhibin
A
[Mass/volume]
in
Serum
or
Plasma
|
|
23884-0
|
Interleukin
2
receptor
[Presence]
in
Tissue
by
Immunocytochemical
assay
|
|
23888-1
|
Isopropanol
[Mass/volume]
in
Gastric
fluid
|
|
23889-9
|
Kanamycin
[Mass/volume]
in
Unspecified
specimen
|
|
23890-7
|
Lead
[Mass/mass]
in
Unspecified
specimen
|
|
23891-5
|
Magnesium
[Moles/volume]
in
24
hour
Stool
|
|
23892-3
|
Magnesium
[Moles/time]
in
24
hour
Stool
|
|
23893-1
|
Malaoxon
[Mass/volume]
in
Blood
|
|
23896-4
|
Mercury
[Mass/mass]
in
Unspecified
specimen
|
|
23899-8
|
Methanol
[Mass/volume]
in
Gastric
fluid
|
|
23900-4
|
Methanol
[Mass/mass]
in
Tissue
|
|
23901-2
|
Microscopic
observation
[Identifier]
in
Body
fluid
by
Wet
preparation
|
|
23905-3
|
Mycophenolate
[Mass/volume]
in
Serum
or
Plasma
|
|
23906-1
|
Mycophenolate
glucuronide
[Mass/volume]
in
Serum
or
Plasma
|
|
23907-9
|
Myelin
associated
glycoprotein/Sulfated
glucuronic
paragloboside
IgM
Ab
[Units/volume]
in
Serum
|
|
23908-7
|
Deprecated
Neisseria
gonorrhoeae
DNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
23929-3
|
Ribonucleoprotein
extractable
nuclear
IgG
Ab
[Presence]
in
Serum
|
|
23930-1
|
Salmonella
typhi
O
D
Ab
[Titer]
in
Serum
by
Agglutination
|
|
23931-9
|
Salmonella
typhi
O
D
[Titer]
in
Serum
by
Immunofluorescence
|
|
23933-5
|
Staphylococcus
aureus
enterotoxin
B
[Presence]
in
Unspecified
specimen
|
|
23934-3
|
Staphylococcus
aureus
enterotoxin
B
Ab
[Presence]
in
Serum
|
|
23935-0
|
Staphylococcus
aureus
toxin
1
[Presence]
in
Unspecified
specimen
|
|
23936-8
|
Staphylococcus
aureus
toxin
1
Ab
[Presence]
in
Serum
|
|
23937-6
|
Trans
nonachlor
[Mass/volume]
in
Serum
or
Plasma
|
|
2394-5
|
Glycogen
synthase
[Enzymatic
activity/volume]
in
Serum
|
|
2395-2
|
Glycolate
[Mass/volume]
in
Serum
or
Plasma
|
|
23950-9
|
Adenovirus
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Complement
fixation
|
|
23953-3
|
Aspergillus
sp
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Complement
fixation
|
|
23954-1
|
Bartonella
henselae
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
23955-8
|
Bartonella
henselae
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
23956-6
|
Aspergillus
sp
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
23957-4
|
Bartonella
henselae
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
23958-2
|
Dengue
virus
IgG
Ab
[Units/volume]
in
Serum
|
|
23959-0
|
Blastomyces
dermatitidis
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
2396-0
|
Glycolate
[Mass/volume]
in
Urine
|
|
23960-8
|
Bartonella
quintana
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
23961-6
|
Bartonella
quintana
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
23962-4
|
Bartonella
henselae
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
23963-2
|
Brucella
abortus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
23964-0
|
Brucella
abortus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
23965-7
|
Burkholderia
pseudomallei
IgG
Ab
[Titer]
in
Serum
|
|
23966-5
|
Borrelia
burgdorferi
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
23967-3
|
Chlamydia
sp
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
23968-1
|
Dengue
virus
IgM
Ab
[Units/volume]
in
Serum
|
|
23969-9
|
Echovirus
7
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
2397-8
|
Glycoproteins
[Presence]
in
Urine
|
|
23970-7
|
Epstein
Barr
virus
nuclear
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
23971-5
|
Epstein
Barr
virus
early
IgG
Ab
[Titer]
in
Serum
|
|
23972-3
|
Epstein
Barr
virus
early
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
23973-1
|
Burkholderia
pseudomallei
IgM
Ab
[Titer]
in
Serum
|
|
23974-9
|
Bartonella
quintana
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
23975-6
|
Bartonella
quintana
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
23976-4
|
Blastomyces
dermatitidis
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Complement
fixation
|
|
23977-2
|
Borrelia
burgdorferi
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
23978-0
|
Borrelia
burgdorferi
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
2398-6
|
Glycosaminoglycans
[Presence]
in
Urine
|
|
23980-6
|
Borrelia
burgdorferi
IgG
Ab
[Presence]
in
Body
fluid
by
Immunoblot
(IB)
|
|
23982-2
|
Borrelia
burgdorferi
IgM
Ab
[Presence]
in
Body
fluid
by
Immunoblot
(IB)
|
|
23984-8
|
Borrelia
burgdorferi
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
23986-3
|
Brucella
abortus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
23987-1
|
Brucella
abortus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
23988-9
|
Burkholderia
pseudomallei
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
23989-7
|
Burkholderia
pseudomallei
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
2399-4
|
Glycosaminoglycans
[Mass/volume]
in
Urine
|
|
23990-5
|
Chlamydia
sp
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Complement
fixation
|
|
23991-3
|
Dengue
virus
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
23992-1
|
Dengue
virus
IgM
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
23993-9
|
Echovirus
7
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Complement
fixation
|
|
23994-7
|
Epstein
Barr
virus
nuclear
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
23995-4
|
Epstein
Barr
virus
early
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
23996-2
|
Epstein
Barr
virus
early
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
2400-0
|
Guanine
deaminase
[Enzymatic
activity/volume]
in
Blood
|
|
24002-8
|
Microscopic
observation
[Identifier]
in
Bronchial
specimen
by
Acid
fast
stain
|
|
24003-6
|
Brucella
sp
identified
in
Bone
marrow
by
Organism
specific
culture
|
|
24004-4
|
Chlamydophila
pneumoniae
IgM
Ab
[Presence]
in
Serum
|
|
24005-1
|
Chlamydia
sp
identified
in
Bronchial
specimen
by
Organism
specific
culture
|
|
24007-7
|
Epstein
Barr
virus
early
IgG
Ab
[Units/volume]
in
Serum
|
|
24008-5
|
Echovirus
14
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
24009-3
|
Fungus
identified
in
Bronchial
specimen
by
Culture
|
|
2401-8
|
Guanine
deaminase
[Enzymatic
activity/volume]
in
Serum
|
|
24010-1
|
Haemophilus
influenzae
B
Ag
[Presence]
in
Cerebral
spinal
fluid
|
|
24012-7
|
HIV
1
Ag
[Presence]
in
Serum
|
|
24014-3
|
Herpes
simplex
virus
2
IgG
Ab
[Titer]
in
Serum
|
|
24015-0
|
Influenza
virus
A+B
Ag
[Presence]
in
Unspecified
specimen
|
|
24017-6
|
Neisseria
meningitidis
B
Ag
[Presence]
in
Cerebral
spinal
fluid
|
|
24018-4
|
Neisseria
meningitidis
B
Ag
[Presence]
in
Urine
|
|
2402-6
|
Guanosine
monophosphate.cyclic
[Mass/volume]
in
Serum
or
Plasma
|
|
24020-0
|
Streptococcus
agalactiae
Ag
[Presence]
in
Urine
|
|
24027-5
|
Streptococcus
pneumoniae
Ag
[Presence]
in
Urine
|
|
24028-3
|
Toxocara
canis
IgA
Ab
[Presence]
in
Serum
|
|
24029-1
|
Toxocara
canis
IgG
Ab
[Presence]
in
Serum
|
|
2403-4
|
Hemopexin
[Mass/volume]
in
Serum
|
|
24030-9
|
Toxocara
canis
IgM
Ab
[Presence]
in
Serum
|
|
24031-7
|
14-3-3
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
24032-5
|
Rifabutin
[Mass/volume]
in
Serum
or
Plasma
|
|
24033-3
|
Bordetella
pertussis
filamentous
hemagglutinin
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
24034-1
|
Bordetella
pertussis
filamentous
hemagglutinin
IgA
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
24035-8
|
Bordetella
pertussis
filamentous
hemagglutinin
IgM
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
24036-6
|
Borrelia
sp
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
24037-4
|
Deprecated
Coccidioides
immitis
rRNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
2404-2
|
Hemopexin
[Mass/volume]
in
Urine
|
|
24041-6
|
Cytomegalovirus
DNA
[Units/volume]
(viral
load)
in
Unspecified
specimen
by
Probe
and
signal
amplification
method
|
|
24042-4
|
Ehrlichia
chaffeensis
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
24043-2
|
Acetyl-CoA:glucosamine
acetyltransferase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24044-0
|
Acetyl-CoA:glucosamine
acetyltransferase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24045-7
|
Alpha
fucosidase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
24046-5
|
Alpha
fucosidase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24047-3
|
Alpha
fucosidase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24048-1
|
Alpha
galactosidase
A
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24049-9
|
Alpha
galactosidase
A
[Enzymatic
activity/mass]
in
Leukocytes
|
|
2405-9
|
Heparan
sulfate
[Presence]
in
Urine
|
|
24050-7
|
Acid
alpha
glucosidase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24051-5
|
Acid
alpha
glucosidase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24052-3
|
Alpha
mannosidase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24053-1
|
Alpha
mannosidase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24054-9
|
Alpha-N-acetylgalactosaminidase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24055-6
|
Alpha-N-acetylgalactosaminidase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24056-4
|
Alpha-L-iduronidase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24057-2
|
Alpha-L-iduronidase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24058-0
|
Aspartylglucosaminidase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24059-8
|
Aspartylglucosaminidase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
2406-7
|
Heparan
sulfate
[Mass/volume]
in
Urine
|
|
24060-6
|
Beta
galactosidase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24061-4
|
Beta
galactosidase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24064-8
|
Beta
glucuronidase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24065-5
|
Beta
glucuronidase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24066-3
|
Beta
mannosidase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
24067-1
|
Beta
mannosidase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24068-9
|
Beta
mannosidase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24072-1
|
Beta-N-acetylhexosaminidase.B
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24073-9
|
Beta-N-acetylhexosaminidase.B
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24074-7
|
Beta-N-acetylhexosaminidase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24075-4
|
Beta-N-acetylhexosaminidase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24076-2
|
Cerebroside
sulfatase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
24077-0
|
Cerebroside
sulfatase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24078-8
|
Cerebroside
sulfatase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24079-6
|
Cholesterol
esterase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
2408-3
|
Hexachlorophene
[Mass/volume]
in
Blood
|
|
24080-4
|
Cholesterol
esterase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24081-2
|
Dihydroxyacetone
phosphate
acylcoa
acyl
transferase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24082-0
|
Galactose
1
phosphate
uridyl
transferase
[Enzymatic
activity/mass]
in
Red
Blood
Cells
|
|
24083-8
|
Galactosylceramidase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24084-6
|
Galactosylceramidase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24085-3
|
Heparan-N-sulfatase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24086-1
|
Heparan-N-sulfatase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24087-9
|
Iduronate-2-Sulfatase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
24088-7
|
Iduronate-2-Sulfatase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24089-5
|
Iduronate-2-Sulfatase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
2409-1
|
Hexokinase
[Enzymatic
activity/volume]
in
Plasma
|
|
24091-1
|
Alpha-N-acetylglucosaminidase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24092-9
|
Alpha-N-acetylglucosaminidase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24093-7
|
N-Acetylgalactosamine-4-Sulfatase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24094-5
|
N-Acetylgalactosamine-4-Sulfatase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24095-2
|
N-Acetylgalactosamine-6-Sulfatase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24096-0
|
N-Acetylgalactosamine-6-Sulfatase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24097-8
|
N-Acetylglucosamine-6-Sulfatase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24098-6
|
N-Acetylglucosamine-6-Sulfatase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24099-4
|
Sialidase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
2410-9
|
Hexokinase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
24100-0
|
Acid
sphingomyelinase
[Enzymatic
activity/mass]
in
Fibroblast
|
|
24101-8
|
Acid
sphingomyelinase
[Enzymatic
activity/mass]
in
Leukocytes
|
|
24102-6
|
Corynebacterium
toxin
[Presence]
in
Unspecified
specimen
by
Immune
diffusion
(ID)
|
|
24108-3
|
Cancer
Ag
19-9
[Units/volume]
in
Serum
or
Plasma
|
|
24109-1
|
Progesterone
[Moles/volume]
in
Saliva
(oral
fluid)
|
|
24110-9
|
Treponema
pallidum
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
24111-7
|
Neisseria
gonorrhoeae
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
24112-5
|
Deprecated
Trichomonas
vaginalis
rRNA
[Presence]
in
Genital
specimen
by
DNA
probe
|
|
24113-3
|
Hepatitis
B
virus
core
IgM
Ab
[Presence]
in
Serum
or
Plasma
by
Immunoassay
|
|
24114-1
|
Epstein
Barr
virus
capsid
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
24115-8
|
Epstein
Barr
virus
capsid
IgM
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
24116-6
|
Rubella
virus
IgM
Ab
[Presence]
in
Serum
or
Plasma
by
Immunoassay
|
|
24117-4
|
Ross
River
virus
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
24118-2
|
Barmah
forest
virus
IgM
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
24119-0
|
Cytomegalovirus
IgM
Ab
[Presence]
in
Serum
or
Plasma
by
Immunoassay
|
|
24120-8
|
Ross
River
virus
IgM
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
24121-6
|
Barmah
forest
virus
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
24126-5
|
Adenovirus
type
[Identifier]
in
Unspecified
specimen
by
Neutralization
test
|
|
24127-3
|
Bordetella
pertussis
toxin
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
24128-1
|
Bordetella
pertussis
toxin
IgA
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
24129-9
|
Bordetella
pertussis
toxin
IgM
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
2413-3
|
Hippuran
renal
clearance
in
24
hour
|
|
24130-7
|
Bordetella
pertussis
secretory
IgA
Ab
[Presence]
in
Unspecified
specimen
by
Immunoassay
|
|
24131-5
|
Deprecated
Food
Allergen
Mix
3
(Oat+Buckwheat+Sesame
seed+Wheat+Corn)
IgE
Ab
[Presence]
in
Serum
by
Multiple
allergens
|
|
24132-3
|
Grass
Allergen
Mix
B
(Sweet
vernal
grass+Perennial
rye
grass+Common
reed+Rye+Velvet
grass)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
24133-1
|
Deprecated
Tree
Allergen
Mix
5
(Grey
alder+Hazelnut+White
elm+Willow+Cottonwood)
IgE
Ab
[Presence]
in
Serum
by
Multiple
allergens
|
|
24134-9
|
Deprecated
Tree
Allergen
Mix
6
(Boxelder+Silver
birch+American
beech+White
oak+California
walnut)
IgE
Ab
[Presence]
in
Serum
by
Multiple
allergens
|
|
24135-6
|
Deprecated
Tree
Allergen
Mix
9
(Grey
alder+Silver
birch+Hazelnut+White
oak+Willow)
IgE
Ab
[Presence]
in
Serum
by
Multiple
allergens
|
|
24136-4
|
Black
Walnut
IgG
Ab
[Units/volume]
in
Serum
|
|
24137-2
|
White
Hickory
IgG
Ab
[Units/volume]
in
Serum
|
|
24138-0
|
Johnson
grass
IgG
Ab
[Units/volume]
in
Serum
|
|
24139-8
|
Cockroach
IgG
Ab
[Units/volume]
in
Serum
|
|
2414-1
|
Hippurate
[Mass/time]
in
24
hour
Urine
|
|
24140-6
|
White
Ash
IgG
Ab
[Units/volume]
in
Serum
|
|
24141-4
|
Marsh
Elder
IgG
Ab
[Units/volume]
in
Serum
|
|
24142-2
|
Red
mulberry
IgG
Ab
[Units/volume]
in
Serum
|
|
24143-0
|
Sheep
Sorrel
IgG
Ab
[Units/volume]
in
Serum
|
|
24144-8
|
Brome
IgG
Ab
[Units/volume]
in
Serum
|
|
24145-5
|
American
Sycamore
IgG
Ab
[Units/volume]
in
Serum
|
|
24146-3
|
Western
Water
Hemp
IgG
Ab
[Units/volume]
in
Serum
|
|
24147-1
|
Epidermal
Allergen
Mix
A
(Chicken
feather+Duck
feather+Goose
feather)
IgE
Ab
[Units/volume]
in
Serum
by
Multidisk
|
|
24148-9
|
Kentucky
blue
grass
IgG
Ab
[Units/volume]
in
Serum
|
|
24149-7
|
Food
Allergen
Mix
D
(Cauliflower+Cabbage+Brussel
sprouts+Broccoli)
IgG
Ab
[Units/volume]
in
Serum
by
Multidisk
|
|
2415-8
|
Histamine
[Mass/volume]
in
Blood
|
|
24150-5
|
Red
Maple
IgG
Ab
[Units/volume]
in
Serum
|
|
24151-3
|
Giant
Ragweed
IgG
Ab
[Units/volume]
in
Serum
|
|
24152-1
|
Deprecated
ALTERNARIA
ALTERNATA+ALTERNARIA
TENUIS
IgG
Ab
[Units/volume]
in
Serum
|
|
24153-9
|
Kamut
flour
IgG
Ab
[Units/volume]
in
Serum
|
|
24154-7
|
Goosefoot
IgG
Ab
[Units/volume]
in
Serum
|
|
24155-4
|
Mango
IgG
Ab
[Units/volume]
in
Serum
|
|
24156-2
|
Maple
syrup
IgG
Ab
[Units/volume]
in
Serum
|
|
24157-0
|
Deprecated
Virginia
Live
Oak
IgE
Ab
[Units/volume]
in
Serum
|
|
24158-8
|
White+Black
Pepper
IgG
Ab
[Units/volume]
in
Serum
|
|
24159-6
|
White+Black
Pepper
IgE
Ab
[Units/volume]
in
Serum
|
|
2416-6
|
Histamine
[Mass/volume]
in
Serum
or
Plasma
|
|
24160-4
|
Deprecated
Wax
Bean
IgE
Ab
[Units/volume]
in
Serum
|
|
24161-2
|
Deprecated
Melon
IgE
Ab
[Units/volume]
in
Serum
|
|
24163-8
|
Food
Allergen
Mix
73
(Beef+Chicken+Pork)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
24164-6
|
Deprecated
Mandarin
IgE
Ab
[Units/volume]
in
Serum
|
|
24165-3
|
Sugar
Beet
Seed
(Beta
vulgaris
seed)
IgE
Ab
[Units/volume]
in
Serum
|
|
24166-1
|
Deprecated
Monterey
Pine
IgE
Ab
[Units/volume]
in
Serum
|
|
24167-9
|
Deprecated
Rat
epithelium,
serum
proteins
&
urine
proteins
IgE
Ab
[Units/volume]
in
Serum
|
|
24168-7
|
Deprecated
Cat
hair
+
Cat
dander
IgG
Ab
[Units/volume]
in
Serum
|
|
24169-5
|
Polio
virus
1
Ab
[Titer]
in
Serum
by
Neutralization
test
--1st
specimen
|
|
2417-4
|
Histamine
[Mass/volume]
in
Urine
|
|
24170-3
|
Polio
virus
1
Ab
[Titer]
in
Serum
by
Neutralization
test
--2nd
specimen
|
|
24171-1
|
Polio
virus
2
Ab
[Titer]
in
Serum
by
Neutralization
test
--1st
specimen
|
|
24172-9
|
Polio
virus
2
Ab
[Titer]
in
Serum
by
Neutralization
test
--2nd
specimen
|
|
24173-7
|
Polio
virus
3
Ab
[Titer]
in
Serum
by
Neutralization
test
--1st
specimen
|
|
24174-5
|
Polio
virus
3
Ab
[Titer]
in
Serum
by
Neutralization
test
--2nd
specimen
|
|
24175-2
|
Adenovirus
Ab
[Titer]
in
Serum
by
Complement
fixation
--1st
specimen
|
|
24176-0
|
Adenovirus
Ab
[Titer]
in
Serum
by
Complement
fixation
--2nd
specimen
|
|
24177-8
|
Coxsackievirus
B1
Ab
[Titer]
in
Serum
by
Complement
fixation
--1st
specimen
|
|
24178-6
|
Coxsackievirus
B1
Ab
[Titer]
in
Serum
by
Complement
fixation
--2nd
specimen
|
|
24179-4
|
Coxsackievirus
B1
Ab
[Titer]
in
Serum
by
Neutralization
test
--1st
specimen
|
|
24180-2
|
Coxsackievirus
B1
Ab
[Titer]
in
Serum
by
Neutralization
test
--2nd
specimen
|
|
24181-0
|
Coxsackievirus
B2
Ab
[Titer]
in
Serum
by
Complement
fixation
--1st
specimen
|
|
24182-8
|
Coxsackievirus
B2
Ab
[Titer]
in
Serum
by
Complement
fixation
--2nd
specimen
|
|
24183-6
|
Coxsackievirus
B2
Ab
[Titer]
in
Serum
by
Neutralization
test
--1st
specimen
|
|
24184-4
|
Coxsackievirus
B2
Ab
[Titer]
in
Serum
by
Neutralization
test
--2nd
specimen
|
|
24185-1
|
Coxsackievirus
B3
Ab
[Titer]
in
Serum
by
Complement
fixation
--1st
specimen
|
|
24186-9
|
Coxsackievirus
B3
Ab
[Titer]
in
Serum
by
Complement
fixation
--2nd
specimen
|
|
24187-7
|
Coxsackievirus
B3
Ab
[Titer]
in
Serum
by
Neutralization
test
--1st
specimen
|
|
24188-5
|
Coxsackievirus
B3
Ab
[Titer]
in
Serum
by
Neutralization
test
--2nd
specimen
|
|
24189-3
|
Coxsackievirus
B4
Ab
[Titer]
in
Serum
by
Complement
fixation
--1st
specimen
|
|
24190-1
|
Coxsackievirus
B4
Ab
[Titer]
in
Serum
by
Complement
fixation
--2nd
specimen
|
|
24191-9
|
Coxsackievirus
B4
Ab
[Titer]
in
Serum
by
Neutralization
test
--1st
specimen
|
|
24192-7
|
Coxsackievirus
B4
Ab
[Titer]
in
Serum
by
Neutralization
test
--2nd
specimen
|
|
24193-5
|
Coxsackievirus
B5
Ab
[Titer]
in
Serum
by
Complement
fixation
--1st
specimen
|
|
24194-3
|
Coxsackievirus
B5
Ab
[Titer]
in
Serum
by
Complement
fixation
--2nd
specimen
|
|
24195-0
|
Coxsackievirus
B5
Ab
[Titer]
in
Serum
by
Neutralization
test
--1st
specimen
|
|
24196-8
|
Coxsackievirus
B5
Ab
[Titer]
in
Serum
by
Neutralization
test
--2nd
specimen
|
|
24197-6
|
Coxsackievirus
B6
Ab
[Titer]
in
Serum
by
Complement
fixation
--1st
specimen
|
|
24198-4
|
Coxsackievirus
B6
Ab
[Titer]
in
Serum
by
Complement
fixation
--2nd
specimen
|
|
24199-2
|
Coxsackievirus
B6
Ab
[Titer]
in
Serum
by
Neutralization
test
--1st
specimen
|
|
24200-8
|
Coxsackievirus
B6
Ab
[Titer]
in
Serum
by
Neutralization
test
--2nd
specimen
|
|
24201-6
|
Saint
Louis
encephalitis
virus
Ab
[Titer]
in
Serum
by
Immunofluorescence
--1st
specimen
|
|
24202-4
|
Saint
Louis
encephalitis
virus
Ab
[Titer]
in
Serum
by
Immunofluorescence
--2nd
specimen
|
|
24203-2
|
Legionella
pneumophila
Ab
[Titer]
in
Serum
by
Immunofluorescence
--1st
specimen
|
|
24204-0
|
Legionella
pneumophila
Ab
[Titer]
in
Serum
by
Immunofluorescence
--2nd
specimen
|
|
24205-7
|
Rickettsia
typhi
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
--1st
specimen
|
|
24206-5
|
Rickettsia
typhi
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
--2nd
specimen
|
|
24207-3
|
Rickettsia
spotted
fever
group
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
--1st
specimen
|
|
24208-1
|
Rickettsia
spotted
fever
group
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
--2nd
specimen
|
|
24209-9
|
La
Crosse
virus
Ab
[Titer]
in
Serum
by
Immunofluorescence
--1st
specimen
|
|
24210-7
|
La
Crosse
virus
Ab
[Titer]
in
Serum
by
Immunofluorescence
--2nd
specimen
|
|
24211-5
|
Western
equine
encephalitis
virus
Ab
[Titer]
in
Serum
by
Immunofluorescence
--1st
specimen
|
|
24212-3
|
Western
equine
encephalitis
virus
Ab
[Titer]
in
Serum
by
Immunofluorescence
--2nd
specimen
|
|
24213-1
|
Eastern
equine
encephalitis
virus
Ab
[Titer]
in
Serum
by
Immunofluorescence
--1st
specimen
|
|
24214-9
|
Eastern
equine
encephalitis
virus
Ab
[Titer]
in
Serum
by
Immunofluorescence
--2nd
specimen
|
|
24215-6
|
Influenza
virus
A
Ab
[Titer]
in
Serum
by
Complement
fixation
--1st
specimen
|
|
24216-4
|
Influenza
virus
A
Ab
[Titer]
in
Serum
by
Complement
fixation
--2nd
specimen
|
|
24217-2
|
Influenza
virus
B
Ab
[Titer]
in
Serum
by
Complement
fixation
--1st
specimen
|
|
24218-0
|
Influenza
virus
B
Ab
[Titer]
in
Serum
by
Complement
fixation
--2nd
specimen
|
|
24219-8
|
Parainfluenza
virus
1
Ab
[Titer]
in
Serum
by
Complement
fixation
--1st
specimen
|
|
24220-6
|
Parainfluenza
virus
2
Ab
[Titer]
in
Serum
by
Complement
fixation
--1st
specimen
|
|
24221-4
|
Parainfluenza
virus
2
Ab
[Titer]
in
Serum
by
Complement
fixation
--2nd
specimen
|
|
24222-2
|
Parainfluenza
virus
3
Ab
[Titer]
in
Serum
by
Complement
fixation
--1st
specimen
|
|
24223-0
|
Parainfluenza
virus
3
Ab
[Titer]
in
Serum
by
Complement
fixation
--2nd
specimen
|
|
24224-8
|
Respiratory
syncytial
virus
Ab
[Titer]
in
Serum
by
Complement
fixation
--1st
specimen
|
|
24225-5
|
Respiratory
syncytial
virus
Ab
[Titer]
in
Serum
by
Complement
fixation
--2nd
specimen
|
|
24226-3
|
Coxsackievirus
A10
Ab
[Titer]
in
Serum
by
Complement
fixation
--1st
specimen
|
|
24227-1
|
Coxsackievirus
A10
Ab
[Titer]
in
Serum
by
Complement
fixation
--2nd
specimen
|
|
24228-9
|
Coxsackievirus
A16
Ab
[Titer]
in
Serum
by
Complement
fixation
--1st
specimen
|
|
24229-7
|
Coxsackievirus
A16
Ab
[Titer]
in
Serum
by
Complement
fixation
--2nd
specimen
|
|
24230-5
|
Coxsackievirus
A7
Ab
[Titer]
in
Serum
by
Complement
fixation
--1st
specimen
|
|
24231-3
|
Coxsackievirus
A7
Ab
[Titer]
in
Serum
by
Complement
fixation
--2nd
specimen
|
|
24232-1
|
Coxsackievirus
A9
Ab
[Titer]
in
Serum
by
Complement
fixation
--1st
specimen
|
|
24233-9
|
Coxsackievirus
A9
Ab
[Titer]
in
Serum
by
Complement
fixation
--2nd
specimen
|
|
24234-7
|
Mycoplasma
pneumoniae
IgG
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
24235-4
|
Mycoplasma
pneumoniae
IgG
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
24236-2
|
Mycoplasma
pneumoniae
Ab
[Titer]
in
Serum
by
Complement
fixation
--1st
specimen
|
|
24237-0
|
Mycoplasma
pneumoniae
Ab
[Titer]
in
Serum
by
Complement
fixation
--2nd
specimen
|
|
24238-8
|
Chlamydia
sp
IgG
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
24239-6
|
Chlamydia
sp
IgG
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
24240-4
|
Mumps
virus
IgG
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
24241-2
|
Mumps
virus
IgG
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
24242-0
|
Toxoplasma
gondii
IgG
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
24243-8
|
Polio
virus
1
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24244-6
|
Polio
virus
1
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24245-3
|
Polio
virus
2
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24246-1
|
Polio
virus
2
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24247-9
|
Polio
virus
3
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24248-7
|
Polio
virus
3
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24249-5
|
Adenovirus
Ab
[Titer]
in
Serum
--1st
specimen
|
|
2425-7
|
Histidine
ammonia
lyase
[Enzymatic
activity/volume]
in
Serum
|
|
24250-3
|
Adenovirus
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24251-1
|
Coxsackievirus
B1
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24252-9
|
Coxsackievirus
B1
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24255-2
|
Coxsackievirus
B2
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24256-0
|
Coxsackievirus
B2
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24259-4
|
Coxsackievirus
B3
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24260-2
|
Coxsackievirus
B3
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24263-6
|
Coxsackievirus
B4
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24264-4
|
Coxsackievirus
B4
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24267-7
|
Coxsackievirus
B5
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24268-5
|
Coxsackievirus
B5
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24271-9
|
Coxsackievirus
B6
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24272-7
|
Coxsackievirus
B6
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24275-0
|
Saint
Louis
encephalitis
virus
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24276-8
|
Saint
Louis
encephalitis
virus
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24277-6
|
Legionella
pneumophila
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24278-4
|
Legionella
pneumophila
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24279-2
|
Rickettsia
typhi
IgG
Ab
[Titer]
in
Serum
--1st
specimen
|
|
2428-1
|
Homocysteine
[Mass/volume]
in
Serum
or
Plasma
|
|
24280-0
|
Rickettsia
typhi
IgG
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24281-8
|
Rickettsia
spotted
fever
group
IgG
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24282-6
|
Rickettsia
spotted
fever
group
IgG
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24283-4
|
La
Crosse
virus
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24284-2
|
La
Crosse
virus
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24285-9
|
Western
equine
encephalitis
virus
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24286-7
|
Western
equine
encephalitis
virus
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24287-5
|
Eastern
equine
encephalitis
virus
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24288-3
|
Eastern
equine
encephalitis
virus
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24289-1
|
Influenza
virus
A
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24290-9
|
Influenza
virus
A
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24291-7
|
Influenza
virus
B
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24292-5
|
Influenza
virus
B
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24293-3
|
Parainfluenza
virus
1
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24294-1
|
Parainfluenza
virus
2
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24295-8
|
Parainfluenza
virus
2
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24296-6
|
Parainfluenza
virus
3
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24297-4
|
Parainfluenza
virus
3
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24298-2
|
Respiratory
syncytial
virus
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24299-0
|
Respiratory
syncytial
virus
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24300-6
|
Coxsackievirus
A10
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24301-4
|
Coxsackievirus
A10
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24302-2
|
Coxsackievirus
A16
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24303-0
|
Coxsackievirus
A16
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24304-8
|
Coxsackievirus
A7
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24305-5
|
Coxsackievirus
A7
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24306-3
|
Coxsackievirus
A9
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24307-1
|
Coxsackievirus
A9
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24310-5
|
Mycoplasma
pneumoniae
Ab
[Titer]
in
Serum
--1st
specimen
|
|
24311-3
|
Mycoplasma
pneumoniae
Ab
[Titer]
in
Serum
--2nd
specimen
|
|
24312-1
|
Treponema
pallidum
Ab
[Presence]
in
Serum
by
Agglutination
|
|
2432-3
|
Homogentisate
[Presence]
in
Urine
|
|
2433-1
|
Homogentisate
[Mass/volume]
in
Urine
|
|
2434-9
|
Homovanillate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
2435-6
|
Homovanillate
[Mass/volume]
in
Serum
|
|
2436-4
|
Homovanillate
[Mass/time]
in
24
hour
Urine
|
|
24373-3
|
Ferritin
[Mass/volume]
in
Blood
|
|
24374-1
|
Platelet
associated
Ab
[Presence]
in
Blood
|
|
24375-8
|
Platelet
Ab
[Presence]
in
Serum
|
|
24376-6
|
von
Willebrand
factor
(vWf)
multimers
in
Platelet
poor
plasma
by
Immunoassay
|
|
24382-4
|
Neutrophil
associated
Ab
[Identifier]
in
Serum
|
|
24383-2
|
Intrinsic
factor
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
24385-7
|
Cardiolipin
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
24386-5
|
Cardiolipin
IgM
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
24387-3
|
Brucella
sp
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
24388-1
|
Brucella
sp
IgM
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
2439-8
|
Hydroxycalcidiol
[Mass/volume]
in
Serum
|
|
24396-4
|
Brucella
sp
IgG
Ab
[Presence]
in
Serum
|
|
24397-2
|
Brucella
sp
IgM
Ab
[Presence]
in
Serum
|
|
24398-0
|
Deprecated
Toxoplasma
gondii
IgM
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
24399-8
|
Deprecated
Toxoplasma
gondii
IgM
Ab
[Units/volume]
in
Serum
|
|
2440-6
|
Hydroxocobalamin
[Mass/volume]
in
Serum
or
Plasma
|
|
24400-4
|
Neuronal
nuclear
type
1
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
24401-2
|
Neuronal
nuclear
type
2
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
24402-0
|
Chlamydophila
pneumoniae+Chlamydophila
psittaci
DNA
[Presence]
in
Unspecified
specimen
by
Probe
with
amplification
|
|
24403-8
|
Neuronal
nuclear
type
1
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
24404-6
|
Neuronal
nuclear
type
2
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
24405-3
|
Aeromonas
salmonicida
[Presence]
in
Unspecified
specimen
|
|
24406-1
|
Aeromonas
salmonicida
serotype
[Identifier]
in
Isolate
|
|
24408-7
|
Babesia
canis
[Presence]
in
Blood
by
Giemsa
stain
|
|
24409-5
|
Brachyspira
sp
identified
in
Unspecified
specimen
by
Organism
specific
culture
|
|
24410-3
|
Brucella
canis
Ab
[Presence]
in
Serum
by
Plate
agglutination
|
|
24411-1
|
Canine
parvovirus
Ab
[Presence]
in
Serum
by
Hemagglutination
inhibition
|
|
24412-9
|
Coccidia
identified
in
Small
intestine
Tissue
by
Giemsa
stain
|
|
24413-7
|
Eperythrozoon
sp
[Presence]
in
Blood
by
Giemsa
stain
|
|
24415-2
|
Feline
panleukopenia
virus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
24416-0
|
Filovirus
Ab
[Titer]
in
Serum
|
|
24418-6
|
Formononetin
[Mass/volume]
in
Serum
or
Plasma
|
|
24420-2
|
Haemophilus
somnus
Ab
[Titer]
in
Serum
|
|
24421-0
|
Haemobartonella
felis
[Presence]
in
Blood
by
Light
microscopy
|
|
24422-8
|
Hydrocarbons.chlorinated
[Identifier]
in
Unspecified
specimen
|
|
24427-7
|
Mycobacterium
avium
ss
paratuberculosis
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
24428-5
|
Mycoplasma
hyopneumoniae
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
24429-3
|
Parasite
identified
in
Blood
|
|
24430-1
|
Streptococcus
suis
serotype
[Identifier]
in
Isolate
by
Agglutination
|
|
24431-9
|
IgA.canine
[Mass/volume]
in
Serum
by
Immune
diffusion
(ID)
|
|
24432-7
|
IgG.canine
[Mass/volume]
in
Serum
by
Immune
diffusion
(ID)
|
|
24433-5
|
IgG.equine
[Mass/volume]
in
Serum
|
|
24434-3
|
IgM.canine
[Mass/volume]
in
Serum
by
Immune
diffusion
(ID)
|
|
24438-4
|
Hexanoylglycine/Creatinine
[Molar
ratio]
in
Urine
|
|
2444-8
|
Hydroxymethylglutaryl
CoA
lyase
[Enzymatic
activity/volume]
in
Serum
|
|
24441-8
|
Phenylpropionylglycine/Creatinine
[Molar
ratio]
in
Urine
|
|
24442-6
|
Propionylglycine/Creatinine
[Molar
ratio]
in
Urine
|
|
24444-2
|
Tiglylglycine/Creatinine
[Molar
ratio]
in
Urine
|
|
24446-7
|
Porphobilinogen
[Mass/volume]
in
Urine
|
|
24447-5
|
Magnesium
[Mass/time]
in
24
hour
Urine
|
|
24448-3
|
Carnitine
[Moles/time]
in
24
hour
Urine
|
|
24449-1
|
Carnitine
esters
[Moles/volume]
in
Urine
|
|
2445-5
|
Hydroxyproline
[Presence]
in
Serum
or
Plasma
|
|
24450-9
|
Carnitine
esters
[Moles/mass]
in
Tissue
|
|
24451-7
|
Carnitine
[Moles/mass]
in
Tissue
|
|
24452-5
|
Carnitine
free
(C0)
[Moles/mass]
in
Tissue
|
|
24456-6
|
Deoxypyridinoline/Creatinine
[Molar
ratio]
in
24
hour
Urine
|
|
24458-2
|
Interleukin
2
receptor
[Mass/volume]
in
Serum
or
Plasma
|
|
2446-3
|
Hydroxyproline
[Mass/volume]
in
Serum
or
Plasma
|
|
24463-2
|
Keratan
sulfate
[Presence]
in
Urine
|
|
24464-0
|
Chondroitin
sulfate
[Presence]
in
Urine
|
|
24465-7
|
Urea
nitrogen
[Mass/time]
in
12
hour
Urine
|
|
2447-1
|
Hydroxyproline
[Mass/time]
in
24
hour
Urine
|
|
24474-9
|
Cancer
associated
serum
Ag
[Units/volume]
in
Serum
|
|
24475-6
|
F2
gene
c.20210G>A
[Presence]
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
24476-4
|
F2
gene
mutations
found
[Identifier]
in
Blood
or
Tissue
by
Molecular
genetics
method
Nominal
|
|
2448-9
|
Hydroxyproline
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
24480-6
|
Weed
Allergen
Mix
1
(Common
ragweed+Mugwort+Goosefoot
or
Lambs
quarters+English
plantain+Saltwort)
IgE
Ab
[Units/volume]
in
Serum
by
Multidisk
|
|
2449-7
|
Hydroxyproline
Free
[Mass/volume]
in
Urine
|
|
24491-3
|
Tree
Allergen
Mix
4
(White
oak+White
elm+London
plane
or
Maple
leaf
sycamore+Willow+Cottonwood)
IgE
Ab
[Units/volume]
in
Serum
by
Multidisk
|
|
24493-9
|
Weed
Allergen
Mix
2
(Western
ragweed+Mugwort+Lenscale+Goosefoot
or
Lambs
quarters+English
plantain)
IgE
Ab
[Units/volume]
in
Serum
by
Multidisk
|
|
24497-0
|
Canary
serum
proteins
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
24498-8
|
Chicken
serum
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
24499-6
|
Cryptostroma
corticale
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
2450-5
|
Hydroxyproline
Free
[Mass/time]
in
24
hour
Urine
|
|
24500-1
|
Parrot
serum
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
24501-9
|
Parrot
droppings
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
24502-7
|
Parakeet
serum
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
24503-5
|
Parakeet
droppings
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
24504-3
|
Pullularia
sp
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
24505-0
|
Pigeon
droppings
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
24507-6
|
Aspergillus
clavatus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
24508-4
|
Aspergillus
nidulans
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
24509-2
|
Aspergillus
terreus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
2451-3
|
Hydroxyproline
[Mass/volume]
in
Urine
|
|
24511-8
|
Western
wheatgrass
IgE
Ab
[Units/volume]
in
Serum
|
|
24512-6
|
Tree
Allergen
Mix
C
(Berry
juniper+Oneseed
juniper+Rocky
mountain
juniper)
IgE
Ab
[Units/volume]
in
Serum
by
Multidisk
|
|
24515-9
|
Grass
Allergen
Mix
A
(Sweet
vernal
grass+Bermuda
grass+Perennial
rye
grass+Timothy+Johnson
grass)
IgE
Ab
[Units/volume]
in
Serum
by
Multidisk
|
|
24517-5
|
Phoma
sp
IgG
Ab
[Units/volume]
in
Serum
|
|
24518-3
|
Calcium/Creatinine
[Molar
ratio]
in
Urine
|
|
24519-1
|
Phosphate
[Moles/volume]
in
Blood
|
|
2452-1
|
Hypoxanthine
[Mass/volume]
in
Body
fluid
|
|
24520-9
|
Phosphate
[Moles/volume]
in
Red
Blood
Cells
|
|
24521-7
|
Epinephrine
[Moles/volume]
in
Urine
|
|
24522-5
|
Epinephrine/Creatinine
[Molar
ratio]
in
Urine
|
|
24523-3
|
Norepinephrine/Creatinine
[Molar
ratio]
in
Urine
|
|
24524-1
|
Dopamine/Creatinine
[Molar
ratio]
in
Urine
|
|
2453-9
|
Hypoxanthine
[Mass/volume]
in
Serum
|
|
24531-6
|
Retroperitoneum
US
|
|
24532-4
|
Abdomen
RUQ
US
|
|
24533-2
|
Abdominal
vessels
MR
angiogram
W
contrast
IV
|
|
24534-0
|
Abdominal
vessels
US.doppler
|
|
24535-7
|
Acetabulum
X-ray
|
|
24536-5
|
Acromioclavicular
Joint
X-ray
|
|
24537-3
|
US
Guidance
for
aspiration
of
amniotic
fluid
of
Uterus
|
|
24538-1
|
Ankle
MR
|
|
24539-9
|
Ankle
MR
WO
and
W
contrast
IV
|
|
2454-7
|
Hypoxanthine
phosphoribosyltransferase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
24540-7
|
Ankle
X-ray
2
views
|
|
24541-5
|
Ankle
X-ray
|
|
24542-3
|
Anus
US
|
|
24543-1
|
Aorta
Fluoroscopic
angiogram
Angioplasty
W
contrast
IA
|
|
24544-9
|
Thoracic
Aorta
CT
|
|
24545-6
|
Thoracic
Aorta
CT
W
contrast
IV
|
|
24546-4
|
Aorta
arch
and
Neck
Fluoroscopic
angiogram
W
contrast
IA
|
|
24547-2
|
Aorta
US
|
|
24548-0
|
Appendix
US
|
|
24549-8
|
Upper
extremity
vessels
MR
angiogram
W
contrast
IV
|
|
2455-4
|
Hypoxanthine
phosphoribosyltransferase
[Enzymatic
activity/mass]
in
Tissue
|
|
24550-6
|
Upper
extremity
veins
Fluoroscopic
angiogram
W
contrast
IV
|
|
24551-4
|
AV
fistula
Fluoroscopic
angiogram
W
contrast
IA
|
|
24552-2
|
Stent
Fluoroscopy
W
contrast
intra
stent
|
|
24553-0
|
Vessel
intracranial
Fluoroscopic
angiogram
Embolectomy
W
contrast
IV
|
|
24554-8
|
Artery
Fluoroscopic
angiogram
Embolization
W
contrast
IA
|
|
24555-5
|
Fluoroscopic
angiogram
Guidance
for
placement
of
stent
in
Artery
|
|
24556-3
|
Abdomen
MR
|
|
24557-1
|
Abdomen
MR
WO
and
W
contrast
IV
|
|
24558-9
|
Abdomen
US
|
|
24559-7
|
US
Guidance
for
drainage
of
Abdomen
|
|
2456-2
|
Iduronate-2-Sulfatase
[Enzymatic
activity/mass]
in
Tissue
|
|
24560-5
|
Abdomen
X-ray
AP
left
lateral-decubitus
portable
|
|
24561-3
|
Abdomen
X-ray
AP
left
lateral-decubitus
|
|
24562-1
|
Abdomen
X-ray
AP
(left
lateral-decubitus
and
right
lateral-decubitus)
|
|
24563-9
|
Abdomen
X-ray
AP
right
lateral-decubitus
|
|
24564-7
|
Abdomen
X-ray
AP
upright
portable
|
|
24565-4
|
Deprecated
Chest
and
Abdomen
Narrative
X-ray
|
|
24566-2
|
Retroperitoneum
CT
|
|
24567-0
|
Deprecated
Abdomen>Retroperitoneum
CT
W
contrast
|
|
24568-8
|
AV
fistula
Fluoroscopic
angiogram
Atherectomy
W
contrast
IV
|
|
24569-6
|
AV
shunt
Fluoroscopic
angiogram
W
contrast
IV
|
|
2457-0
|
IgA
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
24570-4
|
Fluoroscopy
Guidance
for
stone
removal
of
Biliary
duct
common--
W
contrast
intra
biliary
duct
|
|
24571-2
|
Biliary
ducts
and
Gallbladder
NM
for
patency
of
biliary
structures
and
ejection
fraction
W
sincalide
and
W
radionuclide
IV
|
|
24572-0
|
Biliary
ducts
and
Gallbladder
NM
for
patency
of
biliary
structures
W
Tc-99m
IV
|
|
24573-8
|
Biliary
ducts
and
Gallbladder
X-ray
W
contrast
IV
|
|
24574-6
|
Biliary
ducts
and
Gallbladder
Fluoroscopy
during
surgery
W
contrast
biliary
duct
|
|
24575-3
|
Biliary
ducts
and
Gallbladder
Fluoroscopy
W
contrast
percutaneous
transhepatic
|
|
24576-1
|
Urinary
bladder
arteries
Fluoroscopic
angiogram
W
contrast
IA
|
|
24577-9
|
Bone
X-ray
during
surgery
|
|
24578-7
|
Bones
SPECT
|
|
24579-5
|
Long
bones
X-ray
survey
|
|
2458-8
|
IgA
[Mass/volume]
in
Serum
or
Plasma
|
|
24580-3
|
Brachiocephalic
artery
Fluoroscopic
angiogram
Angioplasty
W
contrast
IA
|
|
24581-1
|
Brachial
artery
and
Subclavian
artery
Fluoroscopic
angiogram
W
contrast
IA
|
|
24582-9
|
Brachial
plexus
MR
|
|
24583-7
|
Brachial
plexus
MR
WO
and
W
contrast
IV
|
|
24584-5
|
Thoracic
inlet
vessels
MR
angiogram
W
contrast
IV
|
|
24585-2
|
CT
Guidance
for
stereotactic
biopsy
of
Head--
W
contrast
IV
|
|
24586-0
|
Brain
MR
W
anesthesia
|
|
24587-8
|
Brain
MR
WO
and
W
contrast
IV
|
|
24588-6
|
Brain
MR
WO
and
W
contrast
IV
and
W
anesthesia
|
|
24589-4
|
Brain
MR
W
contrast
IV
|
|
2459-6
|
IgA.monoclonal
[Mass/volume]
in
Serum
|
|
24590-2
|
Brain
MR
|
|
24591-0
|
Brain
NM
brain
death
protocol
W
Tc-99m
HMPAO
IV
|
|
24593-6
|
Head
vessels
MR
angiogram
W
contrast
IV
|
|
24594-4
|
Mammogram
Guidance
for
aspiration
of
cyst
of
Breast
|
|
24595-1
|
Mammogram
Guidance
for
needle
localization
of
mass
of
Breast
|
|
24596-9
|
Breast
specimen
US
|
|
24597-7
|
Breast
specimen
Mammogram
|
|
24598-5
|
Mammogram
Guidance
for
aspiration
of
Breast
|
|
24599-3
|
Breast
US
limited
|
|
2460-4
|
IgD
[Mass/volume]
in
Serum
|
|
24600-9
|
US
Guidance
for
needle
localization
of
Breast
|
|
24601-7
|
Breast
US
|
|
24602-5
|
Mammogram
Guidance
for
biopsy
of
Breast
|
|
24603-3
|
Mammogram
Guidance
for
stereotactic
biopsy
of
Breast
|
|
24604-1
|
Breast
Mammogram
diagnostic
limited
|
|
24605-8
|
Breast
Mammogram
diagnostic
|
|
24606-6
|
Breast
Mammogram
screening
|
|
24609-0
|
Mammogram
Guidance
for
core
needle
percutaneous
biopsy
of
Breast
|
|
2461-2
|
IgD.monoclonal
[Mass/volume]
in
Serum
|
|
24610-8
|
Breast
Mammogram
limited
|
|
24611-6
|
Outpatient
Consultation
2nd
opinion
|
|
24612-4
|
Deprecated
Calcaneus
X-ray
|
|
24613-2
|
Fluoroscopic
angiogram
Guidance
for
placement
of
catheter
in
artery
in
Central
cardiovascular
artery
|
|
24614-0
|
Carotid
artery
extracranial
Fluoroscopic
angiogram
Angioplasty
W
contrast
IA
|
|
24615-7
|
Carotid
artery
intracranial
Fluoroscopic
angiogram
Angioplasty
W
contrast
IA
|
|
24616-5
|
Carotid
arteries
US
|
|
24617-3
|
Carotid
artery
Fluoroscopic
angiogram
W
contrast
IA
|
|
24619-9
|
Wrist
X-ray
|
|
2462-0
|
IgE
[Mass/volume]
in
Serum
|
|
24620-7
|
Catheter
Fluoroscopy
Patency
check
W
contrast
via
catheter
|
|
24621-5
|
Fluoroscopy
Guidance
for
percutaneous
drainage
of
Unspecified
body
region
|
|
24622-3
|
Celiac
artery
Fluoroscopic
angiogram
W
contrast
IA
|
|
24623-1
|
CT
Guidance
for
nerve
block
of
Celiac
plexus
|
|
24624-9
|
Fluoroscopic
angiogram
Guidance
for
change
of
central
venous
catheter
in
Vein--
W
contrast
IV
|
|
24625-6
|
Fluoroscopic
angiogram
Guidance
for
placement
of
central
venous
catheter
in
Vein--
W
contrast
IV
|
|
24626-4
|
Fluoroscopic
angiogram
Guidance
for
reposition
of
central
venous
catheter
in
Vein--
W
contrast
IV
|
|
24627-2
|
Chest
CT
|
|
24628-0
|
Chest
CT
W
contrast
IV
|
|
24629-8
|
Chest
MR
|
|
2463-8
|
IgE.monoclonal
[Mass/volume]
in
Serum
|
|
24630-6
|
Chest
US
|
|
24631-4
|
Unspecified
body
region
Fluoroscopy
Central
vein
catheter
placement
check
|
|
24632-2
|
Chest
X-ray
AP
portable
|
|
24634-8
|
Chest
X-ray
portable
W
inspiration
and
expiration
|
|
24635-5
|
Chest
X-ray
PA
upright
W
inspiration
and
expiration
|
|
24636-3
|
Chest
X-ray
AP
left
lateral-decubitus
portable
|
|
24637-1
|
Chest
X-ray
AP
left
lateral-decubitus
|
|
24638-9
|
Chest
X-ray
left
lateral
upright
portable
|
|
24639-7
|
Chest
X-ray
left
lateral
upright
|
|
2464-6
|
IgG
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
24640-5
|
Chest
X-ray
lordotic
|
|
24641-3
|
Chest
X-ray
left
oblique
portable
|
|
24642-1
|
Chest
X-ray
AP
and
PA
upright
|
|
24643-9
|
Chest
X-ray
PA
and
lateral
and
right
or-left
oblique
upright
|
|
24644-7
|
Chest
X-ray
PA
and
lateral
upright
portable
|
|
24645-4
|
Chest
X-ray
PA
and
right
lateral
and
right
oblique
and
left
oblique
upright
portable
|
|
24646-2
|
Chest
X-ray
PA
and
right
lateral
and
right
oblique
and
left
oblique
upright
|
|
24647-0
|
Chest
X-ray
PA
and
lateral
upright
|
|
24648-8
|
Chest
X-ray
PA
upright
|
|
24649-6
|
Chest
X-ray
AP
(right
lateral-decubitus
and
left
lateral-decubitus)
portable
|
|
2465-3
|
IgG
[Mass/volume]
in
Serum
or
Plasma
|
|
24650-4
|
Chest
X-ray
AP
(right
lateral-decubitus
and
left
lateral-decubitus)
|
|
24651-2
|
Chest
X-ray
right
oblique
and
left
oblique
upright
|
|
24652-0
|
Chest
X-ray
AP
right
lateral-decubitus
portable
|
|
24653-8
|
Chest
X-ray
AP
and
AP
right
lateral-decubitus
|
|
24654-6
|
Chest
X-ray
AP
and
AP
right
lateral-decubitus
portable
|
|
24655-3
|
Chest
Fluoroscopy
Image
intensifier
during
surgery
|
|
24656-1
|
Chest
Fluoroscopy
during
surgery
|
|
24657-9
|
Chest
X-ray
tomograph
|
|
24658-7
|
Aorta
Fluoroscopic
angiogram
W
contrast
IA
|
|
24659-5
|
Chest
vessels
MR
angiogram
W
contrast
IV
|
|
2466-1
|
IgG
subclass
1
[Mass/volume]
in
Serum
|
|
24660-3
|
Thoracic
Aorta
MR
angiogram
|
|
24661-1
|
Pleural
space
Fluoroscopy
W
contrast
intra
pleural
space
|
|
24662-9
|
US
Guidance
for
aspiration
of
Pleural
space
|
|
24663-7
|
Cerebral
cisterns
NM
W
radionuclide
IT
|
|
24664-5
|
Clavicle
X-ray
|
|
24665-2
|
Sacrum
and
Coccyx
X-ray
|
|
24666-0
|
Colon
Fluoroscopy
W
air
and
barium
contrast
PR
|
|
24667-8
|
Colon
Fluoroscopy
W
contrast
PR
|
|
24668-6
|
Colon
Fluoroscopy
transit
Post
solid
contrast
|
|
24669-4
|
Colon
Fluoroscopy
W
water
soluble
contrast
PR
|
|
2467-9
|
IgG
subclass
2
[Mass/volume]
in
Serum
|
|
24670-2
|
US
Guidance
for
biopsy
of
cyst
of
Unspecified
body
region
|
|
24671-0
|
Fluoroscopy
Guidance
for
aspiration
of
cyst
of
Unspecified
body
region
|
|
24672-8
|
Diaphragm
US
for
motion
|
|
24673-6
|
Duodenum
Fluoroscopy
W
contrast
PO
and
hypotonic
agent
per
ng
|
|
24674-4
|
Elbow
MR
|
|
24675-1
|
Elbow
MR
WO
and
W
contrast
IV
|
|
24676-9
|
Elbow
X-ray
|
|
24677-7
|
Pelvis
US
transvaginal
|
|
24678-5
|
Esophagus
Fluoroscopy
W
contrast
PO
|
|
24679-3
|
Esophagus
Fluoroscopy
W
gastrografin
PO
|
|
2468-7
|
IgG
subclass
3
[Mass/volume]
in
Serum
|
|
24680-1
|
Fluoroscopy
Guidance
for
dilation
of
Esophagus
|
|
24681-9
|
Esophagus
and
Hypopharynx
Fluoroscopy
video
W
contrast
PO
during
swallowing
|
|
24682-7
|
Esophagus
and
Hypopharynx
Fluoroscopy
video
W
liquid
and
paste
contrast
PO
during
swallowing
|
|
24683-5
|
Esophagus+Stomach
NM
W
Tc-99m
SC
PO
|
|
24684-3
|
Extracranial
vessels
Fluoroscopic
angiogram
Embolectomy
W
contrast
IA
|
|
24685-0
|
Peripheral
veins
Fluoroscopic
angiogram
W
contrast
IV
|
|
24686-8
|
Lower
extremity
X-ray
|
|
24687-6
|
Lower
Extremity
Joint
MR
|
|
24688-4
|
Upper
extremity
MR
|
|
24689-2
|
Upper
extremity
X-ray
|
|
2469-5
|
IgG
subclass
4
[Mass/volume]
in
Serum
|
|
24690-0
|
Extremity
CT
|
|
24691-8
|
Extremity
CT
W
contrast
IV
|
|
24692-6
|
US
Guidance
for
drainage
of
Extremity
|
|
24693-4
|
Extremity
US
|
|
24694-2
|
Face
MR
WO
and
W
contrast
IV
|
|
24695-9
|
Facial
bones
X-ray
|
|
24696-7
|
Facial
bones
CT
|
|
24697-5
|
Facial
bones
CT
W
contrast
IV
|
|
24698-3
|
Femoral
artery
Fluoroscopic
angiogram
Angioplasty
W
contrast
IA
|
|
24699-1
|
Femoral
artery
Fluoroscopic
angiogram
runoff
W
contrast
IA
|
|
24700-7
|
Femur
and
Tibia
X-ray
for
leg
length
|
|
24702-3
|
Thigh
MR
|
|
24703-1
|
Thigh
MR
WO
and
W
contrast
IV
|
|
24704-9
|
Femur
X-ray
|
|
24705-6
|
Finger
MR
|
|
24706-4
|
Finger
X-ray
|
|
24707-2
|
Foot
MR
|
|
24708-0
|
Foot
X-ray
standing
|
|
24709-8
|
Foot
X-ray
|
|
2471-1
|
IgM
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
24710-6
|
Forearm
MR
|
|
24711-4
|
Gallbladder
US
|
|
24712-2
|
Gallbladder
X-ray
W
contrast
PO
|
|
24713-0
|
Gallbladder
X-ray
48
hours
post
contrast
PO
|
|
24714-8
|
Gastrointestinal
tract
NM
for
gastrointestinal
bleeding
W
Tc-99m
tagged
RBC
IV
|
|
24715-5
|
Gastrointestinal
tract
upper
Fluoroscopy
Single
view
W
contrast
PO
|
|
24716-3
|
Fluoroscopy
Guidance
for
placement
of
decompression
tube
in
Gastrointestinal
tract
|
|
24717-1
|
Ileal
conduit
X-ray
Loopogram
|
|
24718-9
|
Fluoroscopy
Guidance
for
transjugular
biopsy
of
Liver--
W
contrast
IV
|
|
24719-7
|
Groin
US
|
|
2472-9
|
IgM
[Mass/volume]
in
Serum
or
Plasma
|
|
24720-5
|
Hand
MR
|
|
24721-3
|
Hand
X-ray
2
views
|
|
24722-1
|
Hand
X-ray
3
views
|
|
24723-9
|
Hand
X-ray
arthritis
|
|
24724-7
|
Wrist
and
Hand
X-ray
bone
age
|
|
24725-4
|
Head
CT
|
|
24726-2
|
Head
CT
WO
and
W
contrast
IV
|
|
24727-0
|
Head
CT
W
contrast
IV
|
|
24728-8
|
Head
CT
perfusion
|
|
24729-6
|
Head
CT
perfusion
WO
and
W
contrast
IV
|
|
2473-7
|
IgM.monoclonal
[Mass/volume]
in
Serum
|
|
24730-4
|
Brain
NM
|
|
24731-2
|
Head
US
|
|
24732-0
|
Head
US
during
surgery
|
|
24733-8
|
Head
vessels
US.doppler
|
|
24734-6
|
Cerebral
cisterns
CT
W
contrast
IT
|
|
24735-3
|
Internal
auditory
canal
and
Posterior
fossa
MR
|
|
2474-5
|
Indicans
[Presence]
in
Urine
|
|
24740-3
|
Internal
auditory
canal
and
Posterior
fossa
MR
WO
and
W
contrast
IV
|
|
24745-2
|
Petrous
bone
X-ray
|
|
24746-0
|
Deprecated
Head
Sagittal
Sinus
MR
|
|
24747-8
|
Deprecated
Head
Sagittal
Sinus
MR
angiogram
W
contrast
IV
|
|
24748-6
|
Heart
MR
|
|
2475-2
|
Indicans
[Mass/volume]
in
Urine
|
|
24750-2
|
Heart
NM
at
rest
and
W
Tl-201
IV
|
|
24751-0
|
Parathyroid
gland
NM
W
TI-201
subtraction
Tc-99m
IV
|
|
24752-8
|
Heart
Fluoroscopy
video
|
|
24753-6
|
Unspecified
body
region
CT
W
contrast
IV
|
|
24754-4
|
Administration
of
vasodilator
into
catheter
of
Vein
|
|
24755-1
|
Fluoroscopic
angiogram
Guidance
for
atherectomy
of
Vein--
W
contrast
IV
|
|
24756-9
|
Fluoroscopic
angiogram
Guidance
for
placement
of
stent
in
Vein
|
|
24757-7
|
Deprecated
Coronary
arteries
CT
fast
|
|
2476-0
|
Indolamine
[Mass/volume]
in
Serum
|
|
24760-1
|
Hip
US
|
|
24761-9
|
Hip
X-ray
Single
view
|
|
24762-7
|
Hip
X-ray
|
|
24764-3
|
Hip
Fluoroscopy
Arthrogram
|
|
24765-0
|
Humerus
X-ray
2
views
|
|
24766-8
|
Iliac
artery
Fluoroscopic
angiogram
Angioplasty
W
contrast
IA
|
|
24767-6
|
Internal
auditory
canal
X-ray
tomograph
|
|
24769-2
|
CT
Guidance
for
injection
of
Joint
space
|
|
2477-8
|
Indole
[Mass/volume]
in
Serum
|
|
24770-0
|
Joint
NM
W
In-111
Intrajoint
|
|
24771-8
|
Fluoroscopy
Guidance
for
aspiration
of
Joint
space
|
|
24772-6
|
US
Guidance
for
biopsy
of
Kidney
|
|
24773-4
|
Kidney
NM
W
radionuclide
transplant
scan
|
|
24774-2
|
Deprecated
Kidney
-
bilateral
and
Collecting
system
CT
|
|
24775-9
|
Deprecated
Kidney
-
bilateral
and
Collecting
system
CT
W
contrast
IV
|
|
24776-7
|
Kidney
NM
|
|
24777-5
|
Deprecated
Kidney
-
bilateral
and
Collecting
system
US
|
|
24778-3
|
Kidney
-
bilateral
X-ray
3
views
serial
WO
and
W
contrast
IV
|
|
24779-1
|
Fluoroscopy
Guidance
for
placement
of
percutaneous
nephrostomy
in
Kidney
-
bilateral--
W
contrast
via
tube
|
|
2478-6
|
Inhibin
[Mass/volume]
in
Serum
or
Plasma
|
|
24780-9
|
Kidney
-
bilateral
Fluoroscopy
W
contrast
via
nephrostomy
tube
|
|
24781-7
|
Fluoroscopy
Guidance
for
exchange
of
percutaneous
nephrostomy
tube
of
Kidney
-
bilateral--
W
contrast
|
|
24782-5
|
Fluoroscopy
Guidance
for
placement
of
percutaneous
nephroureteral
stent
in
Kidney
-
bilateral--
W
contrast
via
stent
|
|
24783-3
|
Kidney
-
bilateral
Fluoroscopy
Urodynamics
|
|
24784-1
|
Kidney
-
bilateral
X-ray
tomograph
WO
and
W
contrast
IV
|
|
24785-8
|
deprecated
Kidney
-
bilateral
&
Collecting
system
X-ray
tomograph
Single
view
|
|
24786-6
|
Deprecated
Kidney
Bilateral
&
Collecting
system
X-ray
tomograph
Multisection
W
&
WO
contrast
IV
|
|
24787-4
|
Kidney
-
bilateral
X-ray
tomograph
WO
contrast
and
10M
post
contrast
IV
|
|
24788-2
|
Kidney
-
bilateral
X-ray
W
contrast
IV
|
|
24789-0
|
Kidney
-
bilateral
X-ray
tomograph
|
|
2479-4
|
Inosine
[Mass/volume]
in
Serum
|
|
24790-8
|
Kidney
-
bilateral
X-ray
tomograph
W
contrast
IV
|
|
24791-6
|
Deprecated
Kidney
Bilateral
&
Collecting
system
X-ray
tomograph
Multisection
|
|
24792-4
|
Abdomen
X-ray
AP
and
AP
left
lateral-decubitus
portable
|
|
24793-2
|
Abdomen
X-ray
AP
and
lateral
portable
|
|
24794-0
|
Abdomen
X-ray
AP
and
lateral
|
|
24795-7
|
Abdomen
X-ray
AP
(supine
and
upright)
portable
|
|
24796-5
|
Abdomen
X-ray
AP
and
AP
left
lateral-decubitus
|
|
24797-3
|
Abdomen
X-ray
AP
and
oblique
prone
|
|
24798-1
|
Abdomen
X-ray
AP
(supine
and
upright)
|
|
24799-9
|
Abdomen
X-ray
AP
single
view
|
|
2480-2
|
Inositol
Free
[Mass/volume]
in
Serum
|
|
24800-5
|
Knee
Fluoroscopy
Arthrogram
|
|
24801-3
|
Knee
X-ray
Merchants
|
|
24802-1
|
Knee
MR
|
|
24803-9
|
Knee
MR
WO
and
W
contrast
IV
|
|
24804-7
|
Knee
NM
|
|
24805-4
|
Knee
X-ray
AP
and
lateral
standing
|
|
24806-2
|
Knee
X-ray
2
views
|
|
24807-0
|
Knee
X-ray
AP
single
view
standing
|
|
24808-8
|
Knee
X-ray
AP
and
PA
standing
|
|
24809-6
|
Knee
X-ray
standing
|
|
2481-0
|
Insulin
Ab
[Presence]
in
Serum
|
|
24811-2
|
CT
Guidance
for
aspiration
of
Liver
|
|
24812-0
|
CT
Guidance
for
biopsy
of
Liver
|
|
24813-8
|
CT
Guidance
for
core
needle
biopsy
of
Liver
|
|
24814-6
|
Liver
CT
|
|
24815-3
|
Liver
CT
W
contrast
IV
|
|
24816-1
|
US
Guidance
for
biopsy
of
Liver
|
|
24817-9
|
Liver
SPECT
W
Tc-99m
IV
|
|
24818-7
|
Diaphragm
and
Liver
US
|
|
24819-5
|
Deprecated
Liver
and
Spleen
NM
W
Tc-99m
calcium
colloid
IV
|
|
2482-8
|
Insulin
Ab
[Mass/volume]
in
Serum
|
|
24820-3
|
Lower
leg
vessels
MR
angiogram
W
contrast
IV
|
|
24821-1
|
Lower
leg
MR
|
|
24822-9
|
CT
Guidance
for
aspiration
of
Lung
|
|
24823-7
|
CT
Guidance
for
biopsy
of
Lung
|
|
24824-5
|
Lung
NM
portable
|
|
24825-2
|
Lung
X-ray
W
contrast
intrabronchial
|
|
24826-0
|
Lymphatic
vessels
NM
W
radionuclide
intra
lymphatic
|
|
24827-8
|
Lymphatics
Fluoroscopy
W
contrast
intra
lymphatic
|
|
24828-6
|
Mandible
X-ray
tomograph
panoramic
|
|
24829-4
|
Mandible
X-ray
|
|
2483-6
|
Insulin-like
growth
factor
binding
protein
3
[Mass/volume]
in
Serum
or
Plasma
|
|
24830-2
|
Mastoid
X-ray
|
|
24831-0
|
Small
bowel
NM
for
Meckel's
diverticulum
W
Tc-99m
M04
IV
|
|
24832-8
|
Mesenteric
artery
Fluoroscopic
angiogram
Angioplasty
W
contrast
IA
|
|
24833-6
|
Mesenteric
artery
Fluoroscopic
angiogram
W
contrast
IA
|
|
24834-4
|
Nasal
bones
X-ray
|
|
24835-1
|
Nasopharynx
and
Neck
CT
|
|
24836-9
|
Nasopharynx
and
Neck
CT
W
contrast
IV
|
|
24837-7
|
CT
Guidance
for
aspiration
of
Neck
|
|
24838-5
|
CT
Guidance
for
biopsy
of
Neck
|
|
24839-3
|
Neck
MR
|
|
2484-4
|
Insulin-like
growth
factor-I
[Mass/volume]
in
Serum
or
Plasma
|
|
24840-1
|
Neck
MR
WO
and
W
contrast
IV
|
|
24841-9
|
Neck
MR
W
contrast
IV
|
|
24842-7
|
Neck
US
|
|
24843-5
|
Neck
X-ray
lateral
|
|
24844-3
|
Neck
vessels
MR
angiogram
W
contrast
IV
|
|
24845-0
|
Neck
Fluoroscopy
W
contrast
intra
larynx
|
|
24846-8
|
Optic
foramen
X-ray
|
|
24848-4
|
Orbit
-
bilateral
CT
|
|
24849-2
|
Orbit
-
bilateral
CT
WO
and
W
contrast
IV
|
|
2485-1
|
Insulin-like
growth
factor-II
[Mass/volume]
in
Serum
or
Plasma
|
|
24850-0
|
Orbit
-
bilateral
CT
W
contrast
IV
|
|
24851-8
|
Orbit
-
bilateral
MR
WO
and
W
contrast
IV
|
|
24852-6
|
Orbit
-
bilateral
MR
W
contrast
IV
|
|
24853-4
|
Eye+Orbit
-
bilateral
US
|
|
24854-2
|
Orbit
-
bilateral
X-ray
|
|
24855-9
|
Oropharynx
Fluoroscopy
video
|
|
24856-7
|
CT
Guidance
for
aspiration
of
Pancreas
|
|
24857-5
|
Pancreas
CT
|
|
24858-3
|
Pancreas
CT
W
contrast
IV
|
|
24859-1
|
Pancreas
US
|
|
2486-9
|
Somatomedins
[Mass/volume]
in
Serum
or
Plasma
|
|
24860-9
|
Pancreatic
artery
Fluoroscopic
angiogram
W
contrast
IA
|
|
24861-7
|
Patella
X-ray
2
views
|
|
24862-5
|
Iliac
artery
Internal
Fluoroscopic
angiogram
W
contrast
IA
|
|
24863-3
|
CT
Guidance
for
aspiration
of
Pelvis
|
|
24864-1
|
CT
Guidance
for
biopsy
of
Pelvis
|
|
24865-8
|
Pelvis
CT
|
|
24866-6
|
Pelvis
CT
W
contrast
IV
|
|
24867-4
|
Pelvis
MR
|
|
24868-2
|
US
Guidance
for
drainage
of
Pelvis
|
|
24869-0
|
Pelvis
US
|
|
2487-7
|
Inter
alpha
trypsin
inhibitor
[Mass/volume]
in
Serum
|
|
24870-8
|
Pelvis
vessels
US.doppler
|
|
24871-6
|
Pelvis
X-ray
pelvimetry
|
|
24872-4
|
Pelvis
and
Hip
MR
|
|
24873-2
|
Pelvis
vessels
MR
angiogram
W
contrast
IV
|
|
24874-0
|
Peripheral
arteries
Fluoroscopic
angiogram
W
contrast
IA
|
|
24875-7
|
Deprecated
Peripheral
vessel
US.doppler
Peripheral
plane
|
|
24876-5
|
Head
to
Pelvis
NM
for
shunt
patency
W
Tc-99m
DTPA
IT
|
|
24877-3
|
Petrous
part
of
temporal
bone
CT
|
|
24878-1
|
Petrous
part
of
temporal
bone
CT
W
contrast
IV
|
|
24879-9
|
Pituitary
and
Sella
turcica
MR
WO
and
W
contrast
IV
|
|
2488-5
|
Intrinsic
factor
[Mass/volume]
in
Serum
|
|
24880-7
|
Pituitary
and
Sella
turcica
MR
|
|
24881-5
|
Popliteal
space
US
|
|
24882-3
|
Popliteal
artery
Fluoroscopic
angiogram
Percutaneous
transluminal
angioplasty
of
vessel
W
contrast
IA
|
|
24883-1
|
US
Guidance
for
biopsy
of
Prostate
|
|
24884-9
|
Prostate
US
|
|
24885-6
|
Deprecated
US
Guidance
for
repair
of
Pseudoaneurysm/AV
fistula
|
|
24886-4
|
Deprecated
Pulmonary
artery
Bilateral
X-ray
fluoroscopy
angio
W
contrast
IA
|
|
24887-2
|
Pulmonary
arteries
Fluoroscopic
angiogram
Embolectomy
W
contrast
IA
|
|
24888-0
|
Pulmonary
system
NM
ventilation
and
perfusion
W
Xe-133
IH
and
W
Tc-99m
MAA
IV
|
|
24889-8
|
Pylorus
US
for
Pyloric
Stenosis
|
|
2489-3
|
Intrinsic
factor
blocking
Ab
[Titer]
in
Serum
|
|
24891-4
|
Radius
and
Ulna
X-ray
|
|
24892-2
|
Rectum
US
|
|
24893-0
|
Rectum
Fluoroscopy
post
contrast
PR
during
defecation
|
|
24894-8
|
Rectum
and
Urinary
bladder
Fluoroscopy
W
contrast
PR
and
intra
bladder
during
defecation
and
voiding
|
|
24896-3
|
US
Guidance
for
drainage
of
Kidney
|
|
24899-7
|
Ribs
X-ray
|
|
2490-1
|
Inulin
[Mass/volume]
in
Serum
or
Plasma
|
|
24900-3
|
Sacroiliac
Joint
X-ray
|
|
24901-1
|
CT
Guidance
for
injection
of
Sacroiliac
Joint
|
|
24902-9
|
Salivary
gland
Fluoroscopy
W
contrast
intra
salivary
duct
|
|
24903-7
|
Scapula
X-ray
|
|
24904-5
|
Pituitary
and
Sella
turcica
CT
WO
and
W
contrast
IV
|
|
24905-2
|
Shoulder
MR
|
|
24906-0
|
Shoulder
MR
WO
and
W
contrast
IV
|
|
24907-8
|
Shoulder
US
|
|
24908-6
|
Shoulder
X-ray
3
views
|
|
24909-4
|
Shoulder
X-ray
|
|
2491-9
|
Inulin
renal
clearance
in
24
hour
|
|
24910-2
|
Shoulder
Fluoroscopy
Arthrogram
|
|
24911-0
|
Shunt
Fluoroscopy
|
|
24912-8
|
Sinus
tract
Fluoroscopy
W
contrast
intra
sinus
tract
|
|
24913-6
|
Sinuses
CT
limited
|
|
24914-4
|
Sinuses
MR
|
|
24915-1
|
Sinuses
MR
W
contrast
IV
|
|
24916-9
|
Sinuses
X-ray
|
|
24917-7
|
Skull
X-ray
Single
view
|
|
24918-5
|
Skull
X-ray
3
views
|
|
24919-3
|
Skull
X-ray
AP
and
lateral
|
|
2492-7
|
Iodine
[Mass/time]
in
24
hour
Urine
|
|
24920-1
|
Skull
X-ray
lateral
|
|
24921-9
|
Skull
X-ray
Waters
|
|
24922-7
|
Skull
X-ray
5
views
|
|
24923-5
|
Small
bowel
Fluoroscopy
W
positive
contrast
via
enteroclysis
tube
|
|
24924-3
|
Small
bowel
Fluoroscopy
W
contrast
PO
|
|
24925-0
|
Spinal
artery
Fluoroscopic
angiogram
W
contrast
IA
|
|
24926-8
|
Spine
US
|
|
24927-6
|
Spine
Fluoroscopy
W
contrast
intradisc
|
|
24928-4
|
Spine
X-ray
AP
and
lateral
|
|
24929-2
|
Spine
Thoracic
and
Lumbar
X-ray
scoliosis
W
flexion
and
W
extension
|
|
2493-5
|
Iodine
Free
[Mass/volume]
in
Urine
|
|
24930-0
|
Spine
Thoracic
and
Lumbar
X-ray
scoliosis
|
|
24931-8
|
Fluoroscopy
Guidance
for
injection
of
Spine
facet
joint
|
|
24932-6
|
Cervical
spine
CT
|
|
24933-4
|
Cervical
spine
CT
W
contrast
IV
|
|
24934-2
|
Cervical
spine
CT
W
contrast
IT
|
|
24935-9
|
Cervical
spine
MR
|
|
24936-7
|
Cervical
spine
MR
W
anesthesia
|
|
24937-5
|
Cervical
spine
MR
WO
and
W
contrast
IV
|
|
24938-3
|
Cervical
spine
MR
W
contrast
IV
|
|
24939-1
|
Cervical
spine
X-ray
5
views
|
|
2494-3
|
Iodine
[Mass/volume]
in
Serum
or
Plasma
|
|
24940-9
|
Cervical
spine
X-ray
Single
view
|
|
24941-7
|
Cervical
spine
X-ray
3
views
|
|
24942-5
|
Cervical
spine
X-ray
AP
and
lateral
|
|
24943-3
|
Cervical
spine
X-ray
lateral
|
|
24944-1
|
Cervical
spine
X-ray
Swimmers
|
|
24945-8
|
Cervical
spine
X-ray
W
flexion
and
W
extension
|
|
24946-6
|
Cervical
spine
X-ray
|
|
24947-4
|
Cervical
spine
Fluoroscopy
W
contrast
IT
|
|
24948-2
|
Spine
Cervical
Odontoid
and
Cervical
axis
X-ray
AP
single
view
|
|
2495-0
|
Iodine
[Mass/volume]
in
Urine
|
|
2496-8
|
Iodohippuran
renal
clearance
in
24
hour
|
|
24963-1
|
Lumbar
spine
CT
|
|
24964-9
|
Lumbar
spine
CT
W
contrast
IV
|
|
24965-6
|
Lumbar
spine
CT
W
contrast
IT
|
|
24967-2
|
Lumbar
spine
MR
WO
and
W
contrast
IV
|
|
24968-0
|
Lumbar
spine
MR
|
|
24969-8
|
Lumbar
spine
X-ray
lateral
|
|
2497-6
|
Iron
[Mass/mass]
in
Hair
|
|
24970-6
|
Lumbar
spine
X-ray
AP
and
lateral
|
|
24971-4
|
Lumbar
spine
X-ray
W
flexion
and
W
extension
|
|
24972-2
|
Lumbar
spine
X-ray
|
|
24973-0
|
Fluoroscopy
Guidance
for
aspiration
of
Spine
Lumbar
Space
|
|
24974-8
|
Lumbar
spine
Fluoroscopy
W
contrast
IT
|
|
24975-5
|
Spine.lumbar
and
Sacroiliac
joint
-
bilateral
X-ray
|
|
24977-1
|
Lumbar
spine
MR
W
anesthesia
|
|
24978-9
|
Thoracic
spine
CT
|
|
24979-7
|
Thoracic
spine
CT
W
contrast
IV
|
|
2498-4
|
Iron
[Mass/volume]
in
Serum
or
Plasma
|
|
24980-5
|
Thoracic
spine
MR
|
|
24981-3
|
Thoracic
spine
MR
WO
and
W
contrast
IV
|
|
24982-1
|
Thoracic
spine
MR
W
contrast
IV
|
|
24983-9
|
Thoracic
spine
X-ray
|
|
24984-7
|
Spine
Thoracic
and
Lumbar
X-ray
2
views
|
|
24985-4
|
Thoracic
spine
Fluoroscopy
W
contrast
IT
|
|
24986-2
|
CT
Guidance
for
biopsy
of
Spine
|
|
24987-0
|
Spine
CT
W
contrast
IV
|
|
24988-8
|
Spleen
CT
|
|
24989-6
|
Spleen
CT
WO
and
W
contrast
IV
|
|
2499-2
|
Iron
[Mass/time]
in
24
hour
Urine
|
|
24990-4
|
Spleen
US
|
|
24991-2
|
Splenic
vein
and
Portal
vein
Fluoroscopic
angiogram
W
contrast
IA
|
|
24992-0
|
Splenic
artery
Fluoroscopic
angiogram
W
contrast
IA
|
|
24993-8
|
Sternoclavicular
Joints
X-ray
|
|
24994-6
|
Sternum
X-ray
|
|
24995-3
|
Fluoroscopy
Guidance
for
placement
of
tube
in
Stomach
|
|
24996-1
|
Fluoroscopy
Guidance
for
replacement
of
percutaneous
gastrostomy
in
Stomach
|
|
24997-9
|
Stomach
NM
for
gastric
emptying
solid
phase
W
Tc-99m
SC
PO
|
|
24998-7
|
Placement
check
of
gastrostomy
tube
W
contrast
via
GI
tube
|
|
24999-5
|
Temporomandibular
joint
MR
|
|
2500-7
|
Iron
binding
capacity
[Mass/volume]
in
Serum
or
Plasma
|
|
25000-1
|
Temporomandibular
joint
X-ray
|
|
25001-9
|
Scrotum
and
Testicle
NM
W
Tc-99m
pertechnetate
IV
|
|
25002-7
|
Scrotum
and
Testicle
US
|
|
25003-5
|
Thigh
vessels
MR
angiogram
W
contrast
IV
|
|
25004-3
|
Deprecated
Thigh
MRI
Multisection
|
|
25005-0
|
Three
vessels
Fluoroscopic
angiogram
W
contrast
|
|
25006-8
|
Thumb
X-ray
|
|
25007-6
|
Thyroid
gland
NM
W
I-131
IV
|
|
25008-4
|
Thyroid
gland
NM
and
uptake
W
I-131
IV
|
|
25009-2
|
US
Guidance
for
biopsy
of
Thyroid
gland
|
|
2501-5
|
Iron
binding
capacity.unsaturated
[Mass/volume]
in
Serum
or
Plasma
|
|
25010-0
|
Thyroid
gland
US
|
|
25011-8
|
Tibia
and
Fibula
X-ray
|
|
25012-6
|
Tibial
artery
Fluoroscopic
angiogram
Angioplasty
W
contrast
IA
|
|
25013-4
|
Toes
X-ray
|
|
25014-2
|
Two
vessels
Fluoroscopic
angiogram
W
contrast
|
|
25015-9
|
Upper
GI
tract
Replacement
of
percutaneous
gastrojejunostomy
|
|
25016-7
|
Urethra
Fluoroscopy
W
contrast
intra
urethra
|
|
25017-5
|
Urinary
bladder
and
Urethra
Fluoroscopy
W
contrast
intra
bladder
|
|
25018-3
|
Urinary
bladder
NM
|
|
25019-1
|
Urinary
bladder
US
|
|
2502-3
|
Iron
saturation
[Mass
Fraction]
in
Serum
or
Plasma
|
|
25020-9
|
Urinary
bladder
and
Urethra
Fluoroscopy
W
contrast
retrograde
via
urethra
|
|
25021-7
|
Deprecated
Urinary
Bladder
&
Urethra
Fluoroscopy
W
voiding
|
|
25022-5
|
Uterus
and
Fallopian
tubes
Fluoroscopy
W
contrast
IU
|
|
25023-3
|
Vein
Fluoroscopic
angiogram
W
contrast
IV
|
|
25024-1
|
Fluoroscopic
angiogram
Guidance
for
placement
of
peripherally-inserted
central
venous
catheter
in
Vein
|
|
25025-8
|
Vena
cava
Fluoroscopic
angiogram
W
contrast
IV
|
|
25026-6
|
Fluoroscopic
angiogram
Guidance
for
placement
of
IVC
filter
in
Inferior
vena
cava--
W
contrast
IV
|
|
25027-4
|
Guidance
for
placement
of
large
bore
central
venous
catheter
in
Vein
|
|
25028-2
|
Fluoroscopic
angiogram
Guidance
for
placement
of
catheter
for
adminstration
of
thrombolytic
in
Vessel--
W
contrast
intravascular
|
|
25029-0
|
Fluoroscopic
angiogram
Guidance
for
placement
of
catheter
for
vasoconstrictor
infusion
in
Vessels
|
|
2503-1
|
Iron.chelated
[Mass/volume]
in
Urine
|
|
25030-8
|
Abdominal
Arteries
Fluoroscopic
angiogram
W
contrast
IA
|
|
25031-6
|
Bone
NM
|
|
25032-4
|
Bone
NM
W
In-111
tagged
WBC
IV
|
|
25033-2
|
Wrist
MR
|
|
25034-0
|
Wrist
Fluoroscopy
Arthrogram
|
|
25035-7
|
Wrist
MR
WO
and
W
contrast
IV
|
|
25036-5
|
Wrist
US
|
|
25037-3
|
Deprecated
Wrist
X-ray
|
|
25039-9
|
Unspecified
body
region
CT
limited
|
|
2504-9
|
Iron
[Mass/volume]
in
Urine
|
|
25040-7
|
Deprecated
Unspecified
body
region
CT
3D
|
|
25041-5
|
CT
Guidance
for
aspiration
or
biopsy
of
Unspecified
body
region--
W
contrast
IV
|
|
25042-3
|
CT
Guidance
for
aspiration
or
biopsy
of
Unspecified
body
region
|
|
25043-1
|
CT
Guidance
for
aspiration
of
Unspecified
body
region
|
|
25044-9
|
CT
Guidance
for
biopsy
of
Unspecified
body
region
|
|
25045-6
|
Unspecified
body
region
CT
|
|
25046-4
|
Unspecified
body
region
CT
W
anesthesia
|
|
25047-2
|
Unspecified
body
region
CT
W
conscious
sedation
|
|
25049-8
|
Deprecated
Unspecified
body
region
CT
3D
multiple
sagittal
&
coronal
|
|
25050-6
|
Deprecated
Unspecified
body
region
CT
3D
sagittal
and
coronal
disarticulation
|
|
25051-4
|
Deprecated
Unspecified
body
region
CT
Multisectional
sagittal
|
|
25052-2
|
Deprecated
Unspecified
body
region
CT
sagittal
and
coronal
|
|
25053-0
|
CT
Guidance
for
radiosurgery
of
Unspecified
body
region
|
|
25054-8
|
CT
Guidance
for
radiosurgery
of
Unspecified
body
region--
W
contrast
IV
|
|
25055-5
|
Deprecated
Unspecified
body
region
MR
additional
sequence
|
|
25056-3
|
Unspecified
body
region
MR
|
|
25057-1
|
Unspecified
body
region
MR
W
conscious
sedation
|
|
25058-9
|
Unspecified
body
region
MR
angiogram
W
contrast
IV
|
|
25059-7
|
US
Guidance
for
biopsy
of
Unspecified
body
region
|
|
2506-4
|
Isocitrate
dehydrogenase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
25060-5
|
Unspecified
body
region
US
No
charge
|
|
25061-3
|
Unspecified
body
region
US
|
|
25062-1
|
Unspecified
body
region
X-ray
Comparison
view
|
|
25063-9
|
Vessel
Fluoroscopic
angiogram
Single
view
W
contrast
IA
|
|
25064-7
|
Vessel
Fluoroscopic
angiogram
Angioplasty
W
contrast
IA
|
|
25069-6
|
Fluoroscopy
Guidance
for
biopsy
of
Unspecified
body
region
|
|
25070-4
|
Unspecified
body
region
Fluoroscopy
during
surgery
|
|
25071-2
|
Unspecified
body
region
X-ray
tomograph
|
|
25072-0
|
Guidance
for
placement
of
infusion
port
in
Unspecified
body
region
|
|
25073-8
|
Vessel
Fluoroscopic
angiogram
Removal
of
foreign
body
from
vascular
space
|
|
25074-6
|
Zygomatic
arch
X-ray
|
|
25076-1
|
Hepatic
artery
Fluoroscopic
angiogram
W
contrast
IA
|
|
25077-9
|
Fluoroscopic
angiogram
Guidance
for
placement
of
catheter
in
Hepatic
artery--
W
contrast
IA
|
|
25078-7
|
Fluoroscopy
Guidance
for
placement
of
stent
in
Intrahepatic
portal
system
|
|
25079-5
|
Kidney
arteries
Fluoroscopic
angiogram
W
contrast
IA
|
|
25080-3
|
Renal
vein
-
bilateral
Fluoroscopic
angiogram
W
contrast
IV
and
W
renin
sampling
|
|
25081-1
|
Renal
vessel
Fluoroscopic
angiogram
Angioplasty
W
contrast
IA
|
|
25083-7
|
2-Oxo,3-Methylvalerate/Creatinine
[Molar
ratio]
in
Urine
|
|
25088-6
|
4-Hydroxyphenylacetate/Creatinine
[Molar
ratio]
in
Urine
|
|
25090-2
|
Benzoate/Creatinine
[Molar
ratio]
in
Urine
|
|
25091-0
|
C
peptide/Creatinine
[Molar
ratio]
in
Urine
|
|
25095-1
|
Deoxypyridinoline/Creatinine
[Molar
ratio]
in
Urine
|
|
25096-9
|
Deoxypyridinoline/Creatinine
[Molar
ratio]
in
2
hour
Urine
|
|
25099-3
|
Ethylmalonate/Creatinine
[Molar
ratio]
in
Urine
|
|
25100-9
|
Formate/Creatinine
[Molar
ratio]
in
Urine
|
|
25101-7
|
Fumarate/Creatinine
[Molar
ratio]
in
Urine
|
|
25102-5
|
Galactose/Creatinine
[Molar
ratio]
in
Urine
|
|
25103-3
|
Glutaconate/Creatinine
[Molar
ratio]
in
Urine
|
|
25104-1
|
Glutarate/Creatinine
[Molar
ratio]
in
Urine
|
|
25105-8
|
Glycerate/Creatinine
[Molar
ratio]
in
Urine
|
|
25106-6
|
Glycolate/Creatinine
[Molar
ratio]
in
Urine
|
|
25107-4
|
Glyoxylate/Creatinine
[Molar
ratio]
in
Urine
|
|
2511-4
|
Keratan
sulfate
[Mass/volume]
in
Blood
|
|
25110-8
|
Hydroxyproline/Creatinine
[Molar
ratio]
in
Urine
|
|
25111-6
|
Isocitrate/Creatinine
[Molar
ratio]
in
Urine
|
|
25112-4
|
Lactate/Creatinine
[Molar
ratio]
in
Urine
|
|
25113-2
|
Malate/Creatinine
[Molar
ratio]
in
Urine
|
|
25115-7
|
Methylmalonate/Creatinine
[Molar
ratio]
in
24
hour
Urine
|
|
25116-5
|
Methylmalonate/Creatinine
[Molar
ratio]
in
Urine
|
|
25117-3
|
Methylsuccinate/Creatinine
[Molar
ratio]
in
Urine
|
|
25118-1
|
Mevalonate/Creatinine
[Molar
ratio]
in
Urine
|
|
25119-9
|
N-acetyltyrosine/Creatinine
[Molar
ratio]
in
Urine
|
|
2512-2
|
Keratan
sulfate
[Mass/volume]
in
Urine
|
|
25123-1
|
Para
nitrophenol/Creatinine
[Molar
ratio]
in
Urine
|
|
25124-9
|
Phenylacetate/Creatinine
[Molar
ratio]
in
Urine
|
|
25125-6
|
Phenyllactate/Creatinine
[Molar
ratio]
in
Urine
|
|
25126-4
|
Phenylpyruvate/Creatinine
[Molar
ratio]
in
Urine
|
|
25129-8
|
Pyridinoline/Creatinine
[Molar
ratio]
in
Urine
|
|
2513-0
|
Ketones
[Presence]
in
Serum
or
Plasma
|
|
25130-6
|
Pyridinoline/Creatinine
[Molar
ratio]
in
24
hour
Urine
|
|
25131-4
|
Pyridinoline/Creatinine
[Molar
ratio]
in
2
hour
Urine
|
|
25132-2
|
Pyruvate/Creatinine
[Molar
ratio]
in
Urine
|
|
25135-5
|
Suberate/Creatinine
[Molar
ratio]
in
Urine
|
|
25136-3
|
Succinate/Creatinine
[Molar
ratio]
in
Urine
|
|
2514-8
|
Ketones
[Presence]
in
Urine
by
Test
strip
|
|
25140-5
|
Uracil/Creatinine
[Molar
ratio]
in
Urine
|
|
25141-3
|
Carnitine
esters/Creatinine
[Molar
ratio]
in
Urine
|
|
25142-1
|
5-Fluorocytosine
[Mass/volume]
in
Serum
or
Plasma
--peak
|
|
25143-9
|
5-Fluorocytosine
[Mass/volume]
in
Serum
or
Plasma
--trough
|
|
2515-5
|
Kynurenate
[Mass/volume]
in
Urine
|
|
2516-3
|
L-iditol
dehydrogenase
[Enzymatic
activity/volume]
in
Amniotic
fluid
|
|
25168-6
|
Perhexiline
[Mass/volume]
in
Serum
or
Plasma
|
|
25169-4
|
Nickel
[Moles/volume]
in
Blood
|
|
2517-1
|
L-iditol
dehydrogenase
[Enzymatic
activity/volume]
in
Serum
|
|
25170-2
|
Mercury
[Moles/volume]
in
Blood
|
|
25171-0
|
Bromide
[Moles/volume]
in
Blood
|
|
25172-8
|
Fluoride
[Moles/volume]
in
Blood
|
|
25173-6
|
Thallium
[Moles/volume]
in
Blood
|
|
2518-9
|
Lactate
[Moles/volume]
in
Arterial
blood
|
|
2519-7
|
Lactate
[Moles/volume]
in
Venous
blood
|
|
2520-5
|
Lactate
[Moles/volume]
in
Cerebral
spinal
fluid
|
|
2521-3
|
Lactate
[Presence]
in
Gastric
fluid
|
|
2522-1
|
Lactate
[Moles/volume]
in
Pleural
fluid
|
|
2523-9
|
Lactate
[Moles/volume]
in
Peritoneal
fluid
|
|
25232-0
|
Nafcillin
[Mass/volume]
in
Unspecified
specimen
|
|
25233-8
|
Azithromycin
[Mass/volume]
in
Unspecified
specimen
|
|
25234-6
|
Aztreonam
[Mass/volume]
in
Unspecified
specimen
|
|
25235-3
|
Cefazolin
[Mass/volume]
in
Unspecified
specimen
|
|
25236-1
|
Cefixime
[Mass/volume]
in
Unspecified
specimen
|
|
25237-9
|
Cefonicid
[Mass/volume]
in
Unspecified
specimen
|
|
25238-7
|
Cefotaxime
[Mass/volume]
in
Unspecified
specimen
|
|
25239-5
|
Cefotetan
[Mass/volume]
in
Unspecified
specimen
|
|
2524-7
|
Lactate
[Moles/volume]
in
Serum
or
Plasma
|
|
25240-3
|
Cefoxitin
[Mass/volume]
in
Unspecified
specimen
|
|
25241-1
|
Cefpodoxime
[Mass/volume]
in
Unspecified
specimen
|
|
25242-9
|
Cefsulodin
[Mass/volume]
in
Unspecified
specimen
|
|
25243-7
|
Ceftizoxime
[Mass/volume]
in
Unspecified
specimen
|
|
25244-5
|
Ceftriaxone
[Mass/volume]
in
Unspecified
specimen
|
|
25245-2
|
Cefuroxime
Parenteral
[Mass/volume]
in
Unspecified
specimen
|
|
25246-0
|
Cephalothin
[Mass/volume]
in
Unspecified
specimen
|
|
25247-8
|
Chloramphenicol
[Mass/volume]
in
Unspecified
specimen
|
|
25248-6
|
Ciprofloxacin
[Mass/volume]
in
Unspecified
specimen
|
|
25249-4
|
Clindamycin
[Mass/volume]
in
Unspecified
specimen
|
|
2525-4
|
Lactate
[Moles/volume]
in
Synovial
fluid
|
|
25250-2
|
Cloxacillin
[Mass/volume]
in
Unspecified
specimen
|
|
25251-0
|
Cycloserine
[Mass/volume]
in
Unspecified
specimen
|
|
25252-8
|
Dicloxacillin
[Mass/volume]
in
Unspecified
specimen
|
|
25253-6
|
Clarithromycin
[Mass/volume]
in
Unspecified
specimen
|
|
25254-4
|
Ticarcillin
[Mass/volume]
in
Unspecified
specimen
|
|
25255-1
|
Fluconazole
[Mass/volume]
in
Unspecified
specimen
|
|
25256-9
|
Ganciclovir
[Mass/volume]
in
Unspecified
specimen
|
|
25257-7
|
Imipenem
[Mass/volume]
in
Unspecified
specimen
|
|
25258-5
|
Itraconazole
[Mass/volume]
in
Unspecified
specimen
|
|
25259-3
|
Ketoconazole
[Mass/volume]
in
Unspecified
specimen
|
|
2526-2
|
Lactate
[Mass/time]
in
24
hour
Urine
|
|
25261-9
|
Nalidixate
[Mass/volume]
in
Unspecified
specimen
|
|
25262-7
|
Neomycin
[Mass/volume]
in
Unspecified
specimen
|
|
25263-5
|
Netilmicin
[Mass/volume]
in
Unspecified
specimen
|
|
25264-3
|
Ofloxacin
[Mass/volume]
in
Unspecified
specimen
|
|
25265-0
|
Oxacillin
[Mass/volume]
in
Unspecified
specimen
|
|
25266-8
|
Oxytetracycline
[Mass/volume]
in
Unspecified
specimen
|
|
25267-6
|
Penicillin
[Mass/volume]
in
Unspecified
specimen
|
|
25268-4
|
Piperacillin
[Mass/volume]
in
Unspecified
specimen
|
|
25269-2
|
Polymyxin
B
[Mass/volume]
in
Unspecified
specimen
|
|
2527-0
|
Lactate
dehydrogenase
[Enzymatic
activity/volume]
in
Amniotic
fluid
|
|
25270-0
|
Pyrazinamide
[Mass/volume]
in
Unspecified
specimen
|
|
25271-8
|
Sulfamethoxazole
[Mass/volume]
in
Unspecified
specimen
|
|
25272-6
|
Tetracycline
[Mass/volume]
in
Unspecified
specimen
|
|
25273-4
|
Trimethoprim+Sulfamethoxazole
[Mass/volume]
in
Unspecified
specimen
|
|
25274-2
|
Amoxicillin
[Mass/volume]
in
Unspecified
specimen
|
|
25275-9
|
Erythromycin
[Mass/volume]
in
Unspecified
specimen
|
|
2528-8
|
Lactate
dehydrogenase
[Enzymatic
activity/volume]
in
Cerebral
spinal
fluid
|
|
2529-6
|
Lactate
dehydrogenase
[Enzymatic
activity/volume]
in
Body
fluid
|
|
25297-3
|
Parainfluenza
virus
1
Ab
[Titer]
in
Serum
by
Complement
fixation
--2nd
specimen
|
|
2530-4
|
Lactate
dehydrogenase
[Enzymatic
activity/volume]
in
Pleural
fluid
|
|
25302-1
|
Alanine
aminotransferase
[Enzymatic
activity/volume]
in
Body
fluid
|
|
25303-9
|
Alpha
1
antitrypsin
[Mass/mass]
in
Stool
|
|
25308-8
|
Ammonia
[Moles/time]
in
24
hour
Urine
|
|
25309-6
|
Amobarbital
[Moles/volume]
in
Serum
or
Plasma
|
|
2531-2
|
Lactate
dehydrogenase
[Enzymatic
activity/volume]
in
Peritoneal
fluid
|
|
25311-2
|
Amylase
[Enzymatic
activity/volume]
in
24
hour
Urine
|
|
25314-6
|
Androstenediol
[Moles/time]
in
24
hour
Urine
|
|
25315-3
|
11-Deoxycortisol
[Moles/time]
in
24
hour
Urine
|
|
25316-1
|
17-Hydroxypregnenolone
[Moles/volume]
in
Serum
or
Plasma
|
|
25317-9
|
17-Ketosteroids
[Moles/volume]
in
24
hour
Urine
|
|
2532-0
|
Lactate
dehydrogenase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
25321-1
|
Antimony
[Moles/volume]
in
Serum
or
Plasma
|
|
25323-7
|
Arsenic
[Moles/volume]
in
Serum
or
Plasma
|
|
25324-5
|
Arsenic/Creatinine
[Molar
ratio]
in
Urine
|
|
25325-2
|
Ascaris
sp
IgE
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
2533-8
|
Lactate
dehydrogenase
[Enzymatic
activity/volume]
in
Synovial
fluid
|
|
25331-0
|
Bordetella
pertussis
IgG
Ab
[Titer]
in
Serum
|
|
25332-8
|
Bordetella
pertussis
IgM
Ab
[Titer]
in
Serum
|
|
25333-6
|
Campylobacter
fetus
Ab
[Titer]
in
Serum
|
|
25335-1
|
Coxiella
burnetii
IgG
Ab
[Titer]
in
Serum
|
|
25336-9
|
Coxiella
burnetii
IgM
Ab
[Titer]
in
Serum
|
|
25337-7
|
Taenia
solium
larva
IgG
Ab
[Units/volume]
in
Serum
|
|
25338-5
|
Dengue
virus
IgM
Ab
[Presence]
in
Serum
|
|
25339-3
|
Echinococcus
sp
Ab
[Presence]
in
Serum
|
|
2534-6
|
Lactate
dehydrogenase
[Enzymatic
activity/volume]
in
Urine
|
|
25342-7
|
Fasciola
sp
Ab
[Titer]
in
Serum
|
|
25343-5
|
Fasciola
sp
IgG
Ab
[Units/volume]
in
Serum
|
|
25344-3
|
Filaria
Ab
[Titer]
in
Serum
|
|
25349-2
|
Silver
Birch
IgG
Ab
[Units/volume]
in
Serum
|
|
25351-8
|
Bismuth
[Moles/volume]
in
Serum
or
Plasma
|
|
25352-6
|
Bordetella
pertussis
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
25353-4
|
Bordetella
pertussis
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
25354-2
|
Wheat
Bran
IgG
Ab
[Units/volume]
in
Serum
|
|
25357-5
|
Butabarbital
[Moles/volume]
in
Serum
or
Plasma
|
|
25358-3
|
C
peptide
[Moles/time]
in
24
hour
Urine
|
|
25359-1
|
Cadmium
[Moles/volume]
in
Serum
or
Plasma
|
|
25360-9
|
Cadmium
[Moles/volume]
in
Urine
|
|
25361-7
|
Caffeine
[Moles/volume]
in
Serum
or
Plasma
|
|
25362-5
|
Calcium
[Moles/volume]
in
24
hour
Urine
|
|
25363-3
|
Campylobacter
fetus
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
25364-1
|
Campylobacter
jejuni
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
25369-0
|
Chlamydia
sp
IgA
Ab
[Units/volume]
in
Serum
|
|
25372-4
|
Choriogonadotropin
[Units/volume]
in
Urine
|
|
25373-2
|
Choriogonadotropin.beta
subunit
free
[Mass/volume]
in
Serum
or
Plasma
|
|
25374-0
|
Chromium
[Moles/volume]
in
Serum
or
Plasma
|
|
25375-7
|
Chymotrypsin
[Enzymatic
activity/mass]
in
Stool
|
|
25378-1
|
Cobalt
[Moles/volume]
in
Serum
or
Plasma
|
|
25379-9
|
Cobalt
[Moles/time]
in
24
hour
Urine
|
|
25381-5
|
Corticosterone
[Moles/volume]
in
Serum
or
Plasma
|
|
25382-3
|
Cortisone
[Moles/volume]
in
Serum
or
Plasma
|
|
25384-9
|
Coxiella
burnetii
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
25385-6
|
Coxiella
burnetii
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
25386-4
|
Creatinine
[Moles/volume]
in
Body
fluid
|
|
25387-2
|
Cyanide
[Moles/volume]
in
Serum
or
Plasma
|
|
25389-8
|
Taenia
solium
larva
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
25390-6
|
Cytokeratin
19
[Mass/volume]
in
Serum
or
Plasma
|
|
25391-4
|
Dehydroepiandrosterone
(DHEA)
[Moles/time]
in
24
hour
Urine
|
|
25392-2
|
Dengue
virus
IgM
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
25393-0
|
Desethylamiodarone
[Moles/volume]
in
Serum
or
Plasma
|
|
25394-8
|
Nortrimipramine
[Moles/volume]
in
Serum
or
Plasma
|
|
25397-1
|
Echinococcus
sp
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
25398-9
|
Echinococcus
sp
Ab
[Units/volume]
in
Serum
by
Counterimmunoelectrophoresis
(CIE)
|
|
25399-7
|
Endomysium
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
25400-3
|
Entamoeba
histolytica
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
25401-1
|
Estradiol
(E2)
[Moles/time]
in
24
hour
Urine
|
|
25402-9
|
Estrogen
[Moles/time]
in
24
hour
Urine
|
|
25403-7
|
Estrone
(E1)
[Moles/volume]
in
Urine
|
|
25404-5
|
Ethambutol
[Presence]
in
Serum
or
Plasma
|
|
25406-0
|
Fasciola
sp
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
25407-8
|
Fasciola
sp
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
25409-4
|
Filaria
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
25410-2
|
Filaria
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
25412-8
|
Flunitrazepam
[Moles/volume]
in
Serum
or
Plasma
|
|
25413-6
|
Fluoride
[Moles/time]
in
24
hour
Urine
|
|
25415-1
|
Folate
[Moles/volume]
in
Blood
|
|
25416-9
|
Herpes
virus
6
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
25417-7
|
Herpes
virus
6
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
25418-5
|
Mumps
virus
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
25419-3
|
Mumps
virus
IgM
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
25420-1
|
Rubella
virus
IgM
Ab
[Presence]
in
Serum
by
Latex
agglutination
|
|
25421-9
|
Measles
virus
IgM
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
25422-7
|
Schistosoma
sp
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
25423-5
|
Trichinella
spiralis
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
25424-3
|
Trypanosoma
sp
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
25425-0
|
Gabapentin
[Moles/volume]
in
Serum
or
Plasma
|
|
25426-8
|
Galactose
[Moles/volume]
in
Serum
or
Plasma
|
|
25428-4
|
Glucose
[Presence]
in
Urine
by
Test
strip
|
|
25432-6
|
Haemophilus
influenzae
Ab
[Mass/volume]
in
Serum
|
|
25433-4
|
Free
Hemoglobin
[Moles/volume]
in
Plasma
|
|
25435-9
|
Herpes
simplex
virus
IgM
Ab
[Presence]
in
Serum
|
|
25439-1
|
Histamine
[Moles/time]
in
24
hour
Urine
|
|
25447-4
|
Insulin
Free
[Moles/volume]
in
Serum
or
Plasma
|
|
25448-2
|
Iodine
[Moles/volume]
in
Serum
or
Plasma
|
|
25449-0
|
Iodine
[Moles/time]
in
24
hour
Urine
|
|
25451-6
|
Isoniazid
[Moles/volume]
in
Serum
or
Plasma
|
|
25453-2
|
Lactalbumin
alpha
IgA
Ab
[Units/volume]
in
Serum
|
|
25455-7
|
Lactoglobulin
IgA
Ab
[Units/volume]
in
Serum
|
|
25458-1
|
Lamotrigine
[Moles/volume]
in
Serum
or
Plasma
|
|
25459-9
|
Lead
[Moles/volume]
in
Serum
or
Plasma
|
|
25461-5
|
Lithium
[Moles/volume]
in
Blood
|
|
25462-3
|
Lithium
[Moles/volume]
in
Red
Blood
Cells
|
|
25463-1
|
Lithium
[Moles/volume]
in
Urine
|
|
25466-4
|
Manganese
[Moles/volume]
in
Blood
|
|
25467-2
|
Manganese
[Moles/volume]
in
Serum
or
Plasma
|
|
25468-0
|
Mephenytoin
[Moles/volume]
in
Serum
or
Plasma
|
|
25469-8
|
Meprobamate
[Moles/volume]
in
Serum
or
Plasma
|
|
25470-6
|
Mercury
[Moles/volume]
in
Saliva
(oral
fluid)
|
|
25471-4
|
Mercury
[Moles/time]
in
24
hour
Urine
|
|
25472-2
|
Mesoridazine
[Moles/volume]
in
Serum
or
Plasma
|
|
25473-0
|
Metanephrine
[Moles/volume]
in
Serum
or
Plasma
|
|
25474-8
|
Metanephrines
[Moles/volume]
in
Serum
or
Plasma
|
|
25475-5
|
Methaqualone
[Moles/volume]
in
Serum
or
Plasma
|
|
25477-1
|
Methionine
sulfoxide
[Moles/time]
in
24
hour
Urine
|
|
25478-9
|
Methyprylon
[Moles/volume]
in
Serum
or
Plasma
|
|
25479-7
|
Saccharopolyspora
rectivirgula
IgG
Ab
[Units/volume]
in
Serum
|
|
25481-3
|
Molybdenum
[Moles/volume]
in
Serum
or
Plasma
|
|
25484-7
|
Nefazodone
[Moles/volume]
in
Serum
or
Plasma
|
|
25486-2
|
Nickel
[Moles/volume]
in
Serum
or
Plasma
|
|
25487-0
|
Nickel
[Moles/time]
in
24
hour
Urine
|
|
25488-8
|
Nicotinamide
[Moles/volume]
in
Serum
or
Plasma
|
|
25489-6
|
Normetanephrine
[Moles/volume]
in
Serum
or
Plasma
|
|
25492-0
|
Oxipurinol
[Moles/volume]
in
Serum
or
Plasma
|
|
25498-7
|
Adenosine
monophosphate.cyclic
[Moles/volume]
in
Serum
or
Plasma
|
|
25499-5
|
Adrenal
cortex
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
25500-0
|
Phenylbutazone
[Moles/volume]
in
Serum
or
Plasma
|
|
25501-8
|
Phosphate
[Moles/volume]
in
Body
fluid
|
|
25505-9
|
Pituitary
glucoprotein
hormone.alpha
subunit
[Units/volume]
in
Serum
|
|
25506-7
|
Potassium
[Moles/mass]
in
Stool
|
|
25507-5
|
Pregnenolone
[Moles/volume]
in
Serum
or
Plasma
|
|
2551-0
|
Lactoferrin
[Mass/volume]
in
Serum
|
|
25511-7
|
Propafenone
[Moles/volume]
in
Serum
or
Plasma
|
|
25514-1
|
Rubella
virus
IgG
Ab
[Presence]
in
Serum
|